ID,Probe_Id,Definition,Ontology_Component,Ontology_Process,Ontology_Function,Chromosome,Probe_Coordinates,Cytoband,Probe_Chr_Orientation,RefSeq_ID,Entrez_Gene_ID,Symbol,logFC,AveExpr,t,P.Value,adj.P.Val,B
FABP4,ILMN_1773006,"Homo sapiens fatty acid binding protein 4, adipocyte (FABP4), mRNA.",soluble fraction [goid 5625] [pmid 2481498] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS],transport [goid 6810] [evidence IEA],fatty acid binding [goid 5504] [pmid 2481498] [evidence TAS],8,82554256-82554305,8q21.13b,-,NM_001442.1,2167,FABP4,-5.492971661835364,8.293070522148788,-45.99881551452553,2.1072821371858315e-97,4.216250100081412e-93,211.65935744667988
TCF21,ILMN_1719351,"Homo sapiens transcription factor 21 (TCF21), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],"mesoderm development [goid 7498] [pmid 9507058] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [evidence NR ]; DNA binding [goid 3677] [evidence IEA],6,134258098-134258147,6q23.2d,+,NM_198392.1,6943,TCF21,-3.823608210351252,7.889784211150929,-39.64129558025739,2.0174001667986935e-87,2.018207126865413e-83,188.9823607253416
AGER,ILMN_1690829,"Homo sapiens advanced glycosylation end product-specific receptor (AGER), transcript variant 1, mRNA.",plasma membrane [goid 5886] [pmid 1378843] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 1378843] [evidence TAS]; plasma membrane [goid 5886] [pmid 1378843] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 1378843] [evidence TAS]; plasma membrane [goid 5886] [pmid 1378843] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 1378843] [evidence TAS],cell surface receptor linked signal transduction [goid 7166] [pmid 10835680] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; inflammatory response [goid 6954] [pmid 10399917] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 10835680] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; inflammatory response [goid 6954] [pmid 10399917] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 10835680] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; inflammatory response [goid 6954] [pmid 10399917] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 1378843] [evidence TAS]; protein binding [goid 5515] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 1378843] [evidence TAS]; protein binding [goid 5515] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 1378843] [evidence TAS]; protein binding [goid 5515] [evidence IEA],6,32258064-32258113,6p21.32b,-,NM_001136.3,177,AGER,-4.638772508904787,8.127618465662156,-38.09724726596407,8.425680482423559e-85,5.619367169744352e-81,183.01077091861296
ADH1B,ILMN_1811598,"Homo sapiens alcohol dehydrogenase IB (class I), beta polypeptide (ADH1B), mRNA.",,ethanol oxidation [goid 6069] [pmid 2398055] [evidence TAS],"metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 9982] [evidence IDA]; electron carrier activity [goid 9055] [pmid 2398055] [evidence TAS]; alcohol dehydrogenase activity, zinc-dependent [goid 4024] [pmid 9982] [evidence TAS]",4,100446633-100446682,4q23b,-,NM_000668.3,125,ADH1B,-4.221971526427302,7.82278683753539,-37.468167318525616,1.041514556994756e-83,5.2096558140877694e-80,180.52064887921475
LOC401286,ILMN_1784493,"Homo sapiens hypothetical gene supported by AK127120 (LOC401286), mRNA.",,,,6,167810570-167810619,6q27d,-,NM_001023565.1,401286,LOC401286,-6.943095359116975,8.506568844519593,-36.548045588018624,4.3772990612739305e-82,1.751619992359376e-78,176.81675048919655
FMO2,ILMN_1732158,"Homo sapiens flavin containing monooxygenase 2 (FMO2), mRNA.",microsome [goid 5792] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],electron transport [goid 6118] [evidence IEA],dimethylaniline monooxygenase (N-oxide-forming) activity [goid 4499] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; monooxygenase activity [goid 4497] [pmid 9804831] [evidence TAS],1,169448029-169448078,1q24.3a,+,NM_001460.2,2327,FMO2,-3.5608719140085494,9.878092160339977,-36.45937436197636,6.300043259692978e-82,2.1008544256656182e-78,176.4558632400077
CLEC3B,ILMN_1682176,"Homo sapiens C-type lectin domain family 3, member B (CLEC3B), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],skeletal development [goid 1501] [pmid 7798325] [evidence TAS],sugar binding [goid 5529] [evidence IEA],3,45052268-45052317,3p21.31k,+,NM_003278.1,7123,CLEC3B,-4.5380606722087835,9.59097769139925,-36.37190164458017,9.028927638337153e-82,2.5807254883978537e-78,176.09916565557427
ITLN2,ILMN_2118129,"Homo sapiens intelectin 2 (ITLN2), mRNA.",,,sugar binding [goid 5529] [evidence IEA],1,159181495-159181544,1q23.3a,-,NM_080878.2,142683,ITLN2,-5.41581117556205,8.412388036441342,-36.17694987630564,2.0184529051494324e-81,5.04815071577873e-78,175.3017187356379
CAV1,ILMN_1687583,"Homo sapiens caveolin 1, caveolae protein, 22kDa (CAV1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; lipid raft [goid 45121] [pmid 11294831] [evidence IDA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 11294831] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 1360410] [evidence TAS]; caveolar membrane [goid 16599] [pmid 15219854] [evidence IDA]; Golgi membrane [goid 139] [pmid 11294831] [evidence IDA],cholesterol homeostasis [goid 42632] [pmid 11294831] [evidence TAS]; cholesterol transport [goid 30301] [pmid 11294831] [evidence TAS],cholesterol binding [goid 15485] [pmid 11294831] [evidence TAS]; structural molecule activity [goid 5198] [pmid 11865038] [evidence IDA]; protein binding [goid 5515] [pmid 10212252] [evidence IPI],7,115987772-115987821,7q31.2b,+,NM_001753.3,857,CAV1,-4.08360268961024,10.5681006976624,-36.11772309973002,2.578993148353217e-81,5.733388323583463e-78,175.05877475212404
STX11,ILMN_1720771,"Homo sapiens syntaxin 11 (STX11), mRNA.",membrane [goid 16020] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA],intracellular protein transport [goid 6886] [evidence IEA]; membrane fusion [goid 6944] [pmid 9553086] [evidence TAS],protein transporter activity [goid 8565] [evidence IEA]; protein binding [goid 5515] [pmid 16169070] [evidence IPI]; SNAP receptor activity [goid 5484] [pmid 9553086] [evidence TAS],6,144550749-144550798,6q24.2b,+,NM_003764.2,8676,STX11,-3.330843743902501,8.660843172236355,-35.06172632371339,2.1478380470767882e-79,4.2973943645912375e-76,170.6733319757739
FAM107A,ILMN_1743445,"Homo sapiens family with sequence similarity 107, member A (FAM107A), mRNA.",nucleus [goid 5634] [pmid 10564580] [evidence IDA],regulation of cell growth [goid 1558] [pmid 10564580] [evidence IDA],molecular function unknown [goid 5554] [evidence ND ],3,58524932-58524981,3p14.2d,-,NM_007177.1,11170,FAM107A,-4.966735421354172,9.389986808174605,-34.94568302276245,3.513449879923528e-79,6.390645927046359e-76,170.1851140541532
XLKD1,ILMN_1808114,"Homo sapiens extracellular link domain containing 1 (XLKD1), mRNA.",membrane fraction [goid 5624] [pmid 10037799] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 10037799] [evidence TAS],cell-matrix adhesion [goid 7160] [pmid 10037799] [evidence TAS]; morphogenesis [goid 9653] [pmid 10037799] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; response to wounding [goid 9611] [pmid 10037799] [evidence TAS]; cell motility [goid 6928] [pmid 10037799] [evidence TAS],hyaluronic acid binding [goid 5540] [evidence IEA]; receptor activity [goid 4872] [pmid 10037799] [evidence TAS],11,10536730-10536779,11p15.4a,-,NM_006691.2,10894,XLKD1,-4.003683397336625,7.25854574106218,-34.80228864249004,6.465277092041242e-79,1.0779772004796764e-75,169.580075060179
LOC653463,ILMN_1766832,"PREDICTED: Homo sapiens similar to hypothetical gene supported by AK127120 (LOC653463), mRNA.",,,,6,167810570-167810619,,-,XM_376558.2,653463,LOC653463,-6.587043788647642,8.705460169558354,-33.8587954558821,3.7503136846213885e-77,5.772021246300365e-74,165.55021617847348
PECAM1,ILMN_1689518,"Homo sapiens platelet/endothelial cell adhesion molecule (CD31 antigen) (PECAM1), mRNA.",intercellular junction [goid 5911] [evidence NR ]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 1690453] [evidence TAS],signal transduction [goid 7165] [pmid 7994021] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; cell recognition [goid 8037] [pmid 1690453] [evidence TAS]; cell motility [goid 6928] [evidence NR ],protein binding [goid 5515] [evidence IEA],17,59754528-59754577,17q23.3b,-,NM_000442.2,5175,PECAM1,-2.525257276647352,10.502220763962486,-33.44190105364758,2.317386028008079e-76,3.311875689170403e-73,163.74208313581428
CLEC1A,ILMN_1691339,"Homo sapiens C-type lectin domain family 1, member A (CLEC1A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,sugar binding [goid 5529] [evidence IEA],12,10114650-10114699,12p13.2c,-,NM_016511.2,51267,CLEC1A,-2.716031625548945,7.448678450714152,-33.38418943927035,2.9858196790266825e-76,3.982685342531057e-73,163.49043073278565
ETV4,ILMN_1753830,"Homo sapiens ets variant gene 4 (E1A enhancer binding protein, E1AF) (ETV4), mRNA.",nucleus [goid 5634] [evidence NAS]; nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]",transcriptional activator activity [goid 16563] [evidence NAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; transcriptional activator activity [goid 16563] [evidence NAS]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA],17,38961026-38961075,17q21.31b,-,NM_001986.1,2118,ETV4,3.502593002383403,6.988348947008061,32.863546249311895,2.981287215970706e-75,3.728099663571368e-72,161.20516952625
JAM2,ILMN_1672350,"Homo sapiens junctional adhesion molecule 2 (JAM2), mRNA.",integral to plasma membrane [goid 5887] [pmid 10779521] [evidence NAS]; membrane [goid 16020] [evidence IEA]; tight junction [goid 5923] [evidence IEA],cell-cell adhesion [goid 16337] [pmid 10779521] [evidence NAS],,21,26000188-26000237,21q21.3a,+,NM_021219.2,58494,JAM2,-2.8513556455077556,8.074721238187081,-32.76998122605629,4.5208976075367815e-75,5.320830548917407e-72,160.79160255189234
RHOJ,ILMN_1678215,"Homo sapiens ras homolog gene family, member J (RHOJ), mRNA.",intracellular [goid 5622] [evidence IEA]; membrane [goid 16020] [evidence IEA]; intracellular [goid 5622] [evidence IEA]; membrane [goid 16020] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 10967094] [evidence IMP]; regulation of cell shape [goid 8360] [evidence IEA]; small GTPase mediated signal transduction [goid 7264] [evidence IEA]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 10967094] [evidence IMP]; regulation of cell shape [goid 8360] [evidence IEA],protein binding [goid 5515] [evidence ISS]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTPase activity [goid 3924] [pmid 10967094] [evidence NAS]; protein binding [goid 5515] [evidence ISS]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTPase activity [goid 3924] [pmid 10967094] [evidence NAS],14,62827799-62827848,14q23.2b,+,NM_020663.2,57381,RHOJ,-2.4946150062306955,7.233030907915574,-32.4378368387583,1.9960543735767697e-74,2.2187253281402227e-71,159.31632691556194
PLAC9,ILMN_1790859,"Homo sapiens placenta-specific 9 (PLAC9), mRNA.",,,,10,81891873-81891915:81893959-81893965,10q22.3f,+,NM_001012973.1,219348,PLAC9,-3.7428216023620537,9.694239200249001,-31.962260015199316,1.7061514276065483e-73,1.7966672507132535e-70,157.18432016410307
LDB2,ILMN_1800697,"Homo sapiens LIM domain binding 2 (LDB2), mRNA.",nucleus [goid 5634] [evidence IEA],development [goid 7275] [evidence IEA],transcription cofactor activity [goid 3712] [pmid 9880598] [evidence TAS],4,16112426-16112475,4p15.32c,-,NM_001290.2,9079,LDB2,-2.9001142982471304,10.480645948008291,-31.49020978552086,1.4684360243954837e-72,1.4690233988052418e-69,155.0449224586819
SPOCK2,ILMN_1656287,"Homo sapiens sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 (SPOCK2), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10386950] [evidence NAS],extracellular matrix organization and biogenesis [goid 30198] [pmid 10386950] [evidence NAS]; synaptogenesis [goid 7416] [pmid 10386950] [evidence NAS]; regulation of cell differentiation [goid 45595] [pmid 10386950] [evidence NAS],calcium ion binding [goid 5509] [pmid 10386950] [evidence IDA],10,73488877-73488926,10q22.1e,-,NM_014767.1,9806,SPOCK2,-3.236826273338222,11.30493219226556,-31.347130005116917,2.83255561542554e-72,2.698751083496867e-69,154.39184697001747
RGC32,ILMN_1658494,"Homo sapiens response gene to complement 32 (RGC32), mRNA.",cytoplasm [goid 5737] [pmid 9756947] [evidence TAS],,,13,40942716-40942765,13q14.11b,+,NM_014059.1,28984,RGC32,-2.822052552374833,12.68030894002329,-30.998992419567998,1.4134800966757398e-71,1.285495898831282e-68,152.79373860421035
C2orf32,ILMN_2182148,"Homo sapiens chromosome 2 open reading frame 32 (C2orf32), mRNA.",,,protein binding [goid 5515] [pmid 16696853] [evidence IPI],2,68374157-68374206,2p14a,-,NM_015463.1,25927,C2orf32,-2.537773625854233,6.8163338183436855,-30.38768816290928,2.4521869483237912e-70,2.1331894113940182e-67,149.95613230587387
MMRN1,ILMN_1660114,"Homo sapiens multimerin 1 (MMRN1), mRNA.",,blood coagulation [goid 7596] [pmid 9189649] [evidence TAS]; cell adhesion [goid 7155] [pmid 9189649] [evidence TAS],,4,91094532-91094581,4q22.1d,+,NM_007351.2,22915,MMRN1,-3.710862674330505,7.615698080627529,-30.349794965831173,2.930499727591112e-70,2.443059939568457e-67,149.77890386267168
EDG1,ILMN_1653504,"Homo sapiens endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 (EDG1), mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; plasma membrane [goid 5886] [pmid 8626678] [evidence TAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8626678] [evidence TAS]; cell adhesion [goid 7155] [pmid 10555146] [evidence TAS],lysosphingolipid and lysophosphatidic acid receptor activity [goid 1619] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],1,101478843-101478892,1p21.2a,+,NM_001400.2,1901,EDG1,-2.7688913348950113,7.990456491654652,-30.2319547804733,5.105416229234033e-70,4.0859667165805817e-67,149.22675745758573
FHL1,ILMN_1805842,"Homo sapiens four and a half LIM domains 1 (FHL1), mRNA.",nucleus [goid 5634] [evidence IEA],cell differentiation [goid 30154] [evidence IEA]; cell growth [goid 16049] [evidence NAS]; muscle development [goid 7517] [pmid 7626119] [evidence NAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],X,135120766-135120815,Xq26.3b,+,NM_001449.3,2273,FHL1,-3.3469359792796256,8.824419009460764,-30.080192012972518,1.0458764333634036e-69,7.889192505496219e-67,148.5134246181016
TEK,ILMN_1751576,"Homo sapiens TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal) (TEK), mRNA.",integral to plasma membrane [goid 5887] [pmid 8382358] [evidence TAS],cell-cell signaling [goid 7267] [pmid 8980225] [evidence TAS]; signal transduction [goid 7165] [pmid 8382358] [evidence TAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 8980225] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; kinase activity [goid 16301] [evidence IEA]; transmembrane receptor protein tyrosine kinase activity [goid 4714] [pmid 8382358] [evidence TAS]; receptor activity [goid 4872] [pmid 10766762] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],9,27219803-27219852,9p21.2a,+,NM_000459.1,7010,TEK,-3.5563509882320306,8.762183409679885,-30.076440658313683,1.0646151421851156e-69,7.889192505496219e-67,148.49576003710305
GIMAP6,ILMN_1757785,"Homo sapiens GTPase, IMAP family member 6 (GIMAP6), transcript variant 1, mRNA.",,,GTP binding [goid 5525] [evidence IEA],7,149956330-149956379,7q36.1c,-,NM_024711.3,474344,GIMAP6,-1.4889135188655853,6.970243920412235,-30.027151083617316,1.3445798759220432e-69,9.607983627660086e-67,148.26351879208767
CA4,ILMN_1695157,"Homo sapiens carbonic anhydrase IV (CA4), mRNA.",membrane fraction [goid 5624] [pmid 6811592] [evidence TAS]; membrane [goid 16020] [evidence IEA],visual perception [goid 7601] [evidence IEA]; one-carbon compound metabolism [goid 6730] [evidence IEA],carbonate dehydratase activity [goid 4089] [pmid 1311094] [evidence TAS]; lyase activity [goid 16829] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],17,55591584-55591633,17q23.1a,+,NM_000717.2,762,CA4,-5.2961465062118975,9.153886050533133,-29.933371674639456,2.0980553890427852e-69,1.4475135249644153e-66,147.82091232231826
ABCA8,ILMN_1796801,"Homo sapiens ATP-binding cassette, sub-family A (ABC1), member 8 (ABCA8), mRNA.",,,ATPase activity [goid 16887] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],17,64375585-64375634,17q24.2c,-,NM_007168.2,10351,ABCA8,-1.8802387087360364,6.6827520855032905,-29.90190455968297,2.436392257446133e-69,1.6249112095660744e-66,147.67218086025326
MFAP4,ILMN_1766914,"Homo sapiens microfibrillar-associated protein 4 (MFAP4), mRNA.",microfibril [goid 1527] [pmid 7633408] [evidence NAS]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],cell adhesion [goid 7155] [evidence NAS],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],17,19227463-19227512,17p11.2e,-,NM_002404.1,4239,MFAP4,-3.350147231669917,11.747184202302023,-29.18418729860773,7.594565483544062e-68,4.901679554669341e-65,144.2499157273121
CDO1,ILMN_1753931,"Homo sapiens cysteine dioxygenase, type I (CDO1), mRNA.",,L-cysteine metabolism [goid 46439] [evidence IEA],electron transporter activity [goid 5489] [evidence NR ]; cysteine dioxygenase activity [goid 17172] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA],5,115169008-115169028:115169029-115169057,5q22.3b,-,NM_001801.2,1036,CDO1,-2.906489233183459,6.783591636802163,-29.14776158755038,9.056764614185093e-68,5.66274207501923e-65,144.07468778191296
CAV2,ILMN_1658835,"Homo sapiens caveolin 2 (CAV2), transcript variant 1, mRNA.",perinuclear region [goid 48471] [pmid 8552590] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 8552590] [evidence IDA]; caveolar membrane [goid 16599] [pmid 8552590] [evidence NAS]; lipid raft [goid 45121] [pmid 11294831] [evidence IDA]; perinuclear region [goid 48471] [pmid 8552590] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 8552590] [evidence IDA]; caveolar membrane [goid 16599] [pmid 8552590] [evidence NAS]; lipid raft [goid 45121] [pmid 11294831] [evidence IDA],,protein binding [goid 5515] [pmid 10212252] [evidence IPI]; protein homodimerization activity [goid 42803] [pmid 8552590] [evidence IDA]; protein binding [goid 5515] [pmid 10212252] [evidence IPI]; protein homodimerization activity [goid 42803] [pmid 8552590] [evidence IDA],7,115935309-115935358,7q31.2b,+,NM_001233.3,858,CAV2,-2.955575114329635,8.953489195242543,-28.450921952244386,2.7058848591575623e-66,1.6405861897583183e-63,140.69344778761214
EMCN,ILMN_1685917,"Homo sapiens endomucin (EMCN), mRNA.",plasma membrane [goid 5886] [pmid 11418125] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA]; external side of plasma membrane [goid 9897] [pmid 15249540] [evidence IC ]; membrane [goid 16020] [evidence IEA],angiogenesis [goid 1525] [pmid 11594763] [evidence IEP]; cell-cell adhesion [goid 16337] [pmid 15249540] [evidence IDA]; regulation of cell adhesion [goid 30155] [pmid 11418125] [evidence IMP],carbohydrate binding [goid 30246] [pmid 15249540] [evidence IDA],4,101556132-101556139:101557297-101557321:101561462-101561478,4q23c,-,NM_016242.2,51705,EMCN,-3.329699937355876,7.143416699065482,-28.36918532641291,4.0450200607881783e-66,2.3803753345955845e-63,140.29319535164743
SRPX,ILMN_1709486,"Homo sapiens sushi-repeat-containing protein, X-linked (SRPX), mRNA.",membrane [goid 16020] [pmid 8634708] [evidence TAS]; cell surface [goid 9986] [pmid 12493773] [evidence IEP],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],X,37893885-37893907:37893908-37893934,Xp11.4e,-,NM_006307.2,8406,SRPX,-3.236466162625465,8.923789916226827,-28.303148533620618,5.600594384010514e-66,3.2016197838652104e-63,139.96925932880453
MCEMP1,ILMN_1762713,"Homo sapiens mast cell-expressed membrane protein 1 (MCEMP1), mRNA.",,,,19,7650532-7650581,19p13.2e,+,NM_174918.1,199675,MCEMP1,-4.792726379236692,10.101499008337143,-28.07196744289972,1.7564949268949278e-65,9.762208471476033e-63,138.83124614731682
C20orf160,ILMN_1748206,"Homo sapiens chromosome 20 open reading frame 160 (C20orf160), mRNA.",,,,20,30083460-30083509,20q11.21b,+,NM_080625.2,140706,C20orf160,-2.8168882883058233,8.025252437711758,-27.936841507281446,3.43584565451299e-65,1.8579567528512407e-62,138.1631961234294
CD36,ILMN_1665132,"Homo sapiens CD36 molecule (thrombospondin receptor) (CD36), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 2468669] [evidence TAS]; membrane fraction [goid 5624] [pmid 2468669] [evidence TAS],fatty acid metabolism [goid 6631] [evidence NR ]; lipid metabolism [goid 6629] [pmid 7518447] [evidence NAS]; cell adhesion [goid 7155] [pmid 2468670] [evidence TAS]; blood coagulation [goid 7596] [pmid 2468670] [evidence TAS]; transport [goid 6810] [evidence IEA],protein binding [goid 5515] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],7,80069574-80069623,7q21.11c,+,NM_001001547.1,948,CD36,-3.2248388483125403,7.468344761500495,-27.92724285198841,3.6038521902889375e-65,1.8975230164026595e-62,138.11566021632078
HBB,ILMN_2100437,"Homo sapiens hemoglobin, beta (HBB), mRNA.",hemoglobin complex [goid 5833] [pmid 10588683] [evidence NAS],transport [goid 6810] [evidence IEA]; positive regulation of nitric oxide biosynthesis [goid 45429] [pmid 7965120] [evidence NAS]; oxygen transport [goid 15671] [pmid 11747442] [evidence NAS],hemoglobin binding [goid 30492] [pmid 1512262] [evidence IDA]; heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxygen transporter activity [goid 5344] [pmid 11747442] [evidence NAS]; iron ion binding [goid 5506] [evidence IEA]; selenium binding [goid 8430] [pmid 15780970] [evidence IDA]; oxygen binding [goid 19825] [pmid 11747442] [evidence IDA],11,5203383-5203403:5203404-5203432,11p15.4c,-,NM_000518.4,3043,HBB,-4.479145525706734,12.671138422297659,-27.884002858222036,4.469135835304047e-65,2.2927812767375224e-62,137.90138708241187
STX1A,ILMN_1760160,"Homo sapiens syntaxin 1A (brain) (STX1A), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],neurotransmitter transport [goid 6836] [evidence IEA]; regulation of insulin secretion [goid 50796] [pmid 15537656] [evidence TAS]; intracellular protein transport [goid 6886] [evidence IEA]; exocytosis [goid 6887] [evidence NR ],protein transporter activity [goid 8565] [evidence IEA]; protein binding [goid 5515] [pmid 10321247] [evidence IPI],7,72751878-72751927,7q11.23b,-,NM_004603.1,6804,STX1A,2.7308230285649584,7.218154167501352,27.699264883213967,1.1234720234477761e-64,5.619607061285776e-62,136.9834630556912
ANKRD47,ILMN_1755588,"Homo sapiens ankyrin repeat domain 47 (ANKRD47), mRNA.",,,,19,8295547-8295596,19p13.2d,-,NM_198471.1,256949,ANKRD47,-2.681865525812335,7.27115983569305,-27.633898701965936,1.5582094751554047e-64,7.604062238758375e-62,136.65771251776522
CYYR1,ILMN_1812902,"Homo sapiens cysteine/tyrosine-rich 1 (CYYR1), mRNA.",integral to membrane [goid 16021] [evidence NAS],biological process unknown [goid 4] [evidence ND ],molecular function unknown [goid 5554] [evidence ND ],21,26760663-26760712,21q21.3a,-,NM_052954.2,116159,CYYR1,-2.7903934646700854,8.393614604265245,-27.54580731700739,2.423372018431388e-64,1.1544482701136955e-61,136.21791565499313
COX7A1,ILMN_1662419,"Homo sapiens cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) (COX7A1), mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [pmid 9344674] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; mitochondrial electron transport chain [goid 5746] [evidence IEA],electron transport [goid 6118] [evidence IEA],electron carrier activity [goid 9055] [evidence IEA]; cytochrome-c oxidase activity [goid 4129] [pmid 1327965] [evidence TAS],19,41334414-41334463,19q13.12b,-,NM_001864.2,1346,COX7A1,-2.567954018716943,9.81668645185956,-27.282926472769038,9.101312629334083e-64,4.2348619322724726e-61,134.90003007077144
CRYAB,ILMN_1729216,"Homo sapiens crystallin, alpha B (CRYAB), mRNA.",nucleus [goid 5634] [evidence NR ]; cytoplasm [goid 5737] [pmid 11256614] [evidence IDA],visual perception [goid 7601] [evidence NR ]; muscle contraction [goid 6936] [pmid 9731540] [evidence TAS]; protein folding [goid 6457] [pmid 9731540] [evidence NAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 15609325] [evidence NAS],structural constituent of eye lens [goid 5212] [evidence IEA]; unfolded protein binding [goid 51082] [evidence NR ],11,111284752-111284801,11q23.1b,-,NM_001885.1,1410,CRYAB,-2.9946914695701112,9.019865924569544,-27.27627656311406,9.412107914619333e-64,4.279942162629628e-61,134.86658624786304
SYT15,ILMN_1747160,"Homo sapiens synaptotagmin XV (SYT15), transcript variant b, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,10,46375519-46375568,10q11.22a,-,NM_181519.2,83849,SYT15,-1.5314753582609644,6.924688502277493,-27.26077398365288,1.0178690088143679e-63,4.5256718063017496e-61,134.78860005095981
ADH1A,ILMN_1764309,"Homo sapiens alcohol dehydrogenase 1A (class I), alpha polypeptide (ADH1A), mRNA.",cytoplasm [goid 5737] [evidence NAS],alcohol metabolism [goid 6066] [pmid 2347582] [evidence NAS],"zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; alcohol dehydrogenase activity, zinc-dependent [goid 4024] [pmid 2935875] [evidence NAS]",4,100416746-100416795,4q23b,-,NM_000667.2,124,ADH1A,-4.5387283072606746,10.1786504621779,-27.150222632969456,1.7804994992723462e-63,7.744398691617631e-61,134.23163953615528
PYCR1,ILMN_1715178,"Homo sapiens pyrroline-5-carboxylate reductase 1 (PYCR1), transcript variant 1, mRNA.",,proline biosynthesis [goid 6561] [pmid 1730675] [evidence TAS]; amino acid biosynthesis [goid 8652] [evidence IEA]; electron transport [goid 6118] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; pyrroline-5-carboxylate reductase activity [goid 4735] [pmid 1730675] [evidence TAS],17,77484213-77484262,17q25.3g,-,NM_006907.2,5831,PYCR1,1.3576670715959516,6.1982973174697085,27.064050855408656,2.755937609944647e-63,1.1732085042504786e-60,133.7964942587706
ADAMTS8,ILMN_1672403,"Homo sapiens ADAM metallopeptidase with thrombospondin type 1 motif, 8 (ADAMTS8), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; extracellular matrix [goid 31012] [evidence IEA],negative regulation of cell proliferation [goid 8285] [pmid 10438512] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; low affinity phosphate transporter activity [goid 9673] [pmid 10610729] [evidence TAS]; heparin binding [goid 8201] [evidence IEA]; metalloendopeptidase activity [goid 4222] [evidence IEA]; integrin binding [goid 5178] [pmid 10438512] [evidence TAS]; zinc ion binding [goid 8270] [evidence IEA],11,129780216-129780265,11q24.3c,-,NM_007037.3,11095,ADAMTS8,-2.9544007641890557,7.145733431495395,-26.85994731165385,7.783382233233241e-63,3.244373160886056e-60,132.76228392994423
LTC4S,ILMN_1668247,"Homo sapiens leukotriene C4 synthase (LTC4S), mRNA.",integral to membrane [goid 16021] [pmid 8052639] [evidence TAS]; membrane fraction [goid 5624] [pmid 8052639] [evidence TAS]; membrane [goid 16020] [evidence IEA]; microsome [goid 5792] [pmid 1454853] [evidence TAS],leukotriene biosynthesis [goid 19370] [evidence IEA],enzyme activator activity [goid 8047] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; leukotriene-C4 synthase activity [goid 4464] [pmid 8052639] [evidence TAS]; glutathione transferase activity [goid 4364] [pmid 8052639] [evidence TAS],5,179153688-179153737,5q35.3e,+,NM_145867.1,4056,LTC4S,-1.7037701372578793,6.285379979234568,-26.788106161346875,1.1230175538484008e-62,4.585578615795674e-60,132.39707072161275
GHR,ILMN_1775814,"Homo sapiens growth hormone receptor (GHR), mRNA.",integral to plasma membrane [goid 5887] [pmid 2825030] [evidence TAS]; membrane [goid 16020] [evidence IEA],skeletal development [goid 1501] [pmid 9140387] [evidence TAS]; endocytosis [goid 6897] [evidence IEA]; growth [goid 40007] [pmid 9140387] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; growth hormone receptor activity [goid 4903] [pmid 9140387] [evidence TAS]; protein binding [goid 5515] [pmid 10866662] [evidence IPI],5,42757566-42757615,5p12c,+,NM_000163.2,2690,GHR,-2.5520276419310957,6.9725547759065085,-26.71254816327972,1.6524525064242047e-62,6.544461263645398e-60,132.01229330296198
MFNG,ILMN_1764577,"Homo sapiens MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (MFNG), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; extracellular space [goid 5615] [pmid 9187150] [evidence TAS],pattern specification [goid 7389] [pmid 9207795] [evidence TAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]",22,36195146-36195195,22q13.1a,-,NM_002405.2,4242,MFNG,-1.9314687666225883,9.586437498040826,-26.710697879493054,1.6681703540879413e-62,6.544461263645398e-60,132.002862158629
CDH5,ILMN_1719236,"Homo sapiens cadherin 5, type 2, VE-cadherin (vascular epithelium) (CDH5), mRNA.",membrane fraction [goid 5624] [pmid 9219219] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 9219219] [evidence TAS],homophilic cell adhesion [goid 7156] [pmid 9219219] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],16,64995823-64995872,16q21e,+,NM_001795.2,1003,CDH5,-2.850928164218116,9.8221484435687465,-26.694557470120486,1.811809766339756e-62,6.971286500947277e-60,131.92057485054437
JARID1B,ILMN_1755727,"Homo sapiens jumonji, AT rich interactive domain 1B (JARID1B), mRNA.",nucleus [goid 5634] [pmid 12657635] [evidence TAS]; intracellular [goid 5622] [evidence IEA],"negative regulation of transcription, DNA-dependent [goid 45892] [pmid 12657635] [evidence IDA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]",transcriptional repressor activity [goid 16564] [pmid 12657635] [evidence IDA]; DNA binding [goid 3677] [pmid 15640446] [evidence IDA]; zinc ion binding [goid 8270] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein binding [goid 5515] [pmid 12657635] [evidence IPI]; protein kinase activity [goid 4672] [evidence IEA],1,200963341-200963390,1q32.1d,-,NM_006618.3,10765,JARID1B,1.3661885120093107,10.37847683505425,26.657579237807727,2.1895140212632645e-62,8.265621988195357e-60,131.73193351471963
SH3GL3,ILMN_1760990,"Homo sapiens SH3-domain GRB2-like 3 (SH3GL3), mRNA.",cytoplasm [goid 5737] [evidence IEA],signal transduction [goid 7165] [pmid 9169142] [evidence TAS]; central nervous system development [goid 7417] [pmid 9169142] [evidence TAS],,15,82078094-82078143,15q25.2b,+,NM_003027.2,6457,SH3GL3,-2.7095018467488723,6.24058756390693,-26.645812450309062,2.325575590301029e-62,8.533885955218396e-60,131.67187168242845
GRK5,ILMN_1728830,"Homo sapiens G protein-coupled receptor kinase 5 (GRK5), mRNA.",soluble fraction [goid 5625] [pmid 7685906] [evidence TAS]; cytoplasm [goid 5737] [pmid 7685906] [evidence TAS],"signal transduction [goid 7165] [evidence IEA]; G-protein signaling, coupled to cAMP nucleotide second messenger [goid 7188] [pmid 8626574] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [pmid 8288567] [evidence TAS]",nucleotide binding [goid 166] [evidence IEA]; signal transducer activity [goid 4871] [evidence IEA]; phospholipid binding [goid 5543] [pmid 9813065] [evidence TAS]; G-protein coupled receptor kinase activity [goid 4703] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein kinase C binding [goid 5080] [pmid 9813065] [evidence TAS]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],10,121204611-121204660,10q26.11c-q26.11d,+,NM_005308.2,2869,GRK5,-2.1607927020552697,8.322821691262094,-26.64411601861542,2.3458802855708305e-62,8.533885955218396e-60,131.6632111203229
GDF10,ILMN_1678191,"Homo sapiens growth differentiation factor 10 (GDF10), mRNA.",extracellular space [goid 5615] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],skeletal development [goid 1501] [pmid 8670277] [evidence TAS]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 8679252] [evidence TAS],cytokine activity [goid 5125] [evidence IEA]; growth factor activity [goid 8083] [pmid 8679252] [evidence TAS],10,48046174-48046223,10q11.22b,-,NM_004962.2,2662,GDF10,-3.1947422826614673,6.90580594921524,-26.583876730094644,3.1949494113238376e-62,1.1415097825315597e-59,131.3554546709191
CUGBP2,ILMN_1664170,"Homo sapiens CUG triplet repeat, RNA binding protein 2 (CUGBP2), transcript variant 1, mRNA.",,RNA processing [goid 6396] [pmid 9887331] [evidence TAS]; neuromuscular junction development [goid 7528] [evidence NR ],nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [pmid 9887331] [evidence TAS],10,11247080-11247129,10p14b-p14a,+,NM_001025076.1,10659,CUGBP2,-1.4218893828182102,6.701241647222087,-26.486784671072396,5.26128460830847e-62,1.846803200755015e-59,130.85849883129166
HIGD1B,ILMN_1675936,"Homo sapiens HIG1 domain family, member 1B (HIGD1B), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,17,40282207-40282256,17q21.31d,+,NM_016438.2,51751,HIGD1B,-3.368392928883705,8.634446194161118,-26.435015813891834,6.867459492800766e-62,2.3690367160682367e-59,130.59305918488857
FXYD1,ILMN_1764022,"Homo sapiens FXYD domain containing ion transport regulator 1 (phospholemman) (FXYD1), transcript variant a, mRNA.",plasma membrane [goid 5886] [pmid 9169143] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 9169143] [evidence TAS]; plasma membrane [goid 5886] [pmid 9169143] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 9169143] [evidence TAS],ion transport [goid 6811] [evidence IEA]; muscle contraction [goid 6936] [pmid 9169143] [evidence TAS]; chloride transport [goid 6821] [pmid 9169143] [evidence TAS]; ion transport [goid 6811] [evidence IEA]; muscle contraction [goid 6936] [pmid 9169143] [evidence TAS]; chloride transport [goid 6821] [pmid 9169143] [evidence TAS],ion channel activity [goid 5216] [evidence IEA]; chloride channel activity [goid 5254] [pmid 9169143] [evidence TAS]; ion channel activity [goid 5216] [evidence IEA]; chloride channel activity [goid 5254] [pmid 9169143] [evidence TAS],19,40322279-40322328,19q13.12a,+,NM_005031.3,5348,FXYD1,-2.2049766423755024,6.731716748119315,-26.31280358003917,1.2897184739133403e-61,4.373675801026799e-59,129.96513983739334
HBA1,ILMN_1667796,"Homo sapiens hemoglobin, alpha 1 (HBA1), mRNA.",hemoglobin complex [goid 5833] [evidence IEA],transport [goid 6810] [evidence IEA]; oxygen transport [goid 15671] [evidence IEA],heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxygen transporter activity [goid 5344] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [evidence IEA],16,167363-167410:167411-167412,16p13.3f,+,NM_000558.3,3039,HBA1,-4.015066795274791,12.995900484899844,-26.26838318206588,1.6224399399812383e-61,5.410296386524102e-59,129.73646122201342
HBA2,ILMN_2127842,"Homo sapiens hemoglobin, alpha 2 (HBA2), mRNA.",,,,16,163658-163707,16p13.3f,+,NM_000517.3,3040,HBA2,-4.202983699144058,12.42051218954453,-26.218203944819887,2.1032366712278183e-61,6.898616281627244e-59,129.47784726819938
PEBP4,ILMN_1734472,"Homo sapiens phosphatidylethanolamine-binding protein 4 (PEBP4), mRNA.",,,,8,22833642-22833691,8p21.3a,-,NM_144962.1,157310,PEBP4,-4.2969098273221435,8.530034401198218,-26.20094746857221,2.2997592354479412e-61,7.421545610135872e-59,129.3888399852005
MGC9712,ILMN_1815937,"Homo sapiens hypothetical protein MGC9712 (MGC9712), mRNA.",,transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; binding [goid 5488] [evidence IEA],7,1550141-1550190,7p22.3b,-,NM_152689.2,202915,MGC9712,2.750623801740235,6.596981546467056,26.168491394058076,2.720751498551026e-61,8.529260375932477e-59,129.22133638785084
PTPRB,ILMN_1672102,"Homo sapiens protein tyrosine phosphatase, receptor type, B (PTPRB), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 2170109] [evidence TAS]; membrane fraction [goid 5624] [evidence NR ],protein amino acid dephosphorylation [goid 6470] [pmid 2170109] [evidence TAS]; phosphate metabolism [goid 6796] [pmid 2170109] [evidence TAS],transmembrane receptor protein tyrosine phosphatase activity [goid 5001] [pmid 2170109] [evidence TAS]; protein tyrosine phosphatase activity [goid 4725] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],12,69204636-69204638:69212082-69212128,12q15d,-,NM_002837.2,5787,PTPRB,-2.8326781586734873,7.6979871276960194,-26.167958658699987,2.7282720114937948e-61,8.529260375932477e-59,129.21858590667912
AQP4,ILMN_1676649,"Homo sapiens aquaporin 4 (AQP4), transcript variant a, mRNA.",integral to membrane [goid 16021] [evidence IEA]; outer membrane [goid 19867] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7528931] [evidence TAS]; membrane [goid 16020] [pmid 8855281] [evidence NAS],transport [goid 6810] [pmid 7559426] [evidence TAS]; excretion [goid 7588] [pmid 7528931] [evidence TAS]; water transport [goid 6833] [pmid 8855281] [evidence NAS],transporter activity [goid 5215] [evidence IEA]; porin activity [goid 15288] [evidence IEA]; water channel activity [goid 15250] [evidence NR ]; water transporter activity [goid 5372] [pmid 8855281] [evidence NAS],18,22699622-22699651:22699652-22699671,18q11.2e,-,NM_001650.4,361,AQP4,-3.0260231939447797,7.6045052824561274,-26.1454553320215,3.0657691130731995e-61,9.436908986825935e-59,129.10237098242615
SPARCL1,ILMN_1795251,"Homo sapiens SPARC-like 1 (mast9, hevin) (SPARCL1), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],,calcium ion binding [goid 5509] [evidence IEA],4,88619685-88619734,4q22.1a,-,NM_004684.2,8404,SPARCL1,-2.7245520913454655,11.662733412301366,-26.078680244188234,4.335073474530115e-61,1.3141840920969474e-58,128.75715806012172
MME,ILMN_1678170,"Homo sapiens membrane metallo-endopeptidase (neutral endopeptidase, enkephalinase, CALLA, CD10) (MME), transcript variant 2a, mRNA.",integral to plasma membrane [goid 5887] [pmid 2521388] [evidence TAS]; plasma membrane [goid 5886] [pmid 1660144] [evidence TAS],cell-cell signaling [goid 7267] [pmid 2521388] [evidence TAS],neprilysin activity [goid 4245] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; metallopeptidase activity [goid 8237] [pmid 1660144] [evidence TAS]; zinc ion binding [goid 8270] [evidence IEA],3,156383599-156383648,3q25.2c-q25.31a,+,NM_007288.1,4311,MME,-3.6422492489041396,7.80341473573605,-25.935286052263997,9.138606908666964e-61,2.729033537740427e-58,128.01400081790644
TM6SF1,ILMN_1750961,"Homo sapiens transmembrane 6 superfamily member 1 (TM6SF1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence NAS],,,15,81587223-81587233:81596237-81596275,15q25.2b,+,NM_023003.1,53346,TM6SF1,-2.2103117845973994,7.253875558879345,-25.780002908526185,2.0551072195196524e-60,6.046850771786648e-58,127.20638909475142
SNCA,ILMN_1701933,"Homo sapiens synuclein, alpha (non A4 component of amyloid precursor) (SNCA), transcript variant NACP112, mRNA.",cytoplasm [goid 5737] [pmid 8248242] [evidence TAS],anti-apoptosis [goid 6916] [pmid 10818098] [evidence TAS]; central nervous system development [goid 7417] [pmid 9197268] [evidence TAS],protein binding [goid 5515] [pmid 11956199] [evidence IPI],4,90866610-90866659,4q22.1d,-,NM_007308.1,6622,SNCA,-2.247386934687807,6.616662294702517,-25.74147766550501,2.513909871690242e-60,7.289609958373675e-58,127.00556525147809
CCL14,ILMN_1740609,"Homo sapiens chemokine (C-C motif) ligand 14 (CCL14), transcript variant 2, mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 8551235] [evidence TAS],calcium ion homeostasis [goid 6874] [pmid 8551235] [evidence TAS]; immune response [goid 6955] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 8551235] [evidence TAS],signal transducer activity [goid 4871] [pmid 8551235] [evidence TAS]; chemokine activity [goid 8009] [evidence IEA],,,17q12b,,NM_032962.2,6358,CCL14,-3.8831755391528615,9.294421216294454,-25.73680967415176,2.57607782642035e-60,7.36316645014548e-58,126.98121962812698
C9orf19,ILMN_1652631,"Homo sapiens chromosome 9 open reading frame 19 (C9orf19), mRNA.",membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],,,9,36153798-36153847,9p13.3a,+,NM_022343.2,152007,C9orf19,-2.0837069758114115,11.74358558546615,-25.71288025753191,2.9198672383743e-60,8.22826812752014e-58,126.85637517031913
SVEP1,ILMN_2112638,"Homo sapiens sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 (SVEP1), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],,,9q31.3b,,NM_153366.2,79987,SVEP1,-2.7756366553449165,9.726688510213656,-25.705330569536436,3.0376223197707127e-60,8.441214913051725e-58,126.81697236125981
CFD,ILMN_1777190,"Homo sapiens complement factor D (adipsin) (CFD), mRNA.",,"complement activation, alternative pathway [goid 6957] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]",complement factor D activity [goid 3817] [pmid 1374388] [evidence TAS]; peptidase activity [goid 8233] [evidence IEA],19,814271-814320,19p13.3i,+,NM_001928.2,1675,CFD,-3.037857397397067,12.166758579083112,-25.665065503809213,3.751125639607193e-60,1.0220044362025992e-57,126.60670533372269
CLEC14A,ILMN_2142185,"Homo sapiens C-type lectin domain family 14, member A (CLEC14A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,sugar binding [goid 5529] [evidence IEA],14,37793276-37793325,14q21.1a,-,NM_175060.1,161198,CLEC14A,-2.705665517122945,10.372716231021704,-25.6636076101958,3.7799044521687493e-60,1.0220044362025992e-57,126.59908836849561
PPP1R14B,ILMN_1659888,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 14B (PPP1R14B), mRNA.",,,protein phosphatase inhibitor activity [goid 4864] [evidence IEA],11,63768736-63768785,11q13.1b,-,NM_138689.2,26472,PPP1R14B,1.7310127276808593,10.870640411248058,25.617045706967584,4.825564643770587e-60,1.2873319652341585e-57,126.35568171200873
C1orf162,ILMN_1754894,"Homo sapiens chromosome 1 open reading frame 162 (C1orf162), mRNA.",,,,1,111822501-111822550,1p13.2d,+,NM_174896.2,128346,C1orf162,-2.317645105647456,11.146344735064696,-25.531606949750817,7.559174531947124e-60,1.990052158357869e-57,125.90834803838854
ACADL,ILMN_1660890,"Homo sapiens acyl-Coenzyme A dehydrogenase, long chain (ACADL), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [evidence IEA],metabolism [goid 8152] [evidence IEA]; lipid metabolism [goid 6629] [evidence IEA]; fatty acid metabolism [goid 6631] [evidence IEA]; electron transport [goid 6118] [evidence IEA],acyl-CoA dehydrogenase activity [goid 3995] [evidence IEA]; long-chain-acyl-CoA dehydrogenase activity [goid 4466] [pmid 1945557] [evidence TAS]; FAD binding [goid 50660] [evidence IEA],2,210761312-210761361,2q34b,-,NM_001608.2,33,ACADL,-2.6661496659709902,6.467476186130596,-25.442434252383336,1.208736267112951e-59,3.140830549661808e-57,125.44050409845852
LIMS2,ILMN_1760493,"Homo sapiens LIM and senescent cell antigen-like domains 2 (LIMS2), mRNA.",,,metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],2,128112587-128112636,2q14.3e,-,NM_017980.2,55679,LIMS2,-2.31858651774254,7.867061805979823,-25.36276027058512,1.84005316478296e-59,4.7199722719201873e-57,125.0216640535402
HEG1,ILMN_1666122,"PREDICTED: Homo sapiens HEG homolog 1 (zebrafish) (HEG1), mRNA.",,,,3,126167785-126167834,3q21.2b,-,XM_087386.8,57493,HEG1,-2.275359866075447,8.85147588725673,-25.33322805544008,2.1506095440039e-59,5.446758956510131e-57,124.86621598001577
CPA3,ILMN_1766551,"Homo sapiens carboxypeptidase A3 (mast cell) (CPA3), mRNA.",secretory granule [goid 30141] [pmid 2594780] [evidence NAS],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; metallopeptidase activity [goid 8237] [evidence IEA]; carboxypeptidase activity [goid 4180] [evidence IEA]; carboxypeptidase A activity [goid 4182] [pmid 2594780] [evidence NAS],3,150097094-150097143,3q24f,+,NM_001870.1,1359,CPA3,-3.384057521850929,9.532056600087683,-25.32729774594015,2.219055329270877e-59,5.514742351177037e-57,124.83498772378323
C1QR1,ILMN_1704730,"Homo sapiens complement component 1, q subcomponent, receptor 1 (C1QR1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 9047234] [evidence IC ],macrophage activation [goid 42116] [pmid 9047234] [evidence NAS]; phagocytosis [goid 6909] [pmid 11781389] [evidence NAS]; cell-cell adhesion [goid 16337] [pmid 11994479] [evidence IDA],calcium ion binding [goid 5509] [evidence IEA]; complement component C1q binding [goid 1849] [pmid 11781389] [evidence IDA]; protein binding [goid 5515] [pmid 15819698] [evidence IPI]; receptor activity [goid 4872] [pmid 9047234] [evidence NAS]; sugar binding [goid 5529] [evidence IEA],20,23008359-23008408,20p11.21c,-,NM_012072.2,22918,C1QR1,-2.447680005505612,11.127880989429695,-25.326147899222054,2.2325776211782286e-59,5.514742351177037e-57,124.82893227310538
GDDR,ILMN_1813688,"Homo sapiens gastrokine 2 (GKN2), mRNA.",,,,2,69026019-69026068,2p14a,-,NM_182536.2,200504,GDDR,-5.042189298372001,9.083011449119265,-25.283898153989128,2.7912676613098534e-59,6.810693093596043e-57,124.60631842169946
PMP22,ILMN_1659312,"Homo sapiens peripheral myelin protein 22 (PMP22), transcript variant 1, mRNA.",membrane fraction [goid 5624] [evidence NR ]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA],mechanosensory behavior [goid 7638] [evidence IEA]; peripheral nervous system development [goid 7422] [pmid 8275092] [evidence TAS]; synaptic transmission [goid 7268] [pmid 8275092] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [evidence NR ],,17,15109233-15109282,17p12a,-,NM_000304.2,5376,PMP22,-2.435738775213559,8.535713154354164,-25.276102067060368,2.9087723543417295e-59,7.011893646466183e-57,124.5652166827158
RECK,ILMN_1688630,"Homo sapiens reversion-inducing-cysteine-rich protein with kazal motifs (RECK), mRNA.",membrane fraction [goid 5624] [pmid 9789069] [evidence TAS]; membrane [goid 16020] [evidence IEA]; membrane fraction [goid 5624] [pmid 9789069] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell cycle [goid 7049] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],metalloendopeptidase inhibitor activity [goid 8191] [pmid 9789069] [evidence TAS]; serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]; metalloendopeptidase inhibitor activity [goid 8191] [pmid 9789069] [evidence TAS]; serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA],9,36113685-36113734,9p13.3a,+,NM_021111.1,8434,RECK,-2.0677575694709462,7.210190859004238,-25.253189463811648,3.2836780631429558e-59,7.821408415162412e-57,124.44437557739303
CRBN,ILMN_1668582,"Homo sapiens cereblon (CRBN), mRNA.",,ATP-dependent proteolysis [goid 6510] [evidence IEA]; ATP-dependent proteolysis [goid 6510] [evidence IEA],ATP-dependent peptidase activity [goid 4176] [evidence IEA]; ATP-dependent peptidase activity [goid 4176] [evidence IEA],3,3167694-3167729:3169140-3169153,3p26.3a,-,NM_016302.2,51185,CRBN,-1.2418758706110857,9.408332918286446,-25.17656224506427,4.9277098420229285e-59,1.1599249237552324e-56,124.03977055311876
DCN,ILMN_1683194,"Homo sapiens decorin (DCN), transcript variant A1, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],,transferase activity [goid 16740] [evidence IEA],12,90100644-90100693,12q21.33c,-,NM_001920.3,1634,DCN,-3.3878725160390495,10.611308426390638,-25.02550411036195,1.0992037491872803e-58,2.5573103039231516e-56,123.2400216890743
IL33,ILMN_1809099,"Homo sapiens interleukin 33 (IL33), mRNA.",extracellular space [goid 5615] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],,cytokine activity [goid 5125] [evidence IEA]; cytokine activity [goid 5125] [evidence IEA],9,6247132-6247181,9p24.1b,+,NM_033439.2,90865,IL33,-3.5050244561961446,8.04764686137072,-24.9705317277816,1.4729253209776057e-58,3.3873896347264294e-56,122.94827636247456
MS4A7,ILMN_2331082,"Homo sapiens membrane-spanning 4-domains, subfamily A, member 7 (MS4A7), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],11,59919442-59919491,11q12.2a,+,NM_206938.1,58475,MS4A7,-2.5167466508901484,9.361997803241204,-24.92003654281275,1.9278526643984753e-58,4.383235921509624e-56,122.67996040937282
C14orf132,ILMN_1713744,"Homo sapiens chromosome 14 open reading frame 132 (C14orf132), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,14,95629766-95629815,14q32.2a,+,NM_020215.2,56967,C14orf132,-2.6048507452544793,9.110607001489262,-24.905976972153667,2.0779980030916308e-58,4.671526297287343e-56,122.60519559384221
CLDN18,ILMN_1662484,"Homo sapiens claudin 18 (CLDN18), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence ISS]; tight junction [goid 5923] [evidence ISS],calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA],3,139200523-139200572,3q22.3b,+,NM_001002026.2,51208,CLDN18,-3.7015971269960044,8.62684275802938,-24.894405809429138,2.210342363254859e-58,4.913836667111469e-56,122.54364493719828
HSPA12B,ILMN_1676897,"Homo sapiens heat shock 70kD protein 12B (HSPA12B), mRNA.",,,nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],20,3681581-3681630,20p13b,+,NM_052970.3,116835,HSPA12B,-2.5780246583648028,8.064811236102896,-24.852276122332704,2.7678930793538063e-58,6.085714805682522e-56,122.31940277343645
CHMP4B,ILMN_1771233,"Homo sapiens chromatin modifying protein 4B (CHMP4B), mRNA.",,protein transport [goid 15031] [evidence IEA],,20,31905553-31905602,20q11.22a,+,NM_176812.3,128866,CHMP4B,1.9759045868416312,9.572676078501857,24.847808314095637,2.8347501094508596e-58,6.164965238031826e-56,122.29560914403083
WNT3A,ILMN_1815700,"Homo sapiens wingless-type MMTV integration site family, member 3A (WNT3A), mRNA.",extracellular region [goid 5576] [evidence NAS]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],morphogenesis [goid 9653] [evidence NAS]; cell-cell signaling [goid 7267] [evidence NAS]; development [goid 7275] [evidence IEA]; frizzled-2 signaling pathway [goid 7223] [evidence IEA],extracellular matrix structural constituent [goid 5201] [evidence NAS]; signal transducer activity [goid 4871] [evidence IEA],1,226315482-226315531,1q42.13b,+,NM_033131.2,89780,WNT3A,-3.7363109331213282,7.1478200029039005,-24.806607767165072,3.5330672749440905e-58,7.601033337320576e-56,122.07607527671516
ABI3BP,ILMN_1673639,"Homo sapiens ABI gene family, member 3 (NESH) binding protein (ABI3BP), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,3,101950986-101951035,3q12.2a-q12.2b,-,NM_015429.2,25890,ABI3BP,-2.814636934119597,8.98327478603726,-24.76691786714434,4.368863788121674e-58,9.216763714002727e-56,121.8643903045052
FLJ22184,ILMN_1765636,"PREDICTED: Homo sapiens hypothetical protein FLJ22184 (FLJ22184), mRNA.",,,,,,19p13.2e,,XM_940456.1,80164,FLJ22184,2.3408317006386934,7.629212408543638,24.7666038745601,4.376212279239599e-58,9.216763714002727e-56,121.86271484919891
LOC641700,ILMN_1705630,"PREDICTED: Homo sapiens hypothetical protein LOC641700 (LOC641700), mRNA.",,,,5,138822451-138822483:138824748-138824764,5q31.2d,-,XM_930608.1,641700,LOC641700,-2.7550490008573556,6.382015297281483,-24.728240655995265,5.374196057808853e-58,1.1200720283816617e-55,121.65791710650194
VWF,ILMN_1752755,"Homo sapiens von Willebrand factor (VWF), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],response to wounding [goid 9611] [pmid 15029268] [evidence TAS]; cell adhesion [goid 7155] [pmid 10764791] [evidence TAS]; platelet activation [goid 30168] [pmid 12871509] [evidence NAS],serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; growth factor activity [goid 8083] [evidence IEA]; protein binding [goid 5515] [pmid 11943773] [evidence IPI],12,,12p13.31e,-,NM_000552.2,7450,VWF,-2.2370179216562107,13.225667960147945,-24.60314961285685,1.0513966885093518e-57,2.1686953550201145e-55,120.98885382424805
ZFHX1B,ILMN_1688698,"Homo sapiens zinc finger homeobox 1b (ZFHX1B), mRNA.",nucleus [goid 5634] [pmid 9853615] [evidence IC ],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription [goid 16481] [pmid 11592033] [evidence IC ]",metal ion binding [goid 46872] [evidence IEA]; phosphatase regulator activity [goid 19208] [pmid 11477103] [evidence NAS]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; SMAD binding [goid 46332] [evidence NAS]; transcriptional repressor activity [goid 16564] [pmid 11592033] [evidence ISS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],2,144862732-144862781,2q22.3a,-,NM_014795.2,9839,ZFHX1B,-2.046061462835241,7.389966357190083,-24.589331696669316,1.1324341241866397e-57,2.3120144853802332e-55,120.91482702280439
SCARA5,ILMN_1751062,"Homo sapiens scavenger receptor class A, member 5 (putative) (SCARA5), mRNA.",membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],scavenger receptor activity [goid 5044] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],8,27783863-27783912,8p21.1e-p21.1d,-,NM_173833.3,286133,SCARA5,-3.527217622695761,7.054737648080798,-24.552283100616496,1.382046144197012e-57,2.793129217484224e-55,120.71622830444326
MAMDC2,ILMN_1679391,"Homo sapiens MAM domain containing 2 (MAMDC2), mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 11256614] [evidence IDA],,receptor activity [goid 4872] [evidence IEA],9,72031386-72031435,9q21.11b-q21.11c,+,NM_153267.3,256691,MAMDC2,-3.599739419625098,9.246727963929214,-24.545941957352113,1.430002215676477e-57,2.8611484331254952e-55,120.68221941231033
NAP5,ILMN_1809490,"PREDICTED: Homo sapiens Nck-associated protein 5 (NAP5), mRNA.",,,,2,133146543-133146592,,-,XM_929894.1,344148,NAP5,-2.325001406591741,6.1301873133085705,-24.48972432070843,1.9353830896996562e-57,3.83397473848621e-55,120.38049185044827
LAMP3,ILMN_2170813,"Homo sapiens lysosomal-associated membrane protein 3 (LAMP3), mRNA.",lysosome [goid 5764] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; lysosome [goid 5764] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,3,184323144-184323193,3q27.1a,-,NM_014398.2,27074,LAMP3,-2.8418220815476865,10.2782304357483,-24.47898124695145,2.050701096024863e-57,4.022590934241712e-55,120.32278722407139
GRRP1,ILMN_1707055,"Homo sapiens glycine/arginine rich protein 1 (GRRP1), mRNA.",,,,1,26361282-26361298:26361299-26361331,1p36.11b,+,NM_024869.2,79927,GRRP1,-2.5075218234930476,7.3147429065944465,-24.41059528466121,2.965172142416021e-57,5.759918856840753e-55,119.9551238684125
MGC3101,ILMN_1757631,"Homo sapiens dysbindin (dystrobrevin binding protein 1) domain containing 1 (DBNDD1), transcript variant 2, mRNA.",cytoplasm [goid 5737] [evidence IEA],,protein binding [goid 5515] [evidence IEA],16,88599067-88599116,16q24.3b,-,NM_024043.2,79007,MGC3101,2.303527001098157,7.171355867732346,24.400996497342266,3.122832706564378e-57,6.0078496916288535e-55,119.90347092761549
TOP2A,ILMN_1686097,"Homo sapiens topoisomerase (DNA) II alpha 170kDa (TOP2A), mRNA.",chromosome [goid 5694] [pmid 9049244] [evidence IDA]; centriole [goid 5814] [pmid 9049244] [evidence IDA]; nucleus [goid 5634] [pmid 16611985] [evidence IDA]; nucleolus [goid 5730] [pmid 9049244] [evidence IDA]; protein complex [goid 43234] [pmid 16611985] [evidence IPI]; nucleoplasm [goid 5654] [pmid 9049244] [evidence IDA],DNA ligation [goid 6266] [pmid 15491148] [evidence IDA]; DNA topological change [goid 6265] [evidence IEA]; positive regulation of apoptosis [goid 43065] [pmid 16611985] [evidence IDA]; phosphoinositide-mediated signaling [goid 48015] [pmid 15504738] [evidence NAS]; DNA repair [goid 6281] [pmid 15504738] [evidence NAS]; chromosome segregation [goid 7059] [pmid 15965487] [evidence IMP]; DNA replication [goid 6260] [pmid 15504738] [evidence NAS]; apoptotic chromosome condensation [goid 30263] [pmid 10959840] [evidence IDA],DNA topoisomerase (ATP-hydrolyzing) activity [goid 3918] [pmid 16611985] [evidence IDA]; protein homodimerization activity [goid 42803] [pmid 10473615] [evidence IPI]; histone deacetylase binding [goid 42826] [pmid 11136718] [evidence IPI]; protein heterodimerization activity [goid 46982] [pmid 10473615] [evidence IPI]; ATP binding [goid 5524] [evidence IEA]; chromatin binding [goid 3682] [pmid 9049244] [evidence IDA]; DNA-dependent ATPase activity [goid 8094] [pmid 12079377] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; protein C-terminus binding [goid 8022] [pmid 15965487] [evidence IPI]; ubiquitin binding [goid 43130] [pmid 15965487] [evidence IMP]; protein kinase C binding [goid 5080] [pmid 16611985] [evidence IPI]; drug binding [goid 8144] [pmid 16914642] [evidence IDA],17,35798592-35798641,17q21.2a,-,NM_001067.2,7153,TOP2A,3.6013116708222164,8.036351834820065,24.356398018396003,3.973281066708204e-57,7.571181674542643e-55,119.6633260155864
IGSF9,ILMN_1693941,"Homo sapiens immunoglobulin superfamily, member 9 (IGSF9), mRNA.",,,,1,158163600-158163649,1q23.2c,-,NM_020789.2,57549,IGSF9,2.5439867363951993,6.418679319231923,24.259374473475333,6.71549111699565e-57,1.2675806251778204e-54,119.14002950743804
CENPF,ILMN_1664516,"Homo sapiens centromere protein F, 350/400ka (mitosin) (CENPF), mRNA.",kinetochore [goid 776] [pmid 7542657] [evidence IDA]; nuclear matrix [goid 16363] [pmid 7542657] [evidence IDA]; chromatin [goid 785] [pmid 9891037] [evidence NAS]; cytoplasm [goid 5737] [pmid 12974617] [evidence IDA]; spindle pole [goid 922] [pmid 7542657] [evidence IDA]; outer kinetochore of condensed chromosome [goid 940] [pmid 12974617] [evidence TAS],mitotic spindle checkpoint [goid 7094] [pmid 12974617] [evidence NAS]; cell proliferation [goid 8283] [pmid 15927522] [evidence NAS]; G2 phase of mitotic cell cycle [goid 85] [pmid 12154071] [evidence IMP]; response to drug [goid 42493] [pmid 12467231] [evidence NAS]; metaphase plate congression [goid 51310] [pmid 15870278] [evidence IDA]; cell division [goid 51301] [evidence IEA]; kinetochore assembly [goid 51382] [pmid 16252009] [evidence NAS]; mitosis [goid 7067] [evidence IEA]; negative regulation of transcription [goid 16481] [pmid 15677469] [evidence IDA],protein heterodimerization activity [goid 46982] [pmid 7642639] [evidence IDA]; protein C-terminus binding [goid 8022] [pmid 7642639] [evidence IPI]; transcription factor binding [goid 8134] [pmid 15677469] [evidence IPI]; chromatin binding [goid 3682] [pmid 9891037] [evidence NAS]; dynein binding [goid 45502] [pmid 12974617] [evidence IDA]; protein homodimerization activity [goid 42803] [pmid 7642639] [evidence IPI],1,212904364-212904413,1q41a,+,NM_016343.3,1063,CENPF,2.600006373472281,6.573345195309058,24.165789579374895,1.1153477920970387e-56,2.0855961331100515e-54,118.63415706286895
HSPB2,ILMN_1671046,"Homo sapiens heat shock 27kDa protein 2 (HSPB2), mRNA.",cytosol [goid 5829] [pmid 9490724] [evidence TAS],protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [pmid 9344664] [evidence NAS],enzyme activator activity [goid 8047] [pmid 9490724] [evidence TAS]; protein binding [goid 5515] [pmid 14594798] [evidence IPI],11,111289806-111289829:111289830-111289855,11q23.1b,+,NM_001541.2,3316,HSPB2,-2.097743132402763,7.654896047170743,-24.113766597029414,1.4794357406594263e-56,2.7407916943623893e-54,118.35247016428487
DPEP2,ILMN_1689160,"Homo sapiens dipeptidase 2 (DPEP2), mRNA.",membrane [goid 16020] [evidence IEA],,dipeptidyl-peptidase activity [goid 8239] [evidence IEA]; metallopeptidase activity [goid 8237] [evidence IEA]; membrane dipeptidase activity [goid 4237] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],16,66578893-66578909:66578910-66578942,16q22.1b,-,NM_022355.1,64174,DPEP2,-2.429255044121491,8.263121626794742,-24.01685674259391,2.506279746519524e-56,4.600517905354371e-54,117.82682616679956
PPAP2B,ILMN_1672608,"Homo sapiens phosphatidic acid phosphatase type 2B (PPAP2B), transcript variant 1, mRNA.",membrane [goid 16020] [pmid 9305923] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [pmid 9305923] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],germ cell migration [goid 8354] [pmid 9305923] [evidence TAS]; lipid metabolism [goid 6629] [pmid 9705349] [evidence NAS]; germ cell migration [goid 8354] [pmid 9305923] [evidence TAS]; lipid metabolism [goid 6629] [pmid 9705349] [evidence NAS],hydrolase activity [goid 16787] [evidence IEA]; phosphoprotein phosphatase activity [goid 4721] [pmid 9705349] [evidence TAS]; phosphatidate phosphatase activity [goid 8195] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; phosphoprotein phosphatase activity [goid 4721] [pmid 9705349] [evidence TAS]; phosphatidate phosphatase activity [goid 8195] [evidence IEA],1,56817352-56817401,1p32.2c,-,NM_003713.3,8613,PPAP2B,-1.8697560753616456,8.42958715896899,-23.977508348650513,3.1054813709291205e-56,5.648588297231804e-54,117.61306024879947
FLJ13909,ILMN_1656452,"Homo sapiens hypothetical protein FLJ13909 (FLJ13909), mRNA.",,,,16,2454788-2454837,16p13.3d,+,NM_025108.1,80178,FLJ13909,2.0884517161193443,6.185903713867047,23.967007337204514,3.2884315702162566e-56,5.927471969088907e-54,117.55597892516414
SPTBN1,ILMN_1661335,"Homo sapiens spectrin, beta, non-erythrocytic 1 (SPTBN1), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; spectrin [goid 8091] [pmid 1527002] [evidence TAS],barbed-end actin filament capping [goid 51016] [evidence IEA],actin binding [goid 3779] [pmid 1527002] [evidence TAS]; calmodulin binding [goid 5516] [evidence IEA]; structural constituent of cytoskeleton [goid 5200] [pmid 1527002] [evidence TAS],2,54749118-54749167,2p16.2a,+,NM_003128.1,6711,SPTBN1,-1.9401256876694992,8.62343408420917,-23.9518862052192,3.5710569817975945e-56,6.379438222482703e-54,117.47375912363715
SASH1,ILMN_1712673,"Homo sapiens SAM and SH3 domain containing 1 (SASH1), mRNA.",,cell cycle [goid 7049] [evidence IEA],,6,148914326-148914375,6q24.3c,+,NM_015278.3,23328,SASH1,-2.201903128912062,8.994220888280367,-23.900020259667585,4.739292422965728e-56,8.391483433513123e-54,117.19152328695009
LOC131873,ILMN_1815679,"PREDICTED: Homo sapiens hypothetical protein LOC131873 (LOC131873), mRNA.",,,,3,131878080-131878129,3q22.1a,+,XM_067585.11,131873,LOC131873,-2.9094754818739235,7.150201814416545,-23.893178018086125,4.919713239281606e-56,8.634528288732137e-54,117.15426489402924
LOC285016,ILMN_2089752,"Homo sapiens hypothetical protein LOC285016 (LOC285016), mRNA.",,,,2,270097-270146,2p25.3g,-,NM_001002919.1,285016,LOC285016,-3.226226304910382,7.55994099554927,-23.890683552419205,4.987191137404967e-56,8.676845241495528e-54,117.14068018663089
C10orf116,ILMN_1680110,"Homo sapiens chromosome 10 open reading frame 116 (C10orf116), mRNA.",,,,10,88720419-88720468,10q23.2a,+,NM_006829.2,10974,C10orf116,-3.0470758904541846,12.455928452850353,-23.85813524336063,5.957761486496262e-56,1.0276111363949759e-53,116.96335201646164
TCEAL2,ILMN_1765310,"Homo sapiens transcription elongation factor A (SII)-like 2 (TCEAL2), mRNA.",,,translation elongation factor activity [goid 3746] [evidence IEA],X,101269209-101269258,Xq22.1d,+,NM_080390.3,140597,TCEAL2,-3.0659300089800263,7.3684228607113305,-23.84172011591614,6.517078903125455e-56,1.1144761939635393e-53,116.87386909420584
GPM6B,ILMN_1670308,"Homo sapiens glycoprotein M6B (GPM6B), transcript variant 4, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS],cell differentiation [goid 30154] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA],,X,13866617-13866666,Xp22.2,-,NM_001001994.1,2824,GPM6B,-2.5107585300277098,6.55895633830453,-23.796787165641675,8.332967192273065e-56,1.412932267652538e-53,116.62875419787945
GSTM5,ILMN_1750790,"Homo sapiens glutathione S-transferase M5 (GSTM5), mRNA.",,metabolism [goid 8152] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 8473333] [evidence TAS],1,110062202-110062251,1p13.3b,+,NM_000851.2,2949,GSTM5,-2.2543836696678357,6.568645103101246,-23.784993141099783,8.888670025277723e-56,1.4944916795441739e-53,116.56437400476106
EDNRB,ILMN_1675100,"Homo sapiens endothelin receptor type B (EDNRB), transcript variant 1, mRNA.",plasma membrane [goid 5886] [pmid 8810293] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8810293] [evidence TAS],"negative regulation of adenylate cyclase activity [goid 7194] [pmid 9556633] [evidence TAS]; G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) [goid 7200] [pmid 9556633] [evidence TAS]",endothelin receptor activity [goid 4962] [pmid 8810293] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],13,77368878-77368927,13q22.3b,-,NM_000115.1,1910,EDNRB,-1.8321866942308738,6.575011987265611,-23.76316935730946,1.0016981914008239e-55,1.670164784462307e-53,116.44519783215863
SRGN,ILMN_1760347,"Homo sapiens serglycin (SRGN), mRNA.",,,,10,70533801-70533850,10q21.3e,+,NM_002727.2,5552,SRGN,-2.6284263487822024,11.543160740221943,-23.73980481362869,1.1384916611409783e-55,1.8825571203395613e-53,116.3175410266971
CXCL12,ILMN_1689111,"Homo sapiens chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) (CXCL12), transcript variant 3, mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],regulation of actin polymerization and/or depolymerization [goid 8064] [pmid 10570282] [evidence TAS]; immune response [goid 6955] [evidence IEA]; circulation [goid 8015] [pmid 10772939] [evidence TAS]; cell adhesion [goid 7155] [pmid 10198043] [evidence TAS]; cell-cell signaling [goid 7267] [evidence NR ]; response to virus [goid 9615] [pmid 10772939] [evidence TAS]; chemotaxis [goid 6935] [pmid 10620615] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 10772939] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8752280] [evidence TAS]; inflammatory response [goid 6954] [evidence NR ]; signal transduction [goid 7165] [pmid 10491003] [evidence TAS],signal transducer activity [goid 4871] [pmid 10802710] [evidence TAS]; growth factor activity [goid 8083] [evidence IEA]; chemokine activity [goid 8009] [pmid 10772939] [evidence TAS],10,44196274-44196323,10q11.21c,-,NM_001033886.1,6387,CXCL12,-2.5466783299221403,7.787266856322305,-23.73118825921985,1.1935465054251259e-55,1.9574162688972064e-53,116.27044534199811
ANXA8,ILMN_1778087,"Homo sapiens annexin A8-like 2 (ANXA8L2), mRNA.",,blood coagulation [goid 7596] [evidence IEA]; blood coagulation [goid 7596] [evidence IEA],calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],10,47232690-47232739,10q11.22b,+,NM_001630.2,244,ANXA8,-3.302313732109118,7.3515754010585965,-23.72331296386295,1.2462007073541402e-55,2.0158128972647439e-53,116.22739295407723
TMEM100,ILMN_1698259,"Homo sapiens transmembrane protein 100 (TMEM100), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,17,51152729-51152778,17q22b,-,NM_018286.1,55273,TMEM100,-4.500547798122457,8.51759819144509,-23.722859259644974,1.2493042745943036e-55,2.0158128972647439e-53,116.2249124206631
HOXA5,ILMN_1753613,"Homo sapiens homeobox A5 (HOXA5), mRNA.",nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; development [goid 7275] [evidence NAS]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence NAS],7,27147859-27147908,7p15.2a,-,NM_019102.2,3202,HOXA5,-2.5779638860329914,10.294085797155477,-23.705415836568026,1.3747004612744568e-55,2.2004005463343465e-53,116.12952437672097
FXYD6,ILMN_1768812,"Homo sapiens FXYD domain containing ion transport regulator 6 (FXYD6), mRNA.",plasma membrane [goid 5886] [pmid 11256614] [evidence IDA]; integral to membrane [goid 16021] [evidence ISS]; extracellular space [goid 5615] [evidence ISS],ion transport [goid 6811] [evidence IEA],ion channel activity [goid 5216] [evidence IEA],11,117213021-117213070,11q23.3c,-,NM_022003.1,53826,FXYD6,-2.2007849781725843,8.9184604369447,-23.620081510587926,2.1961517284819695e-55,3.4873495066243844e-53,115.66232481573368
C9orf140,ILMN_1702197,"Homo sapiens chromosome 9 open reading frame 140 (C9orf140), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],9,139076854-139076903,9q34.3e,-,NM_178448.2,89958,C9orf140,2.558338317933904,6.401142277542492,23.59218483656931,2.5601160176850938e-55,4.0332914395152247e-53,115.50939239653029
TNNC1,ILMN_1809842,"Homo sapiens troponin C type 1 (slow) (TNNC1), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],3,52460296-52460330:52460331-52460345,3p21.1d,-,NM_003280.1,7134,TNNC1,-3.4568536270837207,9.033819782199565,-23.56223215399307,3.0186476851372294e-55,4.718523662830132e-53,115.34507894648056
ERO1L,ILMN_1744963,"Homo sapiens ERO1-like (S. cerevisiae) (ERO1L), mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 10671517] [evidence IDA],transport [goid 6810] [evidence IEA]; electron transport [goid 6118] [evidence IEA],oxidoreductase activity [goid 16491] [pmid 11707400] [evidence IDA],14,52178370-52178419,14q22.1d,-,NM_014584.1,30001,ERO1L,2.0568347857943747,8.969005425745104,23.537985188771316,3.449616787679659e-55,5.350382378906559e-53,115.21198245341904
SEPP1,ILMN_1785071,"Homo sapiens selenoprotein P, plasma, 1 (SEPP1), transcript variant 1, mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular region [goid 5576] [pmid 14718574] [evidence NAS],response to oxidative stress [goid 6979] [pmid 2037562] [evidence TAS]; response to oxidative stress [goid 6979] [pmid 2037562] [evidence TAS],selenium binding [goid 8430] [pmid 8421687] [evidence TAS]; selenium binding [goid 8430] [pmid 8421687] [evidence TAS],5,42836624-42836673,5p12c,-,NM_005410.2,6414,SEPP1,-1.7788667768956286,7.834759197021852,-23.51578051670163,3.898303223413393e-55,5.999788530311936e-53,115.09003114271266
C10orf54,ILMN_2205963,"Homo sapiens chromosome 10 open reading frame 54 (C10orf54), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA],10,73177396-73177445,10q22.1d-q22.1e,-,NM_022153.1,64115,C10orf54,-2.083690489985309,8.724173125681622,-23.488638390040155,4.5271545701004035e-55,6.914451041112128e-53,114.9408776960707
FOXF1,ILMN_1680973,"Homo sapiens forkhead box F1 (FOXF1), mRNA.",transcription factor complex [goid 5667] [pmid 9722567] [evidence TAS]; nucleus [goid 5634] [pmid 9722567] [evidence TAS],transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [evidence NR ],transcription coactivator activity [goid 3713] [evidence NR ]; protein binding [goid 5515] [pmid 9722567] [evidence TAS]; transcription factor activity [goid 3700] [pmid 8626802] [evidence NAS],16,85105071-85105120,16q24.1c,+,NM_001451.1,2294,FOXF1,-2.819748507185192,7.686194865696229,-23.432459897836058,6.1714211151861974e-55,9.354378308533744e-53,114.63186460957593
PTGER4,ILMN_1795930,"Homo sapiens prostaglandin E receptor 4 (subtype EP4) (PTGER4), mRNA.",integral to membrane [goid 16021] [pmid 8163486] [evidence TAS],"immune response [goid 6955] [pmid 8862514] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; G-protein signaling, coupled to cAMP nucleotide second messenger [goid 7188] [pmid 8163486] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]",rhodopsin-like receptor activity [goid 1584] [evidence IEA]; prostaglandin E receptor activity [goid 4957] [pmid 8163486] [evidence TAS]; receptor activity [goid 4872] [evidence IEA],5,40729369-40729418,5p13.1b,+,NM_000958.2,5734,PTGER4,-2.0376030392505395,9.236798314223174,-23.414712629143835,6.806589864636481e-55,1.0239567670048624e-52,114.53416149988213
OLFML1,ILMN_1776151,"Homo sapiens olfactomedin-like 1 (OLFML1), mRNA.",,,,11,7489027-7489076,11p15.4b,+,NM_198474.2,283298,OLFML1,-2.0352047244993594,8.481362293640204,-23.370288634517166,8.699609531691316e-55,1.2989685635080587e-52,114.28942116982874
TGFBR3,ILMN_1784287,"Homo sapiens transforming growth factor, beta receptor III (TGFBR3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 1333192] [evidence TAS],development [goid 7275] [pmid 10092230] [evidence TAS]; signal transduction [goid 7165] [pmid 1333192] [evidence NAS]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 10092230] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; glycosaminoglycan binding [goid 5539] [pmid 1333192] [evidence TAS],1,91920750-91920799,1p22.2a-p22.1e,-,NM_003243.2,7049,TGFBR3,-2.501581955455295,9.508005520427904,-23.362148215032047,9.099965727639528e-55,1.3466460584108577e-52,114.2445468796542
F10,ILMN_1670708,"Homo sapiens coagulation factor X (F10), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],blood coagulation [goid 7596] [pmid 6587384] [evidence TAS],peptidase activity [goid 8233] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; coagulation factor Xa activity [goid 3804] [pmid 3011603] [evidence TAS],13,112851631-112851680,13q34c,+,NM_000504.2,2159,F10,-2.1469587746899323,6.732188801076735,-23.361086431438295,9.15353178448004e-55,1.3466460584108577e-52,114.23869314777244
TACC1,ILMN_1770084,"Homo sapiens transforming, acidic coiled-coil containing protein 1 (TACC1), mRNA.",nucleus [goid 5634] [evidence IEA],cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],protein binding [goid 5515] [pmid 15064709] [evidence IPI],8,38829434-38829483,8p11.23c,+,NM_006283.1,6867,TACC1,-1.8324535005527292,12.214399632432588,-23.331793835982527,1.0762999197048648e-54,1.5718692549967105e-52,114.07714335149652
KL,ILMN_2352077,"Homo sapiens klotho (KL), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],aging [goid 7568] [pmid 11792841] [evidence IMP]; positive regulation of bone mineralization [goid 30501] [pmid 12110410] [evidence IMP]; carbohydrate metabolism [goid 5975] [evidence IEA]; metabolism [goid 8152] [evidence IEA],glucosidase activity [goid 15926] [evidence IEA]; hormone activity [goid 5179] [evidence IEA]; vitamin D binding [goid 5499] [evidence IEA]; beta-glucuronidase activity [goid 4566] [evidence IEA],13,32538076-32538125,13q13.1b,+,NM_153683.2,9365,KL,-2.395398362409333,6.762228305068193,-23.246714359664516,1.7239030761006088e-54,2.4994096193203608e-52,113.60730896965025
PCOLCE2,ILMN_1746888,"Homo sapiens procollagen C-endopeptidase enhancer 2 (PCOLCE2), mRNA.",,,heparin binding [goid 8201] [evidence IEA],3,144019624-144019673,3q23d,-,NM_013363.2,26577,PCOLCE2,-3.5513419784608997,8.623595963092015,-23.230207190013555,1.8890840756399906e-54,2.7191938262881246e-52,113.51604493636385
CELSR3,ILMN_1691290,"Homo sapiens cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila) (CELSR3), mRNA.",integral to membrane [goid 16021] [pmid 15203201] [evidence TAS]; membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; development [goid 7275] [evidence IEA]; neuropeptide signaling pathway [goid 7218] [evidence IEA]; homophilic cell adhesion [goid 7156] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 15203201] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],3,48648930-48648979,3p21.31e,-,NM_001407.1,1951,CELSR3,2.877240368529316,7.1971199280907925,23.22692694547192,1.9237548984464143e-54,2.7493205720082756e-52,113.49790515772668
CES1,ILMN_1675386,"Homo sapiens carboxylesterase 1 (monocyte/macrophage serine esterase 1) (CES1), transcript variant 2, mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; extracellular space [goid 5615] [evidence NR ],metabolism [goid 8152] [pmid 1918003] [evidence TAS]; response to toxin [goid 9636] [pmid 1918003] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; serine esterase activity [goid 4759] [pmid 1918003] [evidence TAS]; carboxylesterase activity [goid 4091] [evidence IEA],16,54417574-54417623,16q12.2c,-,NM_001025194.1,1066,CES1,-3.268977839308752,9.069731728817928,-23.22529508476426,1.9412402639653465e-54,2.754633702228273e-52,113.48888044574052
BAIAP2L1,ILMN_1703593,"Homo sapiens BAI1-associated protein 2-like 1 (BAIAP2L1), mRNA.",,,,7,97760653-97760702,7q21.3d,-,NM_018842.3,55971,BAIAP2L1,1.9595594775277139,9.376250517554388,23.21247914081135,2.0842287810293485e-54,2.9367077078052962e-52,113.41799241183162
EPAS1,ILMN_1704753,"Homo sapiens endothelial PAS domain protein 1 (EPAS1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [pmid 9079689] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9079689] [evidence TAS]; response to hypoxia [goid 1666] [pmid 11782478] [evidence IDA]; angiogenesis [goid 1525] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]","RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [pmid 9079689] [evidence TAS]; histone acetyltransferase binding [goid 35035] [pmid 15261140] [evidence IPI]; signal transducer activity [goid 4871] [evidence IEA]; transcription coactivator activity [goid 3713] [pmid 9079689] [evidence TAS]; protein binding [goid 5515] [pmid 15261140] [evidence IPI]",2,46466797-46466846,2p21b,+,NM_001430.3,2034,EPAS1,-2.3579517801353322,12.41303358690761,-23.19597942650599,2.2840034081027016e-54,3.1956881251271925e-52,113.32669783992978
SOX17,ILMN_1671092,"Homo sapiens SRY (sex determining region Y)-box 17 (SOX17), mRNA.",nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],8,55535063-55535108:55535109-55535112,8q11.23d,+,NM_022454.2,64321,SOX17,-2.551028442156854,6.627876054129634,-23.172807607448075,2.5974533860239133e-54,3.609017176914337e-52,113.19842744028787
UBE2O,ILMN_1746579,"Homo sapiens ubiquitin-conjugating enzyme E2O (UBE2O), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],ubiquitin-like activating enzyme activity [goid 8642] [evidence IEA],17,71897622-71897671,17q25.1d,-,NM_022066.2,63893,UBE2O,1.5258289114349326,7.945736494505144,23.1564056723185,2.845110066714676e-54,3.925859463091533e-52,113.10759130686999
ANGPT1,ILMN_1677723,"Homo sapiens angiopoietin 1 (ANGPT1), mRNA.",,angiogenesis [goid 1525] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; signal transduction [goid 7165] [pmid 10766762] [evidence TAS]; angiogenesis [goid 1525] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; signal transduction [goid 7165] [pmid 10766762] [evidence TAS],receptor binding [goid 5102] [pmid 10766762] [evidence TAS]; receptor binding [goid 5102] [pmid 10766762] [evidence TAS],8,108331309-108331358,8q23.1b-q23.1c,-,NM_001146.3,284,ANGPT1,-2.758514921151967,7.881600484269644,-23.130585848349835,3.283902823074424e-54,4.5002964167173334e-52,112.96452835553036
FEZ1,ILMN_1727992,"Homo sapiens fasciculation and elongation protein zeta 1 (zygin I) (FEZ1), transcript variant 2, mRNA.",,axon guidance [goid 7411] [pmid 9096408] [evidence TAS]; cell adhesion [goid 7155] [pmid 9096408] [evidence TAS]; axon guidance [goid 7411] [pmid 9096408] [evidence TAS]; cell adhesion [goid 7155] [pmid 9096408] [evidence TAS],protein binding [goid 5515] [pmid 16169070] [evidence IPI]; protein binding [goid 5515] [pmid 16169070] [evidence IPI],11,124864600-124864649,11q24.2b,-,NM_022549.2,9638,FEZ1,-1.3274176167919256,6.977211617003954,-22.985297381201683,7.371970663156499e-54,1.0033904015539811e-51,112.1579310854688
MMP11,ILMN_1655915,"Homo sapiens matrix metallopeptidase 11 (stromelysin 3) (MMP11), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 1701851] [evidence TAS],morphogenesis [goid 9653] [evidence NR ]; collagen catabolism [goid 30574] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; stromelysin 3 activity [goid 4249] [pmid 7746327] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],22,22456201-22456250,22q11.23a,+,NM_005940.3,4320,MMP11,4.621901269935807,7.979060911930257,22.957231909389222,8.620986029436858e-54,1.1654641113308963e-51,112.00181077910771
SRPK1,ILMN_1798804,"Homo sapiens SFRS protein kinase 1 (SRPK1), mRNA.",nucleus [goid 5634] [pmid 11509566] [evidence IDA]; cytoplasm [goid 5737] [pmid 11509566] [evidence IDA],"protein kinase cascade [goid 7243] [pmid 11509566] [evidence IDA]; regulation of mRNA processing [goid 50684] [pmid 8208298] [evidence IDA]; chromosome segregation [goid 7059] [pmid 15034300] [evidence IDA]; cell differentiation [goid 30154] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 11509566] [evidence IDA]; nuclear mRNA splicing, via spliceosome [goid 398] [evidence IEA]",transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 11509566] [evidence IDA]; magnesium ion binding [goid 287] [pmid 11509566] [evidence IDA]; protein serine/threonine kinase activity [goid 4674] [pmid 11509566] [evidence IDA]; protein binding [goid 5515] [pmid 11509566] [evidence IPI],6,35908947-35908996,6p21.31b,-,NM_003137.3,6732,SRPK1,1.5725069769088922,9.204712324194363,22.952558765649776,8.848696046622399e-54,1.1882195335625568e-51,111.97580566749325
SLC31A2,ILMN_1758938,"Homo sapiens solute carrier family 31 (copper transporters), member 2 (SLC31A2), mRNA.",integral to plasma membrane [goid 5887] [pmid 9207117] [evidence TAS],copper ion transport [goid 6825] [pmid 9207117] [evidence TAS]; ion transport [goid 6811] [evidence IEA],copper ion transporter activity [goid 5375] [pmid 9207117] [evidence TAS]; copper ion binding [goid 5507] [evidence IEA],9,114965858-114965907,9q32b,+,NM_001860.1,1318,SLC31A2,-2.1348554607583274,9.64043417995733,-22.888221316370018,1.2673043296154052e-53,1.690415001796335e-51,111.61749818638873
LOC338328,ILMN_1726210,"Homo sapiens high density lipoprotein-binding protein (LOC338328), mRNA.",,,,8,144370348-144370397,8q24.3f,+,NM_178172.2,338328,LOC338328,-2.320705529580228,6.958484524386314,-22.867968458933102,1.4191743229666803e-53,1.8804529704581022e-51,111.50459718751301
ACVRL1,ILMN_1807493,"Homo sapiens activin A receptor type II-like 1 (ACVRL1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8397373] [evidence TAS],protein amino acid phosphorylation [goid 6468] [evidence IEA]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 8928814] [evidence TAS]; circulation [goid 8015] [pmid 9245985] [evidence TAS],manganese ion binding [goid 30145] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; transforming growth factor beta receptor activity [goid 5024] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],12,50600813-50600862,12q13.13c,+,NM_000020.1,94,ACVRL1,-2.423710615196332,8.082477645059228,-22.85602296880594,1.5171853921103786e-53,1.997095087193714e-51,111.43798172945927
STIL,ILMN_2413650,"Homo sapiens SCL/TAL1 interrupting locus (STIL), transcript variant 2, mRNA.",,cell proliferation [goid 8283] [pmid 8825637] [evidence TAS],,,,1p33d,,NM_003035.2,6491,STIL,2.1502640211785247,7.335899098620465,22.849069444187037,1.5773387627484885e-53,2.0627054879131865e-51,111.39919620430284
GPM6A,ILMN_1711312,"Homo sapiens glycoprotein M6A (GPM6A), transcript variant 2, mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; cell surface [goid 9986] [pmid 12493773] [evidence IEP],,,4,176971126-176971175,4q34.2a,-,NM_201591.1,2823,GPM6A,-1.4040366487460023,6.0575003678107056,-22.82973106380235,1.757524101781903e-53,2.2834118330163842e-51,111.2912978024601
FIGF,ILMN_1707612,"Homo sapiens c-fos induced growth factor (vascular endothelial growth factor D) (FIGF), mRNA.",extracellular space [goid 5615] [pmid 9479493] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell proliferation [goid 8283] [evidence IEA]; angiogenesis [goid 1525] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 9479493] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA],platelet-derived growth factor receptor binding [goid 5161] [pmid 9479493] [evidence TAS]; growth factor activity [goid 8083] [evidence IEA],X,15273936-15273985,Xp22.2,-,NM_004469.2,2277,FIGF,-2.909049585426728,6.74555267370674,-22.799997547573135,2.0757218716256655e-53,2.679422142418472e-51,111.12530694623362
CDCA8,ILMN_1709294,"Homo sapiens cell division cycle associated 8 (CDCA8), mRNA.","chromosome [goid 5694] [evidence IEA]; protein complex [goid 43234] [pmid 16239925] [evidence IDA]; nucleus [goid 5634] [evidence IEA]; chromosome, pericentric region [goid 775] [evidence IEA]",mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],protein binding [goid 5515] [pmid 16291752] [evidence IPI],1,37947578-37947627,1p34.3b,+,NM_018101.2,55143,CDCA8,2.014422472097701,6.576639218036162,22.793266575209596,2.1554385105297798e-53,2.7644880588897325e-51,111.08771488173569
PPP1R14A,ILMN_1761968,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 14A (PPP1R14A), mRNA.",,,protein phosphatase inhibitor activity [goid 4864] [evidence IEA],19,43433736-43433785,19q13.2a,-,NM_033256.1,94274,PPP1R14A,-2.215303918292527,10.32518714802949,-22.77784532547079,2.349860228319602e-53,2.99464990116042e-51,111.00156641594668
CD52,ILMN_2208903,"Homo sapiens CD52 molecule (CD52), mRNA.",membrane fraction [goid 5624] [pmid 1711975] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 1711975] [evidence TAS]; membrane [goid 16020] [evidence IEA],,GPI anchor binding [goid 48503] [evidence IEA],1,26519273-26519322,1p36.11b,+,NM_001803.2,1043,CD52,-2.7069461334499536,11.344939289432526,-22.722099577706295,3.2116725836882405e-53,4.0670344971160956e-51,110.68989879545371
CLEC12A,ILMN_1663142,"Homo sapiens C-type lectin domain family 12, member A (CLEC12A), transcript variant 3, mRNA.",,,receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],12,10029269-10029318,12p13.2c,+,NM_201625.1,160364,CLEC12A,-2.2534990806741897,6.698456191523793,-22.70832670101526,3.4696181548309566e-53,4.3660452856514326e-51,110.61283539735203
INMT,ILMN_1781149,"Homo sapiens indolethylamine N-methyltransferase (INMT), mRNA.",,,transferase activity [goid 16740] [evidence IEA]; methyltransferase activity [goid 8168] [evidence IEA]; amine N-methyltransferase activity [goid 30748] [evidence IEA],7,30763562-30763611,7p15.1b,+,NM_006774.4,11185,INMT,-3.5287103193878817,10.691441482007564,-22.68919375143522,3.8628368201418655e-53,4.830477443587403e-51,110.50574070296744
ADRB2,ILMN_1695590,"Homo sapiens adrenergic, beta-2-, receptor, surface (ADRB2), mRNA.",lysosome [goid 5764] [pmid 9507004] [evidence TAS]; endosome [goid 5768] [pmid 10734107] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9228019] [evidence TAS]; plasma membrane [goid 5886] [pmid 10734107] [evidence TAS],"G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9924018] [evidence TAS]; adenylate cyclase activation [goid 7190] [pmid 8386307] [evidence TAS]; G-protein signaling, coupled to cAMP nucleotide second messenger [goid 7188] [pmid 2823249] [evidence TAS]; protein kinase cascade [goid 7243] [pmid 10734107] [evidence TAS]; receptor mediated endocytosis [goid 6898] [pmid 10734107] [evidence TAS]; transmembrane receptor protein tyrosine kinase activation (dimerization) [goid 7171] [pmid 10734107] [evidence TAS]; endosome to lysosome transport [goid 8333] [pmid 9507004] [evidence TAS]",beta2-adrenergic receptor activity [goid 4941] [pmid 10734107] [evidence TAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; protein binding [goid 5515] [pmid 9560162] [evidence IPI]; receptor activity [goid 4872] [evidence IEA],5,148188246-148188295,5q33.1b,+,NM_000024.3,154,ADRB2,-2.4942704653629333,9.116670713335647,-22.684410148201103,3.967953355937252e-53,4.93110625749022e-51,110.47895769960635
GIMAP4,ILMN_1748473,"Homo sapiens GTPase, IMAP family member 4 (GIMAP4), mRNA.",,,GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],7,149901875-149901924,7q36.1c,+,NM_018326.2,55303,GIMAP4,-2.022277142510596,10.739127451824933,-22.669418015450056,4.316368506741141e-53,5.3309815483257253e-51,110.39499910285146
ANKRD25,ILMN_1716089,"Homo sapiens ankyrin repeat domain 25 (ANKRD25), mRNA.",,,,19,11136606-11136655,19p13.2b,-,NM_015493.4,25959,ANKRD25,-2.2521382533678205,8.524835796268157,-22.65280712527614,4.738397686368665e-53,5.816310485206396e-51,110.30194176340969
FLJ20701,ILMN_1671891,"Homo sapiens phosphotyrosine interaction domain containing 1 (PID1), mRNA.",,,,2,229597546-229597595,2q36.3d-q36.3e,-,NM_017933.3,55022,FLJ20701,-2.7633672687516952,7.965890206194261,-22.64199051508893,5.035246279858078e-53,6.143000461426855e-51,110.24132618890128
MSRB3,ILMN_1676088,"Homo sapiens methionine sulfoxide reductase B3 (MSRB3), transcript variant 1, mRNA.",mitochondrion [goid 5739] [pmid 14699060] [evidence IDA]; endoplasmic reticulum [goid 5783] [pmid 14699060] [evidence IDA]; mitochondrion [goid 5739] [pmid 14699060] [evidence IDA]; endoplasmic reticulum [goid 5783] [pmid 14699060] [evidence IDA],protein repair [goid 30091] [pmid 14699060] [evidence IDA]; protein repair [goid 30091] [pmid 14699060] [evidence IDA],zinc ion binding [goid 8270] [pmid 14699060] [evidence IDA]; protein-methionine-R-oxide reductase activity [goid 318] [pmid 14699060] [evidence IDA]; zinc ion binding [goid 8270] [pmid 14699060] [evidence IDA]; protein-methionine-R-oxide reductase activity [goid 318] [pmid 14699060] [evidence IDA],12,64146501-64146550,12q14.3a,+,NM_198080.2,253827,MSRB3,-2.207453942145574,6.9860915747346395,-22.610136187866306,6.022443629930059e-53,7.302851645311553e-51,110.06273010336879
MS4A2,ILMN_1806721,"Homo sapiens membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide) (MS4A2), mRNA.",integral to plasma membrane [goid 5887] [pmid 2448768] [evidence TAS]; membrane [goid 16020] [evidence IEA],humoral immune response [goid 6959] [pmid 2448768] [evidence TAS]; cell proliferation [goid 8283] [pmid 2448768] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9169438] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],IgE binding [goid 19863] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; calcium channel activity [goid 5262] [pmid 9169438] [evidence TAS],11,59622246-59622295,11q12.1d,+,NM_000139.2,2206,MS4A2,-2.6975746026712066,7.278975666447204,-22.607129168566885,6.125130359276509e-53,7.382627001711108e-51,110.04586412353929
PGM5,ILMN_1709590,"PREDICTED: Homo sapiens phosphoglucomutase 5 (PGM5), mRNA.",,,,,,9q13a-q13b,,XM_936702.1,5239,PGM5,-1.8104599007845374,7.19444813630563,-22.58016445856877,7.128208310831188e-53,8.540191130725174e-51,109.89457112838532
SLC2A1,ILMN_1659027,"Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 1 (SLC2A1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [pmid 9462754] [evidence TAS]; membrane [goid 16020] [pmid 3028891] [evidence TAS],glucose transport [goid 15758] [pmid 9462754] [evidence TAS]; carbohydrate transport [goid 8643] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; sugar porter activity [goid 5351] [evidence IEA]; glucose transporter activity [goid 5355] [pmid 9462754] [evidence TAS],1,43164575-43164624,1p34.2a,-,NM_006516.1,6513,SLC2A1,2.94479054559121,9.274131191075396,22.56160774440665,7.9128126015923765e-53,9.423783007896446e-51,109.790399755213
EMP3,ILMN_1765446,"Homo sapiens epithelial membrane protein 3 (EMP3), mRNA.",membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],development [goid 7275] [evidence NR ]; cell growth [goid 16049] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 8996089] [evidence TAS]; cell death [goid 8219] [evidence NR ],,19,53524428-53524477,19q13.32c,+,NM_001425.1,2014,EMP3,-1.5770660882134457,11.557726860008918,-22.526100421852775,9.664053887788763e-53,1.1441324863128852e-50,109.59095096048866
ID2,ILMN_1793990,"Homo sapiens inhibitor of DNA binding 2, dominant negative helix-loop-helix protein (ID2), mRNA.",nucleus [goid 5634] [pmid 14627819] [evidence IC ]; nucleus [goid 5634] [pmid 14627819] [evidence IC ],negative regulation of transcription factor activity [goid 43433] [pmid 14627819] [evidence IDA]; development [goid 7275] [pmid 1741406] [evidence TAS]; negative regulation of transcription [goid 16481] [pmid 14627819] [evidence IDA]; negative regulation of transcription factor activity [goid 43433] [pmid 14627819] [evidence IDA]; development [goid 7275] [pmid 1741406] [evidence TAS]; negative regulation of transcription [goid 16481] [pmid 14627819] [evidence IDA],transcriptional repressor activity [goid 16564] [pmid 14627819] [evidence IDA]; protein binding [goid 5515] [pmid 15249128] [evidence IPI]; transcriptional repressor activity [goid 16564] [pmid 14627819] [evidence IDA]; protein binding [goid 5515] [pmid 15249128] [evidence IPI],2,8739817-8739866,2p25.1e,+,NM_002166.4,3398,ID2,-2.2670747433579166,10.022501849074988,-22.46107042336013,1.3943146286594507e-52,1.6410262994246051e-50,109.22525362617024
VIM,ILMN_1782538,"Homo sapiens vimentin (VIM), mRNA.",cytoskeleton [goid 5856] [pmid 16130169] [evidence TAS]; intermediate filament [goid 5882] [pmid 11889032] [evidence IDA]; cytoplasm [goid 5737] [pmid 9150946] [evidence IDA]; cytoskeleton [goid 5856] [pmid 16130169] [evidence TAS]; intermediate filament [goid 5882] [pmid 11889032] [evidence IDA]; cytoplasm [goid 5737] [pmid 9150946] [evidence IDA],cell motility [goid 6928] [pmid 16130169] [evidence TAS]; cell motility [goid 6928] [pmid 16130169] [evidence TAS],structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 11889032] [evidence IDA]; structural constituent of cytoskeleton [goid 5200] [pmid 11889032] [evidence IDA]; structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 11889032] [evidence IDA]; structural constituent of cytoskeleton [goid 5200] [pmid 11889032] [evidence IDA],10,17316823-17316823:17317174-17317222,10p12.33c,+,NM_003380.2,7431,VIM,-1.608236250186371,13.183585242570432,-22.45469566226273,1.4453714072607624e-52,1.6911690711387915e-50,109.18937606820587
GAS6,ILMN_1768260,"Homo sapiens growth arrest-specific 6 (GAS6), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],cell proliferation [goid 8283] [pmid 7854420] [evidence TAS]; regulation of cell growth [goid 1558] [evidence IEA]; signal transduction [goid 7165] [pmid 7854420] [evidence TAS]; cell proliferation [goid 8283] [pmid 7854420] [evidence TAS]; regulation of cell growth [goid 1558] [evidence IEA]; signal transduction [goid 7165] [pmid 7854420] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; receptor binding [goid 5102] [pmid 7854420] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; receptor binding [goid 5102] [pmid 7854420] [evidence TAS],13,113547353-113547395:113562920-113562926,13q34d,+,NM_000820.1,2621,GAS6,-1.3235135261735689,8.671594749644703,-22.450074495124703,1.4835530524095468e-52,1.7257517135238494e-50,109.16336461295406
MGC7036,ILMN_1668743,"Homo sapiens hypothetical protein MGC7036 (MGC7036), mRNA.",,,,12,122466218-122466267,12q24.31d,-,NM_145058.1,196383,MGC7036,-1.55270864479008,8.87407246081728,-22.413166862937334,1.8271864633579927e-52,2.110346233838572e-50,108.9555227206687
EFEMP1,ILMN_1665250,"Homo sapiens EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1), transcript variant 2, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10369267] [evidence TAS],visual perception [goid 7601] [pmid 10369267] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [pmid 12620389] [evidence IPI],2,56002639-56002688,2p16.1d,-,NM_018894.1,2202,EFEMP1,-1.9833739778338524,8.204042500307633,-22.41238546726326,1.8352671165929204e-52,2.110346233838572e-50,108.95112048897008
SDPR,ILMN_1715991,"Homo sapiens serum deprivation response (phosphatidylserine binding protein) (SDPR), mRNA.",membrane fraction [goid 5624] [evidence NR ]; caveola [goid 5901] [evidence NR ]; cytosol [goid 5829] [pmid 2390065] [evidence IDA],,phosphatidylserine binding [goid 1786] [pmid 10191091] [evidence IDA]; protein binding [goid 5515] [evidence ISS],2,192407481-192407530,2q32.3a,-,NM_004657.4,8436,SDPR,-3.063746904968154,9.858858588263812,-22.378545144466795,2.2219105517457956e-52,2.540342075390279e-50,108.76039609067088
LGI3,ILMN_1737162,"Homo sapiens leucine-rich repeat LGI family, member 3 (LGI3), mRNA.",,,,8,22060537-22060586,8p21.3a,-,NM_139278.2,203190,LGI3,-2.541885139787821,6.392118607968893,-22.372191311221748,2.303152588413156e-52,2.6182657380096833e-50,108.72456956570609
P4HB,ILMN_1719303,"Homo sapiens procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide (P4HB), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; endoplasmic reticulum [goid 5783] [pmid 3034602] [evidence TAS]; cell surface [goid 9986] [pmid 12493773] [evidence IEP]; ER-Golgi intermediate compartment [goid 5793] [pmid 15308636] [evidence IDA],peptidyl-proline hydroxylation to 4-hydroxy-L-proline [goid 18401] [pmid 7753822] [evidence IDA]; electron transport [goid 6118] [evidence IEA],isomerase activity [goid 16853] [evidence IEA]; electron transporter activity [goid 5489] [evidence IEA]; procollagen-proline 4-dioxygenase activity [goid 4656] [pmid 7753822] [evidence IDA]; protein disulfide isomerase activity [goid 3756] [pmid 2846539] [evidence TAS],17,77394447-77394496,17q25.3g,-,NM_000918.2,5034,P4HB,1.1688175292513936,13.092749788100452,22.31597287715163,3.1652869478572946e-52,3.5780260594762003e-50,108.40735414710147
CALCRL,ILMN_1758281,"Homo sapiens calcitonin receptor-like (CALCRL), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7818539] [evidence TAS],"signal transduction [goid 7165] [evidence IEA]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 7818539] [evidence TAS]",calcitonin receptor activity [goid 4948] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 7818539] [evidence TAS],2,187918362-187918411,2q32.1e,-,NM_005795.2,10203,CALCRL,-3.0910839924177367,7.876893808433667,-22.306271908255724,3.343946213727928e-52,3.7587458339476625e-50,108.35257522436754
CLDN5,ILMN_1728197,"Homo sapiens claudin 5 (transmembrane protein deleted in velocardiofacial syndrome) (CLDN5), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence ISS]; tight junction [goid 5923] [evidence ISS],calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA],22,17890627-17890676,22q11.21c,-,NM_003277.2,7122,CLDN5,-2.7871968537458702,10.884785921660045,-22.285255790307534,3.766493542931702e-52,4.2100560227361727e-50,108.23386142185595
ZFP106,ILMN_1800912,"Homo sapiens zinc finger protein 106 homolog (mouse) (ZFP106), mRNA.",intracellular [goid 5622] [evidence IEA]; intracellular [goid 5622] [evidence IEA],electron transport [goid 6118] [evidence IEA]; electron transport [goid 6118] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],15,40492788-40492837,15q15.1d,-,NM_022473.1,64397,ZFP106,-1.4037675225669446,9.808238680738006,-22.23938461390008,4.884465421466195e-52,5.429354675149756e-50,107.97455350361174
ECRG4,ILMN_1676822,"Homo sapiens chromosome 2 open reading frame 40 (C2orf40), mRNA.",,,,2,106060761-106060810,2q12.2b,+,NM_032411.1,84417,ECRG4,-3.7490193721146525,7.6640175479669574,-22.20654584427457,5.88433706399707e-52,6.504630716931125e-50,107.78875276044519
SOX7,ILMN_1815032,"Homo sapiens SRY (sex determining region Y)-box 7 (SOX7), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],8,10619203-10619252,8p23.1b,-,NM_031439.2,83595,SOX7,-2.614770187015682,6.654663860237752,-22.187731663290513,6.5473070618547175e-52,7.19772086228512e-50,107.68224086357938
AP1S2,ILMN_1766411,"Homo sapiens adaptor-related protein complex 1, sigma 2 subunit (AP1S2), mRNA.",plasma membrane [goid 5886] [evidence NR ]; AP-1 adaptor complex [goid 30121] [pmid 2040623] [evidence ISS]; coated pit [goid 5905] [evidence IEA]; Golgi trans face [goid 5802] [pmid 2040623] [evidence ISS]; Golgi apparatus [goid 5794] [evidence NR ]; membrane coat adaptor complex [goid 30119] [pmid 9733768] [evidence TAS]; plasma membrane [goid 5886] [evidence NR ]; AP-1 adaptor complex [goid 30121] [pmid 2040623] [evidence ISS]; coated pit [goid 5905] [evidence IEA]; Golgi trans face [goid 5802] [pmid 2040623] [evidence ISS]; Golgi apparatus [goid 5794] [evidence NR ]; membrane coat adaptor complex [goid 30119] [pmid 9733768] [evidence TAS],intracellular protein transport [goid 6886] [evidence IEA]; transport [goid 6810] [evidence IEA]; receptor mediated endocytosis [goid 6898] [evidence ISS]; intracellular protein transport [goid 6886] [evidence IEA]; transport [goid 6810] [evidence IEA]; receptor mediated endocytosis [goid 6898] [evidence ISS],protein transporter activity [goid 8565] [pmid 2040623] [evidence ISS]; protein transporter activity [goid 8565] [pmid 2040623] [evidence ISS],X,15754397-15754446,Xp22.2,-,NM_003916.3,8905,AP1S2,-1.7183575771815214,9.858259439462373,-22.181399610932225,6.786902570936518e-52,7.420346810890592e-50,107.64638336137962
MARVELD3,ILMN_1710644,"Homo sapiens MARVEL domain containing 3 (MARVELD3), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA],,,16,70233218-70233267,16q22.3a,+,NM_001017967.2,91862,MARVELD3,1.6839353617335222,6.810612387600557,22.17773276493084,6.929655177433072e-52,7.535246782069614e-50,107.6256162066099
MNDA,ILMN_1738992,"Homo sapiens myeloid cell nuclear differentiation antigen (MNDA), mRNA.",nucleus [goid 5634] [evidence IEA],"cellular defense response [goid 6968] [pmid 1644857] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],1,157080517-157080536:157082001-157082030,1q23.1g,+,NM_002432.1,4332,MNDA,-2.9228210463113466,6.788455631416896,-22.141192425047695,8.527782715957874e-52,9.222912247615414e-50,107.41857678414328
PRKCH,ILMN_1780898,"Homo sapiens protein kinase C, eta (PRKCH), mRNA.",,protein amino acid phosphorylation [goid 6468] [pmid 1986216] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; diacylglycerol binding [goid 19992] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; protein kinase C activity [goid 4697] [pmid 1986216] [evidence TAS],14,61087117-61087166,14q23.1c,+,NM_006255.3,5583,PRKCH,-1.400792892594442,10.046111519753374,-22.13685343194103,8.740632221098847e-52,9.402288681706759e-50,107.39398054311546
C1orf186,ILMN_1690209,"Homo sapiens chromosome 1 open reading frame 186 (C1orf186), mRNA.",,,,1,204405726-204405775,1q32.1h,-,NM_001007544.1,440712,C1orf186,-2.403634055804477,6.893720040811032,-22.1329073133364,8.938837093236734e-52,9.564077677084523e-50,107.37160929075658
TUBB6,ILMN_1699489,"PREDICTED: Homo sapiens tubulin, beta 6 (TUBB6), mRNA.",,,,,,18p11.21e,,XM_940079.1,84617,TUBB6,-2.1621248573943213,8.080048452433152,-22.12371803625011,9.418060983406443e-52,1.0023221497659367e-49,107.3195059555254
FAM83A,ILMN_1670158,"Homo sapiens family with sequence similarity 83, member A (FAM83A), transcript variant 2, mRNA.",,,,8,124291158-124291207,8q24.13b,+,NM_207006.1,84985,FAM83A,2.6602556109291973,6.1584980356600365,22.09247602777963,1.1248793508249468e-51,1.1908246587992347e-49,107.14228295196304
RECQL4,ILMN_1703092,"Homo sapiens RecQ protein-like 4 (RECQL4), mRNA.",nucleus [goid 5634] [evidence IEA],development [goid 7275] [pmid 10319867] [evidence TAS]; DNA repair [goid 6281] [pmid 9878247] [evidence TAS],DNA helicase activity [goid 3678] [pmid 9878247] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ATP-dependent helicase activity [goid 8026] [evidence IEA],8,145707910-145707959,8q24.3h,-,NM_004260.1,9401,RECQL4,1.9665702113760801,5.988963993415586,22.085373018682137,1.171257917670953e-51,1.2333962324610753e-49,107.10197319026948
GCNT3,ILMN_1712082,"Homo sapiens glucosaminyl (N-acetyl) transferase 3, mucin type (GCNT3), mRNA.",membrane fraction [goid 5624] [pmid 9988682] [evidence TAS]; membrane [goid 16020] [evidence IEA],carbohydrate metabolism [goid 5975] [pmid 9988682] [evidence NAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [goid 8109] [pmid 9988682] [evidence TAS]",15,57699351-57699400,15q22.2a,+,NM_004751.1,9245,GCNT3,4.498789270215622,7.973402629303792,22.05859690883739,1.364025658909872e-51,1.4288131082495969e-49,106.94996036613625
LEPR,ILMN_1676265,"Homo sapiens leptin receptor (LEPR), transcript variant 3, mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA],development [goid 7275] [pmid 9537324] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 9537324] [evidence TAS]; energy reserve metabolism [goid 6112] [pmid 9537324] [evidence TAS]; development [goid 7275] [pmid 9537324] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 9537324] [evidence TAS]; energy reserve metabolism [goid 6112] [pmid 9537324] [evidence TAS],hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA]; hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA],1,65854386-65854435,1p31.3b,+,NM_001003680.1,3953,LEPR,-1.5502848504999553,6.249306688531032,-22.05768653516191,1.3711121390639876e-51,1.4288131082495969e-49,106.94479040673401
GMFG,ILMN_1711617,"Homo sapiens glia maturation factor, gamma (GMFG), mRNA.",intracellular [goid 5622] [evidence IEA],protein amino acid phosphorylation [goid 6468] [pmid 7598724] [evidence TAS],enzyme activator activity [goid 8047] [pmid 8798479] [evidence TAS]; protein kinase inhibitor activity [goid 4860] [pmid 8639570] [evidence TAS]; growth factor activity [goid 8083] [evidence IEA]; actin binding [goid 3779] [evidence IEA],19,44510871-44510920,19q13.2a,-,NM_004877.1,9535,GMFG,-1.7783251994498723,10.07094198649677,-22.055775665027184,1.386107067974115e-51,1.4369549334728545e-49,106.93393834296813
VSIG4,ILMN_1669409,"Homo sapiens V-set and immunoglobulin domain containing 4 (VSIG4), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,protein binding [goid 5515] [pmid 16530040] [evidence IPI],X,65158578-65158627,Xq12a,-,NM_007268.1,11326,VSIG4,-3.0007166298189416,9.287126529278632,-22.047657245258424,1.4516713313098843e-51,1.4971670101468127e-49,106.88782767162581
C10orf128,ILMN_1674046,"PREDICTED: Homo sapiens chromosome 10 open reading frame 128, transcript variant 8 (C10orf128), mRNA.",,,,,,10q11.22d,,XM_943334.1,170371,C10orf128,-1.9269640988233725,6.534411508196632,-22.03175143859824,1.5892908637898426e-51,1.6306939283439574e-49,106.79746221275313
RRAS,ILMN_1780825,"Homo sapiens related RAS viral (r-ras) oncogene homolog (RRAS), mRNA.",intracellular [goid 5622] [evidence IEA],Ras protein signal transduction [goid 7265] [pmid 3098437] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; GTPase activity [goid 3924] [pmid 3098437] [evidence TAS]; GTP binding [goid 5525] [evidence IEA],19,54830468-54830517,19q13.33b,-,NM_006270.2,6237,RRAS,-1.7431952290093005,11.737680938774737,-22.02696661035288,1.633198556838273e-51,1.6671957512867431e-49,106.77027193210289
C2orf29,ILMN_1708906,"Homo sapiens chromosome 2 open reading frame 29 (C2orf29), mRNA.",,cell proliferation [goid 8283] [pmid 10497265] [evidence NAS],,2,101253114-101253163,2q11.2e,+,NM_017546.3,55571,C2orf29,1.2160449611489526,11.526128373200434,22.024583354525394,1.6555206497340692e-51,1.68140391674514e-49,106.7567277483068
WIF1,ILMN_1721541,"Homo sapiens WNT inhibitory factor 1 (WIF1), mRNA.",,cell-cell signaling [goid 7267] [evidence NR ]; signal transduction [goid 7165] [pmid 10201374] [evidence NAS]; Wnt receptor signaling pathway [goid 16055] [evidence IEA]; development [goid 7275] [evidence IEA],protein-tyrosine kinase activity [goid 4713] [evidence IEA],12,63736151-63736173:63742528-63742554,12q14.3a,-,NM_007191.2,11197,WIF1,-4.238230626131149,7.767992937343077,-22.017337458374666,1.72528623556135e-51,1.735925735448267e-49,106.71554445491908
KAL1,ILMN_1750373,"Homo sapiens Kallmann syndrome 1 sequence (KAL1), mRNA.",extracellular space [goid 5615] [pmid 8842728] [evidence TAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 8832397] [evidence TAS],chemotaxis [goid 6935] [pmid 8842728] [evidence TAS]; axon guidance [goid 7411] [pmid 1922361] [evidence TAS]; cell adhesion [goid 7155] [pmid 1922361] [evidence TAS]; cell motility [goid 6928] [pmid 1922361] [evidence TAS],serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; extracellular matrix structural constituent [goid 5201] [pmid 8842728] [evidence TAS],X,8457273-8457322,Xp22.31b,-,NM_000216.1,3730,KAL1,-3.080503267322169,9.018790631987947,-22.017208375067895,1.7265554845771945e-51,1.735925735448267e-49,106.71481072726819
GYPC,ILMN_1668039,"PREDICTED: Homo sapiens glycophorin C (Gerbich blood group) (GYPC), mRNA.",,,,,,2q14.3d,,XM_940361.1,2995,GYPC,-1.4916118251215549,8.080069081570345,-21.998698287850388,1.9186166929867598e-51,1.9193841396639545e-49,106.60957485132734
FABP5,ILMN_1696302,"Homo sapiens fatty acid binding protein 5 (psoriasis-associated) (FABP5), mRNA.",cytoplasm [goid 5737] [pmid 16130169] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS],transport [goid 6810] [evidence IEA]; lipid metabolism [goid 6629] [pmid 8092987] [evidence TAS]; epidermis development [goid 8544] [pmid 1512466] [evidence TAS]; transport [goid 6810] [evidence IEA]; lipid metabolism [goid 6629] [pmid 8092987] [evidence TAS]; epidermis development [goid 8544] [pmid 1512466] [evidence TAS]; transport [goid 6810] [evidence IEA]; lipid metabolism [goid 6629] [pmid 8092987] [evidence TAS]; epidermis development [goid 8544] [pmid 1512466] [evidence TAS],fatty acid binding [goid 5504] [pmid 8092987] [evidence TAS]; protein binding [goid 5515] [pmid 12839573] [evidence IPI]; fatty acid binding [goid 5504] [pmid 8092987] [evidence TAS]; protein binding [goid 5515] [pmid 12839573] [evidence IPI]; fatty acid binding [goid 5504] [pmid 8092987] [evidence TAS]; protein binding [goid 5515] [pmid 12839573] [evidence IPI],8,82358292-82358328:82358663-82358675,8q21.13b,+,NM_001444.1,2171,FABP5,-2.7814114085707375,8.2725315808674509,-21.997689980007777,1.929674505473045e-51,1.9208421644529694e-49,106.60384104129497
ITM2A,ILMN_2076600,"Homo sapiens integral membrane protein 2A (ITM2A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,X,78503309-78503330:78503482-78503509,Xq21.1b,-,NM_004867.3,9452,ITM2A,-1.8040550996094131,8.145776308552282,-21.988507737845072,2.033364359547754e-51,2.0140373319718545e-49,106.55161965678664
GPT2,ILMN_1684158,"Homo sapiens glutamic pyruvate transaminase (alanine aminotransferase) 2 (GPT2), mRNA.",,biosynthesis [goid 9058] [evidence IEA],transaminase activity [goid 8483] [evidence IEA]; 1-aminocyclopropane-1-carboxylate synthase activity [goid 16847] [evidence IEA],16,45522597-45522646,16q11.2i-q12.1a,+,NM_133443.1,84706,GPT2,2.4461079840416833,9.01267702551582,21.970998947886212,2.246839166808385e-51,2.214520100960698e-49,106.45201369127966
GPC3,ILMN_2051972,"Homo sapiens glypican 3 (GPC3), mRNA.",integral to plasma membrane [goid 5887] [pmid 7657705] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],morphogenesis [goid 9653] [pmid 8589713] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA],X,132497888-132497937,Xq26.2b,-,NM_004484.2,2719,GPC3,-3.167823630158243,8.921068809770729,-21.931534518577187,2.8142249079195914e-51,2.760147644983097e-49,106.2273610792783
SERINC2,ILMN_2111932,"Homo sapiens serine incorporator 2 (SERINC2), mRNA.",membrane [goid 16020] [evidence IEA],positive regulation of transferase activity [goid 51347] [evidence ISS]; phosphatidylserine metabolism [goid 6658] [evidence ISS],,1,31679770-31679819,1p35.2a,+,NM_178865.3,347735,SERINC2,2.863869029860183,8.846490768949165,21.92221863499361,2.967936349256924e-51,2.8950461330040026e-49,106.17430120591763
SPC24,ILMN_2181432,"Homo sapiens SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) (SPC24), mRNA.",,,,19,11117635-11117684,19p13.2b,-,NM_182513.1,147841,SPC24,2.3168906482334135,7.763264883187518,21.9214666775119,2.9807052349001626e-51,2.8950461330040026e-49,106.17001784929133
SEMA6A,ILMN_1713529,"Homo sapiens sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A (SEMA6A), mRNA.",integral to membrane [goid 16021] [pmid 10993894] [evidence NAS]; axon [goid 30424] [pmid 10993894] [evidence NAS]; membrane [goid 16020] [evidence IEA],cytoskeleton organization and biogenesis [goid 7010] [pmid 10993894] [evidence NAS]; axon guidance [goid 7411] [pmid 10993894] [evidence NAS]; development [goid 7275] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [pmid 10993894] [evidence NAS]; apoptosis [goid 6915] [pmid 10993894] [evidence NAS]; cell differentiation [goid 30154] [evidence IEA],protein binding [goid 5515] [pmid 10993894] [evidence IPI]; receptor activity [goid 4872] [evidence IEA],5,115807371-115807420,5q23.1a,-,NM_020796.2,57556,SEMA6A,-2.7856658976996513,8.72831142626016,-21.913210887833042,3.124575022342871e-51,3.0201206302916017e-49,106.12298587388476
ID3,ILMN_1732296,"Homo sapiens inhibitor of DNA binding 3, dominant negative helix-loop-helix protein (ID3), mRNA.",nucleus [goid 5634] [pmid 14627819] [evidence IC ],negative regulation of transcription factor activity [goid 43433] [pmid 14627819] [evidence IDA]; development [goid 7275] [pmid 1628620] [evidence TAS]; negative regulation of transcription [goid 16481] [pmid 14627819] [evidence IDA],transcription corepressor activity [goid 3714] [pmid 8437843] [evidence TAS],1,23757369-23757418,1p36.12a,-,NM_002167.2,3399,ID3,-2.471146854211579,11.130734979650438,-21.890522042626685,3.556901480129759e-51,3.421465616078664e-49,105.99368635741973
EML1,ILMN_1729455,"Homo sapiens echinoderm microtubule associated protein like 1 (EML1), transcript variant 2, mRNA.",microtubule associated complex [goid 5875] [pmid 9226380] [evidence TAS]; microtubule [goid 5874] [evidence IEA]; microtubule associated complex [goid 5875] [pmid 9226380] [evidence TAS]; microtubule [goid 5874] [evidence IEA],visual perception [goid 7601] [evidence NR ]; visual perception [goid 7601] [evidence NR ],acid phosphatase activity [goid 3993] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; acid phosphatase activity [goid 3993] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],14,99477179-99477228,14q32.2b,+,NM_004434.2,2009,EML1,-2.141488244383572,7.587651991754926,-21.886991923431793,3.629368101541008e-51,3.4744687548149515e-49,105.97356298126249
CDC20,ILMN_1663390,"Homo sapiens CDC20 cell division cycle 20 homolog (S. cerevisiae) (CDC20), mRNA.",spindle [goid 5819] [pmid 7513050] [evidence TAS],cell division [goid 51301] [evidence IEA]; mitosis [goid 7067] [evidence IEA]; ubiquitin-dependent protein catabolism [goid 6511] [pmid 9682218] [evidence TAS]; ubiquitin cycle [goid 6512] [evidence IEA],protein binding [goid 5515] [pmid 14743218] [evidence IPI],1,43601352-43601387:43601388-43601401,1p34.2a,+,NM_001255.1,991,CDC20,2.9018408546648686,8.566477499092072,21.866423210717915,4.0820764801001777e-51,3.889246962564017e-49,105.85627993301826
SLC39A11,ILMN_1742705,"Homo sapiens solute carrier family 39 (metal ion transporter), member 11 (SLC39A11), mRNA.",membrane [goid 16020] [evidence IEA],metal ion transport [goid 30001] [evidence IEA],metal ion transporter activity [goid 46873] [evidence IEA],17,68153894-68153943,17q24.3c-q25.1a,-,NM_139177.2,201266,SLC39A11,1.6816350052036846,9.435118595108447,21.865216777138816,4.1103247965838937e-51,3.897600878201448e-49,105.84939916485185
SH2D3C,ILMN_1674440,"Homo sapiens SH2 domain containing 3C (SH2D3C), transcript variant 1, mRNA.",intracellular [goid 5622] [evidence IEA]; intracellular [goid 5622] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA]; small GTPase mediated signal transduction [goid 7264] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA],9,129573299-129573329:129573330-129573348,9q34.11a,-,NM_005489.1,10044,SH2D3C,-1.4841709051747891,6.986635882724906,-21.845195581934043,4.608832589593867e-51,4.3496944553110424e-49,105.73518336059762
TGFBR2,ILMN_1726245,"Homo sapiens transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence TAS],positive regulation of cell proliferation [goid 8284] [pmid 7761852] [evidence TAS]; protein amino acid dephosphorylation [goid 6470] [evidence NAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; transmembrane receptor protein serine/threonine kinase signaling pathway [goid 7178] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 7761852] [evidence TAS]; protein amino acid dephosphorylation [goid 6470] [evidence NAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; transmembrane receptor protein serine/threonine kinase signaling pathway [goid 7178] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 7761852] [evidence TAS]; protein amino acid dephosphorylation [goid 6470] [evidence NAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; transmembrane receptor protein serine/threonine kinase signaling pathway [goid 7178] [evidence IEA],"protein binding [goid 5515] [pmid 8242742] [evidence IPI]; magnesium ion binding [goid 287] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; ATP binding [goid 5524] [evidence NAS]; nucleotide binding [goid 166] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; transforming growth factor beta receptor activity, type II [goid 5026] [pmid 7761852] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; protein binding [goid 5515] [pmid 8242742] [evidence IPI]; magnesium ion binding [goid 287] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; ATP binding [goid 5524] [evidence NAS]; nucleotide binding [goid 166] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; transforming growth factor beta receptor activity, type II [goid 5026] [pmid 7761852] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; protein binding [goid 5515] [pmid 8242742] [evidence IPI]; magnesium ion binding [goid 287] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; ATP binding [goid 5524] [evidence NAS]; nucleotide binding [goid 166] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; transforming growth factor beta receptor activity, type II [goid 5026] [pmid 7761852] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]",3,30710136-30710185,3p24.1a,+,NM_001024847.1,7048,TGFBR2,-1.217418240168712,9.808814096147088,-21.828650267324058,5.0663046507551027e-51,4.7589964062116475e-49,105.64075812876251
BCHE,ILMN_1685641,"Homo sapiens butyrylcholinesterase (BCHE), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular region [goid 5576] [pmid 14718574] [evidence NAS],cocaine metabolism [goid 50783] [pmid 8622553] [evidence TAS]; cocaine metabolism [goid 50783] [pmid 8622553] [evidence TAS],enzyme binding [goid 19899] [pmid 11569538] [evidence NAS]; beta-amyloid binding [goid 1540] [pmid 11569538] [evidence NAS]; serine esterase activity [goid 4759] [evidence IEA]; cholinesterase activity [goid 4104] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA]; enzyme binding [goid 19899] [pmid 11569538] [evidence NAS]; beta-amyloid binding [goid 1540] [pmid 11569538] [evidence NAS]; serine esterase activity [goid 4759] [evidence IEA]; cholinesterase activity [goid 4104] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA],3,166973917-166973966,3q26.1e,-,NM_000055.1,590,BCHE,-2.8005179365416586,6.87330932144294,-21.78872869365745,6.366819801548433e-51,5.952678999503788e-49,105.41277980384695
GPR146,ILMN_1684227,"Homo sapiens G protein-coupled receptor 146 (GPR146), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],7,1065282-1065331,7p22.3b,+,NM_138445.2,115330,GPR146,-1.6816504880418703,6.451226984578158,-21.77384733955794,6.933216974451541e-51,6.452083963945416e-49,105.32774573003603
RPESP,ILMN_1808245,"Homo sapiens RPE-spondin (RPESP), mRNA.",,,,8,74141845-74141894,8q21.11a,-,NM_153225.2,157869,RPESP,-3.030025771937326,7.302632987777956,-21.73024169529898,8.901405341368819e-51,8.245338799542006e-49,105.07841522391273
RASL12,ILMN_1806403,"Homo sapiens RAS-like, family 12 (RASL12), mRNA.",membrane [goid 16020] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],15,63132850-63132899,15q22.31b,-,NM_016563.2,51285,RASL12,-2.154735587745339,9.230125194061767,-21.689246697660337,1.1261078736659854e-50,1.0383025961432735e-48,104.84379182735735
LMO2,ILMN_1800078,"Homo sapiens LIM domain only 2 (rhombotin-like 1) (LMO2), mRNA.",nucleus [goid 5634] [evidence IEA],development [goid 7275] [pmid 1923511] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; protein binding [goid 5515] [evidence ISS],11,33836929-33836978,11p13c,-,NM_005574.2,4005,LMO2,-2.3171635574963583,8.992648954877302,-21.678981014932987,1.1944471168309568e-50,1.0962613721813663e-48,104.785005666379
RSPO1,ILMN_1682937,"Homo sapiens R-spondin homolog (Xenopus laevis) (RSPO1), transcript variant 2, mRNA.",,electron transport [goid 6118] [evidence IEA],electron transporter activity [goid 5489] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA],1,37849704-37849753,1p34.3c-p34.3b,-,NM_173640.1,284654,RSPO1,-1.7675879273222002,5.812376380097532,-21.643123496078534,1.4675267895671866e-50,1.3407431966054916e-48,104.57956358803366
FUT2,ILMN_1794659,"Homo sapiens fucosyltransferase 2 (secretor status included) (FUT2), mRNA.",integral to Golgi membrane [goid 30173] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA]; membrane [goid 16020] [evidence IEA],protein amino acid glycosylation [goid 6486] [pmid 11698403] [evidence TAS]; L-fucose catabolism [goid 42355] [pmid 11698403] [evidence NAS]; carbohydrate metabolism [goid 5975] [pmid 7876235] [evidence TAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; fucosyltransferase activity [goid 8417] [pmid 7876235] [evidence TAS]; galactoside 2-alpha-L-fucosyltransferase activity [goid 8107] [pmid 11698403] [evidence TAS]",19,53900557-53900606,19q13.33a,+,NM_000511.3,2524,FUT2,2.76037486296047,6.410796784757825,21.610465228319082,1.770468713139076e-50,1.6101608187493926e-48,104.39230934636798
LOC653110,ILMN_1661628,"PREDICTED: Homo sapiens similar to annexin A8, transcript variant 1 (LOC653110), mRNA.",,,,10,47898803-47898852,10q11.22b,+,XM_926584.1,653110,LOC653110,-2.7290243305031945,6.654388171072218,-21.55152248364393,2.4850424480678553e-50,2.2498067556987173e-48,104.05400416790017
LOC648470,ILMN_1704554,"PREDICTED: Homo sapiens similar to Caspase-4 precursor (CASP-4) (ICH-2 protease) (TX protease) (ICE(rel)-II) (LOC648470), mRNA.",,,,,,,,XM_937514.1,648470,LOC648470,-1.9602839579900877,8.483466670567921,-21.529960295130127,2.8134940740698535e-50,2.5356932177472806e-48,103.93013673718514
ASPM,ILMN_1815184,"Homo sapiens asp (abnormal spindle)-like, microcephaly associated (Drosophila) (ASPM), mRNA.",nucleus [goid 5634] [evidence IEA],cell division [goid 51301] [evidence IEA]; mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],binding [goid 5488] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA],1,195320084-195320133,1q31.3c,-,NM_018136.2,259266,ASPM,2.65489057278788,6.665306985935783,21.501909913406323,3.306882207921024e-50,2.9669999648468094e-48,103.76890865309704
GIMAP5,ILMN_1769383,"Homo sapiens GTPase, IMAP family member 5 (GIMAP5), mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; outer membrane [goid 19867] [evidence IEA],,GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],7,150071390-150071439,7q36.1c,+,NM_018384.3,55340,GIMAP5,-2.139672115758321,9.38606391778261,-21.48541020478682,3.636767900049683e-50,3.2484130421515205e-48,103.67402499624343
SGCG,ILMN_1659649,"Homo sapiens sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) (SGCG), mRNA.",plasma membrane [goid 5886] [pmid 8641426] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; sarcoglycan complex [goid 16012] [pmid 8641426] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA],muscle development [goid 7517] [pmid 8641426] [evidence TAS]; cytoskeleton organization and biogenesis [goid 7010] [evidence IEA],,13,22796982-22797031,13q12.12a,+,NM_000231.1,6445,SGCG,-2.190386609767576,5.901039919409857,-21.446915857568424,4.540673673898569e-50,4.0377688385494476e-48,103.45252430369383
PI16,ILMN_1766264,"Homo sapiens peptidase inhibitor 16 (PI16), mRNA.",extracellular region [goid 5576] [evidence IEA],,,6,37040423-37040472,6p21.2c,+,NM_153370.2,221476,PI16,-3.8421536756228853,7.227723402300154,-21.428516154204843,5.049272792884692e-50,4.4701703557538463e-48,103.34658410354709
ATAD3A,ILMN_1738530,"Homo sapiens ATPase family, AAA domain containing 3A (ATAD3A), mRNA.",,,ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; nucleoside-triphosphatase activity [goid 17111] [evidence IEA],1,1459776-1459825,1p36.33a,+,NM_018188.2,55210,ATAD3A,1.6626210802764962,8.063447456467614,21.404066669426108,5.814687261078285e-50,5.122979199622326e-48,103.20574467967522
ADARB1,ILMN_1657442,"Homo sapiens adenosine deaminase, RNA-specific, B1 (RED1 homolog rat) (ADARB1), transcript variant 4, mRNA.",intracellular [goid 5622] [evidence IEA]; intracellular [goid 5622] [evidence IEA],mRNA processing [goid 6397] [evidence IEA]; mRNA processing [goid 6397] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; adenosine deaminase activity [goid 4000] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; double-stranded RNA binding [goid 3725] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; adenosine deaminase activity [goid 4000] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; double-stranded RNA binding [goid 3725] [evidence IEA],21,45379071-45379120,21q22.3e,+,NM_001033049.1,104,ADARB1,-1.3821180368859816,7.368101482768032,-21.403377857465692,5.837861143112207e-50,5.122979199622326e-48,103.20177573401428
SFTPA1,ILMN_1689114,"Homo sapiens surfactant, pulmonary-associated protein A1B (SFTPA1B), mRNA.",cytoplasm [goid 5737] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; respiratory gaseous exchange [goid 7585] [evidence IEA]; regulation of liquid surface tension [goid 50828] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA]; respiratory gaseous exchange [goid 7585] [evidence IEA]; regulation of liquid surface tension [goid 50828] [evidence IEA],sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],10,81361590-81361639,10q22.3f,+,NM_005411.3,6435,SFTPA1,-5.332831883055802,10.099050963950665,-21.400019254894925,5.952190459393083e-50,5.200498983036541e-48,103.18242255132319
ARHGEF16,ILMN_1669928,"Homo sapiens Rho guanine exchange factor (GEF) 16 (ARHGEF16), mRNA.",intracellular [goid 5622] [evidence IEA],regulation of Rho protein signal transduction [goid 35023] [evidence IEA],Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA],1,3387466-3387515,1p36.32b,+,NM_014448.2,27237,ARHGEF16,1.9463783445021958,6.996164496949418,21.393450334674707,6.182339231972072e-50,5.378097537099879e-48,103.14456651690004
FLJ21986,ILMN_1677038,"Homo sapiens hypothetical protein FLJ21986 (FLJ21986), mRNA.",endoplasmic reticulum [goid 5783] [pmid 11256614] [evidence IDA],,,7,120724622-120724671,7q31.31d,+,NM_024913.3,79974,FLJ21986,-2.143627990970752,8.695918825741709,-21.383582634903235,6.544962936766245e-50,5.668901231117707e-48,103.08768967989458
FGD5,ILMN_2104141,"Homo sapiens FYVE, RhoGEF and PH domain containing 5 (FGD5), mRNA.",lamellipodium [goid 30027] [evidence ISS]; ruffle [goid 1726] [evidence ISS]; cytoskeleton [goid 5856] [evidence IEA]; Golgi apparatus [goid 5794] [evidence ISS]; cytoplasm [goid 5737] [evidence ISS]; intracellular [goid 5622] [evidence IEA],regulation of Cdc42 GTPase activity [goid 43088] [evidence ISS]; filopodium formation [goid 46847] [evidence ISS]; regulation of cell shape [goid 8360] [evidence ISS]; regulation of Rho protein signal transduction [goid 35023] [evidence IEA]; actin cytoskeleton organization and biogenesis [goid 30036] [evidence ISS]; cytoskeleton organization and biogenesis [goid 7010] [evidence ISS],protein binding [goid 5515] [evidence ISS]; small GTPase binding [goid 31267] [evidence ISS]; Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],3,14950699-14950748,3p24.3e,+,NM_152536.2,152273,FGD5,-2.1781021001360754,8.929162422428734,-21.33642428228865,8.595738427103403e-50,7.413083381443314e-48,102.81570158805914
CGNL1,ILMN_1730229,"Homo sapiens cingulin-like 1 (CGNL1), mRNA.",myosin [goid 16459] [evidence IEA],,motor activity [goid 3774] [evidence IEA],15,55630050-55630099,15q21.3d,+,NM_032866.3,84952,CGNL1,-1.899391404252249,10.999286025559314,-21.311689189535947,9.917934902501179e-50,8.516654142885991e-48,102.67292826710073
CD33,ILMN_1747622,"Homo sapiens CD33 molecule (CD33), mRNA.",integral to plasma membrane [goid 5887] [pmid 3139766] [evidence TAS]; plasma membrane [goid 5886] [pmid 3139766] [evidence TAS],signal transduction [goid 7165] [pmid 10611343] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 10611343] [evidence TAS]; cell adhesion [goid 7155] [pmid 10611343] [evidence NAS]; cell-cell signaling [goid 7267] [pmid 10611343] [evidence TAS],protein binding [goid 5515] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; receptor activity [goid 4872] [pmid 10611343] [evidence TAS],19,56434712-56434755:56434756-56434761,19q13.33d,+,NM_001772.2,945,CD33,-2.267225484575813,7.394851253767871,-21.301113547881332,1.0543843426738211e-49,9.015436721460604e-48,102.6118610414904
RASIP1,ILMN_1755657,"Homo sapiens Ras interacting protein 1 (RASIP1), mRNA.",myosin [goid 16459] [evidence IEA],signal transduction [goid 7165] [evidence IEA],motor activity [goid 3774] [evidence IEA],19,53915773-53915822,19q13.33a,-,NM_017805.2,54922,RASIP1,-2.335140517292702,9.500470019729738,-21.299336681580122,1.0652830026312174e-49,9.069864815593787e-48,102.60159944482677
FRMD4A,ILMN_1678961,"Homo sapiens FERM domain containing 4A (FRMD4A), mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],,cytoskeletal protein binding [goid 8092] [evidence IEA]; binding [goid 5488] [evidence IEA],10,13726018-13726067,10p13d-p13c,-,NM_018027.2,55691,FRMD4A,-1.6513385957234439,7.605789953320756,-21.28817362718759,1.1363879484274884e-49,9.634258505142876e-48,102.53712245774427
C10orf67,ILMN_1719577,"Homo sapiens chromosome 10 open reading frame 67 (C10orf67), mRNA.",,,,10,23645589-23645638,10p12.2a,-,NM_153714.1,256815,C10orf67,-2.611688977623591,6.306185558331402,-21.261013709792618,1.329931993328672e-49,1.1227544017940959e-47,102.38018297727167
C6orf189,ILMN_1751326,"PREDICTED: Homo sapiens chromosome 6 open reading frame 189 (C6orf189), mRNA.",,,,6,117180135-117180184,6q22.2a,-,XM_927381.1,221303,C6orf189,-2.6711133925257737,9.678139985330358,-21.24521111058147,1.4574340956062337e-49,1.2252244279365346e-47,102.28882714731715
DNASE1L3,ILMN_2049184,"Homo sapiens deoxyribonuclease I-like 3 (DNASE1L3), mRNA.",nucleus [goid 5634] [evidence IEA],DNA catabolism [goid 6308] [evidence IEA]; apoptosis [goid 6915] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; deoxyribonuclease activity [goid 4536] [pmid 9070308] [evidence TAS]; DNA binding [goid 3677] [pmid 9070308] [evidence TAS]; endonuclease activity [goid 4519] [evidence IEA]; calcium ion binding [goid 5509] [pmid 9205125] [evidence TAS],3,58153544-58153570:58154110-58154132,3p14.3a,-,NM_004944.2,1776,DNASE1L3,-3.990826267392248,7.596892768670617,-21.235346027603818,1.5431795808277319e-49,1.291880211431015e-47,102.2317804803679
C14orf139,ILMN_1684357,"Homo sapiens chromosome 14 open reading frame 139 (C14orf139), mRNA.",,,,14,94943542-94943591,14q32.13b,-,NM_024633.2,79686,C14orf139,-1.7386677085939182,6.441898987698472,-21.216684349369373,1.71947942509439e-49,1.4334726807203565e-47,102.12383225184271
ARHGEF6,ILMN_1803423,"Homo sapiens Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 (ARHGEF6), mRNA.",intracellular [goid 5622] [pmid 11017088] [evidence IC ],regulation of Rho protein signal transduction [goid 35023] [evidence IEA]; apoptosis [goid 6915] [pmid 11564864] [evidence NAS]; JNK cascade [goid 7254] [pmid 11564864] [evidence NAS],Rho guanyl-nucleotide exchange factor activity [goid 5089] [pmid 11017088] [evidence NAS]; GTPase activator activity [goid 5096] [pmid 9582122] [evidence NAS],X,135575492-135575541,Xq26.3b-q26.3c,-,NM_004840.2,9459,ARHGEF6,-1.657101348198978,10.22630392963179,-21.17995936140247,2.1276835088517805e-49,1.7664187404608475e-47,101.91126861937198
RAI2,ILMN_1760574,"Homo sapiens retinoic acid induced 2 (RAI2), mRNA.",,embryonic development [goid 9790] [pmid 10049581] [evidence NAS],,X,17728570-17728619,Xp22.13d,-,NM_021785.2,10742,RAI2,-1.5239533207196052,6.774367497580266,-21.15089361277213,2.518694835400656e-49,2.0823986060618316e-47,101.74291584768059
C19orf48,ILMN_2383484,"Homo sapiens chromosome 19 open reading frame 48 (C19orf48), mRNA.",,,,19,55993333-55993382,19q13.33c,-,NM_199250.1,84798,C19orf48,1.881401268590678,7.081578161466311,21.132702188251432,2.7993398839532795e-49,2.304905036960379e-47,101.637494404251
FBLN5,ILMN_1664176,"Homo sapiens fibulin 5 (FBLN5), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10428823] [evidence TAS]; membrane [goid 16020] [evidence IEA]; soluble fraction [goid 5625] [pmid 10428823] [evidence TAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10428823] [evidence TAS]; membrane [goid 16020] [evidence IEA]; soluble fraction [goid 5625] [pmid 10428823] [evidence TAS],blood coagulation [goid 7596] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA]; cell-matrix adhesion [goid 7160] [pmid 10428823] [evidence TAS]; blood coagulation [goid 7596] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA]; cell-matrix adhesion [goid 7160] [pmid 10428823] [evidence TAS],integrin binding [goid 5178] [pmid 10428823] [evidence TAS]; transmembrane receptor activity [goid 4888] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; integrin binding [goid 5178] [pmid 10428823] [evidence TAS]; transmembrane receptor activity [goid 4888] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],14,91406198-91406247,14q32.12a,-,NM_006329.2,10516,FBLN5,-2.1902530844085017,9.215239238595856,-21.12741261903969,2.8866869256796473e-49,2.3670832790573107e-47,101.60683289482292
CAT,ILMN_1651705,"Homo sapiens catalase (CAT), mRNA.",peroxisome [goid 5777] [evidence IEA],response to oxidative stress [goid 6979] [evidence IEA]; hydrogen peroxide catabolism [goid 42744] [evidence IEA]; electron transport [goid 6118] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; catalase activity [goid 4096] [pmid 2268310] [evidence TAS],11,34449164-34449164:34449491-34449539,11p13c,+,NM_001752.2,847,CAT,-1.8773689764162267,9.950738473509224,-21.1212048918672,2.9926913432278724e-49,2.4439905467470723e-47,101.57084469117362
TSRC1,ILMN_1687035,"Homo sapiens thrombospondin repeat containing 1 (TSRC1), transcript variant 2, mRNA.",extracellular matrix [goid 31012] [evidence IEA]; extracellular matrix [goid 31012] [evidence IEA],,metalloendopeptidase activity [goid 4222] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; metalloendopeptidase activity [goid 4222] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],1,148797683-148797732,1q21.2b-q21.2c,+,NM_025008.2,54507,TSRC1,-1.5227195082476426,6.477740296950209,-21.03464077905856,4.9508939196311516e-49,4.0267270546333364e-47,101.06849830136962
PPME1,ILMN_1732772,"Homo sapiens protein phosphatase methylesterase 1 (PPME1), mRNA.",,protein amino acid demethylation [goid 6482] [pmid 10318862] [evidence IDA]; aromatic compound metabolism [goid 6725] [evidence IEA],protein phosphatase inhibitor activity [goid 4864] [pmid 10318862] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; serine esterase activity [goid 4759] [evidence IEA]; protein phosphatase type 2A regulator activity [goid 8601] [pmid 10318862] [evidence TAS]; protein binding [goid 5515] [pmid 10318862] [evidence IDA]; carboxylic ester hydrolase activity [goid 16789] [pmid 10318862] [evidence IDA],11,73643195-73643244,11q13.4c,+,NM_016147.1,51400,PPME1,1.1013477112520889,9.15577833402745,21.0219244342645,5.331306585406215e-49,4.3185741765509128e-47,100.99462363504271
TIMP3,ILMN_1701461,"Homo sapiens TIMP metallopeptidase inhibitor 3 (Sorsby fundus dystrophy, pseudoinflammatory) (TIMP3), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 7925969] [evidence NAS],visual perception [goid 7601] [evidence IEA]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 15609325] [evidence NAS]; induction of apoptosis by extracellular signals [goid 8624] [pmid 7925969] [evidence NAS],metalloendopeptidase inhibitor activity [goid 8191] [evidence IEA]; enzyme inhibitor activity [goid 4857] [evidence IEA],22,31588368-31588417,22q12.3a,+,NM_000362.4,7078,TIMP3,-2.5716337112249033,11.04670301558374,-21.00816929881336,5.77590318144451e-49,4.659849631223458e-47,100.9146912650042
PROM2,ILMN_1761946,"Homo sapiens prominin 2 (PROM2), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,2,95320692-95320741,2q11.1c,+,NM_144707.1,150696,PROM2,2.838417005503053,9.265641116833882,20.977791500721505,6.8941493078347e-49,5.539684311291433e-47,100.73807867155635
GPX3,ILMN_1726666,"Homo sapiens glutathione peroxidase 3 (plasma) (GPX3), mRNA.",soluble fraction [goid 5625] [pmid 3619451] [evidence TAS]; extracellular region [goid 5576] [pmid 3619451] [evidence TAS],response to lipid hydroperoxide [goid 6982] [evidence NR ],electron transporter activity [goid 5489] [pmid 3619451] [evidence TAS]; selenium binding [goid 8430] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; glutathione peroxidase activity [goid 4602] [pmid 3619451] [evidence TAS],5,150388662-150388711,5q33.1d,+,NM_002084.2,2878,GPX3,-2.158037611749654,12.678090721320418,-20.966169667799907,7.377327607867965e-49,5.904222831128889e-47,100.6704801220648
ARHGAP30,ILMN_1750805,"Homo sapiens Rho GTPase activating protein 30 (ARHGAP30), transcript variant 2, mRNA.",intracellular [goid 5622] [evidence IEA]; intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],,1,159283524-159283573,1q23.3a,-,NM_181720.2,257106,ARHGAP30,-1.428308205412172,7.934728085430351,-20.944153360882087,8.387820435948607e-49,6.686195668623892e-47,100.5423753882478
FPR1,ILMN_2092118,"Homo sapiens formyl peptide receptor 1 (FPR1), mRNA.",plasma membrane [goid 5886] [pmid 10882119] [evidence TAS]; integral to membrane [goid 16021] [pmid 2161213] [evidence TAS]; endosome [goid 5768] [pmid 10823817] [evidence TAS],"nitric oxide mediated signal transduction [goid 7263] [pmid 10861041] [evidence TAS]; cell motility [goid 6928] [pmid 10882119] [evidence TAS]; G-protein signaling, coupled to cAMP nucleotide second messenger [goid 7188] [pmid 10889468] [evidence TAS]; chemotaxis [goid 6935] [pmid 10857861] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10823817] [evidence TAS]; inflammatory response [goid 6954] [evidence NR ]; signal transduction [goid 7165] [pmid 10820279] [evidence TAS]",N-formyl peptide receptor activity [goid 4982] [pmid 12218158] [evidence IDA]; receptor activity [goid 4872] [pmid 10857861] [evidence TAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],19,56941267-56941316,19q13.33e,-,NM_002029.3,2357,FPR1,-3.2131605465377655,8.420781396206376,-20.94102750846252,8.542138181488957e-49,6.782186537112342e-47,100.5241822684974
STXBP6,ILMN_1750912,"Homo sapiens syntaxin binding protein 6 (amisyn) (STXBP6), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],vesicle-mediated transport [goid 16192] [evidence IEA]; vesicle-mediated transport [goid 16192] [evidence IEA],,14,24395050-24395099,14q12a,-,NM_014178.6,29091,STXBP6,-2.8292322430082733,7.452877286936421,-20.938355983639234,8.676283110770133e-49,6.861465315426436e-47,100.50863245722438
CCL23,ILMN_1686109,"Homo sapiens chemokine (C-C motif) ligand 23 (CCL23), transcript variant CKbeta8-1, mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],cell-cell signaling [goid 7267] [pmid 9104803] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9104803] [evidence TAS]; chemotaxis [goid 6935] [pmid 9104803] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 9886417] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9886417] [evidence TAS]; signal transduction [goid 7165] [pmid 9886417] [evidence NAS]; inflammatory response [goid 6954] [pmid 9104803] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 9104803] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9104803] [evidence TAS]; chemotaxis [goid 6935] [pmid 9104803] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 9886417] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9886417] [evidence TAS]; signal transduction [goid 7165] [pmid 9886417] [evidence NAS]; inflammatory response [goid 6954] [pmid 9104803] [evidence TAS],heparin binding [goid 8201] [evidence IEA]; chemokine activity [goid 8009] [pmid 9886417] [evidence TAS]; heparin binding [goid 8201] [evidence IEA]; chemokine activity [goid 8009] [pmid 9886417] [evidence TAS],17,31364298-31364347,17q12b,-,NM_005064.3,6368,CCL23,-2.3760329960029507,7.803779043855575,-20.930467707226654,9.084842902603737e-49,7.156280976192738e-47,100.46271291338557
PILRA,ILMN_1729915,"Homo sapiens paired immunoglobin-like type 2 receptor alpha (PILRA), transcript variant 2, mRNA.",integral to plasma membrane [goid 5887] [evidence ISS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence ISS]; membrane [goid 16020] [evidence IEA],transmembrane receptor protein tyrosine kinase activation (dimerization) [goid 7171] [evidence ISS]; signal transduction [goid 7165] [pmid 10903717] [evidence IDA]; transmembrane receptor protein tyrosine kinase activation (dimerization) [goid 7171] [evidence ISS]; signal transduction [goid 7165] [pmid 10903717] [evidence IDA],receptor activity [goid 4872] [evidence IEA]; protein binding [goid 5515] [evidence ISS]; receptor activity [goid 4872] [evidence IEA]; protein binding [goid 5515] [evidence ISS],7,99835352-99835401,7q22.1c,+,NM_178272.1,29992,PILRA,-1.6911824967933207,7.73754208917656,-20.927883360507522,9.22285098715825e-49,7.220495376341002e-47,100.44766711140362
SEMA4B,ILMN_1672589,"Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B (SEMA4B), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell differentiation [goid 30154] [evidence IEA]; development [goid 7275] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; development [goid 7275] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],15,88573628-88573677,15q26.1b,+,NM_020210.2,10509,SEMA4B,1.0513194122072589,7.662601986177637,20.927592052310043,9.238538666249982e-49,7.220495376341002e-47,100.44597109224264
UBE2T,ILMN_1711470,"Homo sapiens ubiquitin-conjugating enzyme E2T (putative) (UBE2T), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],1,200568771-200568820,1q32.1d,-,NM_014176.1,29089,UBE2T,2.2408952093090084,7.242901179364376,20.90989594497383,1.0243506035001355e-48,7.974788667249303e-47,100.34292295984352
C5AR1,ILMN_1689836,"Homo sapiens complement component 5a receptor 1 (C5AR1), mRNA.",integral to plasma membrane [goid 5887] [pmid 2007135] [evidence TAS]; plasma membrane [goid 5886] [pmid 2007135] [evidence TAS],chemotaxis [goid 6935] [pmid 10352266] [evidence TAS]; phospholipase C activation [goid 7202] [pmid 7649993] [evidence TAS]; signal transduction [goid 7165] [pmid 8702752] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; sensory perception of chemical stimulus [goid 7606] [pmid 9590258] [evidence TAS]; cellular defense response [goid 6968] [pmid 8779720] [evidence TAS],C5a anaphylatoxin receptor activity [goid 4944] [pmid 10352266] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],19,52516830-52516879,19q13.32b,+,NM_001736.2,728,C5AR1,-2.2782399760299334,7.911687014084309,-20.881325355048993,1.2102855808441319e-48,9.364051597920187e-47,100.1764673740032
C1orf106,ILMN_1713952,"Homo sapiens chromosome 1 open reading frame 106 (C1orf106), mRNA.",,,,1,199151198-199151247,1q32.1b,+,NM_018265.1,55765,C1orf106,2.557235152434467,9.1199736191275,20.88106038522768,1.2121598180034628e-48,9.364051597920187e-47,100.17492314893903
CDGAP,ILMN_1752914,"Homo sapiens Cdc42 GTPase-activating protein (CDGAP), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],,3,120618869-120618918,3q13.32b-q13.33a,+,NM_020754.1,57514,CDGAP,-1.760588829395929,7.061670329522508,-20.852644320154944,1.431039539588496e-48,1.1012399656956395e-46,100.00926518075292
PC,ILMN_1671489,"Homo sapiens pyruvate carboxylase (PC), nuclear gene encoding mitochondrial protein, transcript variant A, mRNA.",mitochondrion [goid 5739] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],metabolism [goid 8152] [evidence IEA]; lipid biosynthesis [goid 8610] [evidence IEA]; gluconeogenesis [goid 6094] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; lipid biosynthesis [goid 8610] [evidence IEA]; gluconeogenesis [goid 6094] [evidence IEA],manganese ion binding [goid 30145] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; biotin binding [goid 9374] [pmid 8048912] [evidence TAS]; ATP binding [goid 5524] [pmid 8048912] [evidence TAS]; ligase activity [goid 16874] [evidence IEA]; pyruvate carboxylase activity [goid 4736] [pmid 7918683] [evidence TAS]; manganese ion binding [goid 30145] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; biotin binding [goid 9374] [pmid 8048912] [evidence TAS]; ATP binding [goid 5524] [pmid 8048912] [evidence TAS]; ligase activity [goid 16874] [evidence IEA]; pyruvate carboxylase activity [goid 4736] [pmid 7918683] [evidence TAS],11,66372712-66372761,11q13.1e-q13.1f,-,NM_000920.2,5091,PC,1.6323690075142343,6.357105500191945,20.839393130787922,1.5462686597531757e-48,1.1853541511241969e-46,99.93197966618878
GNG11,ILMN_1782419,"Homo sapiens guanine nucleotide binding protein (G protein), gamma 11 (GNG11), mRNA.",heterotrimeric G-protein complex [goid 5834] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA],7,93389369-93389385:93389386-93389418,7q21.3a,+,NM_004126.2,2791,GNG11,-3.044043695865051,10.307800146487125,-20.819096665139142,1.7410794449559864e-48,1.329599905903793e-46,99.81356093100018
C1orf21,ILMN_1797735,"Homo sapiens chromosome 1 open reading frame 21 (C1orf21), mRNA.",,,,1,182864519-182864568,1q25.3f,+,NM_030806.3,81563,C1orf21,-2.215214272080921,7.763422099368323,-20.806131103627052,1.8782370760653326e-48,1.4288884949777633e-46,99.73788693768863
MTA3,ILMN_1768751,"Homo sapiens metastasis associated 1 family, member 3 (MTA3), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],2,42789546-42789595,2p21e,+,NM_020744.2,57504,MTA3,1.40343699100245,8.519047553971713,20.77915642106634,2.1993472476150954e-48,1.6664974204507064e-46,99.58038060194214
LPXN,ILMN_1742789,"Homo sapiens leupaxin (LPXN), mRNA.",cytoplasm [goid 5737] [evidence NR ],cell adhesion [goid 7155] [pmid 9565592] [evidence NAS]; signal transduction [goid 7165] [pmid 9565592] [evidence TAS]; protein complex assembly [goid 6461] [pmid 9565592] [evidence TAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],11,58051048-58051097,11q12.1c,-,NM_004811.1,9404,LPXN,-1.5233184502023747,10.558290323022954,-20.778545415867743,2.2072261916205375e-48,1.6664974204507064e-46,99.57681185932452
SDCBP,ILMN_2363586,"Homo sapiens syndecan binding protein (syntenin) (SDCBP), transcript variant 2, mRNA.",interleukin-5 receptor complex [goid 5895] [pmid 11498591] [evidence ISS]; nucleus [goid 5634] [pmid 11179419] [evidence NAS]; membrane [goid 16020] [pmid 9391086] [evidence NAS]; cytoskeleton [goid 5856] [pmid 9391086] [evidence NAS]; adherens junction [goid 5912] [pmid 11179419] [evidence NAS]; endoplasmic reticulum [goid 5783] [evidence IEA]; interleukin-5 receptor complex [goid 5895] [pmid 11498591] [evidence ISS]; nucleus [goid 5634] [pmid 11179419] [evidence NAS]; membrane [goid 16020] [pmid 9391086] [evidence NAS]; cytoskeleton [goid 5856] [pmid 9391086] [evidence NAS]; adherens junction [goid 5912] [pmid 11179419] [evidence NAS]; endoplasmic reticulum [goid 5783] [evidence IEA],"synaptic transmission [goid 7268] [pmid 9883737] [evidence NAS]; substrate-bound cell migration, cell extension [goid 6930] [pmid 12037664] [evidence NAS]; metabolism [goid 8152] [evidence IEA]; protein targeting to membrane [goid 6612] [pmid 10230395] [evidence NAS]; intracellular signaling cascade [goid 7242] [pmid 9391086] [evidence NAS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 12037664] [evidence NAS]; synaptic transmission [goid 7268] [pmid 9883737] [evidence NAS]; substrate-bound cell migration, cell extension [goid 6930] [pmid 12037664] [evidence NAS]; metabolism [goid 8152] [evidence IEA]; protein targeting to membrane [goid 6612] [pmid 10230395] [evidence NAS]; intracellular signaling cascade [goid 7242] [pmid 9391086] [evidence NAS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 12037664] [evidence NAS]",protein heterodimerization activity [goid 46982] [pmid 11152476] [evidence IPI]; neurexin binding [goid 42043] [pmid 11152476] [evidence ISS]; protein binding [goid 5515] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; cytoskeletal adaptor activity [goid 8093] [pmid 9391086] [evidence NAS]; interleukin-5 receptor binding [goid 5137] [pmid 11498591] [evidence ISS]; syndecan binding [goid 45545] [pmid 9391086] [evidence NAS]; protein heterodimerization activity [goid 46982] [pmid 11152476] [evidence IPI]; neurexin binding [goid 42043] [pmid 11152476] [evidence ISS]; protein binding [goid 5515] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; cytoskeletal adaptor activity [goid 8093] [pmid 9391086] [evidence NAS]; interleukin-5 receptor binding [goid 5137] [pmid 11498591] [evidence ISS]; syndecan binding [goid 45545] [pmid 9391086] [evidence NAS],8,59657151-59657200,8q12.1c,+,NM_001007067.1,6386,SDCBP,-1.8865805833485414,9.997973591659308,-20.717761465477054,3.150988663516545e-48,2.37011207442252e-46,99.22155273819425
PKNOX2,ILMN_1807689,"Homo sapiens PBX/knotted 1 homeobox 2 (PKNOX2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],11,124808015-124808064,11q24.2b,+,NM_022062.1,63876,PKNOX2,-1.9367430639657588,6.667344063085675,-20.705634705195006,3.3830963854258114e-48,2.5351682576629078e-46,99.15062104359467
CCDC48,ILMN_1751099,"Homo sapiens coiled-coil domain containing 48 (CCDC48), mRNA.",,,,3,130241920-130241969,3q21.3c,+,NM_024768.1,79825,CCDC48,-2.0674845148502285,6.241771591403173,-20.694459950956166,3.612149338688432e-48,2.69671208837605e-46,99.08524150968104
FCGR1B,ILMN_2261600,"Homo sapiens Fc fragment of IgG, high affinity Ib, receptor (CD64) (FCGR1B), transcript variant 1, mRNA.",,,,1,120736083-120736132,,-,NM_001017986.1,2210,FCGR1B,-2.414875060120554,6.851606415913545,-20.683028290829323,3.862585432052724e-48,2.872959454442784e-46,99.01834273567016
LHFP,ILMN_1767448,"Homo sapiens lipoma HMGIC fusion partner (LHFP), mRNA.",,,,13,38815518-38815567,13q13.3e,-,NM_005780.1,10186,LHFP,-2.1140412958749515,9.341267403086068,-20.674276888111507,4.066020857107131e-48,3.013072048481462e-46,98.9671179392937
CRTAP,ILMN_1665235,"Homo sapiens cartilage associated protein (CRTAP), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],,binding [goid 5488] [evidence IEA]; binding [goid 5488] [evidence IEA],3,33140904-33140953,3p22.3c,+,NM_006371.3,10491,CRTAP,-1.7852484935310091,8.404003504878917,-20.658016426368263,4.473002150872813e-48,3.292775597471368e-46,98.87191474378119
CRTAC1,ILMN_1658384,"Homo sapiens cartilage acidic protein 1 (CRTAC1), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],10,99614982-99615031,10q24.2a,-,NM_018058.4,55118,CRTAC1,-3.69384631968646,9.4332595234378,-20.6578876143961,4.476384258857517e-48,3.292775597471368e-46,98.87116043195941
CCNF,ILMN_1773119,"Homo sapiens cyclin F (CCNF), mRNA.",nucleus [goid 5634] [evidence IEA],cell division [goid 51301] [evidence IEA]; mitosis [goid 7067] [evidence IEA],,16,2448700-2448749,16p13.3d,+,NM_001761.1,899,CCNF,1.9834014781602685,7.853170740939467,20.606139135342247,6.065561482860654e-48,4.445412239892892e-46,98.56795795911877
UBE2E2,ILMN_1707475,"Homo sapiens ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) (UBE2E2), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],3,23606887-23606936,3p24.3a,+,NM_152653.1,7325,UBE2E2,-1.3332641512966994,10.168973377803098,-20.605502791284117,6.088276980493386e-48,4.4457753950989654e-46,98.56422743602374
TSPAN7,ILMN_1809291,"Homo sapiens tetraspanin 7 (TSPAN7), mRNA.",plasma membrane [goid 5886] [pmid 10617319] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8420826] [evidence TAS]; plasma membrane [goid 5886] [pmid 10617319] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8420826] [evidence TAS],,,X,38432497-38432546,Xp11.4e,+,NM_004615.2,7102,TSPAN7,-3.347512421983918,9.01212868456008,-20.596029540703444,6.436717143969748e-48,4.683121331510789e-46,98.50868517626503
TK1,ILMN_1806037,"Homo sapiens thymidine kinase 1, soluble (TK1), mRNA.",cytoplasm [goid 5737] [evidence NR ],"DNA replication [goid 6260] [evidence IEA]; nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 3335503] [evidence TAS]",thymidine kinase activity [goid 4797] [pmid 3335503] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; kinase activity [goid 16301] [evidence IEA],17,73682074-73682123,17q25.3b,-,NM_003258.1,7083,TK1,2.526380191250616,8.281437795067717,20.594401705450025,6.498575459199959e-48,4.710996296654811e-46,98.49913994779949
PTPRM,ILMN_1744937,"Homo sapiens protein tyrosine phosphatase, receptor type, M (PTPRM), mRNA.",integral to plasma membrane [goid 5887] [pmid 1655529] [evidence TAS]; membrane [goid 16020] [evidence IEA],protein amino acid dephosphorylation [goid 6470] [pmid 10809770] [evidence TAS],transmembrane receptor protein tyrosine phosphatase activity [goid 5001] [pmid 10809770] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; protein tyrosine phosphatase activity [goid 4725] [evidence IEA],18,8396361-8396410,18p11.23b-p11.23a,+,NM_002845.2,5797,PTPRM,-1.7657523138250628,9.342978058128045,-20.586004176873097,6.827290460699686e-48,4.931423376811528e-46,98.44989363287623
REM1,ILMN_1719811,"Homo sapiens RAS (RAD and GEM)-like GTP-binding 1 (REM1), mRNA.",,small GTPase mediated signal transduction [goid 7264] [evidence IEA],calmodulin binding [goid 5516] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],20,29536213-29536262,20q11.21b,+,NM_014012.4,28954,REM1,-2.1194510146175602,6.8868062277775826,-20.569318866191807,7.530781075368617e-48,5.4199952430206934e-46,98.35201846629911
RHBDL1,ILMN_1660864,"Homo sapiens rhomboid, veinlet-like 1 (Drosophila) (RHBDL1), mRNA.",membrane fraction [goid 5624] [pmid 9662444] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9662444] [evidence TAS]; membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [pmid 9662444] [evidence TAS],serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],16,668114-668163,16p13.3f,+,NM_003961.1,9028,RHBDL1,2.20678021856558,6.320847278807048,20.547238546121662,8.574844846675821e-48,6.149300920870603e-46,98.22244302764051
FCGR2A,ILMN_1666932,"Homo sapiens Fc fragment of IgG, low affinity IIa, receptor (CD32) (FCGR2A), mRNA.",plasma membrane [goid 5886] [pmid 2139735] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 2139735] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [evidence NR ]; immune response [goid 6955] [evidence NR ],receptor activity [goid 4872] [evidence IEA]; IgG binding [goid 19864] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence NR ]; receptor activity [goid 4872] [evidence IEA]; IgG binding [goid 19864] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence NR ],1,159755359-159755408,1q23.3a,+,NM_021642.2,2212,FCGR2A,-1.6605865680883847,8.429249878785061,-20.52361277547261,9.853447605752951e-48,7.04099213199661e-46,98.0837309469921
TFAP2A,ILMN_1733135,"Homo sapiens transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) (TFAP2A), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 8321221] [evidence TAS]; nucleus [goid 5634] [pmid 12586840] [evidence IMP],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [evidence NR ]; transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 8321221] [evidence TAS]; ectoderm development [goid 7398] [pmid 8661133] [evidence TAS]; transcription [goid 6350] [evidence IEA]; ectoderm development [goid 7398] [pmid 8661133] [evidence TAS]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 8321221] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [evidence NR ]","RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [evidence NR ]; transcription coactivator activity [goid 3713] [pmid 8321221] [evidence TAS]; protein binding [goid 5515] [pmid 10987820] [evidence IPI]; transcription factor activity [goid 3700] [evidence IEA]; transcription coactivator activity [goid 3713] [pmid 8321221] [evidence TAS]; protein dimerization activity [goid 46983] [pmid 12072434] [evidence IDA]; transcription factor activity [goid 3700] [evidence IEA]; RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [evidence NR ]",6,10523193-10523204:10523205-10523242,6p24.3a,-,NM_003220.2,7020,TFAP2A,1.4374820822524779,6.586153112266254,20.514192318436066,1.0415139829867393e-47,7.415876075302022e-46,98.02840196380379
SEC22C,ILMN_1664051,"Homo sapiens SEC22 vesicle trafficking protein homolog C (S. cerevisiae) (SEC22C), transcript variant 2, mRNA.",integral to membrane [goid 16021] [pmid 9501016] [evidence TAS]; endoplasmic reticulum [goid 5783] [pmid 9501016] [evidence TAS]; integral to membrane [goid 16021] [pmid 9501016] [evidence TAS]; endoplasmic reticulum [goid 5783] [pmid 9501016] [evidence TAS],vesicle-mediated transport [goid 16192] [evidence IEA]; vesicle-mediated transport [goid 16192] [evidence IEA],,3,42574132-42574181,3p22.1a,-,NM_004206.2,9117,SEC22C,-1.4472444687072024,8.901836174745005,-20.47872474298271,1.2833831365200056e-47,9.105648863649743e-46,97.8199917251697
HOOK1,ILMN_1741406,"Homo sapiens hook homolog 1 (Drosophila) (HOOK1), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; microtubule [goid 5874] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],microtubule cytoskeleton organization and biogenesis [goid 226] [evidence IEA]; spermatogenesis [goid 7283] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA],microtubule binding [goid 8017] [evidence IEA],1,60111064-60111113,1p32.1c,+,NM_015888.3,51361,HOOK1,2.25909063579439,8.709731238049397,20.468347837471857,1.364278585452385e-47,9.645401391424496e-46,97.75898658077372
CBLC,ILMN_1811729,"Homo sapiens Cas-Br-M (murine) ecotropic retroviral transforming sequence c (CBLC), mRNA.",,,,19,49989338-49989378:49995478-49995486,19q13.31b,+,NM_012116.2,23624,CBLC,2.1174375902889935,6.461541699129183,20.45697576678163,1.4588220918184724e-47,1.0277504370811266e-45,97.69211552357652
FLJ46072,ILMN_1751328,"Homo sapiens FLJ46072 protein (FLJ46072), mRNA.",,,,8,144878338-144878387,8q24.3g,-,NM_198488.1,286077,FLJ46072,1.690107097351083,9.740028255412078,20.437980852124568,1.631633908856416e-47,1.1454642543297955e-45,97.58038403531899
LILRA5,ILMN_1726545,"Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 (LILRA5), transcript variant 4, mRNA.",,,,19,59514620-59514669,19q13.42a,-,NM_181986.1,353514,LILRA5,-1.8341202964120544,6.926512514984351,-20.416147414246442,1.855806572295972e-47,1.2982859405069164e-45,97.45190037477367
EFNA4,ILMN_1665696,"Homo sapiens ephrin-A4 (EFNA4), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 8660976] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell-cell signaling [goid 7267] [pmid 8660976] [evidence TAS],transmembrane-ephrin receptor activity [goid 5005] [pmid 8660976] [evidence TAS]; GPI anchor binding [goid 48503] [evidence IEA],1,153308015-153308064,1q22a,+,NM_005227.2,1945,EFNA4,1.3260635694864567,7.614733711977617,20.3900137001819,2.1651515806615676e-47,1.5094199590897783e-45,97.29803283221649
CARD12,ILMN_1796976,"Homo sapiens NLR family, CARD domain containing 4 (NLRC4), mRNA.",intracellular [goid 5622] [pmid 15107016] [evidence NAS],positive regulation of apoptosis [goid 43065] [pmid 11374873] [evidence IMP]; caspase activation [goid 6919] [pmid 15030775] [evidence IDA],transferase activity [goid 16740] [evidence IEA]; protein homodimerization activity [goid 42803] [pmid 15107016] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 15882992] [evidence IDA]; magnesium ion binding [goid 287] [pmid 15882992] [evidence TAS]; protein binding [goid 5515] [pmid 15107016] [evidence IPI],2,32314083-32314132,2p22.3e,-,NM_021209.3,58484,CARD12,-1.5641382608267964,6.02079705805137,-20.38720130761398,2.201384743981168e-47,1.529350901304695e-45,97.28146923966605
VGLL3,ILMN_1714586,"Homo sapiens vestigial like 3 (Drosophila) (VGLL3), mRNA.",nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA],transcription regulator activity [goid 30528] [evidence IEA],3,87070266-87070315,3p12.1a,-,NM_016206.2,389136,VGLL3,-2.3418507861844313,6.6244060999239895,-20.369751999622718,2.440196600482192e-47,1.6893928575241418e-45,97.17867952923676
AHNAK,ILMN_1714567,"Homo sapiens AHNAK nucleoprotein (AHNAK), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 1608957] [evidence NAS],,protein binding [goid 5515] [evidence IEA],11,62040123-62040172,11q12.3a,-,NM_001620.1,79026,AHNAK,-1.5856046974407336,8.614467076458714,-20.36542455983322,2.503341706869647e-47,1.7271331334844104e-45,97.15318175893789
TNFSF13,ILMN_1784264,"Homo sapiens tumor necrosis factor (ligand) superfamily, member 13 (TNFSF13), transcript variant gamma, mRNA.",membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],immune response [goid 6955] [evidence IEA]; signal transduction [goid 7165] [pmid 9743536] [evidence TAS]; positive regulation of cell proliferation [goid 8284] [pmid 9743536] [evidence TAS]; positive regulation of isotype switching to IgA isotypes [goid 48298] [pmid 14988498] [evidence IDA],tumor necrosis factor receptor binding [goid 5164] [evidence IEA],17,7404833-7404858:7405040-7405046:7405047-7405063,17p13.1d,+,NM_172088.1,8741,TNFSF13,-1.8376080795126848,6.45168078208025,-20.344696583279834,2.829302998029967e-47,1.9453159582331126e-45,97.0310178947831
CHTF18,ILMN_1756705,"Homo sapiens CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) (CHTF18), mRNA.",,,ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; nucleoside-triphosphatase activity [goid 17111] [evidence IEA]; helicase activity [goid 4386] [evidence IEA],16,787085-787093:787695-787735,16p13.3f,+,NM_022092.1,63922,CHTF18,2.0815209691659584,7.044478254529032,20.339428061085904,2.9187364136541224e-47,1.999934183712044e-45,96.99995845677795
FHL5,ILMN_1669023,"Homo sapiens four and a half LIM domains 5 (FHL5), mRNA.",nucleus [goid 5634] [evidence IEA],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],6,97170923-97170972,6q16.1f,+,NM_020482.3,9457,FHL5,-1.9487752193209413,6.226496834567133,-20.33768577587596,2.948931696522249e-47,2.0137278288060464e-45,96.98968643128458
KIAA1324L,ILMN_1652371,"Homo sapiens KIAA1324-like (KIAA1324L), mRNA.",,,,7,86347484-86347533,7q21.12a,-,NM_152748.2,222223,KIAA1324L,-2.5269889910282783,8.239679394905169,-20.300749917718253,3.6682764055051894e-47,2.496424296644484e-45,96.77183431130449
ABCA9,ILMN_1668446,"Homo sapiens ATP-binding cassette, sub-family A (ABC1), member 9 (ABCA9), transcript variant 1, mRNA.",,,ATPase activity [goid 16887] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],17,64483214-64483263,17q24.2c,-,NM_080283.2,10350,ABCA9,-1.3535952505074489,5.944141461041857,-20.26869063685768,4.434071886973295e-47,3.00735289201904e-45,96.58260766001627
XPR1,ILMN_1798030,"Homo sapiens xenotropic and polytropic retrovirus receptor (XPR1), mRNA.",plasma membrane [goid 5886] [pmid 9927670] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9927670] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 9927670] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9927670] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9990033] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9990033] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 9990033] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 9990033] [evidence TAS],1,179121561-179121610,1q25.3a,+,NM_004736.2,9213,XPR1,2.0020089094405744,10.1374800658732,20.23169791660467,5.519284456828034e-47,3.730737953115382e-45,96.3641036266391
ALOX5,ILMN_1680996,"Homo sapiens arachidonate 5-lipoxygenase (ALOX5), mRNA.",,leukotriene biosynthesis [goid 19370] [evidence IEA]; electron transport [goid 6118] [evidence IEA]; inflammatory response [goid 6954] [evidence NR ]; leukotriene biosynthesis [goid 19370] [evidence IEA]; electron transport [goid 6118] [evidence IEA]; inflammatory response [goid 6954] [evidence NR ],iron ion binding [goid 5506] [evidence IEA]; lipoxygenase activity [goid 16165] [evidence IEA]; arachidonate 5-lipoxygenase activity [goid 4051] [pmid 2829172] [evidence TAS]; oxidoreductase activity [goid 16491] [evidence IEA]; protein binding [goid 5515] [pmid 11785969] [evidence IPI]; calcium ion binding [goid 5509] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; lipoxygenase activity [goid 16165] [evidence IEA]; arachidonate 5-lipoxygenase activity [goid 4051] [pmid 2829172] [evidence TAS]; oxidoreductase activity [goid 16491] [evidence IEA]; protein binding [goid 5515] [pmid 11785969] [evidence IPI]; calcium ion binding [goid 5509] [evidence IEA],10,45261351-45261400,10q11.21d,+,NM_000698.2,240,ALOX5,-1.2489183490381244,8.408700726017301,-20.21159234085697,6.217124663798868e-47,4.18829058159218e-45,96.24527542891035
GPR172A,ILMN_2041577,"Homo sapiens G protein-coupled receptor 172A (GPR172A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA],8,145555566-145555615,8q24.3h,+,NM_024531.3,79581,GPR172A,1.332070976535963,10.095073641882452,20.210013626878546,6.275532326180914e-47,4.213451368531132e-45,96.23594277796433
TNFRSF21,ILMN_1699695,"Homo sapiens tumor necrosis factor receptor superfamily, member 21 (TNFRSF21), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],6,47307455-47307504,6p12.3d,-,NM_014452.3,27242,TNFRSF21,1.7800595385039113,11.463664654796288,20.208035248721366,6.349504394350306e-47,4.248858994052205e-45,96.22424705584896
CD300LG,ILMN_2174804,"Homo sapiens CD300 molecule-like family member g (CD300LG), mRNA.",,,,17,39295859-39295908,17q21.31b,+,NM_145273.2,146894,CD300LG,-1.6563388508204753,6.628371488153105,-20.195149458759104,6.853191311388841e-47,4.570621725275597e-45,96.14805734778795
TTK,ILMN_1788166,"Homo sapiens TTK protein kinase (TTK), mRNA.",spindle [goid 5819] [pmid 10366450] [evidence TAS],mitotic spindle organization and biogenesis [goid 7052] [pmid 7737118] [evidence TAS]; mitotic spindle checkpoint [goid 7094] [pmid 10366450] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 1639825] [evidence TAS],kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [pmid 7737118] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; binding [goid 5488] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 7737118] [evidence TAS],6,80807086-80807135,6q14.1d,+,NM_003318.3,7272,TTK,1.9802142878485176,6.069530227362939,20.19170463116489,6.99451065771304e-47,4.6493743933396185e-45,96.12768566436262
CDCA5,ILMN_1683450,"Homo sapiens cell division cycle associated 5 (CDCA5), mRNA.",nucleus [goid 5634] [evidence ISS]; cohesin complex [goid 8278] [pmid 15837422] [evidence IDA]; cytoplasm [goid 5737] [evidence ISS],mitotic metaphase plate congression [goid 7080] [pmid 15837422] [evidence IMP]; G1/S transition of mitotic cell cycle [goid 82] [pmid 15837422] [evidence IDA]; mitosis [goid 7067] [pmid 15837422] [evidence IDA]; mitotic chromosome condensation [goid 7076] [pmid 15837422] [evidence IMP]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],chromatin binding [goid 3682] [pmid 15837422] [evidence TAS]; protein binding [goid 5515] [evidence ISS],11,64601683-64601732,11q13.1c,-,NM_080668.2,113130,CDCA5,2.412581735231046,8.018268195381607,20.156303907395444,8.627595646693805e-47,5.715924956922174e-45,95.91825134536684
AFF3,ILMN_1677951,"Homo sapiens AF4/FMR2 family, member 3 (AFF3), transcript variant 2, mRNA.",nucleus [goid 5634] [pmid 8555498] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [pmid 8555498] [evidence TAS]; transcription [goid 6350] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],2,99994392-99994441,2q11.2c-q11.2d,-,NM_001025108.1,3899,AFF3,-1.0342697628330217,5.7462475220377955,-20.137816157941476,9.627412577499515e-47,6.357269665036643e-45,95.80881437890243
PRC1,ILMN_1728934,"Homo sapiens protein regulator of cytokinesis 1 (PRC1), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 9885575] [evidence TAS]; spindle microtubule [goid 5876] [pmid 9885575] [evidence TAS],cell cycle [goid 7049] [evidence IEA]; cytokinesis [goid 910] [pmid 9885575] [evidence TAS]; mitotic spindle elongation [goid 22] [pmid 9885575] [evidence TAS],protein binding [goid 5515] [pmid 14744859] [evidence IPI],15,89310504-89310553,15q26.1c,-,NM_003981.2,9055,PRC1,1.9500853212207891,8.117200080739389,20.11881644262948,1.077623572775422e-46,7.092464619766658e-45,95.69630290021465
FGR,ILMN_1795158,"Homo sapiens Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog (FGR), mRNA.",,response to virus [goid 9615] [pmid 3003578] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 2995972] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; protein kinase activity [goid 4672] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [pmid 3003578] [evidence TAS],1,27811518-27811567,1p35.3b,-,NM_005248.1,2268,FGR,-1.3725251497204587,7.991505386420396,-20.11213957571482,1.1211823847628417e-46,7.354956444044241e-45,95.65675361571175
HSPB6,ILMN_1721283,"Homo sapiens heat shock protein, alpha-crystallin-related, B6 (HSPB6), mRNA.",,protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [evidence IEA],structural constituent of eye lens [goid 5212] [evidence IEA]; protein binding [goid 5515] [pmid 16225851] [evidence IPI],19,40937371-40937420,19q13.12a,-,NM_144617.1,126393,HSPB6,-2.480265449910359,7.856642219023465,-20.110181536369396,1.1342882506096975e-46,7.416614156274126e-45,95.64515446006986
ADAM8,ILMN_1708348,"Homo sapiens ADAM metallopeptidase domain 8 (ADAM8), mRNA.",integral to plasma membrane [goid 5887] [pmid 9126482] [evidence TAS],,metalloendopeptidase activity [goid 4222] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],10,134926186-134926235,10q26.3f,-,NM_001109.2,101,ADAM8,2.4465226332281285,7.502875385591123,20.08723603704279,1.2998237085123025e-46,8.471294058603958e-45,95.5091932431439
MGP,ILMN_1651958,"Homo sapiens matrix Gla protein (MGP), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9916809] [evidence TAS]; extracellular region [goid 5576] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9916809] [evidence TAS],ossification [goid 1503] [pmid 9916809] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; cartilage condensation [goid 1502] [pmid 9916809] [evidence TAS]; regulation of bone mineralization [goid 30500] [evidence IEA]; ossification [goid 1503] [pmid 9916809] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; cartilage condensation [goid 1502] [pmid 9916809] [evidence TAS]; regulation of bone mineralization [goid 30500] [evidence IEA],structural constituent of bone [goid 8147] [pmid 9916809] [evidence TAS]; extracellular matrix structural constituent [goid 5201] [pmid 9916809] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; structural constituent of bone [goid 8147] [pmid 9916809] [evidence TAS]; extracellular matrix structural constituent [goid 5201] [pmid 9916809] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],12,14930002-14930051,12p12.3e,-,NM_000900.2,4256,MGP,-2.1755665611979236,12.810089670493863,-20.066942251209877,1.4663304963448419e-46,9.525435250281687e-45,95.38889039919903
DUS1L,ILMN_1653342,"Homo sapiens dihydrouridine synthase 1-like (S. cerevisiae) (DUS1L), mRNA.",,tRNA processing [goid 8033] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; FAD binding [goid 50660] [evidence IEA],17,77609348-77609397,17q25.3g,-,NM_022156.3,64118,DUS1L,1.5451355435218215,8.001210110191098,20.030071518329443,1.825556568082122e-46,1.1820626477083203e-44,95.17018856210402
RNF125,ILMN_1747192,"Homo sapiens ring finger protein 125 (RNF125), mRNA.",ubiquitin ligase complex [goid 151] [evidence IEA]; nucleus [goid 5634] [evidence IEA],immune response [goid 6955] [evidence IEA]; protein ubiquitination [goid 16567] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],18,27879682-27879693:27899863-27899900,18q12.1e,+,NM_017831.2,54941,RNF125,-1.7572671643745377,6.5432541722492825,-20.025103664660318,1.88028146229332e-46,1.2135700483085402e-44,95.14070853011987
MYCT1,ILMN_1750225,"Homo sapiens myc target 1 (MYCT1), mRNA.",,,,6,153084758-153084807,6q25.2a,+,NM_025107.1,80177,MYCT1,-1.4117092840963732,5.7026951318954895,-20.016004854969452,1.9848168632776967e-46,1.276920122201291e-44,95.08670687646556
CHPF,ILMN_1731353,"Homo sapiens chondroitin polymerizing factor (CHPF), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [goid 50510] [evidence IEA]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],2,220112075-220112124,2q35f,-,NM_024536.4,79586,CHPF,2.03437941040176,9.508127881457483,20.012571704932416,2.0257584428022028e-46,1.2990825296021304e-44,95.06632840260464
RNF43,ILMN_1700606,"Homo sapiens ring finger protein 43 (RNF43), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],17,53786311-53786360,17q22d,-,NM_017763.3,54894,RNF43,1.9097279222283694,6.9135688834516635,20.00984489998327,2.0588796298410348e-46,1.3161042694523778e-44,95.0501416152978
PVRL4,ILMN_1749044,"Homo sapiens poliovirus receptor-related 4 (PVRL4), mRNA.",,cell adhesion [goid 7155] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],1,159308405-159308454,1q23.3a,-,NM_030916.1,81607,PVRL4,1.7576274092264246,5.930615511880973,19.996609613682924,2.227527797863539e-46,1.4193750375685887e-44,94.97156167095213
HSPB8,ILMN_1791280,"Homo sapiens heat shock 22kDa protein 8 (HSPB8), mRNA.",intracellular [goid 5622] [pmid 11256614] [evidence IDA],protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [evidence IEA],kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 10833516] [evidence NAS],12,118116751-118116800,12q24.23b,+,NM_014365.2,26353,HSPB8,-2.4965672804729424,8.88792807591332,-19.98879283520659,2.333573325554018e-46,1.4822265110376124e-44,94.92514213212431
FCN1,ILMN_1668063,"Homo sapiens ficolin (collagen/fibrinogen domain containing) 1 (FCN1), mRNA.",cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; opsonization [goid 8228] [pmid 8576206] [evidence TAS],antigen binding [goid 3823] [pmid 8576206] [evidence TAS]; sugar binding [goid 5529] [pmid 8576206] [evidence TAS]; calcium ion binding [goid 5509] [pmid 8576206] [evidence TAS],9,136941286-136941335,9q34.3a,-,NM_002003.2,2219,FCN1,-2.8620200325628034,9.619415761771217,-19.97256386263122,2.5702004367667795e-46,1.6273598208490418e-44,94.82874323311461
SGPP2,ILMN_1662140,"Homo sapiens sphingosine-1-phosphate phosphotase 2 (SGPP2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],,hydrolase activity [goid 16787] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],2,222997707-222997756,2q36.1b-q36.1c,+,NM_152386.2,130367,SGPP2,1.3176441363949918,7.22767760899643,19.941822379899982,3.086455559702311e-46,1.9480694901742535e-44,94.64605243198032
GJA12,ILMN_1723048,"Homo sapiens gap junction protein, alpha 12, 47kDa (GJA12), mRNA.",membrane [goid 16020] [evidence IEA]; connexon complex [goid 5922] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell communication [goid 7154] [evidence IEA],connexon channel activity [goid 15285] [evidence IEA],1,226414049-226414098,1q42.13c,+,NM_020435.2,57165,GJA12,-2.3136649871731008,8.233386399768618,-19.927828727626718,3.354765763042445e-46,2.1107595404702277e-44,94.56285239707834
DARC,ILMN_1723684,"Homo sapiens Duffy blood group, chemokine receptor (DARC), mRNA.",plasma membrane [goid 5886] [pmid 7689250] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],defense response [goid 6952] [pmid 10570183] [evidence NAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],chemokine receptor activity [goid 4950] [evidence NAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],1,157442608-157442657,1q23.2a,+,NM_002036.2,2532,DARC,-3.5617771058621566,9.457781888094463,-19.912817269601703,3.668673213258452e-46,2.3010286410932637e-44,94.47357424132291
KRT8,ILMN_1753584,"Homo sapiens keratin 8 (KRT8), mRNA.",intermediate filament [goid 5882] [evidence NAS],cytoskeleton organization and biogenesis [goid 7010] [evidence NAS],structural molecule activity [goid 5198] [evidence NAS]; protein binding [goid 5515] [pmid 15731013] [evidence IPI],12,51577384-51577433,12q13.13e,-,NM_002273.2,3856,KRT8,2.076410292336819,11.13438581810366,19.886895619173668,4.281712458545937e-46,2.677140714705847e-44,94.31934449990923
TIE1,ILMN_1815690,"Homo sapiens tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (TIE1), mRNA.",integral to plasma membrane [goid 5887] [pmid 1312667] [evidence TAS],signal transduction [goid 7165] [pmid 1312667] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; mesoderm development [goid 7498] [pmid 7596437] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; transmembrane receptor protein tyrosine kinase activity [goid 4714] [pmid 1312667] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],1,43561228-43561277,1p34.2a,+,NM_005424.2,7075,TIE1,-1.6114275519596255,7.073821790693322,-19.852367857100386,5.260918463671904e-46,3.2791419508145625e-44,94.11378194415255
AURKB,ILMN_1684217,"Homo sapiens aurora kinase B (AURKB), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],protein serine/threonine kinase activity [goid 4674] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 16179162] [evidence IPI]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],17,8049067-8049087:8049259-8049287,17p13.1c,-,NM_004217.1,9212,AURKB,2.47368245099746,6.769649646192815,19.846138036993977,5.460175749108384e-46,3.3927700741664765e-44,94.07667689916752
DDX56,ILMN_1679405,"Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 56 (DDX56), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleolus [goid 5730] [pmid 10749921] [evidence TAS],rRNA processing [goid 6364] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ATP-dependent RNA helicase activity [goid 4004] [pmid 10749921] [evidence TAS]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],7,44572106-44572125:44572126-44572155,7p13d,-,NM_019082.2,54606,DDX56,1.228226677324626,9.951463880838869,19.807618390576867,6.871930813061842e-46,4.2567675451313105e-44,93.84714705105563
C3orf54,ILMN_1690454,"Homo sapiens chromosome 3 open reading frame 54 (C3orf54), mRNA.",,,,3,49817311-49817360,3p21.31c,+,NM_203370.1,389119,C3orf54,-2.000359184005397,8.085691445253778,-19.793777163756175,7.464227915938628e-46,4.609391115496916e-44,93.76462604253221
NARF,ILMN_2334693,"Homo sapiens nuclear prelamin A recognition factor (NARF), transcript variant 3, mRNA.",nuclear lamina [goid 5652] [pmid 10514485] [evidence TAS]; lamin filament [goid 5638] [pmid 10514485] [evidence IDA],electron transport [goid 6118] [evidence IEA],protein binding [goid 5515] [pmid 10514485] [evidence IPI]; ferredoxin hydrogenase activity [goid 8901] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; electron carrier activity [goid 9055] [evidence IEA]; lamin binding [goid 5521] [pmid 10514485] [evidence TAS],17,78039236-78039285,17q25.3g,+,NM_001038618.1,26502,NARF,1.458017472456378,9.949399433866075,19.783520721913103,7.935934754379384e-46,4.885605617403776e-44,93.70346233497082
UHRF1,ILMN_1786065,"Homo sapiens ubiquitin-like, containing PHD and RING finger domains, 1 (UHRF1), mRNA.",nucleus [goid 5634] [evidence IEA]; ubiquitin ligase complex [goid 151] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"ubiquitin cycle [goid 6512] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; protein ubiquitination [goid 16567] [evidence IEA]; transcription [goid 6350] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]",ligase activity [goid 16874] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],19,4912679-4912728,19p13.3c,+,NM_013282.2,29128,UHRF1,1.4489391676433945,6.241226720450599,19.776085129577627,8.296506874325822e-46,5.091917470598499e-44,93.65911257577663
CLIC5,ILMN_1778964,"Homo sapiens chloride intracellular channel 5 (CLIC5), mRNA.",actin cytoskeleton [goid 15629] [pmid 10793131] [evidence TAS]; Golgi stack [goid 5795] [evidence IEA]; insoluble fraction [goid 5626] [pmid 10793131] [evidence TAS]; membrane [goid 16020] [evidence IEA],chloride transport [goid 6821] [evidence IEA]; ion transport [goid 6811] [evidence IEA]; pregnancy [goid 7565] [pmid 10793131] [evidence TAS],chloride transporter activity [goid 15108] [evidence NR ]; voltage-gated chloride channel activity [goid 5247] [evidence IEA],6,45977706-45977755,6p12.3f,-,NM_016929.1,53405,CLIC5,-3.182847128022427,9.63457933141845,-19.729857724655457,1.0937855458507963e-45,6.692495780239368e-44,93.3832369146258
KIAA1912,ILMN_1669982,"PREDICTED: Homo sapiens KIAA1912 protein (KIAA1912), mRNA.",,,,,,2p16.1d-p16.1c,,XM_941554.1,114800,KIAA1912,-2.5356384995139214,7.177078566008965,-19.728931314447262,1.0998637910961977e-45,6.709169125686806e-44,93.3777056269563
MARCO,ILMN_1731503,"Homo sapiens macrophage receptor with collagenous structure (MARCO), mRNA.",integral to plasma membrane [goid 5887] [pmid 9468508] [evidence TAS]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [pmid 9468508] [evidence TAS],pattern recognition receptor activity [goid 8329] [pmid 10331948] [evidence TAS]; scavenger receptor activity [goid 5044] [evidence IEA],2,119468445-119468494,2q14.2b,+,NM_006770.3,8685,MARCO,-3.4196333077770937,9.986017098362762,-19.72696042926377,1.1129079011351611e-45,6.768103734319849e-44,93.36593777837638
ITPKA,ILMN_1776516,"Homo sapiens inositol 1,4,5-trisphosphate 3-kinase A (ITPKA), mRNA.",,signal transduction [goid 7165] [pmid 2176078] [evidence TAS],kinase activity [goid 16301] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],15,39582984-39583033,15q15.1c,+,NM_002220.1,3706,ITPKA,3.916198886018578,7.308554753367409,19.72570740007374,1.1212815530183339e-45,6.798364034179038e-44,93.35845589018396
ZMYND19,ILMN_1757627,"Homo sapiens zinc finger, MYND-type containing 19 (ZMYND19), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],9,139596627-139596676,9q34.3f,-,NM_138462.2,116225,ZMYND19,1.1955855795547121,8.508325893350783,19.70903410017331,1.2389131727392785e-45,7.488874549899542e-44,93.25888074344094
PRELP,ILMN_1707380,"Homo sapiens proline/arginine-rich end leucine-rich repeat protein (PRELP), transcript variant 1, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 7592739] [evidence TAS],skeletal development [goid 1501] [pmid 7592739] [evidence TAS],extracellular matrix structural constituent [goid 5201] [pmid 7592739] [evidence TAS]; transferase activity [goid 16740] [evidence IEA],1,201726438-201726487,1q32.1e,+,NM_002725.3,5549,PRELP,-1.7433413315200772,6.2450859860319,-19.69691586441711,1.3321089470810053e-45,8.027962594336372e-44,93.18648780832292
HSD11B1,ILMN_1811370,"Homo sapiens hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; endoplasmic reticulum membrane [goid 5789] [pmid 10497258] [evidence IDA]; microsome [goid 5792] [evidence IEA],metabolism [goid 8152] [evidence IEA]; glucocorticoid metabolism [goid 8211] [pmid 10497258] [evidence NAS]; lipid metabolism [goid 6629] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; 11-beta-hydroxysteroid dehydrogenase activity [goid 3845] [pmid 10497258] [evidence IDA],1,207944825-207944874,1q32.2b,+,NM_005525.2,3290,HSD11B1,-2.088469158945319,6.6775298449710885,-19.671616476273236,1.549976937157087e-45,9.312894462053754e-44,93.03529462865446
PLSCR4,ILMN_1757338,"Homo sapiens phospholipid scramblase 4 (PLSCR4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS],phospholipid scrambling [goid 17121] [pmid 10930526] [evidence NAS]; blood coagulation [goid 7596] [evidence NAS],calcium ion binding [goid 5509] [pmid 10930526] [evidence NAS]; phospholipid scramblase activity [goid 17128] [pmid 10930526] [evidence NAS],3,147393419-147393468,3q24c-q24d,-,NM_020353.1,57088,PLSCR4,-2.141102235858936,9.00030321625468,-19.662912290315553,1.6329253802491558e-45,9.781907487432667e-44,92.98325903604393
ESAM,ILMN_1668092,"Homo sapiens endothelial cell adhesion molecule (ESAM), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],11,124128359-124128408,11q24.2a,-,NM_138961.1,90952,ESAM,-2.182004452614745,9.89076057841021,-19.60198114275408,2.3527203640417594e-45,1.4051710162312693e-43,92.61874128721387
PDIA4,ILMN_1815261,"Homo sapiens protein disulfide isomerase family A, member 4 (PDIA4), mRNA.",endoplasmic reticulum lumen [goid 5788] [pmid 2295602] [evidence TAS],electron transport [goid 6118] [evidence IEA]; protein secretion [goid 9306] [pmid 2295602] [evidence TAS],electron transporter activity [goid 5489] [evidence IEA]; protein disulfide isomerase activity [goid 3756] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA],7,148331345-148331394,7q36.1a,-,NM_004911.3,9601,PDIA4,1.8171363252751584,8.544340156743862,19.60133656873584,2.3618329731740303e-45,1.4064153014067262e-43,92.61488274604899
MGC10993,ILMN_1756402,"Homo sapiens transmembrane protein 177 (TMEM177), mRNA.",,,,2,120155837-120155886,2q14.2c,+,NM_030577.1,80775,MGC10993,1.1494538595101487,8.119958375816696,19.5744802829739,2.7747185763296683e-45,1.6473759428843918e-43,92.45407123274914
TMEM45B,ILMN_1771120,"Homo sapiens transmembrane protein 45B (TMEM45B), mRNA.",,,,11,129235043-129235092,11q24.3b,+,NM_138788.2,120224,TMEM45B,2.552642869283206,7.76177289939034,19.569839822152353,2.853072126396194e-45,1.688883642157842e-43,92.42627598137794
SNX1,ILMN_2365479,"Homo sapiens sorting nexin 1 (SNX1), transcript variant 1, mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA]; endocytosis [goid 6897] [pmid 9819414] [evidence TAS]; intracellular protein transport [goid 6886] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA]; endocytosis [goid 6897] [pmid 9819414] [evidence TAS]; intracellular protein transport [goid 6886] [evidence IEA],protein binding [goid 5515] [evidence IEA]; protein transporter activity [goid 8565] [evidence IEA]; phosphoinositide binding [goid 35091] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; protein transporter activity [goid 8565] [evidence IEA]; phosphoinositide binding [goid 35091] [evidence IEA],15,62222858-62222907,15q22.31a,+,NM_003099.3,6642,SNX1,-1.5592418920636621,7.043176876437061,-19.566891063149157,2.904011228207892e-45,1.7139662729788642e-43,92.4086122651595
CD300C,ILMN_1701906,"Homo sapiens CD300c molecule (CD300C), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 1349532] [evidence TAS],cellular defense response [goid 6968] [pmid 1349532] [evidence TAS],transmembrane receptor activity [goid 4888] [pmid 1349532] [evidence TAS],17,70048957-70049006,17q25.1b,-,NM_006678.2,10871,CD300C,-2.4738725548441476,6.865267382943627,-19.545258151678112,3.3067050945150064e-45,1.9458986920898895e-43,92.2789941857333
S100A4,ILMN_1684306,"Homo sapiens S100 calcium binding protein A4 (S100A4), transcript variant 1, mRNA.",,,calcium ion binding [goid 5509] [pmid 8204608] [evidence TAS]; calcium ion binding [goid 5509] [pmid 8204608] [evidence TAS],1,151783859-151783894:151783895-151783908,1q21.3c,-,NM_002961.2,6275,S100A4,-2.4034716785998462,12.78821113555784,-19.538514249111774,3.443355648543437e-45,2.0144637373116107e-43,92.23857512052001
AGTR1,ILMN_1814327,"Homo sapiens angiotensin II receptor, type 1 (AGTR1), transcript variant 5, mRNA.",integral to plasma membrane [goid 5887] [pmid 1378723] [evidence TAS]; plasma membrane [goid 5886] [pmid 1378723] [evidence TAS],"signal transduction [goid 7165] [evidence IEA]; G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) [goid 7200] [pmid 1378723] [evidence TAS]; circulation [goid 8015] [pmid 8135787] [evidence NAS]; fluid secretion [goid 7589] [evidence NR ]",receptor activity [goid 4872] [evidence IEA]; C-X-C chemokine receptor activity [goid 16494] [evidence IEA]; bradykinin receptor activity [goid 4947] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; angiotensin type II receptor activity [goid 4945] [pmid 8135787] [evidence TAS],3,149942964-149943013,3q24f,+,NM_032049.1,185,AGTR1,-1.9690957360113934,6.3712444617789945,-19.531032424759026,3.601599345714606e-45,2.1008979507013945e-43,92.1937269439161
DKFZp762E1312,ILMN_1703906,"Homo sapiens hypothetical protein DKFZp762E1312 (DKFZp762E1312), mRNA.",,,,2,234414010-234414059,2q37.1e,-,NM_018410.2,55355,DKFZp762E1312,1.9971219465407692,6.283737632333649,19.488706370402856,4.6445331166015695e-45,2.7013900754931455e-43,91.93988524194984
PPM1F,ILMN_2059535,"Homo sapiens protein phosphatase 1F (PP2C domain containing) (PPM1F), mRNA.",protein serine/threonine phosphatase complex [goid 8287] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; protein amino acid dephosphorylation [goid 6470] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; protein serine/threonine phosphatase activity [goid 4722] [evidence IEA],22,20603825-20603874,22q11.22a,-,NM_014634.2,9647,PPM1F,-1.5343617214030285,10.76263270012649,-19.48499872254442,4.749209761481196e-45,2.754266345151182e-43,91.91763909454426
EVI2B,ILMN_1763452,"Homo sapiens ecotropic viral integration site 2B (EVI2B), mRNA.",integral to plasma membrane [goid 5887] [pmid 1903357] [evidence TAS],,,17,26655419-26655468,17q11.2d,-,NM_006495.2,2124,EVI2B,-2.3065261429357697,9.091692109247347,-19.454158093470333,5.71692582465293e-45,3.3059032340940987e-43,91.73252891781476
ABCC3,ILMN_1677814,"Homo sapiens ATP-binding cassette, sub-family C (CFTR/MRP), member 3 (ABCC3), transcript variant MRP3A, mRNA.",membrane fraction [goid 5624] [pmid 9813153] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9813153] [evidence TAS],transport [goid 6810] [pmid 9813153] [evidence TAS],"nucleotide binding [goid 166] [evidence IEA]; ATPase activity, coupled to transmembrane movement of substances [goid 42626] [pmid 9813153] [evidence TAS]; ATPase activity [goid 16887] [evidence IEA]; organic anion transporter activity [goid 8514] [pmid 9738950] [evidence TAS]; ATP binding [goid 5524] [pmid 9813153] [evidence TAS]",17,46123787-46123836,17q21.33b,+,NM_020037.1,8714,ABCC3,1.3925183665957483,8.066497540167761,19.451560617869074,5.806951604511391e-45,3.348284948215098e-43,91.7169332380001
RASSF1,ILMN_1683239,"Homo sapiens Ras association (RalGDS/AF-6) domain family 1 (RASSF1), transcript variant C, mRNA.",microtubule [goid 5874] [evidence IEA]; nucleus [goid 5634] [pmid 14743218] [evidence IEP],cell cycle arrest [goid 7050] [pmid 12024041] [evidence IMP]; cell cycle [goid 7049] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA]; Ras protein signal transduction [goid 7265] [pmid 15109305] [evidence IDA],metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 15109305] [evidence IPI]; zinc ion binding [goid 8270] [pmid 11333291] [evidence TAS]; diacylglycerol binding [goid 19992] [evidence IEA],3,50349648-50349697,3p21.31b,-,NM_170713.1,11186,RASSF1,-1.116465845076,8.061718213852147,-19.44889432846133,5.900842065620327e-45,3.392645058877342e-43,91.70092354326998
ALOX5AP,ILMN_1797875,"Homo sapiens arachidonate 5-lipoxygenase-activating protein (ALOX5AP), mRNA.",membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],leukotriene biosynthesis [goid 19370] [evidence IEA]; inflammatory response [goid 6954] [pmid 2300173] [evidence TAS],enzyme activator activity [goid 8047] [pmid 2300173] [evidence TAS]; binding [goid 5488] [pmid 2300173] [evidence TAS],13,30236347-30236396,13q12.3c,+,NM_001629.2,241,ALOX5AP,-2.2593872872553735,12.302453019214449,-19.44274844775107,6.123105670581615e-45,3.51034665492828e-43,91.66401743353994
TMOD1,ILMN_1736911,"Homo sapiens tropomodulin 1 (TMOD1), mRNA.",cytoskeleton [goid 5856] [evidence IEA],cytoskeleton organization and biogenesis [goid 7010] [evidence NR ],actin binding [goid 3779] [evidence IEA]; tropomyosin binding [goid 5523] [evidence IEA],9,99402093-99402142,9q22.33a-q22.33b,+,NM_003275.1,7111,TMOD1,-2.2119256381099985,7.120619170363629,-19.438677661620744,6.274929634388148e-45,3.587108346423945e-43,91.6395697952546
F12,ILMN_1671766,"Homo sapiens coagulation factor XII (Hageman factor) (F12), mRNA.",extracellular space [goid 5615] [evidence IEA],blood coagulation [goid 7596] [pmid 2888762] [evidence TAS]; fibrinolysis [goid 42730] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; coagulation factor XIa activity [goid 3805] [pmid 2888762] [evidence TAS]; coagulation factor XIIa activity [goid 3806] [pmid 3162339] [evidence TAS],5,176761826-176761875,5q35.3a,-,NM_000505.2,2161,F12,2.215787396423991,7.266565820699413,19.409958864791168,7.458931277234125e-45,4.251803333188045e-43,91.46703864393876
LRRN3,ILMN_1773650,"Homo sapiens leucine rich repeat neuronal 3 (LRRN3), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],,,7,110552004-110552053,7q31.1b,+,NM_018334.3,54674,LRRN3,-2.3165290457498164,6.32060983171804,-19.398470148749844,7.993166508631784e-45,4.5433885086563846e-43,91.39799121290561
TLR8,ILMN_1657892,"Homo sapiens toll-like receptor 8 (TLR8), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 12032557] [evidence IC ],positive regulation of interleukin-8 biosynthesis [goid 45416] [pmid 16188996] [evidence IMP]; detection of virus [goid 9597] [pmid 12032557] [evidence NAS]; defense response to virus [goid 51607] [pmid 16188996] [evidence IMP]; positive regulation of interferon-gamma biosynthesis [goid 45078] [pmid 16286015] [evidence IDA]; positive regulation of interferon-beta biosynthesis [goid 45359] [pmid 16286015] [evidence IDA]; positive regulation of innate immune response [goid 45089] [pmid 16123302] [evidence IDA]; innate immune response [goid 45087] [pmid 12032557] [evidence NAS]; I-kappaB kinase/NF-kappaB cascade [goid 7249] [pmid 12032557] [evidence NAS]; inflammatory response [goid 6954] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; DNA binding [goid 3677] [pmid 16123302] [evidence IDA]; double-stranded RNA binding [goid 3725] [pmid 16111635] [evidence IDA]; single-stranded RNA binding [goid 3727] [pmid 14976262] [evidence IDA]; Toll binding [goid 5121] [pmid 12032557] [evidence NAS],X,12850750-12850799,Xp22.2,+,NM_138636.2,51311,TLR8,-2.2736911449870156,6.867243237104814,-19.394000821743397,8.211220576383171e-45,4.654110518194745e-43,91.37112617524633
PLA2G4F,ILMN_1744211,"Homo sapiens phospholipase A2, group IVF (PLA2G4F), mRNA.",membrane [goid 16020] [evidence IEA],phospholipid catabolism [goid 9395] [evidence IEA]; lipid catabolism [goid 16042] [evidence IEA],phospholipase A2 activity [goid 4623] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; phospholipase activity [goid 4620] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],15,40220760-40220809,15q15.1d,-,NM_213600.2,255189,PLA2G4F,-2.679841158189893,8.127001840977451,-19.392620945592604,8.279741710189715e-45,4.679691303318526e-43,91.36283128164987
LOC653626,ILMN_1811426,"PREDICTED: Homo sapiens similar to ARG99 protein (LOC653626), mRNA.",,,,12,29545629-29545678,,-,XM_928461.1,653626,LOC653626,-2.181497654127469,6.652701843583853,-19.389750032740757,8.424147994737071e-45,4.747897269822516e-43,91.34557253840154
ADAMTSL3,ILMN_1798690,"Homo sapiens ADAMTS-like 3 (ADAMTSL3), mRNA.",,integrin-mediated signaling pathway [goid 7229] [evidence IEA],metallopeptidase activity [goid 8237] [evidence IEA],15,82499175-82499224,15q25.2b,+,NM_207517.1,57188,ADAMTSL3,-1.9923636798669895,6.3275665108490164,-19.3724271956115,9.35071742781179e-45,5.247674938756732e-43,91.24141378365064
THBD,ILMN_1759787,"Homo sapiens thrombomodulin (THBD), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 2822087] [evidence TAS],blood coagulation [goid 7596] [pmid 9252393] [evidence TAS],calcium ion binding [goid 5509] [pmid 10336638] [evidence TAS]; transmembrane receptor activity [goid 4888] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],20,22974506-22974555,20p11.21c,-,NM_000361.2,7056,THBD,-2.1991407721509972,6.5681372837219945,-19.372203038021638,9.363354423911202e-45,5.247674938756732e-43,91.24006573276752
CYBRD1,ILMN_1712305,"Homo sapiens cytochrome b reductase 1 (CYBRD1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],electron transport [goid 6118] [evidence IEA]; electron transport [goid 6118] [evidence IEA],,2,172122282-172122331,2q31.1c,+,NM_024843.2,79901,CYBRD1,-1.9694790785882805,10.997696274575345,-19.353244536570795,1.0496575374294496e-44,5.866354192426935e-43,91.12603026343412
TLR4,ILMN_1706217,"Homo sapiens toll-like receptor 4 (TLR4), transcript variant 4, mRNA.",lipopolysaccharide receptor complex [goid 46696] [pmid 11970998] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 9435236] [evidence TAS],mast cell activation [goid 45576] [pmid 11490012] [evidence ISS]; signal transduction [goid 7165] [pmid 10426995] [evidence TAS]; positive regulation of interleukin-1 biosynthesis [goid 45362] [pmid 11490012] [evidence ISS]; positive regulation of interleukin-12 biosynthesis [goid 45084] [pmid 11970998] [evidence NAS]; detection of pathogenic bacteria [goid 9598] [pmid 10835634] [evidence NAS]; innate immune response [goid 45087] [evidence IEA]; macrophage activation [goid 42116] [pmid 10835634] [evidence IMP]; T-helper 1 type immune response [goid 42088] [pmid 11970998] [evidence NAS]; positive regulation of interleukin-6 biosynthesis [goid 45410] [pmid 11490012] [evidence ISS]; positive regulation of interleukin-13 biosynthesis [goid 45368] [pmid 11490012] [evidence ISS]; negative regulation of osteoclast differentiation [goid 45671] [pmid 12133979] [evidence NAS]; activation of NF-kappaB-inducing kinase [goid 7250] [pmid 11490012] [evidence ISS],lipopolysaccharide binding [goid 1530] [pmid 10835634] [evidence NAS]; protein binding [goid 5515] [pmid 11544529] [evidence IPI]; transmembrane receptor activity [goid 4888] [pmid 11970998] [evidence NAS],9,119516825-119516874,9q33.1c,+,NM_138557.1,7099,TLR4,-1.549612553009565,6.305198812550622,-19.34566318010448,1.0987375602974869e-44,6.123549054716467e-43,91.08041630310439
ANLN,ILMN_1739645,"Homo sapiens anillin, actin binding protein (ANLN), mRNA.",contractile ring [goid 5826] [pmid 10931866] [evidence IDA]; nucleus [goid 5634] [evidence IEA],mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cytokinesis [goid 910] [pmid 10931866] [evidence IDA],actin binding [goid 3779] [pmid 10931866] [evidence IDA],7,36459286-36459335,7p14.2a,+,NM_018685.2,54443,ANLN,2.0254833658936944,6.41307468846188,19.32780027024093,1.2236775176448746e-44,6.800927714732958e-43,90.97291514582015
DOCK11,ILMN_1765860,"Homo sapiens dedicator of cytokinesis 11 (DOCK11), mRNA.",,,GTP binding [goid 5525] [evidence IEA]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA]; GTPase binding [goid 51020] [evidence IEA],X,117703748-117703797,Xq24a-q24b,+,NM_144658.2,139818,DOCK11,-1.562825055836968,8.668193070163664,-19.322879315863705,1.260535635687949e-44,6.986370359790716e-43,90.94329352874836
RUSC1,ILMN_1743747,"Homo sapiens RUN and SH3 domain containing 1 (RUSC1), mRNA.",nucleus [goid 5634] [evidence IEA],,SH3/SH2 adaptor activity [goid 5070] [pmid 10760598] [evidence TAS],1,153567467-153567516,1q22a,+,NM_014328.2,23623,RUSC1,1.0473747260415518,11.171733338699898,19.315936160835953,1.314442592123871e-44,7.265018614147626e-43,90.90149436990656
PLEKHK1,ILMN_1740606,"Homo sapiens pleckstrin homology domain containing, family K member 1 (PLEKHK1), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],nucleotide binding [goid 166] [evidence IEA],10,63623463-63623512,10q21.2b,-,NM_145307.2,219790,PLEKHK1,-2.6267700942696317,6.229688443407684,-19.313821673778133,1.3313145664834434e-44,7.338000508595244e-43,90.88876359529348
AOC3,ILMN_1782086,"Homo sapiens amine oxidase, copper containing 3 (vascular adhesion protein 1) (AOC3), mRNA.",plasma membrane [goid 5886] [pmid 9653080] [evidence IDA]; integral to membrane [goid 16021] [pmid 9653080] [evidence IDA]; cell surface [goid 9986] [pmid 9653080] [evidence IDA],amine metabolism [goid 9308] [pmid 9653080] [evidence IDA]; cell adhesion [goid 7155] [pmid 9653080] [evidence IDA]; inflammatory response [goid 6954] [pmid 9653080] [evidence TAS]; electron transport [goid 6118] [pmid 9653080] [evidence IDA],oxidoreductase activity [goid 16491] [evidence IEA]; protein homodimerization activity [goid 42803] [pmid 9653080] [evidence TAS]; copper ion binding [goid 5507] [pmid 8972912] [evidence TAS]; amine oxidase activity [goid 8131] [pmid 9653080] [evidence IDA]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],17,38263530-38263579,17q21.31a,+,NM_003734.2,8639,AOC3,-2.2241768933174955,6.908472249312356,-19.298219598696686,1.462711505890561e-44,8.040091156554491e-43,90.79481103119332
HBEGF,ILMN_2121408,"Homo sapiens heparin-binding EGF-like growth factor (HBEGF), mRNA.",integral to plasma membrane [goid 5887] [pmid 15389565] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [pmid 15389565] [evidence TAS]; cell surface [goid 9986] [pmid 15289334] [evidence NAS],muscle development [goid 7517] [pmid 8347598] [evidence TAS]; signal transduction [goid 7165] [pmid 1840698] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; heparin binding [goid 8201] [pmid 8300582] [evidence IMP]; growth factor activity [goid 8083] [evidence IEA]; epidermal growth factor receptor binding [goid 5154] [pmid 10749879] [evidence TAS],5,139692882-139692931,5q31.3a,-,NM_001945.1,1839,HBEGF,-2.4850193707889936,9.738786304319493,-19.28970151378704,1.539861594054953e-44,8.440972814753835e-43,90.74350454265094
PAICS,ILMN_1773760,"Homo sapiens phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS), mRNA.",phosphoribosylaminoimidazole carboxylase complex [goid 9320] [evidence IEA]; phosphoribosylaminoimidazole carboxylase complex [goid 9320] [evidence IEA]; phosphoribosylaminoimidazole carboxylase complex [goid 9320] [evidence IEA],purine nucleotide biosynthesis [goid 6164] [evidence IEA]; 'de novo' IMP biosynthesis [goid 6189] [evidence IEA]; purine base biosynthesis [goid 9113] [pmid 2253271] [evidence TAS]; purine nucleotide biosynthesis [goid 6164] [evidence IEA]; 'de novo' IMP biosynthesis [goid 6189] [evidence IEA]; purine base biosynthesis [goid 9113] [pmid 2253271] [evidence TAS]; 'de novo' IMP biosynthesis [goid 6189] [evidence IEA]; purine base biosynthesis [goid 9113] [pmid 2253271] [evidence TAS]; purine nucleotide biosynthesis [goid 6164] [evidence IEA],ligase activity [goid 16874] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; phosphoribosylaminoimidazole carboxylase activity [goid 4638] [evidence IEA]; ligase activity [goid 16874] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; phosphoribosylaminoimidazole carboxylase activity [goid 4638] [evidence IEA]; phosphoribosylaminoimidazole carboxylase activity [goid 4638] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],4,57021950-57021999,4q12e,+,NM_006452.2,10606,PAICS,1.385992566630586,10.119019030479505,19.288852267937003,1.5477737559550096e-44,8.461163199220718e-43,90.73838885348138
CES4,ILMN_2150095,Homo sapiens carboxylesterase 4-like (CES4) on chromosome 16.,,,,,,16q12.2c,,NR_003276.1,51716,CES4,-3.3383813438448726,6.8818302556925754,-19.287310208903847,1.562245065103202e-44,8.517002523865087e-43,90.72909957413412
CSTF2,ILMN_1653129,"Homo sapiens cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa (CSTF2), mRNA.",nucleus [goid 5634] [pmid 1741396] [evidence TAS],mRNA cleavage [goid 6379] [pmid 1741396] [evidence TAS],RNA binding [goid 3723] [pmid 1741396] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA],X,99982434-99982483,Xq22.1c,+,NM_001325.2,1478,CSTF2,1.3143451612614498,8.443648854880678,19.273640111256046,1.6966153603257142e-44,9.224423948205677e-43,90.64673922252898
SOSTDC1,ILMN_1715463,"Homo sapiens sclerostin domain containing 1 (SOSTDC1), mRNA.",,Wnt receptor signaling pathway [goid 16055] [evidence IEA],,7,16468320-16468369,7p21.1c,-,NM_015464.1,25928,SOSTDC1,-3.662046574461919,7.360327835915323,-19.271855075241493,1.7149968582543876e-44,9.299094075868235e-43,90.63598299131972
LILRA2,ILMN_1716983,"Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 (LILRA2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [evidence IEA]; signal transduction [goid 7165] [pmid 9548455] [evidence TAS],receptor activity [goid 4872] [pmid 9548455] [evidence TAS]; antigen binding [goid 3823] [pmid 9548455] [evidence TAS],19,59790667-59790716,19q13.42a,+,NM_006866.1,11027,LILRA2,-2.3817148836346522,6.908548602421321,-19.23265887284133,2.1730407281256098e-44,1.1750864564415459e-42,90.3996994567022
SESN1,ILMN_1800626,"Homo sapiens sestrin 1 (SESN1), mRNA.",nucleus [goid 5634] [pmid 9926927] [evidence TAS],response to DNA damage stimulus [goid 6974] [pmid 9926927] [evidence TAS]; cell cycle arrest [goid 7050] [pmid 9926927] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9926927] [evidence TAS],,6,109414622-109414671,6q21f,-,NM_014454.1,27244,SESN1,-1.4841694909517749,9.339300567547749,-19.22304803080611,2.3029657832484483e-44,1.2419875846694058e-42,90.3417351511317
OSTF1,ILMN_1742456,"Homo sapiens osteoclast stimulating factor 1 (OSTF1), mRNA.",intracellular [goid 5622] [pmid 10092216] [evidence TAS],ossification [goid 1503] [pmid 10092216] [evidence TAS]; signal transduction [goid 7165] [pmid 10092216] [evidence TAS],protein binding [goid 5515] [pmid 10092216] [evidence TAS],9,76945597-76945646,9q21.13b,+,NM_012383.3,26578,OSTF1,-1.0284342376212603,10.544838506186666,-19.21856023015017,2.3662763738690923e-44,1.2727004754938923e-42,90.31466483862044
CDH13,ILMN_1766925,"Homo sapiens cadherin 13, H-cadherin (heart) (CDH13), mRNA.",membrane [goid 16020] [evidence IEA],homophilic cell adhesion [goid 7156] [evidence IEA]; cell adhesion [goid 7155] [pmid 8673923] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],16,82387382-82387431,16q23.3a-q23.3b,+,NM_001257.3,1012,CDH13,-2.21231759895121,6.485721970580746,-19.212557813414517,2.4536923016750796e-44,1.3161789697564342e-42,90.27845464376173
OLR1,ILMN_1723035,"Homo sapiens oxidised low density lipoprotein (lectin-like) receptor 1 (OLR1), mRNA.",membrane fraction [goid 5624] [pmid 9052782] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9052782] [evidence TAS],cell adhesion [goid 7155] [evidence IEA]; inflammatory response [goid 6954] [evidence IEA]; circulation [goid 8015] [pmid 9052782] [evidence TAS],protein binding [goid 5515] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],12,10202439-10202488,12p13.2c,-,NM_002543.2,4973,OLR1,-2.4934730309512734,10.945398715996532,-19.2033954209851,2.5934170047630764e-44,1.3874087548475838e-42,90.22317329395126
TRAP1,ILMN_1699737,"Homo sapiens TNF receptor-associated protein 1 (TRAP1), mRNA.",mitochondrion [goid 5739] [evidence IEA],protein folding [goid 6457] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; unfolded protein binding [goid 51082] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; tumor necrosis factor receptor binding [goid 5164] [pmid 7876093] [evidence NAS],16,3648842-3648867:3651989-3652012,16p13.3c,-,NM_016292.1,10131,TRAP1,1.1547358616972847,9.21886335380499,19.1959994356361,2.712006717290066e-44,1.4460306526781073e-42,90.1785422789727
GSDML,ILMN_1666206,"Homo sapiens gasdermin-like (GSDML), mRNA.",,,,17,35314497-35314546,17q12c,-,NM_018530.1,55876,GSDML,1.9130652319766233,7.419320181113635,19.19566775508994,2.7174506467761314e-44,1.4460306526781073e-42,90.17654060275159
RHOD,ILMN_2089167,"Homo sapiens ras homolog gene family, member D (RHOD), mRNA.",intracellular [goid 5622] [evidence IEA]; membrane [goid 16020] [evidence IEA],Rho protein signal transduction [goid 7266] [pmid 9116026] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; GTPase activity [goid 3924] [pmid 9116026] [evidence TAS]; GTP binding [goid 5525] [evidence IEA],11,66595830-66595879,11q13.1f,+,NM_014578.2,29984,RHOD,2.063494629742273,8.39976980282456,19.177760338097013,3.028239195490224e-44,1.60713553908139e-42,90.06845076152568
DDR1,ILMN_1812262,"Homo sapiens discoidin domain receptor family, member 1 (DDR1), transcript variant 2, mRNA.",integral to plasma membrane [goid 5887] [pmid 8390675] [evidence TAS]; membrane [goid 16020] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8390675] [evidence TAS],cell adhesion [goid 7155] [pmid 8302582] [evidence TAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; cell adhesion [goid 7155] [pmid 8302582] [evidence TAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transmembrane receptor protein tyrosine kinase activity [goid 4714] [pmid 9659899] [evidence TAS]; ATP binding [goid 5524] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transmembrane receptor protein tyrosine kinase activity [goid 4714] [pmid 9659899] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],6,30975562-30975611,6p21.33a,+,NM_001954.3,780,DDR1,1.2209841289225567,8.170406069564857,19.162840823730114,3.314243921803631e-44,1.7542696398795515e-42,89.97836688290505
FUT3,ILMN_1653358,"Homo sapiens fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) (FUT3), mRNA.",membrane fraction [goid 5624] [pmid 1977660] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA],protein amino acid glycosylation [goid 6486] [evidence IEA]; carbohydrate metabolism [goid 5975] [pmid 1977660] [evidence TAS],"3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [goid 17060] [evidence IEA]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]",19,5794132-5794181,19p13.3b,-,NM_000149.1,2525,FUT3,2.653065786196576,7.698055026064224,19.123501641738883,4.2051874222408424e-44,2.219983903540759e-42,89.74071049164057
PAFAH1B3,ILMN_1748093,"Homo sapiens platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit 29kDa (PAFAH1B3), mRNA.",soluble fraction [goid 5625] [evidence NR ]; cytoplasm [goid 5737] [evidence NR ],lipid catabolism [goid 16042] [evidence IEA],"hydrolase activity, acting on ester bonds [goid 16788] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [goid 3847] [evidence IEA]",19,47493038-47493069:47493070-47493087,19q13.2c,-,NM_002573.2,5050,PAFAH1B3,1.6594755548661357,10.460027238485406,19.116667804529584,4.38284223175061e-44,2.3076817729701636e-42,89.69940709691853
OCIAD2,ILMN_1700306,"Homo sapiens OCIA domain containing 2 (OCIAD2), transcript variant 1, mRNA.",,,,4,48582339-48582339:48589546-48589594,4p12a,-,NM_001014446.1,132299,OCIAD2,1.74749692519784,10.480641556454232,19.115245609508886,4.420750347934939e-44,2.3215320987265685e-42,89.69081071998738
HCAP-G,ILMN_1751444,"Homo sapiens non-SMC condensin I complex, subunit G (NCAPG), mRNA.",nucleus [goid 5634] [pmid 10910072] [evidence NAS],mitosis [goid 7067] [evidence IEA]; mitotic chromosome condensation [goid 7076] [pmid 10910072] [evidence NAS]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],binding [goid 5488] [evidence IEA],4,17453041-17453090,4p15.32b,+,NM_022346.3,64151,HCAP-G,1.998031677595372,6.3972798349751585,19.102941658034272,4.762750260552883e-44,2.494583958459217e-42,89.61643017360156
FLJ36748,ILMN_1694140,"Homo sapiens actin filament associated protein 1-like 1 (AFAP1L1), mRNA.",,,,5,148701168-148701217,5q33.1b,+,NM_152406.1,134265,FLJ36748,-1.7834784189498771,7.333966819679345,-19.099185424932788,4.872355775483238e-44,2.545328834356883e-42,89.59371920489944
CD302,ILMN_1716797,"Homo sapiens CD302 molecule (CD302), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],2,160334548-160334597,2q24.2a,-,NM_014880.3,9936,CD302,-1.5432517829162506,7.185704681383305,-19.08934720523727,5.171576359850981e-44,2.694606765830688e-42,89.53422735441195
LSR,ILMN_1749396,"Homo sapiens lipolysis stimulated lipoprotein receptor (LSR), transcript variant 1, mRNA.",plasma membrane [goid 5886] [evidence ISS]; integral to membrane [goid 16021] [evidence IEA]; chylomicron [goid 42627] [evidence IEA],lipoprotein transport [goid 42953] [evidence ISS]; liver development [goid 1889] [evidence ISS]; embryonic development [goid 9790] [evidence ISS],low-density lipoprotein binding [goid 30169] [evidence ISS]; triglyceride binding [goid 17129] [evidence ISS]; lipoprotein receptor activity [goid 30228] [evidence ISS]; receptor activity [goid 4872] [evidence IEA]; lipid transporter activity [goid 5319] [evidence IEA]; fatty acid binding [goid 5504] [evidence ISS],19,40450319-40450368,19q13.12a,+,NM_015925.5,51599,LSR,1.1702052778882122,6.48177945344564,19.088668053422598,5.192899829469303e-44,2.6986893451434237e-42,89.53012009099315
UBE2C,ILMN_1714730,"Homo sapiens ubiquitin-conjugating enzyme E2C (UBE2C), transcript variant 6, mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA]; phosphoinositide-mediated signaling [goid 48015] [pmid 15504738] [evidence NAS]; protein ubiquitination [goid 16567] [pmid 9122200] [evidence IDA]; ubiquitin-dependent protein catabolism [goid 6511] [pmid 9122200] [evidence IDA]; cyclin catabolism [goid 8054] [pmid 9122200] [evidence IDA]; spindle organization and biogenesis [goid 7051] [pmid 15504738] [evidence NAS]; mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [pmid 15504738] [evidence NAS]; cell division [goid 51301] [evidence IEA],ligase activity [goid 16874] [evidence IEA]; ubiquitin-protein ligase activity [goid 4842] [pmid 9122200] [evidence IDA],20,43875503-43875510:43877900-43877923:43877924-43877941,20q13.12b,+,NM_181803.1,11065,UBE2C,2.4297809044674414,7.405283933867201,19.08816841178398,5.208643475860131e-44,2.699858514637552e-42,89.52709840502466
OR7E37P,ILMN_2199926,"Homo sapiens olfactory receptor, family 7, subfamily E, member 37 pseudogene (OR7E37P) on chromosome 13.",,,,13,40915657-40915706,13q14.11b,+,NR_002163.2,26636,OR7E37P,-1.80262980170595,6.761311357849172,-19.07051292043206,5.796809383256486e-44,2.996965429979219e-42,89.42030420299031
C13orf1,ILMN_2223350,"Homo sapiens chromosome 13 open reading frame 1 (C13orf1), mRNA.",,,,13,49385160-49385209,13q14.3a,-,NM_020456.1,57213,C13orf1,-1.4730332692622339,7.683791221708359,-19.06588063845559,5.961870750046414e-44,3.074358504302285e-42,89.392278434776
Gcom1,ILMN_1660403,"Homo sapiens GRINL1A combined protein (Gcom1), transcript variant 9, mRNA.",,,,15,55788274-55788323,15q21.3d,+,NM_001018097.1,145781,Gcom1,-1.2351162116781689,5.574721893644543,-19.051010279054086,6.524288756508744e-44,3.347127421544281e-42,89.30229412823793
UBL3,ILMN_1810729,"Homo sapiens ubiquitin-like 3 (UBL3), mRNA.",membrane [goid 16020] [evidence IEA]; intracellular [goid 5622] [pmid 11256614] [evidence IDA],protein modification [goid 6464] [evidence IEA],,13,29236843-29236892,13q12.3b,-,NM_007106.2,5412,UBL3,-1.3716410640544172,10.391740342392676,-19.019267906438408,7.909376278315626e-44,4.047335053108415e-42,89.11012559144868
KIF2C,ILMN_1685916,"Homo sapiens kinesin family member 2C (KIF2C), mRNA.","microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromosome, pericentric region [goid 775] [evidence IEA]; kinesin complex [goid 5871] [pmid 9434124] [evidence TAS]",microtubule-based movement [goid 7018] [evidence IEA]; cell proliferation [goid 8283] [pmid 9434124] [evidence TAS]; mitosis [goid 7067] [pmid 9434124] [evidence TAS],centromeric DNA binding [goid 19237] [pmid 9434124] [evidence TAS]; microtubule motor activity [goid 3777] [pmid 9434124] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein binding [goid 5515] [pmid 11092768] [evidence IPI],1,45005776-45005825,1p34.1d,+,NM_006845.2,11004,KIF2C,1.9274603671122392,6.395132404384148,19.000434250414873,8.86694965728378e-44,4.5142475507107854e-42,88.9960503034264
SRL,ILMN_1736692,"PREDICTED: Homo sapiens sarcalumenin, transcript variant 4 (SRL), mRNA.",,,,,,16p13.3c-p13.3b,,XM_945656.1,6345,SRL,-1.4220638530936558,5.903875388288176,-18.979468198027178,1.0070407184528467e-43,5.1139265722854203e-42,88.8690099320754
GOLPH2,ILMN_1737011,"Homo sapiens golgi phosphoprotein 2 (GOLPH2), transcript variant 2, mRNA.",Golgi apparatus [goid 5794] [pmid 10831838] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 10831838] [evidence TAS]; membrane [goid 16020] [evidence IEA],,,9,87904772-87904821,9q21.33b,-,NM_177937.1,51280,GOLPH2,1.2637143323482931,6.80979721944077,18.9725406699834,1.0503039536825854e-43,5.320121900071182e-42,88.82702232834359
PTRF,ILMN_1757552,"Homo sapiens polymerase I and transcript release factor (PTRF), mRNA.",membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"transcription termination [goid 6353] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",rRNA binding [goid 19843] [evidence IEA],17,37808068-37808117,17q21.31a,-,NM_012232.2,284119,PTRF,-1.6321055668499547,12.295817292223754,-18.97059636937517,1.0627780665087457e-43,5.3697130188654e-42,88.81523694750473
IL17D,ILMN_1753823,"Homo sapiens interleukin 17D (IL17D), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],inflammatory response [goid 6954] [evidence IEA],cytokine activity [goid 5125] [evidence IEA],13,20195083-20195132,13q12.11b,+,NM_138284.1,53342,IL17D,-1.8038114393594649,7.51624524908356,-18.947699160363037,1.221356549860135e-43,6.155390894106191e-42,88.6764120264966
RAMP3,ILMN_1761782,"Homo sapiens receptor (G protein-coupled) activity modifying protein 3 (RAMP3), mRNA.",integral to membrane [goid 16021] [evidence IEA]; lysosome [goid 5764] [pmid 10882736] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9620797] [evidence TAS]; plasma membrane [goid 5886] [pmid 9620797] [evidence TAS]; plasma membrane [goid 5886] [pmid 9620797] [evidence TAS]; lysosome [goid 5764] [pmid 10882736] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9620797] [evidence TAS],intracellular protein transport [goid 6886] [evidence IEA]; receptor mediated endocytosis [goid 6898] [pmid 10882736] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [evidence NR ]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [evidence IEA]; intracellular protein transport [goid 6886] [evidence IEA]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [evidence NR ]; receptor mediated endocytosis [goid 6898] [pmid 10882736] [evidence TAS],protein transporter activity [goid 8565] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; protein transporter activity [goid 8565] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],7,45190165-45190214,7p13c,+,NM_005856.2,10268,RAMP3,-2.8009213307911685,8.559784486722128,-18.943403622969434,1.2536506090128986e-43,6.302271704806552e-42,88.6503614771464
CDC45L,ILMN_1670238,"Homo sapiens CDC45 cell division cycle 45-like (S. cerevisiae) (CDC45L), mRNA.",nucleus [goid 5634] [pmid 9660782] [evidence TAS],DNA replication checkpoint [goid 76] [pmid 9660782] [evidence TAS]; DNA replication initiation [goid 6270] [pmid 9660782] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; DNA replication [goid 6260] [evidence IEA],protein binding [goid 5515] [pmid 10518787] [evidence IPI],22,17886374-17886423,22q11.21c,+,NM_003504.3,8318,CDC45L,2.201307984151325,6.92389264521386,18.928972883572893,1.3685473467514557e-43,6.862630404461937e-42,88.5628295005074
MT1M,ILMN_1657435,"Homo sapiens metallothionein 1M (MT1M), mRNA.",,,cadmium ion binding [goid 46870] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; copper ion binding [goid 5507] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],16,55224074-55224123,16q13b,+,NM_176870.1,4499,MT1M,-4.034353581863391,8.46662143774036,-18.908758655278028,1.5474756512941075e-43,7.740473207773127e-42,88.44017572926505
KIF20A,ILMN_1695658,"Homo sapiens kinesin family member 20A (KIF20A), mRNA.",microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA]; Golgi apparatus [goid 5794] [pmid 9438855] [evidence TAS],vesicle-mediated transport [goid 16192] [pmid 9438855] [evidence TAS]; microtubule-based movement [goid 7018] [evidence IEA]; protein transport [goid 15031] [evidence IEA],microtubule motor activity [goid 3777] [evidence IEA]; transporter activity [goid 5215] [pmid 9438855] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],5,137550940-137550989,5q31.2c,+,NM_005733.1,10112,KIF20A,2.189915254283263,6.6982177087878645,18.903819472056778,1.5946524525621534e-43,7.93676772907054e-42,88.41019898448303
SC65,ILMN_1655663,"Homo sapiens synaptonemal complex protein SC65 (SC65), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleolus [goid 5730] [pmid 8862517] [evidence TAS]; synaptonemal complex [goid 795] [pmid 8862517] [evidence TAS],synaptonemal complex formation [goid 7130] [pmid 8862517] [evidence TAS],binding [goid 5488] [evidence IEA],17,37211920-37211969,17q21.2b,-,NM_006455.2,10609,SC65,1.8026581805552864,8.524576452289814,18.89070579554478,1.7270286452926971e-43,8.574290107944487e-42,88.33059596972231
SPDEF,ILMN_2161330,"Homo sapiens SAM pointed domain containing ets transcription factor (SPDEF), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [pmid 10625666] [evidence TAS]; transcription [goid 6350] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; protein binding [goid 5515] [pmid 10625666] [evidence TAS],6,34613689-34613738,6p21.31e,-,NM_012391.1,25803,SPDEF,3.2353093595581974,7.291792341975527,18.884696920651976,1.7913152583407403e-43,8.871444477445924e-42,88.29411399287805
SCN4B,ILMN_1695947,"Homo sapiens sodium channel, voltage-gated, type IV, beta (SCN4B), mRNA.",membrane [goid 16020] [evidence IEA]; voltage-gated sodium channel complex [goid 1518] [pmid 12930796] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA],sodium ion transport [goid 6814] [pmid 12930796] [evidence IDA]; synaptic transmission [goid 7268] [pmid 12930796] [evidence ISS]; ion transport [goid 6811] [evidence IEA],voltage-gated sodium channel activity [goid 5248] [pmid 12930796] [evidence IDA]; sodium ion binding [goid 31402] [evidence IEA],11,117509646-117509695,11q23.3d,-,NM_174934.1,6330,SCN4B,-2.3181551916879277,6.884731395354277,-18.862375337363087,2.0518740233412303e-43,1.0121489181442373e-41,88.15855484674113
FMO3,ILMN_1808657,"Homo sapiens flavin containing monooxygenase 3 (FMO3), transcript variant 1, mRNA.",microsome [goid 5792] [pmid 9207220] [evidence TAS]; intrinsic to endoplasmic reticulum membrane [goid 31227] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],electron transport [goid 6118] [evidence IEA],FAD binding [goid 50660] [evidence IEA]; monooxygenase activity [goid 4497] [evidence IEA]; dimethylaniline monooxygenase (N-oxide-forming) activity [goid 4499] [evidence IEA]; NADP binding [goid 50661] [evidence IEA],1,169353085-169353134,1q24.3a,+,NM_006894.4,2328,FMO3,-2.419090170222855,8.418305890463898,-18.862217899300063,2.0538407675257914e-43,1.0121489181442373e-41,88.15759851709713
CTNNAL1,ILMN_1721901,"Homo sapiens catenin (cadherin-associated protein), alpha-like 1 (CTNNAL1), mRNA.",actin cytoskeleton [goid 15629] [evidence IEA]; actin cytoskeleton [goid 15629] [evidence IEA],cell adhesion [goid 7155] [evidence IEA]; apoptosis [goid 6915] [evidence NR ]; cell adhesion [goid 7155] [evidence IEA]; apoptosis [goid 6915] [evidence NR ],cadherin binding [goid 45296] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; cadherin binding [goid 45296] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA],9,110754381-110754430,9q31.3a,-,NM_003798.1,8727,CTNNAL1,-1.8923391346644145,8.94753105345162,-18.83038889560585,2.4929303855631335e-43,1.2255172273795375e-41,87.9641993577519
MELK,ILMN_1731184,"Homo sapiens maternal embryonic leucine zipper kinase (MELK), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],protein serine/threonine kinase activity [goid 4674] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],9,36667223-36667272,9p13.2b,+,NM_014791.2,9833,MELK,2.218164194484899,6.464876649013482,18.829237372537733,2.510471455633921e-43,1.231115511870674e-41,87.9572002632023
SLCO2B1,ILMN_1761199,"Homo sapiens solute carrier organic anion transporter family, member 2B1 (SLCO2B1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],ion transport [goid 6811] [evidence IEA]; ion transport [goid 6811] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; transporter activity [goid 5215] [evidence IEA],11,74594467-74594516,11q13.4c,+,NM_007256.2,11309,SLCO2B1,-1.7294771741391841,10.645699912938188,-18.820912144768755,2.641027186011997e-43,1.2919724190153553e-41,87.90659393075639
TMEM88,ILMN_1757129,"Homo sapiens transmembrane protein 88 (TMEM88), mRNA.",,,,17,7699966-7700015,17p13.1d,+,NM_203411.1,92162,TMEM88,-2.043481702066164,7.07250605658491,-18.81937457720411,2.665874088822148e-43,1.3009465553452082e-41,87.8972466762374
PLEK2,ILMN_1811470,"Homo sapiens pleckstrin 2 (PLEK2), mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],intracellular signaling cascade [goid 7242] [evidence IEA]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 10419454] [evidence TAS],,14,66923812-66923861,14q23.3b,-,NM_016445.1,26499,PLEK2,2.1361163370354044,6.927848018893061,18.818181985453837,2.6853075943403812e-43,1.3072417116195218e-41,87.8899964252752
NSUN5,ILMN_1751958,"Homo sapiens NOL1/NOP2/Sun domain family, member 5 (NSUN5), transcript variant 1, mRNA.",,,,7,72355419-72355462:72355533-72355538,7q11.23a,-,NM_148956.1,55695,NSUN5,1.113582791240436,7.547515108602311,18.803118799006462,2.9433531945764863e-43,1.429383755269086e-41,87.79840689850195
MSRA,ILMN_2228180,"Homo sapiens methionine sulfoxide reductase A (MSRA), mRNA.",,protein metabolism [goid 19538] [evidence IEA]; protein modification [goid 6464] [pmid 10452521] [evidence TAS]; response to oxidative stress [goid 6979] [pmid 10452521] [evidence TAS]; methionine metabolism [goid 6555] [pmid 10452521] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; protein-methionine-S-oxide reductase activity [goid 8113] [pmid 10452521] [evidence TAS],8,10323581-10323630,8p23.1c,+,NM_012331.2,4482,MSRA,-1.4362445656915135,9.052314865318126,-18.791744094996776,3.154574326639746e-43,1.5282499546587903e-41,87.72922712575689
RGS17,ILMN_1725485,"Homo sapiens regulator of G-protein signalling 17 (RGS17), mRNA.",membrane [goid 16020] [evidence IEA],negative regulation of signal transduction [goid 9968] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA],6,153373768-153373817,6q25.2a,-,NM_012419.4,26575,RGS17,2.9350497541740594,6.769248777975162,18.782884364074164,3.329575422244627e-43,1.6091339383640214e-41,87.67533271605261
PIAS3,ILMN_1814966,"Homo sapiens protein inhibitor of activated STAT, 3 (PIAS3), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; ubiquitin cycle [goid 6512] [evidence IEA]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; transcription corepressor activity [goid 3714] [evidence NR ]; zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],1,144297547-144297596,1q21.1b,+,NM_006099.2,10401,PIAS3,1.1640444038073312,7.571591003304729,18.779156984094453,3.4060804043116113e-43,1.6421411260112463e-41,87.65265605148974
TMPRSS4,ILMN_1687358,"Homo sapiens transmembrane protease, serine 4 (TMPRSS4), transcript variant 2, mRNA.",integral to membrane [goid 16021] [pmid 10825129] [evidence NAS]; membrane [goid 16020] [evidence IEA],,scavenger receptor activity [goid 5044] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; serine-type endopeptidase activity [goid 4252] [pmid 10825129] [evidence NAS],11,117493943-117493992,11q23.3d,+,NM_183247.1,56649,TMPRSS4,2.337035249057779,6.439418864255353,18.775285188859833,3.487417410521175e-43,1.677313643021819e-41,87.62909907966016
DUOX1,ILMN_1690289,"Homo sapiens dual oxidase 1 (DUOX1), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; apical plasma membrane [goid 16324] [pmid 10806195] [evidence NAS],hydrogen peroxide biosynthesis [goid 50665] [pmid 10806195] [evidence NAS]; cytokine and chemokine mediated signaling pathway [goid 19221] [pmid 16111680] [evidence IDA]; hormone biosynthesis [goid 42446] [evidence IEA]; electron transport [goid 6118] [pmid 10601291] [evidence TAS]; hydrogen peroxide catabolism [goid 42744] [evidence IEA]; superoxide release [goid 42554] [pmid 10806195] [evidence NAS],NAD(P)H oxidase activity [goid 16174] [pmid 10806195] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence IEA]; NADP binding [goid 50661] [pmid 10806195] [evidence NAS]; iron ion binding [goid 5506] [evidence IEA]; peroxidase activity [goid 4601] [evidence IEA]; FAD binding [goid 50660] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],15,43244887-43244936,15q21.1a,+,NM_017434.3,53905,DUOX1,-2.442025847091439,7.989203585767858,-18.77245930377097,3.5480098287892155e-43,1.7023640444703746e-41,87.611904585654
AMICA1,ILMN_1778723,"Homo sapiens adhesion molecule, interacts with CXADR antigen 1 (AMICA1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],11,117570158-117570207,11q23.3d,-,NM_153206.1,120425,AMICA1,-1.936764467739735,9.457276927057318,-18.77024953345974,3.596126458128931e-43,1.7213229228287955e-41,87.5984582809413
NME1,ILMN_1713875,"Homo sapiens non-metastatic cells 1, protein (NM23A) expressed in (NME1), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 16130169] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS]; nucleus [goid 5634] [pmid 16130169] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS],UTP biosynthesis [goid 6228] [evidence IEA]; GTP biosynthesis [goid 6183] [evidence IEA]; regulation of apoptosis [goid 42981] [pmid 16130169] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; nucleoside triphosphate biosynthesis [goid 9142] [evidence NAS]; nucleotide metabolism [goid 9117] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 1851158] [evidence TAS]; CTP biosynthesis [goid 6241] [evidence IEA]; UTP biosynthesis [goid 6228] [evidence IEA]; GTP biosynthesis [goid 6183] [evidence IEA]; regulation of apoptosis [goid 42981] [pmid 16130169] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; nucleoside triphosphate biosynthesis [goid 9142] [evidence NAS]; nucleotide metabolism [goid 9117] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 1851158] [evidence TAS]; CTP biosynthesis [goid 6241] [evidence IEA],kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; DNA binding [goid 3677] [pmid 11555662] [evidence IC ]; ATP binding [goid 5524] [evidence NAS]; deoxyribonuclease activity [goid 4536] [pmid 11555662] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [pmid 11555662] [evidence IDA]; kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; DNA binding [goid 3677] [pmid 11555662] [evidence IC ]; ATP binding [goid 5524] [evidence NAS]; deoxyribonuclease activity [goid 4536] [pmid 11555662] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [pmid 11555662] [evidence IDA],17,46586724-46586733:46586734-46586773,17q21.33b,+,NM_198175.1,4830,NME1,1.283093290125712,8.179183551958996,18.767081672068944,3.666249143238673e-43,1.7506995908811305e-41,87.57918106498298
TTYH3,ILMN_1692731,"Homo sapiens tweety homolog 3 (Drosophila) (TTYH3), mRNA.",,,,7,2670726-2670775,7p22.2c,+,NM_025250.2,80727,TTYH3,2.0566882868010197,9.004580008195257,18.74573598438255,4.175885618368775e-43,1.9893123679124393e-41,87.44925687964816
NCF1,ILMN_1697309,"Homo sapiens neutrophil cytosolic factor 1 (47kDa, chronic granulomatous disease, autosomal 1) (NCF1), mRNA.",cytosol [goid 5829] [pmid 2848318] [evidence TAS]; soluble fraction [goid 5625] [pmid 2848318] [evidence TAS],superoxide metabolism [goid 6801] [evidence NR ]; electron transport [goid 6118] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA]; cellular defense response [goid 6968] [pmid 2848318] [evidence TAS],protein binding [goid 5515] [pmid 12681507] [evidence IPI]; GTPase activity [goid 3924] [pmid 2547247] [evidence TAS]; electron transporter activity [goid 5489] [pmid 2848318] [evidence TAS]; phosphoinositide binding [goid 35091] [evidence IEA]; GTP binding [goid 5525] [pmid 2848318] [evidence TAS],7,74222428-74222452:74222864-74222865:74225612-74225634,7q11.23d,-,NM_000265.1,4687,NCF1,-3.1850224832867227,7.026809250328093,-18.734910858665867,4.460914988162284e-43,2.120047199124726e-41,87.38334766295354
AQP9,ILMN_1715068,"Homo sapiens aquaporin 9 (AQP9), mRNA.",integral to plasma membrane [goid 5887] [evidence ISS]; membrane [goid 16020] [evidence IEA],carboxylic acid transport [goid 46942] [pmid 9733774] [evidence TAS]; immune response [goid 6955] [evidence ISS]; response to mercury ion [goid 46689] [pmid 9733774] [evidence IDA]; purine transport [goid 6863] [pmid 9733774] [evidence IDA]; response to osmotic stress [goid 6970] [pmid 9733774] [evidence TAS]; amine transport [goid 15837] [pmid 9733774] [evidence IDA]; water transport [goid 6833] [pmid 9733774] [evidence IDA]; metabolism [goid 8152] [pmid 9733774] [evidence TAS]; water homeostasis [goid 30104] [pmid 9733774] [evidence NAS]; response to organic substance [goid 10033] [pmid 9733774] [evidence IDA]; pyrimidine transport [goid 15855] [pmid 9733774] [evidence IDA]; polyol transport [goid 15791] [pmid 9733774] [evidence IDA]; nutrient import [goid 9935] [pmid 9733774] [evidence TAS]; excretion [goid 7588] [pmid 9733774] [evidence TAS],polyol transporter activity [goid 15166] [pmid 9733774] [evidence TAS]; purine transporter activity [goid 5345] [pmid 9733774] [evidence IDA]; water channel activity [goid 15250] [pmid 9733774] [evidence IDA]; pyrimidine transporter activity [goid 5350] [pmid 9733774] [evidence IDA]; amine transporter activity [goid 5275] [pmid 9733774] [evidence TAS]; porin activity [goid 15288] [pmid 9733774] [evidence NAS]; carboxylic acid transporter activity [goid 46943] [pmid 9733774] [evidence TAS],15,56265152-56265201,15q22.1a,+,NM_020980.2,366,AQP9,-2.461092497392869,8.635941745029015,-18.731609560400667,4.551663388509576e-43,2.1580493146279526e-41,87.36324486695449
LTBP4,ILMN_1665219,"Homo sapiens latent transforming growth factor beta binding protein 4 (LTBP4), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9660815] [evidence NAS],regulation of cell differentiation [goid 45595] [evidence ISS]; development [goid 7275] [evidence ISS]; regulation of proteolysis [goid 30162] [evidence ISS]; growth hormone secretion [goid 30252] [evidence ISS]; regulation of transforming growth factor beta receptor signaling pathway [goid 17015] [evidence ISS]; protein folding [goid 6457] [evidence ISS]; regulation of cell growth [goid 1558] [evidence ISS]; cell growth [goid 16049] [pmid 9660815] [evidence TAS],growth factor activity [goid 8083] [pmid 9660815] [evidence TAS]; growth factor binding [goid 19838] [evidence IEA]; glycosaminoglycan binding [goid 5539] [evidence ISS]; integrin binding [goid 5178] [evidence ISS]; calcium ion binding [goid 5509] [evidence NAS]; transforming growth factor beta receptor activity [goid 5024] [pmid 9660815] [evidence NAS],19,45827396-45827445,19q13.2b,+,NM_003573.1,8425,LTBP4,-1.7611141698981099,8.193252778347253,-18.728913576159602,4.627144525067324e-43,2.18865029923279e-41,87.34682710795697
WASF3,ILMN_1810797,"Homo sapiens WAS protein family, member 3 (WASF3), mRNA.",actin cytoskeleton [goid 15629] [evidence NR ],actin filament polymerization [goid 30041] [pmid 10381382] [evidence TAS]; protein complex assembly [goid 6461] [pmid 10381382] [evidence TAS],actin binding [goid 3779] [evidence IEA],13,26160641-26160690,13q12.13c,+,NM_006646.4,10810,WASF3,-2.1306472141953314,7.432811546093695,-18.723337140913664,4.787279895938308e-43,2.2590541546682467e-41,87.31286556423574
MUSTN1,ILMN_1773814,"Homo sapiens musculoskeletal, embryonic nuclear protein 1 (MUSTN1), mRNA.",,,,3,52842264-52842313,3p21.1c,-,NM_205853.1,389125,MUSTN1,-1.5330598177474748,6.776993333598609,-18.721324576616258,4.84642895638392e-43,2.2815847190430466e-41,87.30060778151386
GPR30,ILMN_1665435,"Homo sapiens G protein-coupled receptor 30 (GPR30), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8920907] [evidence TAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8920907] [evidence TAS],"rhodopsin-like receptor activity [goid 1584] [evidence IEA]; purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]",7,1098987-1099018:1099019-1099036,7p22.3b,+,NM_001505.1,2852,GPR30,-2.0173563942459705,7.364327562820863,-18.68810862314574,5.93566235322796e-43,2.787810618858803e-41,87.09823389759815
KIAA0406,ILMN_1741398,"Homo sapiens KIAA0406 (KIAA0406), mRNA.",,,binding [goid 5488] [evidence IEA],20,36045150-36045199,20q11.23c,-,NM_014657.1,9675,KIAA0406,1.2114180248346642,7.095515168893986,18.668574275885504,6.687685363689958e-43,3.1336582847004374e-41,86.97915787725155
SDHAP3,ILMN_2148679,"Homo sapiens succinate dehydrogenase complex, subunit A, flavoprotein pseudogene 3 (SDHAP3) on chromosome 5.",,,,,,5p15.33d,,NR_003263.1,728609,SDHAP3,2.012724146255085,6.511475191953356,18.654365131750207,7.294098822913698e-43,3.4098207768424596e-41,86.89251511011176
FCN3,ILMN_1780060,"Homo sapiens ficolin (collagen/fibrinogen domain containing) 3 (Hakata antigen) (FCN3), transcript variant 2, mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [pmid 9694814] [evidence TAS]; extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [pmid 9694814] [evidence TAS],,sugar binding [goid 5529] [pmid 9694814] [evidence TAS]; sugar binding [goid 5529] [pmid 9694814] [evidence TAS],1,27568218-27568267,1p36.11a,-,NM_173452.1,8547,FCN3,-4.085764269942032,9.312732415880072,-18.640968628153328,7.916274540591914e-43,3.6769130333881003e-41,86.810806199579
CPSF6,ILMN_1795454,"Homo sapiens cleavage and polyadenylation specific factor 6, 68kDa (CPSF6), mRNA.",nucleus [goid 5634] [evidence IEA]; mRNA cleavage factor complex [goid 5849] [pmid 9659921] [evidence IDA],mRNA processing [goid 6397] [pmid 14690600] [evidence IDA],RNA binding [goid 3723] [pmid 8626397] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 15169763] [evidence IPI],12,67950813-67950862,12q15c,+,NM_007007.1,11052,CPSF6,1.0530017030129644,6.572333709420916,18.640879665821792,7.920579355209272e-43,3.6769130333881003e-41,86.81026352491881
WNT3,ILMN_1803593,"Homo sapiens wingless-type MMTV integration site family, member 3 (WNT3), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],cell-cell signaling [goid 7267] [evidence NAS]; frizzled-2 signaling pathway [goid 7223] [evidence IEA]; morphogenesis [goid 9653] [evidence NAS],signal transducer activity [goid 4871] [evidence IEA]; extracellular matrix structural constituent [goid 5201] [evidence NAS],17,42196988-42197037,17q21.32a,-,NM_030753.3,7473,WNT3,1.797473497868891,6.81423443503582,18.63344140899315,8.288943076582721e-43,3.839008636024701e-41,86.76488655628006
PHLDA2,ILMN_1671557,"Homo sapiens pleckstrin homology-like domain, family A, member 2 (PHLDA2), mRNA.",,,,11,2906093-2906142,11p15.4d,-,NM_003311.3,7262,PHLDA2,2.429475244328449,6.99906223448007,18.623797307672344,8.79225182465296e-43,4.0627107276595017e-41,86.70604336476576
IGSF10,ILMN_1682100,"Homo sapiens immunoglobulin superfamily, member 10 (IGSF10), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; vascular endothelial growth factor receptor activity [goid 5021] [evidence IEA],3,152637696-152637745,3q25.1c,-,NM_178822.3,285313,IGSF10,-1.778150789145796,5.687625128320305,-18.60670661539848,9.76067879378253e-43,4.4998078641935676e-41,86.6017386863695
CYP4B1,ILMN_1659215,"Homo sapiens cytochrome P450, family 4, subfamily B, polypeptide 1 (CYP4B1), mRNA.",membrane [goid 16020] [evidence IEA]; microsome [goid 5792] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],electron transport [goid 6118] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; heme binding [goid 20037] [evidence IEA]; unspecific monooxygenase activity [goid 50381] [evidence IEA]; oxygen binding [goid 19825] [pmid 2574990] [evidence TAS]; monooxygenase activity [goid 4497] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA],1,47056997-47057046,1p33d,+,NM_000779.2,1580,CYP4B1,-3.9489181861766385,9.466997534422235,-18.593211089496158,1.0600447720664881e-42,4.875718574599148e-41,86.51935157349592
ST14,ILMN_1699887,"Homo sapiens suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin) (ST14), mRNA.",integral to plasma membrane [goid 5887] [pmid 10831593] [evidence TAS]; plasma membrane [goid 5886] [pmid 10831593] [evidence TAS],,serine-type endopeptidase activity [goid 4252] [evidence IEA],11,129585022-129585071,11q24.3c,+,NM_021978.2,6768,ST14,1.8505583278208508,9.309183760762046,18.589588127954674,1.0837980427031465e-42,4.97353927486343e-41,86.49723064885846
SLC19A3,ILMN_1716359,"Homo sapiens solute carrier family 19, member 3 (SLC19A3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 11136550] [evidence NAS],transport [goid 6810] [evidence NAS],folic acid binding [goid 5542] [evidence IEA]; reduced folate carrier activity [goid 8518] [evidence IEA]; carrier activity [goid 5386] [pmid 11136550] [evidence NAS],2,228258197-228258246,2q36.3c,-,NM_025243.2,80704,SLC19A3,-2.8024322531583685,7.487908443241667,-18.57622701920105,1.176107214626288e-42,5.384794771222602e-41,86.41563790738306
LOC400120,ILMN_1797526,"Homo sapiens hypothetical LOC400120 (LOC400120), mRNA.",,,,13,36169230-36169279,13q13.3b,+,NM_203451.1,400120,LOC400120,-1.865312942922193,6.4522026386612055,-18.569570962760807,1.2249953115590659e-42,5.595823331888993e-41,86.37498348008974
ARMCX1,ILMN_1788192,"Homo sapiens armadillo repeat containing, X-linked 1 (ARMCX1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,binding [goid 5488] [evidence IEA]; binding [goid 5488] [evidence IEA],X,100695454-100695503,Xq22.1c,+,NM_016608.1,51309,ARMCX1,-1.8434989363969114,7.023237260198752,-18.562182337273306,1.2816552573085916e-42,5.841311705747221e-41,86.32984864365515
NTAN1,ILMN_1801864,"PREDICTED: Homo sapiens N-terminal asparagine amidase, transcript variant 3 (NTAN1), mRNA.",,,,,,16p13.11b,,XM_942894.1,123803,NTAN1,-1.247457194182859,9.125632324018781,-18.558956376831507,1.3072111162752277e-42,5.944245457826082e-41,86.31014027885865
SLIT2,ILMN_1676449,"Homo sapiens slit homolog 2 (Drosophila) (SLIT2), mRNA.",extracellular region [goid 5576] [pmid 10102268] [evidence IEP]; extracellular space [goid 5615] [evidence NR ]; integral to membrane [goid 16021] [evidence IEA],induction of negative chemotaxis [goid 50929] [pmid 10197527] [evidence IDA]; chemotaxis [goid 6935] [evidence IEA]; positive regulation of axonogenesis [goid 50772] [pmid 10197527] [evidence TAS]; ureteric bud development [goid 1657] [pmid 15130495] [evidence IMP]; mesoderm migration [goid 7509] [pmid 10102268] [evidence IMP]; glial cell migration [goid 8347] [pmid 10102268] [evidence IMP]; neuron recognition [goid 8038] [pmid 10432110] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; motor axon guidance [goid 8045] [pmid 10102268] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; receptor binding [goid 5102] [pmid 10102268] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],4,20229660-20229709,4p15.31d,+,NM_004787.1,9353,SLIT2,-2.1181258473516653,9.946125593548013,-18.554441524559284,1.3438380980510875e-42,6.096941647575093e-41,86.2825556789565
PPARG,ILMN_1679901,"Homo sapiens peroxisome proliferative activated receptor, gamma (PPARG), transcript variant 3, mRNA.",nucleus [goid 5634] [evidence IEA],signal transduction [goid 7165] [pmid 9568716] [evidence TAS]; generation of precursor metabolites and energy [goid 6091] [pmid 10622252] [evidence TAS]; white fat cell differentiation [goid 50872] [pmid 12588810] [evidence TAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 9568715] [evidence TAS]; lipid metabolism [goid 6629] [pmid 9568716] [evidence TAS]; response to nutrient [goid 7584] [pmid 10973253] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 12040021] [evidence IPI]; steroid hormone receptor activity [goid 3707] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10622252] [evidence TAS],3,12305445-12305494,3p25.2a-p25.1d,+,NM_138711.2,5468,PPARG,-1.4923254563369968,6.794925956735471,-18.550011562955106,1.3807768592090745e-42,6.250358235080354e-41,86.25548746520865
TPX2,ILMN_1796949,"Homo sapiens TPX2, microtubule-associated, homolog (Xenopus laevis) (TPX2), mRNA.",nucleus [goid 5634] [pmid 9207457] [evidence TAS]; spindle pole [goid 922] [pmid 14718566] [evidence IDA],cell proliferation [goid 8283] [pmid 10512675] [evidence TAS]; mitosis [goid 7067] [pmid 9207457] [evidence TAS],ATP binding [goid 5524] [pmid 10512675] [evidence TAS]; GTP binding [goid 5525] [pmid 10512675] [evidence TAS],20,29852491-29852540,20q11.21b,+,NM_012112.4,22974,TPX2,2.082682140377136,6.393276271156659,18.547232065554567,1.4044716520633692e-42,6.343266098077627e-41,86.23850286577711
COLEC12,ILMN_1679049,"Homo sapiens collectin sub-family member 12 (COLEC12), transcript variant II, mRNA.",membrane [goid 16020] [pmid 11564734] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],"protein homooligomerization [goid 51260] [pmid 11564734] [evidence NAS]; innate immune response [goid 45087] [pmid 11564734] [evidence TAS]; oxidized low-density lipoprotein catabolism [goid 45194] [pmid 11564734] [evidence NAS]; antibacterial humoral response (sensu Vertebrata) [goid 19733] [pmid 11564734] [evidence IDA]; carbohydrate mediated signaling [goid 9756] [pmid 11564734] [evidence NAS]; phosphate transport [goid 6817] [evidence IEA]; antifungal humoral response (sensu Vertebrata) [goid 19734] [pmid 11564734] [evidence IDA]; symbiotic interaction between host and other organism [goid 44404] [pmid 11564734] [evidence NAS]; phagocytosis, recognition [goid 6910] [pmid 11564734] [evidence IDA]",low-density lipoprotein binding [goid 30169] [pmid 11564734] [evidence IDA]; sugar binding [goid 5529] [evidence IEA]; galactose binding [goid 5534] [pmid 11564734] [evidence NAS]; scavenger receptor activity [goid 5044] [pmid 11564734] [evidence TAS]; pattern recognition receptor activity [goid 8329] [pmid 11564734] [evidence IDA],18,323443-323492,18p11.32c,-,NM_030781.2,81035,COLEC12,-1.170740471259081,7.3941979200619565,-18.546422375630286,1.4114505406813452e-42,6.360428472511792e-41,86.23355494877984
FGFR4,ILMN_1730355,"Homo sapiens fibroblast growth factor receptor 4 (FGFR4), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 10918587] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 10918587] [evidence TAS]; membrane [goid 16020] [evidence IEA],fibroblast growth factor receptor signaling pathway [goid 8543] [pmid 10918587] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; fibroblast growth factor receptor signaling pathway [goid 8543] [pmid 10918587] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; fibroblast growth factor receptor activity [goid 5007] [pmid 10918587] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; fibroblast growth factor receptor activity [goid 5007] [pmid 10918587] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],5,176457351-176457400,5q35.2d,+,NM_022963.2,2264,FGFR4,-2.399342546977997,7.39884585172878,-18.537834730343995,1.4876448545217648e-42,6.688718707701455e-41,86.18107226070211
SMAD6,ILMN_1767068,"Homo sapiens SMAD, mothers against DPP homolog 6 (Drosophila) (SMAD6), mRNA.",intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]","transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity [goid 30617] [pmid 9436979] [evidence TAS]; signal transducer activity [goid 4871] [pmid 9436979] [evidence TAS]; receptor signaling protein serine/threonine kinase signaling protein activity [goid 5076] [evidence NR ]; protein binding [goid 5515] [pmid 9436979] [evidence TAS]",15,64861015-64861064,15q22.31c,+,NM_005585.2,4091,SMAD6,-2.9192483537236082,9.457218344455896,-18.527030420314187,1.589395374845328e-42,7.130184452893571e-41,86.1150305970813
POLQ,ILMN_1740291,"Homo sapiens polymerase (DNA directed), theta (POLQ), mRNA.",nucleoplasm [goid 5654] [pmid 10395804] [evidence TAS],DNA replication [goid 6260] [evidence IEA]; DNA repair [goid 6281] [pmid 10395804] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; DNA-directed DNA polymerase activity [goid 3887] [pmid 10395804] [evidence TAS]; damaged DNA binding [goid 3684] [pmid 10395804] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],3,122633049-122633098,3q13.33c,-,NM_199420.2,10721,POLQ,1.7622393544090658,6.096805253432297,18.522608736525115,1.6330238283065283e-42,7.309516947820362e-41,86.08799906698786
TYROBP,ILMN_1778977,"Homo sapiens TYRO protein tyrosine kinase binding protein (TYROBP), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 9490415] [evidence TAS]; membrane [goid 16020] [evidence IEA],cellular defense response [goid 6968] [pmid 9490415] [evidence TAS]; intracellular signaling cascade [goid 7242] [pmid 9490415] [evidence TAS],receptor signaling protein activity [goid 5057] [pmid 9490415] [evidence TAS],19,41090225-41090274,19q13.12a,-,NM_003332.2,7305,TYROBP,-2.1233050820858548,12.244410867747561,-18.491304200946235,1.978256376739011e-42,8.835034282543333e-41,85.89655784437865
SLIT3,ILMN_1811313,"Homo sapiens slit homolog 3 (Drosophila) (SLIT3), mRNA.",extracellular space [goid 5615] [pmid 9813312] [evidence TAS],cell differentiation [goid 30154] [evidence IEA]; central nervous system development [goid 7417] [pmid 10349621] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; structural molecule activity [goid 5198] [evidence NAS]; calcium ion binding [goid 5509] [evidence NAS]; protein binding [goid 5515] [pmid 9813312] [evidence TAS],5,168026045-168026094,5q35.1a-q35.1b,-,NM_003062.1,6586,SLIT3,-2.273562578165806,7.606097890903343,-18.481289483088833,2.1034800149953604e-42,9.373369296219859e-41,85.83528970882507
BCL9,ILMN_1704452,"Homo sapiens B-cell CLL/lymphoma 9 (BCL9), mRNA.",nucleus [goid 5634] [evidence IEA],Wnt receptor signaling pathway [goid 16055] [evidence IEA],protein binding [goid 5515] [pmid 11955446] [evidence IPI],1,145564526-145564575,1q21.1c,+,NM_004326.2,607,BCL9,1.1528095001454286,8.653364525331499,18.47996933308264,2.12056972748788e-42,9.428524246128334e-41,85.82721242784005
C9orf61,ILMN_2179717,"Homo sapiens chromosome 9 open reading frame 61 (C9orf61), mRNA.",,,,9,71196936-71196985,9q21.11a,+,NM_004816.2,9413,C9orf61,-2.400850555383368,8.802798438478119,-18.469544524855216,2.260507028578541e-42,1.0028431181330255e-40,85.7634216965984
FLJ11235,ILMN_1689831,"PREDICTED: Homo sapiens hypothetical protein FLJ11235 (FLJ11235), misc RNA.",,,,,,5q22.2a,,XR_000626.1,54508,FLJ11235,-1.7401923128945507,7.20385473869185,-18.4649598889483,2.3249464362252405e-42,1.0291488561060757e-40,85.73536379718503
PARP1,ILMN_1686871,"Homo sapiens poly (ADP-ribose) polymerase family, member 1 (PARP1), mRNA.",nucleus [goid 5634] [pmid 2513174] [evidence TAS]; nucleolus [goid 5730] [pmid 9518481] [evidence IDA]; intracellular [goid 5622] [evidence IEA],transcription from RNA polymerase II promoter [goid 6366] [pmid 10944198] [evidence TAS]; protein amino acid ADP-ribosylation [goid 6471] [pmid 2513174] [evidence TAS]; DNA repair [goid 6281] [pmid 10958667] [evidence TAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; DNA binding [goid 3677] [pmid 2513174] [evidence TAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; NAD binding [goid 51287] [evidence IEA]; NAD+ ADP-ribosyltransferase activity [goid 3950] [pmid 2513174] [evidence TAS]",1,224615431-224615480,1q42.12d,-,NM_001618.2,142,PARP1,1.0525238296596022,11.152106836506979,18.439549757759572,2.716996322884402e-42,1.1973934455566324e-40,85.5798107341937
GPBAR1,ILMN_1727709,"Homo sapiens G protein-coupled bile acid receptor 1 (GPBAR1), mRNA.",integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],2,218836680-218836684:218836685-218836729,2q35e,+,NM_170699.1,151306,GPBAR1,-1.7554589599834483,6.850219473746323,-18.4338270420095,2.814071055406095e-42,1.2374490917926408e-40,85.5447678649901
LNK,ILMN_1752046,"Homo sapiens SH2B adaptor protein 3 (SH2B3), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA],,12,110373463-110373512,12q24.12a,+,NM_005475.1,10019,LNK,-1.388212739415076,9.749709179793923,-18.42693172199246,2.9356696185614715e-42,1.2880894238635508e-40,85.50253963772813
FLJ40629,ILMN_1751776,"Homo sapiens cytoskeleton associated protein 2-like (CKAP2L), mRNA.",,,,2,113212054-113212103,2q13d,-,NM_152515.2,150468,FLJ40629,1.8662076043297686,6.061161730710338,18.413589090393327,3.186136655118434e-42,1.3949282756150902e-40,85.4208115082422
HMMR,ILMN_1781942,"Homo sapiens hyaluronan-mediated motility receptor (RHAMM) (HMMR), transcript variant 2, mRNA.",,cell motility [goid 6928] [evidence NR ],hyaluronic acid binding [goid 5540] [evidence IEA],5,162851071-162851120,5q34c,+,NM_012485.1,3161,HMMR,1.8748708153392108,6.200599091008639,18.397969060805824,3.506726541195946e-42,1.528596615168812e-40,85.32510783009067
EPB41L3,ILMN_2109197,"Homo sapiens erythrocyte membrane protein band 4.1-like 3 (EPB41L3), mRNA.",plasma membrane [goid 5886] [pmid 9892180] [evidence NAS]; intercellular junction [goid 5911] [pmid 12234973] [evidence IDA]; cytoskeleton [goid 5856] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],cortical actin cytoskeleton organization and biogenesis [goid 30866] [evidence IEA],binding [goid 5488] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; actin binding [goid 3779] [evidence IEA],18,5382986-5383035,18p11.31c-p11.31b,-,NM_012307.2,23136,EPB41L3,-1.9309760312864803,8.373000481698517,-18.3975636143172,3.5154654845711474e-42,1.529074639463033e-40,85.32262329667853
FPRL1,ILMN_1740875,"Homo sapiens formyl peptide receptor-like 1 (FPRL1), transcript variant 1, mRNA.",integral to membrane [goid 16021] [pmid 9054386] [evidence TAS]; plasma membrane [goid 5886] [pmid 9054386] [evidence TAS]; integral to membrane [goid 16021] [pmid 9054386] [evidence TAS]; plasma membrane [goid 5886] [pmid 9054386] [evidence TAS],inflammatory response [goid 6954] [pmid 9054386] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9054386] [evidence TAS]; chemotaxis [goid 6935] [pmid 9054386] [evidence TAS]; cell adhesion [goid 7155] [pmid 9054386] [evidence TAS]; cell motility [goid 6928] [pmid 1374236] [evidence TAS]; inflammatory response [goid 6954] [pmid 9054386] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9054386] [evidence TAS]; chemotaxis [goid 6935] [pmid 9054386] [evidence TAS]; cell adhesion [goid 7155] [pmid 9054386] [evidence TAS]; cell motility [goid 6928] [pmid 1374236] [evidence TAS],rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; N-formyl peptide receptor activity [goid 4982] [pmid 1374236] [evidence TAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; N-formyl peptide receptor activity [goid 4982] [pmid 1374236] [evidence TAS],19,56964814-56964863,19q13.33e,+,NM_001462.3,2358,FPRL1,-2.2740248884929564,5.976184731863271,-18.39178047002628,3.642519071460724e-42,1.5809006850712836e-40,85.28718276512522
CBX7,ILMN_1657361,"Homo sapiens chromobox homolog 7 (CBX7), mRNA.",nucleus [goid 5634] [evidence IEA]; chromatin [goid 785] [evidence IEA],"chromatin modification [goid 16568] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; chromatin assembly or disassembly [goid 6333] [evidence IEA]",chromatin binding [goid 3682] [evidence IEA],22,37857028-37857077,22q13.1c,-,NM_175709.2,23492,CBX7,-1.520764425924602,9.37285232731738,-18.378969663467238,3.9406133652367545e-42,1.7065755889969043e-40,85.20866147148462
HYOU1,ILMN_1673649,"Homo sapiens hypoxia up-regulated 1 (HYOU1), mRNA.",endoplasmic reticulum [goid 5783] [pmid 9020069] [evidence TAS],protein folding [goid 6457] [evidence IEA]; response to stress [goid 6950] [pmid 9020069] [evidence TAS],ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],11,118420565-118420614,11q23.3e,-,NM_006389.2,10525,HYOU1,1.4567708133757034,8.982529726173865,18.375168097030073,4.033693032620522e-42,1.7431129632110453e-40,85.18535694323779
BIRC5,ILMN_1803124,"Homo sapiens baculoviral IAP repeat-containing 5 (survivin) (BIRC5), transcript variant 3, mRNA.","chromosome, pericentric region [goid 775] [pmid 11084331] [evidence IDA]; midbody [goid 30496] [pmid 11084331] [evidence IDA]; spindle microtubule [goid 5876] [pmid 9859993] [evidence TAS]; intracellular [goid 5622] [evidence IEA]",G2/M transition of mitotic cell cycle [goid 86] [pmid 9859993] [evidence IDA]; apoptosis [goid 6915] [evidence IEA]; anti-apoptosis [goid 6916] [pmid 9859993] [evidence IDA],metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 11024045] [evidence IPI]; microtubule binding [goid 8017] [pmid 9859993] [evidence IDA]; cysteine protease inhibitor activity [goid 4869] [evidence IEA]; zinc ion binding [goid 8270] [evidence NAS]; caspase inhibitor activity [goid 43027] [pmid 9859993] [evidence IMP],17,73733114-73733163,17q25.3b,+,NM_001012271.1,332,BIRC5,1.720879789047693,6.007470127759135,18.364201302064494,4.3147533088641476e-42,1.8605513837015917e-40,85.11811863836829
C1QA,ILMN_1737918,"Homo sapiens complement component 1, q subcomponent, alpha polypeptide (C1QA), mRNA.",complement component C1q complex [goid 5602] [pmid 9461517] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],"immune response [goid 6955] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 9461517] [evidence TAS]; phosphate transport [goid 6817] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",,1,22838328-22838377,1p36.12a,+,NM_015991.1,712,C1QA,-2.218761744657119,10.015034097011617,-18.36280163478382,4.3520102222850344e-42,1.872581086612451e-40,85.10953618458811
BTK,ILMN_1662026,"Homo sapiens Bruton agammaglobulinemia tyrosine kinase (BTK), mRNA.",lipid raft [goid 45121] [pmid 15046600] [evidence IDA]; cytoplasm [goid 5737] [pmid 15046600] [evidence TAS],mesoderm development [goid 7498] [pmid 8013627] [evidence TAS]; calcium-mediated signaling [goid 19722] [pmid 15046600] [evidence TAS]; intracellular signaling cascade [goid 7242] [pmid 11913944] [evidence TAS]; induction of apoptosis by extracellular signals [goid 8624] [pmid 8688094] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 11913944] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [pmid 11913944] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; ATP binding [goid 5524] [pmid 11913944] [evidence TAS]; protein binding [goid 5515] [pmid 11788586] [evidence IPI],X,100491221-100491270,Xq22.1c,-,NM_000061.1,695,BTK,-1.7634514843085105,8.630396316093647,-18.3453068298827,4.8458445254085227e-42,2.080593503527333e-40,85.00224314935491
TMEM132A,ILMN_2317923,"Homo sapiens transmembrane protein 132A (TMEM132A), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA],,,11,60460878-60460927,11q12.2a,+,NM_178031.2,54972,TMEM132A,2.0156673010128188,7.619043312141138,18.33531489559496,5.152721448160674e-42,2.2076156474260976e-40,84.94094856342134
METTL7B,ILMN_2064725,"Homo sapiens methyltransferase like 7B (METTL7B), mRNA.",,,transferase activity [goid 16740] [evidence IEA]; methyltransferase activity [goid 8168] [evidence IEA],12,54364456-54364505,12q13.2b,+,NM_152637.1,196410,METTL7B,2.8911327808772267,7.036504188062651,18.333115323997852,5.222851745149192e-42,2.2328807204475435e-40,84.9274539810793
FCER1G,ILMN_2123743,"Homo sapiens Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide (FCER1G), mRNA.",plasma membrane [goid 5886] [pmid 1535625] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 1535625] [evidence TAS],immune response [goid 6955] [evidence NR ]; cell surface receptor linked signal transduction [goid 7166] [evidence IEA],IgE binding [goid 19863] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence NR ]; protein binding [goid 5515] [pmid 11788586] [evidence IPI],1,159455128-159455137:159455295-159455334,1q23.3a,+,NM_004106.1,2207,FCER1G,-1.971321613738871,11.259359917260559,-18.318394572019006,5.7174979299932964e-42,2.439140694739997e-40,84.83712668436853
CASQ2,ILMN_1722329,"Homo sapiens calsequestrin 2 (cardiac muscle) (CASQ2), mRNA.",smooth endoplasmic reticulum [goid 5790] [evidence NR ],striated muscle contraction [goid 6941] [pmid 9795116] [evidence TAS]; heart development [goid 7507] [pmid 9795116] [evidence TAS]; muscle development [goid 7517] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA],1,116044535-116044584,1p13.1d,-,NM_001232.1,845,CASQ2,-2.119054217535708,6.141249346922933,-18.315464793320135,5.82141528418627e-42,2.4781888724680616e-40,84.8191464899925
LPL,ILMN_1786444,"Homo sapiens lipoprotein lipase (LPL), mRNA.",chylomicron [goid 42627] [evidence IEA]; membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [pmid 1969408] [evidence TAS],fatty acid metabolism [goid 6631] [evidence NR ]; lipid catabolism [goid 16042] [evidence IEA]; circulation [goid 8015] [pmid 1969408] [evidence TAS],lipoprotein lipase activity [goid 4465] [pmid 1969408] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; lipid transporter activity [goid 5319] [evidence IEA]; heparin binding [goid 8201] [pmid 1969408] [evidence TAS],8,19868711-19868760,8p21.3c,+,NM_000237.1,4023,LPL,-2.701047159206629,9.060635371349495,-18.287619199602897,6.908724220261164e-42,2.934814314203511e-40,84.64820838300524
C7,ILMN_1687848,"Homo sapiens complement component 7 (C7), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane attack complex [goid 5579] [pmid 3335508] [evidence TAS],"complement activation, alternative pathway [goid 6957] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]; cytolysis [goid 19835] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",,5,41018553-41018602,5p13.1b,+,NM_000587.2,730,C7,-3.290906911518083,9.186170131868373,-18.264180919846062,7.980417555332741e-42,3.382885475574099e-40,84.50425810925992
PTGDS,ILMN_1664464,"Homo sapiens prostaglandin D2 synthase 21kDa (brain) (PTGDS), mRNA.",membrane [goid 16020] [evidence IEA]; Golgi apparatus [goid 5794] [evidence ISS]; nucleus [goid 5634] [evidence IEA]; rough endoplasmic reticulum [goid 5791] [pmid 9065498] [evidence IDA]; extracellular region [goid 5576] [pmid 7692978] [evidence IDA],"lipid metabolism [goid 6629] [evidence IEA]; regulation of circadian sleep/wake cycle, sleep [goid 45187] [evidence ISS]; prostaglandin biosynthesis [goid 1516] [evidence ISS]; transport [goid 6810] [evidence ISS]; fatty acid biosynthesis [goid 6633] [evidence IEA]",binding [goid 5488] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA]; prostaglandin-D synthase activity [goid 4667] [evidence ISS]; transporter activity [goid 5215] [evidence ISS]; retinoid binding [goid 5501] [evidence ISS],9,138994544-138994557:138995106-138995128:138995852-138995864,9q34.3e,+,NM_000954.5,5730,PTGDS,-2.5453399394229166,11.456750334342134,-18.263417796234112,8.017983442258653e-42,3.3916239474146116e-40,84.49957021365782
PLEKHC1,ILMN_1695290,"Homo sapiens pleckstrin homology domain containing, family C (with FERM domain) member 1 (PLEKHC1), mRNA.",stress fiber [goid 1725] [evidence NAS]; cytoskeleton [goid 5856] [evidence IEA],regulation of cell shape [goid 8360] [evidence IEA]; cell adhesion [goid 7155] [evidence NAS]; actin cytoskeleton organization and biogenesis [goid 30036] [evidence NAS],protein binding [goid 5515] [evidence NAS],14,52393815-52393864,14q22.2a,-,NM_006832.1,10979,PLEKHC1,-1.3383511548400673,11.221372821069451,-18.244649788783775,8.999820900489221e-42,3.798911742130556e-40,84.38425707116669
MAOB,ILMN_1727360,"Homo sapiens monoamine oxidase B (MAOB), nuclear gene encoding mitochondrial protein, mRNA.",integral to membrane [goid 16021] [evidence IEA],electron transport [goid 6118] [evidence IEA],electron transporter activity [goid 5489] [pmid 8602220] [evidence TAS]; amine oxidase activity [goid 8131] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA],X,43511097-43511146,Xp11.3c,-,NM_000898.3,4129,MAOB,-2.253383122370211,7.6219839762027926,-18.207582229457845,1.1307576614630675e-41,4.762989324326958e-40,84.1563928794663
LOC654260,ILMN_1763310,"PREDICTED: Homo sapiens similar to beta-tubulin cofactor D isoform 1 (LOC654260), mRNA.",,,,,,,,XM_942439.1,654260,LOC654260,1.613323688422617,7.093012410742604,18.20268355161992,1.1654022680012511e-41,4.898606844153158e-40,84.12626787763618
FAM65A,ILMN_1680037,"Homo sapiens family with sequence similarity 65, member A (FAM65A), mRNA.",,,binding [goid 5488] [evidence IEA]; DNA-directed RNA polymerase activity [goid 3899] [evidence IEA],16,66138095-66138144,16q22.1b,+,NM_024519.2,79567,FAM65A,-1.5216219674926066,10.630273450406442,-18.192589855877024,1.240180880293089e-41,5.201999801447405e-40,84.0641870266753
DKFZP686A01247,ILMN_2139761,"Homo sapiens LIM and calponin homology domains 1 (LIMCH1), mRNA.",actin cytoskeleton [goid 15629] [pmid 11256614] [evidence IDA],actomyosin structure organization and biogenesis [goid 31032] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; actin binding [goid 3779] [evidence IEA],4,41395534-41395583,4p13d,+,NM_014988.1,22998,DKFZP686A01247,-1.6793402078478081,11.563243013878356,-18.18938125698568,1.2649454139789583e-41,5.294775699349581e-40,84.04445028671562
BST1,ILMN_1770161,"Homo sapiens bone marrow stromal cell antigen 1 (BST1), mRNA.",membrane [goid 16020] [evidence IEA]; extrinsic to membrane [goid 19898] [pmid 8202488] [evidence TAS],development [goid 7275] [pmid 8202488] [evidence TAS]; humoral immune response [goid 6959] [pmid 8202488] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; NAD+ nucleosidase activity [goid 3953] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA],4,15342563-15342566:15342567-15342612,4p15.32d,+,NM_004334.1,683,BST1,-1.253573079869824,5.866007477566523,-18.179409745907638,1.345118135446614e-41,5.618606190817506e-40,83.98310616057931
FBLN1,ILMN_1672536,"Homo sapiens fibulin 1 (FBLN1), transcript variant D, mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [pmid 2269669] [evidence TAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 2269669] [evidence TAS]; soluble fraction [goid 5625] [pmid 2269669] [evidence TAS],,extracellular matrix structural constituent [goid 5201] [pmid 2269669] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],22,44375589-44375638,22q13.31c,+,NM_006486.2,2192,FBLN1,-1.3175824238787701,8.5488325830519,-18.176416949273175,1.3701608644312318e-41,5.711287203237517e-40,83.96469249066072
LRRC45,ILMN_1742507,"PREDICTED: Homo sapiens leucine rich repeat containing 45 (LRRC45), mRNA.",,,,,,17q25.3g,,XM_938258.1,201255,LRRC45,1.5097073144234923,6.88429584387846,18.16567170947675,1.463989780106823e-41,6.089710503196947e-40,83.8985724046663
TCEAL7,ILMN_1753525,"Homo sapiens transcription elongation factor A (SII)-like 7 (TCEAL7), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",,X,102473239-102473288,Xq22.1e,+,NM_152278.1,56849,TCEAL7,-1.5062840966946647,5.8654150211612075,-18.15154001023143,1.5972727285758135e-41,6.630338745507236e-40,83.81159435758434
GIMAP8,ILMN_1747305,"Homo sapiens GTPase, IMAP family member 8 (GIMAP8), mRNA.",,,GTP binding [goid 5525] [evidence IEA],7,149807193-149807242,7q36.1c,+,NM_175571.2,155038,GIMAP8,-1.95988876926351,8.87860089388951,-18.14535303015414,1.6593930023146522e-41,6.8739410331907996e-40,83.77350760721501
MYH10,ILMN_1815154,"Homo sapiens myosin, heavy chain 10, non-muscle (MYH10), mRNA.",myosin [goid 16459] [pmid 7499478] [evidence NAS],regulation of cell shape [goid 8360] [evidence IEA]; cytokinesis [goid 910] [evidence NAS],nucleotide binding [goid 166] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; ATP binding [goid 5524] [pmid 7782316] [evidence NAS]; motor activity [goid 3774] [evidence IEA]; actin binding [goid 3779] [pmid 7782316] [evidence NAS]; protein binding [goid 5515] [pmid 7542763] [evidence IPI],17,8318410-8318459,17p13.1c,-,NM_005964.1,4628,MYH10,-1.5217110004148982,12.17788949841517,-18.11566996260946,1.992843596632649e-41,8.238184851534305e-40,83.59072078753601
C20orf100,ILMN_2082209,"Homo sapiens chromosome 20 open reading frame 100 (C20orf100), mRNA.",nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],20,42131524-42131573,20q13.12a,+,NM_032883.1,84969,C20orf100,-1.75880625571644,10.457695528950545,-18.114818979375972,2.0033356277305025e-41,8.264482317449876e-40,83.58547903055975
CEP55,ILMN_1747016,"Homo sapiens centrosomal protein 55kDa (CEP55), mRNA.",,mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],,10,95278458-95278507,10q23.33b,+,NM_018131.3,55165,CEP55,1.95113216488671,6.8612187631837385,18.114427648460104,2.0081790440899221e-41,8.26741693706814e-40,83.5830685429334
COL13A1,ILMN_2311052,"Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 19, mRNA.",plasma membrane [goid 5886] [pmid 9624150] [evidence TAS]; collagen type XIII [goid 5600] [pmid 9624150] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],,10,71388731-71388780,10q21.3e-q22.1a,+,NM_080815.2,1305,COL13A1,-1.9217845739046684,7.395130741027081,-18.112990103131036,2.0260722549690599e-41,8.32395352719116e-40,83.57421352465542
CACNA2D2,ILMN_1711049,"Homo sapiens calcium channel, voltage-dependent, alpha 2/delta subunit 2 (CACNA2D2), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,3,50375436-50375485,3p21.31b,-,NM_001005505.1,9254,CACNA2D2,-2.2189594213997195,7.940558957778029,-18.099505603496063,2.2018974868999947e-41,9.027779696289978e-40,83.49114027536548
SLC7A7,ILMN_1810275,"Homo sapiens solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 (SLC7A7), mRNA.",integral to plasma membrane [goid 5887] [pmid 9829974] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [pmid 9829974] [evidence TAS]; amino acid transport [goid 6865] [evidence IEA]; amino acid metabolism [goid 6520] [pmid 9829974] [evidence TAS]; protein complex assembly [goid 6461] [pmid 9829974] [evidence TAS],basic amino acid permease activity [goid 5286] [pmid 9829974] [evidence TAS]; amino acid-polyamine transporter activity [goid 5279] [evidence IEA],14,22312594-22312643,14q11.2e-q11.2f,-,NM_003982.2,9056,SLC7A7,-1.7463637342807754,10.589347787731404,-18.092872561150845,2.2939222523458845e-41,9.385847939659807e-40,83.45026902998951
MCM4,ILMN_1737205,"Homo sapiens MCM4 minichromosome maintenance deficient 4 (S. cerevisiae) (MCM4), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 8265339] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; DNA replication initiation [goid 6270] [evidence IEA]; DNA replication [goid 6260] [pmid 9465298] [evidence NAS]",nucleotide binding [goid 166] [evidence IEA]; DNA-dependent ATPase activity [goid 8094] [evidence IEA]; protein binding [goid 5515] [pmid 15232106] [evidence IPI]; DNA binding [goid 3677] [evidence IEA]; ATP binding [goid 5524] [evidence NAS],8,49051904-49051953,8q11.21b,+,NM_005914.2,4173,MCM4,1.7237260942599066,8.136975895524913,18.087045057256724,2.3779492894951427e-41,9.709797833514044e-40,83.41435729373981
SOCS2,ILMN_1798926,"Homo sapiens suppressor of cytokine signaling 2 (SOCS2), mRNA.",cytoplasm [goid 5737] [pmid 9727029] [evidence NAS]; cytoplasm [goid 5737] [pmid 9727029] [evidence NAS],JAK-STAT cascade [goid 7259] [pmid 9266833] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; negative regulation of signal transduction [goid 9968] [evidence IEA]; anti-apoptosis [goid 6916] [pmid 9266833] [evidence TAS]; regulation of cell growth [goid 1558] [pmid 9727029] [evidence NAS]; JAK-STAT cascade [goid 7259] [pmid 9266833] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; negative regulation of signal transduction [goid 9968] [evidence IEA]; anti-apoptosis [goid 6916] [pmid 9266833] [evidence TAS]; regulation of cell growth [goid 1558] [pmid 9727029] [evidence NAS],insulin-like growth factor receptor binding [goid 5159] [pmid 9727029] [evidence IPI]; JAK pathway signal transduction adaptor activity [goid 8269] [pmid 9266833] [evidence TAS]; SH3/SH2 adaptor activity [goid 5070] [pmid 9344848] [evidence TAS]; growth hormone receptor binding [goid 5131] [pmid 12135564] [evidence NAS]; prolactin receptor binding [goid 5148] [evidence NAS]; protein binding [goid 5515] [pmid 11781573] [evidence IPI]; insulin-like growth factor receptor binding [goid 5159] [pmid 9727029] [evidence IPI]; JAK pathway signal transduction adaptor activity [goid 8269] [pmid 9266833] [evidence TAS]; SH3/SH2 adaptor activity [goid 5070] [pmid 9344848] [evidence TAS]; growth hormone receptor binding [goid 5131] [pmid 12135564] [evidence NAS]; prolactin receptor binding [goid 5148] [evidence NAS]; protein binding [goid 5515] [pmid 11781573] [evidence IPI],12,92493453-92493502,12q22b,+,NM_003877.3,8835,SOCS2,-2.355919948192386,8.910303548677176,-18.070944771822802,2.6264972498556107e-41,1.0702842561122415e-39,83.31512041902157
SOX18,ILMN_1812968,"Homo sapiens SRY (sex determining region Y)-box 18 (SOX18), mRNA.",nucleus [goid 5634] [evidence IEA],transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 10807548] [evidence TAS],RNA polymerase II transcription factor activity [goid 3702] [pmid 10807548] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],20,62149664-62149713,20q13.33e,-,NM_018419.2,54345,SOX18,-2.7645691529425633,10.67211379293585,-18.05653032226049,2.8710528379000524e-41,1.1675614874126878e-39,83.22625011987535
PPP1R15A,ILMN_1659936,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 15A (PPP1R15A), mRNA.",,apoptosis [goid 6915] [pmid 9153226] [evidence TAS]; response to DNA damage stimulus [goid 6974] [pmid 9153226] [evidence TAS]; cell cycle arrest [goid 7050] [pmid 9153226] [evidence TAS],,19,54071014-54071042:54071043-54071063,19q13.33a,+,NM_014330.2,23645,PPP1R15A,-1.7232120990335584,11.77481755079038,-18.052832700181597,2.9373859952382503e-41,1.192113975511702e-39,83.20344923525614
FER1L4,ILMN_1809199,Homo sapiens fer-1-like 4 (C. elegans) (FER1L4) on chromosome 20.,,,,20,,20q11.22b,-,NR_001442.1,80307,FER1L4,1.5863291358942186,5.912903359722899,18.051801818439827,2.956151898755383e-41,1.1973013601274837e-39,83.19709217332661
SLC22A18AS,ILMN_1691048,"Homo sapiens solute carrier family 22 (organic cation transporter), member 18 antisense (SLC22A18AS), mRNA.",,,,11,2866156-2866205,11p15.4d,-,NM_007105.1,5003,SLC22A18AS,2.4217110219077416,7.049643401119056,18.04879176453591,3.0116370742739486e-41,1.2173097895368315e-39,83.17852962470675
DPYSL2,ILMN_1672503,"Homo sapiens dihydropyrimidinase-like 2 (DPYSL2), mRNA.",,"nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 8973361] [evidence TAS]; signal transduction [goid 7165] [pmid 8973361] [evidence TAS]",hydrolase activity [goid 16787] [evidence IEA]; dihydropyrimidinase activity [goid 4157] [pmid 8973361] [evidence TAS],8,26571233-26571282,8p21.2a,+,NM_001386.4,1808,DPYSL2,-1.4457907108607948,12.684420591161086,-18.045773561962783,3.068321220379107e-41,1.2377211890593784e-39,83.15991581856403
LAYN,ILMN_1716397,"Homo sapiens layilin (LAYN), mRNA.",ruffle [goid 1726] [evidence ISS]; focal adhesion [goid 5925] [evidence ISS]; cell surface [goid 9986] [evidence ISS],,hyaluronic acid binding [goid 5540] [pmid 11294894] [evidence IDA]; protein binding [goid 5515] [pmid 9786953] [evidence ISS]; sugar binding [goid 5529] [evidence IEA],11,110936530-110936579,11q23.1b,+,NM_178834.2,143903,LAYN,-1.4477228558981166,7.596149423406935,-18.0122845572818,3.7738539074733826e-41,1.516210220496535e-39,82.95331549565675
TMEM47,ILMN_2129234,"Homo sapiens transmembrane protein 47 (TMEM47), mRNA.",plasma membrane [goid 5886] [pmid 11256614] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA],,,X,34555202-34555251,Xp21.1c,-,NM_031442.2,83604,TMEM47,-1.8420734305677957,9.65844091309671,-18.008067581816086,3.8735327473698143e-41,1.5531391424724496e-39,82.92729136497834
OSR1,ILMN_2197128,"Homo sapiens odd-skipped related 1 (Drosophila) (OSR1), mRNA.",intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA],,nucleic acid binding [goid 3676] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],2,19414793-19414842,2p24.1d,-,NM_145260.2,130497,OSR1,-2.2312197865317724,8.814088675573018,-17.992968776815083,4.2525846460845766e-41,1.6949345338418365e-39,82.83409636758044
CANT1,ILMN_1664012,"Homo sapiens calcium activated nucleotidase 1 (CANT1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP],hydrolase activity [goid 16787] [evidence IEA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; nucleoside-diphosphatase activity [goid 17110] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],17,74499665-74499714,17q25.3c,-,NM_138793.2,124583,CANT1,1.2591945143985637,10.020040327058279,17.990145367301423,4.32748977944523e-41,1.7213601492473195e-39,82.81666653124144
ST6GALNAC3,ILMN_1779061,"Homo sapiens ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (ST6GALNAC3), mRNA.",integral to Golgi membrane [goid 30173] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to Golgi membrane [goid 30173] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein amino acid glycosylation [goid 6486] [evidence IEA]; protein amino acid glycosylation [goid 6486] [evidence IEA],sialyltransferase activity [goid 8373] [evidence IEA]; sialyltransferase activity [goid 8373] [evidence IEA],1,76868513-76868562,1p31.1g-p31.1f,+,NM_152996.1,256435,ST6GALNAC3,-1.0916976596829233,5.584996961391719,-17.98702253502885,4.4118807548852577e-41,1.751446629836195e-39,82.79738723806963
XPO5,ILMN_1759495,"Homo sapiens exportin 5 (XPO5), mRNA.",nucleus [goid 5634] [evidence IEA],protein transport [goid 15031] [evidence IEA],binding [goid 5488] [evidence IEA]; tRNA binding [goid 49] [evidence IEA]; protein binding [goid 5515] [pmid 12702765] [evidence IPI],6,43598330-43598379,6p21.1c,-,NM_020750.1,57510,XPO5,1.1929734874226892,7.931625209144852,17.977699387538177,4.673775855717765e-41,1.8480811723557516e-39,82.73982294878327
KIAA0101,ILMN_1732150,"Homo sapiens KIAA0101 (KIAA0101), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],,,15,62444630-62444679,15q22.31a,-,NM_014736.4,9768,KIAA0101,1.0832891063033117,9.329673579735582,17.970433703604556,4.888640007412413e-41,1.925431284809204e-39,82.69495551621668
TROAP,ILMN_1700337,"Homo sapiens trophinin associated protein (tastin) (TROAP), mRNA.",cytoplasm [goid 5737] [pmid 7758945] [evidence TAS],cell adhesion [goid 7155] [pmid 7758945] [evidence TAS],protein binding [goid 5515] [evidence IEA],12,48011638-48011667:48011668-48011687,12q13.12b,+,NM_005480.2,10024,TROAP,1.8254484411205052,5.984426588676298,17.962588427143103,5.131782190415952e-41,2.0172239305666477e-39,82.64650244247865
MGC34774,ILMN_1749234,"Homo sapiens ribosomal protein L13A-like (MGC34774), mRNA.",,,,7,77826605-77826654,7q21.11a,+,NM_203308.1,399670,MGC34774,-2.840134424198814,6.731392194221168,-17.933031606021007,6.161882248195847e-41,2.4126602744012236e-39,82.46389644235653
DOCK2,ILMN_1799725,"Homo sapiens dedicator of cytokinesis 2 (DOCK2), mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],lymphocyte chemotaxis [goid 48247] [pmid 11518968] [evidence ISS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 12176041] [evidence TAS],Rac guanyl-nucleotide exchange factor activity [goid 30676] [pmid 10559471] [evidence IDA]; T cell receptor binding [goid 42608] [pmid 12176041] [evidence IDA]; protein binding [goid 5515] [pmid 12134158] [evidence IPI],5,169442689-169442738,5q35.1b-q35.1c,+,NM_004946.1,1794,DOCK2,-1.575704743596761,9.912043106244287,-17.906606929395355,7.257298450510392e-41,2.836016160113514e-39,82.30056025818816
ELMO3,ILMN_1752665,"Homo sapiens engulfment and cell motility 3 (ced-12 homolog, C. elegans) (ELMO3), mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; phagocytosis [goid 6909] [evidence IEA],,16,65794952-65794987:65795069-65795082,16q22.1a,+,NM_024712.2,79767,ELMO3,1.6063690040196068,8.529261196395613,17.905374991269436,7.312884900369838e-41,2.8521676625068173e-39,82.29294354118369
NUP155,ILMN_1768293,"Homo sapiens nucleoporin 155kDa (NUP155), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA]; nuclear pore [goid 5643] [evidence IEA],transport [goid 6810] [evidence IEA]; nucleocytoplasmic transport [goid 6913] [evidence IEA],structural constituent of nuclear pore [goid 17056] [evidence IEA]; nucleocytoplasmic transporter activity [goid 5487] [evidence IEA]; transporter activity [goid 5215] [pmid 10191094] [evidence TAS],5,37327831-37327880,5p13.2b,-,NM_004298.2,9631,NUP155,1.2962120804668764,8.68172101976782,17.886626714909593,8.213496537787517e-41,3.197191414942658e-39,82.17700792546158
Pfs2,ILMN_1809590,"Homo sapiens GINS complex subunit 2 (Psf2 homolog) (GINS2), mRNA.",nucleus [goid 5634] [evidence IEA],DNA replication [goid 6260] [evidence IEA],,16,84268826-84268875,16q24.1b,-,NM_016095.1,51659,Pfs2,2.062637441383969,7.5699576065724,17.878247065194667,8.651225373748066e-41,3.361043053940802e-39,82.12517743862014
LMCD1,ILMN_1754969,"Homo sapiens LIM and cysteine-rich domains 1 (LMCD1), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],3,8584584-8584633,3p26.1a,+,NM_014583.2,29995,LMCD1,-1.720801134469676,10.440631208654336,-17.86824015520919,9.20471774091626e-41,3.569147142640553e-39,82.06327186619505
ZNF25,ILMN_1808765,"Homo sapiens zinc finger protein 25 (ZNF25), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],10,38279101-38279150,10p11.21a,-,NM_145011.2,219749,ZNF25,-1.1504300635718572,8.752692502907777,-17.859579660867073,9.712328833036336e-41,3.7586900443209095e-39,82.00968680081601
LOC400986,ILMN_1811117,"Homo sapiens protein immuno-reactive with anti-PTH polyclonal antibodies (LOC400986), mRNA.",integral to membrane [goid 16021] [evidence NAS]; integral to membrane [goid 16021] [evidence NAS],"di-, tri-valent inorganic anion homeostasis [goid 30319] [pmid 8608414] [evidence NAS]; di-, tri-valent inorganic anion homeostasis [goid 30319] [pmid 8608414] [evidence NAS]",ion channel inhibitor activity [goid 8200] [pmid 8608414] [evidence NAS]; ion channel inhibitor activity [goid 8200] [pmid 8608414] [evidence NAS],2,95943639-95943655:95943750-95943778:95945455-95945458,2q11.2a,-,NM_001010914.1,400986,LOC400986,3.195957214384677,7.426212813749644,17.8516686502834,1.0200509691631765e-40,3.9399960986518984e-39,81.9607318846482
TSPAN4,ILMN_1718607,"Homo sapiens tetraspanin 4 (TSPAN4), transcript variant 3, mRNA.",plasma membrane [goid 5886] [pmid 9360996] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9360996] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],protein complex assembly [goid 6461] [pmid 9360996] [evidence TAS],,11,857045-857094,11p15.5c,+,NM_001025235.1,7106,TSPAN4,-1.0644784107394472,8.80718875055383,-17.841271984084756,1.0879699498065828e-40,4.194239451971119e-39,81.896384889697
SFXN1,ILMN_2205935,"Homo sapiens sideroflexin 1 (SFXN1), mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cation transport [goid 6812] [evidence IEA]; iron ion transport [goid 6826] [evidence IEA],iron ion binding [goid 5506] [evidence IEA]; cation transporter activity [goid 8324] [evidence IEA],5,174887440-174887489,5q35.2c,+,NM_022754.4,94081,SFXN1,1.5134363124095334,6.947579554938853,17.839073693016942,1.1029018799011216e-40,4.243627079434931e-39,81.88277773367895
HHIP,ILMN_1675453,"Homo sapiens hedgehog interacting protein (HHIP), mRNA.",,,,4,145878446-145878495,4q31.22a,+,NM_022475.1,64399,HHIP,-2.292005359152385,6.585495570713308,-17.830160451203355,1.165581086962557e-40,4.476189325901505e-39,81.82760046833157
RAB26,ILMN_1790317,"Homo sapiens RAB26, member RAS oncogene family (RAB26), mRNA.",membrane [goid 16020] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"protein transport [goid 15031] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; small GTPase mediated signal transduction [goid 7264] [evidence IEA]",nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; GTP binding [goid 5525] [pmid 11043516] [evidence NAS]; transcription factor binding [goid 8134] [evidence IEA]; protein binding [goid 5515] [pmid 16696853] [evidence IPI],16,2143907-2143956,16p13.3d,+,NM_014353.4,25837,RAB26,1.7156572123201492,6.118253658697251,17.82970301633143,1.1688925237552116e-40,4.480306822853309e-39,81.82476849328587
RAG1AP1,ILMN_1776522,"Homo sapiens recombination activating gene 1 activating protein 1 (RAG1AP1), mRNA.",membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [pmid 8630032] [evidence IC ]; membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [pmid 8630032] [evidence IC ],"positive regulation of gene expression, epigenetic [goid 45815] [pmid 8630032] [evidence ISS]; positive regulation of gene expression, epigenetic [goid 45815] [pmid 8630032] [evidence ISS]",,1,153377450-153377499,1q22a,+,NM_018845.1,55974,RAG1AP1,1.4594940173372102,9.245255438220253,17.825350837486713,1.2008743171164851e-40,4.594090504181001e-39,81.79782305914317
MSI2,ILMN_1713088,"Homo sapiens musashi homolog 2 (Drosophila) (MSI2), transcript variant 1, mRNA.",,,RNA binding [goid 3723] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],17,53112002-53112051,17q22c-q22d,+,NM_138962.2,124540,MSI2,1.0078039476302978,6.151101273985761,17.814350349399877,1.285678325480732e-40,4.909132048896658e-39,81.72970711431086
SBK1,ILMN_1728298,"Homo sapiens SH3-binding domain kinase 1 (SBK1), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],16,28242520-28242569,16p11.2e,+,NM_001024401.2,388228,SBK1,2.1018040050617977,8.927768437782706,17.792081232842353,1.476188011059506e-40,5.625822804814971e-39,81.5917747586595
KIF14,ILMN_1808071,"Homo sapiens kinesin family member 14 (KIF14), mRNA.",microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],1,198788286-198788335,1q32.1b,-,NM_014875.1,9928,KIF14,1.4348210549683182,6.0218598617959,17.788718576051636,1.5073189868290328e-40,5.733543400850815e-39,81.57094218599188
BOP1,ILMN_1715583,"Homo sapiens block of proliferation 1 (BOP1), mRNA.",nucleus [goid 5634] [evidence IEA],rRNA processing [goid 6364] [evidence IEA],,8,,8q24.3g,-,NM_015201.3,23246,BOP1,1.2798023086532293,10.589037908345952,17.775938342928683,1.6317629463836019e-40,6.195125812380097e-39,81.49175402289836
AURKA,ILMN_1680955,"Homo sapiens aurora kinase A (AURKA), transcript variant 3, mRNA.",spindle [goid 5819] [pmid 9153231] [evidence TAS]; nucleus [goid 5634] [pmid 9153231] [evidence TAS]; spindle [goid 5819] [pmid 9153231] [evidence TAS]; nucleus [goid 5634] [pmid 9153231] [evidence TAS],regulation of protein stability [goid 31647] [pmid 15987997] [evidence IMP]; protein amino acid phosphorylation [goid 6468] [pmid 9153231] [evidence TAS]; cell cycle [goid 7049] [pmid 15504738] [evidence NAS]; mitosis [goid 7067] [pmid 9153231] [evidence TAS]; spindle organization and biogenesis [goid 7051] [pmid 15504738] [evidence NAS]; phosphoinositide-mediated signaling [goid 48015] [pmid 15504738] [evidence NAS]; regulation of protein stability [goid 31647] [pmid 15987997] [evidence IMP]; protein amino acid phosphorylation [goid 6468] [pmid 9153231] [evidence TAS]; cell cycle [goid 7049] [pmid 15504738] [evidence NAS]; mitosis [goid 7067] [pmid 9153231] [evidence TAS]; spindle organization and biogenesis [goid 7051] [pmid 15504738] [evidence NAS]; phosphoinositide-mediated signaling [goid 48015] [pmid 15504738] [evidence NAS],protein kinase activity [goid 4672] [evidence IEA]; protein binding [goid 5515] [pmid 15987997] [evidence IPI]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein kinase activity [goid 4672] [evidence IEA]; protein binding [goid 5515] [pmid 15987997] [evidence IPI]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],20,54378045-54378094,20q13.2d-q13.31a,-,NM_198434.1,6790,AURKA,2.0948880459801833,7.782216647590826,17.766920697875918,1.7257214994644471e-40,6.539438591152396e-39,81.43586878583899
AIF1,ILMN_1703538,"Homo sapiens allograft inflammatory factor 1 (AIF1), transcript variant 3, mRNA.",nucleus [goid 5634] [pmid 9614071] [evidence TAS]; nucleus [goid 5634] [pmid 9614071] [evidence TAS],response to stress [goid 6950] [pmid 9614071] [evidence TAS]; cell cycle arrest [goid 7050] [pmid 9614071] [evidence TAS]; inflammatory response [goid 6954] [pmid 8912632] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9614071] [evidence TAS]; response to stress [goid 6950] [pmid 9614071] [evidence TAS]; cell cycle arrest [goid 7050] [pmid 9614071] [evidence TAS]; inflammatory response [goid 6954] [pmid 8912632] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9614071] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],6,31691054-31691085:31691086-31691103,6p21.33a,+,NM_001623.3,199,AIF1,-1.1666652381736897,8.33332152925318,-17.76315127386733,1.7665871807026011e-40,6.681640134498609e-39,81.4125058570983
CYB5A,ILMN_1714167,"Homo sapiens cytochrome b5 type A (microsomal) (CYB5A), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence NR ]; endoplasmic reticulum [goid 5783] [evidence IEA]; microsome [goid 5792] [evidence IEA],transport [goid 6810] [evidence IEA]; electron transport [goid 6118] [evidence IEA],cytochrome-c oxidase activity [goid 4129] [pmid 1712589] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA],18,70071744-70071793,18q22.3c,-,NM_148923.2,1528,CYB5A,-1.6608531790471606,12.283369819001031,-17.729910127665654,2.1716992157307464e-40,8.198369416668072e-39,81.20641062754486
KIF11,ILMN_1794539,"Homo sapiens kinesin family member 11 (KIF11), mRNA.",microtubule [goid 5874] [evidence IEA]; spindle [goid 5819] [pmid 8548803] [evidence TAS]; kinesin complex [goid 5871] [pmid 8548803] [evidence TAS]; microtubule associated complex [goid 5875] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; mitotic spindle organization and biogenesis [goid 7052] [pmid 8548803] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; microtubule motor activity [goid 3777] [pmid 8548803] [evidence TAS]; ATP binding [goid 5524] [evidence IEA],10,94404566-94404615,10q23.33a,+,NM_004523.2,3832,KIF11,1.5780683415339771,6.159703129968528,17.720778273806964,2.298481329053732e-40,8.660643019153875e-39,81.14977228892599
CD69,ILMN_1651316,"Homo sapiens CD69 molecule (CD69), mRNA.",integral to plasma membrane [goid 5887] [pmid 8340758] [evidence TAS]; membrane [goid 16020] [evidence IEA],defense response [goid 6952] [evidence NR ]; cell surface receptor linked signal transduction [goid 7166] [evidence NR ],sugar binding [goid 5529] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 8340758] [evidence TAS],12,9796974-9797023,12p13.31a,-,NM_001781.1,969,CD69,-2.3926693596778703,7.696745087165643,-17.70701383498898,2.503745468605167e-40,9.416341980423342e-39,81.064384429411
ZSWIM4,ILMN_1735231,"Homo sapiens zinc finger, SWIM-type containing 4 (ZSWIM4), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],19,13803473-13803522,19p13.13a-p13.12c,+,NM_023072.1,65249,ZSWIM4,1.253631553415877,8.046495796326262,17.697179175479896,2.6615744023913023e-40,9.991140833591966e-39,81.00336255538552
FZD4,ILMN_1743367,"Homo sapiens frizzled homolog 4 (Drosophila) (FZD4), mRNA.",integral to membrane [goid 16021] [pmid 10544037] [evidence TAS]; membrane [goid 16020] [evidence IEA],frizzled signaling pathway [goid 7222] [pmid 10544037] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; development [goid 7275] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; Wnt receptor activity [goid 42813] [pmid 10544037] [evidence TAS]; G-protein coupled receptor activity [goid 4930] [evidence IEA]; non-G-protein coupled 7TM receptor activity [goid 4926] [evidence IEA],11,86334627-86334676,11q14.2a,-,NM_012193.2,8322,FZD4,-1.7213062041857672,9.686519176945875,-17.693489232215796,2.7233326431575784e-40,1.0203827626272815e-38,80.9804646043603
TMEM62,ILMN_1745807,"Homo sapiens transmembrane protein 62 (TMEM62), mRNA.",,,,15,41264348-41264397,15q15.2b,+,NM_024956.3,80021,TMEM62,1.242589839010062,9.647462229792565,17.692625525269666,2.7379947617337423e-40,1.0239588634162376e-38,80.97510465836255
PHKA1,ILMN_1812503,"Homo sapiens phosphorylase kinase, alpha 1 (muscle) (PHKA1), mRNA.",,generation of precursor metabolites and energy [goid 6091] [pmid 7874115] [evidence TAS]; glycogen catabolism [goid 5980] [evidence NR ]; carbohydrate metabolism [goid 5975] [evidence IEA]; muscle development [goid 7517] [evidence IEA],phosphorylase kinase activity [goid 4689] [pmid 8226841] [evidence TAS]; phosphorylase kinase regulator activity [goid 8607] [evidence NR ]; calmodulin binding [goid 5516] [evidence IEA],X,71717443-71717492,Xq13.1e,-,NM_002637.1,5255,PHKA1,1.4132440601320315,6.3304095322895915,17.690030182189705,2.7825308329366097e-40,1.0386730765932031e-38,80.95899813750177
CRABP2,ILMN_1690170,"Homo sapiens cellular retinoic acid binding protein 2 (CRABP2), mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [pmid 1334086] [evidence TAS]; transport [goid 6810] [evidence IEA]; signal transduction [goid 7165] [pmid 1654334] [evidence TAS]; epidermis development [goid 8544] [pmid 1654334] [evidence TAS]",retinal binding [goid 16918] [evidence IEA]; lipid binding [goid 8289] [evidence IEA],1,154936143-154936192,1q23.1a,-,NM_001878.2,1382,CRABP2,3.7141637658913105,8.62026719381859,17.672942219004884,3.094460693560351e-40,1.1529603269414433e-38,80.85293341365455
MGC4172,ILMN_1756701,"Homo sapiens short-chain dehydrogenase/reductase (MGC4172), mRNA.",,metabolism [goid 8152] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA],17,32031237-32031286,17q12b,+,NM_024308.2,79154,MGC4172,1.462890726320781,8.092098159053325,17.65300948606886,3.5029122422095017e-40,1.3027187387012584e-38,80.72917181182514
CCNA2,ILMN_1786125,"Homo sapiens cyclin A2 (CCNA2), mRNA.",nucleus [goid 5634] [evidence IEA],mitotic G2 checkpoint [goid 7095] [pmid 1312467] [evidence TAS]; mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],protein binding [goid 5515] [pmid 7630397] [evidence IPI],4,122958685-122958734,4q27c,-,NM_001237.2,890,CCNA2,1.7799467725735338,6.3864268547495895,17.64798594612241,3.614117424055453e-40,1.3415818445362058e-38,80.69797414728852
CIRBP,ILMN_1674661,"Homo sapiens cold inducible RNA binding protein (CIRBP), mRNA.",nucleus [goid 5634] [evidence IEA],response to cold [goid 9409] [pmid 9151692] [evidence TAS],RNA binding [goid 3723] [pmid 9151692] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA],19,1223846-1223895,19p13.3i,+,NM_001280.1,1153,CIRBP,-1.134112790444803,12.669939289818327,-17.647137979494936,3.6332349103038347e-40,1.3461808163955394e-38,80.69270775897387
PTPNS1,ILMN_1758146,"Homo sapiens protein tyrosine phosphatase, non-receptor type substrate 1 (PTPNS1), mRNA.",plasma membrane [goid 5886] [pmid 9070220] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 9070220] [evidence TAS],cell adhesion [goid 7155] [pmid 9070220] [evidence TAS]; cell adhesion [goid 7155] [pmid 9070220] [evidence TAS],,20,1868371-1868420,20p13d,+,NM_080792.1,140885,PTPNS1,-1.5027754599279888,9.549514291466252,-17.643021678677997,3.727488093792548e-40,1.3785504950203567e-38,80.66714193894612
GRTP1,ILMN_1745068,"Homo sapiens growth hormone regulated TBC protein 1 (GRTP1), mRNA.",,,,13,113027458-113027507,13q34d,-,NM_024719.2,79774,GRTP1,1.4187526819512115,6.650765532006288,17.639707562586338,3.805152040551899e-40,1.4046767901727377e-38,80.64655707375377
IRAK1,ILMN_2379130,"Homo sapiens interleukin-1 receptor-associated kinase 1 (IRAK1), transcript variant 3, mRNA.",interleukin-1 receptor complex [goid 45323] [pmid 10854325] [evidence NAS],transmembrane receptor protein serine/threonine kinase signaling pathway [goid 7178] [pmid 11397809] [evidence NAS]; signal transduction [goid 7165] [pmid 10854325] [evidence NAS]; positive regulation of transcription [goid 45941] [pmid 11397809] [evidence NAS]; activation of NF-kappaB-inducing kinase [goid 7250] [pmid 11397809] [evidence IDA]; protein amino acid phosphorylation [goid 6468] [evidence IEA],transcriptional activator activity [goid 16563] [pmid 11397809] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; protein homodimerization activity [goid 42803] [pmid 11397809] [evidence NAS]; protein kinase binding [goid 19901] [evidence ISS]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 11397809] [evidence NAS]; protein kinase activity [goid 4672] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; NF-kappaB-inducing kinase activity [goid 4704] [pmid 8599092] [evidence TAS],X,152929380-152929429,Xq28g,-,NM_001025243.1,3654,IRAK1,1.168810802476747,10.569565888069656,17.638332948728014,3.837839324561965e-40,1.4141342395181546e-38,80.63801863449672
ANKRD29,ILMN_1749338,"Homo sapiens ankyrin repeat domain 29 (ANKRD29), mRNA.",,,,18,19434820-19434869,18q11.2b,-,NM_173505.2,147463,ANKRD29,-2.1643542753693685,7.566852675616175,-17.62753640716629,4.104559446578992e-40,1.5096328199844205e-38,80.57094872088892
DLG7,ILMN_1749829,"Homo sapiens discs, large homolog 7 (Drosophila) (DLG7), mRNA.",nucleus [goid 5634] [pmid 12527899] [evidence IDA],M phase of mitotic cell cycle [goid 87] [pmid 12527899] [evidence IDA]; cell-cell signaling [goid 7267] [evidence IEA]; mitotic chromosome movement towards spindle pole [goid 7079] [pmid 12527899] [evidence NAS]; cell proliferation [goid 8283] [pmid 12527899] [evidence NAS]; positive regulation of mitotic metaphase/anaphase transition [goid 45842] [pmid 12527899] [evidence NAS]; cell cycle [goid 7049] [evidence IEA],phosphoprotein phosphatase activity [goid 4721] [pmid 15145941] [evidence IDA]; protein binding [goid 5515] [pmid 15145941] [evidence IPI],14,54684927-54684944:54687270-54687301,14q22.3a,-,NM_014750.3,9787,DLG7,1.7147984401481153,6.329394884561575,17.62691401580749,4.12048985223841e-40,1.5127112103410296e-38,80.56708194387343
CPB2,ILMN_1744806,"Homo sapiens carboxypeptidase B2 (plasma, carboxypeptidase U) (CPB2), transcript variant 1, mRNA.",,,metal ion binding [goid 46872] [evidence IEA]; carboxypeptidase A activity [goid 4182] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metallopeptidase activity [goid 8237] [evidence IEA]; carboxypeptidase activity [goid 4180] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; carboxypeptidase A activity [goid 4182] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metallopeptidase activity [goid 8237] [evidence IEA]; carboxypeptidase activity [goid 4180] [evidence IEA],13,45525386-45525435,13q14.12b,-,NM_001872.2,1361,CPB2,-3.1058952067451626,6.952150675733755,-17.621392608313865,4.2645555781630726e-40,1.5627331136975595e-38,80.5327768809712
CD300LF,ILMN_2112357,"Homo sapiens CD300 molecule-like family member f (CD300LF), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA],17,70202077-70202126,17q25.1b,-,NM_139018.2,146722,CD300LF,-2.2039561037712128,8.304696597168581,-17.608458237027474,4.622130869471095e-40,1.690669002493193e-38,80.45240163416648
ZFP36L2,ILMN_2150258,"Homo sapiens zinc finger protein 36, C3H type-like 2 (ZFP36L2), mRNA.",nucleus [goid 5634] [evidence IEA],cell proliferation [goid 8283] [pmid 7835719] [evidence TAS],transcription factor activity [goid 3700] [pmid 7835719] [evidence TAS]; nucleic acid binding [goid 3676] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],2,43304551-43304600,2p21e,-,NM_006887.3,678,ZFP36L2,-1.9344877876424649,8.499741618417945,-17.57930038945517,5.5424238233517825e-40,2.019905571177094e-38,80.27114722899016
LOC647108,ILMN_1774206,"PREDICTED: Homo sapiens hypothetical protein LOC647108 (LOC647108), mRNA.",,,,16,31456416-31456465,,+,XM_934378.1,647108,LOC647108,-2.3545970560274485,7.123487221896164,-17.578637495867284,5.565356474750521e-40,2.0245754972146985e-38,80.2670254250104
PDK4,ILMN_1684982,"Homo sapiens pyruvate dehydrogenase kinase, isozyme 4 (PDK4), mRNA.",mitochondrion [goid 5739] [pmid 8798399] [evidence TAS],glucose metabolism [goid 6006] [pmid 8798399] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA],[pyruvate dehydrogenase (lipoamide)] kinase activity [goid 4740] [pmid 8798399] [evidence TAS]; ATP binding [goid 5524] [evidence IEA],7,95051128-95051177,7q21.3b,-,NM_002612.2,5166,PDK4,-2.840584481224666,9.104150958344269,-17.56204781355579,6.171317111911233e-40,2.240938525864246e-38,80.16385734519915
CCNB2,ILMN_1801939,"Homo sapiens cyclin B2 (CCNB2), mRNA.",nucleus [goid 5634] [evidence IEA]; microtubule cytoskeleton [goid 15630] [pmid 11256614] [evidence IDA],mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],protein binding [goid 5515] [pmid 15232106] [evidence IPI],15,57204299-57204348,15q22.2a,+,NM_004701.2,9133,CCNB2,2.336278850372051,7.561211314167918,17.540234394472545,7.069933373589746e-40,2.5625946909199933e-38,80.02815956980463
FLJ38159,ILMN_1695972,"Homo sapiens coiled-coil domain containing 89 (CCDC89), mRNA.",,,,11,85073673-85073696:85073697-85073722,11q14.1e,-,NM_152723.1,220388,FLJ38159,-1.7225152652771527,6.705641406619295,-17.534444523568368,7.3297495119497055e-40,2.6519643442150035e-38,79.99213328003196
ALDH1A2,ILMN_1748538,"Homo sapiens aldehyde dehydrogenase 1 family, member A2 (ALDH1A2), transcript variant 2, mRNA.",,metabolism [goid 8152] [evidence IEA]; vitamin A metabolism [goid 6776] [pmid 8663198] [evidence TAS]; metabolism [goid 8152] [evidence IEA]; vitamin A metabolism [goid 6776] [pmid 8663198] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; electron carrier activity [goid 9055] [pmid 8797830] [evidence TAS]; retinal dehydrogenase activity [goid 1758] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; electron carrier activity [goid 9055] [pmid 8797830] [evidence TAS]; retinal dehydrogenase activity [goid 1758] [evidence IEA],15,56033099-56033148,15q22.1a,-,NM_170696.1,8854,ALDH1A2,-2.234799459296114,7.462643781629608,-17.528613824989378,7.601075160061214e-40,2.7451680830777037e-38,79.95584937726146
KLF2,ILMN_1735930,"Homo sapiens Kruppel-like factor 2 (lung) (KLF2), mRNA.",nucleus [goid 5634] [evidence NAS]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; transcriptional activator activity [goid 16563] [evidence NAS]; transcription factor activity [goid 3700] [evidence NAS],19,16299231-16299280,19p13.11f,+,NM_016270.2,10365,KLF2,-1.712581570697104,12.437894945163494,-17.52745895899932,7.655999010794432e-40,2.760022129873423e-38,79.94866232706046
MAL,ILMN_2320330,"Homo sapiens mal, T-cell differentiation protein (MAL), transcript variant a, mRNA.",lipid raft [goid 45121] [pmid 12153479] [evidence IDA]; insoluble fraction [goid 5626] [pmid 9003426] [evidence TAS]; membrane fraction [goid 5624] [pmid 9003426] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9003426] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 8132541] [evidence IDA]; apical plasma membrane [goid 16324] [pmid 10739088] [evidence TAS]; endosome [goid 5768] [pmid 9003426] [evidence TAS],apical protein localization [goid 45176] [pmid 10739088] [evidence TAS]; induction of apoptosis [goid 6917] [pmid 10366425] [evidence NAS]; lipid raft polarization [goid 1766] [pmid 12153479] [evidence TAS]; signal transduction [goid 7165] [pmid 3494249] [evidence TAS]; cell differentiation [goid 30154] [pmid 10739088] [evidence TAS]; central nervous system development [goid 7417] [pmid 10739088] [evidence TAS]; myelination [goid 42552] [pmid 12153479] [evidence NAS],apoptotic protease activator activity [goid 16505] [pmid 10366425] [evidence NAS]; structural constituent of myelin sheath [goid 19911] [pmid 12153479] [evidence IDA]; channel or pore class transporter activity [goid 15267] [pmid 3494249] [evidence TAS]; lipid binding [goid 8289] [pmid 10739088] [evidence TAS],2,95082940-95082989,2q11.1c,+,NM_002371.2,4118,MAL,-2.2670492380660976,8.781582105460863,-17.526379294142114,7.707706270947397e-40,2.7736652350560345e-38,79.94194314722812
C20orf46,ILMN_1751228,"Homo sapiens chromosome 20 open reading frame 46 (C20orf46), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,20,1109274-1109323,20p13e,-,NM_018354.1,55321,C20orf46,-2.2006243326719748,8.628345507699171,-17.5027610821043,8.9307291192618e-40,3.2022585702184603e-38,79.79492701296158
SLC16A3,ILMN_2364022,"Homo sapiens solute carrier family 16, member 3 (monocarboxylic acid transporter 4) (SLC16A3), transcript variant 2, mRNA.",membrane fraction [goid 5624] [pmid 9425115] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9425115] [evidence TAS]; membrane [goid 16020] [evidence IEA],organic anion transport [goid 15711] [evidence IEA]; transport [goid 6810] [evidence IEA]; monocarboxylic acid transport [goid 15718] [pmid 9425115] [evidence TAS],symporter activity [goid 15293] [evidence IEA]; monocarboxylate porter activity [goid 15355] [evidence IEA]; transporter activity [goid 5215] [evidence IEA],,,17q25.3g,,NM_004207.2,9123,SLC16A3,1.69572871172649,11.199124402304504,17.472179646530478,1.0807969447822098e-39,3.868441014526378e-38,79.60447989634078
KCNK5,ILMN_1766918,"Homo sapiens potassium channel, subfamily K, member 5 (KCNK5), mRNA.",membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 9812978] [evidence TAS],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 9812978] [evidence TAS]; excretion [goid 7588] [pmid 9812978] [evidence TAS],potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [pmid 9812978] [evidence TAS]; voltage-gated ion channel activity [goid 5244] [evidence IEA],6,39265062-39265111,6p21.2b,-,NM_003740.2,8645,KCNK5,1.97935680732426,7.412025002185442,17.466887308007177,1.1170882462977382e-39,3.991196719986633e-38,79.57151169594022
MYADM,ILMN_2308849,"Homo sapiens myeloid-associated differentiation marker (MYADM), transcript variant 4, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,19,59071241-59071290,19q13.41b,+,NM_001020820.1,91663,MYADM,-1.654139712948,10.31837493376205,-17.461552752112215,1.1549058145762182e-39,4.118958206424416e-38,79.53827753914915
TINF2,ILMN_1697420,"Homo sapiens TERF1 (TRF1)-interacting nuclear factor 2 (TINF2), mRNA.","chromosome, telomeric region [goid 781] [pmid 10581025] [evidence TAS]; nucleus [goid 5634] [evidence IEA]; chromosome [goid 5694] [evidence IEA]",,protein binding [goid 5515] [pmid 12768206] [evidence IPI]; DNA binding [goid 3677] [pmid 10581025] [evidence TAS]; telomeric DNA binding [goid 42162] [pmid 12768206] [evidence IDA],14,23778890-23778939,14q12a,-,NM_012461.1,26277,TINF2,-1.0145675553929259,10.830360686411934,-17.46091721881745,1.159495961219445e-39,4.127970674747092e-38,79.53431798331088
GRASP,ILMN_1705210,"Homo sapiens GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein (GRASP), mRNA.",membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [evidence IEA],,protein binding [goid 5515] [evidence IEA],12,50695586-50695635,12q13.13c,+,NM_181711.1,160622,GRASP,-1.9580326262445968,7.770610805632928,-17.455556093543965,1.1989520205802638e-39,4.2608582642575343e-38,79.50091494463368
SPTBN2,ILMN_1667079,"Homo sapiens spectrin, beta, non-erythrocytic 2 (SPTBN2), mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; spectrin [goid 8091] [pmid 9826670] [evidence IEP],vesicle-mediated transport [goid 16192] [pmid 9826670] [evidence IDA]; barbed-end actin filament capping [goid 51016] [evidence IEA],actin binding [goid 3779] [pmid 9826670] [evidence TAS]; structural constituent of cytoskeleton [goid 5200] [pmid 9826670] [evidence TAS],11,66209455-66209504,11q13.1e,-,NM_006946.1,6712,SPTBN2,1.4845299510529593,5.924635262736352,17.43251023550781,1.3844836015904862e-39,4.911480124223838e-38,79.35729117596811
NPNT,ILMN_1735762,"Homo sapiens nephronectin (NPNT), mRNA.",membrane [goid 16020] [evidence IEA],,calcium ion binding [goid 5509] [evidence IEA],4,107111934-107111983,4q24e,+,NM_001033047.1,255743,NPNT,-2.14686538147932,7.793493491363309,-17.427728234003286,1.4264503276044735e-39,5.051401443311558e-38,79.3274823887917
PDZK3,ILMN_1717722,"Homo sapiens PDZ domain containing 3 (PDZK3), transcript variant 1, mRNA.",intercellular junction [goid 5911] [pmid 12671685] [evidence ISS]; endoplasmic reticulum [goid 5783] [pmid 12671685] [evidence ISS]; extracellular region [goid 5576] [pmid 12671685] [evidence ISS]; nucleus [goid 5634] [pmid 12671685] [evidence ISS]; intercellular junction [goid 5911] [pmid 12671685] [evidence ISS]; endoplasmic reticulum [goid 5783] [pmid 12671685] [evidence ISS]; extracellular region [goid 5576] [pmid 12671685] [evidence ISS]; nucleus [goid 5634] [pmid 12671685] [evidence ISS],cell adhesion [goid 7155] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 12671685] [evidence ISS]; structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 12671685] [evidence ISS],5,32073096-32073145,5p13.3c,+,NM_178140.1,23037,PDZK3,-1.1788579614236419,6.122195196709654,-17.413095813988278,1.5629546581750747e-39,5.525017102608993e-38,79.23625584721941
KNTC1,ILMN_1732516,"Homo sapiens kinetochore associated 1 (KNTC1), mRNA.",spindle pole [goid 922] [pmid 11146660] [evidence IDA]; nucleus [goid 5634] [pmid 11146660] [evidence NAS]; kinetochore microtubule [goid 5828] [pmid 11146660] [evidence IDA],"mitotic checkpoint [goid 7093] [pmid 11146660] [evidence IDA]; regulation of exit from mitosis [goid 7096] [pmid 11146660] [evidence NAS]; mitosis [goid 7067] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; protein complex assembly [goid 6461] [pmid 11146660] [evidence NAS]",sequence-specific DNA binding [goid 43565] [evidence IEA]; protein dimerization activity [goid 46983] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],12,121675137-121675186,12q24.31c,+,NM_014708.3,9735,KNTC1,1.6692360447443848,7.8781750553339105,17.402779383536412,1.6669978316434152e-39,5.88241492337239e-38,79.17192416168233
MRPL12,ILMN_1699603,"Homo sapiens mitochondrial ribosomal protein L12 (MRPL12), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [evidence IEA]; ribosome [goid 5840] [evidence IEA]; mitochondrial large ribosomal subunit [goid 5762] [pmid 8626705] [evidence TAS]; intracellular [goid 5622] [evidence IEA],protein biosynthesis [goid 6412] [pmid 9169145] [evidence TAS],RNA binding [goid 3723] [pmid 8626705] [evidence TAS]; structural constituent of ribosome [goid 3735] [pmid 9169145] [evidence TAS],17,77284452-77284475:77284559-77284584,17q25.3f,+,NM_002949.2,6182,MRPL12,1.4790512571458088,9.358512406517614,17.373073437538437,2.0070339256098476e-39,7.069847673169336e-38,78.98662067621319
FLJ25006,ILMN_2144162,"Homo sapiens hypothetical protein FLJ25006 (FLJ25006), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],17,23959389-23959438,17q11.2a,-,NM_144610.1,124923,FLJ25006,1.3893086962621037,5.909610656325514,17.3654119664287,2.105493171664633e-39,7.403639258113528e-38,78.93881414723545
GPR109A,ILMN_1750497,"Homo sapiens G protein-coupled receptor 109A (GPR109A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],"receptor activity [goid 4872] [evidence IEA]; purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]",12,121752686-121752691:121752692-121752735,12q24.31c,-,NM_177551.3,338442,GPR109A,-1.8545874481304283,5.831883948549117,-17.357915800209522,2.2065143776563684e-39,7.745252573359406e-38,78.89203321772438
PODXL2,ILMN_1657347,"Homo sapiens podocalyxin-like 2 (PODXL2), mRNA.",integral to plasma membrane [goid 5887] [pmid 10722749] [evidence TAS],,glycosaminoglycan binding [goid 5539] [pmid 10722749] [evidence TAS],3,128874153-128874202,3q21.3b,+,NM_015720.1,50512,PODXL2,2.841386692610377,8.003702454236826,17.35590952876526,2.2343666564044104e-39,7.829283373264351e-38,78.87951179923506
ANKRD22,ILMN_1799848,"Homo sapiens ankyrin repeat domain 22 (ANKRD22), mRNA.",,,,10,90572750-90572755:90573017-90573060,10q23.31b,-,NM_144590.1,118932,ANKRD22,2.544049821720522,6.983474404451586,17.351699512416378,2.2939639933317967e-39,8.024061464787166e-38,78.85323515014416
C1orf135,ILMN_1787280,"Homo sapiens chromosome 1 open reading frame 135 (C1orf135), mRNA.",,,,1,26033122-26033171,1p36.11b,-,NM_024037.1,79000,C1orf135,1.2921648576636597,5.607061478114061,17.351294393575042,2.299782290165257e-39,8.030374181784722e-38,78.850706520432
WFDC2,ILMN_1685427,"Homo sapiens WAP four-disulfide core domain 2 (WFDC2), transcript variant 3, mRNA.",extracellular space [goid 5615] [pmid 1686187] [evidence TAS],spermatogenesis [goid 7283] [pmid 1686187] [evidence TAS],serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA],20,43533226-43533275,20q13.12b,+,NM_080733.1,10406,WFDC2,1.4637832120579537,6.053087772143041,17.348182944897133,2.3449647997494512e-39,8.173877301983801e-38,78.83128523021696
ENTPD5,ILMN_1745849,"Homo sapiens ectonucleoside triphosphate diphosphohydrolase 5 (ENTPD5), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],,hydrolase activity [goid 16787] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; nucleoside-diphosphatase activity [goid 17110] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],14,73503185-73503234,14q24.3a,-,NM_001249.1,957,ENTPD5,1.50478367921108,6.3387188921850965,17.33680024501105,2.517975282831723e-39,8.761678166764716e-38,78.76022726092714
SALL4,ILMN_1695687,"Homo sapiens sal-like 4 (Drosophila) (SALL4), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],20,49834172-49834210:49834211-49834221,20q13.2a,-,NM_020436.2,57167,SALL4,2.114359529095135,5.934160219151624,17.329693186427367,2.6324311311068802e-39,9.14404202624765e-38,78.71585375297961
CEECAM1,ILMN_1750563,"Homo sapiens cerebral endothelial cell adhesion molecule 1 (CEECAM1), mRNA.",plasma membrane [goid 5886] [pmid 10608765] [evidence NAS]; integral to membrane [goid 16021] [evidence NR ]; membrane fraction [goid 5624] [evidence NR ],cell motility [goid 6928] [pmid 10608765] [evidence TAS]; lipopolysaccharide biosynthesis [goid 9103] [evidence IEA]; leukocyte adhesion [goid 7159] [pmid 10608765] [evidence TAS]; cell adhesion [goid 7155] [pmid 10608765] [evidence IDA],"procollagen-lysine 5-dioxygenase activity [goid 8475] [evidence IEA]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [goid 16702] [evidence IEA]",9,130239121-130239170,9q34.11b,+,NM_016174.3,51148,CEECAM1,2.064988276261814,7.547957476857595,17.329408522173004,2.6371226270378326e-39,9.144462655419924e-38,78.71407631968354
EPB41L2,ILMN_1805448,"Homo sapiens erythrocyte membrane protein band 4.1-like 2 (EPB41L2), mRNA.",plasma membrane [goid 5886] [pmid 9598318] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA]; spectrin [goid 8091] [pmid 9598318] [evidence TAS]; plasma membrane [goid 5886] [pmid 9598318] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA]; spectrin [goid 8091] [pmid 9598318] [evidence TAS],cortical actin cytoskeleton organization and biogenesis [goid 30866] [evidence IEA]; cortical actin cytoskeleton organization and biogenesis [goid 30866] [evidence IEA],structural constituent of cytoskeleton [goid 5200] [evidence NR ]; binding [goid 5488] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; actin binding [goid 3779] [evidence IEA]; structural constituent of cytoskeleton [goid 5200] [evidence NR ]; binding [goid 5488] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; actin binding [goid 3779] [evidence IEA],6,131202612-131202661,6q23.1e-q23.2a,-,NM_001431.1,2037,EPB41L2,-1.1559832515564743,6.692481277803545,-17.320055665441284,2.796017786821533e-39,9.678671951336544e-38,78.65567277657787
C1QTNF7,ILMN_1662935,"Homo sapiens C1q and tumor necrosis factor related protein 7 (C1QTNF7), mRNA.",cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],,4,15055905-15055954,4p15.33a,+,NM_031911.3,114905,C1QTNF7,-1.6245302496747325,5.846720965973465,-17.318917922464202,2.8159905264961872e-39,9.730973826275599e-38,78.64856757093177
CANX,ILMN_1762825,"Homo sapiens calnexin (CANX), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 15467828] [evidence IDA]; cytoplasm [goid 5737] [pmid 15467828] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 15467828] [evidence IDA]; cytoplasm [goid 5737] [pmid 15467828] [evidence IDA],angiogenesis [goid 1525] [pmid 15467828] [evidence IDA]; protein secretion [goid 9306] [pmid 8055875] [evidence TAS]; protein folding [goid 6457] [evidence IEA]; angiogenesis [goid 1525] [pmid 15467828] [evidence IDA]; protein secretion [goid 9306] [pmid 8055875] [evidence TAS]; protein folding [goid 6457] [evidence IEA],unfolded protein binding [goid 51082] [evidence NAS]; sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [pmid 8136357] [evidence TAS]; unfolded protein binding [goid 51082] [evidence NAS]; sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [pmid 8136357] [evidence TAS],5,179090717-179090766,5q35.3e,+,NM_001024649.1,821,CANX,-1.0225380053659734,10.00884546465534,-17.31754372778086,2.840304934562201e-39,9.798072608744917e-38,78.63998554651883
TSC22D1,ILMN_1692177,"Homo sapiens TSC22 domain family, member 1 (TSC22D1), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9022669] [evidence TAS]",transcription factor activity [goid 3700] [evidence IEA],13,43908708-43908757,13q14.11e,-,NM_006022.2,8848,TSC22D1,-1.3355106416248788,9.06275308837554,-17.29809562316816,3.2078633442428406e-39,1.1046975867747119e-37,78.51850877569323
L2HGDH,ILMN_1723211,"Homo sapiens L-2-hydroxyglutarate dehydrogenase (L2HGDH), mRNA.",,electron transport [goid 6118] [evidence IEA],2-hydroxyglutarate dehydrogenase activity [goid 47545] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA],14,49783034-49783083,14q22.1b,-,NM_024884.1,79944,L2HGDH,1.6573669757368013,7.913496968241623,17.28495607118558,3.482832917746105e-39,1.197328539832716e-37,78.43641449669013
GJA4,ILMN_1671106,"Homo sapiens gap junction protein, alpha 4, 37kDa (GJA4), mRNA.",integral to plasma membrane [goid 5887] [pmid 7680674] [evidence TAS]; membrane [goid 16020] [evidence IEA]; connexon complex [goid 5922] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],intercellular junction assembly [goid 7043] [pmid 7680674] [evidence TAS]; transport [goid 6810] [pmid 7680674] [evidence TAS]; cell communication [goid 7154] [evidence IEA],connexon channel activity [goid 15285] [pmid 7680674] [evidence TAS],1,35033688-35033737,1p34.3f,+,NM_002060.2,2701,GJA4,-1.827754230177315,8.288596798510829,-17.281613046935217,3.556485965521881e-39,1.2205518215808198e-37,78.4155248722223
HYAL1,ILMN_1712620,"Homo sapiens hyaluronoglucosaminidase 1 (HYAL1), transcript variant 1, mRNA.",extracellular space [goid 5615] [pmid 9223416] [evidence TAS]; lysosome [goid 5764] [evidence NR ],carbohydrate metabolism [goid 5975] [evidence IEA],hyalurononglucosaminidase activity [goid 4415] [pmid 9223416] [evidence TAS],3,50315431-50315480,3p21.31b,-,NM_007312.3,3373,HYAL1,-1.7963015607735686,7.912118779479513,-17.257698019920472,4.1309683960191946e-39,1.4128618062829409e-37,78.2660531621996
DACH1,ILMN_1666882,"Homo sapiens dachshund homolog 1 (Drosophila) (DACH1), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]; transcription [goid 6350] [evidence IEA]; eye development (sensu Endopterygota) [goid 7456] [pmid 9651501] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]; transcription [goid 6350] [evidence IEA]; eye development (sensu Endopterygota) [goid 7456] [pmid 9651501] [evidence TAS]",DNA binding [goid 3677] [evidence IEA]; protein binding [goid 5515] [pmid 14525983] [evidence IPI]; DNA binding [goid 3677] [evidence IEA]; protein binding [goid 5515] [pmid 14525983] [evidence IPI],13,71032055-71032088:71044973-71044988,13q21.33d,-,NM_080759.3,1602,DACH1,-1.0904370843735105,6.000674428357077,-17.251451644412832,4.295774666413679e-39,1.4667211523140766e-37,78.22700294927444
C16orf30,ILMN_1751559,"Homo sapiens chromosome 16 open reading frame 30 (C16orf30), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,16,1545239-1545288,16p13.3e,+,NM_024600.1,79652,C16orf30,-1.8540120901495838,8.9048463639814,-17.237511627329418,4.687739264816377e-39,1.5951069253477224e-37,78.13984033954844
HSD17B6,ILMN_1779855,"Homo sapiens hydroxysteroid (17-beta) dehydrogenase 6 homolog (mouse) (HSD17B6), mRNA.",intracellular [goid 5622] [pmid 11513953] [evidence NAS],metabolism [goid 8152] [evidence IEA]; androgen catabolism [goid 6710] [pmid 9188497] [evidence TAS]; androgen biosynthesis [goid 6702] [pmid 9188497] [evidence NAS],oxidoreductase activity [goid 16491] [pmid 9188497] [evidence NAS]; electron carrier activity [goid 9055] [pmid 9188497] [evidence TAS],12,55467249-55467298,12q13.3a,+,NM_003725.2,8630,HSD17B6,-3.153472405395174,9.449485925117429,-17.224299767095104,5.092283053501664e-39,1.729820022656389e-37,78.05721237540291
SELP,ILMN_1715417,"Homo sapiens selectin P (granule membrane protein 140kDa, antigen CD62) (SELP), mRNA.",platelet alpha granule membrane [goid 31092] [pmid 15297306] [evidence IDA]; membrane fraction [goid 5624] [pmid 15297306] [evidence IDA]; membrane [goid 16020] [evidence IEA]; soluble fraction [goid 5625] [pmid 1701178] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 1701178] [evidence TAS]; plasma membrane [goid 5886] [pmid 1701178] [evidence TAS],cell adhesion [goid 7155] [pmid 2466574] [evidence TAS],protein binding [goid 5515] [pmid 11237770] [evidence IPI]; sugar binding [goid 5529] [evidence IEA],1,167824803-167824852,1q24.2b,-,NM_003005.2,6403,SELP,-2.0599753984425524,6.619737575196707,-17.213797777922277,5.438682165637322e-39,1.8443585215266366e-37,77.99151946671603
CCNB1,ILMN_1712803,"Homo sapiens cyclin B1 (CCNB1), mRNA.",nucleus [goid 5634] [evidence IEA],cell division [goid 51301] [evidence IEA]; mitosis [goid 7067] [evidence IEA]; G2/M transition of mitotic cell cycle [goid 86] [evidence NAS]; cell cycle [goid 7049] [evidence IEA],protein binding [goid 5515] [pmid 10373560] [evidence IPI],5,68509546-68509595,5q13.2a,+,NM_031966.2,891,CCNB1,1.7538459684138266,6.022756169296687,17.212531120014212,5.482027600274698e-39,1.8559121527292072e-37,77.98359540541566
DNASE1,ILMN_1719616,"Homo sapiens deoxyribonuclease I (DNASE1), mRNA.",extracellular region [goid 5576] [pmid 2349940] [evidence TAS],apoptosis [goid 6915] [evidence IEA]; DNA catabolism [goid 6308] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; deoxyribonuclease activity [goid 4536] [evidence IEA]; deoxyribonuclease I activity [goid 4530] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; actin binding [goid 3779] [evidence IEA]; protein binding [goid 5515] [pmid 12849983] [evidence IPI],16,3647803-3647818:3647908-3647941,16p13.3c,+,NM_005223.3,1773,DNASE1,1.335379123326165,5.6908918873665035,17.20173739348795,5.865729533639171e-39,1.9824580491394007e-37,77.91606451932783
PRKCE,ILMN_1717799,"Homo sapiens protein kinase C, epsilon (PRKCE), mRNA.",membrane fraction [goid 5624] [pmid 7935319] [evidence TAS],induction of apoptosis [goid 6917] [pmid 10438519] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 1382605] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; protein kinase C activity [goid 4697] [pmid 1382605] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; diacylglycerol binding [goid 19992] [evidence IEA]; signal transducer activity [goid 4871] [pmid 10438519] [evidence TAS],2,46267860-46267909,2p21b,+,NM_005400.2,5581,PRKCE,-1.7633847574265173,7.3588963442548785,-17.196328544535515,6.068020102000979e-39,2.0473684013631633e-37,77.88221963697207
TMEM16J,ILMN_1762629,"Homo sapiens transmembrane protein 16J (TMEM16J), mRNA.",,,,11,408229-408278,11p15.5d,-,NM_001012302.1,338440,TMEM16J,1.5102460318976245,6.82847538003698,17.19309271284969,6.192368815449574e-39,2.0858066542005904e-37,77.86197059287429
ATIC,ILMN_1673991,"Homo sapiens 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC), mRNA.",,"purine nucleotide biosynthesis [goid 6164] [evidence IEA]; nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 8567683] [evidence TAS]",transferase activity [goid 16740] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; IMP cyclohydrolase activity [goid 3937] [pmid 8567683] [evidence TAS]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [goid 4643] [pmid 8567683] [evidence TAS],2,215922199-215922217:215922504-215922534,2q35a,+,NM_004044.4,471,ATIC,1.021424846708186,10.98007081493097,17.192023732661546,6.234007188313167e-39,2.096302786954115e-37,77.8552809425948
LIMK1,ILMN_1797362,"Homo sapiens LIM domain kinase 1 (LIMK1), transcript variant dLIMK, mRNA.",cytoplasm [goid 5737] [pmid 8537403] [evidence TAS],signal transduction [goid 7165] [pmid 10436159] [evidence TAS]; Rho protein signal transduction [goid 7266] [pmid 10436159] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 8537403] [evidence TAS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 10428028] [evidence TAS]; cell motility [goid 6928] [evidence NR ],metal ion binding [goid 46872] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 15220930] [evidence IPI]; protein serine/threonine kinase activity [goid 4674] [pmid 8537403] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],7,73174332-73174381,7q11.23b,+,NM_016735.1,3984,LIMK1,1.4155232210183648,6.0637496268587645,17.185425223995708,6.497316194873837e-39,2.1811795709234185e-37,77.81398508115959
OGN,ILMN_1790098,"Homo sapiens osteoglycin (osteoinductive factor, mimecan) (OGN), transcript variant 2, mRNA.",cellular component unknown [goid 8372] [pmid 10373482] [evidence ND ],biological process unknown [goid 4] [pmid 10373482] [evidence ND ],growth factor activity [goid 8083] [evidence IEA],9,94186594-94186643,9q22.31a,-,NM_024416.2,4969,OGN,-2.3514608101166976,6.017029132039821,-17.17417711090877,6.97212702324409e-39,2.3366552341887396e-37,77.74358013720425
MSR1,ILMN_1694400,"Homo sapiens macrophage scavenger receptor 1 (MSR1), transcript variant SR-AI, mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8093617] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; receptor mediated endocytosis [goid 6898] [pmid 2251254] [evidence TAS],scavenger receptor activity [goid 5044] [pmid 2251254] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; lipid transporter activity [goid 5319] [evidence IEA],8,16022341-16022390,8p22c,-,NM_138715.1,4481,MSR1,-1.776623083911666,6.451784672930694,-17.17209605302568,7.063714209903409e-39,2.3633912025375824e-37,77.73055283579322
TUBB3,ILMN_1791726,"Homo sapiens tubulin, beta 3 (TUBB3), mRNA.",microtubule [goid 5874] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; protein complex [goid 43234] [evidence IEA]; cytoskeleton [goid 5856] [evidence NR ]; cytoplasm [goid 5737] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; microtubule-based movement [goid 7018] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; protein polymerization [goid 51258] [evidence IEA],GTPase activity [goid 3924] [evidence IEA]; melanocyte stimulating hormone receptor activity [goid 4980] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; structural constituent of cytoskeleton [goid 5200] [evidence NR ]; receptor activity [goid 4872] [evidence IEA],16,88529862-88529911,16q24.3b,+,NM_006086.2,10381,TUBB3,3.211019486990298,8.490091685911471,17.165661114930522,7.354617559503149e-39,2.456614159107496e-37,77.69026772518568
WISP2,ILMN_1812461,"Homo sapiens WNT1 inducible signaling pathway protein 2 (WISP2), mRNA.",extracellular region [goid 5576] [evidence IEA]; soluble fraction [goid 5625] [pmid 9843955] [evidence TAS],regulation of cell growth [goid 1558] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 9843955] [evidence TAS]; signal transduction [goid 7165] [pmid 9843955] [evidence TAS],protein binding [goid 5515] [evidence IEA]; insulin-like growth factor binding [goid 5520] [evidence IEA],20,42789604-42789653,20q13.12a,+,NM_003881.2,8839,WISP2,-2.5566344389079125,8.272993806720859,-17.15816595711064,7.708628499891043e-39,2.570570650430333e-37,77.64333996587872
LOC652846,ILMN_1799098,"PREDICTED: Homo sapiens similar to Annexin A8 (Annexin VIII) (Vascular anticoagulant-beta) (VAC-beta) (LOC652846), mRNA.",,,,,,,,XM_942545.1,652846,LOC652846,-2.7513310909407744,6.207468173536504,-17.142739481246437,8.491943007529204e-39,2.8223720215057197e-37,77.54673576065728
KIAA1522,ILMN_1700384,"Homo sapiens KIAA1522 (KIAA1522), mRNA.",,,,1,33012857-33012906,1p35.1b,+,NM_020888.1,57648,KIAA1522,1.308333730309343,9.340454939918892,17.134540450725993,8.94025431203099e-39,2.966444581676883e-37,77.49538174299992
BTG2,ILMN_1770085,"Homo sapiens BTG family, member 2 (BTG2), mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; DNA repair [goid 6281] [pmid 8944033] [evidence TAS]; transcription [goid 6350] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 8944033] [evidence TAS]",transcription factor activity [goid 3700] [evidence NR ],1,201544859-201544908,1q32.1e,+,NM_006763.2,7832,BTG2,-2.2288718491855253,10.355909028807165,-17.130973270173115,9.142638673923421e-39,3.0285747448321164e-37,77.47303685883861
FOXM1,ILMN_1716400,"Homo sapiens forkhead box M1 (FOXM1), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; protein binding [goid 5515] [pmid 10523841] [evidence IPI],12,2837460-2837509,12p13.33a,-,NM_202002.1,2305,FOXM1,1.7705679933514853,6.007283964149104,17.121969636033004,9.674126585324538e-39,3.1993375986640227e-37,77.41663223388103
C10orf32,ILMN_1772706,"Homo sapiens chromosome 10 open reading frame 32 (C10orf32), mRNA.",,,,10,104604121-104604170,10q24.32b,+,NM_144591.1,119032,C10orf32,-1.2562230963228416,9.011409481966819,-17.110264104312748,1.0411698000161084e-38,3.4375784420333828e-37,77.34328897613617
UHMK1,ILMN_2096012,"Homo sapiens U2AF homology motif (UHM) kinase 1 (UHMK1), mRNA.",cytoplasm [goid 5737] [evidence ISS]; nucleus [goid 5634] [evidence ISS],cell cycle arrest [goid 7050] [pmid 12093740] [evidence IMP]; regulation of protein export from nucleus [goid 46825] [pmid 12093740] [evidence IDA]; peptidyl-serine phosphorylation [goid 18105] [evidence ISS],protein binding [goid 5515] [pmid 12093740] [evidence IPI]; protein serine/threonine kinase activity [goid 4674] [evidence ISS]; ATP binding [goid 5524] [evidence ISS]; nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [evidence ISS]; transferase activity [goid 16740] [pmid 12093740] [evidence IC ],1,160760315-160760364,1q23.3b,+,NM_175866.2,127933,UHMK1,1.7647184709505614,6.636649629111861,17.109749152606614,1.0445409766923763e-38,3.443027324820604e-37,77.34006213118633
LDHA,ILMN_1807106,"Homo sapiens lactate dehydrogenase A (LDHA), mRNA.",cytosol [goid 5829] [pmid 2434947] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],tricarboxylic acid cycle intermediate metabolism [goid 6100] [evidence IEA]; anaerobic glycolysis [goid 19642] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; L-lactate dehydrogenase activity [goid 4459] [pmid 2334430] [evidence TAS]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],11,18385623-18385672,11p15.1c,+,NM_005566.1,3939,LDHA,1.1661847858899108,13.009077265128283,17.1087988366913,1.0507910626889563e-38,3.4579321681382624e-37,77.33410709098604
AOX1,ILMN_1767113,"Homo sapiens aldehyde oxidase 1 (AOX1), mRNA.",,oxygen and reactive oxygen species metabolism [goid 6800] [pmid 7570184] [evidence TAS]; inflammatory response [goid 6954] [pmid 8248161] [evidence TAS]; electron transport [goid 6118] [evidence IEA],"oxidoreductase activity [goid 16491] [evidence IEA]; 2 iron, 2 sulfur cluster binding [goid 51537] [evidence IEA]; aldehyde oxidase activity [goid 4031] [pmid 7570184] [evidence TAS]; xanthine dehydrogenase activity [goid 4854] [pmid 8248161] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA]; electron carrier activity [goid 9055] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; molybdenum ion binding [goid 30151] [evidence IEA]",2,201243679-201243728,2q33.1e,+,NM_001159.3,316,AOX1,-2.4568539294889247,6.531002355013131,-17.103401947609587,1.0870033943796953e-38,3.5712256017650155e-37,77.30028641644887
STOM,ILMN_1696419,"Homo sapiens stomatin (STOM), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [pmid 7592848] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 7592848] [evidence TAS]; membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [pmid 7592848] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 7592848] [evidence TAS],,,9,123150194-123150243,9q33.2a,-,NM_004099.4,2040,STOM,-1.767505630037915,10.864032676766403,-17.10294306924419,1.0901395186246527e-38,3.5756576210888604e-37,77.29741062944392
SHMT2,ILMN_1661264,"Homo sapiens serine hydroxymethyltransferase 2 (mitochondrial) (SHMT2), mRNA.",mitochondrion [goid 5739] [pmid 8505317] [evidence TAS],one-carbon compound metabolism [goid 6730] [evidence IEA]; L-serine metabolism [goid 6563] [evidence IEA]; glycine metabolism [goid 6544] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; glycine hydroxymethyltransferase activity [goid 4372] [evidence IEA],12,55914669-55914718,12q13.3b,+,NM_005412.4,6472,SHMT2,1.1209198807220684,11.123345276389273,17.097816309447197,1.1258003929629066e-38,3.6865817123407256e-37,77.26527983108211
LOC404266,ILMN_1683798,"PREDICTED: Homo sapiens hypothetical LOC404266 (LOC404266), misc RNA.",,,,,,,,XR_001389.1,404266,LOC404266,-1.6623102950007995,6.350483674914213,-17.08404685626404,1.227475222773067e-38,4.006415050121293e-37,77.17896988352476
ECM2,ILMN_1746763,"Homo sapiens extracellular matrix protein 2, female organ and adipocyte specific (ECM2), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9790758] [evidence TAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9790758] [evidence TAS],cell-matrix adhesion [goid 7160] [pmid 9790758] [evidence TAS]; cell-matrix adhesion [goid 7160] [pmid 9790758] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; integrin binding [goid 5178] [pmid 9790758] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; integrin binding [goid 5178] [pmid 9790758] [evidence TAS],9,94303013-94303062,9q22.31a-q22.31b,-,NM_001393.2,1842,ECM2,-1.746171779882812,7.317961201534977,-17.083522118676555,1.2315269940264302e-38,4.013093175322609e-37,77.17568033786499
ABCB6,ILMN_2193980,"Homo sapiens ATP-binding cassette, sub-family B (MDR/TAP), member 6 (ABCB6), nuclear gene encoding mitochondrial protein, mRNA.",integral to membrane [goid 16021] [evidence IEA]; ATP-binding cassette (ABC) transporter complex [goid 43190] [pmid 11955620] [evidence NAS]; membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [pmid 10837493] [evidence IDA],transport [goid 6810] [pmid 10837493] [evidence IDA]; iron ion homeostasis [goid 6879] [pmid 11977179] [evidence NAS],"ATPase activity, coupled to transmembrane movement of substances [goid 42626] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 10837493] [evidence IDA]",2,219782844-219782893,2q35f,-,NM_005689.1,10058,ABCB6,1.5297428112389522,8.5973316851842,17.079153668914216,1.265782766774243e-38,4.118013267905537e-37,77.1482937422129
GABARAPL1,ILMN_2151281,"Homo sapiens GABA(A) receptor-associated protein like 1 (GABARAPL1), mRNA.",plasma membrane [goid 5886] [evidence ISS]; autophagic vacuole [goid 5776] [pmid 15292400] [evidence IDA]; microtubule [goid 5874] [evidence IEA]; intracellular [goid 5622] [pmid 11256614] [evidence IDA],protein targeting [goid 6605] [evidence ISS]; synaptic transmission [goid 7268] [evidence ISS],beta-tubulin binding [goid 48487] [evidence ISS]; GABA receptor binding [goid 50811] [evidence ISS]; protein binding [goid 5515] [pmid 9892355] [evidence IPI],12,10266658-10266707,12p13.2c,+,NM_031412.2,23710,GABARAPL1,-1.3087296562821926,10.530610836522099,-17.069882767389572,1.3416800243690128e-38,4.350783456657246e-37,77.09016647397041
SAMD10,ILMN_1767801,"Homo sapiens sterile alpha motif domain containing 10 (SAMD10), mRNA.",,,,20,62076085-62076134,20q13.33e,-,NM_080621.3,140700,SAMD10,1.1732150210441556,5.74300912244155,17.066616412498245,1.3694936589263992e-38,4.433791121003138e-37,77.06968483518087
SRD5A1,ILMN_1793241,"Homo sapiens steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) (SRD5A1), mRNA.",microsome [goid 5792] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],cell-cell signaling [goid 7267] [evidence NR ]; sex differentiation [goid 7548] [evidence IEA]; sex determination [goid 7530] [pmid 1686016] [evidence NAS],3-oxo-5-alpha-steroid 4-dehydrogenase activity [goid 3865] [evidence IEA]; electron transporter activity [goid 5489] [pmid 1686016] [evidence TAS]; oxidoreductase activity [goid 16491] [evidence IEA],5,6722048-6722097,5p15.31c,+,NM_001047.1,6715,SRD5A1,1.4781812720061982,6.8875433720605805,17.06471568317335,1.385944038753842e-38,4.479801022194971e-37,77.05776584455366
FGF11,ILMN_1719938,"Homo sapiens fibroblast growth factor 11 (FGF11), mRNA.",extracellular space [goid 5615] [evidence NR ],cell-cell signaling [goid 7267] [pmid 8790420] [evidence TAS]; signal transduction [goid 7165] [pmid 8790420] [evidence TAS],growth factor activity [goid 8083] [pmid 8790420] [evidence TAS],17,7288858-7288907,17p13.1d,+,NM_004112.2,2256,FGF11,1.830216451891224,5.945953867717961,17.063532860260743,1.3962809527816358e-38,4.5059337585895114e-37,77.05034848054527
MAN1C1,ILMN_1713807,"Homo sapiens mannosidase, alpha, class 1C, member 1 (MAN1C1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to Golgi membrane [goid 30173] [pmid 10915796] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],metabolism [goid 8152] [evidence IEA],"calcium ion binding [goid 5509] [pmid 10915796] [evidence TAS]; hydrolase activity, acting on glycosyl bonds [goid 16798] [evidence IEA]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [goid 4571] [pmid 10915796] [evidence TAS]",1,25983100-25983149,1p36.11b,+,NM_020379.1,57134,MAN1C1,-1.4919830368244806,7.877386660907875,-17.05556064437352,1.4679969643163016e-38,4.729739655723118e-37,77.00035187147427
CD53,ILMN_1662843,"Homo sapiens CD53 antigen (CD53), mRNA.",plasma membrane [goid 5886] [pmid 8452817] [evidence TAS]; integral to plasma membrane [goid 5887] [evidence NR ]; plasma membrane [goid 5886] [pmid 8452817] [evidence TAS]; integral to plasma membrane [goid 5887] [evidence NR ],antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ]; signal transduction [goid 7165] [pmid 8404042] [evidence NAS]; signal transduction [goid 7165] [pmid 8404042] [evidence NAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ],,1,111243669-111243718,1p13.3a,+,NM_000560.2,963,CD53,-1.6813591876943077,8.370461102293218,-17.047767675605122,1.5416688561519834e-38,4.9511573794364174e-37,76.95147325925149
KLF4,ILMN_1779857,"Homo sapiens Kruppel-like factor 4 (gut) (KLF4), mRNA.",nucleus [goid 5634] [pmid 9422764] [evidence ISS],"mesodermal cell fate determination [goid 7500] [pmid 8940147] [evidence TAS]; transcription [goid 6350] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 8702718] [evidence TAS]; negative regulation of transcription, DNA-dependent [goid 45892] [pmid 9422764] [evidence IEP]",metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [pmid 9422764] [evidence NAS]; transcriptional activator activity [goid 16563] [pmid 9422764] [evidence NAS]; transcriptional repressor activity [goid 16564] [pmid 9422764] [evidence IEP]; transcription factor activity [goid 3700] [pmid 9422764] [evidence NAS],9,109287552-109287601,9q31.2b,-,NM_004235.3,9314,KLF4,-1.7715697619738746,7.173077613027578,-17.0444644028374,1.57400488172188e-38,5.046905396392849e-37,76.93075283496253
PYGO2,ILMN_1695334,"Homo sapiens pygopus homolog 2 (Drosophila) (PYGO2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; Wnt receptor signaling pathway [goid 16055] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; protein binding [goid 5515] [evidence IEA],1,153196432-153196481,1q21.3e,-,NM_138300.3,90780,PYGO2,1.747976064311361,7.290107637786022,17.026164880059053,1.7658588147663332e-38,5.653008506535167e-37,76.81594583058168
SAP18,ILMN_1752793,"Homo sapiens Sin3A-associated protein, 18kDa (SAP18), mRNA.",histone deacetylase complex [goid 118] [pmid 9150135] [evidence TAS],transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 9150135] [evidence TAS],transcription corepressor activity [goid 3714] [pmid 9150135] [evidence TAS]; protein binding [goid 5515] [pmid 9150135] [evidence IPI],13,20620710-20620759,13q12.11b,+,NM_005870.3,10284,SAP18,-1.4165023286958274,8.141233110763972,-17.022726637420366,1.804440387944146e-38,5.76729125910327e-37,76.79437137091305
C20orf94,ILMN_1715625,"Homo sapiens chromosome 20 open reading frame 94 (C20orf94), mRNA.",,,,20,10551897-10551946,20p12.2b-p12.2a,+,NM_001009608.1,128710,C20orf94,1.8357421256138045,7.167744273341271,17.01868381936329,1.8508885802632077e-38,5.906312394562402e-37,76.76900178912629
RAMP2,ILMN_1814464,"Homo sapiens receptor (G protein-coupled) activity modifying protein 2 (RAMP2), mRNA.",coated pit [goid 5905] [pmid 10882736] [evidence TAS]; lysosome [goid 5764] [pmid 10882736] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9620797] [evidence TAS]; plasma membrane [goid 5886] [pmid 9620797] [evidence TAS]; lysosome [goid 5764] [pmid 10882736] [evidence TAS]; coated pit [goid 5905] [pmid 10882736] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9620797] [evidence TAS],intracellular protein transport [goid 6886] [evidence IEA]; receptor mediated endocytosis [goid 6898] [pmid 10882736] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [evidence NR ]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [evidence IEA]; intracellular protein transport [goid 6886] [evidence IEA]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [evidence NR ]; receptor mediated endocytosis [goid 6898] [pmid 10882736] [evidence TAS],protein transporter activity [goid 8565] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; protein transporter activity [goid 8565] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],17,38168393-38168396:38168397-38168442,17q21.31a,+,NM_005854.2,10266,RAMP2,-1.925940394741838,8.238103456433471,-17.01525567252675,1.8912127517948968e-38,6.025379735336353e-37,76.74748813491956
CDT1,ILMN_1651237,"Homo sapiens chromatin licensing and DNA replication factor 1 (CDT1), mRNA.",nucleus [goid 5634] [pmid 11125146] [evidence IDA]; replication fork [goid 5657] [evidence IPI],DNA replication checkpoint [goid 76] [pmid 14672932] [evidence IDA]; regulation of DNA replication initiation [goid 30174] [pmid 11125146] [evidence IDA]; DNA replication [goid 6260] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],DNA binding [goid 3677] [evidence ISS]; protein binding [goid 5515] [pmid 14672932] [evidence IPI],16,87403077-87403126,16q24.3a,+,NM_030928.2,81620,CDT1,1.9925009324451821,6.475735008042095,17.010518461733074,1.9483885449024177e-38,6.197672179079106e-37,76.71775740967716
PFC,ILMN_1658121,"Homo sapiens complement factor properdin (CFP), mRNA.",extracellular space [goid 5615] [pmid 8530058] [evidence TAS],"complement activation, alternative pathway [goid 6957] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]",,X,47368761-47368783:47370401-47370427,Xp11.23f,-,NM_002621.1,5199,PFC,-1.2364469200713373,5.883686818736645,-17.00949912058524,1.9609162900230624e-38,6.227621131870069e-37,76.7113597358076
C6orf105,ILMN_2078592,"Homo sapiens chromosome 6 open reading frame 105 (C6orf105), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,6,11831673-11831719:11843787-11843789,6p24.1c,-,NM_032744.1,84830,C6orf105,-2.3818262604019944,6.514280855178597,-17.008134589311247,1.9778129347432691e-38,6.2713282406249335e-37,76.70279538968086
GNG2,ILMN_1807925,"Homo sapiens guanine nucleotide binding protein (G protein), gamma 2 (GNG2), mRNA.",heterotrimeric G-protein complex [goid 5834] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA],14,51505271-51505320,14q22.1d,+,NM_053064.2,54331,GNG2,-1.6596356358010045,6.220977924556733,-17.007831556012185,1.9815850820677306e-38,6.2733472028498665e-37,76.700893405988
CCNDBP1,ILMN_1658743,"Homo sapiens cyclin D-type binding-protein 1 (CCNDBP1), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 12437976] [evidence IDA],,,15,41265312-41265361,15q15.2b,+,NM_012142.2,23582,CCNDBP1,-1.221117767044328,8.712705698143854,-16.995417853583685,2.1424711706073236e-38,6.771968907031806e-37,76.62297118155917
KIAA0284,ILMN_1664960,"Homo sapiens KIAA0284 (KIAA0284), mRNA.",,,,14,104433874-104433923,14q32.33c,+,NM_015005.1,283638,KIAA0284,1.2556478266180493,6.030935608581969,16.979041478388012,2.3749236074194926e-38,7.49486932764183e-37,76.52015148865311
KLF13,ILMN_1679929,"Homo sapiens Kruppel-like factor 13 (KLF13), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 10023774] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [pmid 10023774] [evidence TAS]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],15,29456936-29456985,15q13.3a,+,NM_015995.2,51621,KLF13,-1.4170479945832675,10.322816315200534,-16.96179032725624,2.64719790775236e-38,8.340966258001453e-37,76.41181084690955
CSNK1D,ILMN_1720708,"Homo sapiens casein kinase 1, delta (CSNK1D), transcript variant 2, mRNA.",,Wnt receptor signaling pathway [goid 16055] [evidence IEA]; DNA repair [goid 6281] [pmid 8786104] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 8786104] [evidence TAS]; signal transduction [goid 7165] [pmid 8786104] [evidence TAS]; Wnt receptor signaling pathway [goid 16055] [evidence IEA]; DNA repair [goid 6281] [pmid 8786104] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 8786104] [evidence TAS]; signal transduction [goid 7165] [pmid 8786104] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; casein kinase I activity [goid 4681] [pmid 8786104] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; casein kinase I activity [goid 4681] [pmid 8786104] [evidence TAS],17,77795637-77795686,17q25.3g,-,NM_139062.1,1453,CSNK1D,1.011688069179959,9.76703871032313,16.94986256804855,2.8535476170813345e-38,8.977009547572852e-37,76.33688501486222
TIMELESS,ILMN_1735093,"Homo sapiens timeless homolog (Drosophila) (TIMELESS), mRNA.",nucleus [goid 5634] [pmid 9856465] [evidence IC ],"morphogenesis of an epithelium [goid 2009] [evidence ISS]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]; circadian rhythm [goid 7623] [evidence ISS]; negative regulation of transcription [goid 16481] [pmid 9856465] [evidence IDA]",protein heterodimerization activity [goid 46982] [evidence ISS]; protein binding [goid 5515] [evidence ISS],12,55097382-55097431,12q13.2c,-,NM_003920.2,8914,TIMELESS,1.2712194724573083,8.392641470614157,16.93997481122791,3.036778555664084e-38,9.538440399015226e-37,76.27476312635437
MCM2,ILMN_1681503,"Homo sapiens MCM2 minichromosome maintenance deficient 2, mitotin (S. cerevisiae) (MCM2), mRNA.",chromatin [goid 785] [pmid 8798650] [evidence TAS]; nucleus [goid 5634] [pmid 8175912] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [pmid 8175912] [evidence TAS]; transcription [goid 6350] [evidence IEA]; DNA replication initiation [goid 6270] [evidence IEA]; DNA replication [goid 6260] [pmid 8175912] [evidence TAS]",metal ion binding [goid 46872] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; DNA-dependent ATPase activity [goid 8094] [evidence IEA]; protein binding [goid 5515] [pmid 15654075] [evidence IPI]; DNA binding [goid 3677] [pmid 8175912] [evidence TAS]; ATP binding [goid 5524] [evidence IEA],3,128823652-128823701,3q21.3b,+,NM_004526.2,4171,MCM2,1.8650418295395994,8.066291120736011,16.929334821207817,3.247147597314153e-38,1.0183217731514353e-36,76.20790445160854
KIFC1,ILMN_2222008,"Homo sapiens kinesin family member C1 (KIFC1), mRNA.",microtubule associated complex [goid 5875] [evidence NAS]; microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; mitotic sister chromatid segregation [goid 70] [pmid 8276466] [evidence NAS],ATP binding [goid 5524] [pmid 8276466] [evidence NAS]; microtubule motor activity [goid 3777] [pmid 8276466] [evidence NAS]; nucleotide binding [goid 166] [evidence IEA],6,33482588-33482630:33485401-33485407,6p21.32a,+,NM_002263.2,3833,KIFC1,2.099003059176269,6.900520166875099,16.924919698114678,3.3386743370639614e-38,1.0453864810011852e-36,76.18015781214557
ECT2,ILMN_1717173,"Homo sapiens epithelial cell transforming sequence 2 oncogene (ECT2), mRNA.",intracellular [goid 5622] [evidence IEA],positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP]; regulation of Rho protein signal transduction [goid 35023] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; GTPase activator activity [goid 5096] [evidence IEA]; protein binding [goid 5515] [pmid 16129829] [evidence IPI],3,174021849-174021898,3q26.31b,+,NM_018098.4,1894,ECT2,1.9390175097242466,8.074104076954615,16.92082233637908,3.4259261597501345e-38,1.0710301656918857e-36,76.15440642021392
PTD015,ILMN_1779163,"Homo sapiens chromosome 11 open reading frame 67 (C11orf67), mRNA.",,,,11,77209896-77209935:77231173-77231182,11q14.1a,+,NM_024684.2,28971,PTD015,-1.495573896430681,9.39968808928959,-16.918936446250775,3.4668501488149377e-38,1.082133194656619e-36,76.14255329043344
LST1,ILMN_1688373,"Homo sapiens leukocyte specific transcript 1 (LST1), transcript variant 2, mRNA.",integral to membrane [goid 16021] [pmid 10706707] [evidence IDA]; Golgi apparatus [goid 5794] [pmid 11478849] [evidence NAS]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [pmid 11478849] [evidence IDA]; integral to membrane [goid 16021] [pmid 10706707] [evidence IDA]; Golgi apparatus [goid 5794] [pmid 11478849] [evidence NAS]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [pmid 11478849] [evidence IDA],regulation of cell shape [goid 8360] [evidence IEA]; immune response [goid 6955] [pmid 10944527] [evidence NAS]; negative regulation of lymphocyte proliferation [goid 50672] [pmid 10706707] [evidence IDA]; regulation of cell shape [goid 8360] [evidence IEA]; immune response [goid 6955] [pmid 10944527] [evidence NAS]; negative regulation of lymphocyte proliferation [goid 50672] [pmid 10706707] [evidence IDA],protein binding [goid 5515] [pmid 14667819] [evidence IPI]; protein binding [goid 5515] [pmid 14667819] [evidence IPI],6,31664410-31664459,6p21.33a,+,NM_205837.1,7940,LST1,-1.854521205518484,8.644281049693644,-16.918356423484955,3.4795349683692494e-38,1.0844008667777562e-36,76.13890768187122
LMO6,ILMN_1656942,"Homo sapiens LIM domain only 6 (LMO6), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],X,48919010-48919059,Xp11.23b,-,NM_006150.3,4007,LMO6,1.0332616942613715,5.710323571727432,16.89361807035629,4.066158643113315e-38,1.265251977160361e-36,75.98338944342686
CHEK1,ILMN_1664630,"Homo sapiens CHK1 checkpoint homolog (S. pombe) (CHEK1), mRNA.",condensed nuclear chromosome [goid 794] [pmid 9382850] [evidence TAS]; nucleus [goid 5634] [evidence IEA],gametogenesis [goid 7276] [pmid 9382850] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; DNA damage checkpoint [goid 77] [pmid 9278511] [evidence TAS]; meiotic recombination [goid 7131] [pmid 9278511] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9278511] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; DNA repair [goid 6281] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],11,125030428-125030477,11q24.2b,+,NM_001274.2,1111,CHEK1,1.517026956278702,6.272284859037051,16.890526240240916,4.146128684263166e-38,1.287094917366507e-36,75.96394837808467
RASGRP2,ILMN_1794594,"Homo sapiens RAS guanyl releasing protein 2 (calcium and DAG-regulated) (RASGRP2), transcript variant 1, mRNA.",intracellular [goid 5622] [evidence IEA]; cytosol [goid 5829] [pmid 10918068] [evidence IDA]; plasma membrane [goid 5886] [pmid 10918068] [evidence IDA]; intracellular [goid 5622] [evidence IEA]; cytosol [goid 5829] [pmid 10918068] [evidence IDA]; plasma membrane [goid 5886] [pmid 10918068] [evidence IDA]; intracellular [goid 5622] [evidence IEA]; cytosol [goid 5829] [pmid 10918068] [evidence IDA]; plasma membrane [goid 5886] [pmid 10918068] [evidence IDA],Ras protein signal transduction [goid 7265] [pmid 10918068] [evidence NAS]; regulation of cell growth [goid 1558] [pmid 10918068] [evidence NAS]; regulation of small GTPase mediated signal transduction [goid 51056] [evidence IEA]; Ras protein signal transduction [goid 7265] [pmid 10918068] [evidence NAS]; regulation of cell growth [goid 1558] [pmid 10918068] [evidence NAS]; regulation of small GTPase mediated signal transduction [goid 51056] [evidence IEA]; Ras protein signal transduction [goid 7265] [pmid 10918068] [evidence NAS]; regulation of cell growth [goid 1558] [pmid 10918068] [evidence NAS]; regulation of small GTPase mediated signal transduction [goid 51056] [evidence IEA],calcium ion binding [goid 5509] [pmid 10918068] [evidence NAS]; diacylglycerol binding [goid 19992] [pmid 10918068] [evidence NAS]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA]; Ras guanyl-nucleotide exchange factor activity [goid 5088] [pmid 10918068] [evidence IEP]; kinase activity [goid 16301] [evidence IEA]; calcium ion binding [goid 5509] [pmid 10918068] [evidence NAS]; diacylglycerol binding [goid 19992] [pmid 10918068] [evidence NAS]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA]; Ras guanyl-nucleotide exchange factor activity [goid 5088] [pmid 10918068] [evidence IEP]; kinase activity [goid 16301] [evidence IEA]; calcium ion binding [goid 5509] [pmid 10918068] [evidence NAS]; diacylglycerol binding [goid 19992] [pmid 10918068] [evidence NAS]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA]; Ras guanyl-nucleotide exchange factor activity [goid 5088] [pmid 10918068] [evidence IEP]; kinase activity [goid 16301] [evidence IEA],11,64251346-64251349:64251350-64251395,11q13.1b,-,NM_005825.2,10235,RASGRP2,-1.0508856874662609,6.234709532260747,-16.884620542757016,4.3032878025798584e-38,1.3328201602789133e-36,75.92681145331895
WDR74,ILMN_1789775,"Homo sapiens WD repeat domain 74 (WDR74), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],,,11,62358339-62358379:62358475-62358483,11q12.3b,-,NM_018093.1,54663,WDR74,1.20430309849635,8.93732172674908,16.879086571796016,4.4559708102741126e-38,1.377976259226653e-36,75.89200897933218
FLJ10815,ILMN_1784105,"Homo sapiens amino acid transporter (FLJ10815), mRNA.",,,,16,57257934-57257983,16q21a,-,NM_018231.1,55238,FLJ10815,1.5033352093108112,6.679276818541717,16.857997654530656,5.089292115111911e-38,1.571397478999369e-36,75.75935600991698
ITGA11,ILMN_1651343,"Homo sapiens integrin, alpha 11 (ITGA11), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integrin complex [goid 8305] [pmid 10486209] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integrin complex [goid 8305] [pmid 10486209] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],integrin-mediated signaling pathway [goid 7229] [evidence IEA]; cell-matrix adhesion [goid 7160] [pmid 10464311] [evidence TAS]; muscle development [goid 7517] [pmid 10464311] [evidence TAS]; cell adhesion [goid 7155] [pmid 10486209] [evidence TAS]; integrin-mediated signaling pathway [goid 7229] [evidence IEA]; cell-matrix adhesion [goid 7160] [pmid 10464311] [evidence TAS]; muscle development [goid 7517] [pmid 10464311] [evidence TAS]; cell adhesion [goid 7155] [pmid 10486209] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; collagen binding [goid 5518] [pmid 10464311] [evidence TAS]; magnesium ion binding [goid 287] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; collagen binding [goid 5518] [pmid 10464311] [evidence TAS]; magnesium ion binding [goid 287] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],15,66381222-66381271,15q23a,-,NM_012211.3,22801,ITGA11,1.9474206037131987,6.153054280364237,16.850566172083866,5.33334865773613e-38,1.6442163319566177e-36,75.71260039172947
KSP37,ILMN_1761945,"Homo sapiens fibroblast growth factor binding protein 2 (FGFBP2), mRNA.",,,growth factor binding [goid 19838] [evidence IEA],4,15573160-15573178:15573179-15573209,4p15.32d,-,NM_031950.2,83888,KSP37,-2.6297761739766523,6.294208637914943,-16.839225968908583,5.728575495578827e-38,1.7633436694698642e-36,75.64124249979575
MC1R,ILMN_1653319,"Homo sapiens melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) (MC1R), mRNA.",integral to plasma membrane [goid 5887] [pmid 9571181] [evidence TAS]; membrane [goid 16020] [evidence IEA],"UV protection [goid 9650] [pmid 7581459] [evidence TAS]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 9571181] [evidence TAS]; development [goid 7275] [pmid 7581459] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]",melanocyte stimulating hormone receptor activity [goid 4980] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],16,88514810-88514859,16q24.3b,+,NM_002386.2,4157,MC1R,1.831918243693666,7.738320977408534,16.832678284966576,5.970010004465738e-38,1.834838097839485e-36,75.60003572022678
NEK2,ILMN_1653822,"Homo sapiens NIMA (never in mitosis gene a)-related kinase 2 (NEK2), mRNA.",centrosome [goid 5813] [pmid 9430639] [evidence TAS]; nucleus [goid 5634] [evidence IEA]; centrosome [goid 5813] [pmid 9430639] [evidence TAS]; nucleus [goid 5634] [evidence IEA],regulation of mitosis [goid 7088] [pmid 9430639] [evidence TAS]; meiosis [goid 7126] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; cell division [goid 51301] [evidence IEA]; regulation of mitosis [goid 7088] [pmid 9430639] [evidence TAS]; meiosis [goid 7126] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; cell division [goid 51301] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 9430639] [evidence TAS]; protein binding [goid 5515] [pmid 9647649] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 9430639] [evidence TAS]; protein binding [goid 5515] [pmid 9647649] [evidence IPI],1,209903459-209903508,1q32.3a,-,NM_002497.2,4751,NEK2,1.5602923315162025,5.89347037343773,16.83192517421319,5.998425805549046e-38,1.8407439189789158e-36,75.59529587462832
FBXO7,ILMN_1667112,"Homo sapiens F-box protein 7 (FBXO7), transcript variant 1, mRNA.",ubiquitin ligase complex [goid 151] [pmid 10531035] [evidence TAS]; ubiquitin ligase complex [goid 151] [pmid 10531035] [evidence TAS],ubiquitin-dependent protein catabolism [goid 6511] [pmid 10531035] [evidence TAS]; regulation of protein stability [goid 31647] [pmid 15145941] [evidence IDA]; ubiquitin-dependent protein catabolism [goid 6511] [pmid 10531035] [evidence TAS]; regulation of protein stability [goid 31647] [pmid 15145941] [evidence IDA],ubiquitin-protein ligase activity [goid 4842] [pmid 10531035] [evidence TAS]; protein binding [goid 5515] [pmid 15145941] [evidence IPI]; ubiquitin-protein ligase activity [goid 4842] [pmid 10531035] [evidence TAS]; protein binding [goid 5515] [pmid 15145941] [evidence IPI],22,31201076-31201111:31204968-31204981,22q12.3a,+,NM_012179.3,25793,FBXO7,-1.1242300411054247,7.544231165664373,-16.828110098596742,6.144469996990436e-38,1.882673134759336e-36,75.57128412856858
TMEM178,ILMN_1678403,"Homo sapiens transmembrane protein 178 (TMEM178), mRNA.",tight junction [goid 5923] [evidence IEA]; tight junction [goid 5923] [evidence IEA],,structural molecule activity [goid 5198] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA],2,39797960-39798009,2p22.1b,+,NM_152390.1,130733,TMEM178,-1.9593152578475435,6.727465739887348,-16.82258784019923,6.362203773405122e-38,1.94640631648761e-36,75.53652503352882
LAMA4,ILMN_1795442,"Homo sapiens laminin, alpha 4 (LAMA4), mRNA.",laminin-1 [goid 5606] [evidence IEA]; basal lamina [goid 5605] [pmid 7959779] [evidence TAS]; laminin-1 [goid 5606] [evidence IEA]; basal lamina [goid 5605] [pmid 7959779] [evidence TAS],regulation of embryonic development [goid 45995] [evidence IEA]; regulation of cell adhesion [goid 30155] [evidence IEA]; regulation of cell migration [goid 30334] [evidence IEA]; regulation of embryonic development [goid 45995] [evidence IEA]; regulation of cell adhesion [goid 30155] [evidence IEA]; regulation of cell migration [goid 30334] [evidence IEA],extracellular matrix structural constituent [goid 5201] [pmid 7959779] [evidence TAS]; receptor binding [goid 5102] [evidence IEA]; extracellular matrix structural constituent [goid 5201] [pmid 7959779] [evidence TAS]; receptor binding [goid 5102] [evidence IEA],6,112537392-112537441,6q21i,-,NM_002290.2,3910,LAMA4,-1.5481465562623535,8.363383825209862,-16.82210749455145,6.381504809878073e-38,1.9493305074204653e-36,75.53350142467578
XDH,ILMN_1712632,"Homo sapiens xanthine dehydrogenase (XDH), mRNA.",,electron transport [goid 6118] [evidence IEA],"xanthine dehydrogenase activity [goid 4854] [pmid 8224915] [evidence TAS]; iron ion binding [goid 5506] [evidence IEA]; electron transporter activity [goid 5489] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; 2 iron, 2 sulfur cluster binding [goid 51537] [evidence IEA]; xanthine oxidase activity [goid 4855] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; molybdenum ion binding [goid 30151] [evidence IEA]",2,31412008-31412057,2p23.1a,-,NM_000379.2,7498,XDH,1.8243091539556717,5.777068125043013,16.81682460217158,6.597692022906591e-38,2.0122960669865104e-36,75.50024598347238
EPN3,ILMN_1726893,"Homo sapiens epsin 3 (EPN3), mRNA.",,,lipid binding [goid 8289] [evidence IEA],17,45974948-45974997,17q21.33b,+,NM_017957.1,55040,EPN3,1.3921937282358146,5.7196628889921,16.802915056458254,7.202670404905081e-38,2.1934707680569386e-36,75.41267347767611
KIF15,ILMN_1753063,"Homo sapiens kinesin family member 15 (KIF15), mRNA.",plus-end kinesin complex [goid 5873] [pmid 10878014] [evidence TAS]; centrosome [goid 5813] [pmid 10878014] [evidence TAS]; microtubule associated complex [goid 5875] [evidence IEA],cell proliferation [goid 8283] [pmid 10878014] [evidence TAS]; microtubule-based movement [goid 7018] [evidence IEA]; mitosis [goid 7067] [pmid 10878014] [evidence TAS],microtubule motor activity [goid 3777] [evidence IEA]; DNA binding [goid 3677] [pmid 10878014] [evidence TAS]; ATP binding [goid 5524] [evidence IEA],3,44868721-44868770,3p21.31k,+,NM_020242.1,56992,KIF15,1.4194069597248848,5.771709795030853,16.788876911183056,7.869652972277974e-38,2.3856972222626927e-36,75.32427242855991
KIAA1754,ILMN_1805192,"Homo sapiens KIAA1754 (KIAA1754), mRNA.",,,,10,106062072-106062121,10q25.1a,-,NM_033397.2,85450,KIAA1754,-1.39290517104655,9.512999826215703,-16.787856857535168,7.920464870526575e-38,2.3974683983282258e-36,75.31784820489793
ANXA6,ILMN_1678612,"Homo sapiens annexin A6 (ANXA6), transcript variant 1, mRNA.",,,calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],5,150460633-150460682,5q33.1d,-,NM_001155.3,309,ANXA6,-1.0915151150507425,6.735032720466564,-16.786969407590398,7.964938839053139e-38,2.407288463621982e-36,75.31225902834383
C1orf97,ILMN_1808769,"Homo sapiens chromosome 1 open reading frame 97 (C1orf97), mRNA.",,,,1,209672321-209672370,1q32.3a,+,NM_032705.3,84791,C1orf97,1.6205840421540687,7.89816615057429,16.78332862635147,8.150029685417069e-38,2.4595142374935855e-36,75.28932852695151
WDR46,ILMN_2212354,"Homo sapiens WD repeat domain 46 (WDR46), mRNA.",,,,6,33355001-33355030:33355031-33355050,6p21.32a,-,NM_005452.4,9277,WDR46,1.0816591320571245,9.546019977564933,16.777448657126325,8.458105658319161e-38,2.5486412351152073e-36,75.2522924012492
BEX1,ILMN_1702637,"Homo sapiens brain expressed, X-linked 1 (BEX1), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],cell differentiation [goid 30154] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA],,X,102205743-102205792,Xq22.1e,-,NM_018476.3,55859,BEX1,-1.7406522466015257,6.949569733277124,-16.76523778605626,9.13568985174346e-38,2.7486749256192954e-36,75.1753692647492
IPO4,ILMN_1798172,"Homo sapiens importin 4 (IPO4), mRNA.",nucleus [goid 5634] [evidence IEA]; nuclear pore [goid 5643] [pmid 11823430] [evidence NAS]; cytoplasm [goid 5737] [evidence IEA],protein transport [goid 15031] [pmid 11823430] [evidence NAS],binding [goid 5488] [evidence IEA]; protein transporter activity [goid 8565] [evidence IEA],14,23719762-23719804:23720559-23720565,14q12a,-,NM_024658.3,79711,IPO4,1.2273925681555387,7.643227873692466,16.75964251328012,9.464099021968627e-38,2.8432086070803047e-36,75.14011672376684
TLCD1,ILMN_1784655,"Homo sapiens TLC domain containing 1 (TLCD1), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,17,24075691-24075740,17q11.2a,-,NM_138463.2,116238,TLCD1,1.8666862710871754,8.172744188082776,16.754341511678405,9.786147330165959e-38,2.935550761348733e-36,75.1067154483968
CAD,ILMN_1810992,"Homo sapiens carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (CAD), mRNA.",cytoplasm [goid 5737] [evidence IEA],'de novo' pyrimidine base biosynthesis [goid 6207] [evidence IEA]; pyrimidine nucleotide biosynthesis [goid 6221] [evidence IEA]; glutamine metabolism [goid 6541] [evidence IEA]; nitrogen compound metabolism [goid 6807] [evidence IEA]; biosynthesis [goid 9058] [evidence IEA]; amino acid metabolism [goid 6520] [evidence IEA]; arginine biosynthesis [goid 6526] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; dihydroorotase activity [goid 4151] [evidence IEA]; amino acid binding [goid 16597] [evidence IEA]; aspartate carbamoyltransferase activity [goid 4070] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [goid 4088] [pmid 8619816] [evidence TAS]; ligase activity [goid 16874] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],2,27319652-27319664:27319788-27319824,2p23.3a,+,NM_004341.3,790,CAD,1.3365472251375419,7.5718981804381,16.754074434345988,9.802660510651052e-38,2.9361022679207522e-36,75.10503253989337
HLX1,ILMN_1686862,"Homo sapiens H2.0-like homeobox (HLX), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [pmid 8094082] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [evidence NR ]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [pmid 8094082] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [evidence NR ]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],1,219124373-219124422,1q41d,+,NM_021958.2,3142,HLX1,-1.4138572571799042,7.532994840198912,-16.744553643195726,1.0409931561185099e-37,3.1133319981493494e-36,75.04503564658391
SGPL1,ILMN_1761531,"Homo sapiens sphingosine-1-phosphate lyase 1 (SGPL1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; integral to endoplasmic reticulum membrane [goid 30176] [pmid 11018465] [evidence NAS],apoptosis [goid 6915] [pmid 14570870] [evidence IDA]; sphingolipid catabolism [goid 30149] [pmid 11018465] [evidence NAS]; ceramide metabolism [goid 6672] [pmid 14570870] [evidence IDA]; lipid metabolism [goid 6629] [evidence IEA]; carboxylic acid metabolism [goid 19752] [evidence IEA],sphinganine-1-phosphate aldolase activity [goid 8117] [pmid 11018465] [evidence NAS]; lyase activity [goid 16829] [evidence IEA]; carboxy-lyase activity [goid 16831] [evidence IEA],10,72309382-72309431,10q22.1c,+,NM_003901.2,8879,SGPL1,1.404415850417525,7.591941453026189,16.73976849993956,1.0729243831166068e-37,3.2040404563279204e-36,75.01487797789592
GYPE,ILMN_1695187,"Homo sapiens glycophorin E (GYPE), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 7622054] [evidence TAS]; plasma membrane [goid 5886] [pmid 2295603] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 7622054] [evidence TAS]; plasma membrane [goid 5886] [pmid 2295603] [evidence TAS],,,4,145016057-145016106,4q31.22a,-,NM_002102.2,2996,GYPE,-1.1947161693843267,5.475367320708288,-16.730520078538625,1.1374484659571149e-37,3.386617396855648e-36,74.95658495547865
IBRDC2,ILMN_1752526,"Homo sapiens IBR domain containing 2 (IBRDC2), mRNA.",ubiquitin ligase complex [goid 151] [pmid 12853982] [evidence IC ]; integral to membrane [goid 16021] [evidence ISS]; membrane [goid 16020] [evidence IEA],protein ubiquitination during ubiquitin-dependent protein catabolism [goid 42787] [pmid 12853982] [evidence IDA]; electron transport [goid 6118] [evidence IEA]; ubiquitin cycle [goid 6512] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 12853982] [evidence IPI]; iron ion binding [goid 5506] [evidence IEA]; ubiquitin-protein ligase activity [goid 4842] [pmid 12853982] [evidence IDA]; electron transporter activity [goid 5489] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],6,18576211-18576260,6p22.3d,+,NM_182757.2,255488,IBRDC2,-1.8278093124467443,8.881966433402237,-16.72008370881005,1.2149444684805619e-37,3.611977552059299e-36,74.89079447533864
ABHD6,ILMN_1706344,"Homo sapiens abhydrolase domain containing 6 (ABHD6), mRNA.",,aromatic compound metabolism [goid 6725] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA],3,58255167-58255216,3p14.3a,+,NM_020676.4,57406,ABHD6,-1.1531561092686875,7.661630264341337,-16.71381983963797,1.2639766277676447e-37,3.7521727549517856e-36,74.8513023019158
OTUD1,ILMN_1723141,"PREDICTED: Homo sapiens OTU domain containing 1 (OTUD1), mRNA.",,,,10,23770773-23770822,10p12.2a,+,XM_166659.6,220213,OTUD1,-1.4286146492353184,6.814301196761866,-16.710499768694127,1.2907647500522854e-37,3.826017943562389e-36,74.83036854818867
PPP3CC,ILMN_1690546,"Homo sapiens protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (PPP3CC), mRNA.",calcineurin complex [goid 5955] [evidence NR ],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; phosphoprotein phosphatase activity [goid 4721] [evidence IEA],8,22454144-22454193,8p21.3a,+,NM_005605.3,5533,PPP3CC,-1.1095563183077397,8.449814170573372,-16.698138894853876,1.3956004348757647e-37,4.118462168288245e-36,74.75242140223686
SFN,ILMN_1806607,"Homo sapiens stratifin (SFN), mRNA.",cytoplasm [goid 5737] [pmid 10767298] [evidence TAS]; extracellular space [goid 5615] [pmid 8515476] [evidence TAS],signal transduction [goid 7165] [pmid 8515476] [evidence TAS]; cell proliferation [goid 8283] [pmid 10767298] [evidence TAS]; negative regulation of protein kinase activity [goid 6469] [pmid 8515476] [evidence TAS],protein kinase C inhibitor activity [goid 8426] [pmid 8515476] [evidence TAS]; protein domain specific binding [goid 19904] [evidence IEA],1,27063337-27063386,1p36.11a,+,NM_006142.3,2810,SFN,2.671318713101895,9.221293563788759,16.696102135356288,1.4136759685772816e-37,4.165659614034499e-36,74.73957629168918
ARFGAP1,ILMN_1675709,"Homo sapiens ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1), transcript variant 2, mRNA.",,regulation of GTPase activity [goid 43087] [evidence IEA]; protein transport [goid 15031] [evidence IEA]; regulation of GTPase activity [goid 43087] [evidence IEA]; protein transport [goid 15031] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; GTPase activator activity [goid 5096] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; GTPase activator activity [goid 5096] [evidence IEA],20,61391358-61391407,20q13.33d,+,NM_175609.1,55738,ARFGAP1,1.5396050173752878,8.40206686308276,16.69410735385929,1.4316064153750156e-37,4.212291346885781e-36,74.7269955399981
GAS7,ILMN_1745994,"Homo sapiens growth arrest-specific 7 (GAS7), transcript variant b, mRNA.",,cell differentiation [goid 30154] [evidence IEA]; cell cycle arrest [goid 7050] [pmid 9736752] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; cell cycle arrest [goid 7050] [pmid 9736752] [evidence TAS],transcription factor activity [goid 3700] [pmid 9736752] [evidence TAS]; transcription factor activity [goid 3700] [pmid 9736752] [evidence TAS],17,9755047-9755096,17p13.1b,-,NM_201432.1,8522,GAS7,-1.3717677215153836,8.23333371960409,-16.693868224751302,1.4337711153340868e-37,4.212465855448518e-36,74.72548736757479
WFDC1,ILMN_1660808,"Homo sapiens WAP four-disulfide core domain 1 (WFDC1), mRNA.",extracellular space [goid 5615] [pmid 10967136] [evidence NAS],negative regulation of cell growth [goid 30308] [pmid 10967136] [evidence NAS],serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA],16,82920607-82920656,16q24.1a,+,NM_021197.2,58189,WFDC1,-2.204093219757323,7.456476160300315,-16.692913656907038,1.4424450155360215e-37,4.231736051443507e-36,74.71946691349551
C2orf11,ILMN_1801441,"Homo sapiens raftlin family member 2 (RFTN2), mRNA.",,,,2,198143958-198144007,2q33.1b,-,NM_144629.1,130132,C2orf11,-1.8506445028484189,7.106707452555011,-16.689037353392465,1.4782117987805146e-37,4.330316496339757e-36,74.69501820148078
SLC5A3,ILMN_1787813,"Homo sapiens solute carrier family 5 (inositol transporters), member 3 (SLC5A3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 1372904] [evidence TAS],ion transport [goid 6811] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA],symporter activity [goid 15293] [evidence IEA]; transporter activity [goid 5215] [evidence IEA]; myo-inositol:sodium symporter activity [goid 5367] [pmid 1372904] [evidence TAS]; sodium ion binding [goid 31402] [evidence IEA],21,34391192-34391241,21q22.11c,+,NM_006933.2,6526,SLC5A3,1.7325216590948687,6.168477624863732,16.680324095276017,1.5618882729526093e-37,4.568751544625118e-36,74.6400565421006
CBX8,ILMN_1775183,"Homo sapiens chromobox homolog 8 (Pc class homolog, Drosophila) (CBX8), mRNA.",nucleus [goid 5634] [evidence IEA]; chromatin [goid 785] [evidence IEA],"chromatin modification [goid 16568] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; chromatin assembly or disassembly [goid 6333] [evidence IEA]",chromatin binding [goid 3682] [evidence IEA],17,75382966-75383015,17q25.3d,-,NM_020649.1,57332,CBX8,1.0517462485374685,6.167034973252532,16.676871733843402,1.5963412890264044e-37,4.662714819100774e-36,74.6182776821745
LOC652773,ILMN_1687526,"PREDICTED: Homo sapiens similar to Shwachman-Bodian-Diamond syndrome (predicted) (LOC652773), mRNA.",,,,,,,,XM_942415.1,652773,LOC652773,-2.035492043871031,6.289633854697591,-16.673579569483245,1.6299050011778772e-37,4.753810388275068e-36,74.59750835893925
DOPEY2,ILMN_1741711,"Homo sapiens dopey family member 2 (DOPEY2), mRNA.",cellular component unknown [goid 8372] [evidence ND ],development [goid 7275] [pmid 10950924] [evidence NAS],molecular function unknown [goid 5554] [evidence ND ],21,36587619-36587668,21q22.12b,+,NM_005128.2,9980,DOPEY2,1.418179752201202,8.508738657784097,16.669335270587837,1.6742217538651812e-37,4.875957620281593e-36,74.57073077988568
GLDN,ILMN_1704376,"Homo sapiens gliomedin (GLDN), mRNA.",cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],,15,49487325-49487374,15q21.2b,+,NM_181789.1,342035,GLDN,-2.6199177444834296,8.25948065275998,-16.659294068991706,1.7839359345810142e-37,5.187934619054786e-36,74.50737336397391
CA2,ILMN_1662795,"Homo sapiens carbonic anhydrase II (CA2), mRNA.",cytoplasm [goid 5737] [pmid 114507] [evidence IDA]; cytoplasm [goid 5737] [pmid 114507] [evidence IDA],one-carbon compound metabolism [goid 6730] [evidence IEA]; one-carbon compound metabolism [goid 6730] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 3151020] [evidence IDA]; carbonate dehydratase activity [goid 4089] [pmid 1928091] [evidence TAS]; lyase activity [goid 16829] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 3151020] [evidence IDA]; carbonate dehydratase activity [goid 4089] [pmid 1928091] [evidence TAS]; lyase activity [goid 16829] [evidence IEA],8,86580426-86580475,8q21.2b,+,NM_000067.1,760,CA2,-2.5250160063756137,9.374749510925698,-16.648748244689227,1.9069326783576256e-37,5.5375775077763966e-36,74.4408216716939
PLA2G1B,ILMN_1721549,"Homo sapiens phospholipase A2, group IB (pancreas) (PLA2G1B), mRNA.",,signal transduction [goid 7165] [pmid 9886417] [evidence TAS]; phospholipid metabolism [goid 6644] [evidence IEA]; lipid catabolism [goid 16042] [evidence IEA]; actin filament organization [goid 7015] [pmid 9886417] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; phospholipase A2 activity [goid 4623] [pmid 9886417] [evidence TAS],12,119244480-119244503:119247120-119247145,12q24.31a,-,NM_000928.2,5319,PLA2G1B,-3.6247470575412084,8.97478662041161,-16.648158855889577,1.9140523242962614e-37,5.550196942684e-36,74.4371018978278
GFPT1,ILMN_2220184,"Homo sapiens glutamine-fructose-6-phosphate transaminase 1 (GFPT1), mRNA.",cytoplasm [goid 5737] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],metabolism [goid 8152] [evidence IEA]; energy reserve metabolism [goid 6112] [pmid 1460020] [evidence TAS]; carbohydrate metabolism [goid 5975] [evidence IEA]; carbohydrate biosynthesis [goid 16051] [evidence IEA]; fructose 6-phosphate metabolism [goid 6002] [pmid 8144040] [evidence TAS]; glutamine metabolism [goid 6541] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; energy reserve metabolism [goid 6112] [pmid 1460020] [evidence TAS]; carbohydrate metabolism [goid 5975] [evidence IEA]; carbohydrate biosynthesis [goid 16051] [evidence IEA]; fructose 6-phosphate metabolism [goid 6002] [pmid 8144040] [evidence TAS]; glutamine metabolism [goid 6541] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [goid 4360] [pmid 8144040] [evidence TAS]; sugar binding [goid 5529] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [goid 4360] [pmid 8144040] [evidence TAS]; sugar binding [goid 5529] [evidence IEA],2,69406509-69406558,2p14a,-,NM_002056.1,2673,GFPT1,1.3473435852508562,9.193793161149522,16.642513368890516,1.983612685554384e-37,5.7435778021088445e-36,74.40147022105775
RHOT2,ILMN_1669310,"Homo sapiens ras homolog gene family, member T2 (RHOT2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; outer membrane [goid 19867] [evidence IEA]; membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],apoptosis [goid 6915] [pmid 12482879] [evidence IMP]; cell homeostasis [goid 19725] [pmid 12482879] [evidence IMP]; small GTPase mediated signal transduction [goid 7264] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],16,663941-663990,16p13.3f,+,NM_138769.1,89941,RHOT2,1.2828747642699199,9.59115506188944,16.641322057927965,1.9986120604535983e-37,5.778645969010924e-36,74.39395083965158
TIMP1,ILMN_1711566,"Homo sapiens TIMP metallopeptidase inhibitor 1 (TIMP1), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; extracellular region [goid 5576] [pmid 1653055] [evidence NAS],positive regulation of cell proliferation [goid 8284] [pmid 3839290] [evidence TAS]; development [goid 7275] [evidence NR ]; negative regulation of membrane protein ectodomain proteolysis [goid 51045] [pmid 12714508] [evidence IDA]; erythrocyte maturation [goid 43249] [evidence IEA],protein binding [goid 5515] [pmid 2251898] [evidence IPI]; enzyme inhibitor activity [goid 4857] [evidence IEA]; metalloendopeptidase inhibitor activity [goid 8191] [pmid 12714508] [evidence IDA],X,47331009-47331034:47331035-47331058,Xp11.23f,+,NM_003254.2,7076,TIMP1,1.6050267865476489,13.72655009037516,16.638244495613925,2.0378888901060976e-37,5.8837057594866956e-36,74.374525096606
FLJ13236,ILMN_1749636,"Homo sapiens hypothetical protein FLJ13236 (FLJ13236), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein folding [goid 6457] [evidence IEA],heat shock protein binding [goid 31072] [evidence IEA],12,48031542-48031552:48031553-48031591,12q13.12b,+,NM_024902.2,79962,FLJ13236,2.043901316356572,6.251632264727206,16.62666810507133,2.1926866295971383e-37,6.321509234146908e-36,74.30144631238431
HOXA4,ILMN_1677018,"Homo sapiens homeo box A4 (HOXA4), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; morphogenesis [goid 9653] [pmid 1675427] [evidence TAS]",transcription factor activity [goid 3700] [evidence IEA],7,27135116-27135165,7p15.2a,-,NM_002141.2,3201,HOXA4,-1.6581958480176633,6.345751625910407,-16.621527178573245,2.265158317053895e-37,6.521048576635156e-36,74.26898892909365
ANKS1A,ILMN_1813669,"Homo sapiens ankyrin repeat and sterile alpha motif domain containing 1A (ANKS1A), mRNA.",,,,6,35166819-35166868,6p21.31d,+,NM_015245.1,23294,ANKS1A,-1.0028080792328247,10.109272467962882,-16.60361735331922,2.536908868631922e-37,7.292884000515445e-36,74.15589540867143
RCC1,ILMN_1707493,"Homo sapiens regulator of chromosome condensation 1 (RCC1), mRNA.",nucleus [goid 5634] [evidence IEA]; condensed nuclear chromosome [goid 794] [pmid 15014043] [evidence IDA]; nuclear chromatin [goid 790] [pmid 15014043] [evidence IDA]; condensed nuclear chromosome [goid 794] [pmid 15014043] [evidence IDA]; nuclear chromatin [goid 790] [pmid 15014043] [evidence IDA]; nucleus [goid 5634] [evidence IEA],G1/S transition of mitotic cell cycle [goid 82] [pmid 3678831] [evidence IMP]; mitotic spindle organization and biogenesis [goid 7052] [pmid 15014043] [evidence IDA]; regulation of mitosis [goid 7088] [pmid 15014043] [evidence IDA]; regulation of S phase of mitotic cell cycle [goid 7090] [pmid 3678831] [evidence IMP]; cell cycle [goid 7049] [evidence IEA]; DNA packaging [goid 6323] [evidence NR ]; cell division [goid 51301] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; regulation of S phase of mitotic cell cycle [goid 7090] [pmid 3678831] [evidence IMP]; G1/S transition of mitotic cell cycle [goid 82] [pmid 3678831] [evidence IMP]; cell division [goid 51301] [evidence IEA]; regulation of mitosis [goid 7088] [pmid 15014043] [evidence IDA]; DNA packaging [goid 6323] [evidence NR ]; mitotic spindle organization and biogenesis [goid 7052] [pmid 15014043] [evidence IDA],Ran guanyl-nucleotide exchange factor activity [goid 5087] [pmid 1944575] [evidence IDA]; histone binding [goid 42393] [pmid 11375490] [evidence IDA]; chromatin binding [goid 3682] [pmid 2677018] [evidence IDA]; protein binding [goid 5515] [pmid 1961752] [evidence IPI]; DNA binding [goid 3677] [evidence IEA]; histone binding [goid 42393] [pmid 11375490] [evidence IDA]; Ran guanyl-nucleotide exchange factor activity [goid 5087] [pmid 1944575] [evidence IDA]; chromatin binding [goid 3682] [pmid 2677018] [evidence IDA],1,28737782-28737831,1p35.3b,+,NM_001269.2,1104,RCC1,1.0352096591521391,6.037672056288687,16.6015295794015,2.5706430254076055e-37,7.37925762587595e-36,74.14270998237161
C20orf20,ILMN_1790136,"Homo sapiens chromosome 20 open reading frame 20 (C20orf20), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; regulation of cell growth [goid 1558] [evidence IEA]; transcription [goid 6350] [evidence IEA]; chromatin modification [goid 16568] [evidence IEA]",,20,60902321-60902370,20q13.33d,+,NM_018270.3,55257,C20orf20,1.1374606614137086,10.281219415930426,16.583642367433253,2.878727765284689e-37,8.251803026907745e-36,74.02972584246365
WDR77,ILMN_1742889,"Homo sapiens WD repeat domain 77 (WDR77), mRNA.",,,receptor activity [goid 4872] [evidence IEA],1,111784725-111784774,1p13.2d,-,NM_024102.2,79084,WDR77,1.078513188603167,7.093981964056715,16.580946010859883,2.928276198599627e-37,8.381824060312066e-36,74.01269178370302
RGS18,ILMN_2101278,"Homo sapiens regulator of G-protein signalling 18 (RGS18), mRNA.",,negative regulation of signal transduction [goid 9968] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA],1,190421142-190421191,1q31.2a,+,NM_130782.2,64407,RGS18,-1.597513149465681,6.742017425221119,-16.56966009824271,3.145116249440319e-37,8.98964084554313e-36,73.94138641283166
ATP13A2,ILMN_1704164,"Homo sapiens ATPase type 13A2 (ATP13A2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],metabolism [goid 8152] [evidence IEA]; cation transport [goid 6812] [evidence IEA],"ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism [goid 15662] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances [goid 16820] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]",1,17185182-17185231,1p36.13e,-,NM_022089.1,23400,ATP13A2,1.2807084232424044,7.994224040500227,16.564559759399206,3.248322186959535e-37,9.271388062294776e-36,73.90915814492766
PSME4,ILMN_1763540,"Homo sapiens proteasome (prosome, macropain) activator subunit 4 (PSME4), mRNA.",,,binding [goid 5488] [evidence IEA],2,53945667-53945716,2p16.2a,-,NM_014614.1,23198,PSME4,1.2154075582400488,10.164438898846875,16.563207714845618,3.2762456810872617e-37,9.337766892762668e-36,73.90061437507329
TSEN54,ILMN_1657509,"Homo sapiens tRNA splicing endonuclease 54 homolog (S. cerevisiae) (TSEN54), mRNA.",nucleus [goid 5634] [evidence IEA],mRNA processing [goid 6397] [evidence IEA]; tRNA processing [goid 8033] [evidence IEA],,17,71032138-71032187,17q25.1c,+,NM_207346.1,283989,TSEN54,1.257276093104191,8.0233939884594,16.55854853767307,3.374326879194629e-37,9.603631891739138e-36,73.87117104380917
KIAA0672,ILMN_2065022,"Homo sapiens KIAA0672 gene product (KIAA0672), mRNA.",intracellular [goid 5622] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],signal transduction [goid 7165] [evidence IEA],protein binding [goid 5515] [evidence IEA],17,12835495-12835544,17p12c,+,NM_014859.3,9912,KIAA0672,-1.9351527013096614,9.257313931394362,-16.55198057560199,3.5176097925300924e-37,9.997206921724729e-36,73.82966186375364
SPP1,ILMN_1651354,"Homo sapiens secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) (SPP1), transcript variant 2, mRNA.",extracellular region [goid 5576] [pmid 1107524] [evidence TAS]; extracellular space [goid 5615] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 1107524] [evidence TAS],cell-cell signaling [goid 7267] [pmid 1107524] [evidence TAS]; ossification [goid 1503] [pmid 10766759] [evidence TAS]; cell-matrix adhesion [goid 7160] [evidence NAS]; induction of positive chemotaxis [goid 50930] [pmid 1107524] [evidence TAS]; positive regulation of T cell proliferation [goid 42102] [pmid 1107524] [evidence TAS]; regulation of myeloid cell differentiation [goid 45637] [pmid 1107524] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; negative regulation of bone mineralization [goid 30502] [pmid 1729712] [evidence NAS]; T-helper 1 type immune response [goid 42088] [pmid 1107524] [evidence TAS]; anti-apoptosis [goid 6916] [evidence ISS],cytokine activity [goid 5125] [evidence ISS]; growth factor activity [goid 8083] [pmid 1107524] [evidence TAS]; protein binding [goid 5515] [evidence IEA]; integrin binding [goid 5178] [evidence NAS],4,89122810-89122859,4q22.1b,+,NM_000582.2,6696,SPP1,3.738849304582759,8.823105021543384,16.551519607628016,3.5278920867312678e-37,1.0012207783165845e-35,73.82674841979312
AGRP,ILMN_1714253,"Homo sapiens agouti related protein homolog (mouse) (AGRP), transcript variant 2, mRNA.",extracellular region [goid 5576] [evidence IEA],neuropeptide signaling pathway [goid 7218] [pmid 9311920] [evidence TAS]; feeding behavior [goid 7631] [pmid 9751529] [evidence TAS]; hormone-mediated signaling [goid 9755] [evidence IEA],neuropeptide hormone activity [goid 5184] [pmid 9311920] [evidence TAS]; receptor binding [goid 5102] [pmid 10318826] [evidence TAS],16,66074070-66074119,16q22.1b,-,NM_007316.1,181,AGRP,-1.6097044025212437,6.275094021775231,-16.541145914065424,3.767424237936542e-37,1.0676858945132341e-35,73.76117862586452
CLEC4A,ILMN_1709204,"Homo sapiens C-type lectin domain family 4, member A (CLEC4A), transcript variant 4, mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 10438934] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 10438934] [evidence TAS],cell adhesion [goid 7155] [pmid 10438934] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 10438934] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 10438934] [evidence TAS]; immune response [goid 6955] [evidence IEA]; cell adhesion [goid 7155] [pmid 10438934] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 10438934] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 10438934] [evidence TAS]; immune response [goid 6955] [evidence IEA],transmembrane receptor activity [goid 4888] [pmid 10438934] [evidence TAS]; sugar binding [goid 5529] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 10438934] [evidence TAS]; sugar binding [goid 5529] [evidence IEA],12,8179527-8179576,12p13.31b,+,NM_194448.1,50856,CLEC4A,-1.5948172062126114,7.7564171224076235,-16.53181277734687,3.9968311936255534e-37,1.1279068902970392e-35,73.70217744739574
C7orf21,ILMN_1666050,"Homo sapiens transmembrane and ubiquitin-like domain containing 1 (TMUB1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein modification [goid 6464] [evidence IEA],,7,150409212-150409261,7q36.1d,-,NM_031434.2,83590,C7orf21,1.06312534246684,10.44349382255367,16.529086092513584,4.066458659129952e-37,1.1459395049559448e-35,73.68493867674208
DSCR1,ILMN_1712112,"Homo sapiens Down syndrome critical region gene 1 (DSCR1), transcript variant 3, mRNA.",nucleus [goid 5634] [pmid 8595418] [evidence TAS],signal transduction [goid 7165] [pmid 8595418] [evidence TAS]; circulation [goid 8015] [pmid 8595418] [evidence TAS]; calcium-mediated signaling [goid 19722] [evidence IEA]; central nervous system development [goid 7417] [pmid 8595418] [evidence TAS],transcription factor activity [goid 3700] [pmid 8595418] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA],21,34820937-34820986,21q22.12a,-,NM_203418.1,1827,DSCR1,-1.4641444622090054,7.047074066015078,-16.518514522890403,4.3480992182644835e-37,1.223583251181938e-35,73.61809612965973
BYSL,ILMN_1682792,"Homo sapiens bystin-like (BYSL), mRNA.",cytoplasm [goid 5737] [pmid 9560222] [evidence TAS],pregnancy [goid 7565] [pmid 9560222] [evidence TAS]; cell adhesion [goid 7155] [pmid 9560222] [evidence TAS],protein binding [goid 5515] [evidence IEA],6,42008511-42008560,6p21.1f,+,NM_004053.3,705,BYSL,1.2657832076882087,8.431919448019269,16.51631200913416,4.409194684684003e-37,1.239033247909516e-35,73.60416864744744
LOC642342,ILMN_1770818,"PREDICTED: Homo sapiens similar to Contactin-associated protein-like 3 precursor (Cell recognition molecule Caspr3) (LOC642342), mRNA.",,,,9,40022224-40022273,,+,XM_925876.1,642342,LOC642342,-1.4191938772308408,5.860444555632009,-16.50442398390712,4.7541236438139685e-37,1.3303567253906278e-35,73.52898761715693
SETDB1,ILMN_1718207,"Homo sapiens SET domain, bifurcated 1 (SETDB1), mRNA.",nucleus [goid 5634] [evidence IEA],chromatin modification [goid 16568] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; protein binding [goid 5515] [pmid 11791185] [evidence IPI]; histone-lysine N-methyltransferase activity [goid 18024] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; methyltransferase activity [goid 8168] [evidence IEA],1,149203600-149203649,1q21.2c-q21.2d,+,NM_012432.2,9869,SETDB1,1.031158482301736,8.938362184315523,16.500916975982218,4.860953617159242e-37,1.3583513962586888e-35,73.5068064727916
CHST7,ILMN_1732831,"Homo sapiens carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 (CHST7), mRNA.",intrinsic to Golgi membrane [goid 31228] [evidence ISS]; integral to membrane [goid 16021] [pmid 10913333] [evidence NAS]; membrane [goid 16020] [evidence IEA],N-acetylglucosamine metabolism [goid 6044] [pmid 10913333] [evidence IDA]; chondroitin sulfate biosynthesis [goid 30206] [pmid 10781596] [evidence IDA]; sulfur metabolism [goid 6790] [pmid 10913333] [evidence IDA]; polysaccharide metabolism [goid 5976] [pmid 10781596] [evidence TAS],N-acetylglucosamine 6-O-sulfotransferase activity [goid 1517] [pmid 10913333] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; chondroitin 6-sulfotransferase activity [goid 8459] [pmid 10781596] [evidence IDA],X,46342593-46342642,Xp11.3a,+,NM_019886.2,56548,CHST7,-1.3024627158193027,8.943324907731649,-16.471424516830723,5.860058618638812e-37,1.6329812373499353e-35,73.32022772077669
GPR120,ILMN_1755942,"Homo sapiens G protein-coupled receptor 120 (GPR120), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; lipid binding [goid 8289] [evidence IEA],10,95337155-95337204,10q23.33b,+,NM_181745.2,338557,GPR120,-2.046173659549825,6.238828951828746,-16.46015728054567,6.293977800754424e-37,1.7514590797982547e-35,73.2489265436059
MYH4,ILMN_1729251,"Homo sapiens myosin, heavy polypeptide 4, skeletal muscle (MYH4), mRNA.",striated muscle thick filament [goid 5863] [evidence IEA]; muscle myosin [goid 5859] [evidence NR ]; myosin [goid 16459] [evidence IEA],actin filament-based movement [goid 30048] [pmid 10388558] [evidence NAS]; striated muscle contraction [goid 6941] [evidence IEA]; muscle development [goid 7517] [evidence IEA],"actin binding [goid 3779] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; microfilament motor activity [goid 146] [pmid 10388558] [evidence NAS]; ATP binding [goid 5524] [evidence IEA]; ATPase activity, coupled [goid 42623] [evidence NR ]",17,10287517-10287566,17p13.1a,-,NM_017533.1,4622,MYH4,-1.6275884658295903,6.235070726337708,-16.45445126559836,6.525865352424326e-37,1.8134654718236932e-35,73.21281339151938
RRBP1,ILMN_1803810,"Homo sapiens ribosome binding protein 1 homolog 180kDa (dog) (RRBP1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to endoplasmic reticulum membrane [goid 30176] [evidence NAS]; endoplasmic reticulum [goid 5783] [pmid 9628588] [evidence NAS]; ribosome [goid 5840] [pmid 9628588] [evidence TAS],signal transduction [goid 7165] [evidence NAS]; protein targeting [goid 6605] [evidence IEA]; protein biosynthesis [goid 6412] [pmid 9628588] [evidence TAS]; protein transport [goid 15031] [evidence IEA],ribosome receptor activity [goid 30376] [evidence NAS]; receptor activity [goid 4872] [pmid 9628588] [evidence TAS]; extracellular matrix structural constituent [goid 5201] [evidence NR ],20,17544091-17544140,20p12.1a,-,NM_004587.1,6238,RRBP1,1.6123759911094382,9.087253928454427,16.453024348433097,6.585180394933459e-37,1.8274103930905497e-35,73.20378202258784
RAB8B,ILMN_2173004,"Homo sapiens RAB8B, member RAS oncogene family (RAB8B), mRNA.",intracellular [goid 5622] [evidence IEA]; membrane [goid 16020] [evidence IEA],"small GTPase mediated signal transduction [goid 7264] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; protein transport [goid 15031] [evidence NAS]",transcription factor binding [goid 8134] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTPase activity [goid 3924] [pmid 9030196] [evidence NAS],15,61346835-61346884,15q22.2b,+,NM_016530.2,51762,RAB8B,-1.231923539281743,9.733552726909748,-16.44773033557623,6.81000606200936e-37,1.8871828433335634e-35,73.17027307126864
COL10A1,ILMN_1672776,"Homo sapiens collagen, type X, alpha 1(Schmid metaphyseal chondrodysplasia) (COL10A1), mRNA.",cytoplasm [goid 5737] [evidence IEA]; collagen [goid 5581] [pmid 8554571] [evidence TAS],phosphate transport [goid 6817] [evidence IEA]; skeletal development [goid 1501] [pmid 8554571] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA],6,116547372-116547421,6q22.1d,-,NM_000493.2,1300,COL10A1,2.815681391356322,6.611192804926625,16.44636489699064,6.869231088252419e-37,1.9009623183091896e-35,73.16162998521477
S100A8,ILMN_1729801,"Homo sapiens S100 calcium binding protein A8 (S100A8), mRNA.",extracellular space [goid 5615] [evidence NR ],inflammatory response [goid 6954] [pmid 3313057] [evidence TAS],calcium ion binding [goid 5509] [pmid 2149559] [evidence TAS],1,151629237-151629286,1q21.3c,-,NM_002964.3,6279,S100A8,-2.952065254634789,10.87828034206365,-16.442675136673117,7.03186732520632e-37,1.943281787882984e-35,73.13827333178244
PPAT,ILMN_1674302,"Homo sapiens phosphoribosyl pyrophosphate amidotransferase (PPAT), mRNA.",,purine nucleotide biosynthesis [goid 6164] [pmid 8106516] [evidence TAS]; metabolism [goid 8152] [evidence IEA]; purine base biosynthesis [goid 9113] [evidence IEA]; nucleoside metabolism [goid 9116] [evidence IEA]; glutamine metabolism [goid 6541] [evidence IEA],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; 4 iron, 4 sulfur cluster binding [goid 51539] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; amidophosphoribosyltransferase activity [goid 4044] [pmid 8106516] [evidence TAS]; magnesium ion binding [goid 287] [evidence IEA]",4,56954676-56954725,4q12e,-,NM_002703.3,5471,PPAT,1.3386830188254173,7.366943160150445,16.44034352312889,7.13662385199219e-37,1.9695113107677205e-35,73.1235132815442
PRKCB1,ILMN_1713603,"Homo sapiens protein kinase C, beta 1 (PRKCB1), transcript variant 1, mRNA.",plasma membrane [goid 5886] [pmid 10828076] [evidence TAS]; cytoplasm [goid 5737] [pmid 10828076] [evidence TAS]; plasma membrane [goid 5886] [pmid 10828076] [evidence TAS]; cytoplasm [goid 5737] [pmid 10828076] [evidence TAS],intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 3755548] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 3755548] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; protein kinase C activity [goid 4697] [pmid 3755548] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; diacylglycerol binding [goid 19992] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein kinase C activity [goid 4697] [pmid 3755548] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; diacylglycerol binding [goid 19992] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],16,24109987-24110036,16p12.1b,+,NM_212535.1,5579,PRKCB1,-1.010657630067496,6.53763951610261,-16.41986089738729,8.126788783867999e-37,2.236599587175116e-35,72.99382879348036
SKIV2L,ILMN_1666512,"Homo sapiens superkiller viralicidic activity 2-like (S. cerevisiae) (SKIV2L), mRNA.",,regulation of translation [goid 6445] [pmid 7610041] [evidence TAS],ATP-dependent helicase activity [goid 8026] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; ATP-dependent RNA helicase activity [goid 4004] [pmid 7610041] [evidence TAS]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],6,32045380-32045429,6p21.32b,+,NM_006929.4,6499,SKIV2L,1.1204747633226475,9.903310056785529,16.41880677413265,8.181319552183197e-37,2.2485143076934256e-35,72.98715364628357
COX4I2,ILMN_1815634,"Homo sapiens cytochrome c oxidase subunit IV isoform 2 (lung) (COX4I2), nuclear gene encoding mitochondrial protein, mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; respiratory chain complex IV (sensu Eukaryota) [goid 5751] [pmid 11311561] [evidence IC ],cellular respiration [goid 45333] [pmid 11911854] [evidence NAS]; electron transport [goid 6118] [pmid 11311561] [evidence NAS],oxidoreductase activity [goid 16491] [evidence IEA]; cytochrome-c oxidase activity [goid 4129] [pmid 11311561] [evidence IDA],20,29694869-29694918,20q11.21b,+,NM_032609.2,84701,COX4I2,-2.1806792817308738,8.057810432637812,-16.417884919210493,8.229308474235376e-37,2.2586008772633938e-35,72.98131599464435
TXNL5,ILMN_1659437,"Homo sapiens thioredoxin-like 5 (TXNL5), mRNA.",,,protein disulfide oxidoreductase activity [goid 15035] [evidence IEA]; electron carrier activity [goid 9055] [evidence IEA],17,6486367-6486368:6486995-6487042,17p13.2a,+,NM_032731.2,84817,TXNL5,1.2920187486827928,12.320694953253069,16.416412564135513,8.306540577181182e-37,2.2735603812344883e-35,72.97199213782363
NPLOC4,ILMN_1807600,"Homo sapiens nuclear protein localization 4 homolog (S. cerevisiae) (NPLOC4), mRNA.",nucleus [goid 5634] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 11574150] [evidence ISS]; intracellular [goid 5622] [evidence IEA]; nuclear envelope-endoplasmic reticulum network [goid 42175] [pmid 11574150] [evidence ISS],ubiquitin cycle [goid 6512] [evidence IEA]; membrane fusion [goid 6944] [pmid 11574150] [evidence ISS]; Golgi organization and biogenesis [goid 7030] [pmid 11574150] [evidence ISS]; protein folding [goid 6457] [evidence IEA]; ER-associated protein catabolism [goid 30433] [pmid 11574150] [evidence ISS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 11574150] [evidence IPI],17,77134616-77134665,17q25.3f,-,NM_017921.1,55666,NPLOC4,1.0474426737488312,9.209772784580197,16.39341986238168,9.61134653758025e-37,2.6235173468472803e-35,72.82636276755827
DES,ILMN_1698995,"Homo sapiens desmin (DES), mRNA.",intermediate filament [goid 5882] [pmid 9736733] [evidence TAS],muscle contraction [goid 6936] [pmid 9697706] [evidence TAS]; cytoskeleton organization and biogenesis [goid 7010] [pmid 9736733] [evidence TAS],structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 15731013] [evidence IPI]; structural constituent of cytoskeleton [goid 5200] [pmid 9736733] [evidence TAS],2,219999247-219999296,2q35f,+,NM_001927.3,1674,DES,-2.357220254387973,6.644955534566939,-16.386084366669838,1.0069410587895537e-36,2.744806090498827e-35,72.77989173044169
LOC654017,ILMN_1661138,"PREDICTED: Homo sapiens similar to Dingo protein isoform 1 (LOC654017), mRNA.",,,,,,,,XM_937953.1,654017,LOC654017,1.283505103408686,8.571812320704975,16.384236791656875,1.0188191640452734e-36,2.7734059638391606e-35,72.76818640853044
WWC2,ILMN_2207170,"Homo sapiens WW and C2 domain containing 2 (WWC2), mRNA.",,,,4,184476781-184476830,4q35.1c,+,NM_024949.4,80014,WWC2,-1.3777242728433254,6.159060537822604,-16.37979289059772,1.0479674392711134e-36,2.848876701757668e-35,72.74003078868175
LHX6,ILMN_1683752,"Homo sapiens LIM homeobox 6 (LHX6), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; brain development [goid 7420] [pmid 10393337] [evidence TAS]",transcription factor activity [goid 3700] [pmid 10393337] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],9,124011739-124011788,9q33.2b,-,NM_014368.2,26468,LHX6,-1.182962527499428,7.291309694294108,-16.37338237388705,1.0914938635489433e-36,2.9631762851950146e-35,72.6994119742543
TBX4,ILMN_1745827,"Homo sapiens T-box 4 (TBX4), mRNA.",nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [pmid 10945475] [evidence NAS]; development [goid 7275] [pmid 10945475] [evidence NAS]; transcription [goid 6350] [evidence IEA]",transcription factor activity [goid 3700] [pmid 10945475] [evidence TAS],17,56916188-56916237,17q23.2b,+,NM_018488.2,9496,TBX4,-1.6116241861063978,5.680310071813595,-16.371092727090453,1.107475548290829e-36,3.0024892642551364e-35,72.68490324007544
C16orf9,ILMN_1810055,"Homo sapiens integrin alpha FG-GAP repeat containing 3 (ITFG3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,16,255781-255830,16p13.3f,+,NM_032039.1,83986,C16orf9,1.1750739890815556,10.488639332625949,16.357736249783247,1.2054904646706733e-36,3.263796105159788e-35,72.60025827397261
LYZ,ILMN_1815205,"Homo sapiens lysozyme (renal amyloidosis) (LYZ), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],metabolism [goid 8152] [evidence IEA]; cell wall catabolism [goid 16998] [evidence IEA]; cytolysis [goid 19835] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; cell wall catabolism [goid 16998] [evidence IEA]; cytolysis [goid 19835] [evidence IEA],"hydrolase activity, acting on glycosyl bonds [goid 16798] [evidence IEA]; lysozyme activity [goid 3796] [evidence IEA]; hydrolase activity, acting on glycosyl bonds [goid 16798] [evidence IEA]; lysozyme activity [goid 3796] [evidence IEA]",12,68032310-68032345:68033200-68033213,12q15c,+,NM_000239.1,4069,LYZ,-2.8657425051705694,9.72267299206488,-16.355860388483606,1.2199356154844578e-36,3.2984421344071663e-35,72.58836896059027
SEZ6L2,ILMN_2297887,"Homo sapiens seizure related 6 homolog (mouse)-like 2 (SEZ6L2), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],16,29815816-29815865,16p11.2d,-,NM_201575.1,26470,SEZ6L2,1.494314558697039,7.957005206721687,16.342456718949776,1.3283261705949791e-36,3.581826148418375e-35,72.50340658071414
ADCK5,ILMN_1761309,"Homo sapiens aarF domain containing kinase 5 (ADCK5), mRNA.",,,kinase activity [goid 16301] [evidence IEA],8,145588894-145588915:145588992-145589019,8q24.3h,+,NM_174922.3,203054,ADCK5,1.3102631553479789,7.042584722979796,16.339607134097992,1.3525860398483271e-36,3.642333981868819e-35,72.48534172959593
F13A1,ILMN_1717163,"Homo sapiens coagulation factor XIII, A1 polypeptide (F13A1), mRNA.",extracellular space [goid 5615] [evidence IEA],blood coagulation [goid 7596] [pmid 10801785] [evidence TAS]; peptide cross-linking [goid 18149] [evidence IEA],protein-glutamine gamma-glutamyltransferase activity [goid 3810] [pmid 2877456] [evidence TAS]; acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],6,6089880-6089929,6p25.1a,-,NM_000129.2,2162,F13A1,-2.3057575049035206,7.83620026344032,-16.333091026154776,1.4097426834955628e-36,3.7911467219595726e-35,72.44403034615101
LRRC32,ILMN_2129161,"Homo sapiens leucine rich repeat containing 32 (LRRC32), mRNA.",integral to plasma membrane [goid 5887] [pmid 8180135] [evidence TAS]; membrane [goid 16020] [evidence IEA],,transferase activity [goid 16740] [evidence IEA],11,76046296-76046345,11q13.5b,-,NM_005512.1,2615,LRRC32,-1.8728663525762776,10.075304437447125,-16.33211606808355,1.4185003722069829e-36,3.80957791236474e-35,72.43784889661204
BZW2,ILMN_1676548,"Homo sapiens basic leucine zipper and W2 domains 2 (BZW2), mRNA.",,regulation of translational initiation [goid 6446] [evidence IEA],translation initiation factor activity [goid 3743] [evidence IEA],7,16712406-16712455,7p21.1b,+,NM_014038.1,28969,BZW2,1.2310497093131314,10.171450519498896,16.3103474308668,1.628891004154866e-36,4.368746811143506e-35,72.29980885228875
LOC387758,ILMN_1716247,"Homo sapiens similar to RIKEN cDNA 1110018M03 (LOC387758), mRNA.",,,,11,26974881-26974930,11p14.2a,+,NM_203371.1,387758,LOC387758,-1.8974547169808016,5.988618580534567,-16.308701709106195,1.646014074409867e-36,4.4087616600793334e-35,72.28937122822302
DUSP1,ILMN_1781285,"Homo sapiens dual specificity phosphatase 1 (DUSP1), mRNA.",,response to oxidative stress [goid 6979] [pmid 1406996] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; protein amino acid dephosphorylation [goid 6470] [evidence IEA],MAP kinase phosphatase activity [goid 17017] [evidence IEA]; non-membrane spanning protein tyrosine phosphatase activity [goid 4726] [pmid 1406996] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA],5,172128082-172128131,5q35.1e,-,NM_004417.2,1843,DUSP1,-1.8972250183558028,13.085486937175945,-16.306674686699225,1.6673525701653224e-36,4.4599452170946216e-35,72.27651495870165
EEF1A2,ILMN_2108735,"Homo sapiens eukaryotic translation elongation factor 1 alpha 2 (EEF1A2), mRNA.",nucleus [goid 5634] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA]; translational elongation [goid 6414] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; translation elongation factor activity [goid 3746] [evidence IEA],20,61589812-61589861,20q13.33e,-,NM_001958.2,1917,EEF1A2,4.418453163119822,7.4471145411717705,16.291026199960168,1.841693657028589e-36,4.919707168201336e-35,72.17725307723781
OBFC2B,ILMN_1704672,"Homo sapiens oligonucleotide/oligosaccharide-binding fold containing 2B (OBFC2B), mRNA.",,,nucleic acid binding [goid 3676] [evidence IEA],12,54909410-54909459,12q13.2c,+,NM_024068.2,79035,OBFC2B,1.100557956087334,8.715828607743322,16.2871242441198,1.887940524209627e-36,5.036521867784829e-35,72.15249870834646
C17orf53,ILMN_1776490,"Homo sapiens chromosome 17 open reading frame 53 (C17orf53), mRNA.",,,,17,39595293-39595342,17q21.31c,+,NM_024032.2,78995,C17orf53,1.9233800646845758,6.884626717848199,16.28188330042214,1.9518942507189678e-36,5.193284596859721e-35,72.11924755497378
LRRK2,ILMN_1776649,"PREDICTED: Homo sapiens leucine-rich repeat kinase 2, transcript variant 2 (LRRK2), mRNA.",,,,12,39045111-39045119:39047075-39047115,12q12c,+,XM_930820.1,120892,LRRK2,-1.7579066028099382,6.44523686531212,-16.27932973490647,1.9838368847558482e-36,5.271262734421648e-35,72.10304558470102
ZNF408,ILMN_1739618,"Homo sapiens zinc finger protein 408 (ZNF408), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],11,46683788-46683837,11p11.2b,+,NM_024741.1,79797,ZNF408,1.1449372020396984,6.911753310692493,16.2744618744587,2.046187633782427e-36,5.429724426620531e-35,72.07215818109037
ROBO4,ILMN_1665449,"Homo sapiens roundabout homolog 4, magic roundabout (Drosophila) (ROBO4), mRNA.",integral to membrane [goid 16021] [pmid 14527427] [evidence TAS],angiogenesis [goid 1525] [pmid 15849270] [evidence IGI]; cell differentiation [goid 30154] [evidence IEA]; regulation of cell migration [goid 30334] [pmid 15894287] [evidence NAS],receptor activity [goid 4872] [pmid 14527427] [evidence TAS],11,124259599-124259648,11q24.2a,-,NM_019055.4,54538,ROBO4,-1.7285059907948002,6.634449466350968,-16.273381378296712,2.0602915540930736e-36,5.459909061495923e-35,72.065301964919
CASP1,ILMN_2326509,"Homo sapiens caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) (CASP1), transcript variant delta, mRNA.",intracellular [goid 5622] [evidence IEA]; intracellular [goid 5622] [evidence IEA],positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IEP]; regulation of apoptosis [goid 42981] [evidence IEA]; signal transduction [goid 7165] [pmid 1373520] [evidence TAS]; positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IEP]; regulation of apoptosis [goid 42981] [evidence IEA]; signal transduction [goid 7165] [pmid 1373520] [evidence TAS],cysteine-type peptidase activity [goid 8234] [evidence IEA]; caspase activity [goid 30693] [pmid 10353249] [evidence TAS]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IEP]; caspase activator activity [goid 8656] [pmid 10799503] [evidence TAS]; protein binding [goid 5515] [pmid 12888622] [evidence IPI]; cysteine-type peptidase activity [goid 8234] [evidence IEA]; caspase activity [goid 30693] [pmid 10353249] [evidence TAS]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IEP]; caspase activator activity [goid 8656] [pmid 10799503] [evidence TAS]; protein binding [goid 5515] [pmid 12888622] [evidence IPI],11,104402250-104402293:104402779-104402784,11q22.3b,-,NM_033294.2,834,CASP1,-1.4863654737079166,9.823671239792615,-16.265675219899155,2.163747270957251e-36,5.726488809168344e-35,72.0164000624645
SFTPA2,ILMN_2205012,"Homo sapiens surfactant, pulmonary-associated protein A2 (SFTPA2), mRNA.",cytoplasm [goid 5737] [evidence IEA],regulation of liquid surface tension [goid 50828] [evidence IEA]; respiratory gaseous exchange [goid 7585] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],10,81306454-81306503,10q22.3f,-,NM_006926.1,6436,SFTPA2,-4.385482829056592,10.855428535948692,-16.255361683823274,2.3104009006401945e-36,6.106539130780584e-35,71.95094401233452
ABCB9,ILMN_2343047,"Homo sapiens ATP-binding cassette, sub-family B (MDR/TAP), member 9 (ABCB9), transcript variant 2, mRNA.",lysosome [goid 5764] [evidence IEA]; integral to membrane [goid 16021] [pmid 10748049] [evidence NAS]; ATP-binding cassette (ABC) transporter complex [goid 43190] [pmid 10748049] [evidence NAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; lysosome [goid 5764] [evidence IEA]; integral to membrane [goid 16021] [pmid 10748049] [evidence NAS]; ATP-binding cassette (ABC) transporter complex [goid 43190] [pmid 10748049] [evidence NAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],oligopeptide transport [goid 6857] [evidence IEA]; transport [goid 6810] [evidence IEA]; protein transport [goid 15031] [evidence IEA]; spermatogenesis [goid 7283] [pmid 10748049] [evidence TAS]; oligopeptide transport [goid 6857] [evidence IEA]; transport [goid 6810] [evidence IEA]; protein transport [goid 15031] [evidence IEA]; spermatogenesis [goid 7283] [pmid 10748049] [evidence TAS],"ATPase activity, coupled to transmembrane movement of substances [goid 42626] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; transporter activity [goid 5215] [pmid 10748049] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 10748049] [evidence NAS]; oligopeptide transporter activity [goid 15198] [evidence IEA]; ATPase activity, coupled to transmembrane movement of substances [goid 42626] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; transporter activity [goid 5215] [pmid 10748049] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 10748049] [evidence NAS]; oligopeptide transporter activity [goid 15198] [evidence IEA]",12,121979605-121979654,12q24.31d,-,NM_019624.2,23457,ABCB9,1.6763994208044615,7.891833698738187,16.254647684166002,2.3209148456541554e-36,6.12623538678738e-35,71.94641218408279
TARSL1,ILMN_1778187,"Homo sapiens threonyl-tRNA synthetase 2, mitochondrial (putative) (TARS2), mRNA.",,threonyl-tRNA aminoacylation [goid 6435] [evidence IEA]; protein biosynthesis [goid 6412] [evidence IEA]; electron transport [goid 6118] [evidence IEA],ligase activity [goid 16874] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; electron carrier activity [goid 9055] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; threonine-tRNA ligase activity [goid 4829] [evidence IEA],1,148746173-148746222,1q21.2b,+,NM_025150.3,80222,TARSL1,1.0583416866194009,7.063013296398884,16.25185156453917,2.3625525271821058e-36,6.227925028176492e-35,71.92866449724534
NDRG2,ILMN_1670535,"Homo sapiens NDRG family member 2 (NDRG2), transcript variant 1, mRNA.",cytosol [goid 5829] [pmid 11936845] [evidence NAS],cell differentiation [goid 30154] [pmid 11978393] [evidence ISS],,14,20555000-20555049,14q11.2c,-,NM_201535.1,57447,NDRG2,-1.4780026111344213,7.735917231888233,-16.250657457309746,2.3805616138902802e-36,6.267141680357464e-35,71.92108498344273
JM11,ILMN_1714710,"Homo sapiens coiled-coil domain containing 120 (CCDC120), mRNA.",,,,X,48814301-48814350,Xp11.23c,+,NM_033626.2,90060,JM11,1.0605638781384457,8.046301061975525,16.24923582850778,2.4021815867847473e-36,6.315748907804104e-35,71.91206112850388
CG018,ILMN_1799487,"Homo sapiens hypothetical gene CG018 (CG018), mRNA.",,,,13,31874187-31874236,13q13.1a,-,NM_052818.1,90634,CG018,-1.470669034568611,7.682838617438755,-16.244578845949263,2.4743921891584184e-36,6.49706547515507e-35,71.88249947067968
GSTA4,ILMN_1771964,"Homo sapiens glutathione S-transferase A4 (GSTA4), mRNA.",,metabolism [goid 8152] [evidence IEA]; response to stress [goid 6950] [evidence NR ],transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 11851347] [evidence IDA],6,52950929-52950978,6p12.1d,-,NM_001512.2,2941,GSTA4,-1.622878870675967,9.112063907468205,-16.240311088530774,2.54247636673732e-36,6.667086126563604e-35,71.85540686821895
RPL15,ILMN_1762747,"Homo sapiens ribosomal protein L15 (RPL15), mRNA.",ribosome [goid 5840] [evidence IEA]; intracellular [goid 5622] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA],structural constituent of ribosome [goid 3735] [evidence IEA],3,23936823-23936872,3p24.2b,+,NM_002948.2,6138,RPL15,-1.0103095520581498,12.536461938587449,-16.2378170583568,2.583129944964263e-36,6.764825122885468e-35,71.83957351101557
PGM2L1,ILMN_1716265,"Homo sapiens phosphoglucomutase 2-like 1 (PGM2L1), mRNA.",,carbohydrate metabolism [goid 5975] [evidence IEA]; glucose metabolism [goid 6006] [evidence IEA],phosphoglucomutase activity [goid 4614] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA],11,73719291-73719340,11q13.4c,-,NM_173582.3,283209,PGM2L1,1.5450594547907537,7.41799832383743,16.237242982960364,2.5925794394882255e-36,6.7806966568994e-35,71.83592891454379
TSTA3,ILMN_1697777,"Homo sapiens tissue specific transplantation antigen P35B (TSTA3), mRNA.",cytoplasm [goid 5737] [pmid 11698403] [evidence IC ],leukocyte adhesion [goid 7159] [pmid 11698403] [evidence NAS]; 'de novo' GDP-L-fucose biosynthesis [goid 42351] [pmid 11698403] [evidence TAS]; nucleotide-sugar metabolism [goid 9225] [pmid 9525924] [evidence TAS]; protein amino acid glycosylation [goid 6486] [evidence NR ],isomerase activity [goid 16853] [evidence IEA]; electron carrier activity [goid 9055] [pmid 8910301] [evidence TAS]; GDP-L-fucose synthase activity [goid 50577] [evidence IEA]; GDP-4-dehydro-D-rhamnose reductase activity [goid 42356] [pmid 11698403] [evidence TAS],8,144766164-144766213,8q24.3g,-,NM_003313.2,7264,TSTA3,1.4641514383604113,8.655624449147961,16.22814721312321,2.747007255763111e-36,7.175211641424063e-35,71.77817931436482
DENR,ILMN_1760954,"Homo sapiens density-regulated protein (DENR), mRNA.",cellular component unknown [goid 8372] [evidence ND ],translational initiation [goid 6413] [evidence IEA],translation initiation factor activity [goid 3743] [evidence IEA],12,121821401-121821450,12q24.31d,+,NM_003677.3,8562,DENR,1.5482764707846677,10.021635075711513,16.221123708930836,2.872532394004399e-36,7.493302234581488e-35,71.73358169688687
CDH1,ILMN_1770940,"Homo sapiens cadherin 1, type 1, E-cadherin (epithelial) (CDH1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 8033105] [evidence NAS],homophilic cell adhesion [goid 7156] [pmid 8033105] [evidence NAS]; cell adhesion [goid 7155] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],16,67426402-67426451,16q22.1d,+,NM_004360.2,999,CDH1,1.3057378944341256,11.720943493507527,16.220917381792784,2.876305565964853e-36,7.493375229664685e-35,71.73227150229476
RASAL1,ILMN_1793517,"Homo sapiens RAS protein activator like 1 (GAP1 like) (RASAL1), mRNA.",intracellular [goid 5622] [evidence IEA],regulation of small GTPase mediated signal transduction [goid 51056] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; Ras GTPase activator activity [goid 5099] [pmid 9751798] [evidence TAS]; phospholipid binding [goid 5543] [pmid 9751798] [evidence TAS],12,112021796-112021845,12q24.13b,-,NM_004658.1,8437,RASAL1,1.3851519570622228,5.870854301798993,16.212710418817714,3.03048667739177e-36,7.884782502113723e-35,71.68015358235486
MCM8,ILMN_1798581,"Homo sapiens minichromosome maintenance complex component 8 (MCM8), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"DNA replication initiation [goid 6270] [evidence IEA]; transcription [goid 6350] [evidence IEA]; DNA replication [goid 6260] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; DNA replication initiation [goid 6270] [evidence IEA]; transcription [goid 6350] [evidence IEA]; DNA replication [goid 6260] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]",DNA-dependent ATPase activity [goid 8094] [evidence IEA]; nucleoside-triphosphatase activity [goid 17111] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; DNA-dependent ATPase activity [goid 8094] [evidence IEA]; nucleoside-triphosphatase activity [goid 17111] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],20,5923495-5923544,20p12.3c,+,NM_032485.4,84515,MCM8,1.3305519944678519,9.364597533465876,16.195459068559828,3.382123666649897e-36,8.788250691211835e-35,71.57058055297136
KIAA1698,ILMN_1796968,"Homo sapiens integrator complex subunit 5 (INTS5), mRNA.",,,protein binding [goid 5515] [pmid 16239144] [evidence IPI],11,62171080-62171129,11q12.3a,-,NM_030628.1,80789,KIAA1698,1.1338304214016333,8.904924130743067,16.170778325801898,3.957480758008942e-36,1.0256641840186905e-34,71.413774251789
LOC650128,ILMN_1660323,"PREDICTED: Homo sapiens similar to CG1486-PA, isoform A, transcript variant 2 (LOC650128), mRNA.",,,,,,,,XM_945831.1,650128,LOC650128,1.5288902438717162,6.444341856469654,16.168353521125287,4.019049743731459e-36,1.0402735740307766e-34,71.39836567911857
LRRC8C,ILMN_2094396,"Homo sapiens leucine rich repeat containing 8 family, member C (LRRC8C), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,transferase activity [goid 16740] [evidence IEA],1,89952665-89952714,1p22.2c,+,NM_032270.2,84230,LRRC8C,-1.3439575128127945,5.905858539650542,-16.165795811476297,4.085033997209414e-36,1.0559865661003353e-34,71.38211200176585
ASPA,ILMN_1692824,"Homo sapiens aspartoacylase (Canavan disease) (ASPA), mRNA.",,metabolism [goid 8152] [evidence IEA]; aspartate catabolism [goid 6533] [pmid 8252036] [evidence TAS],"hydrolase activity, acting on ester bonds [goid 16788] [evidence IEA]; aspartoacylase activity [goid 19807] [evidence IEA]; aminoacylase activity [goid 4046] [pmid 8252036] [evidence TAS]",17,3348980-3349029,17p13.3a,+,NM_000049.2,443,ASPA,-1.0303860478998956,5.305879900098705,-16.155466198316294,4.362751781780194e-36,1.1248703305394088e-34,71.31646384422606
AHDC1,ILMN_1680111,"Homo sapiens AT hook, DNA binding motif, containing 1 (AHDC1), mRNA.",,,,1,27733961-27734010,1p36.11a-p35.3b,-,NM_001029882.1,27245,AHDC1,1.7729521679243234,6.941827719400506,16.150676986173405,4.497857083433197e-36,1.1582126708536858e-34,71.28602366601363
CCND2,ILMN_1667081,"Homo sapiens cyclin D2 (CCND2), mRNA.",nucleus [goid 5634] [evidence IEA],cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],protein binding [goid 5515] [pmid 11896535] [evidence IPI],12,4284268-4284317,12p13.32a,+,NM_001759.2,894,CCND2,-1.6065276623203921,10.435212101574722,-16.138093198173777,4.873172604384828e-36,1.2516359110209453e-34,71.2060318242705
LOC441193,ILMN_1788439,"Homo sapiens similar to zinc finger protein 469 (LOC441193), mRNA.",,,,7,5426395-5426444,7p22.1c,-,NM_001013722.1,441193,LOC441193,1.9668816896764465,6.31490532627818,16.13652615157347,4.922056432902664e-36,1.2625705783271346e-34,71.19606956472926
RETN,ILMN_1675190,"Homo sapiens resistin (RETN), mRNA.",extracellular region [goid 5576] [evidence NAS],,hormone activity [goid 5179] [evidence NAS],19,7640707-7640756,19p13.2e,+,NM_020415.2,56729,RETN,-3.136873613024271,7.189038930802679,-16.135496335141838,4.954448718058631e-36,1.2692523681295403e-34,71.18952254890785
CNFN,ILMN_1803838,"Homo sapiens cornifelin (CNFN), mRNA.",cornified envelope [goid 1533] [pmid 15147942] [evidence IDA],,,19,47583079-47583128,19q13.2c,-,NM_032488.2,84518,CNFN,2.010326232577638,7.398760954343205,16.126574369474667,5.244179772259974e-36,1.3417589371275903e-34,71.13279769988719
CD163,ILMN_1722622,"Homo sapiens CD163 molecule (CD163), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],inflammatory response [goid 6954] [evidence IEA]; acute-phase response [goid 6953] [evidence IEA]; inflammatory response [goid 6954] [evidence IEA]; acute-phase response [goid 6953] [evidence IEA],scavenger receptor activity [goid 5044] [evidence IEA]; scavenger receptor activity [goid 5044] [evidence IEA],12,7526586-7526625:7526829-7526838,12p13.31c,-,NM_203416.1,9332,CD163,-2.0248923063658246,9.336016832623145,-16.11551984905461,5.62682747492289e-36,1.437823296529466e-34,71.06250482770281
SOX4,ILMN_1815745,"Homo sapiens SRY (sex determining region Y)-box 4 (SOX4), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",transcription factor activity [goid 3700] [pmid 8268656] [evidence TAS],6,21706556-21706605,6p22.3b,+,NM_003107.2,6659,SOX4,1.4799838928972378,9.713366090259859,16.11364699210462,5.6943733950985955e-36,1.4532273327695497e-34,71.05059477068588
GFRA2,ILMN_1656300,"Homo sapiens GDNF family receptor alpha 2 (GFRA2), mRNA.",membrane [goid 16020] [evidence IEA]; extrinsic to membrane [goid 19898] [pmid 10829012] [evidence TAS],transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 9192898] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; glial cell line-derived neurotrophic factor receptor activity [goid 16167] [pmid 10829012] [evidence TAS]; GPI anchor binding [goid 48503] [evidence IEA],8,,8p21.3b,-,NM_001495.4,2675,GFRA2,-1.3090335207578168,7.978240938872665,-16.11161095826257,5.768726605391455e-36,1.470327158225124e-34,71.03764668218955
MST1R,ILMN_1688154,"Homo sapiens macrophage stimulating 1 receptor (c-met-related tyrosine kinase) (MST1R), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7939629] [evidence TAS],defense response [goid 6952] [pmid 9045873] [evidence TAS]; development [goid 7275] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 10871856] [evidence TAS]; fertilization (sensu Metazoa) [goid 7338] [pmid 9045873] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; cell motility [goid 6928] [pmid 9045873] [evidence TAS]; signal transduction [goid 7165] [pmid 7939629] [evidence TAS],macrophage colony stimulating factor receptor activity [goid 5011] [pmid 9045873] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],3,49899719-49899743:49899744-49899768,3p21.31c,-,NM_002447.1,4486,MST1R,1.5666680830866229,7.8480426879257585,16.105791842209292,5.986640762510226e-36,1.5239275874847913e-34,71.00063825361997
SH3BGRL,ILMN_1702835,"Homo sapiens SH3 domain binding glutamic acid-rich protein like (SH3BGRL), mRNA.",nucleus [goid 5634] [pmid 16130169] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS]; nucleus [goid 5634] [pmid 16130169] [evidence TAS]; cytoplasm [goid 5737] [pmid 16130169] [evidence TAS],,SH3/SH2 adaptor activity [goid 5070] [pmid 9642120] [evidence TAS]; SH3/SH2 adaptor activity [goid 5070] [pmid 9642120] [evidence TAS],X,80440189-80440238,Xq21.1c,+,NM_003022.1,6451,SH3BGRL,-1.3196327411876325,10.437733083564133,-16.10337940738114,6.079382988911898e-36,1.5455691847795332e-34,70.98529479530963
DCBLD1,ILMN_1695604,"Homo sapiens discoidin, CUB and LCCL domain containing 1 (DCBLD1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],,6,117971011-117971060,6q22.2b,+,NM_173674.1,285761,DCBLD1,1.4432237968891801,7.913060291465365,16.098182398674854,6.284094933339445e-36,1.595585931805274e-34,70.95223932688003
EGR2,ILMN_1743199,"Homo sapiens early growth response 2 (Krox-20 homolog, Drosophila) (EGR2), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"mechanosensory behavior [goid 7638] [evidence IEA]; peripheral nervous system development [goid 7422] [pmid 9537424] [evidence TAS]; transcription [goid 6350] [evidence IEA]; brain development [goid 7420] [pmid 9537424] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [pmid 14532282] [evidence IDA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 14532282] [evidence IPI],10,64242090-64242139,10q21.2b,-,NM_000399.2,1959,EGR2,-2.2614795183284295,8.975245266711367,-16.08660779565732,6.765193756126752e-36,1.713392362944102e-34,70.87861101435593
DMN,ILMN_1712075,"Homo sapiens desmuslin (DMN), transcript variant B, mRNA.",intermediate filament [goid 5882] [pmid 11353857] [evidence NAS],,structural constituent of muscle [goid 8307] [pmid 11353857] [evidence NAS]; protein binding [goid 5515] [pmid 11353857] [evidence IPI],15,97493060-97493109,15q26.3b,+,NM_015286.4,23336,DMN,-1.5997060753034562,7.802358501979002,-16.085042725195606,6.833018638698162e-36,1.7283822619857501e-34,70.86865441862206
JAZF1,ILMN_1682727,"Homo sapiens juxtaposed with another zinc finger gene 1 (JAZF1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],7,27837063-27837112,7p15.2a-p15.1d,-,NM_175061.2,221895,JAZF1,-1.392420170844452,7.5356176521275025,-16.0663934288013,7.695625246380502e-36,1.9441170445654176e-34,70.74999611883433
MORC2,ILMN_2103591,"Homo sapiens MORC family CW-type zinc finger 2 (MORC2), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],22,29654119-29654168,22q12.2c,-,NM_014941.1,22880,MORC2,1.0997732771545499,8.048296089388192,16.063575964550278,7.835113677773813e-36,1.9743697035881414e-34,70.7320671090154
MPP1,ILMN_1733675,"Homo sapiens membrane protein, palmitoylated 1, 55kDa (MPP1), mRNA.",membrane fraction [goid 5624] [pmid 1713685] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 1713685] [evidence TAS]; membrane [goid 16020] [evidence IEA]; intracellular [goid 5622] [pmid 11256614] [evidence IDA],signal transduction [goid 7165] [pmid 1713685] [evidence TAS],guanylate kinase activity [goid 4385] [pmid 1310897] [evidence TAS]; protein binding [goid 5515] [evidence IEA],X,153660447-153660496,Xq28g,-,NM_002436.2,4354,MPP1,-1.415988411799579,8.651542070857502,-16.060863554172574,7.971794326974579e-36,2.0062850426931745e-34,70.71480597643071
UNC5CL,ILMN_1745491,"Homo sapiens unc-5 homolog C (C. elegans)-like (UNC5CL), mRNA.",,signal transduction [goid 7165] [evidence IEA],protein binding [goid 5515] [evidence IEA],6,41102842-41102891,6p21.1h,-,NM_173561.1,222643,UNC5CL,1.483934840165423,5.549696899684297,16.045589526716366,8.787304218679124e-36,2.2087485277303006e-34,70.61759407847816
SLC5A6,ILMN_1741054,"Homo sapiens solute carrier family 5 (sodium-dependent vitamin transporter), member 6 (SLC5A6), mRNA.",membrane fraction [goid 5624] [pmid 9516450] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9516450] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA],symporter activity [goid 15293] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA]; transporter activity [goid 5215] [evidence IEA]; sodium-dependent multivitamin transporter activity [goid 8523] [pmid 9516450] [evidence TAS],2,27276165-27276214,2p23.3a,-,NM_021095.1,8884,SLC5A6,1.1127144348007114,8.654872588369972,16.04228368800796,8.97453442210452e-36,2.2501564500935745e-34,70.5965513956327
PTK6,ILMN_1764508,"Homo sapiens PTK6 protein tyrosine kinase 6 (PTK6), mRNA.",nucleus [goid 5634] [evidence IEA],protein amino acid phosphorylation [goid 6468] [pmid 8036022] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; non-membrane spanning protein tyrosine kinase activity [goid 4715] [pmid 8036022] [evidence TAS],20,61630757-61630806,20q13.33e,-,NM_005975.2,5753,PTK6,1.7213987698652806,7.106338034941072,16.031545449707703,9.610737227711408e-36,2.4036453806506234e-34,70.52819283489032
EFCBP1,ILMN_1695941,"Homo sapiens EF-hand calcium binding protein 1 (EFCBP1), mRNA.",cytoplasm [goid 5737] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],antibiotic biosynthesis [goid 17000] [evidence IEA]; antibiotic biosynthesis [goid 17000] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA],8,92038407-92038456,8q21.3e,+,NM_022351.2,64168,EFCBP1,-1.6495576921603892,5.715229555864695,-16.028294104792298,9.812139848066851e-36,2.4509524853947757e-34,70.50749317873918
SNRK,ILMN_1794399,"Homo sapiens SNF related kinase (SNRK), mRNA.",nucleus [goid 5634] [evidence ISS]; nucleus [goid 5634] [evidence ISS],protein amino acid phosphorylation [goid 6468] [pmid 12234663] [evidence IDA]; protein amino acid phosphorylation [goid 6468] [pmid 12234663] [evidence IDA],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 12234663] [evidence IDA]; magnesium ion binding [goid 287] [pmid 12234663] [evidence IDA]; protein serine/threonine kinase activity [goid 4674] [pmid 12234663] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 12234663] [evidence IDA]; magnesium ion binding [goid 287] [pmid 12234663] [evidence IDA]; protein serine/threonine kinase activity [goid 4674] [pmid 12234663] [evidence IDA],3,43367082-43367131,3p22.1a,+,NM_017719.3,54861,SNRK,-1.110231204050498,9.606570884230234,-16.022968909399513,1.0151183518820538e-35,2.5302329075118163e-34,70.4735884515079
SETD1A,ILMN_1714327,"Homo sapiens SET domain containing 1A (SETD1A), mRNA.",nucleus [goid 5634] [evidence IEA],chromatin modification [goid 16568] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; histone-lysine N-methyltransferase activity [goid 18024] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; methyltransferase activity [goid 8168] [evidence IEA]; protein binding [goid 5515] [pmid 12670868] [evidence IPI],16,30903280-30903329,16p11.2c,+,NM_014712.1,9739,SETD1A,1.0309655100877677,9.067148579519952,16.02291271493933,1.015482319438219e-35,2.5302329075118163e-34,70.47323065701774
PKMYT1,ILMN_1766658,"Homo sapiens protein kinase, membrane associated tyrosine/threonine 1 (PKMYT1), transcript variant 2, mRNA.",membrane fraction [goid 5624] [pmid 9001210] [evidence TAS]; Golgi apparatus [goid 5794] [pmid 9001210] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 9001210] [evidence TAS],regulation of mitosis [goid 7088] [pmid 9001210] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; protein binding [goid 5515] [pmid 10373560] [evidence IPI],16,2964384-2964419:2964552-2964565,16p13.3d,-,NM_182687.1,9088,PKMYT1,1.089668257574897,5.51821022940863,16.007195869022173,1.1225884165481619e-35,2.7901551600367234e-34,70.37314986848627
LASS6,ILMN_1767662,"Homo sapiens LAG1 homolog, ceramide synthase 6 (LASS6), mRNA.",nucleus [goid 5634] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],2,169339205-169339254,2q24.3f,+,NM_203463.1,253782,LASS6,1.1353049896335303,10.603758240263273,16.006475235222897,1.127762126512903e-35,2.7995365542518814e-34,70.36856056294582
CD37,ILMN_1786176,"Homo sapiens CD37 antigen (CD37), mRNA.",plasma membrane [goid 5886] [pmid 8436422] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 2466944] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 2466944] [evidence TAS]; plasma membrane [goid 5886] [pmid 8436422] [evidence TAS],,,19,54533817-54533866,19q13.33a,+,NM_001774.1,951,CD37,-1.8749743603454787,8.711709823489075,-16.00433769343213,1.1432493485106427e-35,2.8344650514251475e-34,70.35494752283164
ICAM2,ILMN_1786823,"Homo sapiens intercellular adhesion molecule 2 (ICAM2), mRNA.",integral to plasma membrane [goid 5887] [pmid 2497351] [evidence TAS]; plasma membrane [goid 5886] [pmid 2497351] [evidence TAS],cell-cell adhesion [goid 16337] [evidence IEA],protein binding [goid 5515] [evidence IEA]; integrin binding [goid 5178] [pmid 2497351] [evidence TAS],17,59433952-59434001,17q23.3b,-,NM_000873.2,3384,ICAM2,-1.4081840717179048,10.651168446364586,-16.003552798580376,1.1489895245897876e-35,2.845171090098078e-34,70.34994878526658
PDE2A,ILMN_1681356,"Homo sapiens phosphodiesterase 2A, cGMP-stimulated (PDE2A), mRNA.",membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [evidence IEA],"hydrolase activity [goid 16787] [evidence IEA]; 3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [evidence IEA]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [goid 4118] [pmid 9210593] [evidence TAS]; catalytic activity [goid 3824] [evidence IEA]",11,71965053-71965102,11q13.4a,-,NM_002599.1,5138,PDE2A,-1.5582992416051793,6.410465429258908,-15.987454832751379,1.273303365456685e-35,3.1491042937030104e-34,70.24741476022781
COMT,ILMN_1730084,"Homo sapiens catechol-O-methyltransferase (COMT), transcript variant MB-COMT, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; soluble fraction [goid 5625] [pmid 1707278] [evidence TAS]; microsome [goid 5792] [pmid 1707278] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; soluble fraction [goid 5625] [pmid 1707278] [evidence TAS]; microsome [goid 5792] [pmid 1707278] [evidence TAS],catecholamine metabolism [goid 6584] [evidence IEA]; neurotransmitter catabolism [goid 42135] [evidence IEA]; catecholamine metabolism [goid 6584] [evidence IEA]; neurotransmitter catabolism [goid 42135] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; catechol O-methyltransferase activity [goid 16206] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein binding [goid 5515] [pmid 15231747] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; catechol O-methyltransferase activity [goid 16206] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],22,18336317-18336366,22q11.21c,+,NM_000754.2,1312,COMT,-1.3418381214240966,9.758661500374865,-15.974805211471406,1.3803755045587986e-35,3.4096979129891904e-34,70.16682936678333
ZNF669,ILMN_1770172,"Homo sapiens zinc finger protein 669 (ZNF669), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],1,245330375-245330424,1q44d,-,NM_024804.1,79862,ZNF669,1.511956763391657,7.747814665714195,15.965920842790968,1.4609274576840054e-35,3.604221525689467e-34,70.1102228435524
COL11A1,ILMN_1731446,"Homo sapiens collagen, type XI, alpha 1 (COL11A1), transcript variant A, mRNA.",cytoplasm [goid 5737] [evidence IEA]; collagen [goid 5581] [evidence IEA]; collagen type XI [goid 5592] [pmid 3182841] [evidence TAS],cartilage condensation [goid 1502] [pmid 3182841] [evidence TAS]; visual perception [goid 7601] [pmid 8872475] [evidence TAS]; extracellular matrix organization and biogenesis [goid 30198] [pmid 10486316] [evidence NAS]; cell adhesion [goid 7155] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA]; cell-cell adhesion [goid 16337] [pmid 10486316] [evidence NAS],"protein binding, bridging [goid 30674] [pmid 10486316] [evidence NAS]; extracellular matrix structural constituent [goid 5201] [pmid 10486316] [evidence NAS]",1,103264392-103264441,1p21.1d-p21.1c,-,NM_001854.2,1301,COL11A1,1.1448133347332865,5.500573500655742,15.960730268385676,1.510151654806774e-35,3.7210731908095977e-34,70.07714819899525
WFDC3,ILMN_1740415,"Homo sapiens WAP four-disulfide core domain 3 (WFDC3), transcript variant 4, mRNA.",,,serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA],20,43837497-43837546,20q13.12b,-,NM_181530.1,140686,WFDC3,2.9777155355310185,7.139127492847625,15.954618541585269,1.570246442864791e-35,3.864390015847323e-34,70.03820105171314
PSAT1,ILMN_1692938,"Homo sapiens phosphoserine aminotransferase 1 (PSAT1), transcript variant 2, mRNA.",,metabolism [goid 8152] [evidence IEA]; amino acid biosynthesis [goid 8652] [evidence IEA]; L-serine biosynthesis [goid 6564] [pmid 10637769] [evidence NAS]; pyridoxine biosynthesis [goid 8615] [pmid 10637769] [evidence NAS],transferase activity [goid 16740] [evidence IEA]; phosphoserine transaminase activity [goid 4648] [pmid 10637769] [evidence NAS],9,80134501-80134550,9q21.2c,+,NM_021154.3,29968,PSAT1,2.089251744423324,7.0292271423034824,15.950278028916381,1.6143752441056842e-35,3.9681105508681244e-34,70.01053913527737
ALDH2,ILMN_1793859,"Homo sapiens aldehyde dehydrogenase 2 family (mitochondrial) (ALDH2), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [evidence IEA],metabolism [goid 8152] [evidence IEA]; carbohydrate metabolism [goid 5975] [pmid 8903321] [evidence TAS]; alcohol metabolism [goid 6066] [pmid 1306115] [evidence TAS],electron carrier activity [goid 9055] [pmid 8903321] [evidence TAS]; aldehyde dehydrogenase (NAD) activity [goid 4029] [pmid 1306115] [evidence TAS]; aldehyde dehydrogenase [NAD(P)+] activity [goid 4030] [pmid 8903321] [evidence TAS],12,110731770-110731819,12q24.12b,+,NM_000690.2,217,ALDH2,-1.32497460688616,11.628409227752346,-15.945582979922829,1.6635087858386e-35,4.083863041356897e-34,69.98061601681937
TSC22D3,ILMN_1695382,"Homo sapiens TSC22 domain family, member 3 (TSC22D3), transcript variant 3, mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [pmid 8982256] [evidence TAS]",transcription factor activity [goid 3700] [pmid 8982256] [evidence TAS],X,106846216-106846265,Xq22.3b,-,NM_001015881.1,1831,TSC22D3,-1.1924969029987889,8.095217058578754,-15.939377607696457,1.7307544910954609e-35,4.243742139440929e-34,69.94106430620774
GATA2,ILMN_2102670,"Homo sapiens GATA binding protein 2 (GATA2), mRNA.",nucleus [goid 5634] [pmid 1370462] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; positive regulation of phagocytosis [goid 50766] [evidence ISS]; transcription [goid 6350] [evidence IEA]; phagocytosis [goid 6909] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 1370462] [evidence TAS]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 8078582] [evidence TAS],3,129681589-129681638,3q21.3c,-,NM_032638.3,2624,GATA2,-2.0848161114047885,7.2026896823215845,-15.931558745108864,1.8193773684470594e-35,4.444701146262364e-34,69.89122402669953
GLIPR1,ILMN_1769245,"Homo sapiens GLI pathogenesis-related 1 (glioma) (GLIPR1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],,,12,74175624-74175673,12q21.2a,+,NM_006851.1,11010,GLIPR1,-1.921414664785198,8.075476622394998,-15.921249948721353,1.9432106489080943e-35,4.74143398333575e-34,69.82550429930652
RAPGEF4,ILMN_1661802,"Homo sapiens Rap guanine nucleotide exchange factor (GEF) 4 (RAPGEF4), mRNA.",intracellular [goid 5622] [evidence IEA]; membrane fraction [goid 5624] [pmid 10777494] [evidence TAS]; cAMP-dependent protein kinase complex [goid 5952] [evidence IEA],exocytosis [goid 6887] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; regulation of small GTPase mediated signal transduction [goid 51056] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9856955] [evidence TAS],protein binding [goid 5515] [pmid 11438518] [evidence IPI]; guanyl-nucleotide exchange factor activity [goid 5085] [pmid 9856955] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; cAMP-dependent protein kinase regulator activity [goid 8603] [evidence IEA],2,173625165-173625214,2q31.1e,+,NM_007023.1,11069,RAPGEF4,-1.21129063711569,6.283843988656374,-15.908980169851434,2.1016571106363728e-35,5.121797255738434e-34,69.74727169659775
NIP,ILMN_1710622,"Homo sapiens dual oxidase maturation factor 1 (DUOXA1), mRNA.",,,,15,43197005-43197054,15q21.1a,-,NM_144565.2,90527,NIP,-2.249670216473322,7.774819344627174,-15.90396775915924,2.1700520495535582e-35,5.282043966845206e-34,69.71530880950552
MS4A6A,ILMN_1721035,"Homo sapiens membrane-spanning 4-domains, subfamily A, member 6A (MS4A6A), transcript variant 3, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],11,59697120-59697169,11q12.1d-q12.2a,-,NM_152851.1,64231,MS4A6A,-1.8087819228804864,10.044417224286862,-15.90257651036117,2.1894282020048183e-35,5.322731405311349e-34,69.7064367993662
SGCE,ILMN_1674620,"Homo sapiens sarcoglycan, epsilon (SGCE), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 9475163] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA]; sarcoglycan complex [goid 16012] [pmid 9475163] [evidence TAS],cell-matrix adhesion [goid 7160] [pmid 9405466] [evidence TAS]; muscle development [goid 7517] [pmid 9405466] [evidence TAS],protein binding [goid 5515] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],7,94066091-94066140,7q21.3b,-,NM_003919.1,8910,SGCE,-1.7324959106377147,9.938749994443816,-15.882138626438909,2.494890942110691e-35,6.057982763319261e-34,69.57608592168265
FRK,ILMN_1727605,"Homo sapiens fyn-related kinase (FRK), mRNA.",nucleus [goid 5634] [pmid 7696183] [evidence TAS]; intracellular [goid 5622] [pmid 7510261] [evidence TAS],negative regulation of cell proliferation [goid 8285] [pmid 7664264] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 7696183] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; non-membrane spanning protein tyrosine kinase activity [goid 4715] [pmid 7510261] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],6,116369422-116369471,6q22.1d,-,NM_002031.2,2444,FRK,1.3576028943843017,5.785687024588404,15.877422556379893,2.571237069004267e-35,6.235795306259075e-34,69.54600243320087
GSN,ILMN_1787518,"Homo sapiens gelsolin (amyloidosis, Finnish type) (GSN), transcript variant 1, mRNA.",actin cytoskeleton [goid 15629] [pmid 1321812] [evidence TAS]; cytosol [goid 5829] [pmid 3020431] [evidence IDA]; extracellular region [goid 5576] [pmid 14718574] [evidence NAS],actin filament polymerization [goid 30041] [pmid 3020431] [evidence IDA]; actin filament severing [goid 51014] [pmid 3020431] [evidence IDA]; barbed-end actin filament capping [goid 51016] [pmid 1321812] [evidence TAS],actin binding [goid 3779] [evidence IEA]; calcium ion binding [goid 5509] [pmid 1321812] [evidence TAS]; protein binding [goid 5515] [pmid 10793131] [evidence IPI],9,123101929-123101960:123101961-123101978,9q33.2a,+,NM_000177.3,2934,GSN,-1.5679347906700194,8.390498341289659,-15.874716382821829,2.616098542224322e-35,6.336912788477511e-34,69.5287391188432
FAM43A,ILMN_1706015,"Homo sapiens family with sequence similarity 43, member A (FAM43A), mRNA.",,,,3,195890991-195891040,3q29d,+,NM_153690.4,131583,FAM43A,-1.623476436917695,8.927155097667638,-15.868541715342136,2.7214172948778904e-35,6.584052870122954e-34,69.4893472385549
CPVL,ILMN_1682928,"Homo sapiens carboxypeptidase, vitellogenic-like (CPVL), transcript variant 1, mRNA.",,,serine carboxypeptidase activity [goid 4185] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],7,29036794-29036843,7p15.1c,-,NM_031311.2,54504,CPVL,-1.7333012586782601,10.035936980430092,-15.867978442720355,2.731233737464065e-35,6.59982181391075e-34,69.48575363278255
QDPR,ILMN_1672443,"Homo sapiens quinoid dihydropteridine reductase (QDPR), mRNA.",cytoplasm [goid 5737] [pmid 11256614] [evidence IDA],metabolism [goid 8152] [evidence IEA]; dihydrobiopterin metabolism [goid 51066] [pmid 3033643] [evidence TAS]; tetrahydrobiopterin biosynthesis [goid 6729] [evidence IEA]; L-phenylalanine catabolism [goid 6559] [evidence IEA]; amino acid metabolism [goid 6520] [pmid 3033643] [evidence TAS],"electron carrier activity [goid 9055] [pmid 3033643] [evidence TAS]; 6,7-dihydropteridine reductase activity [goid 4155] [pmid 3033643] [evidence TAS]",4,17097488-17097537,4p15.32b,-,NM_000320.1,5860,QDPR,-1.229007471059088,10.459717607617389,-15.86119517480235,2.852273162234399e-35,6.883990522314337e-34,69.4424752447611
EZH2,ILMN_1652913,"Homo sapiens enhancer of zeste homolog 2 (Drosophila) (EZH2), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],"establishment and/or maintenance of chromatin architecture [goid 6325] [pmid 8921387] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [pmid 8921387] [evidence TAS]; transcription [goid 6350] [evidence IEA]",DNA binding [goid 3677] [pmid 8954776] [evidence TAS],7,148160666-148160715,7q36.1a,-,NM_004456.3,2146,EZH2,1.1504135762989858,5.806024406024257,15.853150535041118,3.002807007160242e-35,7.238573807140015e-34,69.39114425230909
TACC3,ILMN_1724407,"Homo sapiens transforming, acidic coiled-coil containing protein 3 (TACC3), mRNA.",,,,4,1716348-1716357:1716473-1716512,4p16.3b,+,NM_006342.1,10460,TACC3,1.5113526256295522,7.4947546939622,15.849028314544784,3.083002302945098e-35,7.422949467788871e-34,69.36483928104792
MRPL2,ILMN_1763264,"Homo sapiens mitochondrial ribosomal protein L2 (MRPL2), nuclear gene encoding mitochondrial protein, mRNA.",intracellular [goid 5622] [evidence IEA]; ribosome [goid 5840] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA],structural constituent of ribosome [goid 3735] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],6,43130105-43130154,6p21.1d,-,NM_015950.3,51069,MRPL2,1.3575577580363491,8.299015267841984,15.846880892381437,3.1256257186857517e-35,7.516528771570255e-34,69.35113547148494
ZNF366,ILMN_1733535,"Homo sapiens zinc finger protein 366 (ZNF366), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],5,71775161-71775210,5q13.2c,-,NM_152625.1,167465,ZNF366,-1.1691556071340727,6.116672185449109,-15.83573964199831,3.356429061870188e-35,8.06187667105627e-34,69.28003141595107
STK39,ILMN_1791328,"Homo sapiens serine threonine kinase 39 (STE20/SPS1 homolog, yeast) (STK39), mRNA.",cytoplasm [goid 5737] [pmid 10980603] [evidence NAS]; nucleus [goid 5634] [pmid 10980603] [evidence NAS],response to stress [goid 6950] [pmid 10980603] [evidence NAS]; protein amino acid phosphorylation [goid 6468] [pmid 10980603] [evidence NAS],nucleotide binding [goid 166] [evidence IEA]; receptor signaling protein serine/threonine kinase activity [goid 4702] [pmid 10980603] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence NAS],2,168518970-168519019,2q24.3f,-,NM_013233.1,27347,STK39,1.3813052193915851,9.476284779325097,15.833228455693165,3.4107660381609727e-35,8.182566773564118e-34,69.26400350658642
LCP1,ILMN_1662932,"Homo sapiens lymphocyte cytosolic protein 1 (L-plastin) (LCP1), mRNA.",cytosol [goid 5829] [pmid 2111166] [evidence IDA]; cytoplasm [goid 5737] [pmid 2378651] [evidence NAS],,calcium ion binding [goid 5509] [pmid 2378651] [evidence NAS]; actin binding [goid 3779] [pmid 2252891] [evidence NAS]; protein binding [goid 5515] [pmid 16115810] [evidence IPI],13,45598252-45598301,13q14.12b,-,NM_002298.2,3936,LCP1,-1.3163507444988447,12.282505920221046,-15.826380195234869,3.563470149617403e-35,8.538671946532335e-34,69.2202911839684
ESPN,ILMN_1806710,"Homo sapiens espin (ESPN), mRNA.",actin cytoskeleton [goid 15629] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA],1,6443495-6443544,1p36.31a,+,NM_031475.1,83715,ESPN,2.133327332651736,6.298894672012797,15.813143965521393,3.878303319861051e-35,9.270859357679798e-34,69.13579387198828
EIF1B,ILMN_1679324,"Homo sapiens eukaryotic translation initiation factor 1B (EIF1B), mRNA.",,protein biosynthesis [goid 6412] [evidence IEA]; regulation of translational initiation [goid 6446] [pmid 7904817] [evidence TAS],translation initiation factor activity [goid 3743] [evidence IEA],3,40328048-40328066:40328465-40328495,3p22.1c,+,NM_005875.2,10289,EIF1B,-1.4480728314117783,9.667343884508961,-15.808099396460335,4.005498851192752e-35,9.563486994590046e-34,69.10358669850062
MCM10,ILMN_2413898,"Homo sapiens minichromosome maintenance complex component 10 (MCM10), transcript variant 2, mRNA.",,,protein binding [goid 5515] [pmid 15232106] [evidence IPI]; protein binding [goid 5515] [pmid 15232106] [evidence IPI],10,13293016-13293065,10p13e,+,NM_018518.3,55388,MCM10,1.0587685165595087,5.561421037936237,15.80390160144111,4.114524262787722e-35,9.812085989255869e-34,69.07678421901132
MGC24665,ILMN_1790537,"Homo sapiens chromosome 16 open reading frame 75 (C16orf75), mRNA.",,,nucleic acid binding [goid 3676] [evidence IEA],16,11352686-11352735,16p13.13c,+,NM_152308.1,116028,MGC24665,1.3605895190213388,8.332886642614923,15.79994730774626,4.2199439061540206e-35,1.0051504485039243e-33,69.0515351788465
DBNDD1,ILMN_2374352,"Homo sapiens dysbindin (dystrobrevin binding protein 1) domain containing 1 (DBNDD1), transcript variant 1, mRNA.",cytoplasm [goid 5737] [evidence IEA],,protein binding [goid 5515] [evidence IEA],,,16q24.3b,,NM_001042610.1,79007,DBNDD1,1.5301207032929156,9.015213002669205,15.796649807427013,4.3099203425146043e-35,1.0253613104997883e-33,69.03047895288023
CHPT1,ILMN_1729112,"Homo sapiens choline phosphotransferase 1 (CHPT1), mRNA.",membrane [goid 16020] [pmid 10893425] [evidence NAS]; microsome [goid 5792] [pmid 10893425] [evidence NAS]; membrane [goid 16020] [pmid 10893425] [evidence NAS]; microsome [goid 5792] [pmid 10893425] [evidence NAS],CDP-choline pathway [goid 6657] [pmid 10893425] [evidence NAS]; regulation of cell growth [goid 1558] [pmid 10893425] [evidence NAS]; platelet activating factor biosynthesis [goid 6663] [pmid 10893425] [evidence IDA]; CDP-choline pathway [goid 6657] [pmid 10893425] [evidence NAS]; regulation of cell growth [goid 1558] [pmid 10893425] [evidence NAS]; platelet activating factor biosynthesis [goid 6663] [pmid 10893425] [evidence IDA],transferase activity [goid 16740] [evidence IEA]; diacylglycerol cholinephosphotransferase activity [goid 4142] [pmid 10893425] [evidence IEP]; diacylglycerol binding [goid 19992] [pmid 10893425] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; diacylglycerol cholinephosphotransferase activity [goid 4142] [pmid 10893425] [evidence IEP]; diacylglycerol binding [goid 19992] [pmid 10893425] [evidence NAS],12,100638149-100638163:100641077-100641111,12q23.2a,+,NM_020244.2,56994,CHPT1,-1.801702880907417,8.6243396322231,-15.792507962112499,4.425664456548359e-35,1.050399696875677e-33,69.00402992048943
MLSTD1,ILMN_1694596,"Homo sapiens male sterility domain containing 1 (MLSTD1), mRNA.",,,,12,29366103-29366124:29376800-29376827,12p11.22a,+,NM_018099.3,55711,MLSTD1,-1.4027032343044414,6.356687988721551,-15.787705954041183,4.5637613192439856e-35,1.0818926122681714e-33,68.97336349961579
KCNJ8,ILMN_1735779,"Homo sapiens potassium inwardly-rectifying channel, subfamily J, member 8 (KCNJ8), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; voltage-gated potassium channel complex [goid 8076] [pmid 7890693] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 7890693] [evidence TAS],voltage-gated ion channel activity [goid 5244] [evidence IEA]; ATP-activated inward rectifier potassium channel activity [goid 15272] [evidence IEA]; potassium ion binding [goid 30955] [evidence IEA],12,21809316-21809365,12p12.1e,-,NM_004982.2,3764,KCNJ8,-1.4536517164855187,8.890678996265285,-15.786449364942506,4.6006058705078137e-35,1.08933635807243e-33,68.96533840916771
C1orf172,ILMN_1676322,"Homo sapiens chromosome 1 open reading frame 172 (C1orf172), mRNA.",,,,1,27148981-27149030,1p36.11a,-,NM_152365.1,126695,C1orf172,1.221932526692754,6.710367645004737,15.781766119148283,4.7405685112337893e-35,1.1211500564156696e-33,68.93542818241637
LYSMD2,ILMN_1724493,"Homo sapiens LysM, putative peptidoglycan-binding, domain containing 2 (LYSMD2), mRNA.",,cell wall catabolism [goid 16998] [evidence IEA],,15,49802846-49802895,15q21.2b,-,NM_153374.1,256586,LYSMD2,-1.1257679014031705,9.801065712183885,-15.772284311734099,5.03714052416711e-35,1.1898832067005375e-33,68.874865898847915
NAALADL1,ILMN_1770963,"Homo sapiens N-acetylated alpha-linked acidic dipeptidase-like 1 (NAALADL1), mRNA.",integral to membrane [goid 16021] [pmid 9388249] [evidence NAS],,metal ion binding [goid 46872] [evidence IEA]; glutamate carboxypeptidase II activity [goid 43275] [evidence IEA]; metallopeptidase activity [goid 8237] [evidence IEA]; carboxypeptidase activity [goid 4180] [evidence IEA]; dipeptidase activity [goid 16805] [evidence IEA],11,64568981-64569030,11q13.1c,-,NM_005468.2,10004,NAALADL1,-1.202583709399513,7.121550040050693,-15.770314287202503,5.101054101301639e-35,1.2035600289957923e-33,68.86228204355
NTNG1,ILMN_1727778,"Homo sapiens netrin G1 (NTNG1), mRNA.",membrane [goid 16020] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; anchored to plasma membrane [goid 46658] [evidence ISS]; membrane [goid 16020] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; anchored to plasma membrane [goid 46658] [evidence ISS],cell differentiation [goid 30154] [evidence IEA]; axonogenesis [goid 7409] [evidence ISS]; cell differentiation [goid 30154] [evidence IEA]; axonogenesis [goid 7409] [evidence ISS],GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [pmid 14595443] [evidence IPI]; GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [pmid 14595443] [evidence IPI],1,107825560-107825609,1p13.3d,+,NM_014917.2,22854,NTNG1,-2.1651101802481127,6.351853378112847,-15.762606371160388,5.359028846794525e-35,1.2629381527286791e-33,68.81304350122211
BTNL9,ILMN_1772976,"Homo sapiens butyrophilin-like 9 (BTNL9), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,5,180420676-180420725,5q35.3g,+,NM_152547.2,153579,BTNL9,-2.167744363087227,6.2623823656702,-15.736370946435306,6.33913351593688e-35,1.4886547345876186e-33,68.64541506880164
ALDH1A1,ILMN_1709348,"Homo sapiens aldehyde dehydrogenase 1 family, member A1 (ALDH1A1), mRNA.",cytoplasm [goid 5737] [pmid 2987944] [evidence TAS],metabolism [goid 8152] [evidence IEA]; aldehyde metabolism [goid 6081] [pmid 1709013] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; Ras GTPase activator activity [goid 5099] [pmid 1709013] [evidence TAS]; retinal dehydrogenase activity [goid 1758] [evidence IEA]; aldehyde dehydrogenase (NAD) activity [goid 4029] [pmid 1709013] [evidence TAS]; androgen binding [goid 5497] [pmid 1709013] [evidence TAS],9,74710736-74710768:74714338-74714354,9q21.13a,-,NM_000689.3,216,ALDH1A1,-2.3216968016533794,9.832261724622741,-15.73167002334692,6.5328498203746795e-35,1.5323477046431019e-33,68.61537328384603
GAS1,ILMN_1772910,"Homo sapiens growth arrest-specific 1 (GAS1), mRNA.",membrane [goid 16020] [evidence IEA]; anchored to plasma membrane [goid 46658] [evidence ISS],cell cycle arrest [goid 7050] [pmid 8127893] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 8127893] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; negative regulation of S phase of mitotic cell cycle [goid 45749] [pmid 8127893] [evidence NAS],molecular function unknown [goid 5554] [evidence ND ],9,88749559-88749608,9q21.33c,-,NM_002048.1,2619,GAS1,-2.28736439738966,7.933709547468281,-15.70745630528174,7.628702220605108e-35,1.785205544208971e-33,68.46060524226598
RTN1,ILMN_1756928,"Homo sapiens reticulon 1 (RTN1), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; integral to endoplasmic reticulum membrane [goid 30176] [pmid 8833145] [evidence TAS],neuron differentiation [goid 30182] [pmid 9560466] [evidence TAS]; signal transduction [goid 7165] [evidence NAS],signal transducer activity [goid 4871] [evidence NAS],14,59132824-59132873,14q23.1b-q23.1c,-,NM_206857.1,6252,RTN1,-1.0326966618254065,6.57399842800743,-15.700246985387821,7.989260429331249e-35,1.8652173007008125e-33,68.41451619221606
C10orf132,ILMN_1717887,"Homo sapiens chromosome 10 open reading frame 132 (C10orf132), mRNA.",,,,10,99617480-99617529,10q24.2a,+,NM_001010917.1,401647,C10orf132,1.8647452512941678,5.757411702318111,15.669643170390561,9.719962817586741e-35,2.2639932020288186e-33,68.21882144883197
FLJ22662,ILMN_1707286,"Homo sapiens hypothetical protein FLJ22662 (FLJ22662), mRNA.",,,,12,14548081-14548130,12p13.1a,-,NM_024829.4,79887,FLJ22662,-1.91804245928817,10.32794485060094,-15.668108649285452,9.816019277829534e-35,2.283708298962946e-33,68.2090071050494
PAK6,ILMN_1708223,"Homo sapiens p21(CDKN1A)-activated kinase 6 (PAK6), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],15,38356636-38356685,15q15.1a,+,NM_020168.3,56924,PAK6,1.519259227850597,6.941525082678139,15.66240769599759,1.01812876003318e-34,2.360454256169625e-33,68.17254389375815
ZFP36,ILMN_1720829,"Homo sapiens zinc finger protein 36, C3H type, homolog (mouse) (ZFP36), mRNA.",cytoplasm [goid 5737] [pmid 9703499] [evidence TAS]; cytosol [goid 5829] [pmid 10751406] [evidence IDA]; nucleus [goid 5634] [evidence IEA],mRNA catabolism [goid 6402] [pmid 11782475] [evidence IDA],protein binding [goid 5515] [pmid 15231747] [evidence IPI]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; mRNA binding [goid 3729] [pmid 11782475] [evidence IDA]; single-stranded RNA binding [goid 3727] [pmid 9703499] [evidence TAS],19,44591555-44591604,19q13.2a,+,NM_003407.1,7538,ZFP36,-2.0919651124581407,12.64274149888924,-15.6515753500966,1.0913275920127504e-34,2.5272317663184154e-33,68.10325344598907
ZNF341,ILMN_2043728,"Homo sapiens zinc finger protein 341 (ZNF341), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",nutrient reservoir activity [goid 45735] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],20,31843452-31843501,20q11.22a,+,NM_032819.3,84905,ZNF341,1.4680250572894034,7.574733535659769,15.644321479524777,1.143270309257339e-34,2.6383566721592663e-33,68.05684809678347
GSTM3,ILMN_1736184,"Homo sapiens glutathione S-transferase M3 (brain) (GSTM3), mRNA.",,establishment of blood-nerve barrier [goid 8065] [pmid 2345169] [evidence TAS]; metabolism [goid 8152] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 2345169] [evidence TAS],1,110078131-110078180,1p13.3b,-,NM_000849.3,2947,GSTM3,-2.1284819931330725,8.428056159130705,-15.642798700012824,1.154485184963711e-34,2.6611681544647385e-33,68.04710587018587
ESD,ILMN_1669818,"Homo sapiens esterase D/formylglutathione hydrolase (ESD), mRNA.",cytoplasmic membrane-bound vesicle [goid 16023] [evidence NAS]; cytoplasmic membrane-bound vesicle [goid 16023] [evidence NAS],,hydrolase activity [goid 16787] [evidence IEA]; serine esterase activity [goid 4759] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA]; serine esterase activity [goid 4759] [evidence NAS],13,46254883-46254927:46256388-46256392,13q14.2a,-,NM_001984.1,2098,ESD,-1.0434105950728547,9.18033605616539,-15.637230664162805,1.1964389021354853e-34,2.7547007541918056e-33,68.01148194664404
CDCA3,ILMN_1737728,"Homo sapiens cell division cycle associated 3 (CDCA3), mRNA.",,cell division [goid 51301] [evidence IEA],,12,6828529-6828578,12p13.31d,-,NM_031299.3,83461,CDCA3,1.68178845880679,5.893725005923519,15.632153224150128,1.2360263309093216e-34,2.8425764171073222e-33,67.97899474452797
NCF2,ILMN_1796642,"Homo sapiens neutrophil cytosolic factor 2 (65kDa, chronic granulomatous disease, autosomal 2) (NCF2), mRNA.",cytosol [goid 5829] [evidence NR ]; soluble fraction [goid 5625] [evidence NR ],cellular defense response [goid 6968] [pmid 1692159] [evidence TAS]; superoxide metabolism [goid 6801] [evidence NR ],electron carrier activity [goid 9055] [pmid 1692159] [evidence TAS]; binding [goid 5488] [evidence IEA]; protein binding [goid 5515] [pmid 11090627] [evidence IPI],1,181791603-181791652,1q25.3e,-,NM_000433.2,4688,NCF2,-1.841835499297897,7.126106831646235,-15.629246239047676,1.259279351197717e-34,2.892728043486099e-33,67.96039396575935
GCN5L2,ILMN_1782247,"Homo sapiens GCN5 general control of amino-acid synthesis 5-like 2 (yeast) (GCN5L2), mRNA.",nucleus [goid 5634] [evidence IEA],protein amino acid acetylation [goid 6473] [pmid 8552087] [evidence TAS]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 8552087] [evidence TAS]; transcription [goid 6350] [evidence IEA]; chromatin remodeling [goid 6338] [pmid 8552087] [evidence TAS],protein binding [goid 5515] [pmid 12887892] [evidence IPI]; histone acetyltransferase activity [goid 4402] [evidence IEA]; N-acetyltransferase activity [goid 8080] [evidence IEA]; histone deacetylase binding [goid 42826] [pmid 12887892] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; transcription coactivator activity [goid 3713] [pmid 8552087] [evidence TAS],17,37518751-37518800,17q21.2b,-,NM_021078.1,2648,GCN5L2,1.2238780455986102,9.957869401366867,15.627537800214599,1.2731491415753998e-34,2.921234865211078e-33,67.94946196191324
DLL1,ILMN_1743373,"Homo sapiens delta-like 1 (Drosophila) (DLL1), mRNA.",extracellular region [goid 5576] [pmid 11823422] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 10079256] [evidence NAS],embryonic development (sensu Mammalia) [goid 1701] [pmid 10473134] [evidence ISS]; cell communication [goid 7154] [evidence IEA]; odontogenesis (sensu Vertebrata) [goid 42475] [pmid 9882480] [evidence ISS]; inner ear morphogenesis [goid 42472] [pmid 9858718] [evidence ISS]; regulation of cell adhesion [goid 30155] [pmid 11912004] [evidence TAS]; Notch signaling pathway [goid 7219] [pmid 10079256] [evidence NAS]; cell differentiation [goid 30154] [pmid 11912004] [evidence TAS]; auditory receptor cell fate commitment [goid 9912] [pmid 10473135] [evidence ISS]; hemopoiesis [goid 30097] [pmid 11581320] [evidence NAS]; cell fate determination [goid 1709] [pmid 11581320] [evidence NAS],calcium ion binding [goid 5509] [evidence IEA]; Notch binding [goid 5112] [pmid 11823422] [evidence IPI],6,170433567-170433616,6q27f,-,NM_005618.2,28514,DLL1,-1.7656737440259693,7.9228018313202595,-15.625226608990399,1.2921562154572497e-34,2.961450350385871e-33,67.93467269377305
ASF1B,ILMN_1695414,"Homo sapiens ASF1 anti-silencing function 1 homolog B (S. cerevisiae) (ASF1B), mRNA.",,,,19,14091475-14091524,19p13.12c,-,NM_018154.2,55723,ASF1B,1.802763773530467,6.741986371423139,15.621219412623363,1.3257873879130647e-34,3.0350519516435468e-33,67.90902975110662
KIFC2,ILMN_1803018,"Homo sapiens kinesin family member C2 (KIFC2), mRNA.",microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],8,145670113-145670162,8q24.3h,+,NM_145754.2,90990,KIFC2,1.7275439827429997,7.6648223816884355,15.615022744547122,1.3795290557681196e-34,3.1544705540352614e-33,67.86937347049928
PDE7B,ILMN_1806533,"Homo sapiens phosphodiesterase 7B (PDE7B), mRNA.",,synaptic transmission [goid 7268] [pmid 10814504] [evidence TAS]; signal transduction [goid 7165] [pmid 10814504] [evidence TAS],"hydrolase activity [goid 16787] [evidence IEA]; 3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA]",6,136558046-136558095,6q23.3b,+,NM_018945.3,27115,PDE7B,-1.8063946301925853,7.163370834764773,-15.608161375669495,1.4415856450090927e-34,3.292607943532183e-33,67.82545993692027
TMEM106C,ILMN_1692511,"Homo sapiens transmembrane protein 106C (TMEM106C), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,12,46648846-46648895,12q13.11c,+,NM_024056.2,79022,TMEM106C,1.1364046314546048,10.414748333899405,15.60632243509875,1.4586878065714944e-34,3.327870653806438e-33,67.8136898993779
KIF4A,ILMN_1799667,"Homo sapiens kinesin family member 4A (KIF4A), mRNA.",spindle microtubule [goid 5876] [pmid 7929562] [evidence TAS]; microtubule associated complex [goid 5875] [evidence IEA]; cytoplasm [goid 5737] [pmid 7929562] [evidence TAS]; nucleus [goid 5634] [evidence IEA],organelle organization and biogenesis [goid 6996] [pmid 7929562] [evidence TAS]; microtubule-based movement [goid 7018] [evidence IEA]; anterograde axon cargo transport [goid 8089] [pmid 7929562] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; microtubule motor activity [goid 3777] [pmid 7929562] [evidence TAS]; DNA binding [goid 3677] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],X,69556993-69557042,Xq13.1b-q13.1c,+,NM_012310.2,24137,KIF4A,1.4864862319448067,5.600061692311136,15.600165596209086,1.517439905120876e-34,3.4579655605533585e-33,67.77428151526279
PEAR1,ILMN_2407669,"Homo sapiens platelet endothelial aggregation receptor 1 (PEAR1), mRNA.",,,,,,1q23.1a,,NM_001080471.1,375033,PEAR1,-1.4068436313993162,6.364597211596413,-15.593608770644778,1.582618255931187e-34,3.6023920437623656e-33,67.73230974237885
BEXL1,ILMN_1804798,"PREDICTED: Homo sapiens brain expressed X-linked-like 1 (BEXL1), mRNA.",,,,,,Xq22.1e,,XM_936467.1,56271,BEXL1,-1.671033363776841,9.84175109978643,-15.585940883908371,1.66240810166328e-34,3.774569005550813e-33,67.68322166135296
MUC20,ILMN_1653278,"Homo sapiens mucin 20, cell surface associated (MUC20), mRNA.",basal plasma membrane [goid 9925] [pmid 15314156] [evidence IDA],protein homooligomerization [goid 51260] [pmid 15314156] [evidence IDA],"glucan 1,4-alpha-glucosidase activity [goid 4339] [evidence IEA]",3,196945843-196945892,3q29e,+,NM_152673.1,200958,MUC20,2.5153881716823534,8.859794338460816,15.585799235053834,1.6639193637024275e-34,3.774569005550813e-33,67.68231481534741
NDN,ILMN_1692058,"Homo sapiens necdin homolog (mouse) (NDN), mRNA.",nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 9630521] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; regulation of cell growth [goid 1558] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],15,21482033-21482082,15q11.2d,-,NM_002487.2,4692,NDN,-1.6046837010866764,10.731549711567968,-15.576412468120166,1.7671971634396553e-34,4.0043126666025625e-33,67.62221667790904
IRF3,ILMN_1765649,"Homo sapiens interferon regulatory factor 3 (IRF3), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; response to virus [goid 9615] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 8524823] [evidence TAS]",RNA polymerase II transcription factor activity [goid 3702] [pmid 8524823] [evidence TAS]; transcription cofactor activity [goid 3712] [pmid 8524823] [evidence TAS]; transcription factor activity [goid 3700] [evidence IEA],19,54854799-54854848,19q13.33b,-,NM_001571.2,3661,IRF3,1.206196267820939,8.891621553676508,15.566655436297207,1.8813624591469916e-34,4.258178742377037e-33,67.55974087650786
ENPP2,ILMN_1780799,"Homo sapiens ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin) (ENPP2), mRNA.",integral to plasma membrane [goid 5887] [pmid 1733949] [evidence TAS]; plasma membrane [goid 5886] [pmid 8579579] [evidence TAS],chemotaxis [goid 6935] [pmid 7982964] [evidence NAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 1733949] [evidence TAS]; phosphate metabolism [goid 6796] [pmid 8579579] [evidence TAS]; nucleotide metabolism [goid 9117] [evidence IEA]; cell motility [goid 6928] [pmid 1733949] [evidence TAS],nucleic acid binding [goid 3676] [evidence IEA]; transcription factor binding [goid 8134] [pmid 8586446] [evidence TAS]; hydrolase activity [goid 16787] [pmid 7982964] [evidence TAS]; nucleotide diphosphatase activity [goid 4551] [pmid 8579579] [evidence TAS]; endonuclease activity [goid 4519] [evidence IEA]; phosphodiesterase I activity [goid 4528] [pmid 7982964] [evidence TAS],8,120638968-120639017,8q24.12b,-,NM_006209.2,5168,ENPP2,-2.1469469322350356,9.509682735871698,-15.562468257069884,1.9325948197622635e-34,4.369192898734844e-33,67.53292750790597
TPSAB1,ILMN_1676256,"Homo sapiens tryptase alpha/beta 1 (TPSAB1), mRNA.",,defense response [goid 6952] [pmid 2677049] [evidence TAS]; defense response [goid 6952] [pmid 2677049] [evidence TAS],tryptase activity [goid 30019] [pmid 2187193] [evidence NAS]; serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; tryptase activity [goid 30019] [pmid 2187193] [evidence NAS]; serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],16,1232163-1232212,16p13.3e,+,NM_003294.3,7177,TPSAB1,-2.4149167916876557,10.705761860898054,-15.558228059488838,1.9859005264379852e-34,4.4846385703127776e-33,67.50577327933631
PRNP,ILMN_1737988,"Homo sapiens prion protein (p27-30) (Creutzfeldt-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia) (PRNP), transcript variant 2, mRNA.",Golgi apparatus [goid 5794] [evidence ISS]; endoplasmic reticulum [goid 5783] [evidence ISS]; extrinsic to membrane [goid 19898] [pmid 16004966] [evidence TAS]; lipid raft [goid 45121] [evidence ISS]; plasma membrane [goid 5886] [evidence ISS]; lipid raft [goid 45121] [evidence ISS]; Golgi apparatus [goid 5794] [evidence ISS]; endoplasmic reticulum [goid 5783] [evidence ISS]; extrinsic to membrane [goid 19898] [pmid 16004966] [evidence TAS]; cytoplasm [goid 5737] [pmid 16004966] [evidence TAS],metabolism [goid 8152] [pmid 3755672] [evidence TAS]; copper ion homeostasis [goid 6878] [pmid 16004966] [evidence NAS]; response to oxidative stress [goid 6979] [evidence ISS]; metabolism [goid 8152] [pmid 3755672] [evidence TAS]; copper ion homeostasis [goid 6878] [pmid 16004966] [evidence NAS]; response to oxidative stress [goid 6979] [evidence ISS],microtubule binding [goid 8017] [pmid 16004966] [evidence IDA]; copper ion binding [goid 5507] [pmid 16294306] [evidence TAS]; microtubule binding [goid 8017] [pmid 16004966] [evidence IDA]; GPI anchor binding [goid 48503] [evidence IEA]; copper ion binding [goid 5507] [pmid 16294306] [evidence TAS],20,4630022-4630071,20p13a,+,NM_183079.2,5621,PRNP,-1.2064287550437172,10.877491704859079,-15.554595694844405,2.0327348151443246e-34,4.585226401511572e-33,67.48251053638795
HCK,ILMN_1791771,"Homo sapiens hemopoietic cell kinase (HCK), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 3496523] [evidence TAS]; mesoderm development [goid 7498] [pmid 3453117] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 12029088] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [pmid 3496523] [evidence TAS],20,30153066-30153115,20q11.21b,+,NM_002110.2,3055,HCK,-1.563555105143502,9.031424478206578,-15.521610600024536,2.512052887741027e-34,5.6536731358742926e-33,67.2712188610649
SH3GL2,ILMN_1661491,"Homo sapiens SH3-domain GRB2-like 2 (SH3GL2), mRNA.",cytoplasm [goid 5737] [evidence IEA],central nervous system development [goid 7417] [pmid 9169142] [evidence TAS]; signal transduction [goid 7165] [pmid 9169142] [evidence TAS],acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; lipid binding [goid 8289] [evidence IEA],9,17786995-17787044,9p22.2a,+,NM_003026.1,6456,SH3GL2,-1.9713952285412493,6.292135053775144,-15.516892351999154,2.5893105770638825e-34,5.8149305252199896e-33,67.24098866457794
PLEKHG6,ILMN_1744614,"Homo sapiens pleckstrin homology domain containing, family G (with RhoGef domain) member 6 (PLEKHG6), mRNA.",intracellular [goid 5622] [evidence IEA],regulation of Rho protein signal transduction [goid 35023] [evidence IEA],Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA],12,6307583-6307632,12p13.31d,+,NM_018173.1,55200,PLEKHG6,1.5886654295524965,6.104220045919372,15.508239520566311,2.737233110968302e-34,6.139748888369259e-33,67.18554496698883
PKHD1,ILMN_1720034,"Homo sapiens polycystic kidney and hepatic disease 1 (autosomal recessive) (PKHD1), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA],6,51588533-51588582,6p12.2a,-,NM_138694.2,5314,PKHD1,-1.211443030197068,6.665958364517166,-15.495591815260955,2.968815501449174e-34,6.651742503134946e-33,67.10449379559228
STK32A,ILMN_1756612,"Homo sapiens serine/threonine kinase 32A (STK32A), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],5,146683786-146683827:146702762-146702769,5q32e,+,NM_145001.1,202374,STK32A,1.849631692371661,5.9144904597700325,15.486929783732801,3.138647741849801e-34,7.008712502112815e-33,67.04897745871169
IKBKE,ILMN_1755024,"Homo sapiens inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (IKBKE), mRNA.",cytoplasm [goid 5737] [evidence NAS],immune response [goid 6955] [pmid 10421793] [evidence NAS]; positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IEP]; protein amino acid phosphorylation [goid 6468] [pmid 10882136] [evidence IDA],nucleotide binding [goid 166] [evidence IEA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IEP]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; NF-kappaB-inducing kinase activity [goid 4704] [pmid 10882136] [evidence IDA]; ATP binding [goid 5524] [evidence NAS],1,204736599-204736648,1q32.1h,+,NM_014002.2,9641,IKBKE,1.5980108838040321,7.3229825526179,15.485420956164301,3.1692107166491264e-34,7.069071128061954e-33,67.03930657581986
VMD2,ILMN_1718982,"Homo sapiens vitelliform macular dystrophy 2 (Best disease, bestrophin) (VMD2), mRNA.",membrane fraction [goid 5624] [pmid 10737974] [evidence TAS]; integral to membrane [goid 16021] [pmid 10737974] [evidence TAS]; basolateral plasma membrane [goid 16323] [pmid 11050159] [evidence IDA],ion transport [goid 6811] [evidence IEA]; visual perception [goid 7601] [pmid 9662395] [evidence TAS]; sensory perception [goid 7600] [evidence IEA],ion channel activity [goid 5216] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],11,61488158-61488170:61488171-61488207,11q12.3a,+,NM_004183.1,7439,VMD2,-1.130216706510084,6.500333259244072,-15.48004707862631,3.2805069284365276e-34,7.301043673432486e-33,67.00486115539123
SELI,ILMN_1696133,"Homo sapiens selenoprotein I (SELI), mRNA.",integral to membrane [goid 16021] [evidence IEA],phospholipid biosynthesis [goid 8654] [evidence IEA],transferase activity [goid 16740] [evidence IEA],2,26471813-26471862,2p23.3b,+,NM_033505.1,85465,SELI,1.1727696829415546,7.287965324731168,15.477662210826269,3.3311454042674286e-34,7.405506360953635e-33,66.98957397400483
MYL9,ILMN_1675062,"Homo sapiens myosin, light chain 9, regulatory (MYL9), transcript variant 1, mRNA.",myosin [goid 16459] [evidence IEA]; muscle myosin [goid 5859] [pmid 2526655] [evidence TAS]; myosin [goid 16459] [evidence IEA]; muscle myosin [goid 5859] [pmid 2526655] [evidence TAS],regulation of muscle contraction [goid 6937] [pmid 2526655] [evidence TAS]; regulation of muscle contraction [goid 6937] [pmid 2526655] [evidence TAS],structural constituent of muscle [goid 8307] [pmid 2526655] [evidence TAS]; motor activity [goid 3774] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; structural constituent of muscle [goid 8307] [pmid 2526655] [evidence TAS]; motor activity [goid 3774] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],20,34611451-34611500,20q11.23a,+,NM_006097.3,10398,MYL9,-1.6118424727979983,8.687631252940296,-15.47584844311508,3.3701811992495212e-34,7.483971746346773e-33,66.9779473064413
PRG4,ILMN_1780349,"Homo sapiens proteoglycan 4 (PRG4), mRNA.",extracellular space [goid 5615] [evidence NR ],cell proliferation [goid 8283] [pmid 10545950] [evidence TAS],,1,184549495-184549533:184549534-184549544,1q31.1a,+,NM_005807.2,10216,PRG4,-3.613690964840467,8.415111861175953,-15.474930711326596,3.390106833708607e-34,7.519873340226365e-33,66.97206434260887
MAP3K8,ILMN_1741159,"Homo sapiens mitogen-activated protein kinase kinase kinase 8 (MAP3K8), mRNA.",cytosol [goid 5829] [pmid 8226782] [evidence TAS],protein amino acid phosphorylation [goid 6468] [pmid 2072910] [evidence TAS],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 8226782] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; protein kinase activity [goid 4672] [evidence IEA],10,30790328-30790377,10p11.23a,+,NM_005204.2,1326,MAP3K8,-1.7452560400844277,8.674971063059266,-15.465778933528291,3.5953814361329965e-34,7.966377826594573e-33,66.91339503496717
PUSL1,ILMN_1780315,"Homo sapiens pseudouridylate synthase-like 1 (PUSL1), mRNA.",,tRNA processing [goid 8033] [evidence IEA],pseudouridylate synthase activity [goid 4730] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA],1,1236597-1236622:1236623-1236646,1p36.33a,+,NM_153339.1,126789,PUSL1,1.1922684782976631,7.520117811720158,15.459560228646687,3.7419281516506193e-34,8.281913546263894e-33,66.87352526916388
CLEC10A,ILMN_1653166,"Homo sapiens C-type lectin domain family 10, member A (CLEC10A), transcript variant 2, mRNA.",plasma membrane [goid 5886] [pmid 8598452] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 8598452] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],endocytosis [goid 6897] [evidence IEA]; immune response [goid 6955] [evidence IEA]; endocytosis [goid 6897] [evidence IEA]; immune response [goid 6955] [evidence IEA],sugar binding [goid 5529] [pmid 8598452] [evidence TAS]; sugar binding [goid 5529] [pmid 8598452] [evidence TAS],17,6918736-6918785,17p13.1d,-,NM_006344.2,10462,CLEC10A,-1.4390963895214899,6.113444456958097,-15.456605124334262,3.8136493837386486e-34,8.422019522057713e-33,66.85457831796627
FLJ10159,ILMN_1666502,"Homo sapiens hypothetical protein FLJ10159 (FLJ10159), mRNA.",,,,6,108087919-108087968,6q21d,+,NM_018013.2,55084,FLJ10159,-1.1952389272978694,6.37798221904531,-15.45410979230355,3.875283219203289e-34,8.548695330740838e-33,66.83857874530665
ADAMTS1,ILMN_1673566,"Homo sapiens ADAM metallopeptidase with thrombospondin type 1 motif, 1 (ADAMTS1), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],negative regulation of cell proliferation [goid 8285] [pmid 10438512] [evidence TAS]; integrin-mediated signaling pathway [goid 7229] [pmid 8995297] [evidence TAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; integrin binding [goid 5178] [evidence NR ]; heparin binding [goid 8201] [evidence IEA]; metalloendopeptidase activity [goid 4222] [evidence IEA],21,27130839-27130888,21q21.3a,-,NM_006988.3,9510,ADAMTS1,-2.708663257575301,8.68828597266684,-15.451125336478333,3.950310133725703e-34,8.704604092024653e-33,66.81944240968869
ACAT1,ILMN_1800008,"Homo sapiens acetyl-Coenzyme A acetyltransferase 1 (acetoacetyl Coenzyme A thiolase) (ACAT1), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [pmid 1715688] [evidence TAS],,acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; acetyl-CoA C-acetyltransferase activity [goid 3985] [pmid 1979337] [evidence TAS],11,107522294-107522296:107523207-107523253,11q22.3c,+,NM_000019.2,38,ACAT1,-1.101740085214118,10.940514747469193,-15.446592766927372,4.067048074411182e-34,8.951979964006484e-33,66.7903783206855
SLC29A2,ILMN_1730809,"Homo sapiens solute carrier family 29 (nucleoside transporters), member 2 (SLC29A2), mRNA.",nucleus [goid 5634] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7639753] [evidence TAS]; membrane [goid 16020] [evidence IEA]; nucleolus [goid 5730] [pmid 7639753] [evidence TAS],"transport [goid 6810] [evidence IEA]; nucleoside transport [goid 15858] [pmid 9396714] [evidence TAS]; cell proliferation [goid 8283] [pmid 7639753] [evidence TAS]; nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 9396714] [evidence TAS]",nucleoside transporter activity [goid 5337] [pmid 9396714] [evidence TAS],11,65886733-65886782,11q13.1e,-,NM_001532.2,3177,SLC29A2,1.4262664992465233,7.870218159293447,15.446076814492264,4.08055382656509e-34,8.971837468342233e-33,66.78706979587604
LOC647954,ILMN_1687867,"PREDICTED: Homo sapiens similar to Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keraton-8) (K8) (LOC647954), mRNA.",,,,,,,,XM_938141.1,647954,LOC647954,1.7365032446318907,9.036794175110328,15.439801521238195,4.248459581875718e-34,9.330755138767218e-33,66.74682816810777
ADCY4,ILMN_2148944,"Homo sapiens adenylate cyclase 4 (ADCY4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cAMP biosynthesis [goid 6171] [evidence IEA]; cyclic nucleotide biosynthesis [goid 9190] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],magnesium ion binding [goid 287] [evidence IEA]; adenylate cyclase activity [goid 4016] [evidence IEA],14,23857547-23857596,14q12a,-,NM_139247.2,196883,ADCY4,-1.6822460503605,8.501148392846298,-15.437229903331446,4.31925097810311e-34,9.475830435294628e-33,66.7303363020241
DPT,ILMN_1708107,"Homo sapiens dermatopontin (DPT), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [pmid 8104875] [evidence TAS],1,166931501-166931550,1q24.2b,-,NM_001937.3,1805,DPT,-2.490087268400009,8.697538747155791,-15.4277992469876,4.58912230812845e-34,1.0056862994636805e-32,66.6698530881046
ARHGAP15,ILMN_2208413,"Homo sapiens Rho GTPase activating protein 15 (ARHGAP15), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],GTPase activator activity [goid 5096] [evidence IEA],2,144242060-144242109,2q22.2a,+,NM_018460.2,55843,ARHGAP15,-1.3644334233280313,8.621762027797027,-15.423204009063685,4.726678837885339e-34,1.03469792328676e-32,66.64037933396055
SLC9A9,ILMN_1758315,"Homo sapiens solute carrier family 9 (sodium/hydrogen exchanger), member 9 (SLC9A9), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],ion transport [goid 6811] [evidence IEA]; regulation of pH [goid 6885] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA],sodium:hydrogen antiporter activity [goid 15385] [evidence IEA]; solute:hydrogen antiporter activity [goid 15299] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA]; antiporter activity [goid 15297] [evidence IEA],3,144467024-144467073,3q24a,-,NM_173653.1,285195,SLC9A9,-1.4023042096461733,7.187625319903314,-15.421251078958365,4.7863826818684215e-34,1.0466223464352283e-32,66.62785281956927
PADI4,ILMN_1807529,"Homo sapiens peptidyl arginine deiminase, type IV (PADI4), mRNA.",nucleus [goid 5634] [evidence IEA],"chromatin modification [goid 16568] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; protein modification [goid 6464] [pmid 10488123] [evidence TAS]",protein-arginine deiminase activity [goid 4668] [pmid 10488123] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],1,17562982-17563031,1p36.13d,+,NM_012387.1,23569,PADI4,-2.1219789040321038,6.1137145198837874,-15.420588623359208,4.806806016446536e-34,1.0499407726753525e-32,66.62360362383052
PPAP2A,ILMN_1676296,"Homo sapiens phosphatidic acid phosphatase type 2A (PPAP2A), transcript variant 2, mRNA.",plasma membrane [goid 5886] [pmid 9705349] [evidence TAS]; membrane fraction [goid 5624] [pmid 9468526] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 9705349] [evidence NAS]; plasma membrane [goid 5886] [pmid 9705349] [evidence TAS]; membrane fraction [goid 5624] [pmid 9468526] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 9705349] [evidence NAS],regulation of lipid metabolism [goid 19216] [pmid 9468526] [evidence NAS]; germ cell migration [goid 8354] [pmid 9305923] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9468526] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 9468526] [evidence NAS]; protein kinase C activation [goid 7205] [pmid 9468526] [evidence TAS]; phospholipid dephosphorylation [goid 46839] [pmid 9468526] [evidence TAS]; regulation of lipid metabolism [goid 19216] [pmid 9468526] [evidence NAS]; germ cell migration [goid 8354] [pmid 9305923] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9468526] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 9468526] [evidence NAS]; protein kinase C activation [goid 7205] [pmid 9468526] [evidence TAS]; phospholipid dephosphorylation [goid 46839] [pmid 9468526] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; phosphatidate phosphatase activity [goid 8195] [pmid 9570154] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA]; phosphatidate phosphatase activity [goid 8195] [pmid 9570154] [evidence NAS],5,54822546-54822595,5q11.2e,-,NM_176895.1,8611,PPAP2A,-1.271618214770359,7.941506790966347,-15.39669767469213,5.604736301230438e-34,1.2228960077973675e-32,66.47033845170795
MTA1,ILMN_1671911,"Homo sapiens metastasis associated 1 (MTA1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [pmid 8083195] [evidence TAS]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],14,105007804-105007853,14q32.33c,+,NM_004689.2,9112,MTA1,1.190689009887155,9.395840958424898,15.379709792143945,6.251625559538267e-34,1.3610720804705294e-32,66.36133280286934
PROS1,ILMN_1671928,"Homo sapiens protein S (alpha) (PROS1), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],blood coagulation [goid 7596] [pmid 9657428] [evidence TAS],endopeptidase inhibitor activity [goid 4866] [pmid 8146182] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],3,95074739-95074788,3q11.2a,-,NM_000313.1,5627,PROS1,-1.4727603514086844,10.755497914080436,-15.37858127844482,6.297158137877228e-34,1.3694950002461695e-32,66.35409076862597
MGC10911,ILMN_1802627,"Homo sapiens chromosome 7 open reading frame 48 (C7orf48), mRNA.",,,,7,1573637-1573686,7p22.3b-p22.3a,-,NM_032302.2,84262,MGC10911,1.1710975790108504,8.28623676803194,15.370669294333377,6.625853449660159e-34,1.4394145040260637e-32,66.30331447037113
RBMS3,ILMN_1665040,"Homo sapiens RNA binding motif, single stranded interacting protein (RBMS3), transcript variant 2, mRNA.",,,RNA binding [goid 3723] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],3,29952642-29952691,3p24.1b-p24.1a,+,NM_014483.2,27303,RBMS3,-1.5958083659241078,6.427004553482928,-15.370258325780076,6.643388744913826e-34,1.4416585901110178e-32,66.30067689817905
MXD3,ILMN_1711904,"Homo sapiens MAX dimerization protein 3 (MXD3), mRNA.",nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA],transcription regulator activity [goid 30528] [evidence IEA],5,176667071-176667120,5q35.3a,-,NM_031300.2,83463,MXD3,1.170718077873115,6.93908503697602,15.359679342386395,7.111132120992201e-34,1.5381570970466158e-32,66.23277745172412
CAMP,ILMN_1688580,"Homo sapiens cathelicidin antimicrobial peptide (CAMP), mRNA.",extracellular region [goid 5576] [evidence IEA],,,3,48241909-48241918:48241919-48241958,3p21.31f,+,NM_004345.3,820,CAMP,-3.003491836543957,7.436916918070907,-15.35776833762402,7.19907868015598e-34,1.5550203780983994e-32,66.22051113474184
NOSTRIN,ILMN_1670099,"Homo sapiens nitric oxide synthase trafficker (NOSTRIN), transcript variant 1, mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],,2,169426732-169426781,2q24.3f,+,NM_052946.2,115677,NOSTRIN,-2.1049153536742384,8.802153317598005,-15.357648334056544,7.204637597447102e-34,1.5550203780983994e-32,66.21974084970452
LOC200810,ILMN_1782084,"Homo sapiens similar to beta-1,4-mannosyltransferase; beta-1,4 mannosyltransferase (LOC200810), mRNA.",,biosynthesis [goid 9058] [evidence IEA]; biosynthesis [goid 9058] [evidence IEA],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]",3,127133270-127133285:127134183-127134216,3q21.2c,-,NM_001015050.1,200810,LOC200810,2.391925191863188,7.4248869065117304,15.356571106788541,7.254730868347713e-34,1.5641449915291062e-32,66.21282624232758
SAC3D1,ILMN_1776674,"Homo sapiens SAC3 domain containing 1 (SAC3D1), mRNA.",,,,11,64568681-64568730,11q13.1c,+,NM_013299.2,29901,SAC3D1,1.2685967522121526,8.992796717711865,15.344456216378216,7.842707297680353e-34,1.6872783614192314e-32,66.13505636914199
CRIM1,ILMN_2146418,"Homo sapiens cysteine rich transmembrane BMP regulator 1 (chordin-like) (CRIM1), mRNA.",integral to membrane [goid 16021] [pmid 10642437] [evidence TAS]; extracellular region [goid 5576] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA],regulation of cell growth [goid 1558] [evidence IEA],insulin-like growth factor receptor activity [goid 5010] [pmid 10642437] [evidence TAS]; serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; insulin-like growth factor binding [goid 5520] [evidence IEA]; cysteine-type endopeptidase activity [goid 4197] [evidence IEA],2,36630135-36630184,2p22.2b,+,NM_016441.1,51232,CRIM1,-1.818274778882694,7.013374892372189,-15.341697389688347,7.983141668291178e-34,1.7156466004207293e-32,66.11734500482784
JUP,ILMN_1733811,"Homo sapiens junction plakoglobin (JUP), transcript variant 2, mRNA.",membrane fraction [goid 5624] [pmid 1639850] [evidence TAS]; cytoskeleton [goid 5856] [pmid 1639850] [evidence TAS]; soluble fraction [goid 5625] [pmid 1639850] [evidence TAS]; cytoplasm [goid 5737] [pmid 1639850] [evidence TAS]; membrane fraction [goid 5624] [pmid 1639850] [evidence TAS]; cytoskeleton [goid 5856] [pmid 1639850] [evidence TAS]; soluble fraction [goid 5625] [pmid 1639850] [evidence TAS]; cytoplasm [goid 5737] [pmid 1639850] [evidence TAS],cell adhesion [goid 7155] [pmid 1639850] [evidence NAS]; cell adhesion [goid 7155] [pmid 1639850] [evidence NAS],structural molecule activity [goid 5198] [evidence IEA]; cytoskeletal protein binding [goid 8092] [pmid 1639850] [evidence TAS]; structural molecule activity [goid 5198] [evidence IEA]; cytoskeletal protein binding [goid 8092] [pmid 1639850] [evidence TAS],17,37164659-37164708,17q21.2b,-,NM_021991.1,3728,JUP,1.1830445758953818,8.656143421996706,15.339500886223135,8.096750821000474e-34,1.7381951762508315e-32,66.10324330837673
BTG1,ILMN_1775743,"Homo sapiens B-cell translocation gene 1, anti-proliferative (BTG1), mRNA.",nucleus [goid 5634] [pmid 11420681] [evidence IMP]; cytoplasm [goid 5737] [pmid 11420681] [evidence IMP],positive regulation of angiogenesis [goid 45766] [pmid 15033446] [evidence IMP]; negative regulation of cell growth [goid 30308] [pmid 15033446] [evidence NAS]; negative regulation of cell proliferation [goid 8285] [pmid 1373383] [evidence IDA]; regulation of transcription [goid 45449] [pmid 11420681] [evidence NAS]; positive regulation of myoblast differentiation [goid 45663] [pmid 15033446] [evidence NAS]; positive regulation of endothelial cell differentiation [goid 45603] [pmid 15033446] [evidence IMP]; regulation of apoptosis [goid 42981] [pmid 9690562] [evidence IMP]; positive regulation of enzyme activity [goid 43085] [evidence ISS]; cell migration [goid 16477] [pmid 15033446] [evidence NAS],transcription cofactor activity [goid 3712] [pmid 11420681] [evidence NAS]; kinase binding [goid 19900] [pmid 9820826] [evidence NAS],12,91061324-91061373,12q21.33d,-,NM_001731.1,694,BTG1,-1.0994418139784337,12.39146468524863,-15.33693720539655,8.231401428371016e-34,1.7652077146714605e-32,66.08678387729474
TARP,ILMN_1723944,"Homo sapiens TCR gamma alternate reading frame protein (TARP), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA.",,,,7,38271612-38271615:38271616-38271661,7p14.1e,-,NM_001003799.1,445347,TARP,-1.360034195272398,5.826246356178373,-15.336013726924767,8.280452333677059e-34,1.773825377860927e-32,66.08085481541683
FLJ11000,ILMN_1736863,"Homo sapiens hypothetical protein FLJ11000 (FLJ11000), mRNA.",,,,7,134500907-134500956,7q33b,+,NM_018295.1,55281,FLJ11000,-1.2100507032245762,9.545333654316638,-15.329682906187202,8.624693111263365e-34,1.8455920831032877e-32,66.04020706069353
NR2F6,ILMN_1672080,"Homo sapiens nuclear receptor subfamily 2, group F, member 6 (NR2F6), mRNA.",nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [pmid 2905047] [evidence TAS]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; thyroid hormone receptor activity [goid 4887] [pmid 2905047] [evidence TAS]; steroid hormone receptor activity [goid 3707] [pmid 2905047] [evidence TAS],19,17203837-17203886,19p13.11e,-,NM_005234.3,2063,NR2F6,1.0128528256486753,9.863124751150965,15.317517696388975,9.326941016880527e-34,1.9916055055042218e-32,65.96209101270195
MAPK8IP3,ILMN_1811574,"Homo sapiens mitogen-activated protein kinase 8 interacting protein 3 (MAPK8IP3), transcript variant 2, mRNA.",cytoplasm [goid 5737] [evidence ISS],regulation of JNK cascade [goid 46328] [evidence ISS]; vesicle-mediated transport [goid 16192] [evidence ISS],kinesin binding [goid 19894] [evidence ISS]; MAP-kinase scaffold activity [goid 5078] [evidence ISS]; protein kinase binding [goid 19901] [evidence ISS],16,1760148-1760197,16p13.3e,+,NM_033392.3,23162,MAPK8IP3,1.1599548962579345,7.063628325026951,15.313582007487016,9.56617834440075e-34,2.040512753888808e-32,65.93681667789133
UNQ5783,ILMN_1682761,"Homo sapiens chromosome 17 open reading frame 87 (C17orf87), mRNA.",,,,17,5054544-5054593,17p13.2b,-,NM_207103.1,388325,UNQ5783,-1.5511350963507713,7.180859562373987,-15.312321848703952,9.644070951587596e-34,2.054936864742967e-32,65.92872391933356
KIF26B,ILMN_2055330,"Homo sapiens kinesin family member 26B (KIF26B), mRNA.",microtubule [goid 5874] [evidence IEA]; microtubule associated complex [goid 5875] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],,,1q44b-q44c,,NM_018012.2,55083,KIF26B,1.4513864629922226,5.584165373238356,15.30015936543614,1.042929519660479e-33,2.2198865775922197e-32,65.85061054640742
KCNN4,ILMN_1709937,"Homo sapiens potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 (KCNN4), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; voltage-gated potassium channel complex [goid 8076] [pmid 9380751] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 9380751] [evidence TAS]; defense response [goid 6952] [pmid 9407042] [evidence TAS],calmodulin binding [goid 5516] [evidence IEA]; ion channel activity [goid 5216] [evidence IEA]; calcium-activated potassium channel activity [goid 15269] [pmid 9380751] [evidence TAS]; voltage-gated potassium channel activity [goid 5249] [evidence IEA],19,48962909-48962958,19q13.31b,-,NM_002250.2,3783,KCNN4,1.7331556911475747,6.878645940239414,15.295836773306366,1.0723532335220743e-33,2.2776691609670559e-32,65.8228462672871
OSCAR,ILMN_1741917,"Homo sapiens osteoclast-associated receptor (OSCAR), transcript variant 3, mRNA.",,,receptor activity [goid 4872] [evidence IEA],19,59290134-59290183,19q13.42a,-,NM_130771.2,126014,OSCAR,-1.7452758789466873,8.667642424435435,-15.291317679866046,1.1040040612059779e-33,2.3424086168196398e-32,65.79381845273963
GIMAP1,ILMN_1757186,"Homo sapiens GTPase, IMAP family member 1 (GIMAP1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],,GTP binding [goid 5525] [evidence IEA],7,150048984-150049033,7q36.1c,+,NM_130759.2,170575,GIMAP1,-1.7994916910303766,6.774490093168369,-15.289366507938192,1.117957335430297e-33,2.3695010982298073e-32,65.78128491087058
CMTM2,ILMN_1799030,"Homo sapiens CKLF-like MARVEL transmembrane domain containing 2 (CMTM2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],chemotaxis [goid 6935] [evidence IEA],cytokine activity [goid 5125] [evidence IEA],16,65179379-65179428,16q21e,+,NM_144673.2,146225,CMTM2,-2.1718213081016318,5.896170460457901,-15.283636876562909,1.1599606772987644e-33,2.4533290942276613e-32,65.74447853568907
MRAS,ILMN_1748881,"Homo sapiens muscle RAS oncogene homolog (MRAS), mRNA.",intracellular [goid 5622] [evidence IEA]; plasma membrane [goid 5886] [pmid 9395237] [evidence TAS],Ras protein signal transduction [goid 7265] [pmid 10446149] [evidence TAS]; development [goid 7275] [pmid 10446149] [evidence TAS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 9395237] [evidence TAS]; muscle development [goid 7517] [pmid 9395237] [evidence TAS],GTP binding [goid 5525] [evidence IEA]; GTP-dependent protein binding [goid 30742] [pmid 10934204] [evidence IPI]; nucleotide binding [goid 166] [evidence IEA]; GTPase activity [goid 3924] [pmid 10446149] [evidence TAS],3,139606278-139606327,3q22.3c,+,NM_012219.2,22808,MRAS,-1.1819891553373152,6.466923053588957,-15.275367324971167,1.2233868896610223e-33,2.58474391640314e-32,65.69135203119774
DDX27,ILMN_1676759,"Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 (DDX27), mRNA.",nucleus [goid 5634] [evidence IEA],,ATP binding [goid 5524] [evidence IEA]; ATP-dependent helicase activity [goid 8026] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],20,47289227-47289276,20q13.13c,+,NM_017895.6,55661,DDX27,1.3284755235505,8.722587132063513,15.274659421041397,1.2289752156249783e-33,2.5938118263949966e-32,65.68680398698497
STX2,ILMN_1747775,"Homo sapiens syntaxin 2 (STX2), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; soluble fraction [goid 5625] [pmid 8466509] [evidence TAS]; microsome [goid 5792] [pmid 8466509] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; soluble fraction [goid 5625] [pmid 8466509] [evidence TAS]; microsome [goid 5792] [pmid 8466509] [evidence TAS],signal transduction [goid 7165] [pmid 1581962] [evidence TAS]; ectoderm development [goid 7398] [pmid 8466509] [evidence TAS]; signal transduction [goid 7165] [pmid 1581962] [evidence TAS]; ectoderm development [goid 7398] [pmid 8466509] [evidence TAS],,12,129840467-129840516,12q24.33b,-,NM_001980.2,2054,STX2,-1.0345721097773932,8.663557975320062,-15.262846157674344,1.3260971628369174e-33,2.7929002141095835e-32,65.61090262524321
EFEMP2,ILMN_1653203,"Homo sapiens EGF-containing fibulin-like extracellular matrix protein 2 (EFEMP2), mRNA.",basement membrane [goid 5604] [pmid 10601734] [evidence TAS]; membrane [goid 16020] [evidence IEA],blood coagulation [goid 7596] [evidence IEA]; homophilic cell adhesion [goid 7156] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI]; extracellular matrix structural constituent [goid 5201] [pmid 10601734] [evidence TAS],11,65390547-65390596,11q13.1d,-,NM_016938.1,30008,EFEMP2,-1.376594811032307,10.380160589262287,-15.251703050664906,1.4247465601388526e-33,2.9975109542858216e-32,65.5392982415159
HMGB3,ILMN_1733519,"Homo sapiens high-mobility group box 3 (HMGB3), mRNA.",chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromatin [goid 785] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [pmid 9598312] [evidence TAS]",DNA bending activity [goid 8301] [pmid 9598312] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],X,149909484-149909533,Xq28c-q28d,+,NM_005342.2,3149,HMGB3,2.6846322891116188,8.809275812465449,15.250687029269935,1.4340990989760944e-33,3.0140183584363127e-32,65.53276897352977
GAPDH,ILMN_1343295,"Homo sapiens glyceraldehyde-3-phosphate dehydrogenase (GAPDH), mRNA.",cytoplasm [goid 5737] [evidence NAS]; cytoplasm [goid 5737] [evidence NAS]; cytoplasm [goid 5737] [evidence NAS],glucose metabolism [goid 6006] [evidence IEA]; glycolysis [goid 6096] [evidence NAS]; glucose metabolism [goid 6006] [evidence IEA]; glycolysis [goid 6096] [evidence NAS]; glucose metabolism [goid 6006] [evidence IEA]; glycolysis [goid 6096] [evidence NAS],glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity [goid 4365] [pmid 3170585] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence IEA]; NAD binding [goid 51287] [evidence IEA]; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity [goid 4365] [pmid 3170585] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence IEA]; NAD binding [goid 51287] [evidence IEA]; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity [goid 4365] [pmid 3170585] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence IEA]; NAD binding [goid 51287] [evidence IEA],12,6517340-6517389,12p13.31d,+,NM_002046.2,2597,GAPDH,1.0299066600707576,12.638811696182463,15.24434234071424,1.4939095790625649e-33,3.1331386643484065e-32,65.49199443399172
CDH3,ILMN_1704294,"Homo sapiens cadherin 3, type 1, P-cadherin (placental) (CDH3), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [pmid 2793940] [evidence TAS]; visual perception [goid 7601] [evidence IEA]; homophilic cell adhesion [goid 7156] [evidence IEA],protein binding [goid 5515] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],16,67290098-67290147,16q22.1c,+,NM_001793.3,1001,CDH3,2.798268644500861,8.385599524481298,15.240699769539482,1.5293701112993548e-33,3.2041504907725125e-32,65.46858397123843
GLUL,ILMN_1653496,"Homo sapiens glutamate-ammonia ligase (glutamine synthetase) (GLUL), transcript variant 2, mRNA.",,nitrogen compound metabolism [goid 6807] [evidence IEA]; regulation of neurotransmitter levels [goid 1505] [evidence NR ]; glutamine biosynthesis [goid 6542] [evidence IEA],ligase activity [goid 16874] [evidence IEA]; glutamate-ammonia ligase activity [goid 4356] [evidence IEA],1,180618492-180618541,1q25.3c,-,NM_001033044.1,2752,GLUL,-1.0023507629853539,5.924579233601353,-15.23016776306736,1.6367145601594844e-33,3.4254586736057493e-32,65.40089063551935
GPR65,ILMN_1734740,"Homo sapiens G protein-coupled receptor 65 (GPR65), mRNA.",integral to plasma membrane [goid 5887] [pmid 9655242] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 9655242] [evidence TAS]; membrane [goid 16020] [evidence IEA],immune response [goid 6955] [pmid 9655242] [evidence TAS]; apoptosis [goid 6915] [pmid 9655242] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9655242] [evidence TAS]; development [goid 7275] [pmid 9655242] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; immune response [goid 6955] [pmid 9655242] [evidence TAS]; apoptosis [goid 6915] [pmid 9655242] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9655242] [evidence TAS]; development [goid 7275] [pmid 9655242] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],14,87547553-87547602,14q31.3c,+,NM_003608.2,8477,GPR65,-1.3328211563281114,6.776075910664704,-15.222991467907812,1.7141489877374175e-33,3.580030578982281e-32,65.35476142433235
C22orf18,ILMN_1668814,"Homo sapiens centromere protein M (CENPM), transcript variant 1, mRNA.","chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromosome, pericentric region [goid 775] [evidence IEA]",,,22,40669560-40669609,22q13.2b,-,NM_024053.3,79019,C22orf18,1.5418254418123745,6.119031936004768,15.217423501795373,1.7767485973612028e-33,3.7030402016669733e-32,65.31896812730461
APIN,ILMN_1729851,"Homo sapiens APin protein (APIN), mRNA.",,,,4,71103111-71103160,4q13.3a,+,NM_017855.2,54959,APIN,-1.337052208539637,5.931660981277389,-15.214591002462766,1.8094674846858994e-33,3.767307537314826e-32,65.30075878444308
PTHR1,ILMN_1795166,"Homo sapiens parathyroid hormone receptor 1 (PTHR1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; nucleus [goid 5634] [pmid 10709993] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9745456] [evidence TAS]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [pmid 10709993] [evidence TAS],"skeletal development [goid 1501] [pmid 9745456] [evidence TAS]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 9927325] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]",parathyroid hormone receptor activity [goid 4991] [pmid 9927325] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [evidence IEA],3,46920155-46920204,3p21.31h,+,NM_000316.2,5745,PTHR1,-1.6926777850486419,8.335068802807818,-15.210724579758562,1.85510588216098e-33,3.8543051391772475e-32,65.27590175722607
BUB1,ILMN_2202948,"Homo sapiens BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) (BUB1), mRNA.",spindle pole body [goid 5816] [pmid 9660858] [evidence TAS]; kinetochore [goid 776] [pmid 9660858] [evidence TAS]; nucleus [goid 5634] [evidence IEA],cell proliferation [goid 8283] [pmid 9790499] [evidence TAS]; mitosis [goid 7067] [evidence IEA]; mitotic spindle checkpoint [goid 7094] [pmid 9790499] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; cell division [goid 51301] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA],2,111112194-111112208:111113791-111113825,2q13b,-,NM_004336.2,699,BUB1,1.7082104241374392,6.297424669163086,15.209270811382531,1.8725625734298076e-33,3.886538586014896e-32,65.26655529423107
PPM1M,ILMN_1657810,"Homo sapiens protein phosphatase 1M (PP2C domain containing) (PPM1M), mRNA.",nucleus [goid 5634] [evidence ISS],protein amino acid dephosphorylation [goid 6470] [evidence ISS],hydrolase activity [goid 16787] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; phosphoprotein phosphatase activity [goid 4721] [evidence IEA]; CTD phosphatase activity [goid 8420] [evidence ISS]; manganese ion binding [goid 30145] [evidence ISS],3,52259576-52259625,3p21.1d,+,NM_144641.1,132160,PPM1M,-1.0091133625586792,10.312237606321705,-15.205384535652891,1.920040692314553e-33,3.9809506913813033e-32,65.24156922524023
LOC652888,ILMN_1703060,"PREDICTED: Homo sapiens similar to synaptotagmin XV isoform b (LOC652888), mRNA.",,,,,,,,XM_942613.1,652888,LOC652888,-1.276834531907486,5.515881701690594,-15.202895381682442,1.9510819658855447e-33,4.0411229786167684e-32,65.22556514577072
WNT2,ILMN_1694011,"Homo sapiens wingless-type MMTV integration site family member 2 (WNT2), mRNA.",extracellular region [goid 5576] [pmid 2971536] [evidence NAS],development [goid 7275] [evidence NAS]; frizzled-2 signaling pathway [goid 7223] [evidence IEA],extracellular matrix structural constituent [goid 5201] [evidence NAS]; signal transducer activity [goid 4871] [evidence IEA],7,116704775-116704824,7q31.2c,-,NM_003391.1,7472,WNT2,-1.4511673614599072,7.107512038983418,-15.19568260863738,2.043897696791807e-33,4.224618297253148e-32,65.17918806490184
TMEM54,ILMN_2059689,"Homo sapiens transmembrane protein 54 (TMEM54), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],glycolysis [goid 6096] [evidence IEA],pyruvate kinase activity [goid 4743] [evidence IEA],1,33132955-33132992:33132993-33133004,1p35.1b,-,NM_033504.2,113452,TMEM54,1.3898796876321935,9.949344454541325,15.193148504305897,2.0775465303861454e-33,4.289736943236945e-32,65.16289330710292
HOXA2,ILMN_1799836,"Homo sapiens homeobox A2 (HOXA2), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],7,27106946-27106995,7p15.2a,-,NM_006735.3,3199,HOXA2,-1.2921205584418258,6.132859226307725,-15.189812530920237,2.1226904357498216e-33,4.3784319833487043e-32,65.14144172185061
ZNF692,ILMN_1800750,"Homo sapiens zinc finger protein 692 (ZNF692), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],1,247111025-247111031:247111032-247111074,1q44f,-,NM_017865.2,55657,ZNF692,1.4611591513314872,8.05369767165125,15.186442846178236,2.169288181942701e-33,4.4607521011623396e-32,65.11977259695007
MS4A4A,ILMN_1741712,"Homo sapiens membrane-spanning 4-domains, subfamily A, member 4 (MS4A4A), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],11,59832682-59832731,11q12.2a,+,NM_148975.1,51338,MS4A4A,-1.3512158249113453,6.617826271261061,-15.18219055854085,2.2295562135716286e-33,4.5799754333820477e-32,65.09242670525039
SMPDL3B,ILMN_1678095,"Homo sapiens sphingomyelin phosphodiesterase, acid-like 3B (SMPDL3B), transcript variant 1, mRNA.",,metabolism [goid 8152] [evidence IEA]; metabolism [goid 8152] [evidence IEA],"hydrolase activity, acting on glycosyl bonds [goid 16798] [evidence IEA]; hydrolase activity, acting on glycosyl bonds [goid 16798] [evidence IEA]",1,28155132-28155180:28157574-28157574,1p35.3b,+,NM_014474.2,27293,SMPDL3B,1.6668355379096385,7.377153631750655,15.179651939180362,2.266332873018925e-33,4.650747499832067e-32,65.07610060392291
TBC1D3B,ILMN_2153679,"Homo sapiens TBC1 domain family, member 3B (TBC1D3B), mRNA.",,,,17,31517652-31517701,17q12b,-,NM_001001417.4,414059,TBC1D3B,1.6617326625380437,7.066132655525484,15.163779588763713,2.5104568622803667e-33,5.141168976510294e-32,64.97401419998414
TPPP,ILMN_1718687,"Homo sapiens brain-specific protein p25 alpha (TPPP), mRNA.",,,,5,714007-714056,5p15.33e,-,NM_007030.1,11076,TPPP,-1.6877313896406108,6.220310826917288,-15.154857260232756,2.659077486331414e-33,5.434404734067306e-32,64.91662093390619
MGC15619,ILMN_1815168,"Homo sapiens hypothetical protein MGC15619 (MGC15619), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 16554753] [evidence IDA]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; response to pH [goid 9268] [pmid 16556803] [evidence ISS]; response to zinc ion [goid 10043] [pmid 16556803] [evidence ISS]; proton transport [goid 15992] [pmid 16556803] [evidence ISS]; cation transport [goid 6812] [evidence IEA],ion channel activity [goid 5216] [evidence IEA]; voltage-gated proton channel activity [goid 30171] [pmid 16556803] [evidence ISS]; cation channel activity [goid 5261] [evidence IEA]; voltage-gated ion channel activity [goid 5244] [evidence IEA],12,109571013-109571062,12q24.11d,-,NM_032369.1,84329,MGC15619,-1.2050936106318701,6.496188208117417,-15.136042197885182,3.002008297156517e-33,6.128998164235469e-32,64.79557483503451
TBC1D3G,ILMN_2068991,"Homo sapiens TBC1 domain family, member 3G (TBC1D3G), mRNA.",,,,17,31871671-31871720,17q12b,-,NM_001040282.1,654341,TBC1D3G,1.3558156710628726,6.8258254716678906,15.121927829406273,3.288047230330222e-33,6.706141588628653e-32,64.70475508274234
PCNXL3,ILMN_1783350,"PREDICTED: Homo sapiens pecanex-like 3 (Drosophila), transcript variant 4 (PCNXL3), mRNA.",,,,,,11q13.1d,,XM_941490.1,399909,PCNXL3,1.313874919835774,8.812329828467075,15.119025775805298,3.350161511846914e-33,6.825868791143896e-32,64.68608001311797
MOSC2,ILMN_1665775,"Homo sapiens MOCO sulphurase C-terminal domain containing 2 (MOSC2), mRNA.",mitochondrion [goid 5739] [evidence ISS],transport [goid 6810] [evidence IEA],,1,219021878-219021897:219023884-219023913,1q41d,+,NM_017898.3,54996,MOSC2,-1.6031692634070716,7.709882901308461,-15.104859372962569,3.670664888406778e-33,7.456107927638864e-32,64.59490952029336
CST1,ILMN_1753449,"Homo sapiens cystatin SN (CST1), mRNA.",,,cysteine protease inhibitor activity [goid 4869] [pmid 3446578] [evidence TAS],20,23676424-23676452:23676453-23676473,20p11.21b,-,NM_001898.2,1469,CST1,3.9748301314213492,7.097791332385409,15.10398812601888,3.691349996480153e-33,7.490520357969056e-32,64.58930201987613
TMEM16F,ILMN_1674941,"Homo sapiens transmembrane protein 16F (TMEM16F), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,12,44111807-44111856,12q12h,+,NM_001025356.1,196527,TMEM16F,-1.2760047192333435,9.452047223417859,-15.099840860657519,3.791426256500894e-33,7.685801067889552e-32,64.56260879961897
FCER1A,ILMN_1688423,"Homo sapiens Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A), mRNA.",plasma membrane [goid 5886] [pmid 1535625] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 2964640] [evidence TAS],immune response [goid 6955] [evidence NR ],receptor activity [goid 4872] [evidence IEA]; IgE binding [goid 19863] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence NR ],1,157544285-157544334,1q23.2a,+,NM_002001.2,2205,FCER1A,-2.684613950262559,8.629822894496606,-15.09692000322744,3.863535168246733e-33,7.824049761769296e-32,64.54380848482118
PHACTR1,ILMN_1736982,"Homo sapiens phosphatase and actin regulator 1 (PHACTR1), mRNA.",,,protein phosphatase inhibitor activity [goid 4864] [evidence IEA]; actin binding [goid 3779] [evidence IEA],6,13391737-13391773:13394357-13394369,6p24.1a,+,NM_030948.1,221692,PHACTR1,-1.4547426360398203,6.9181825196816025,-15.093497330995026,3.949782557784009e-33,7.990621781207528e-32,64.52177749186377
RARRES2,ILMN_1810844,"Homo sapiens retinoic acid receptor responder (tazarotene induced) 2 (RARRES2), mRNA.",,retinoid metabolism [goid 1523] [pmid 9204961] [evidence IDA],,7,149666666-149666715,7q36.1c,-,NM_002889.2,5919,RARRES2,-1.4386296524110271,11.87306793789835,-15.086451049518454,4.133460653761375e-33,8.345336100954348e-32,64.47641970954469
PLXNB3,ILMN_1686313,"Homo sapiens plexin B3 (PLXNB3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],development [goid 7275] [evidence IEA],receptor activity [goid 4872] [evidence IEA],X,152697649-152697688:152697689-152697698,Xq28f,+,NM_005393.1,5365,PLXNB3,1.4741171518295682,5.591475450488901,15.074530833120534,4.463878551031982e-33,8.994288222462024e-32,64.39968044421157
MEIS1,ILMN_1705685,"Homo sapiens Meis homeobox 1 (MEIS1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [pmid 7565694] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],2,66652810-66652859,2p14b,+,NM_002398.2,4211,MEIS1,-1.233556480958411,8.195214164854782,-15.072736931200746,4.5158442765844893e-33,9.089840270211516e-32,64.38813096906156
TRIM46,ILMN_1770865,"Homo sapiens tripartite motif-containing 46 (TRIM46), mRNA.",intracellular [goid 5622] [evidence IEA],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],1,153423851-153423900,1q22a,+,NM_025058.3,80128,TRIM46,1.4279495296694016,5.732677113033674,15.066666935295022,4.6962156176638156e-33,9.443405233991721e-32,64.34904965606907
FGD3,ILMN_1772686,"Homo sapiens FYVE, RhoGEF and PH domain containing 3 (FGD3), mRNA.",intracellular [goid 5622] [evidence IEA]; cytoplasm [goid 5737] [evidence ISS]; Golgi apparatus [goid 5794] [evidence ISS]; cytoskeleton [goid 5856] [evidence IEA]; ruffle [goid 1726] [evidence ISS]; lamellipodium [goid 30027] [evidence ISS],cytoskeleton organization and biogenesis [goid 7010] [evidence ISS]; actin cytoskeleton organization and biogenesis [goid 30036] [evidence ISS]; regulation of Rho protein signal transduction [goid 35023] [evidence IEA]; regulation of cell shape [goid 8360] [evidence ISS]; filopodium formation [goid 46847] [evidence ISS]; regulation of Cdc42 GTPase activity [goid 43088] [evidence ISS],metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA]; small GTPase binding [goid 31267] [evidence ISS]; protein binding [goid 5515] [evidence ISS],9,94838248-94838297,9q22.31b,+,NM_033086.1,89846,FGD3,-1.3236248778761368,9.790863321239113,-15.059821460123528,4.908303317491859e-33,9.859973170318989e-32,64.30497260452431
DENND2A,ILMN_1666503,"Homo sapiens DENN/MADD domain containing 2A (DENND2A), mRNA.",,,,7,139864739-139864788,7q34c,-,NM_015689.2,27147,DENND2A,-1.6028854496774958,8.962456047862446,-15.056678711079398,5.008860137231456e-33,1.0051883011607518e-31,64.28473587182592
KLF6,ILMN_1700727,"Homo sapiens Kruppel-like factor 6 (KLF6), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 9689109] [evidence TAS]; nucleus [goid 5634] [pmid 9689109] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]; B cell differentiation [goid 30183] [pmid 9000136] [evidence NAS]; cell growth [goid 16049] [pmid 9000136] [evidence NAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]; B cell differentiation [goid 30183] [pmid 9000136] [evidence NAS]; cell growth [goid 16049] [pmid 9000136] [evidence NAS]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcriptional activator activity [goid 16563] [pmid 9689109] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcriptional activator activity [goid 16563] [pmid 9689109] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA],10,3808441-3808490,10p15.1e,-,NM_001008490.1,1316,KLF6,-1.3350203941800256,9.855666912913096,-15.04426121886637,5.4267716316406975e-33,1.0879643968523754e-31,64.20477115764058
RNASE4,ILMN_1696974,"Homo sapiens ribonuclease, RNase A family, 4 (RNASE4), transcript variant 1, mRNA.",cellular component unknown [goid 8372] [pmid 7742370] [evidence ND ],mRNA cleavage [goid 6379] [pmid 7742370] [evidence NAS],pancreatic ribonuclease activity [goid 4522] [pmid 7742370] [evidence NAS]; nucleic acid binding [goid 3676] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],14,20231551-20231600,14q11.2b,+,NM_194430.1,6038,RNASE4,-1.668564038401188,8.917609919542606,-15.040824246734031,5.548494619779026e-33,1.1112540575829706e-31,64.18263639534041
SLFN13,ILMN_2215862,"Homo sapiens schlafen family member 13 (SLFN13), mRNA.",intracellular [goid 5622] [pmid 11256614] [evidence IDA],,,17,30786595-30786644,17q12a,-,NM_144682.3,146857,SLFN13,1.7109156670267556,6.7057364321183375,15.028038576807806,6.025812250222705e-33,1.2044400749496092e-31,64.10028757674414
POMT2,ILMN_1678805,"Homo sapiens protein-O-mannosyltransferase 2 (POMT2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],,"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; mannosyltransferase activity [goid 30] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [goid 4169] [evidence IEA]",14,76811245-76811294,14q24.3c,-,NM_013382.3,29954,POMT2,1.2467326402636454,7.549860622512932,15.022654808948719,6.238908556883707e-33,1.2457892455701517e-31,64.06560915365756
LOC650580,ILMN_1736701,"PREDICTED: Homo sapiens hypothetical protein LOC650580 (LOC650580), mRNA.",,,,,,,,XM_942530.1,650580,LOC650580,1.3711310296913162,5.869893888273311,15.018168523061544,6.422235798468201e-33,1.2798415722684438e-31,64.0367102639446
PRSS22,ILMN_1776925,"Homo sapiens protease, serine, 22 (PRSS22), mRNA.",,,serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],16,2842952-2843001,16p13.3d,-,NM_022119.3,64063,PRSS22,1.3017245068295438,5.947613730222141,15.015874729892472,6.518043936196473e-33,1.2976420206509355e-31,64.02193405560553
LOC89944,ILMN_2144401,"Homo sapiens hypothetical protein BC008326 (LOC89944), mRNA.",beta-galactosidase complex [goid 9341] [evidence IEA],carbohydrate metabolism [goid 5975] [evidence IEA],beta-galactosidase activity [goid 4565] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA],11,133750797-133750846,11q25e,+,NM_138342.2,89944,LOC89944,2.3043049407507716,7.1489976271009414,15.007567360908766,6.877168226755299e-33,1.3650656989776958e-31,63.968416663678035
XRCC3,ILMN_1696266,"Homo sapiens X-ray repair complementing defective repair in Chinese hamster cells 3 (XRCC3), mRNA.",nucleus [goid 5634] [evidence IEA],DNA recombination [goid 6310] [pmid 9660962] [evidence TAS]; DNA repair [goid 6281] [pmid 9660962] [evidence TAS],DNA binding [goid 3677] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; DNA-dependent ATPase activity [goid 8094] [evidence IEA],14,103233872-103233921,14q32.33a,-,NM_005432.2,7517,XRCC3,1.1802571046969303,6.40330294306489,15.007567090105058,6.877180250747289e-33,1.3650656989776958e-31,63.96841491904616
ETS2,ILMN_1720158,"Homo sapiens v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) (ETS2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; skeletal development [goid 1501] [pmid 8596630] [evidence TAS]",transcription factor activity [goid 3700] [pmid 8596630] [evidence NAS],21,39118265-39118314,21q22.2a,+,NM_005239.4,2114,ETS2,-1.349788576857529,10.473189758077325,-15.005671633993007,6.961858614065216e-33,1.3805041342935268e-31,63.95620347633557
SNURF,ILMN_1656537,"Homo sapiens SNRPN upstream reading frame (SNURF), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 10318933] [evidence NAS],,,15,22770551-22770600,15q11.2e,+,NM_005678.3,8926,SNURF,-1.0974898889602036,7.88655150001405,-14.994192413123493,7.497469411258301e-33,1.4852412671332287e-31,63.882243943841324
C1orf188,ILMN_1789058,"Homo sapiens chromosome 1 open reading frame 188 (C1orf188), mRNA.",,,,1,6202992-6203041,1p36.31b-p36.31a,+,NM_173795.2,148646,C1orf188,1.4375361048776734,6.467483687839006,14.989550423110163,7.725607063850301e-33,1.528921326741017e-31,63.85233368146536
HS6ST2,ILMN_1739429,"Homo sapiens heparan sulfate 6-O-sulfotransferase 2 (HS6ST2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,transferase activity [goid 16740] [evidence IEA],X,131587967-131588016,Xq26.2a-q26.2b,-,NM_147175.2,90161,HS6ST2,2.106060537365214,6.209468952347403,14.985008870766158,7.955536104396894e-33,1.5713165486354694e-31,63.82306926834129
EIF4E3,ILMN_1796146,"Homo sapiens eukaryotic translation initiation factor 4E family member 3 (EIF4E3), mRNA.",cytoplasm [goid 5737] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],translational initiation [goid 6413] [evidence IEA]; translational initiation [goid 6413] [evidence IEA],RNA binding [goid 3723] [evidence IEA]; translation initiation factor activity [goid 3743] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; translation initiation factor activity [goid 3743] [evidence IEA],3,71815183-71815232,3p13d,-,NM_173359.3,317649,EIF4E3,-1.2347770965085312,8.256470483247329,-14.983675488522735,8.024334922609836e-33,1.5833421413370572e-31,63.81447710343571
H1F0,ILMN_1757467,"Homo sapiens H1 histone family, member 0 (H1F0), mRNA.",nucleosome [goid 786] [evidence IEA]; chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA],nucleosome assembly [goid 6334] [evidence IEA]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [evidence IEA],DNA binding [goid 3677] [evidence IEA],22,36533168-36533217,22q13.1a,+,NM_005318.2,3005,H1F0,1.17631503050678,11.633972221000755,14.981647746417714,8.130104667926123e-33,1.6010544704317505e-31,63.80141034789823
FLJ20152,ILMN_1811330,"Homo sapiens hypothetical protein FLJ20152 (FLJ20152), mRNA.",,,,5,16526588-16526637,5p15.1b,-,NM_019000.2,54463,FLJ20152,-1.5310497973638046,6.844780815694742,-14.97754156581126,8.348584658221513e-33,1.640849526932181e-31,63.77494935973157
C1orf112,ILMN_1727540,"Homo sapiens chromosome 1 open reading frame 112 (C1orf112), mRNA.",,,binding [goid 5488] [evidence IEA],1,168088633-168088682,1q24.2c,+,NM_018186.2,55732,C1orf112,1.3332840397033872,7.041850542941647,14.976424939837752,8.409008069364339e-33,1.6494846416847225e-31,63.76775343246742
STARD8,ILMN_1799600,"Homo sapiens START domain containing 8 (STARD8), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],GTPase activator activity [goid 5096] [evidence IEA],X,67862329-67862378,Xq13.1a,+,NM_014725.2,9754,STARD8,-1.5040414576858971,7.855249798555857,-14.970256278627163,8.750790115630776e-33,1.7148463137467243e-31,63.727999021870765
MGC35295,ILMN_1721088,"Homo sapiens hypothetical protein MGC35295 (MGC35295), mRNA.",integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA],11,60300600-60300649,11q12.2a,+,NM_152717.1,219995,MGC35295,-2.737597862489361,7.397876405001943,-14.965537734289194,9.021589209858415e-33,1.7661835314172915e-31,63.697588395901725
LYL1,ILMN_2216582,"Homo sapiens lymphoblastic leukemia derived sequence 1 (LYL1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription regulator activity [goid 30528] [evidence IEA]; DNA binding [goid 3677] [pmid 2752424] [evidence TAS],19,,19p13.13b,-,NM_005583.3,4066,LYL1,-1.2999276790211525,10.2990562635282,-14.96177049455126,9.243805800174814e-33,1.807918538122167e-31,63.67330785216078
ATP10B,ILMN_1698804,"PREDICTED: Homo sapiens ATPase, Class V, type 10B (ATP10B), mRNA.",,,,5,159922890-159922939,5q34a,-,XM_927593.1,23120,ATP10B,2.632814621726208,6.3210036083556735,14.950309644103823,9.954121418133088e-33,1.9449420052149105e-31,63.59943516289352
TMEM63A,ILMN_1719649,"Homo sapiens transmembrane protein 63A (TMEM63A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,nucleotide binding [goid 166] [evidence IEA],1,224100110-224100159,1q42.12c,-,NM_014698.1,9725,TMEM63A,1.5572659500417263,8.61946822719138,14.946033342576111,1.0232942914762047e-32,1.9974704569615515e-31,63.571869510132665
C20orf42,ILMN_1696585,"Homo sapiens chromosome 20 open reading frame 42 (C20orf42), mRNA.",cytoskeleton [goid 5856] [evidence IEA],,binding [goid 5488] [evidence IEA],20,6004160-6004209,20p12.3c,-,NM_017671.3,55612,C20orf42,1.8186228401547844,6.187195913157535,14.942029728876108,1.050107051170185e-32,2.0478110993969845e-31,63.54606061629526
NAG8,ILMN_1655961,"Homo sapiens nasopharyngeal carcinoma associated gene protein-8 (NAG8), mRNA.",,,,7,127427193-127427242,7q32.1a,+,NM_014411.2,27099,NAG8,2.4985697010514425,7.741813627550974,14.938221871631168,1.0762614192446354e-32,2.096771029819539e-31,63.52151272767804
SLA,ILMN_1667371,"Homo sapiens Src-like-adaptor (SLA), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA],SH3/SH2 adaptor activity [goid 5070] [pmid 7543898] [evidence TAS],8,134118388-134118437,8q24.22c,-,NM_006748.1,6503,SLA,-1.1156494629145541,7.501429072738581,-14.930199046745859,1.1335215050261045e-32,2.2061768747628693e-31,63.469789528970345
SEPT10,ILMN_1691864,"Homo sapiens septin 10 (SEPT10), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],2,109659184-109659190:109660916-109660958,2q13a,-,NM_144710.2,151011,SEPT10,-1.489884029329227,6.802867620994479,-14.928905289226682,1.143036780252408e-32,2.2225344897269366e-31,63.461448295656744
LOC387763,ILMN_1677402,"PREDICTED: Homo sapiens hypothetical LOC387763 (LOC387763), mRNA.",,,,11,43921776-43921825,11p11.2e,+,XM_373497.4,387763,LOC387763,-1.989039335296491,11.855891955125795,-14.925035893743836,1.1719753468953307e-32,2.276590557347745e-31,63.436500556714726
C10orf56,ILMN_1754660,"Homo sapiens chromosome 10 open reading frame 56 (C10orf56), mRNA.",,,nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],10,80812398-80812447,10q22.3e,-,NM_153367.1,219654,C10orf56,-1.004955860711041,9.447606080632298,-14.919972599233938,1.2109540990796258e-32,2.3477489936419724e-31,63.40385382379818
IRF8,ILMN_1666594,"Homo sapiens interferon regulatory factor 8 (IRF8), mRNA.",nucleus [goid 5634] [evidence IEA],"immune response [goid 6955] [pmid 8861914] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 1460054] [evidence TAS]","RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [pmid 1460054] [evidence TAS]",16,84513378-84513427,16q24.1b,+,NM_002163.2,3394,IRF8,-1.4632332947025404,9.9578254694750985,-14.913256648098152,1.2646660271618977e-32,2.447140993370914e-31,63.36054879165875
SLC6A4,ILMN_1683694,"Homo sapiens solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 (SLC6A4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7681602] [evidence TAS],serotonin transport [goid 6837] [pmid 7681602] [evidence TAS]; neurotransmitter uptake [goid 1504] [pmid 7681602] [evidence TAS]; monoamine transport [goid 15844] [pmid 16024787] [evidence IDA],serotonin transporter activity [goid 15222] [pmid 7681602] [evidence TAS]; symporter activity [goid 15293] [evidence IEA]; serotonin:sodium symporter activity [goid 5335] [evidence IEA]; protein binding [goid 5515] [pmid 11343649] [evidence IPI]; monoamine transporter activity [goid 8504] [pmid 16024787] [evidence IDA],17,25549322-25549371,17q11.2c,-,NM_001045.2,6532,SLC6A4,-3.6298330924455797,6.588915589119418,-14.907291144465647,1.3143739603127671e-32,2.540869004631676e-31,63.322080397991236
CLDN9,ILMN_1740276,"Homo sapiens claudin 9 (CLDN9), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence ISS]; tight junction [goid 5923] [evidence ISS],calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA],16,3004266-3004315,16p13.3d,+,NM_020982.2,9080,CLDN9,1.6249435328698834,6.2219440697761454,14.900368061753197,1.37451933688864e-32,2.6545736382691034e-31,63.27743436110365
LOC653764,ILMN_1677946,"PREDICTED: Homo sapiens similar to muscle RAS oncogene homolog (LOC653764), mRNA.",,,,3,139605911-139605956:139606331-139606334,,+,XM_929539.1,653764,LOC653764,-1.1943790371622347,5.69707961939805,-14.896781928504984,1.4067503461414016e-32,2.714200667849292e-31,63.25430671996599
FBXL6,ILMN_1799389,"Homo sapiens F-box and leucine-rich repeat protein 6 (FBXL6), transcript variant 1, mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; ubiquitin conjugating enzyme activity [goid 4840] [pmid 10531035] [evidence TAS]; ubiquitin-protein ligase activity [goid 4842] [pmid 10531035] [evidence TAS],8,145549935-145549984,8q24.3h,-,NM_012162.1,26233,FBXL6,1.02213458495884,8.051552784939767,14.8923668293995,1.4474733398555185e-32,2.787396206335824e-31,63.22583185137011
PLXNA3,ILMN_1719972,"Homo sapiens plexin A3 (PLXNA3), mRNA.",membrane [goid 16020] [pmid 8570614] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],development [goid 7275] [pmid 8570614] [evidence TAS],transmembrane receptor activity [goid 4888] [pmid 8570614] [evidence NAS]; receptor activity [goid 4872] [evidence IEA],X,153354914-153354963,Xq28g,+,NM_017514.2,55558,PLXNA3,1.4650292169205548,8.373414526189466,14.881415965579052,1.5536487132379396e-32,2.9889811013908364e-31,63.15519993695691
PA2G4,ILMN_1728984,"Homo sapiens proliferation-associated 2G4, 38kDa (PA2G4), mRNA.",nucleus [goid 5634] [pmid 7556453] [evidence TAS],cell proliferation [goid 8283] [pmid 7556453] [evidence TAS]; cell cycle arrest [goid 7050] [pmid 7556453] [evidence TAS],methionyl aminopeptidase activity [goid 4239] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; cobalt ion binding [goid 50897] [evidence IEA],12,54793008-54793057,12q13.2c,+,NM_006191.1,5036,PA2G4,1.1730514358752622,9.986162842855375,14.865015946759348,1.7274223180406967e-32,3.3137359289892863e-31,63.04940802514181
Ells1,ILMN_1672605,"Homo sapiens hypothetical protein Ells1 (Ells1), mRNA.",,,,7,30168829-30168878,7p15.1b,+,NM_152793.1,222166,Ells1,-1.5226815461391894,10.280582092161914,-14.85674835108759,1.8222748681739046e-32,3.4923444025309847e-31,62.996069969987325
SPAG4,ILMN_1684620,"Homo sapiens sperm associated antigen 4 (SPAG4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],spermatogenesis [goid 7283] [pmid 9691178] [evidence TAS],structural molecule activity [goid 5198] [pmid 9691178] [evidence TAS],20,33670934-33670983,20q11.22b,+,NM_003116.1,6676,SPAG4,1.8902829461198367,6.754283520182025,14.85198301684602,1.87929842877632e-32,3.5981821017183354e-31,62.96532475504899
ALDH18A1,ILMN_2302716,"Homo sapiens aldehyde dehydrogenase 18 family, member A1 (ALDH18A1), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],proline biosynthesis [goid 6561] [pmid 8761662] [evidence TAS]; amino acid biosynthesis [goid 8652] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; glutamate 5-kinase activity [goid 4349] [evidence IEA]; glutamate-5-semialdehyde dehydrogenase activity [goid 4350] [evidence IEA]; N-acetyl-gamma-glutamyl-phosphate reductase activity [goid 3942] [evidence NR ],10,97355874-97355923,10q23.33d,-,NM_002860.3,5832,ALDH18A1,1.2353850841393612,9.291491271993358,14.849828318492046,1.9056656611145552e-32,3.645177681413004e-31,62.95142252285182
UBB,ILMN_1762436,"Homo sapiens ubiquitin B (UBB), mRNA.",,protein modification [goid 6464] [evidence IEA]; protein modification [goid 6464] [evidence IEA],,17,16225155-16225204,17p11.2i,+,NM_018955.2,7314,UBB,-1.1000769393076855,13.719092834297387,-14.84508561016931,1.965015201680225e-32,3.7551121447199564e-31,62.920821334047154
PRKCDBP,ILMN_1793476,"Homo sapiens protein kinase C, delta binding protein (PRKCDBP), mRNA.",,,kinase activity [goid 16301] [evidence IEA],11,6296938-6296968:6296969-6296987,11p15.4c,-,NM_145040.2,112464,PRKCDBP,-1.3999358936252957,10.627812256234906,-14.843444636255231,1.9859782648118454e-32,3.79155087045376e-31,62.910233031588625
TSCOT,ILMN_1707585,"Homo sapiens solute carrier family 46, member 2 (SLC46A2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 10978518] [evidence NAS],transport [goid 6810] [evidence NAS]; tetracycline transport [goid 15904] [evidence IEA],symporter activity [goid 15293] [pmid 10978518] [evidence NAS]; tetracycline:hydrogen antiporter activity [goid 15520] [evidence IEA],9,114681119-114681168,9q32b,-,NM_033051.2,57864,TSCOT,-1.5302687874993781,8.475103254948516,-14.84185163471844,2.0065427137014292e-32,3.8271598299083122e-31,62.8999541154521
SFTPC,ILMN_2206949,"Homo sapiens surfactant, pulmonary-associated protein C (SFTPC), mRNA.",extracellular space [goid 5615] [evidence NR ]; extracellular region [goid 5576] [evidence IEA],regulation of liquid surface tension [goid 50828] [evidence IEA]; respiratory gaseous exchange [goid 7585] [evidence IEA],,8,22077751-22077800,8p21.3a,+,NM_003018.2,6440,SFTPC,-3.9927364744543272,12.91047985505636,-14.827593749868894,2.200363604852552e-32,4.192845238656177e-31,62.807947755506085
REEP1,ILMN_1733746,"Homo sapiens receptor accessory protein 1 (REEP1), mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,2,86294886-86294935,2p11.2f,-,NM_022912.1,65055,REEP1,-1.9255077654317985,6.9635004254475925,-14.827354710505904,2.2037680761512914e-32,4.195336980745485e-31,62.806405128180366
LOC255783,ILMN_1703316,"PREDICTED: Homo sapiens hypothetical protein LOC255783, transcript variant 2 (LOC255783), misc RNA.",,,,,,19q13.32b,,XR_001409.1,255783,LOC255783,-1.202809363923361,10.582755039388815,-14.823639659185389,2.2573621771929958e-32,4.289202511042494e-31,62.78242981637667
TAOK1,ILMN_1758087,"Homo sapiens TAO kinase 1 (TAOK1), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],17,24895361-24895410,17q11.2b,+,NM_020791.1,57551,TAOK1,1.5902226868693194,7.632168822534169,14.815974182638227,2.372106944290725e-32,4.502952157625126e-31,62.73295762369279
PRICKLE2,ILMN_1683148,"Homo sapiens prickle-like 2 (Drosophila) (PRICKLE2), mRNA.",membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],3,64054830-64054879,3p14.1d,-,NM_198859.1,166336,PRICKLE2,-1.1910966243941452,9.229105261749908,-14.815689875031731,2.3764733079781162e-32,4.506964734220488e-31,62.7311226653566
GFOD1,ILMN_1778240,"Homo sapiens glucose-fructose oxidoreductase domain containing 1 (GFOD1), mRNA.",,electron transport [goid 6118] [evidence IEA]; metabolism [goid 8152] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA],6,13471893-13471942,6p24.1a-p23b,-,NM_018988.1,54438,GFOD1,-1.5568418117789928,8.669904629896205,-14.808477061776937,2.489980024253181e-32,4.717757606558489e-31,62.6845686422616
CLIC3,ILMN_1796423,"Homo sapiens chloride intracellular channel 3 (CLIC3), mRNA.",cytoplasm [goid 5737] [pmid 9880541] [evidence IDA]; membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [pmid 9880541] [evidence IDA],signal transduction [goid 7165] [pmid 9880541] [evidence TAS]; chloride transport [goid 6821] [pmid 9880541] [evidence IMP]; ion transport [goid 6811] [evidence IEA],protein binding [goid 5515] [pmid 9880541] [evidence IPI]; voltage-gated chloride channel activity [goid 5247] [evidence IEA],9,139008985-139009034,9q34.3e,-,NM_004669.2,9022,CLIC3,-1.8789315533312099,10.781956594070733,-14.80800495490648,2.497596047842452e-32,4.7277106646387686e-31,62.68152139283158
GPR56,ILMN_1697228,"Homo sapiens G protein-coupled receptor 56 (GPR56), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 10049584] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [pmid 15674329] [evidence IDA]; cell-cell signaling [goid 7267] [pmid 10049584] [evidence TAS]; brain development [goid 7420] [pmid 15044805] [evidence IMP]; neuropeptide signaling pathway [goid 7218] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 15004227] [evidence TAS]; protein binding [goid 5515] [pmid 15004227] [evidence IPI],16,56211486-56211535,16q13d,+,NM_005682.4,9289,GPR56,1.0023658942061537,9.09349933130406,14.804731622881915,2.5510469314251465e-32,4.824323913417234e-31,62.66039306545546
E2F2,ILMN_1777233,"Homo sapiens E2F transcription factor 2 (E2F2), mRNA.",transcription factor complex [goid 5667] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; transcription initiation from RNA polymerase II promoter [goid 6367] [pmid 8246996] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [pmid 8246996] [evidence TAS]; transcription factor activity [goid 3700] [pmid 8246995] [evidence NAS]; protein binding [goid 5515] [pmid 8246996] [evidence TAS],1,23705554-23705603,1p36.12a,-,NM_004091.2,1870,E2F2,1.7479959828537757,7.46537563525454,14.8006442433901,2.619401771425922e-32,4.94891318627855e-31,62.634009438636646
FLJ20054,ILMN_1789436,"Homo sapiens hypothetical protein FLJ20054 (FLJ20054), mRNA.",,,,1,195745406-195745455,1q31.3c,-,NM_019049.1,54530,FLJ20054,1.1787836795652868,9.522751306497113,14.781878723482238,2.957537635770654e-32,5.577230256031973e-31,62.512867391091795
LOC149620,ILMN_1782691,"Homo sapiens similar to CHIA protein (LOC149620), mRNA.",,metabolism [goid 8152] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA],1,111630063-111630112,1p13.2d,+,NM_001013621.1,149620,LOC149620,-3.941728857891115,7.315717776579807,-14.77978260867369,2.997923905134396e-32,5.648066054042279e-31,62.49933451519143
C13orf21,ILMN_1696767,"Homo sapiens chromosome 13 open reading frame 21 (C13orf21), mRNA.",,,,13,43869663-43869712,13q14.11e,+,NM_001010897.1,387923,C13orf21,-1.5178540949530515,7.074263158243627,-14.776459475529396,3.0630862711802364e-32,5.760323614114842e-31,62.47787927815228
LRRC33,ILMN_1746148,"Homo sapiens leucine rich repeat containing 33 (LRRC33), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,transferase activity [goid 16740] [evidence IEA],3,197872952-197872990:197872991-197873001,3q29g,+,NM_198565.1,375387,LRRC33,-1.3270763773679821,7.72182774404327,-14.769459197188787,3.205031162524635e-32,6.021245399041587e-31,62.43268110008261
INT1,ILMN_1793854,"PREDICTED: Homo sapiens integrator complex subunit 1, transcript variant 5 (INT1), mRNA.",,,,7,1476711-1476738:1476739-1476760,7p22.3b,-,XM_931339.1,26173,INT1,1.3577396980671121,8.792734034861923,14.766768556289666,3.2613255989732825e-32,6.12125727807293e-31,62.41530788721753
GYLTL1B,ILMN_1697916,"Homo sapiens glycosyltransferase-like 1B (GYLTL1B), mRNA.",integral to Golgi membrane [goid 30173] [evidence ISS],carbohydrate biosynthesis [goid 16051] [evidence IEA]; myelination [goid 42552] [evidence ISS]; synaptic transmission [goid 7268] [evidence ISS]; glycosphingolipid biosynthesis [goid 6688] [evidence ISS]; muscle maintenance [goid 46716] [evidence ISS]; glycoprotein biosynthesis [goid 9101] [evidence ISS],"transferase activity, transferring hexosyl groups [goid 16758] [evidence IEA]",11,45906880-45906929,11p11.2c,+,NM_152312.2,120071,GYLTL1B,1.1722386017047812,5.676796287203057,14.758000193380935,3.4517432024793656e-32,6.466524156854602e-31,62.3586885129771
CAPN12,ILMN_1787514,"Homo sapiens calpain 12 (CAPN12), mRNA.",intracellular [goid 5622] [evidence IEA],,calpain activity [goid 4198] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],19,43913136-43913185,19q13.2a,-,NM_144691.3,147968,CAPN12,2.239441366980394,7.557950415309542,14.755680675030412,3.503951112239244e-32,6.558190257594274e-31,62.343710101813734
IFI30,ILMN_1807277,"Homo sapiens interferon, gamma-inducible protein 30 (IFI30), mRNA.",lysosome [goid 5764] [pmid 3136170] [evidence TAS]; extracellular region [goid 5576] [pmid 3136170] [evidence TAS],immune response [goid 6955] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA],19,18149528-18149574:18149659-18149661,19p13.11c,+,NM_006332.3,10437,IFI30,-1.6431557730400428,10.525939739737854,-14.75502414732698,3.518871365478762e-32,6.5799605869625295e-31,62.33947048386448
CHAF1B,ILMN_1674231,"Homo sapiens chromatin assembly factor 1, subunit B (p60) (CHAF1B), mRNA.",heterotrimeric G-protein complex [goid 5834] [evidence IEA]; cytoplasm [goid 5737] [pmid 9614144] [evidence NAS]; chromatin assembly complex [goid 5678] [pmid 7600578] [evidence TAS]; nucleus [goid 5634] [pmid 9614144] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; transcription [goid 6350] [evidence IEA]; DNA replication-dependent nucleosome assembly [goid 6335] [pmid 7600578] [evidence TAS]; protein complex assembly [goid 6461] [pmid 7600578] [evidence TAS]; DNA replication [goid 6260] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]",signal transducer activity [goid 4871] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 7600578] [evidence TAS]; histone binding [goid 42393] [pmid 7600578] [evidence NAS]; chromatin binding [goid 3682] [pmid 7600578] [evidence TAS],21,36710816-36710865,21q22.12b-q22.13a,+,NM_005441.2,8208,CHAF1B,1.46723971667479,6.557944502286687,14.75186325725093,3.591601170387342e-32,6.709687788712413e-31,62.31905825627265
GALNT6,ILMN_1677574,"Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) (GALNT6), mRNA.",integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA]; membrane [goid 16020] [evidence IEA],,"manganese ion binding [goid 30145] [evidence IEA]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; polypeptide N-acetylgalactosaminyltransferase activity [goid 4653] [pmid 10464263] [evidence TAS]; sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]",12,50033971-50034020,12q13.13c,-,NM_007210.2,11226,GALNT6,1.8405527625502112,7.341678323085717,14.746752802953752,3.7123870496076957e-32,6.928865679902124e-31,62.28605502915146
LOC440345,ILMN_1656868,"PREDICTED: Homo sapiens hypothetical protein LOC440345, transcript variant 11 (LOC440345), mRNA.",,,,16,21753690-21753739,16p12.1c,-,XM_933731.1,440345,LOC440345,1.450480728641426,8.003035839793741,14.743473710073081,3.7920225685198106e-32,7.070902847245514e-31,62.264877918428404
TBCD,ILMN_1673376,"Homo sapiens tubulin-specific chaperone d (TBCD), transcript variant 1, mRNA.",microtubule [goid 5874] [pmid 8706133] [evidence TAS]; microtubule [goid 5874] [pmid 8706133] [evidence TAS],beta-tubulin folding [goid 7025] [pmid 8706133] [evidence TAS]; protein folding [goid 6457] [pmid 8706133] [evidence TAS]; beta-tubulin folding [goid 7025] [pmid 8706133] [evidence TAS]; protein folding [goid 6457] [pmid 8706133] [evidence TAS],chaperone binding [goid 51087] [pmid 8706133] [evidence TAS]; binding [goid 5488] [evidence IEA]; chaperone binding [goid 51087] [pmid 8706133] [evidence TAS]; binding [goid 5488] [evidence IEA],17,78494084-78494133,17q25.3h,+,NM_005993.3,6904,TBCD,1.0144822963067721,8.336781864681623,14.742941148959684,3.8051167860587485e-32,7.088712910192126e-31,62.261438462561465
ANXA3,ILMN_1694548,"Homo sapiens annexin A3 (ANXA3), mRNA.",cytoplasm [goid 5737] [pmid 16130169] [evidence TAS],signal transduction [goid 7165] [pmid 16130169] [evidence TAS],calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; phospholipase A2 inhibitor activity [goid 19834] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; diphosphoinositol-polyphosphate diphosphatase activity [goid 8486] [evidence NR ],4,79750287-79750293:79750294-79750336,4q21.21a,+,NM_005139.1,306,ANXA3,-2.3650251338555064,8.207869409641619,-14.736805671497685,3.959277071452889e-32,7.3690433158725016e-31,62.22181235569307
PTGIS,ILMN_1667692,"Homo sapiens prostaglandin I2 (prostacyclin) synthase (PTGIS), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],fatty acid biosynthesis [goid 6633] [evidence IEA]; prostaglandin biosynthesis [goid 1516] [evidence IEA]; lipid metabolism [goid 6629] [pmid 8812456] [evidence NAS]; electron transport [goid 6118] [evidence IEA],heme binding [goid 20037] [evidence IEA]; prostaglandin-I synthase activity [goid 8116] [pmid 8812456] [evidence TAS]; isomerase activity [goid 16853] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; monooxygenase activity [goid 4497] [evidence IEA],20,47554109-47554158,20q13.13d,-,NM_000961.3,5740,PTGIS,-1.8278822785271576,8.504182850182817,-14.723619015798233,4.312103346895457e-32,8.010823005077464e-31,62.13663884470591
FGFRL1,ILMN_1795865,"Homo sapiens fibroblast growth factor receptor-like 1 (FGFRL1), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],4,1010460-1010509,4p16.3c,+,NM_001004358.1,53834,FGFRL1,1.243191227632221,7.817897159489385,14.717728943567405,4.479711837748161e-32,8.314478149319592e-31,62.09859129103898
COL1A1,ILMN_1701308,"Homo sapiens collagen, type I, alpha 1 (COL1A1), mRNA.",collagen [goid 5581] [evidence IEA]; collagen type I [goid 5584] [evidence NR ]; cytoplasm [goid 5737] [evidence IEA],epidermis development [goid 8544] [pmid 1303238] [evidence TAS]; skeletal development [goid 1501] [pmid 1874719] [evidence TAS]; phosphate transport [goid 6817] [evidence IEA],extracellular matrix structural constituent [goid 5201] [evidence IEA]; structural constituent of bone [goid 8147] [evidence NR ],17,45616596-45616645,17q21.33a,-,NM_000088.2,1277,COL1A1,2.8571428645924577,11.272695560012576,14.715996793011804,4.5302323365007385e-32,8.400453066608599e-31,62.08740190681018
FUT6,ILMN_1761275,"Homo sapiens fucosyltransferase 6 (alpha (1,3) fucosyltransferase) (FUT6), mRNA.",integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA]; extracellular region [goid 5576] [evidence NR ]; membrane [goid 16020] [evidence IEA],protein amino acid glycosylation [goid 6486] [pmid 11698403] [evidence TAS]; L-fucose catabolism [goid 42355] [pmid 11698403] [evidence NAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; alpha(1,3)-fucosyltransferase activity [goid 46920] [pmid 11698403] [evidence TAS]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [goid 17060] [evidence IEA]",19,5782314-5782363,19p13.3b,-,NM_000150.1,2528,FUT6,1.6705891380103344,6.431300018745691,14.708423074226321,4.757917140938798e-32,8.811624223299308e-31,62.03847505133961
PTGES,ILMN_1713829,"Homo sapiens prostaglandin E synthase (PTGES), mRNA.",membrane fraction [goid 5624] [pmid 10377395] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],prostaglandin metabolism [goid 6693] [pmid 10377395] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ]; signal transduction [goid 7165] [pmid 10377395] [evidence NAS],prostaglandin-E synthase activity [goid 50220] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA],9,131540755-131540804,9q34.11d,-,NM_004878.3,9536,PTGES,2.0640828200314427,7.628682814266743,14.7083302183139,4.7607785812607714e-32,8.811624223299308e-31,62.037875174420556
ILKAP,ILMN_1684647,"Homo sapiens integrin-linked kinase-associated serine/threonine phosphatase 2C (ILKAP), mRNA.",protein serine/threonine phosphatase complex [goid 8287] [evidence IEA],protein amino acid dephosphorylation [goid 6470] [evidence IEA]; integrin-mediated signaling pathway [goid 7229] [evidence IEA],kinase activity [goid 16301] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein serine/threonine phosphatase activity [goid 4722] [evidence IEA],2,238743860-238743909,2q37.3c,-,NM_030768.2,80895,ILKAP,1.1737433889082958,8.526210841309627,14.704365242310711,4.8845843600607136e-32,9.032418103151086e-31,62.012259794922976
C3orf10,ILMN_1764500,"Homo sapiens chromosome 3 open reading frame 10 (C3orf10), mRNA.",,,,3,10143726-10143775,3p25.3b,+,NM_018462.4,55845,C3orf10,-1.0585166393418355,10.361411808026052,-14.704058725559015,4.8942884954636027e-32,9.042005929569322e-31,62.010279533700064
SYT11,ILMN_1717934,"Homo sapiens synaptotagmin XI (SYT11), mRNA.",synapse [goid 45202] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; synaptic vesicle [goid 8021] [evidence IEA],transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],1,154121345-154121394,1q22c,+,NM_152280.2,23208,SYT11,-1.179722065237641,9.652885137630228,-14.695539302473655,5.171872951945017e-32,9.528437755296125e-31,61.95523742923567
VPS24,ILMN_1683827,"Homo sapiens vacuolar protein sorting 24 homolog (S. cerevisiae) (VPS24), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; membrane [goid 16020] [evidence IEA],protein transport [goid 15031] [evidence IEA]; protein transport [goid 15031] [evidence IEA],,2,86584529-86584578,2p11.2e,-,NM_016079.2,51652,VPS24,-1.6703352641821212,9.486355963267888,-14.681650013443456,5.658628203294336e-32,1.0406050835617011e-30,61.865493145682244
PROK2,ILMN_1775257,"Homo sapiens prokineticin 2 (PROK2), mRNA.",extracellular region [goid 5576] [pmid 12466223] [evidence TAS],angiogenesis [goid 1525] [pmid 12604792] [evidence IDA]; spermatogenesis [goid 7283] [pmid 10580115] [evidence IMP]; chemotaxis [goid 6935] [pmid 12604792] [evidence IDA]; anti-apoptosis [goid 6916] [pmid 12604792] [evidence IDA]; cell proliferation [goid 8283] [pmid 12604792] [evidence IDA]; rhythmic process [goid 48511] [evidence IEA]; neuropeptide signaling pathway [goid 7218] [evidence IEA]; positive regulation of smooth muscle contraction [goid 45987] [pmid 11259612] [evidence IDA]; inflammatory response [goid 6954] [pmid 11259612] [evidence NAS],G-protein-coupled receptor binding [goid 1664] [pmid 12728244] [evidence TAS],3,71903840-71903889,3p13d,-,NM_021935.2,60675,PROK2,-2.2608138199928156,6.193031566842289,-14.671319221815436,6.050195563255657e-32,1.1105716773359559e-30,61.798734813891194
RHBDD3,ILMN_1815264,"Homo sapiens rhomboid domain containing 3 (RHBDD3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,22,27986094-27986143,22q12.2a,-,NM_012265.1,25807,RHBDD3,1.206237510713911,7.296829517311369,14.657518276452835,6.615955834795662e-32,1.2133092973656426e-30,61.70954292266919
SIX1,ILMN_1812702,"Homo sapiens sine oculis homeobox homolog 1 (Drosophila) (SIX1), mRNA.",nucleus [goid 5634] [evidence IEA],"muscle development [goid 7517] [pmid 8617500] [evidence TAS]; development [goid 7275] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",protein binding [goid 5515] [pmid 16189514] [evidence IPI]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA],14,60182827-60182876,14q23.1c,-,NM_005982.1,6495,SIX1,1.7889428607684756,6.023068835373811,14.646014601747014,7.127824216726798e-32,1.3047896333784973e-30,61.63518971689289
FRMD3,ILMN_1698725,"Homo sapiens FERM domain containing 3 (FRMD3), mRNA.",membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],,cytoskeletal protein binding [goid 8092] [evidence IEA]; binding [goid 5488] [evidence IEA],9,85052548-85052597,9q21.32b-q21.32c,-,NM_174938.3,257019,FRMD3,-1.6688119383688047,6.771205784077302,-14.642041806772182,7.313660256947996e-32,1.3375842268831398e-30,61.60951015514859
PDE4B,ILMN_1782922,"Homo sapiens phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila) (PDE4B), mRNA.",soluble fraction [goid 5625] [pmid 9371714] [evidence TAS]; insoluble fraction [goid 5626] [pmid 9371714] [evidence TAS],signal transduction [goid 7165] [evidence IEA],"3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]",1,66611705-66611754,1p31.3b,+,NM_002600.2,5142,PDE4B,-1.5125270236568635,7.353711034277769,-14.637291937147056,7.542224578061252e-32,1.3743609231133835e-30,61.578806571368595
C9orf42,ILMN_1723353,"Homo sapiens family with sequence similarity 122A (FAM122A), mRNA.",,,,9,70587743-70587792,9q21.11a,+,NM_138333.3,116224,C9orf42,-1.1145216874325232,7.013938540241359,-14.633228304829522,7.743436050359031e-32,1.4097422065112236e-30,61.55253791585604
KLRD1,ILMN_1797988,"Homo sapiens killer cell lectin-like receptor subfamily D, member 1 (KLRD1), transcript variant 1, mRNA.",plasma membrane [goid 5886] [pmid 7589107] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],cell surface receptor linked signal transduction [goid 7166] [pmid 7589107] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 7589107] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 7589107] [evidence TAS],12,10353263-10353312,12p13.2c,+,NM_002262.2,3824,KLRD1,-1.3676424321216833,5.881820217464174,-14.624053474553165,8.217720361275552e-32,1.4933710171516918e-30,61.493225511420896
DCLRE1C,ILMN_1678464,"Homo sapiens DNA cross-link repair 1C (PSO2 homolog, S. cerevisiae) (DCLRE1C), transcript variant c, mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],immune response [goid 6955] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; DNA recombination [goid 6310] [evidence IEA]; immune response [goid 6955] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; DNA recombination [goid 6310] [evidence IEA],exonuclease activity [goid 4527] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA]; exonuclease activity [goid 4527] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA],10,15024208-15024257,10p13c,-,NM_001033858.1,64421,DCLRE1C,1.4039501801592253,8.03969078530585,14.622365468502325,8.308097244014728e-32,1.508424770038536e-30,61.48231258624731
LRDD,ILMN_2400352,"Homo sapiens leucine-rich repeats and death domain containing (LRDD), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; signal transduction [goid 7165] [evidence IEA]; apoptosis [goid 6915] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; protein binding [goid 5515] [pmid 15073321] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; protein binding [goid 5515] [pmid 15073321] [evidence IPI],11,789511-789560,11p15.5c,-,NM_018494.3,55367,LRDD,1.3953124878753087,7.308966106107012,14.61116153559956,8.933718903805763e-32,1.6205425913630617e-30,61.409875502330316
TFAP2C,ILMN_1683891,"Homo sapiens transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) (TFAP2C), mRNA.",nucleus [goid 5634] [evidence IEA],cell-cell signaling [goid 7267] [pmid 9113991] [evidence TAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 9113991] [evidence TAS],transcription factor activity [goid 3700] [pmid 9113991] [evidence TAS],20,54647265-54647314,20q13.31a,+,NM_003222.3,7022,TFAP2C,1.3572258354882294,7.981794499324623,14.596710488607252,9.810828820722666e-32,1.776425909909675e-30,61.31643484298434
LOC144501,ILMN_1705814,"Homo sapiens hypothetical protein LOC144501 (LOC144501), mRNA.",intermediate filament [goid 5882] [evidence IEA]; intermediate filament [goid 5882] [evidence IEA],,structural molecule activity [goid 5198] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA],12,50849804-50849853,12q13.13d,-,NM_182507.1,144501,LOC144501,1.7365533289778394,6.830461942846263,14.577494488219257,1.111215224875396e-31,2.0084186286636787e-30,61.1921667433267
KIAA1893,ILMN_1653263,"Homo sapiens G protein-regulated inducer of neurite outgrowth 1 (KIAA1893), mRNA.",,,,5,175955597-175955646,5q35.2d,-,NM_052899.1,114787,KIAA1893,1.0229593702444006,5.394251547400178,14.566541155712116,1.1929862912237923e-31,2.154266219747801e-30,61.12132383789413
RAD54L,ILMN_1658027,"Homo sapiens RAD54-like (S. cerevisiae) (RAD54L), mRNA.",nucleus [goid 5634] [pmid 8805304] [evidence TAS],DNA recombination [goid 6310] [pmid 8805304] [evidence TAS]; meiosis [goid 7126] [pmid 8805304] [evidence TAS]; DNA repair [goid 6281] [pmid 8805304] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; helicase activity [goid 4386] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],1,46516548-46516597,1p34.1a-p33d,+,NM_003579.2,8438,RAD54L,1.15394382412466,6.205009921712173,14.562160353181943,1.2273535064481356e-31,2.214327227864229e-30,61.09298834504134
TSPAN32,ILMN_1718621,"Homo sapiens tetraspanin 32 (TSPAN32), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS],cell-cell signaling [goid 7267] [pmid 10950922] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 10950922] [evidence TAS],,11,2295848-2295897,11p15.5a,+,NM_139022.2,10077,TSPAN32,-1.1160748478262192,6.36501109842128,-14.557847273302615,1.262157793432954e-31,2.2730200837989686e-30,61.065089909335846
KDELR2,ILMN_1724293,"Homo sapiens KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 (KDELR2), mRNA.",endoplasmic reticulum [goid 5783] [pmid 1316805] [evidence TAS]; membrane [goid 16020] [evidence IEA]; Golgi apparatus [goid 5794] [pmid 1316805] [evidence TAS]; integral to membrane [goid 16021] [pmid 1325562] [evidence TAS],protein transport [goid 15031] [evidence IEA]; protein retention in ER [goid 6621] [evidence IEA]; intracellular protein transport [goid 6886] [pmid 1325562] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; ER retention sequence binding [goid 46923] [evidence IEA]; KDEL sequence binding [goid 5046] [pmid 1316805] [evidence TAS],7,6469227-6469276,7p22.1b,-,NM_006854.2,11014,KDELR2,1.2156190207047608,10.481077989621058,14.553646032975,1.297009524246319e-31,2.3328569796513944e-30,61.037913956118565
ENG,ILMN_1760778,"Homo sapiens endoglin (Osler-Rendu-Weber syndrome 1) (ENG), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7894484] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA]; circulation [goid 8015] [pmid 7894484] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [pmid 8194490] [evidence TAS],9,129617495-129617544,9q34.11a,-,NM_000118.1,2022,ENG,-1.388504983485383,10.557994305877381,-14.55147002240184,1.3154379396341258e-31,2.3625926657270726e-30,61.023837951241
C16orf34,ILMN_1706118,"Homo sapiens hematological and neurological expressed 1-like (HN1L), mRNA.",nucleus [goid 5634] [evidence IEA],,DNA binding [goid 3677] [evidence IEA],16,1691736-1691785,16p13.3e,+,NM_144570.2,90861,C16orf34,1.3047811904068523,7.997925533451362,14.54981926969465,1.329592688886714e-31,2.3858735891699886e-30,61.01315952861567
GJB2,ILMN_1769388,"Homo sapiens gap junction protein, beta 2, 26kDa (connexin 26) (GJB2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; connexon complex [goid 5922] [pmid 1324944] [evidence TAS]; plasma membrane [goid 5886] [pmid 1324944] [evidence TAS],cell-cell signaling [goid 7267] [pmid 1324944] [evidence TAS]; transport [goid 6810] [pmid 1324944] [evidence TAS],connexon channel activity [goid 15285] [pmid 1324944] [evidence TAS],13,19659909-19659958,13q12.11a,-,NM_004004.3,2706,GJB2,2.468291232330862,6.5192567965195085,14.546774108686034,1.3561054833696058e-31,2.4312686838045763e-30,60.993460557914666
RAVER1,ILMN_1740395,"Homo sapiens RAVER1 (RAVER1), mRNA.",,,nucleotide binding [goid 166] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],19,10288082-10288131,19p13.2c,-,NM_133452.1,125950,RAVER1,1.057263357388683,8.576247415906968,14.539376275602583,1.4227411841071891e-31,2.5484517109773178e-30,60.94560240083397
BDP1,ILMN_1687149,"Homo sapiens B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB (BDP1), mRNA.",nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA],DNA binding [goid 3677] [evidence IEA],5,70876655-70876704,5q13.2b,+,NM_018429.1,55814,BDP1,1.2033890222920807,5.8574901663567935,14.537550472178726,1.4396853870004052e-31,2.5741934962559524e-30,60.93379045428785
DOK2,ILMN_1791211,"Homo sapiens docking protein 2, 56kDa (DOK2), transcript variant 2, mRNA.",,cell surface receptor linked signal transduction [goid 7166] [pmid 10799545] [evidence TAS],insulin receptor binding [goid 5158] [evidence IEA]; protein binding [goid 5515] [pmid 10799545] [evidence TAS],8,21822473-21822522,8p21.3b,-,NM_201349.1,9046,DOK2,-1.0685672390051977,6.203041958959695,-14.510608063218118,1.7145489440448065e-31,3.054736889799509e-30,60.75946792782056
HKDC1,ILMN_1752502,"Homo sapiens hexokinase domain containing 1 (HKDC1), mRNA.",,glycolysis [goid 6096] [evidence IEA],kinase activity [goid 16301] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; hexokinase activity [goid 4396] [evidence IEA],10,70697054-70697103,10q21.3e,+,NM_025130.2,80201,HKDC1,2.0155331578102285,7.278714334391372,14.509549147293892,1.726365026625496e-31,3.0730526203490148e-30,60.75261578160569
GUSBL2,ILMN_1657288,"Homo sapiens glucuronidase, beta-like 2 (GUSBL2), transcript variant 3, mRNA.",,carbohydrate metabolism [goid 5975] [evidence IEA],"hydrolase activity, hydrolyzing O-glycosyl compounds [goid 4553] [evidence IEA]",6,58395604-58395653,6p11.2a,-,NM_206910.1,375513,GUSBL2,1.5227976767030373,7.108884418061455,14.508825262135652,1.734489502124193e-31,3.084770307422298e-30,60.7479315554068
FGL2,ILMN_1693009,"Homo sapiens fibrinogen-like 2 (FGL2), mRNA.",fibrinogen complex [goid 5577] [pmid 7642106] [evidence TAS],,,7,76663704-76663753,7q11.23g,-,NM_006682.1,10875,FGL2,-1.7490370651223408,9.141395510238338,-14.50433407199329,1.7857586893409203e-31,3.17313142596209e-30,60.71886868380401
MIA3,ILMN_2312906,"Homo sapiens melanoma inhibitory activity family, member 3 (MIA3), mRNA.",,glycolysis [goid 6096] [evidence IEA],phosphoglycerate kinase activity [goid 4618] [evidence IEA],,,1q41e,,NM_198551.2,375056,MIA3,1.167969064137135,6.399662215268629,14.498099879776357,1.8594497647047292e-31,3.301142048998423e-30,60.678525002386245
KIAA0562,ILMN_2228453,"Homo sapiens KIAA0562 (KIAA0562), mRNA.",,,binding [goid 5488] [evidence IEA],,,1p36.32b,,NM_014704.2,9731,KIAA0562,1.238897587750154,7.753605366317087,14.495534724747163,1.8906482390092793e-31,3.3535540750086575e-30,60.66192439812831
C1orf176,ILMN_1783996,"Homo sapiens chromosome 1 open reading frame 176 (C1orf176), mRNA.",,,,1,40754073-40754122,1p34.2c,+,NM_022774.1,64789,C1orf176,1.4240204786710482,9.267530631981908,14.490276379572332,1.9562504907023873e-31,3.4668432079692974e-30,60.627893561840374
EDG6,ILMN_1784737,"Homo sapiens endothelial differentiation, G-protein-coupled receptor 6 (EDG6), mRNA.",integral to plasma membrane [goid 5887] [pmid 9790765] [evidence TAS],immune response [goid 6955] [pmid 9790765] [evidence TAS]; phospholipase C activation [goid 7202] [pmid 10679247] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9790765] [evidence TAS],lipid binding [goid 8289] [pmid 10679247] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; lysosphingolipid and lysophosphatidic acid receptor activity [goid 1619] [evidence IEA],19,3130929-3130945:3130946-3130978,19p13.3f,+,NM_003775.1,8698,EDG6,-1.5472331463772457,7.832421139459955,-14.487702441271109,1.9891885680896193e-31,3.5220960062245226e-30,60.61123509976171
HCN3,ILMN_1787256,"Homo sapiens hyperpolarization activated cyclic nucleotide-gated potassium channel 3 (HCN3), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA],sodium ion binding [goid 31402] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; potassium ion binding [goid 30955] [evidence IEA]; sodium channel activity [goid 5272] [evidence IEA]; voltage-gated potassium channel activity [goid 5249] [evidence IEA],1,153526081-153526130,1q22a,+,NM_020897.1,57657,HCN3,1.334114134669063,6.503086088787595,14.47521627497447,2.1570244307340714e-31,3.8158925561562596e-30,60.53042023414569
FAM64A,ILMN_1728972,"Homo sapiens family with sequence similarity 64, member A (FAM64A), mRNA.",,,,17,6294796-6294845,17p13.2a,+,NM_019013.1,54478,FAM64A,1.4083099170993698,5.778970284633707,14.46258005607946,2.34131880461229e-31,4.1346078237142714e-30,60.44862624569026
FLJ46380,ILMN_1727916,"Homo sapiens FLJ46380 protein (FLJ46380), mRNA.",ubiquitin ligase complex [goid 151] [evidence IEA],protein ubiquitination [goid 16567] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],1,6190669-6190718,1p36.31b,+,NM_207396.1,388591,FLJ46380,1.198064584609904,5.755892518231853,14.459412343380247,2.389939398796245e-31,4.2130314970145615e-30,60.4281204615443
ETS1,ILMN_1687538,"Homo sapiens v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) (ETS1), mRNA.",nucleus [goid 5634] [evidence IEA],"immune response [goid 6955] [pmid 2187191] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 2187191] [evidence TAS]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 7753825] [evidence TAS]",RNA polymerase II transcription factor activity [goid 3702] [pmid 7753825] [evidence TAS]; transcription factor activity [goid 3700] [evidence IEA],11,127834393-127834442,11q24.3a,-,NM_005238.2,2113,ETS1,-1.1998310416602145,10.655564985662455,-14.455226158552621,2.4557465174813287e-31,4.3252267888878894e-30,60.40102096569007
GIMAP7,ILMN_1776678,"Homo sapiens GTPase, IMAP family member 7 (GIMAP7), mRNA.",,,GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],7,149848443-149848492,7q36.1c,+,NM_153236.3,168537,GIMAP7,-1.1823374644345854,7.168980059869472,-14.454716218768645,2.463885783161937e-31,4.3357455364559396e-30,60.39771978346652
STAC,ILMN_1774127,"Homo sapiens SH3 and cysteine rich domain (STAC), mRNA.",soluble fraction [goid 5625] [pmid 8954993] [evidence TAS],intracellular signaling cascade [goid 7242] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; diacylglycerol binding [goid 19992] [evidence IEA],3,36564237-36564286,3p22.3a-p22.2b,+,NM_003149.1,6769,STAC,-1.4439792690959745,6.414642670453241,-14.452023012244108,2.507322824470583e-31,4.408305366608737e-30,60.38028463835885
SPIRE2,ILMN_1703284,"Homo sapiens spire homolog 2 (Drosophila) (SPIRE2), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA],16,88465064-88465113,16q24.3b,+,NM_032451.1,84501,SPIRE2,1.769608248896155,7.663335691782639,14.451227745948408,2.5202952021327937e-31,4.427222686942313e-30,60.37513621490887
VEGFC,ILMN_1701204,"Homo sapiens vascular endothelial growth factor C (VEGFC), mRNA.",membrane [goid 16020] [evidence IEA],cell proliferation [goid 8283] [evidence IEA]; signal transduction [goid 7165] [pmid 8617204] [evidence TAS]; angiogenesis [goid 1525] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 8617204] [evidence TAS]; substrate-bound cell migration [goid 6929] [pmid 8617204] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA],growth factor activity [goid 8083] [evidence IEA],4,177842138-177842187,4q34.3a,-,NM_005429.2,7424,VEGFC,-1.7134936863597465,7.138517573402587,-14.441108248605646,2.6913528855997186e-31,4.723560397813962e-30,60.30962153171189
ASNS,ILMN_1796417,"Homo sapiens asparagine synthetase (ASNS), transcript variant 1, mRNA.",soluble fraction [goid 5625] [pmid 2564390] [evidence IDA],metabolism [goid 8152] [evidence IEA]; amino acid biosynthesis [goid 8652] [evidence IEA]; glutamine metabolism [goid 6541] [evidence IEA]; asparagine biosynthesis [goid 6529] [evidence NAS],ligase activity [goid 16874] [evidence IEA]; asparagine synthase (glutamine-hydrolyzing) activity [goid 4066] [pmid 2886907] [evidence IDA],7,97319516-97319565,7q21.3d,-,NM_133436.1,440,ASNS,1.1212576864122363,8.094631187041767,14.44046759389695,2.702565605064193e-31,4.734932804389174e-30,60.30547369687256
TMEM49,ILMN_1692754,"Homo sapiens transmembrane protein 49 (TMEM49), mRNA.",integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 11256614] [evidence IDA],,,17,55272524-55272573,17q23.1a,+,NM_030938.2,81671,TMEM49,1.0092354509778865,11.371570421929468,14.439755167372608,2.7150894062979777e-31,4.748558465140729e-30,60.30086116120527
TMEM79,ILMN_2090802,"Homo sapiens transmembrane protein 79 (TMEM79), mRNA.",,,,1,154528742-154528791,1q22d,+,NM_032323.1,84283,TMEM79,1.2690806453914405,8.5221854710502285,14.434884685129076,2.8022786467356917e-31,4.896767787239102e-30,60.269327035876024
KIAA0907,ILMN_1670752,"Homo sapiens KIAA0907 (KIAA0907), mRNA.",,,,1,154149728-154149777,1q22c,-,NM_014949.2,22889,KIAA0907,1.128605529831134,9.216643507000054,14.43257046415782,2.844683840433763e-31,4.966530041832349e-30,60.25434311640047
PRX,ILMN_1786648,"Homo sapiens periaxin (PRX), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [evidence IEA],mechanosensory behavior [goid 7638] [evidence IEA]; mechanosensory behavior [goid 7638] [evidence IEA],protein binding [goid 5515] [evidence IEA]; protein binding [goid 5515] [evidence IEA],19,45591839-45591888,19q13.2b,-,NM_020956.1,57716,PRX,-1.0830481245249493,5.749643166332614,-14.430216917816184,2.888468633889882e-31,5.034188190493794e-30,60.23910430831608
POU2F1,ILMN_1794333,"Homo sapiens POU class 2 homeobox 1 (POU2F1), mRNA.",nucleus [goid 5634] [pmid 11891224] [evidence IDA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription [goid 16481] [pmid 11891224] [evidence IDA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 2341156] [evidence TAS]; protein binding [goid 5515] [pmid 12670868] [evidence IPI],1,165651657-165651671:165651672-165651706,1q24.1c-q24.2a,+,NM_002697.2,5451,POU2F1,1.3462576215461954,6.985112081436714,14.428792945520302,2.9152868284557616e-31,5.076506428524184e-30,60.22988420131204
BPHL,ILMN_1657746,"Homo sapiens biphenyl hydrolase-like (serine hydrolase; breast epithelial mucin-associated antigen) (BPHL), mRNA.",mitochondrion [goid 5739] [evidence ISS],response to toxin [goid 9636] [pmid 7759552] [evidence TAS]; aromatic compound metabolism [goid 6725] [evidence IEA]; amino acid and derivative metabolism [goid 6519] [pmid 7759552] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; serine esterase activity [goid 4759] [evidence IEA],6,3097823-3097872,6p25.2b,+,NM_004332.1,670,BPHL,1.0309866071614486,9.553667539263865,14.42803610375021,2.9296420258826925e-31,5.097067622074862e-30,60.22498367103915
RAB25,ILMN_1791826,"Homo sapiens RAB25, member RAS oncogene family (RAB25), mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; intracellular protein transport [goid 6886] [evidence IEA]; small GTPase mediated signal transduction [goid 7264] [evidence IEA]; two-component signal transduction system (phosphorelay) [goid 160] [evidence IEA]",nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],1,154306744-154306793,1q22c,+,NM_020387.1,57111,RAB25,1.1134543230072627,11.372246578748136,14.425139890736858,2.985231834341699e-31,5.189271810730557e-30,60.20623051161619
SLC15A3,ILMN_2085862,"Homo sapiens solute carrier family 15, member 3 (SLC15A3), mRNA.",membrane [goid 16020] [evidence IEA],oligopeptide transport [goid 6857] [evidence IEA],transporter activity [goid 5215] [evidence IEA],11,60461216-60461265,11q12.2a,-,NM_016582.1,51296,SLC15A3,-1.4093432754882418,11.426107861051923,-14.423352867127715,3.020057493667221e-31,5.245252633098417e-30,60.19465921916771
BTN3A3,ILMN_1700067,"Homo sapiens butyrophilin, subfamily 3, member A3 (BTN3A3), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,6,26551781-26551781:26551782-26551830,6p22.1d,+,NM_006994.3,10384,BTN3A3,-1.4440370333244612,7.726480125028172,-14.413009277634274,3.2297762862432847e-31,5.599771571503955e-30,60.12767961520418
SPATS2,ILMN_1746029,"Homo sapiens spermatogenesis associated, serine-rich 2 (SPATS2), mRNA.",,,,12,48206714-48206763,12q13.12b-q13.12c,+,NM_023071.1,65244,SPATS2,1.0002802048108892,7.154402984415983,14.412130653681038,3.2482487268318673e-31,5.626922989303204e-30,60.12198987371249
C1QB,ILMN_1796409,"Homo sapiens complement component 1, q subcomponent, beta polypeptide (C1QB), mRNA.",complement component C1q complex [goid 5602] [pmid 1706597] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],"immune response [goid 6955] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",,1,22860377-22860426,1p36.12a,+,NM_000491.2,713,C1QB,-1.7243742893097966,12.55865127156122,-14.407482933107543,3.3477379454549974e-31,5.794250935351521e-30,60.091891818118775
TNRC9,ILMN_1732808,"PREDICTED: Homo sapiens trinucleotide repeat containing 9, transcript variant 2 (TNRC9), mRNA.",,,,16,51029619-51029668,16q12.1d,-,XM_931515.1,27324,TNRC9,1.3607499222910793,5.60140434733647,14.39192960461959,3.703399698255774e-31,6.39323737383102e-30,59.9911628696948
MYH11,ILMN_1660086,"Homo sapiens myosin, heavy polypeptide 11, smooth muscle (MYH11), transcript variant SM1, mRNA.",striated muscle thick filament [goid 5863] [evidence IEA]; muscle myosin [goid 5859] [pmid 7684189] [evidence TAS]; myosin [goid 16459] [evidence IEA],striated muscle contraction [goid 6941] [evidence IEA],actin binding [goid 3779] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; motor activity [goid 3774] [evidence IEA],16,15704616-15704665,16p13.11a,-,NM_002474.1,4629,MYH11,-2.0639792303899167,9.304263585448087,-14.391367136193042,3.7169476115092592e-31,6.411093776817005e-30,59.98751990512083
MMRN2,ILMN_1715788,"Homo sapiens multimerin 2 (MMRN2), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],,,10,88685778-88685827,10q23.2a,-,NM_024756.1,79812,MMRN2,-1.3200503687255507,5.732882406365645,-14.387765150827448,3.8048910965555766e-31,6.557128428930574e-30,59.96419040701834
RNU33,ILMN_1682354,"Homo sapiens small nucleolar RNA, C/D box 33 (SNORD33) on chromosome 19.",,,,19,54685717-54685766,19q13.33b,+,NR_000020.1,26818,RNU33,1.4658989790578634,6.51574493458947,14.387359238671868,3.814931262225855e-31,6.568773209519356e-30,59.96156133849497
CLEC7A,ILMN_1700610,"Homo sapiens C-type lectin domain family 7, member A (CLEC7A), transcript variant 8, mRNA.",integral to membrane [goid 16021] [pmid 11567029] [evidence TAS],"reduction of virulence [goid 46803] [pmid 11567029] [evidence NAS]; antibacterial humoral response (sensu Vertebrata) [goid 19733] [pmid 11567029] [evidence NAS]; carbohydrate mediated signaling [goid 9756] [pmid 11567029] [evidence TAS]; antifungal humoral response (sensu Vertebrata) [goid 19734] [pmid 11567029] [evidence NAS]; cell recognition [goid 8037] [pmid 11567029] [evidence IDA]; phagocytosis, recognition [goid 6910] [pmid 11567029] [evidence IDA]",sugar binding [goid 5529] [pmid 11567029] [evidence IDA]; MHC protein binding [goid 42287] [pmid 11567029] [evidence NAS]; pattern recognition receptor activity [goid 8329] [pmid 11567029] [evidence IDA],12,10174011-10174060,12p13.2c,-,NM_197953.1,64581,CLEC7A,-1.1687321745083947,5.82754643638189,-14.38111454033223,3.972778543552302e-31,6.834682123765645e-30,59.921113817788076
TRAF2,ILMN_1691487,"Homo sapiens TNF receptor-associated factor 2 (TRAF2), mRNA.",,regulation of apoptosis [goid 42981] [evidence IEA]; signal transduction [goid 7165] [pmid 8702708] [evidence TAS]; protein complex assembly [goid 6461] [pmid 8702708] [evidence TAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; signal transducer activity [goid 4871] [pmid 8702708] [evidence NAS]; protein binding [goid 5515] [pmid 11777919] [evidence IPI],9,138940540-138940589,9q34.3e,+,NM_021138.3,7186,TRAF2,1.3300470697520224,7.527157334176524,14.36783373428732,4.3305585461646235e-31,7.437409046494574e-30,59.835086604200505
MMP15,ILMN_1718646,"Homo sapiens matrix metallopeptidase 15 (membrane-inserted) (MMP15), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7649159] [evidence TAS],peptidoglycan metabolism [goid 270] [evidence IEA]; protein modification [goid 6464] [pmid 7559440] [evidence TAS],enzyme activator activity [goid 8047] [pmid 7559440] [evidence TAS]; metalloendopeptidase activity [goid 4222] [pmid 7649159] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; zinc ion binding [goid 8270] [pmid 7649159] [evidence TAS],16,56637889-56637938,16q13d,+,NM_002428.2,4324,MMP15,1.6184860530224983,7.8913732758829935,14.362796538867176,4.474545438707098e-31,7.678105071839762e-30,59.802455697227025
CYP27A1,ILMN_1704985,"Homo sapiens cytochrome P450, family 27, subfamily A, polypeptide 1 (CYP27A1), nuclear gene encoding mitochondrial protein, mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],electron transport [goid 6118] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; steroid hydroxylase activity [goid 8395] [pmid 9790667] [evidence TAS]; iron ion binding [goid 5506] [evidence IEA]; heme binding [goid 20037] [evidence IEA],2,219387910-219387959,2q35e,+,NM_000784.2,1593,CYP27A1,-1.7329815817375138,10.726990835932122,-14.361114347998328,4.523690267633998e-31,7.755783622521082e-30,59.79155821463204
NPM3,ILMN_2110252,"Homo sapiens nucleophosmin/nucleoplasmin, 3 (NPM3), mRNA.",nucleus [goid 5634] [evidence IEA],protein folding [goid 6457] [evidence IEA],nucleic acid binding [goid 3676] [evidence IEA],10,103531194-103531243,10q24.32a,-,NM_006993.1,10360,NPM3,1.356279051863373,8.984222687488154,14.356679472929391,4.65586011892814e-31,7.955119492699762e-30,59.76282779945797
XKRX,ILMN_1769071,"Homo sapiens XK, Kell blood group complex subunit-related, X-linked (XKRX), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,X,100055351-100055400,Xq22.1c,-,NM_212559.1,402415,XKRX,2.2819658651702497,6.575722215345538,14.3546545264327,4.71748729677559e-31,8.046673984133505e-30,59.749709299307746
FLJ14082,ILMN_1814967,"PREDICTED: Homo sapiens hypothetical protein FLJ14082 (FLJ14082), mRNA.",,,,2,95561545-95561594,2q11.1c,+,XM_496575.2,80092,FLJ14082,1.3186858028680017,5.813880532227436,14.345561524642628,5.004447973294596e-31,8.528875217178728e-30,59.69079845162087
ZNF606,ILMN_1681829,"Homo sapiens zinc finger protein 606 (ZNF606), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],19,63180378-63180427,19q13.43c,-,NM_025027.3,80095,ZNF606,1.1374914162540781,6.606288949555145,14.340428007294591,5.174105353024288e-31,8.803018699261052e-30,59.6575382272292
CDKL5,ILMN_1680317,"Homo sapiens cyclin-dependent kinase-like 5 (CDKL5), mRNA.",,protein amino acid phosphorylation [goid 6468] [pmid 9721213] [evidence TAS],protein serine/threonine kinase activity [goid 4674] [pmid 9721213] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],X,18581581-18581585:18581586-18581630,Xp22.13c-p22.13b,+,NM_003159.1,6792,CDKL5,-1.284073388771855,5.715211601511518,-14.33837979768831,5.243392880121694e-31,8.913322408281634e-30,59.6442674706821
PGC,ILMN_1795484,"Homo sapiens progastricsin (pepsinogen C) (PGC), mRNA.",extracellular space [goid 5615] [pmid 3335549] [evidence TAS],digestion [goid 7586] [pmid 3335549] [evidence TAS],peptidase activity [goid 8233] [evidence IEA]; pepsin A activity [goid 4194] [evidence IEA],6,41812566-41812567:41812568-41812615,6p21.1f,-,NM_002630.1,5225,PGC,-4.050866638041697,11.353267707714323,-14.333212269351796,5.422358228515715e-31,9.209723551455215e-30,59.610785168054825
SDC2,ILMN_1784553,"Homo sapiens syndecan 2 (SDC2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NAS],,cytoskeletal protein binding [goid 8092] [evidence IEA],8,97692961-97693010,8q22.1d,+,NM_002998.3,6383,SDC2,-1.4244371453636866,6.938190187917376,-14.330270890971336,5.526944031865143e-31,9.379397471548581e-30,59.59172635412495
AQP1,ILMN_1681103,"Homo sapiens aquaporin 1 (Colton blood group) (AQP1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; outer membrane [goid 19867] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 1722319] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA]; excretion [goid 7588] [pmid 1722319] [evidence TAS]; water transport [goid 6833] [pmid 7521540] [evidence TAS],transporter activity [goid 5215] [evidence IEA]; porin activity [goid 15288] [evidence IEA]; water transporter activity [goid 5372] [pmid 7521540] [evidence TAS],7,30930996-30931045,7p15.1a,+,NM_198098.1,358,AQP1,-2.133488286968766,7.915702517019649,-14.328595177974096,5.587427455670576e-31,9.474004112970923e-30,59.580868306837466
PFKP,ILMN_1805737,"Homo sapiens phosphofructokinase, platelet (PFKP), mRNA.",6-phosphofructokinase complex [goid 5945] [evidence NAS]; cytoplasm [goid 5737] [evidence IEA],glycolysis [goid 6096] [evidence NAS],kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; 6-phosphofructokinase activity [goid 3872] [pmid 1834056] [evidence TAS],10,3168718-3168767,10p15.2b,+,NM_002627.3,5214,PFKP,1.582332663289158,10.26864483901793,14.324216214667372,5.7486292872368625e-31,9.739083385185025e-30,59.55249351320614
LRRC36,ILMN_1774389,"Homo sapiens leucine rich repeat containing 36 (LRRC36), mRNA.",,,,16,65976304-65976353,16q22.1b,+,NM_018296.4,55282,LRRC36,-2.0499274729955426,6.382231697341669,-14.32176372025096,5.840938078569821e-31,9.88709721455372e-30,59.536601463142695
IDH2,ILMN_1751753,"Homo sapiens isocitrate dehydrogenase 2 (NADP+), mitochondrial (IDH2), mRNA.",mitochondrion [goid 5739] [pmid 8707889] [evidence IDA],tricarboxylic acid cycle [goid 6099] [evidence IEA]; metabolism [goid 8152] [pmid 8707889] [evidence NAS]; carbohydrate metabolism [goid 5975] [pmid 8954790] [evidence NAS]; main pathways of carbohydrate metabolism [goid 6092] [evidence IEA]; glyoxylate cycle [goid 6097] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; isocitrate dehydrogenase (NADP+) activity [goid 4450] [pmid 8707889] [evidence NAS],15,88428515-88428564,15q26.1b,-,NM_002168.2,3418,IDH2,1.1457015390722756,10.349691424356568,14.289238144032034,7.2151712850497115e-31,1.2202971011942066e-29,59.32581137771651
RAB28,ILMN_2293992,"Homo sapiens RAB28, member RAS oncogene family (RAB28), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; GTPase activity [goid 3924] [pmid 8647132] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA],4,12979199-12979248,4p15.33c,-,NM_001017979.1,9364,RAB28,-1.1041665609628808,6.772576058763032,-14.28487903651107,7.4224385961066095e-31,1.2542918195177453e-29,59.29755747230964
FOLR3,ILMN_1730454,"Homo sapiens folate receptor 3 (gamma) (FOLR3), mRNA.",membrane fraction [goid 5624] [pmid 8110752] [evidence TAS]; extrinsic to membrane [goid 19898] [pmid 8110752] [evidence TAS],folic acid transport [goid 15884] [pmid 8110752] [evidence TAS],folic acid binding [goid 5542] [pmid 8110752] [evidence TAS]; receptor activity [goid 4872] [evidence IEA],11,71528496-71528523:71528524-71528545,11q13.4a,+,NM_000804.2,2352,FOLR3,-3.5847294924545023,7.092653671655444,-14.282923464567668,7.517349142876877e-31,1.2692584105542662e-29,59.28488199957605
AP1G2,ILMN_1754179,"Homo sapiens adaptor-related protein complex 1, gamma 2 subunit (AP1G2), transcript variant 1, mRNA.",AP-1 adaptor complex [goid 30121] [pmid 9733768] [evidence TAS]; transport vesicle [goid 30133] [pmid 9733768] [evidence IDA]; coated pit [goid 5905] [evidence IEA]; Golgi apparatus [goid 5794] [pmid 9762922] [evidence TAS]; membrane [goid 16020] [pmid 9733768] [evidence IDA],intracellular protein transport [goid 6886] [evidence IEA]; endocytosis [goid 6897] [evidence IEA]; protein complex assembly [goid 6461] [evidence IEA],protein binding [goid 5515] [evidence ISS],14,23099000-23099049,14q11.2g,-,NM_003917.2,8906,AP1G2,1.1417399105963248,9.159393735999865,14.281358809878116,7.594161360355075e-31,1.2811465472005426e-29,59.27474022064424
RBM12B,ILMN_1805778,"Homo sapiens RNA binding motif protein 12B (RBM12B), mRNA.",,,nucleotide binding [goid 166] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],8,94813465-94813514,8q22.1b,-,NM_203390.1,389677,RBM12B,1.156366354852718,7.645547029446109,14.271233491864729,8.110588652143742e-31,1.3648162973262573e-29,59.209107298255056
B3GNT1,ILMN_1711102,"Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS]; Golgi stack [goid 5795] [evidence IEA],protein amino acid glycosylation [goid 6486] [evidence IEA],"manganese ion binding [goid 30145] [evidence IEA]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; galactosyltransferase activity [goid 8378] [evidence IEA]",2,62303799-62303848,2p15c,+,NM_006577.3,10678,B3GNT1,-1.801694488087052,6.978181012790693,-14.268272092497302,8.268172355024472e-31,1.3901646426834425e-29,59.189910468769035
XPNPEP3,ILMN_1659000,"Homo sapiens X-prolyl aminopeptidase (aminopeptidase P) 3, putative (XPNPEP3), mRNA.",,,peptidase activity [goid 8233] [evidence IEA]; metalloexopeptidase activity [goid 8235] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; metalloexopeptidase activity [goid 8235] [evidence IEA],22,39653117-39653166,22q13.2a,+,NM_022098.2,63929,XPNPEP3,1.1997799568231855,10.25298429003697,14.266339655401637,8.37265131203084e-31,1.4065491809497318e-29,59.177383524458456
SCARA3,ILMN_1654966,"Homo sapiens scavenger receptor class A, member 3 (SCARA3), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA],,8,27590114-27590163,8p21.1e,+,NM_182826.1,51435,SCARA3,-1.3855007802288988,6.457894638015432,-14.257669012741339,8.857948460442108e-31,1.4855811634243563e-29,59.12117441074947
BAT2,ILMN_1760563,"Homo sapiens HLA-B associated transcript 2 (BAT2), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],,protein binding [goid 5515] [pmid 16713569] [evidence IPI]; protein binding [goid 5515] [pmid 16713569] [evidence IPI],6,31713066-31713080:31713202-31713236,6p21.33a,+,NM_080686.1,7916,BAT2,1.197977427523445,8.652562239682688,14.248331720043371,9.412097206310073e-31,1.575876492919263e-29,59.06063991662872
KIAA0256,ILMN_1784333,"Homo sapiens KIAA0256 gene product (KIAA0256), mRNA.",,,,15,47068447-47068496,15q21.1d,-,NM_014701.2,9728,KIAA0256,-1.3128733803203776,9.750757352750325,-14.243207715412462,9.730809388426029e-31,1.627876540498562e-29,59.027418922274315
LOC642560,ILMN_1787823,"PREDICTED: Homo sapiens similar to phosphodiesterase 4D interacting protein isoform 1 (LOC642560), mRNA.",,,,1,149636-149685,,-,XM_926046.1,642560,LOC642560,1.2745288593400828,6.491473162757096,14.23786149203906,1.0074866587484596e-30,1.681217103272659e-29,58.9927559759772
C3orf63,ILMN_1661409,"Homo sapiens chromosome 3 open reading frame 63 (C3orf63), mRNA.",,,,3,56630278-56630327,3p14.3b,-,NM_015224.1,23272,C3orf63,-1.01464896223548,7.040979860670218,-14.236400129600653,1.0171014401382148e-30,1.6958471345237832e-29,58.983280823441625
ProSAPiP1,ILMN_1736154,"Homo sapiens ProSAPiP1 protein (ProSAPiP1), mRNA.",membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],,structural molecule activity [goid 5198] [evidence IEA],20,3091550-3091599,20p13c,-,NM_014731.2,9762,ProSAPiP1,1.64420685020285,7.925284964592328,14.232553465434096,1.0428513153599397e-30,1.7373329823248685e-29,58.958339457220454
CD59,ILMN_1724789,"Homo sapiens CD59 molecule, complement regulatory protein (CD59), transcript variant 3, mRNA.",plasma membrane [goid 5886] [pmid 1381503] [evidence NAS]; membrane fraction [goid 5624] [pmid 1381503] [evidence TAS],immune response [goid 6955] [evidence NR ]; cell surface receptor linked signal transduction [goid 7166] [pmid 7691713] [evidence TAS]; blood coagulation [goid 7596] [pmid 1381503] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [pmid 12577067] [evidence IPI],11,33681376-33681425,11p13d-p13c,-,NM_203329.1,966,CD59,-1.0756244849298913,7.5562610793817715,-14.229550364223575,1.0634071241651058e-30,1.7701039717383892e-29,58.938867220005015
GNG7,ILMN_1728107,"Homo sapiens guanine nucleotide binding protein (G protein), gamma 7 (GNG7), mRNA.",membrane [goid 16020] [evidence IEA]; heterotrimeric G-protein complex [goid 5834] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [pmid 9600093] [evidence TAS],signal transducer activity [goid 4871] [evidence IEA],19,2462391-2462440,19p13.3g,-,NM_052847.1,2788,GNG7,-1.1529174704048302,7.697130012078978,-14.224649328698233,1.0978288100190376e-30,1.825881864576966e-29,58.907087860178486
PDLIM1,ILMN_1788955,"Homo sapiens PDZ and LIM domain 1 (elfin) (PDLIM1), mRNA.",cytoskeleton [goid 5856] [evidence IEA],response to oxidative stress [goid 6979] [pmid 8522188] [evidence TAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],10,96987501-96987550,10q23.33c,-,NM_020992.2,9124,PDLIM1,-1.0012777434973508,11.320954850387835,-14.219709411041528,1.1336524322171634e-30,1.8838968325416119e-29,58.8750553354405
LY86,ILMN_1807825,"Homo sapiens lymphocyte antigen 86 (LY86), mRNA.",plasma membrane [goid 5886] [pmid 9763566] [evidence TAS],cell proliferation [goid 8283] [pmid 9763566] [evidence TAS]; humoral immune response [goid 6959] [pmid 9763566] [evidence TAS]; apoptosis [goid 6915] [pmid 9763566] [evidence TAS]; signal transduction [goid 7165] [evidence NR ]; inflammatory response [goid 6954] [evidence IEA],signal transducer activity [goid 4871] [evidence NR ],6,6600007-6600056,6p25.1a,+,NM_004271.3,9450,LY86,-1.7238508997042299,9.722378576159242,-14.207498595939501,1.2273061466120214e-30,2.0344607606804742e-29,58.795870743585176
CDC42EP2,ILMN_1652777,"Homo sapiens CDC42 effector protein (Rho GTPase binding) 2 (CDC42EP2), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; membrane [goid 16020] [pmid 11035016] [evidence IDA]; cytoplasm [goid 5737] [pmid 11035016] [evidence IDA],regulation of cell shape [goid 8360] [pmid 11035016] [evidence IDA]; positive regulation of actin filament polymerization [goid 30838] [pmid 11035016] [evidence IDA]; positive regulation of pseudopodium formation [goid 31274] [pmid 11035016] [evidence IDA]; actin filament organization [goid 7015] [pmid 11035016] [evidence NAS]; positive regulation of protein complex assembly [goid 31334] [pmid 11584266] [evidence TAS],GTP-Rho binding [goid 17049] [pmid 11035016] [evidence IPI]; protein binding [goid 5515] [pmid 11584266] [evidence IPI],11,64846266-64846315,11q13.1c,+,NM_006779.2,10435,CDC42EP2,-1.5398423081441361,7.515615760106402,-14.198940863979246,1.2975211120243436e-30,2.147295484647069e-29,58.740371855429636
NUSAP1,ILMN_1726720,"Homo sapiens nucleolar and spindle associated protein 1 (NUSAP1), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],positive regulation of mitosis [goid 45840] [pmid 12963707] [evidence IDA]; mitotic chromosome condensation [goid 7076] [pmid 12963707] [evidence IDA]; establishment of mitotic spindle localization [goid 40001] [pmid 12963707] [evidence IDA],,15,39460433-39460482,15q15.1c,+,NM_016359.2,51203,NUSAP1,1.35346845987333,7.217770853554846,14.19194399173685,1.3579074086118038e-30,2.243518697894713e-29,58.69499320692193
TCF3,ILMN_1664434,"Homo sapiens transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) (TCF3), mRNA.",nucleus [goid 5634] [pmid 2493990] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [pmid 2493990] [evidence NAS]",transcription factor activity [goid 3700] [pmid 2493990] [evidence NAS],19,1560558-1560607,19p13.3h,-,NM_003200.1,6929,TCF3,1.1477194376109479,8.198981598070555,14.176136016252833,1.5048998661214077e-30,2.4822783612000924e-29,58.592462039238505
SAMD4B,ILMN_1753467,"Homo sapiens sterile alpha motif domain containing 4B (SAMD4B), mRNA.",,,,19,44567062-44567111,19q13.2a,+,NM_018028.2,55095,SAMD4B,1.328292315615367,7.822080297375325,14.173395749202085,1.5319545018712907e-30,2.5248225431170335e-29,58.57468749637828
ZMYM6,ILMN_1657632,"Homo sapiens zinc finger, MYM-type 6 (ZMYM6), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],development [goid 7275] [pmid 10486218] [evidence TAS]; development [goid 7275] [pmid 10486218] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [pmid 10486218] [evidence TAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [pmid 10486218] [evidence TAS],1,35219996-35220045,1p34.3f-p34.3e,-,NM_007167.3,9204,ZMYM6,-1.0657355436433598,10.65639443585285,-14.172078877535151,1.5451286444445415e-30,2.5444390056005254e-29,58.56614559320372
CGI-38,ILMN_1695036,"Homo sapiens tubulin polymerization-promoting protein family member 3 (TPPP3), mRNA.",,,,16,65984371-65984420,16q22.1b,-,NM_016140.2,51673,CGI-38,-1.4950245137622913,7.14155005932452,-14.167407294847598,1.592785220088702e-30,2.620760418053844e-29,58.53584273892543
ZAK,ILMN_1672390,"Homo sapiens sterile alpha motif and leucine zipper containing kinase AZK (ZAK), transcript variant 1, mRNA.",cytoplasm [goid 5737] [evidence ISS]; cytoplasm [goid 5737] [evidence ISS],cell cycle [goid 7049] [evidence IEA]; cell cycle checkpoint [goid 75] [pmid 15342622] [evidence IDA]; protein amino acid phosphorylation [goid 6468] [pmid 11836244] [evidence IDA]; positive regulation of apoptosis [goid 43065] [pmid 10924358] [evidence IDA]; protein kinase cascade [goid 7243] [pmid 11836244] [evidence IDA]; cell cycle [goid 7049] [evidence IEA]; cell cycle checkpoint [goid 75] [pmid 15342622] [evidence IDA]; protein amino acid phosphorylation [goid 6468] [pmid 11836244] [evidence IDA]; positive regulation of apoptosis [goid 43065] [pmid 10924358] [evidence IDA]; protein kinase cascade [goid 7243] [pmid 11836244] [evidence IDA],nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [pmid 11836244] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 11836244] [evidence IDA]; ATP binding [goid 5524] [pmid 11836244] [evidence IDA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [pmid 11836244] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 11836244] [evidence IDA]; ATP binding [goid 5524] [pmid 11836244] [evidence IDA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],2,173840775-173840824,2q31.1e,+,NM_016653.1,51776,ZAK,-1.088938125515261,7.155062736680455,-14.167006170819402,1.5969451983332027e-30,2.623623613268104e-29,58.533240751456596
MRGPRF,ILMN_2075603,"Homo sapiens MAS-related GPR, member F (MRGPRF), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],11,68528756-68528805,11q13.2c,-,NM_145015.2,219928,MRGPRF,-1.4103723690243637,6.8910947111860645,-14.161252209264132,1.657829442243017e-30,2.7188402852785476e-29,58.4959155653765
GGTL3,ILMN_1737036,"Homo sapiens gamma-glutamyltransferase-like 3 (GGTL3), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],glutathione biosynthesis [goid 6750] [evidence IEA]; glutathione biosynthesis [goid 6750] [evidence IEA],acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; gamma-glutamyltransferase activity [goid 3840] [evidence IEA]; acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; gamma-glutamyltransferase activity [goid 3840] [evidence IEA],20,32912946-32912995,20q11.22b,-,NM_178025.1,2686,GGTL3,1.0930688849798846,5.912795793788746,14.149594153317084,1.788403228280802e-30,2.9281809976630344e-29,58.42028713050886
CCNE1,ILMN_1795852,"Homo sapiens cyclin E1 (CCNE1), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence NAS]; nucleus [goid 5634] [evidence NAS]; nucleus [goid 5634] [evidence NAS],"G1/S transition of mitotic cell cycle [goid 82] [pmid 8207080] [evidence NAS]; positive regulation of transcription, DNA-dependent [goid 45893] [pmid 15572661] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 15572661] [evidence NAS]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; G1/S transition of mitotic cell cycle [goid 82] [pmid 8207080] [evidence NAS]; positive regulation of transcription, DNA-dependent [goid 45893] [pmid 15572661] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 15572661] [evidence NAS]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; G1/S transition of mitotic cell cycle [goid 82] [pmid 8207080] [evidence NAS]; positive regulation of transcription, DNA-dependent [goid 45893] [pmid 15572661] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 15572661] [evidence NAS]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]",transcription coactivator activity [goid 3713] [pmid 15572661] [evidence NAS]; androgen receptor binding [goid 50681] [pmid 15572661] [evidence NAS]; protein binding [goid 5515] [pmid 9891079] [evidence IPI]; transcription coactivator activity [goid 3713] [pmid 15572661] [evidence NAS]; androgen receptor binding [goid 50681] [pmid 15572661] [evidence NAS]; protein binding [goid 5515] [pmid 9891079] [evidence IPI]; transcription coactivator activity [goid 3713] [pmid 15572661] [evidence NAS]; androgen receptor binding [goid 50681] [pmid 15572661] [evidence NAS]; protein binding [goid 5515] [pmid 9891079] [evidence IPI],19,35006560-35006609,19q12c,+,NM_001238.1,898,CCNE1,1.5186129599096017,6.07338207666002,14.140007648236883,1.903453776497097e-30,3.111462676483163e-29,58.35809315483976
NOL3,ILMN_1813925,"Homo sapiens nucleolar protein 3 (apoptosis repressor with CARD domain) (NOL3), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleolus [goid 5730] [pmid 10196175] [evidence TAS]; cytosol [goid 5829] [pmid 10196175] [evidence TAS]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; nucleolus [goid 5730] [pmid 10196175] [evidence TAS]; cytosol [goid 5829] [pmid 10196175] [evidence TAS]; intracellular [goid 5622] [evidence IEA],"RNA splicing [goid 8380] [pmid 10196175] [evidence TAS]; anti-apoptosis [goid 6916] [pmid 9560245] [evidence TAS]; regulation of apoptosis [goid 42981] [evidence IEA]; nuclear mRNA splicing, via spliceosome [goid 398] [evidence IEA]; RNA splicing [goid 8380] [pmid 10196175] [evidence TAS]; anti-apoptosis [goid 6916] [pmid 9560245] [evidence TAS]; regulation of apoptosis [goid 42981] [evidence IEA]; nuclear mRNA splicing, via spliceosome [goid 398] [evidence IEA]",RNA binding [goid 3723] [pmid 10196175] [evidence TAS]; RNA binding [goid 3723] [pmid 10196175] [evidence TAS],16,65766308-65766348:65766451-65766458:65766459-65766459,16q22.1a,+,NM_003946.3,8996,NOL3,1.1156558175724696,8.048178293614928,14.135531696027307,1.9596800179928517e-30,3.200757371428651e-29,58.32905342622093
RSNL2,ILMN_1759792,"Homo sapiens CAP-GLY domain containing linker protein family, member 4 (CLIP4), mRNA.",,,,2,29258931-29258980,2p23.2a,+,NM_024692.3,79745,RSNL2,-1.2987302866702137,7.586301946132034,-14.135257988601031,1.9631717407519553e-30,3.2038450398829623e-29,58.32727760139877
EPHB3,ILMN_1741346,"Homo sapiens EPH receptor B3 (EPHB3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8397371] [evidence TAS],signal transduction [goid 7165] [pmid 8397371] [evidence TAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ephrin receptor activity [goid 5003] [evidence IEA],3,185782572-185782621,3q27.1b,+,NM_004443.3,2049,EPHB3,1.1959275345414602,6.748028301317661,14.1335707868307,1.984833544041691e-30,3.2365566054756433e-29,58.31633090146379
IL6,ILMN_1699651,"Homo sapiens interleukin 6 (interferon, beta 2) (IL6), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [pmid 10925276] [evidence TAS],humoral immune response [goid 6959] [pmid 2829354] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 3023045] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 1883960] [evidence NAS]; acute-phase response [goid 6953] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [pmid 10925276] [evidence TAS]; negative regulation of chemokine biosynthesis [goid 45079] [evidence ISS]; neutrophil apoptosis [goid 1781] [evidence ISS]; positive regulation of cell proliferation [goid 8284] [pmid 2829354] [evidence TAS],cytokine activity [goid 5125] [evidence IEA]; interleukin-6 receptor binding [goid 5138] [pmid 1883960] [evidence NAS],7,22737683-22737717:22737718-22737732,7p15.3c,+,NM_000600.1,3569,IL6,-3.5271412807082223,8.36196007524542,-14.130148571071535,2.0295086325480548e-30,3.306710807819339e-29,58.294126939552946
REV3L,ILMN_2199947,"Homo sapiens REV3-like, catalytic subunit of DNA polymerase zeta (yeast) (REV3L), mRNA.",nucleus [goid 5634] [evidence IEA]; zeta DNA polymerase complex [goid 16035] [evidence NR ],DNA-dependent DNA replication [goid 6261] [pmid 9618506] [evidence TAS]; DNA repair [goid 6281] [evidence IEA]; DNA replication [goid 6260] [evidence IEA],zeta DNA polymerase activity [goid 3894] [pmid 9618506] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; 3'-5' exonuclease activity [goid 8408] [evidence IEA]; DNA-directed DNA polymerase activity [goid 3887] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],6,111735413-111735462,6q21h,-,NM_002912.1,5980,REV3L,-1.1052893894508395,5.807537277528221,-14.107707888749776,2.3484700210406008e-30,3.82017790089271e-29,58.14851606404114
BCL9L,ILMN_1743966,"Homo sapiens B-cell CLL/lymphoma 9-like (BCL9L), mRNA.",intracellular [goid 5622] [evidence IEA]; ribosome [goid 5840] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA],structural constituent of ribosome [goid 3735] [evidence IEA],11,118272330-118272379,11q23.3e,-,NM_182557.1,283149,BCL9L,1.3271723740935935,7.299049127615643,14.107226587930796,2.35583451462658e-30,3.829044432871536e-29,58.14539282746893
SBDSP,ILMN_1765725,Homo sapiens Shwachman-Bodian-Diamond syndrome pseudogene (SBDSP) on chromosome 7.,,,,7,71938143-71938192,7q11.23a,+,NR_001588.1,155370,SBDSP,-1.7671611267807865,7.772126873356854,-14.105359534691859,2.384622155859631e-30,3.869547452914801e-29,58.13327713919342
GPR162,ILMN_1730816,"Homo sapiens G protein-coupled receptor 162 (GPR162), transcript variant A-1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],12,6806759-6806808,12p13.31d,+,NM_014449.1,27239,GPR162,-1.6542865652063217,9.102830911290377,-14.101566272647705,2.4441985791526387e-30,3.963008522827066e-29,58.10866146619036
CHRNA5,ILMN_1770044,"Homo sapiens cholinergic receptor, nicotinic, alpha 5 (CHRNA5), mRNA.",nicotinic acetylcholine-gated receptor-channel complex [goid 5892] [pmid 1542648] [evidence IC ]; integral to membrane [goid 16021] [evidence IEA]; postsynaptic membrane [goid 45211] [evidence IEA],ion transport [goid 6811] [evidence IEA]; synaptic transmission [goid 7268] [pmid 9009220] [evidence TAS]; signal transduction [goid 7165] [pmid 9009220] [evidence NAS],acetylcholine receptor activity [goid 15464] [pmid 1542648] [evidence IDA]; nicotinic acetylcholine-activated cation-selective channel activity [goid 4889] [pmid 1542648] [evidence NAS]; ion channel activity [goid 5216] [evidence IEA]; extracellular ligand-gated ion channel activity [goid 5230] [evidence IEA],15,76669832-76669881,15q25.1a,+,NM_000745.2,1138,CHRNA5,1.5288279181892657,8.692943598848665,14.10099407879217,2.453313794337071e-30,3.9745669957162855e-29,58.104948270667684
NMU,ILMN_2162253,"Homo sapiens neuromedin U (NMU), mRNA.",,digestion [goid 7586] [pmid 7619205] [evidence TAS]; neuropeptide signaling pathway [goid 7218] [evidence IEA]; regulation of smooth muscle contraction [goid 6940] [pmid 7619205] [evidence TAS]; signal transduction [goid 7165] [pmid 7619205] [evidence TAS],receptor binding [goid 5102] [pmid 10811630] [evidence TAS],4,56166204-56166253,4q12d,-,NM_006681.1,10874,NMU,2.385868731535856,6.041932241299398,14.092562412356585,2.5916461018791382e-30,4.195279547443187e-29,58.05023031207464
TNPO3,ILMN_1683811,"Homo sapiens transportin 3 (TNPO3), mRNA.",nucleus [goid 5634] [evidence IEA],protein transport [goid 15031] [evidence IEA],binding [goid 5488] [evidence IEA]; receptor activity [goid 4872] [pmid 10366588] [evidence TAS],7,128382581-128382630,7q32.1a,-,NM_012470.2,23534,TNPO3,1.2116603872984868,9.253427012572322,14.082598718575893,2.7652124962489275e-30,4.472625030311119e-29,57.985566557659276
MGC2408,ILMN_1762883,"Homo sapiens hypothetical protein MGC2408 (MGC2408), mRNA.",,,methyltransferase activity [goid 8168] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],3,185459123-185459172,3q27.1b,+,NM_032331.2,84291,MGC2408,1.4231332945082658,7.291860554237246,14.0808583412385,2.796702052656001e-30,4.519904254405596e-29,57.97427122038399
ANXA8L1,ILMN_2095610,"Homo sapiens annexin A8 (ANXA8), mRNA. XM_931361 XM_931369 XM_931374 XM_931375 XM_931378 XM_931383 XM_931388 XM_931391 XM_931399 XM_931404 XM_931411",,,calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],10,47882230-47882279,,+,NM_001040084.1,653145,ANXA8L1,-2.075816867429773,5.887435976831757,-14.076569763216058,2.87583813506091e-30,4.644049185334842e-29,57.946437137424915
ARHGEF19,ILMN_1808999,"Homo sapiens Rho guanine nucleotide exchange factor (GEF) 19 (ARHGEF19), mRNA.",,,,1,16397350-16397399,1p36.13f,-,NM_153213.2,128272,ARHGEF19,1.3881693476428278,8.92877004834976,14.070824687826683,2.9853745114856254e-30,4.8170462278874517e-29,57.90914886139907
PKM2,ILMN_1672650,"Homo sapiens pyruvate kinase, muscle (PKM2), transcript variant 1, mRNA.",cytosol [goid 5829] [pmid 2813362] [evidence NAS]; cytoplasm [goid 5737] [pmid 11256614] [evidence IDA],glycolysis [goid 6096] [evidence NAS],transferase activity [goid 16740] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; pyruvate kinase activity [goid 4743] [pmid 2854097] [evidence TAS]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],15,70281933-70281982,15q23b,-,NM_002654.3,5315,PKM2,1.2913013773984368,9.3171911615458,14.059218417154558,3.2195674034681414e-30,5.190741708991988e-29,57.83381476690129
MGC17330,ILMN_1719986,"Homo sapiens phosphoinositide-3-kinase interacting protein 1 (PIK3IP1), mRNA.",,,,22,30007802-30007851,22q12.2c,-,NM_052880.3,113791,MGC17330,-1.115138957706927,10.695355923975102,-14.04903502124298,3.440148833309805e-30,5.537449546006643e-29,57.767712049152514
CDKN1C,ILMN_1718565,"Homo sapiens cyclin-dependent kinase inhibitor 1C (p57, Kip2) (CDKN1C), mRNA.",nucleus [goid 5634] [evidence IEA],G1 phase of mitotic cell cycle [goid 80] [pmid 7729684] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; cell cycle arrest [goid 7050] [pmid 7729684] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 7729684] [evidence TAS],protein binding [goid 5515] [pmid 9106657] [evidence IPI]; cyclin-dependent protein kinase inhibitor activity [goid 4861] [pmid 7729684] [evidence TAS],11,2861687-2861721:2861805-2861809:2861810-2861819,11p15.4d,-,NM_000076.1,1028,CDKN1C,-1.3574679514515244,8.289037927231817,-14.04860600438543,3.4497667700887766e-30,5.54846732603989e-29,57.764927117707764
PLEK,ILMN_1795762,"Homo sapiens pleckstrin (PLEK), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA],calcium ion binding [goid 5509] [pmid 2897630] [evidence TAS],2,68477871-68477920,2p14a,+,NM_002664.1,5341,PLEK,-1.6550280639653927,9.763194986840892,-14.048378548263734,3.454876920167661e-30,5.552223085840528e-29,57.76345060016349
SPON1,ILMN_1791890,"Homo sapiens spondin 1, extracellular matrix protein (SPON1), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],cell adhesion [goid 7155] [evidence IEA]; development [goid 7275] [evidence IEA],protein binding [goid 5515] [evidence IEA],11,14245674-14245723,11p15.2b,+,NM_006108.1,10418,SPON1,-1.616586439125971,9.8390223168242,-14.03859183773171,3.682078505762743e-30,5.907861005878184e-29,57.69991891737562
PLAC8,ILMN_1653026,"Homo sapiens placenta-specific 8 (PLAC8), mRNA.",,,,4,84248065-84248098:84248099-84248114,4q21.22a,-,NM_016619.1,51316,PLAC8,-2.3057868706474647,9.13148235082326,-14.031446636892506,3.857347762338215e-30,6.184119713851202e-29,57.653532661508855
PCSK9,ILMN_1668850,"Homo sapiens proprotein convertase subtilisin/kexin type 9 (PCSK9), mRNA.",,cholesterol metabolism [goid 8203] [evidence IEA]; lipid metabolism [goid 6629] [evidence IEA]; steroid metabolism [goid 8202] [evidence IEA]; negative regulation of enzyme activity [goid 43086] [evidence IEA],peptidase activity [goid 8233] [evidence IEA]; subtilase activity [goid 4289] [pmid 12730697] [evidence NAS]; calcium ion binding [goid 5509] [evidence IEA],1,55302870-55302919,1p32.3a,+,NM_174936.2,255738,PCSK9,-1.5907634710408622,6.436702475084174,-14.029910311508267,3.8961108160327865e-30,6.23627081657472e-29,57.64355867140545
CNN1,ILMN_1810054,"Homo sapiens calponin 1, basic, smooth muscle (CNN1), mRNA.",,actomyosin structure organization and biogenesis [goid 31032] [evidence IEA]; regulation of smooth muscle contraction [goid 6940] [pmid 14550641] [evidence TAS],calmodulin binding [goid 5516] [evidence IEA]; actin binding [goid 3779] [evidence IEA],19,11521806-11521855,19p13.2a,+,NM_001299.4,1264,CNN1,-1.9944433612475274,7.589126034122844,-14.024111534920467,4.0459659602464254e-30,6.470958188058392e-29,57.60591159693954
CLDN11,ILMN_1754103,"Homo sapiens claudin 11 (oligodendrocyte transmembrane protein) (CLDN11), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence ISS]; tight junction [goid 5923] [evidence ISS],calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA],3,171634465-171634514,3q26.2c,+,NM_005602.4,5010,CLDN11,-1.8093446929548795,7.649554102134334,-14.023035903497092,4.074390847508861e-30,6.511215022121189e-29,57.5989281976561
PRR11,ILMN_1782403,"Homo sapiens proline rich 11 (PRR11), mRNA.",,,,17,54629932-54629932:54633706-54633754,17q22d,+,NM_018304.1,55771,PRR11,1.3339036016423043,5.985180000237757,14.019222405867946,4.176787463408224e-30,6.664207621042405e-29,57.57416920750027
TBC1D2,ILMN_1769876,"Homo sapiens TBC1 domain family, member 2 (TBC1D2), mRNA.",,,GTPase activator activity [goid 5096] [evidence IEA],9,100001298-100001347,9q22.33b,-,NM_018421.2,55357,TBC1D2,-1.2070802178879259,9.387316973004701,-14.00192099234403,4.6746788022691595e-30,7.4289891561399e-29,57.461833708784305
BMP6,ILMN_1747650,"Homo sapiens bone morphogenetic protein 6 (BMP6), mRNA.",extracellular space [goid 5615] [evidence IEA],growth [goid 40007] [evidence IEA]; cartilage development [goid 51216] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; ossification [goid 1503] [evidence IEA],cytokine activity [goid 5125] [evidence IEA]; growth factor activity [goid 8083] [evidence IEA],6,7826459-7826508,6p24.3c,+,NM_001718.2,654,BMP6,-1.883269197097257,6.776919481876956,-13.994080936376838,4.919449803790259e-30,7.805579038400912e-29,57.410925796591535
C1orf155,ILMN_1742779,"Homo sapiens centromere protein L (CENPL), mRNA.","chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromosome, pericentric region [goid 775] [evidence IEA]",,,1,172036047-172036096,1q25.1a,-,NM_033319.1,91687,C1orf155,1.200953436191976,6.867296324286902,13.98703644743839,5.150305858418453e-30,8.152477817661108e-29,57.36518185090885
ZSCAN1,ILMN_1716999,"Homo sapiens zinc finger and SCAN domain containing 1 (ZSCAN1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],19,63257592-63257641,19q13.43c,+,NM_182572.2,284312,ZSCAN1,-1.2047266243737784,5.546127622715075,-13.985289143033796,5.209226083841008e-30,8.239224939564497e-29,57.35383531507912
NCF1C,ILMN_2112988,Homo sapiens neutrophil cytosolic factor 1C pseudogene (NCF1C) on chromosome 7.,,,,,,,,NR_003187.1,654817,NCF1C,-1.8095407486620063,8.146275378522622,-13.983559579976848,5.2682124740166554e-30,8.325939587687618e-29,57.342603878954314
MAP4,ILMN_1708064,"Homo sapiens microtubule-associated protein 4 (MAP4), transcript variant 1, mRNA.",microtubule associated complex [goid 5875] [pmid 1905296] [evidence TAS]; microtubule [goid 5874] [evidence IEA],negative regulation of microtubule depolymerization [goid 7026] [evidence IEA],structural molecule activity [goid 5198] [pmid 1905296] [evidence TAS],3,47931376-47931425,3p21.31f,-,NM_002375.3,4134,MAP4,1.386863339121983,6.443216909825299,13.977769408895911,5.470593873102684e-30,8.638961500634451e-29,57.30500288797412
STX7,ILMN_1792518,"Homo sapiens syntaxin 7 (STX7), mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; endosome [goid 5768] [evidence NR ]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; endosome [goid 5768] [evidence NR ],intracellular protein transport [goid 6886] [evidence IEA]; intracellular protein transport [goid 6886] [evidence IEA],protein transporter activity [goid 8565] [evidence IEA]; protein transporter activity [goid 8565] [evidence IEA],6,132823658-132823682:132826825-132826849,6q23.2b,-,NM_003569.1,8417,STX7,-1.1509318778312743,8.06510869756251,-13.965973076596985,5.907303588351793e-30,9.313895208490361e-29,57.22839458641628
PPP1R16B,ILMN_1727098,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 16B (PPP1R16B), mRNA.",plasma membrane [goid 5886] [pmid 12055102] [evidence NAS],signal transduction [goid 7165] [pmid 12055102] [evidence NAS],protein phosphatase binding [goid 19903] [pmid 12055102] [evidence NAS],20,36984885-36984934,20q11.23c,+,NM_015568.2,26051,PPP1R16B,-1.4247973832868048,7.998617467670725,-13.951260625546148,6.501189765667477e-30,1.0218052225567546e-28,57.13284140798833
C8orf13,ILMN_1687213,"Homo sapiens chromosome 8 open reading frame 13 (C8orf13), mRNA.",,,,8,11316511-11316560,8p23.1b,-,NM_053279.1,83648,C8orf13,-2.1074641197726907,8.051323891399793,-13.950604831892495,6.529010474507413e-30,1.0253723828410072e-28,57.12858203863643
MGC14376,ILMN_2390310,"Homo sapiens hypothetical protein MGC14376 (MGC14376), transcript variant 2, mRNA.",,,,17,1561813-1561862,17p13.3d,-,NM_001001870.1,84981,MGC14376,-1.627618938844332,8.741021228741834,-13.95024909070551,6.544151888673996e-30,1.0269442430477594e-28,57.126271499015196
CD9,ILMN_1695423,"Homo sapiens CD9 molecule (CD9), mRNA.",plasma membrane [goid 5886] [pmid 6198179] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 2037603] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],cell motility [goid 6928] [pmid 8478605] [evidence IDA]; paranodal junction assembly [goid 30913] [evidence ISS]; fusion of sperm to egg plasma membrane [goid 7342] [pmid 14575715] [evidence IDA]; cell adhesion [goid 7155] [pmid 7511626] [evidence IDA]; platelet activation [goid 30168] [pmid 2037603] [evidence NAS],protein binding [goid 5515] [pmid 11504738] [evidence IPI],12,6214685-6214734,12p13.31e,+,NM_001769.2,928,CD9,-1.3582727553270004,10.33175381636123,-13.947326109928454,6.669900978627466e-30,1.0458572004731846e-28,57.107286567077885
E2F3,ILMN_1669502,"Homo sapiens E2F transcription factor 3 (E2F3), mRNA.",transcription factor complex [goid 5667] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; transcription initiation from RNA polymerase II promoter [goid 6367] [pmid 8246996] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]",transcription factor activity [goid 3700] [pmid 8246996] [evidence TAS]; protein binding [goid 5515] [pmid 8246996] [evidence TAS],6,20601815-20601864,6p22.3c,+,NM_001949.2,1871,E2F3,1.2131521557245613,9.087303474577153,13.942446222511604,6.885250249701862e-30,1.0787790680973754e-28,57.075590750522714
LOC152485,ILMN_1727574,"Homo sapiens hypothetical protein LOC152485 (LOC152485), mRNA.",nucleus [goid 5634] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],4,146901403-146901452,4q31.22b,-,NM_178835.2,152485,LOC152485,1.4065745573574926,8.785697245371793,13.937954537164494,7.089613822119674e-30,1.1099295254536028e-28,57.04641565375335
SFTPD,ILMN_1768575,"Homo sapiens surfactant, pulmonary-associated protein D (SFTPD), mRNA.",lysosome [goid 5764] [pmid 10485905] [evidence TAS]; extracellular region [goid 5576] [pmid 9751757] [evidence TAS]; endocytic vesicle [goid 30139] [pmid 10485905] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],oxygen and reactive oxygen species metabolism [goid 6800] [pmid 10485905] [evidence TAS]; surfactant homeostasis [goid 43129] [pmid 9751757] [evidence IMP]; regulation of cytokine production [goid 1817] [pmid 9751757] [evidence NAS]; phosphate transport [goid 6817] [evidence IEA]; positive regulation of phagocytosis [goid 50766] [pmid 10485905] [evidence TAS]; negative regulation of interleukin-2 biosynthesis [goid 45085] [pmid 10485905] [evidence TAS]; macrophage chemotaxis [goid 48246] [pmid 10485905] [evidence TAS]; respiratory gaseous exchange [goid 7585] [evidence IEA]; regulation of liquid surface tension [goid 50828] [evidence IEA]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ]; innate immune response [goid 45087] [pmid 10485905] [evidence TAS]; alveolus development [goid 48286] [pmid 9751757] [evidence IMP]; receptor mediated endocytosis [goid 6898] [pmid 10485905] [evidence TAS],sugar binding [goid 5529] [pmid 10485905] [evidence TAS]; bacterial binding [goid 8367] [pmid 9751757] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],10,81687578-81687587:81687588-81687627,10q22.3f,-,NM_003019.4,6441,SFTPD,-2.4657942671334876,13.474172991480485,-13.92311625331105,7.808880454022667e-30,1.2196727566283022e-28,56.950030787929485
GCAT,ILMN_1724437,"Homo sapiens glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase) (GCAT), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [evidence NAS],biosynthesis [goid 9058] [evidence IEA]; amino acid metabolism [goid 6520] [pmid 10712613] [evidence NAS],"acyltransferase activity [goid 8415] [evidence IEA]; ligase activity [goid 16874] [evidence IEA]; glycine C-acetyltransferase activity [goid 8890] [pmid 10712613] [evidence NAS]; transferase activity, transferring nitrogenous groups [goid 16769] [evidence IEA]",22,36542575-36542624,22q13.1a,+,NM_014291.2,23464,GCAT,1.472735019322779,8.225161497081173,13.918659486608849,8.03885626349369e-30,1.2546133862713083e-28,56.92107955482194
SLC25A13,ILMN_1668012,"Homo sapiens solute carrier family 25, member 13 (citrin) (SLC25A13), mRNA.",mitochondrion [goid 5739] [pmid 10642534] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 10642534] [evidence TAS]; mitochondrial inner membrane [goid 5743] [evidence IEA],transport [goid 6810] [pmid 10642534] [evidence TAS],calcium ion binding [goid 5509] [pmid 10642534] [evidence TAS]; carrier activity [goid 5386] [pmid 10642534] [evidence TAS]; binding [goid 5488] [evidence IEA],7,95587736-95587785,7q21.3c,-,NM_014251.1,10165,SLC25A13,1.1535978881823592,8.29679560540881,13.915244207245568,8.219667164815175e-30,1.2818324289448325e-28,56.898893386162364
PLA2G5,ILMN_1807171,"Homo sapiens phospholipase A2, group V (PLA2G5), mRNA.",extracellular region [goid 5576] [pmid 8300559] [evidence TAS],lipid catabolism [goid 16042] [evidence IEA]; phospholipid metabolism [goid 6644] [pmid 8300559] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; calcium-dependent phospholipase A2 activity [goid 47498] [pmid 8300559] [evidence TAS],1,20289860-20289909,1p36.13a,+,NM_000929.1,5322,PLA2G5,-1.0503318186836115,5.6400205157614955,-13.90850539324206,8.588458468762638e-30,1.3383012230763463e-28,56.855115882972775
RHPN1,ILMN_1742003,"Homo sapiens rhophilin, Rho GTPase binding protein 1 (RHPN1), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],protein binding [goid 5515] [evidence IEA],8,144535784-144535833,8q24.3f,+,NM_052924.1,114822,RHPN1,1.1331267544722703,7.1310850899752145,13.905909014277691,8.734928768027892e-30,1.360065796036592e-28,56.83824856318943
POLM,ILMN_1716973,"Homo sapiens polymerase (DNA directed), mu (POLM), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],DNA replication [goid 6260] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; DNA-directed DNA polymerase activity [goid 3887] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; DNA nucleotidylexotransferase activity [goid 3912] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA],7,44078607-44078656,7p13d,-,NM_013284.1,27434,POLM,1.031057409732977,7.898323983292184,13.901696798644391,8.977890771419516e-30,1.396809008977929e-28,56.81088351592522
DHRS8,ILMN_1675117,"Homo sapiens hydroxysteroid (17-beta) dehydrogenase 11 (HSD17B11), mRNA.",,steroid biosynthesis [goid 6694] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; steroid biosynthesis [goid 6694] [evidence IEA]; metabolism [goid 8152] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA],4,88514916-88514965,4q22.1a,-,NM_016245.2,51170,DHRS8,-1.1792615613741608,7.783063270013301,-13.897621629988636,9.219383347860221e-30,1.4332666823930637e-28,56.78440824422584
DNAJC3,ILMN_1659843,"Homo sapiens DnaJ (Hsp40) homolog, subfamily C, member 3 (DNAJC3), mRNA.",cytoplasm [goid 5737] [pmid 8666242] [evidence TAS],regulation of translation [goid 6445] [pmid 7511204] [evidence TAS]; response to virus [goid 9615] [evidence IEA]; defense response [goid 6952] [evidence NR ]; protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [evidence IEA],binding [goid 5488] [evidence IEA]; heat shock protein binding [goid 31072] [evidence IEA]; protein kinase inhibitor activity [goid 4860] [pmid 7511204] [evidence TAS],13,95241143-95241192,13q32.1b,+,NM_006260.2,5611,DNAJC3,1.195029601644892,6.188467407024096,13.89425596122996,9.423725835038728e-30,1.4638967896541527e-28,56.76254198621768
DGCR5,ILMN_2221808,Homo sapiens DiGeorge syndrome critical region gene 5 (non-coding) (DGCR5) on chromosome 22.,,,,22,17361966-17362015,22q11.21b,+,NR_002733.1,26220,DGCR5,1.8729663811823123,6.015839011926813,13.893159808782352,9.491251157223342e-30,1.4732424604633406e-28,56.75542036299152
AVPI1,ILMN_1671731,"Homo sapiens arginine vasopressin-induced 1 (AVPI1), mRNA.",,,,10,99427209-99427258,10q24.2a,-,NM_021732.1,60370,AVPI1,-1.253379965041546,11.280368190241438,-13.892510043986873,9.531506436156802e-30,1.4783440370125992e-28,56.751198869323595
TRPV2,ILMN_2049536,"Homo sapiens transient receptor potential cation channel, subfamily V, member 2 (TRPV2), mRNA.",integral to plasma membrane [goid 5887] [pmid 10201375] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; sensory perception [goid 7600] [pmid 10201375] [evidence TAS]; calcium ion transport [goid 6816] [evidence IEA],ion channel activity [goid 5216] [pmid 10201375] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; calcium channel activity [goid 5262] [evidence IEA],17,16280844-16280893,17p11.2i,+,NM_016113.3,51393,TRPV2,-1.416844605698211,9.353327284438985,-13.876537121810127,1.0576657337227652e-29,1.6366416086871684e-28,56.647419122441725
RPP40,ILMN_1810423,"Homo sapiens ribonuclease P 40kDa subunit (RPP40), mRNA.",nucleolar ribonuclease P complex [goid 5655] [pmid 9630247] [evidence TAS]; nucleus [goid 5634] [pmid 9630247] [evidence TAS],tRNA processing [goid 8033] [evidence IEA],ribonuclease P activity [goid 4526] [pmid 9630247] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; protein binding [goid 5515] [pmid 15096576] [evidence IPI],6,4940314-4940363,6p25.1c,-,NM_006638.2,10799,RPP40,1.1485320977211764,8.946427634536866,13.875632739155566,1.0639152220337934e-29,1.6450398579947556e-28,56.641542890923056
IL7R,ILMN_1691341,"PREDICTED: Homo sapiens interleukin 7 receptor (IL7R), mRNA.",,,,,,5p13.2c,,XM_937367.1,3575,IL7R,-1.8144333347756803,9.874406233107043,-13.857924309028922,1.1940113775980118e-29,1.8419259555112584e-28,56.52647693504131
MBTD1,ILMN_2101650,"Homo sapiens mbt domain containing 1 (MBTD1), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA]; regulation of transcription [goid 45449] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],17,46623964-46624013,17q21.33b,-,NM_017643.1,54799,MBTD1,2.648555303962069,8.388106710390666,13.853259972614676,1.2308519022413609e-29,1.8958340923822285e-28,56.496167304209074
RCN1,ILMN_1800276,"Homo sapiens reticulocalbin 1, EF-hand calcium binding domain (RCN1), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; endoplasmic reticulum lumen [goid 5788] [pmid 8416973] [evidence TAS]; endoplasmic reticulum [goid 5783] [evidence IEA]; endoplasmic reticulum lumen [goid 5788] [pmid 8416973] [evidence TAS],,calcium ion binding [goid 5509] [pmid 8416973] [evidence TAS]; calcium ion binding [goid 5509] [pmid 8416973] [evidence TAS],11,32083535-32083584,11p13e,+,NM_002901.1,5954,RCN1,1.0005023860899325,11.649931611173873,13.846117668172896,1.2894810732633108e-29,1.9846105626040248e-28,56.449754086543486
DAB2,ILMN_1764228,"Homo sapiens disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) (DAB2), mRNA.",,cell proliferation [goid 8283] [pmid 9620555] [evidence TAS],,5,39408932-39408981,5p13.1c,-,NM_001343.1,1601,DAB2,-1.151806088773057,10.598424149793031,-13.84456130459259,1.3026232018669784e-29,2.0032963122947352e-28,56.43964007194463
DAPK2,ILMN_1791847,"Homo sapiens death-associated protein kinase 2 (DAPK2), mRNA.",cytoplasm [goid 5737] [pmid 10376525] [evidence IEP],induction of apoptosis [goid 6917] [pmid 10376525] [evidence IMP]; apoptosis [goid 6915] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 10376525] [evidence IDA]; protein kinase cascade [goid 7243] [pmid 10376525] [evidence IDA],nucleotide binding [goid 166] [evidence IEA]; calcium- and calmodulin-dependent protein kinase activity [goid 4685] [pmid 10376525] [evidence IDA]; calmodulin binding [goid 5516] [pmid 10376525] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [pmid 10376525] [evidence IDA],15,61986611-61986660,15q22.31a,-,NM_014326.3,23604,DAPK2,-1.6416191133884537,7.1433905775566044,-13.83593533759925,1.3779302468880995e-29,2.1158578956053026e-28,56.38358292217914
TMEM37,ILMN_1670672,"Homo sapiens transmembrane protein 37 (TMEM37), mRNA.",,,,2,119911220-119911269,2q14.2b,+,NM_183240.1,140738,TMEM37,-1.7863435809023018,7.417628462742521,-13.835152190713282,1.3849794076452522e-29,2.123422834342238e-28,56.378493408337924
FAM26B,ILMN_1766200,"Homo sapiens family with sequence similarity 26, member B (FAM26B), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,10,105196743-105196792,10q24.33a,-,NM_015916.3,51063,FAM26B,-1.126569832027534,7.226898861994068,-13.829532862816208,1.4366291783309244e-29,2.1992407498121755e-28,56.34197396741039
SLC43A2,ILMN_1787127,"Homo sapiens solute carrier family 43, member 2 (SLC43A2), mRNA.",,,,17,1424557-1424606,17p13.3e,-,NM_152346.1,124935,SLC43A2,-1.1278851325867922,8.989806014865756,-13.826872646524878,1.4617484040326432e-29,2.2342751770729663e-28,56.32468514970696
GPD1,ILMN_1764175,"Homo sapiens glycerol-3-phosphate dehydrogenase 1 (soluble) (GPD1), mRNA.",glycerol-3-phosphate dehydrogenase complex [goid 9331] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],glycerol-3-phosphate catabolism [goid 46168] [evidence IEA]; carbohydrate metabolism [goid 5975] [evidence IEA],glycerol-3-phosphate dehydrogenase (NAD+) activity [goid 4367] [pmid 7772607] [evidence TAS]; NAD binding [goid 51287] [evidence IEA],12,48791043-48791092,12q13.13a,+,NM_005276.2,2819,GPD1,-1.7506303105560184,5.809080271034654,-13.812001146851687,1.6104909473689995e-29,2.4578720728420246e-28,56.22803084976196
PHACTR2,ILMN_1790533,"Homo sapiens phosphatase and actin regulator 2 (PHACTR2), mRNA.",,,actin binding [goid 3779] [evidence IEA]; protein phosphatase inhibitor activity [goid 4864] [evidence IEA],6,144188366-144188415,6q24.2b,+,NM_014721.1,9749,PHACTR2,-1.6019851654157993,9.25526684893389,-13.811005574217406,1.6209731777410227e-29,2.4719840960550595e-28,56.221560085004135
NEK6,ILMN_1660871,"Homo sapiens NIMA (never in mitosis gene a)-related kinase 6 (NEK6), mRNA.",nucleus [goid 5634] [pmid 12054534] [evidence IDA]; cytoplasm [goid 5737] [pmid 12054534] [evidence IDA],apoptosis [goid 6915] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; chromosome segregation [goid 7059] [pmid 14563848] [evidence IDA]; positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP]; mitosis [goid 7067] [evidence IEA]; regulation of mitotic metaphase/anaphase transition [goid 30071] [pmid 14563848] [evidence IDA]; protein amino acid phosphorylation [goid 6468] [pmid 14563848] [evidence IDA],transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; ATP binding [goid 5524] [pmid 14563848] [evidence IDA]; protein serine/threonine kinase activity [goid 4674] [pmid 14563848] [evidence IDA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; protein kinase activity [goid 4672] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [pmid 14563848] [evidence IDA],9,126154389-126154438,9q33.3a,+,NM_014397.3,10783,NEK6,1.3057085396486405,8.582510384104127,13.80660455914878,1.66813496070076e-29,2.5400338123059976e-28,56.192955147478564
ATR,ILMN_2376771,"Homo sapiens ataxia telangiectasia and Rad3 related (ATR), mRNA.",nucleus [goid 5634] [evidence IEA]; chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromosome [goid 5694] [evidence IEA],cell cycle [goid 7049] [pmid 9590286] [evidence TAS]; cell cycle checkpoint [goid 75] [pmid 8610130] [evidence TAS]; DNA repair [goid 6281] [pmid 8610130] [evidence TAS]; development [goid 7275] [pmid 9590286] [evidence TAS]; cell cycle [goid 7049] [pmid 9590286] [evidence TAS]; cell cycle checkpoint [goid 75] [pmid 8610130] [evidence TAS]; DNA repair [goid 6281] [pmid 8610130] [evidence TAS]; development [goid 7275] [pmid 9590286] [evidence TAS],"phosphotransferase activity, alcohol group as acceptor [goid 16773] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; binding [goid 5488] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; phosphotransferase activity, alcohol group as acceptor [goid 16773] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; binding [goid 5488] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]",3,143769659-143769686:143780178-143780199,3q23d,-,NM_001184.2,545,ATR,-1.4581811266494826,5.938877698466388,-13.799641584141416,1.7455719032578364e-29,2.6559241551621895e-28,56.147697238079324
LOC440157,ILMN_1803559,"Homo sapiens hypothetical gene supported by AK096951; BC066547 (LOC440157), mRNA.",,,,14,18757335-18757384,14q11.1d,+,NM_001013701.1,440157,LOC440157,1.6499213951833376,7.26622622635635,13.798283809060369,1.761086100080559e-29,2.6774932135571293e-28,56.138871808133715
AUH,ILMN_2231911,"Homo sapiens AU RNA binding protein/enoyl-Coenzyme A hydratase (AUH), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [evidence IEA],metabolism [goid 8152] [evidence IEA]; branched chain family amino acid catabolism [goid 9083] [evidence IEA]; mRNA catabolism [goid 6402] [pmid 7892223] [evidence TAS],enoyl-CoA hydratase activity [goid 4300] [pmid 7892223] [evidence TAS]; RNA binding [goid 3723] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; mRNA 3'-UTR binding [goid 3730] [pmid 7892223] [evidence TAS]; methylglutaconyl-CoA hydratase activity [goid 4490] [evidence IEA],9,93019407-93019430:93022908-93022933,9q22.31a,-,NM_001698.1,549,AUH,-1.021174353695037,7.665098546340016,-13.79795615694069,1.7648505374119266e-29,2.6811791611646037e-28,56.136742087133356
SSFA2,ILMN_1742260,"Homo sapiens sperm specific antigen 2 (SSFA2), mRNA.",plasma membrane [goid 5886] [pmid 1555770] [evidence NAS],,,2,182495136-182495185,2q31.3b,+,NM_006751.3,6744,SSFA2,-1.5773659544685783,7.01839658803471,-13.797533826619967,1.7697146269652668e-29,2.6865288510107027e-28,56.13399695820383
WFS1,ILMN_1759023,"Homo sapiens Wolfram syndrome 1 (wolframin) (WFS1), mRNA.",integral to membrane [goid 16021] [pmid 9771706] [evidence TAS]; membrane fraction [goid 5624] [pmid 9771706] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],visual perception [goid 7601] [pmid 9771706] [evidence TAS]; generation of precursor metabolites and energy [goid 6091] [pmid 9771706] [evidence TAS],,4,6355789-6355838,4p16.1f,+,NM_006005.2,7466,WFS1,-1.205233547717981,11.418049652908756,-13.787665601461983,1.8872685963687416e-29,2.862810468244563e-28,56.069852398747784
RASGRF1,ILMN_1748083,"Homo sapiens Ras protein-specific guanine nucleotide-releasing factor 1 (RASGRF1), transcript variant 2, mRNA.",plasma membrane [goid 5886] [pmid 10918068] [evidence NAS]; synaptosome [goid 19717] [pmid 10918068] [evidence NAS]; intracellular [goid 5622] [evidence IEA],long-term memory [goid 7616] [pmid 10918068] [evidence NAS]; regulation of Rho protein signal transduction [goid 35023] [evidence IEA],Ras guanyl-nucleotide exchange factor activity [goid 5088] [pmid 7684828] [evidence TAS]; Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence IEA],15,77052715-77052764,15q25.1a,-,NM_153815.1,5923,RASGRF1,-1.3997125794192469,5.906523925386938,-13.778013001400572,2.009811095524382e-29,3.0463863938827147e-28,56.00710662575703
DPP9,ILMN_1673069,"Homo sapiens dipeptidyl-peptidase 9 (DPP9), mRNA.",membrane [goid 16020] [evidence IEA],,dipeptidyl-peptidase IV activity [goid 4274] [evidence IEA]; serine-type endopeptidase activity [goid 4252] [evidence IEA]; aminopeptidase activity [goid 4177] [evidence IEA],19,4626532-4626581,19p13.3d,-,NM_139159.3,91039,DPP9,1.4229246603775998,9.935327673791699,13.772520270148485,2.0830654460246297e-29,3.1550320548115666e-28,55.971400443618165
DDX51,ILMN_1682323,"Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 51 (DDX51), mRNA.",,,nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ATP-dependent helicase activity [goid 8026] [evidence IEA],12,131189475-131189524,12q24.33c,-,NM_175066.2,317781,DDX51,1.3855783598307223,10.38380601550651,13.772144775699417,2.0881697571914627e-29,3.1603706884937054e-28,55.96895946301246
GOLGA8A,ILMN_1712469,"Homo sapiens golgi autoantigen, golgin subfamily a, 8A (GOLGA8A), mRNA.",,,,15,32467354-32467403,15q14a,-,NM_181077.2,23015,GOLGA8A,2.133851442188897,7.414813722749341,13.769139461922865,2.1294763025336118e-29,3.220450631979781e-28,55.94942264067569
HES6,ILMN_1694268,"Homo sapiens hairy and enhancer of split 6 (Drosophila) (HES6), mRNA.",nucleus [goid 5634] [evidence IEA]; transcription factor complex [goid 5667] [pmid 10851137] [evidence ISS],"cell differentiation [goid 30154] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]",transcription cofactor activity [goid 3712] [pmid 10851137] [evidence ISS]; transcription factor activity [goid 3700] [pmid 10851137] [evidence TAS],2,238811723-238811772,2q37.3c,-,NM_018645.3,55502,HES6,1.669342769535505,8.68774240009184,13.768994442158547,2.1314900799833025e-29,3.2210614441318666e-28,55.94847989539187
LPHN2,ILMN_1697548,"Homo sapiens latrophilin 2 (LPHN2), mRNA.",integral to membrane [goid 16021] [pmid 15203201] [evidence TAS]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; neuropeptide signaling pathway [goid 7218] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],latrotoxin receptor activity [goid 16524] [pmid 10030676] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 15203201] [evidence TAS]; sugar binding [goid 5529] [evidence IEA],1,82230373-82230422,1p31.1b,+,NM_012302.2,23266,LPHN2,-1.5867995456077368,8.444220303784828,-13.763306606331179,2.2119941875840388e-29,3.3376756942067458e-28,55.91150389873186
GNAQ,ILMN_1659923,"Homo sapiens guanine nucleotide binding protein (G protein), q polypeptide (GNAQ), mRNA.",heterotrimeric G-protein complex [goid 5834] [evidence NR ]; plasma membrane [goid 5886] [pmid 10633085] [evidence TAS]; cytoplasm [goid 5737] [pmid 9175863] [evidence TAS],phospholipase C activation [goid 7202] [pmid 8825633] [evidence TAS]; blood coagulation [goid 7596] [pmid 9238049] [evidence TAS]; protein amino acid ADP-ribosylation [goid 6471] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],GTPase activity [goid 3924] [pmid 9238049] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; signal transducer activity [goid 4871] [evidence IEA]; GTP binding [goid 5525] [evidence IEA],9,79525637-79525686,9q21.2a-q21.2b,-,NM_002072.2,2776,GNAQ,-1.8810412078745982,7.088422979980416,-13.758445596768684,2.2832028203220376e-29,3.4425261513943726e-28,55.879902266642574
CCRL1,ILMN_1773992,"Homo sapiens chemokine (C-C motif) receptor-like 1 (CCRL1), transcript variant 1, mRNA.",plasma membrane [goid 5886] [pmid 10767544] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 10767544] [evidence TAS]; plasma membrane [goid 5886] [pmid 10767544] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 10767544] [evidence TAS],immune response [goid 6955] [pmid 10706668] [evidence TAS]; chemotaxis [goid 6935] [pmid 10706668] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10734104] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; immune response [goid 6955] [pmid 10706668] [evidence TAS]; chemotaxis [goid 6935] [pmid 10706668] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10734104] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],C-C chemokine receptor activity [goid 16493] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; C-C chemokine receptor activity [goid 16493] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],3,133802055-133802104,3q22.1c,+,NM_178445.1,51554,CCRL1,-1.0084621032340264,5.331691899444192,-13.756158622703474,2.317493664610783e-29,3.4889701460897326e-28,55.86503431444908
CTSL,ILMN_1694757,"Homo sapiens cathepsin L (CTSL), transcript variant 1, mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; lysosome [goid 5764] [evidence NAS],,cysteine-type endopeptidase activity [goid 4197] [evidence IEA]; cathepsin L activity [goid 4217] [pmid 8419312] [evidence TAS],9,89531002-89531051,9q21.33c,+,NM_001912.2,1514,CTSL,-1.4499283197410735,6.9463226215464795,-13.753339580679683,2.3604723591732424e-29,3.551002327995356e-28,55.84670710420549
GALNTL4,ILMN_1673773,"Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 4 (GALNTL4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; polypeptide N-acetylgalactosaminyltransferase activity [goid 4653] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]",11,11249312-11249361,11p15.3d-p15.3c,-,NM_198516.1,374378,GALNTL4,-1.2777313906246874,9.491763528091216,-13.752915099626179,2.3670126711533678e-29,3.5581660048412157e-28,55.843947440093416
C8orf72,ILMN_1679217,"Homo sapiens chromosome 8 open reading frame 72 (C8orf72), mRNA.",,,,8,59223712-59223761,8q12.1c,+,NM_147189.1,90362,C8orf72,-1.0918293542601534,6.307126164123972,-13.75203595567771,2.3806160628485123e-29,3.5759283923027804e-28,55.838231875309084
SPARC,ILMN_1796734,"Homo sapiens secreted protein, acidic, cysteine-rich (osteonectin) (SPARC), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; basement membrane [goid 5604] [evidence IEA],transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 15609325] [evidence NAS]; ossification [goid 1503] [pmid 7034958] [evidence TAS],copper ion binding [goid 5507] [evidence IEA]; calcium ion binding [goid 5509] [pmid 7034958] [evidence TAS]; collagen binding [goid 5518] [pmid 7034958] [evidence TAS],5,151021513-151021562,5q33.1d,-,NM_003118.2,6678,SPARC,-1.4306791920494462,11.949178311316368,-13.747379739309542,2.453979122745276e-29,3.683361912069579e-28,55.807960120996164
H2AFX,ILMN_1785756,"Homo sapiens H2A histone family, member X (H2AFX), mRNA.",chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [pmid 15604234] [evidence IDA]; nucleosome [goid 786] [evidence NAS]; chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [pmid 15604234] [evidence IDA]; nucleosome [goid 786] [evidence NAS],chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [evidence NAS]; DNA recombination [goid 6310] [evidence IEA]; nucleosome assembly [goid 6334] [pmid 2587254] [evidence NAS]; meiosis [goid 7126] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [evidence NAS]; DNA recombination [goid 6310] [evidence IEA]; nucleosome assembly [goid 6334] [pmid 2587254] [evidence NAS]; meiosis [goid 7126] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],DNA binding [goid 3677] [pmid 2587254] [evidence NAS]; protein binding [goid 5515] [pmid 12607005] [evidence IPI]; DNA binding [goid 3677] [pmid 2587254] [evidence NAS]; protein binding [goid 5515] [pmid 12607005] [evidence IPI],11,118470028-118470077,11q23.3e,-,NM_002105.2,3014,H2AFX,1.0076310592714384,7.990443875292002,13.74637401622837,2.4701199998824047e-29,3.7048096669900413e-28,55.801421468794885
IL1B,ILMN_1775501,"Homo sapiens interleukin 1, beta (IL1B), mRNA.",extracellular region [goid 5576] [pmid 1919436] [evidence NAS]; extracellular space [goid 5615] [pmid 3493774] [evidence TAS],apoptosis [goid 6915] [pmid 9218611] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ]; cell-cell signaling [goid 7267] [pmid 2989698] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 3493774] [evidence TAS]; fever [goid 1660] [evidence IEA]; cell proliferation [goid 8283] [evidence IEA]; signal transduction [goid 7165] [pmid 10786823] [evidence TAS],interleukin-1 receptor binding [goid 5149] [pmid 1919436] [evidence NAS]; signal transducer activity [goid 4871] [pmid 10786823] [evidence TAS],2,113304123-113304172,2q13d,-,NM_000576.2,3553,IL1B,-2.4254754979065414,7.8316549812889145,-13.740695892639785,2.563262023151985e-29,3.841628955747185e-28,55.76450492890865
OPLAH,ILMN_1711030,"Homo sapiens 5-oxoprolinase (ATP-hydrolysing) (OPLAH), mRNA.",,,catalytic activity [goid 3824] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; 5-oxoprolinase (ATP-hydrolyzing) activity [goid 17168] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; 5-oxoprolinase (ATP-hydrolyzing) activity [goid 17168] [evidence IEA],8,145178201-145178214:145178215-145178250,8q24.3g,-,NM_017570.1,26873,OPLAH,1.1282503499678285,7.590917647445284,13.735072899502327,2.658963109597967e-29,3.9820758904817454e-28,55.72794592541044
APCDD1,ILMN_1656951,"Homo sapiens adenomatosis polyposis coli down-regulated 1 (APCDD1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,18,10478228-10478277,18p11.22a,+,NM_153000.3,147495,APCDD1,-1.3647689541479622,7.884210057497117,-13.73246550602808,2.704545386893083e-29,4.04731070313813e-28,55.710993139255535
RAB32,ILMN_2115434,"Homo sapiens RAB32, member RAS oncogene family (RAB32), mRNA.",mitochondrion [goid 5739] [evidence IEA],protein transport [goid 15031] [evidence IEA]; small GTPase mediated signal transduction [goid 7264] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA],6,146917424-146917434:146917435-146917473,6q24.3b,+,NM_006834.2,10981,RAB32,-1.1655337382402546,9.677997736368626,-13.719382688921886,2.945338929042898e-29,4.401071044980605e-28,55.625928245618184
CHRDL1,ILMN_1678233,"Homo sapiens chordin-like 1 (CHRDL1), mRNA.",,ossification [goid 1503] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; ossification [goid 1503] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA],,X,109805406-109805455,Xq22.3d,-,NM_145234.2,91851,CHRDL1,-1.3211642692883467,5.39570288746652,-13.710991614691999,3.1109561560516705e-29,4.645075430618046e-28,55.57136672976623
FOXO1A,ILMN_1738816,"Homo sapiens forkhead box O1A (rhabdomyosarcoma) (FOXO1A), mRNA.",nucleus [goid 5634] [evidence IEA],anti-apoptosis [goid 6916] [pmid 10871843] [evidence TAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 10871843] [evidence TAS],transcription factor activity [goid 3700] [pmid 10871843] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA],13,40028101-40028150,13q14.11a,-,NM_002015.2,2308,FOXO1A,-1.0959144533788407,9.410644767302026,-13.706005161347097,3.2137571165427633e-29,4.791419701027393e-28,55.538942265241865
ELF3,ILMN_1769201,"Homo sapiens E74-like factor 3 (ets domain transcription factor, epithelial-specific ) (ELF3), mRNA.",nucleus [goid 5634] [pmid 9234700] [evidence NAS],"morphogenesis [goid 9653] [evidence NR ]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; epidermis development [goid 8544] [pmid 9234700] [evidence NAS]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9234700] [evidence TAS]",transcription coactivator activity [goid 3713] [pmid 9234700] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10821850] [evidence TAS],1,200251463-200251512,1q32.1c,+,NM_004433.3,1999,ELF3,1.575424879685432,10.737599538019522,13.700320096168898,3.335114387699678e-29,4.968649938130689e-28,55.50197424874409
AK3L1,ILMN_1764090,"Homo sapiens adenylate kinase 3-like 1 (AK3L1), nuclear gene encoding mitochondrial protein, transcript variant 5, mRNA.",mitochondrion [goid 5739] [evidence IEA],"nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [evidence IEA]",kinase activity [goid 16301] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; adenylate kinase activity [goid 4017] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],1,65465168-65465217,1p31.3b,+,NM_001005353.1,205,AK3L1,1.6904071388012705,6.854218067158494,13.697985148660559,3.386276629687917e-29,5.0411177683627865e-28,55.48679063888979
RERG,ILMN_1746359,"Homo sapiens RAS-like, estrogen-regulated, growth inhibitor (RERG), mRNA.",nucleus [goid 5634] [pmid 11533059] [evidence IDA]; cytosol [goid 5829] [pmid 11533059] [evidence IEP]; intracellular [goid 5622] [evidence IEA],response to hormone stimulus [goid 9725] [pmid 11533059] [evidence IDA]; negative regulation of cell growth [goid 30308] [pmid 11533059] [evidence IDA]; negative regulation of cell proliferation [goid 8285] [pmid 11533059] [evidence IDA]; small GTPase mediated signal transduction [goid 7264] [pmid 11533059] [evidence NAS],GDP binding [goid 19003] [pmid 11533059] [evidence TAS]; GTPase activity [goid 3924] [pmid 11533059] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; estrogen receptor binding [goid 30331] [pmid 11533059] [evidence NAS]; GTP binding [goid 5525] [evidence IEA],12,15152396-15152445,12p12.3e,-,NM_032918.1,85004,RERG,-1.800479431397008,7.651711666158078,-13.686580596002113,3.6476813147779225e-29,5.422199683958148e-28,55.4126274443283
GPA33,ILMN_1729170,"Homo sapiens glycoprotein A33 (transmembrane) (GPA33), mRNA.",integral to plasma membrane [goid 5887] [pmid 9012807] [evidence TAS],,receptor activity [goid 4872] [pmid 9012807] [evidence TAS],1,165289017-165289066,1q24.1c,-,NM_005814.1,10223,GPA33,-2.1034828239240255,6.769887714239586,-13.686274859471057,3.654960356745916e-29,5.4289864007254855e-28,55.410639208497166
IFT57,ILMN_1811636,"Homo sapiens intraflagellar transport 57 homolog (Chlamydomonas) (IFT57), mRNA.",flagellum [goid 19861] [evidence IEA],regulation of apoptosis [goid 42981] [pmid 11788820] [evidence IDA]; caspase activation [goid 6919] [pmid 11788820] [evidence IDA],protein binding [goid 5515] [pmid 11788820] [evidence IDA],3,109362379-109362428,3q13.12b,-,NM_018010.2,55081,IFT57,-1.602048916885435,9.253222044367782,-13.674096698294905,3.9570329558992046e-29,5.868963334442645e-28,55.33144138513001
FAM13A1,ILMN_1752510,"Homo sapiens family with sequence similarity 13, member A1 (FAM13A1), transcript variant 1, mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],,4,89867383-89867432,4q22.1c,-,NM_014883.2,10144,FAM13A1,1.0515458751574362,7.374273409133199,13.669892625485375,4.0670124734008614e-29,6.023152151576938e-28,55.30410028114431
SLPI,ILMN_2114720,"Homo sapiens secretory leukocyte peptidase inhibitor (SLPI), mRNA.",,,serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA],20,43315182-43315206:43315630-43315654,20q13.12b,-,NM_003064.2,6590,SLPI,-2.352459840731173,12.02199167996372,-13.663226687158634,4.247699123580285e-29,6.276806799453054e-28,55.26074754641622
MBOAT2,ILMN_2347424,"Homo sapiens membrane bound O-acyltransferase domain containing 2 (MBOAT2), mRNA.",,,,2,8914407-8914456,2p25.1e,-,NM_138799.2,129642,MBOAT2,1.8557405371529425,8.055657430604736,13.653791461817779,4.5172662870667346e-29,6.665299695548026e-28,55.199382471118845
GBP4,ILMN_1771385,"Homo sapiens guanylate binding protein 4 (GBP4), mRNA.",,immune response [goid 6955] [evidence IEA],GTPase activity [goid 3924] [evidence IEA]; GTP binding [goid 5525] [evidence IEA],1,89420346-89420395,1p22.2c,-,NM_052941.2,115361,GBP4,-1.88096226751051,9.568522506173956,-13.652812115647794,4.5462091165134055e-29,6.703062048872529e-28,55.19301284301777
RAB15,ILMN_1731699,"Homo sapiens RAB15, member RAS onocogene family (RAB15), mRNA.",membrane [goid 16020] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA]; protein transport [goid 15031] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],14,64482581-64482630,14q23.3a,-,NM_198686.1,376267,RAB15,1.4932332119464897,7.024377662407783,13.651992025357616,4.570588129593621e-29,6.734044719949128e-28,55.1876789900604
PRRG4,ILMN_1661809,"Homo sapiens proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) (PRRG4), mRNA.",membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [evidence IEA]; integral to membrane [goid 16021] [pmid 11171957] [evidence NAS]; membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [evidence IEA]; integral to membrane [goid 16021] [pmid 11171957] [evidence NAS],,calcium ion binding [goid 5509] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],11,32831507-32831556,11p13d,+,NM_024081.4,79056,PRRG4,1.169409442713084,7.809041657777959,13.65082849045649,4.6054014400117886e-29,6.7765164839630335e-28,55.18011135013879
SPSB1,ILMN_1714170,"Homo sapiens splA/ryanodine receptor domain and SOCS box containing 1 (SPSB1), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA],,1,9351943-9351992,1p36.22d,+,NM_025106.2,80176,SPSB1,1.408826910641249,9.119147551503612,13.637966446588187,5.0083762463523973e-29,7.354386915806003e-28,55.096454250715
RAB3IP,ILMN_1803197,"Homo sapiens RAB3A interacting protein (rabin3) (RAB3IP), transcript variant beta 1, mRNA.",cytosol [goid 5829] [pmid 12007189] [evidence IDA]; nucleus [goid 5634] [pmid 12007189] [evidence IDA],protein transport [goid 15031] [evidence IEA],GTPase activator activity [goid 5096] [evidence IEA]; protein binding [goid 5515] [pmid 12007189] [evidence IPI],12,68495484-68495533,12q15c,+,NM_175624.1,117177,RAB3IP,1.0872860861235,9.206385562736015,13.637842321614203,5.012432289194e-29,7.354386915806003e-28,55.09564689891588
FAM108A2,ILMN_2239772,"Homo sapiens family with sequence similarity 108, member A3 (FAM108A3), mRNA.",,,,,,1q21.1c,,NM_001080422.1,653401,FAM108A2,-1.125662431312815,7.711313074729541,-13.635746198473907,5.081426069146201e-29,7.448291046994665e-28,55.082012930652965
LOC441155,ILMN_1767514,"PREDICTED: Homo sapiens similar to Zinc finger CCCH-type domain containing protein 11A, transcript variant 3 (LOC441155), mRNA.",,,,6,66069519-66069568,6q12c,+,XM_930970.1,441155,LOC441155,1.4549180069240455,7.036914798649214,13.630246624192715,5.266995498490575e-29,7.703365930833292e-28,55.04624112772532
ANKRD38,ILMN_1776936,"Homo sapiens ankyrin repeat domain 38 (ANKRD38), mRNA.",,,,1,62475456-62475505,1p31.3d,-,NM_181712.2,163782,ANKRD38,-1.644663663505626,7.789815886130994,-13.627443073274689,5.364188618475849e-29,7.839787135022994e-28,55.02800523502336
RAD9A,ILMN_1684183,"Homo sapiens RAD9 homolog A (S. pombe) (RAD9A), mRNA.",nucleus [goid 5634] [pmid 12628935] [evidence IDA],DNA replication checkpoint [goid 76] [pmid 8943031] [evidence TAS]; DNA damage checkpoint [goid 77] [pmid 8943031] [evidence TAS]; DNA repair [goid 6281] [pmid 8943031] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; histone deacetylase binding [goid 42826] [pmid 10846170] [evidence IPI]; 3'-5' exonuclease activity [goid 8408] [pmid 10713044] [evidence IDA]; protein kinase binding [goid 19901] [pmid 12628935] [evidence IPI]; SH3 domain binding [goid 17124] [pmid 11971963] [evidence IPI]; exodeoxyribonuclease III activity [goid 8853] [evidence IEA]; protein binding [goid 5515] [pmid 15897895] [evidence IPI],11,66922099-66922148,11q13.1f,+,NM_004584.2,5883,RAD9A,1.2933359150951613,7.853063482703735,13.623210951937523,5.514317361162388e-29,8.047444329842235e-28,55.00047674189768
P2RY14,ILMN_2342835,"Homo sapiens purinergic receptor P2Y, G-protein coupled, 14 (P2RY14), transcript variant 2, mRNA.",integral to membrane [goid 16021] [pmid 10753868] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 10753868] [evidence NAS]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10753868] [evidence NAS]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10753868] [evidence NAS]; signal transduction [goid 7165] [evidence IEA],"purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; UDP-activated nucleotide receptor activity [goid 45029] [pmid 10753868] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; UDP-activated nucleotide receptor activity [goid 45029] [pmid 10753868] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]",,,3q25.1b-q25.1c,,NM_014879.3,9934,P2RY14,-1.1835175544269187,5.370961508113329,-13.62133835997101,5.58207986499225e-29,8.135740247262481e-28,54.988296036140035
SLC35F2,ILMN_1790577,"Homo sapiens solute carrier family 35, member F2 (SLC35F2), mRNA.",,,,11,107167398-107167447,11q22.3c,-,NM_017515.3,54733,SLC35F2,1.4671317304866331,8.285540015824232,13.621202766554193,5.587018742372375e-29,8.135740247262481e-28,54.98741403421998
FAM83E,ILMN_1658301,"Homo sapiens family with sequence similarity 83, member E (FAM83E), mRNA.",,,,19,53796039-53796088,19q13.32c-q13.33a,-,NM_017708.1,54854,FAM83E,1.6328829814790877,7.70404865511834,13.620987760588394,5.594859121225937e-29,8.141232094362803e-28,54.98601547223072
C1orf198,ILMN_1657683,"Homo sapiens chromosome 1 open reading frame 198 (C1orf198), mRNA.",,,,1,229039792-229039841,1q42.2a,-,NM_032800.1,84886,C1orf198,-1.2291419363289808,10.628720420510358,-13.618268613055058,5.694970475822102e-29,8.280884395366905e-28,54.96832797613366
GRHL2,ILMN_2060145,"Homo sapiens grainyhead-like 2 (Drosophila) (GRHL2), mRNA.",nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],8,102750453-102750502,8q22.3a-q22.3b,+,NM_024915.1,79977,GRHL2,1.1642942582548068,7.080041797541261,13.613369500455963,5.8798878413137e-29,8.543558164778832e-28,54.93645980424962
THOP1,ILMN_1726659,"Homo sapiens thimet oligopeptidase 1 (THOP1), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; metalloendopeptidase activity [goid 4222] [pmid 7639763] [evidence TAS]; protein binding [goid 5515] [pmid 15231747] [evidence IPI],19,2764369-2764418,19p13.3g-p13.3f,+,NM_003249.3,7064,THOP1,1.0830559872312424,8.698201592354287,13.606676473349552,6.142266201413013e-29,8.91185367352223e-28,54.89292149083311
NIPSNAP3A,ILMN_1700159,"Homo sapiens nipsnap homolog 3A (C. elegans) (NIPSNAP3A), mRNA.",,,,9,106556744-106556793,9q31.1d,+,NM_015469.1,25934,NIPSNAP3A,-1.4732507875359193,6.859957518443517,-13.597383470076075,6.526106461913618e-29,9.455057066616052e-28,54.832468500085675
ABCA3,ILMN_1758523,"Homo sapiens ATP-binding cassette, sub-family A (ABC1), member 3 (ABCA3), mRNA.",membrane fraction [goid 5624] [pmid 9027511] [evidence TAS]; integral to membrane [goid 16021] [pmid 9027511] [evidence TAS]; lamellar body [goid 42599] [pmid 11718719] [evidence IDA]; plasma membrane [goid 5886] [pmid 11718719] [evidence IDA],transport [goid 6810] [pmid 15531465] [evidence IDA]; response to drug [goid 42493] [pmid 8706931] [evidence TAS],"nucleotide binding [goid 166] [evidence IEA]; ATPase activity, coupled to transmembrane movement of substances [goid 42626] [pmid 9027511] [evidence TAS]; ATPase activity [goid 16887] [evidence IEA]; transporter activity [goid 5215] [pmid 9027511] [evidence TAS]; ATP binding [goid 5524] [pmid 9027511] [evidence TAS]",16,2265911-2265960,16p13.3d,-,NM_001089.1,21,ABCA3,-2.035003186388,11.224417626989728,-13.594343516301535,6.65680833558174e-29,9.63744002737478e-28,54.812692503499804
B3GAT3,ILMN_2210581,"Homo sapiens beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) (B3GAT3), mRNA.",integral to membrane [goid 16021] [pmid 10842173] [evidence NAS]; membrane [goid 16020] [evidence IEA]; Golgi membrane [goid 139] [evidence NAS],glycosaminoglycan biosynthesis [goid 6024] [pmid 10842173] [evidence NAS],transferase activity [goid 16740] [evidence IEA]; manganese ion binding [goid 30145] [evidence NAS]; metal ion binding [goid 46872] [evidence IEA]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [goid 15018] [pmid 10842173] [evidence NAS],11,62139628-62139677,11q12.3a,-,NM_012200.2,26229,B3GAT3,1.1625799938451928,7.982741089328837,13.589413503730844,6.874364177155472e-29,9.945211746675826e-28,54.780620533228486
TGM1,ILMN_1721134,"Homo sapiens transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase) (TGM1), mRNA.",intrinsic to membrane [goid 31224] [pmid 8824274] [evidence IDA]; cornified envelope [goid 1533] [pmid 8824274] [evidence TAS],peptide cross-linking [goid 18149] [evidence IEA]; cell envelope organization and biogenesis [goid 43163] [pmid 14645372] [evidence TAS]; keratinization [goid 31424] [evidence IEA]; keratinocyte differentiation [goid 30216] [pmid 8824274] [evidence IDA],protein binding [goid 5515] [pmid 10066784] [evidence IPI]; acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; protein-glutamine gamma-glutamyltransferase activity [goid 3810] [pmid 7961731] [evidence IDA],14,23788297-23788346,14q12a,-,NM_000359.1,7051,TGM1,-1.2761639802706055,5.946214771378264,-13.578812193293727,7.366589599599947e-29,1.0649618837340734e-27,54.711652288979614
DKFZP564J0863,ILMN_1751086,"Homo sapiens DKFZP564J0863 protein (DKFZP564J0863), mRNA.",,immune response [goid 6955] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; GTPase activity [goid 3924] [evidence IEA],11,63153293-63153342,11q13.1a,-,NM_015459.3,25923,DKFZP564J0863,1.0973985646322255,9.192566874944756,13.57805072751813,7.403273405645076e-29,1.0694923776183875e-27,54.70669837205606
P2RY13,ILMN_1664094,"Homo sapiens purinergic receptor P2Y, G-protein coupled, 13 (P2RY13), transcript variant 2, mRNA.",,,,3,152526923-152526972,3q25.1c,-,NM_176894.1,53829,P2RY13,-1.0882153122645333,7.025562206035394,-13.575585437995615,7.523297896578921e-29,1.0848557437991323e-27,54.690659688526864
ENC1,ILMN_1779147,"Homo sapiens ectodermal-neural cortex (with BTB-like domain) (ENC1), mRNA.",nucleus [goid 5634] [pmid 9566959] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA],development [goid 7275] [pmid 9566959] [evidence TAS],actin binding [goid 3779] [evidence IEA]; protein binding [goid 5515] [evidence IEA],5,73959244-73959293,5q13.3a,-,NM_003633.1,8507,ENC1,1.255434173770631,9.358625658527714,13.575532662104022,7.525888506563353e-29,1.0848557437991323e-27,54.69031633755445
AK1,ILMN_1779965,"Homo sapiens adenylate kinase 1 (AK1), mRNA.",cytoplasm [goid 5737] [evidence IEA]; cytosol [goid 5829] [evidence NR ],"nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [evidence IEA]; ATP metabolism [goid 46034] [evidence IEA]",ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; adenylate kinase activity [goid 4017] [pmid 2542324] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; kinase activity [goid 16301] [evidence IEA],9,129668725-129668774,9q34.11a,-,NM_000476.1,203,AK1,-1.5269581352313395,9.365090302662777,-13.56705193554208,7.953994007988004e-29,1.1440942639239681e-27,54.63514135345704
EMILIN2,ILMN_1697268,"Homo sapiens elastin microfibril interfacer 2 (EMILIN2), mRNA.",extracellular region [goid 5576] [pmid 11278945] [evidence IDA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],extracellular matrix constituent conferring elasticity [goid 30023] [pmid 11278945] [evidence NAS]; protein binding [goid 5515] [pmid 11278945] [evidence IPI],18,2903925-2903974,18p11.32a-p11.31e,+,NM_032048.2,84034,EMILIN2,-1.3005709431419632,9.952238305251159,-13.563071854994625,8.163226542075638e-29,1.1733465276856994e-27,54.609246683419414
H3F3B,ILMN_1695706,"Homo sapiens H3 histone, family 3B (H3.3B) (H3F3B), mRNA.",,,,17,71284232-71284281,17q25.1d,-,NM_005324.3,3021,H3F3B,-1.1336893079350574,11.081567528847227,-13.553057097452747,8.714390335905656e-29,1.2498747085362034e-27,54.54408844145015
NOS1AP,ILMN_1710315,"Homo sapiens nitric oxide synthase 1 (neuronal) adaptor protein (NOS1AP), mRNA.",cytoplasm [goid 5737] [pmid 9459447] [evidence ISS],neurotransmitter secretion [goid 7269] [pmid 9459447] [evidence ISS]; regulation of nitric-oxide synthase activity [goid 50999] [pmid 9459447] [evidence ISS],nitric-oxide synthase binding [goid 50998] [pmid 9459447] [evidence ISS]; PDZ domain binding [goid 30165] [pmid 9459447] [evidence ISS]; protein binding [goid 5515] [pmid 9459447] [evidence ISS],1,160604747-160604796,1q23.3b,+,NM_014697.1,9722,NOS1AP,1.1108115007039219,5.544974109358076,13.551535433813994,8.801333724860453e-29,1.26053747435224e-27,54.53418796520958
SAMD1,ILMN_1658821,"Homo sapiens sterile alpha motif domain containing 1 (SAMD1), mRNA.",,,,19,,19p13.12c,-,NM_138352.1,90378,SAMD1,1.1568741847879753,6.820337260478987,13.551243282682133,8.818125434729658e-29,1.2620390107158153e-27,54.53228712187136
NRIP3,ILMN_1759563,"Homo sapiens nuclear receptor interacting protein 3 (NRIP3), mRNA.",,,,11,8960988-8961037,11p15.4a,-,NM_020645.1,56675,NRIP3,1.8993301422210145,7.349072637408009,13.55089614430481,8.8381192755147e-29,1.2639963578591718e-27,54.53002850873962
JAK1,ILMN_1793384,"Homo sapiens Janus kinase 1 (a protein tyrosine kinase) (JAK1), mRNA.",cytoskeleton [goid 5856] [evidence IEA],intracellular signaling cascade [goid 7242] [pmid 8232552] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 1848670] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; Janus kinase activity [goid 4718] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [pmid 1848670] [evidence TAS],1,65074399-65074448,1p31.3b,-,NM_002227.1,3716,JAK1,-1.455910740631282,8.406378908544687,-13.54814459662593,8.998211023115638e-29,1.2859729010749836e-27,54.51212580906119
SNRPN,ILMN_1660000,"Homo sapiens small nuclear ribonucleoprotein polypeptide N (SNRPN), transcript variant 1, mRNA.",ribonucleoprotein complex [goid 30529] [evidence IEA]; nucleus [goid 5634] [evidence IEA],mRNA metabolism [goid 16071] [evidence IEA],RNA binding [goid 3723] [evidence IEA],15,22751231-22751280,15q11.2e,+,NM_003097.3,6638,SNRPN,-1.443019353369463,9.640472128924221,-13.547861253091558,9.014860537558942e-29,1.287432759710773e-27,54.51028225021846
ATG12,ILMN_1673898,"Homo sapiens ATG12 autophagy related 12 homolog (S. cerevisiae) (ATG12), mRNA.",cytoplasm [goid 5737] [pmid 9852036] [evidence TAS],autophagic vacuole formation [goid 45] [evidence IEA]; apoptosis [goid 6915] [pmid 9852036] [evidence TAS]; ubiquitin cycle [goid 6512] [evidence IEA]; autophagy [goid 6914] [pmid 9852036] [evidence TAS],protein binding [goid 5515] [pmid 11825910] [evidence IPI],5,115194222-115194271,5q22.3b-q23.1a,-,NM_004707.2,9140,ATG12,1.0843492267968085,8.996956671843293,13.544877529739946,9.192069186048001e-29,1.3108689969668452e-27,54.490868715103964
SLC29A4,ILMN_1801377,"Homo sapiens solute carrier family 29 (nucleoside transporters), member 4 (SLC29A4), mRNA.",membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA],nucleoside transporter activity [goid 5337] [evidence IEA],7,5310144-5310193,7p22.1c,+,NM_153247.1,222962,SLC29A4,1.641130233411502,6.835402554559051,13.541745593835161,9.381831229163504e-29,1.3360261867124796e-27,54.470490630100535
ABCG2,ILMN_1789641,"Homo sapiens ATP-binding cassette, sub-family G (WHITE), member 2 (ABCG2), mRNA.",integral to membrane [goid 16021] [pmid 9850061] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [pmid 9850061] [evidence TAS]; response to drug [goid 42493] [pmid 9861027] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; transporter activity [goid 5215] [pmid 9861027] [evidence TAS]; xenobiotic-transporting ATPase activity [goid 8559] [pmid 9861027] [evidence TAS]; ATP binding [goid 5524] [pmid 9850061] [evidence TAS],4,89230773-89230822,4q22.1b,-,NM_004827.2,9429,ABCG2,-1.2972396778365862,5.431650539177786,-13.53783186457589,9.624480723325129e-29,1.3696060477403214e-27,54.44502547289364
ZNF365,ILMN_1658094,"Homo sapiens zinc finger protein 365 (ZNF365), transcript variant A, mRNA.",intracellular [goid 5622] [evidence IEA],,protein binding [goid 5515] [pmid 16682949] [evidence IPI]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],10,63831868-63831917,10q21.2b,+,NM_014951.1,22891,ZNF365,-1.3167556051286073,6.2346937351741865,-13.515233197217588,1.1153589355761474e-28,1.5838255204405647e-27,54.29797811540934
KCTD13,ILMN_1786843,"Homo sapiens potassium channel tetramerisation domain containing 13 (KCTD13), mRNA.",nucleus [goid 5634] [evidence IEA]; voltage-gated potassium channel complex [goid 8076] [evidence IEA]; membrane [goid 16020] [evidence IEA],potassium ion transport [goid 6813] [evidence IEA]; protein homooligomerization [goid 51260] [pmid 15726626] [evidence ISS]; DNA replication [goid 6260] [pmid 15726626] [evidence ISS]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 15726626] [evidence ISS]; regulation of transcription [goid 45449] [pmid 15726626] [evidence ISS]; protein heterooligomerization [goid 51291] [pmid 15726626] [evidence ISS]; DNA repair [goid 6281] [pmid 15726626] [evidence ISS],protein binding [goid 5515] [pmid 15726626] [evidence ISS]; voltage-gated potassium channel activity [goid 5249] [evidence IEA],16,29825334-29825383,16p11.2d,-,NM_178863.2,253980,KCTD13,1.3192963351737426,8.029572326099347,13.512559495866917,1.1349883857211149e-28,1.609415139724172e-27,54.28057989044843
ANKS3,ILMN_1751636,"Homo sapiens ankyrin repeat and sterile alpha motif domain containing 3 (ANKS3), mRNA.",,,,16,4686831-4686880,16p13.3b,-,NM_133450.1,124401,ANKS3,1.30114271985276,6.607488193479218,13.511281488910457,1.1444928269776068e-28,1.6217430936379575e-27,54.27226363186869
PAPSS2,ILMN_2410929,"Homo sapiens 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPSS2), transcript variant 1, mRNA.",intracellular [goid 5622] [evidence ISS],"skeletal development [goid 1501] [evidence ISS]; sulfate assimilation [goid 103] [evidence IEA]; nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [evidence NR ]",sulfate adenylyltransferase (ATP) activity [goid 4781] [evidence ISS]; adenylylsulfate kinase activity [goid 4020] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence ISS]; nucleotidyltransferase activity [goid 16779] [evidence ISS],10,89496772-89496821,10q23.2b,+,NM_004670.3,9060,PAPSS2,-1.3389737044787822,10.522282296525603,-13.510687101449266,1.148940333099614e-28,1.6268930066990145e-27,54.268395816884194
KIAA1794,ILMN_1655642,"Homo sapiens KIAA1794 (KIAA1794), mRNA.",,,,15,87661081-87661130,15q26.1a,+,NM_018193.1,55215,KIAA1794,1.219172051537993,5.981977550903794,13.510519520310162,1.1501973816810634e-28,1.627521160726642e-27,54.267305326819695
TRIM22,ILMN_1779252,"Homo sapiens tripartite motif-containing 22 (TRIM22), mRNA.",ubiquitin ligase complex [goid 151] [evidence IEA]; nucleus [goid 5634] [pmid 7797467] [evidence TAS],"immune response [goid 6955] [pmid 7797467] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [pmid 7797467] [evidence TAS]; response to virus [goid 9615] [pmid 7797467] [evidence TAS]; protein ubiquitination [goid 16567] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; transcription corepressor activity [goid 3714] [pmid 7797467] [evidence TAS]; ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [pmid 7797467] [evidence TAS],11,5687843-5687892,11p15.4c,+,NM_006074.2,10346,TRIM22,-1.2863771209228467,9.000756506438012,-13.5103522087021,1.151453781261304e-28,1.6281475092209307e-27,54.26621659008189
ZBED2,ILMN_1651365,"Homo sapiens zinc finger, BED-type containing 2 (ZBED2), mRNA.",,,metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],3,112794641-112794690,3q13.13d,-,NM_024508.3,79413,ZBED2,-2.4361962157643084,7.137211363105606,-13.510097949349854,1.1533657304444088e-28,1.6296992609273822e-27,54.26456206243095
KLF9,ILMN_1778523,"Homo sapiens Kruppel-like factor 9 (KLF9), mRNA.",nucleus [goid 5634] [evidence IEA],transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 1356762] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [pmid 8051167] [evidence TAS],9,72189657-72189706,9q21.11c,-,NM_001206.2,687,KLF9,-1.5924544753756624,11.103323318660504,-13.508694715426559,1.1639748862012453e-28,1.6435292535719488e-27,54.25543085301015
SLC1A4,ILMN_1656904,"Homo sapiens solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 (SLC1A4), mRNA.",membrane fraction [goid 5624] [pmid 8910405] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8910405] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA]; neutral amino acid transport [goid 15804] [pmid 8910405] [evidence TAS]; dicarboxylic acid transport [goid 6835] [evidence IEA],symporter activity [goid 15293] [evidence IEA]; sodium:dicarboxylate symporter activity [goid 17153] [evidence IEA]; neutral amino acid transporter activity [goid 15175] [pmid 8910405] [evidence TAS],2,65104245-65104294,2p14c,+,NM_003038.2,6509,SLC1A4,1.2467597074125774,6.985067222461875,13.494722470949496,1.2750878011148495e-28,1.792829003844407e-27,54.164507626724365
STON1,ILMN_1668592,"Homo sapiens stonin 1 (STON1), mRNA.",,,,2,48679254-48679303,2p16.3d,+,NM_006873.2,11037,STON1,-1.5201134291704506,6.922471725104735,-13.49162488720761,1.3011241078526296e-28,1.8268695543800292e-27,54.144349824470325
GYG2,ILMN_1684017,"Homo sapiens glycogenin 2 (GYG2), mRNA.",soluble fraction [goid 5625] [pmid 9346895] [evidence TAS],carbohydrate biosynthesis [goid 16051] [evidence IEA]; glycogen biosynthesis [goid 5978] [pmid 9346895] [evidence TAS],"transferase activity [goid 16740] [evidence IEA]; transferase activity, transferring hexosyl groups [goid 16758] [evidence IEA]; glycogenin glucosyltransferase activity [goid 8466] [pmid 9346895] [evidence TAS]",X,2810548-2810597,Xp22.33c,+,NM_003918.1,8908,GYG2,1.3323409040691416,6.247626325758328,13.48535264723232,1.3554849916691684e-28,1.900528641437752e-27,54.103532080370215
FEN1,ILMN_1755834,"Homo sapiens flap structure-specific endonuclease 1 (FEN1), mRNA.",nucleus [goid 5634] [evidence IEA],UV protection [goid 9650] [pmid 8007985] [evidence TAS]; double-strand break repair [goid 6302] [pmid 8131753] [evidence TAS]; phosphoinositide-mediated signaling [goid 48015] [pmid 15504738] [evidence NAS]; DNA replication [goid 6260] [pmid 15504738] [evidence NAS],exonuclease activity [goid 4527] [pmid 9778254] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; double-stranded DNA specific exodeoxyribonuclease activity [goid 8309] [pmid 8131753] [evidence TAS]; damaged DNA binding [goid 3684] [pmid 8007985] [evidence TAS]; endonuclease activity [goid 4519] [pmid 8131753] [evidence TAS]; double-stranded DNA binding [goid 3690] [pmid 8131753] [evidence TAS],11,61320359-61320408,11q12.2b,+,NM_004111.4,2237,FEN1,1.0414762958607433,8.155928521246096,13.481823535260567,1.3870644809322637e-28,1.943444407177362e-27,54.08056540054156
LSAMP,ILMN_1739154,"Homo sapiens limbic system-associated membrane protein (LSAMP), mRNA.",membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [evidence IEA],3,117011947-117011951:117043382-117043426,3q13.31b-q13.31c,-,NM_002338.2,4045,LSAMP,-1.0607876245557977,7.101732316853905,-13.480818911165354,1.3961880027379382e-28,1.9548586115311874e-27,54.07402748462161
EPHB2,ILMN_1785061,"Homo sapiens EPH receptor B2 (EPHB2), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence TAS]; synapse [goid 45202] [evidence ISS]; membrane [goid 16020] [evidence IEA],transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence TAS],transmembrane-ephrin receptor activity [goid 5005] [pmid 8589679] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [evidence ISS]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ephrin receptor activity [goid 5003] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence ISS],1,23114084-23114133,1p36.12a,+,NM_017449.2,2048,EPHB2,1.1619049524543055,5.829014163480866,13.476115708064839,1.43970528549254e-28,2.0129715829584026e-27,54.04341960927023
ZNF537,ILMN_1743933,"Homo sapiens zinc finger protein 537 (ZNF537), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA],19,36457754-36457803,19q12d,-,NM_020856.1,57616,ZNF537,-1.1886427857299466,7.9426454945567295,-13.459976671141206,1.599617345397243e-28,2.2334364163787886e-27,53.93838548072946
LOC643313,ILMN_1731907,"PREDICTED: Homo sapiens similar to hypothetical protein LOC284701, transcript variant 1 (LOC643313), mRNA.",,,,1,684306-684355,,-,XM_933030.1,643313,LOC643313,1.3502375107101967,5.92135157164802,13.45694875228803,1.631542344694498e-28,2.2764225406309283e-27,53.91867899546326
PITPNM1,ILMN_1653220,"Homo sapiens phosphatidylinositol transfer protein, membrane-associated 1 (PITPNM1), mRNA.",membrane fraction [goid 5624] [pmid 9245688] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; intracellular [goid 5622] [evidence IEA],protein transport [goid 15031] [evidence IEA]; brain development [goid 7420] [pmid 9245688] [evidence TAS]; phototransduction [goid 7602] [pmid 9680295] [evidence TAS]; lipid metabolism [goid 6629] [pmid 9680295] [evidence NAS],phosphatidylinositol transporter activity [goid 8526] [pmid 9245688] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],11,67015922-67015971,11q13.1f,-,NM_004910.1,9600,PITPNM1,1.1285071061265022,9.954072680124305,13.450073423713112,1.7064199090607548e-28,2.37592550734082e-27,53.873931929785655
NUP210,ILMN_1784467,"Homo sapiens nucleoporin 210kDa (NUP210), mRNA.",,,protein binding [goid 5515] [pmid 15231747] [evidence IPI],3,13333037-13333086,3p25.1c,-,NM_024923.2,23225,NUP210,1.3223040268101238,7.714961656498078,13.448093712852144,1.728611201291068e-28,2.4051497159549158e-27,53.86104711030332
FRAT1,ILMN_1736180,"Homo sapiens frequently rearranged in advanced T-cell lymphomas (FRAT1), mRNA.",,Wnt receptor signaling pathway [goid 16055] [evidence IEA],,10,99071131-99071180,10q24.1b,+,NM_005479.2,10023,FRAT1,-1.0066260307411614,6.263612409244958,-13.44776898052825,1.732278708879625e-28,2.4085776516513924e-27,53.85893360418973
ACOT2,ILMN_1716237,"Homo sapiens acyl-CoA thioesterase 2 (ACOT2), mRNA.",peroxisome [goid 5777] [pmid 10944470] [evidence NAS],acyl-CoA metabolism [goid 6637] [evidence NAS]; lipid metabolism [goid 6629] [evidence IEA],palmitoyl-CoA hydrolase activity [goid 16290] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; acyl-CoA thioesterase activity [goid 16291] [pmid 10944470] [evidence NAS]; serine esterase activity [goid 4759] [evidence IEA],14,73105757-73105806,14q24.3a,+,NM_006821.3,10965,ACOT2,-1.9385192039438452,7.2687567229933014,-13.447200413210018,1.7387188328964107e-28,2.415853222818846e-27,53.85523310402447
NDST1,ILMN_1807283,"Homo sapiens N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 (NDST1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA]; intracellular [goid 5622] [evidence IEA]; ribosome [goid 5840] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA]; heparan sulfate proteoglycan biosynthesis [goid 15012] [pmid 9915799] [evidence TAS]; protein amino acid sulfation [goid 6477] [evidence NR ]; protein amino acid deacetylation [goid 6476] [evidence NR ],structural constituent of ribosome [goid 3735] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; [heparan sulfate]-glucosamine N-sulfotransferase activity [goid 15016] [evidence IEA],5,149917621-149917670,5q33.1c,+,NM_001543.3,3340,NDST1,-1.586577543310832,7.17550545482422,-13.441333443657802,1.8065888431882231e-28,2.503201494079638e-27,53.817047796018265
CYP27B1,ILMN_1740418,"Homo sapiens cytochrome P450, family 27, subfamily B, polypeptide 1 (CYP27B1), nuclear gene encoding mitochondrial protein, mRNA.",membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],calcium ion homeostasis [goid 6874] [evidence NR ]; vitamin biosynthesis [goid 9110] [pmid 9333115] [evidence TAS]; lipid metabolism [goid 6629] [pmid 9344864] [evidence NAS]; electron transport [goid 6118] [evidence IEA],heme binding [goid 20037] [evidence IEA]; calcidiol 1-monooxygenase activity [goid 4498] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [evidence NR ]; monooxygenase activity [goid 4497] [evidence IEA],12,56442565-56442614,12q14.1a,-,NM_000785.3,1594,CYP27B1,1.7159962919315035,6.331857671269631,13.418645727742664,2.0949363890131793e-28,2.894715971780089e-27,53.669378451979945
ZHX3,ILMN_1774387,"Homo sapiens zinc fingers and homeoboxes 3 (ZHX3), mRNA.",nucleus [goid 5634] [pmid 12659632] [evidence IDA]; intracellular [goid 5622] [evidence IEA],"negative regulation of transcription, DNA-dependent [goid 45892] [pmid 12659632] [evidence IDA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 12659632] [evidence IDA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; protein binding [goid 5515] [pmid 12659632] [evidence IPI],20,39240659-39240708,20q12c,-,NM_015035.3,23051,ZHX3,-1.0469345803158854,7.73242068423208,-13.416206205433015,2.128561933321616e-28,2.9391488724567904e-27,53.65349959947629
VEPH1,ILMN_1684336,"Homo sapiens ventricular zone expressed PH domain homolog 1 (zebrafish) (VEPH1), mRNA.",,,,3,158461765-158461814,3q25.32a,-,NM_024621.1,79674,VEPH1,-1.7026605175066711,6.058059985886859,-13.405603122731252,2.281098651133614e-28,3.143265965005602e-27,53.58448293853733
TACSTD1,ILMN_2160209,"Homo sapiens tumor-associated calcium signal transducer 1 (TACSTD1), mRNA.",plasma membrane [goid 5886] [pmid 1729376] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 1729376] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],,,2,47465832-47465853:47467215-47467242,2p21a,+,NM_002354.1,4072,TACSTD1,1.1628975345055572,9.944573771916064,13.399277566749708,2.3772580467663896e-28,3.273515416359389e-27,53.543308273709194
LRRC20,ILMN_1690523,"Homo sapiens leucine rich repeat containing 20 (LRRC20), transcript variant 1, mRNA.",,,transferase activity [goid 16740] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],10,71728811-71728860,10q22.1a-q22.1b,-,NM_207119.1,55222,LRRC20,1.2053439946690832,8.317122641990013,13.388784654298457,2.5457945935044467e-28,3.5031814461373435e-27,53.47500575023753
TMEM92,ILMN_2092223,"Homo sapiens transmembrane protein 92 (TMEM92), mRNA.",,,,17,45713595-45713644,17q21.33a,+,NM_153229.1,162461,TMEM92,1.0705057309143333,5.529656272458568,13.38721935129396,2.571941110493126e-28,3.536728366924156e-27,53.464816418034665
DGAT1,ILMN_1704091,"Homo sapiens diacylglycerol O-acyltransferase homolog 1 (mouse) (DGAT1), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],triacylglycerol metabolism [goid 6641] [pmid 9756920] [evidence TAS]; fat body development [goid 7503] [evidence NR ],diacylglycerol O-acyltransferase activity [goid 4144] [pmid 9789033] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; acyltransferase activity [goid 8415] [pmid 9756920] [evidence TAS],8,145510844-145510893,8q24.3h,-,NM_012079.2,8694,DGAT1,1.0382144958348416,8.817234673442638,13.375583664464765,2.7749109403378457e-28,3.8105983592504884e-27,53.38907273257418
LOC649841,ILMN_1697377,"PREDICTED: Homo sapiens similar to protein immuno-reactive with anti-PTH polyclonal antibodies (LOC649841), mRNA.",,,,,,,,XM_938906.1,649841,LOC649841,2.9081836509116066,7.97863141264925,13.36322443216506,3.008081768344494e-28,4.127962964405805e-27,53.308616706288404
C20orf59,ILMN_1785405,"Homo sapiens chromosome 20 open reading frame 59 (C20orf59), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA],20,61070035-61070084,20q13.33d,+,NM_022082.2,63910,C20orf59,1.523175569272551,5.981888325377643,13.363094800686566,3.0106285250280214e-28,4.128626150017865e-27,53.30777281979398
ACTG2,ILMN_1795325,"Homo sapiens actin, gamma 2, smooth muscle, enteric (ACTG2), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; actin filament [goid 5884] [evidence IEA],,ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; structural constituent of cytoskeleton [goid 5200] [evidence IEA],2,74000212-74000261,2p13.1b,+,NM_001615.3,72,ACTG2,-2.0574153533124093,10.961307120325893,-13.362298904951443,3.02631214323508e-28,4.147291326153937e-27,53.30259162148774
LOC442578,ILMN_1791375,"Homo sapiens similar to Cohesin subunit SA-3 (Stromal antigen 3) (Stromalin 3) (SCC3 homolog 3) (LOC442578), mRNA.",,,binding [goid 5488] [evidence IEA],7,72107119-72107168,7q11.23a,-,NM_001013739.1,442578,LOC442578,1.9285450188772142,9.94775249530925,13.360165100478204,3.0687645956167286e-28,4.202590145728919e-27,53.28870072869817
C14orf153,ILMN_1662895,"Homo sapiens chromosome 14 open reading frame 153 (C14orf153), mRNA.",,,,14,103127703-103127752,14q32.33a,+,NM_032374.2,84334,C14orf153,1.5718455227337103,9.301374388815288,13.359459179761862,3.0829397701547785e-28,4.219114837295267e-27,53.28410522715835
KIAA0241,ILMN_1722292,"Homo sapiens KIAA0241 (KIAA0241), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,7,32590042-32590044:32590045-32590091,7p14.3c,+,NM_015060.1,23080,KIAA0241,1.1769521325143266,6.610652957664494,13.358203501730213,3.1083163840881505e-28,4.25093603642076e-27,53.27593081965536
PCDHB4,ILMN_1722673,"Homo sapiens protocadherin beta 4 (PCDHB4), mRNA.",integral to plasma membrane [goid 5887] [pmid 10380929] [evidence TAS]; membrane [goid 16020] [evidence IEA],calcium-dependent cell-cell adhesion [goid 16339] [pmid 11322959] [evidence NAS]; synaptogenesis [goid 7416] [pmid 12231349] [evidence TAS]; synaptic transmission [goid 7268] [pmid 12231349] [evidence TAS]; cell adhesion [goid 7155] [pmid 10380929] [evidence TAS]; homophilic cell adhesion [goid 7156] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [pmid 11322959] [evidence NAS],5,140484978-140485027,5q31.3b,+,NM_018938.2,56131,PCDHB4,-1.305073047145357,6.208222702945271,-13.356307427689948,3.147031649493411e-28,4.3009432543076615e-27,53.26358741746432
MARCH6,ILMN_1757106,"Homo sapiens membrane-associated ring finger (C3HC4) 6 (MARCH6), mRNA.",ubiquitin ligase complex [goid 151] [evidence IEA],protein ubiquitination [goid 16567] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],5,10488390-10488439,5p15.2c,+,NM_005885.2,10299,MARCH6,1.6075428998415013,10.72614502983588,13.356074672586866,3.1518173186773327e-28,4.304543406969015e-27,53.2620721828694
SHANK3,ILMN_2317580,"Homo sapiens SH3 and multiple ankyrin repeat domains 3 (SHANK3), mRNA.",,,,,,22q13.33b,,NM_001080420.1,85358,SHANK3,-1.3172006613657743,9.468680139477236,-13.334927178724984,3.6184454172286014e-28,4.935095835576677e-27,53.124398730744915
MYO7A,ILMN_1811719,"Homo sapiens myosin VIIA (MYO7A), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; myosin [goid 16459] [evidence IEA],actin filament-based movement [goid 30048] [pmid 12466270] [evidence NAS]; visual perception [goid 7601] [pmid 7870171] [evidence TAS]; sensory perception [goid 7600] [evidence IEA],"actin binding [goid 3779] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; microfilament motor activity [goid 146] [pmid 12466270] [evidence NAS]; ATP binding [goid 5524] [evidence IEA]; ATPase activity, coupled [goid 42623] [evidence NR ]",11,76603587-76603636,11q13.5c,+,NM_000260.1,4647,MYO7A,1.3484200789426648,6.341972062771203,13.322379694308824,3.927357791552446e-28,5.345481271658595e-27,53.042709603303116
LOC644743,ILMN_1671971,"PREDICTED: Homo sapiens hypothetical protein LOC644743 (LOC644743), mRNA.",,,,1,44341805-44341854,1p34.1e,-,XM_932346.1,644743,LOC644743,1.40351451402441,11.42288212166945,13.321074064551086,3.9609800646187026e-28,5.3875791388777024e-27,53.03420930552927
CEACAM1,ILMN_1664330,"Homo sapiens carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (CEACAM1), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [pmid 2457922] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 15687237] [evidence NAS]; membrane [goid 16020] [evidence IEA],angiogenesis [goid 1525] [pmid 15687237] [evidence NAS]; pregnancy [goid 7565] [evidence TAS]; homophilic cell adhesion [goid 7156] [pmid 15687237] [evidence NAS]; cell migration [goid 16477] [pmid 15687237] [evidence NAS]; integrin-mediated signaling pathway [goid 7229] [pmid 15687237] [evidence NAS],,19,47707570-47707619,19q13.2c,-,NM_001712.3,634,CEACAM1,1.1947646556888314,8.391407856962514,13.317143235939835,4.063954397214172e-28,5.5238858409960025e-27,53.00861751743158
AADAC,ILMN_1760414,"Homo sapiens arylacetamide deacetylase (esterase) (AADAC), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; endoplasmic reticulum membrane [goid 5789] [pmid 15152005] [evidence IDA]; microsome [goid 5792] [pmid 8063807] [evidence TAS],metabolism [goid 8152] [evidence IEA],deacetylase activity [goid 19213] [pmid 9665742] [evidence IDA]; lipase activity [goid 16298] [pmid 11481320] [evidence TAS],3,153028383-153028432,3q25.1c,+,NM_001086.2,13,AADAC,-2.541155593610358,6.728385799915034,-13.314300025817921,4.140102008579535e-28,5.623568295156778e-27,52.99010657238618
SNX30,ILMN_1738491,"PREDICTED: Homo sapiens sorting nexin family member 30, transcript variant 2 (SNX30), mRNA.",,,,9,114676426-114676475,9q32b,+,XM_933299.1,401548,SNX30,-1.2889617095871468,9.088060982583158,-13.296839697578664,4.64005289128272e-28,6.2941137795786215e-27,52.87642732999448
KIAA1688,ILMN_1784436,"Homo sapiens KIAA1688 protein (KIAA1688), mRNA.",nucleus [goid 5634] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],,8,145725377-145725426,8q24.3h,-,NM_025251.1,80728,KIAA1688,1.6969261153158444,8.560743045895277,13.2927487666979,4.765668425066262e-28,6.460128309534266e-27,52.84979185836187
ID1,ILMN_1664861,"Homo sapiens inhibitor of DNA binding 1, dominant negative helix-loop-helix protein (ID1), transcript variant 2, mRNA.",nucleus [goid 5634] [pmid 15138269] [evidence IC ]; nucleus [goid 5634] [pmid 15138269] [evidence IC ],negative regulation of transcription factor activity [goid 43433] [pmid 15138269] [evidence IDA]; development [goid 7275] [evidence IEA]; negative regulation of transcription [goid 16481] [pmid 15138269] [evidence IDA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [evidence NR ]; negative regulation of transcription factor activity [goid 43433] [pmid 15138269] [evidence IDA]; development [goid 7275] [evidence IEA]; negative regulation of transcription [goid 16481] [pmid 15138269] [evidence IDA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [evidence NR ],transcriptional repressor activity [goid 16564] [pmid 15138269] [evidence IDA]; protein binding [goid 5515] [pmid 15138269] [evidence IPI]; transcriptional repressor activity [goid 16564] [pmid 15138269] [evidence IDA]; protein binding [goid 5515] [pmid 15138269] [evidence IPI],20,29657653-29657702,20q11.21b,+,NM_181353.1,3397,ID1,-1.7918624277682298,9.245798921710694,-13.284047895508502,5.044263815027552e-28,6.823910102168442e-27,52.793141004264974
BEAN,ILMN_1733066,"PREDICTED: Homo sapiens brain expressed, associated with Nedd4 (BEAN), mRNA.",,,,16,65073833-65073882,,+,XM_375359.2,146227,BEAN,1.6552908465742364,5.70961323850589,13.277271447570033,5.272478845109487e-28,7.118202208701122e-27,52.74901929492026
TNFAIP8L3,ILMN_1682099,"Homo sapiens tumor necrosis factor, alpha-induced protein 8-like 3 (TNFAIP8L3), mRNA.",,,,15,49136179-49136228,15q21.2b,-,NM_207381.2,388121,TNFAIP8L3,-1.2279853679999357,7.193461394846011,-13.268000190304495,5.601538783412353e-28,7.55226334087024e-27,52.68865287284789
PPAN,ILMN_1798459,"Homo sapiens peter pan homolog (Drosophila) (PPAN), mRNA.",nucleus [goid 5634] [pmid 15302935] [evidence IDA],RNA splicing [goid 8380] [pmid 10944437] [evidence TAS],,19,10082538-10082542:10082621-10082665,19p13.2c,+,NM_020230.4,56342,PPAN,1.104743492118434,7.554394030762315,13.267732605202264,5.611335098800524e-28,7.558421430270068e-27,52.6869105742679
PENK,ILMN_1726711,"Homo sapiens proenkephalin (PENK), mRNA.",soluble fraction [goid 5625] [evidence NR ],neuropeptide signaling pathway [goid 7218] [evidence IEA]; cell-cell signaling [goid 7267] [evidence NR ]; signal transduction [goid 7165] [pmid 7057924] [evidence TAS],opioid peptide activity [goid 1515] [evidence IEA]; neuropeptide hormone activity [goid 5184] [pmid 7057924] [evidence TAS],8,57516311-57516360,8q12.1b,-,NM_006211.2,5179,PENK,-1.9492029851909107,6.355285790466041,-13.267016948253598,5.637619663474863e-28,7.585574594943178e-27,52.68225078864335
IL8RB,ILMN_1680397,"Homo sapiens interleukin 8 receptor, beta (IL8RB), mRNA.",integral to plasma membrane [goid 5887] [pmid 10438939] [evidence TAS]; membrane [goid 16020] [pmid 10725748] [evidence IDA]; cell surface [goid 9986] [pmid 10878382] [evidence IDA]; intracellular [goid 5622] [pmid 10878382] [evidence IDA],"neutrophil activation [goid 42119] [pmid 10878382] [evidence IDA]; G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) [goid 7200] [pmid 10438939] [evidence IDA]; chemotaxis [goid 6935] [pmid 10725748] [evidence IDA]; cellular defense response [goid 6968] [pmid 10725748] [evidence IDA]; neutrophil chemotaxis [goid 30593] [pmid 10820279] [evidence IDA]; positive regulation of cell proliferation [goid 8284] [pmid 10438939] [evidence IDA]",receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; interleukin-8 receptor activity [goid 4918] [pmid 10820279] [evidence IDA],2,218708265-218708314,2q35e,+,NM_001557.2,3579,IL8RB,-1.835983045311596,5.928184700750847,-13.265373989002205,5.698428973642692e-28,7.662242399505576e-27,52.67155312899634
KCNA5,ILMN_1790508,"Homo sapiens potassium voltage-gated channel, shaker-related subfamily, member 5 (KCNA5), mRNA.",membrane [goid 16020] [evidence IEA]; voltage-gated potassium channel complex [goid 8076] [pmid 1986382] [evidence TAS]; membrane fraction [goid 5624] [evidence NR ]; integral to membrane [goid 16021] [evidence IEA],potassium ion transport [goid 6813] [pmid 1986382] [evidence TAS]; ion transport [goid 6811] [evidence IEA],protein binding [goid 5515] [evidence IEA]; delayed rectifier potassium channel activity [goid 5251] [pmid 1986382] [evidence TAS]; potassium ion binding [goid 30955] [evidence IEA],12,5025988-5026037,12p13.32a,+,NM_002234.2,3741,KCNA5,-1.6312665661655856,6.309244927159025,-13.257470546660164,6.00024852998568e-28,8.057246482412985e-27,52.620091676967874
PPP1R3C,ILMN_1736670,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 3C (PPP1R3C), mRNA.",,,protein phosphatase type 1 activity [goid 163] [pmid 8985175] [evidence TAS]; phosphoprotein phosphatase activity [goid 4721] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],10,93378527-93378576,10q23.32a,-,NM_005398.3,5507,PPP1R3C,-1.8322563749593357,8.716583262518776,-13.256255776799577,6.048035812595857e-28,8.115969184333865e-27,52.61218191691821
CCL21,ILMN_1677505,"Homo sapiens chemokine (C-C motif) ligand 21 (CCL21), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],immune response [goid 6955] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 9235955] [evidence TAS]; chemotaxis [goid 6935] [pmid 10861057] [evidence TAS]; signal transduction [goid 7165] [pmid 10201891] [evidence NAS]; inflammatory response [goid 6954] [pmid 9235955] [evidence TAS],chemokine activity [goid 8009] [pmid 10861057] [evidence TAS],9,34699244-34699293,9p13.3c,-,NM_002989.2,6366,CCL21,-2.0294433123179942,9.747247940316027,-13.252879000649632,6.18288287508901e-28,8.291361968148856e-27,52.59019454417092
MGC15476,ILMN_1733851,"Homo sapiens dapper, antagonist of beta-catenin, homolog 3 (Xenopus laevis) (DACT3), mRNA.",,,,19,51842736-51842785,19q13.32b,-,NM_145056.1,147906,MGC15476,-1.2535142480908004,9.156287757035587,-13.252227609897842,6.209239294033157e-28,8.321129256196611e-27,52.58595309568478
FCGR3B,ILMN_1728639,"Homo sapiens Fc fragment of IgG, low affinity IIIb, receptor (CD16b) (FCGR3B), mRNA.",membrane [goid 16020] [evidence IEA]; membrane [goid 16020] [evidence IEA],immune response [goid 6955] [pmid 2139735] [evidence TAS]; immune response [goid 6955] [pmid 2139735] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA]; IgG binding [goid 19864] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]; IgG binding [goid 19864] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],1,159860148-159860197,1q23.3b,-,NM_000570.2,2215,FCGR3B,-1.7670267134032747,6.635721584181405,-13.251881983423575,6.223269559257931e-28,8.334349219654129e-27,52.58370259064817
ZFPM2,ILMN_1814077,"Homo sapiens zinc finger protein, multitype 2 (ZFPM2), mRNA.",nucleus [goid 5634] [evidence IEA],transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 10438528] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; transcription corepressor activity [goid 3714] [pmid 10438528] [evidence TAS]; zinc ion binding [goid 8270] [pmid 10438528] [evidence TAS]; RNA polymerase II transcription factor activity [goid 3702] [pmid 10438528] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],8,106884536-106884585,8q23.1a,+,NM_012082.2,23414,ZFPM2,-1.0847190474725181,5.53787479487435,-13.25026652404189,6.289268765624581e-28,8.417102974088068e-27,52.57318370398829
RP2,ILMN_1659255,"Homo sapiens retinitis pigmentosa 2 (X-linked recessive) (RP2), mRNA.",,beta-tubulin folding [goid 7025] [pmid 9697692] [evidence TAS]; UTP biosynthesis [goid 6228] [evidence IEA]; visual perception [goid 7601] [pmid 9697692] [evidence TAS]; GTP biosynthesis [goid 6183] [evidence IEA]; CTP biosynthesis [goid 6241] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 9697692] [evidence TAS],X,46625612-46625661,Xp11.3a,+,NM_006915.1,6102,RP2,-1.483674220102654,7.060743280705195,-13.248069948102838,6.380134076629021e-28,8.53300284794074e-27,52.558880893107535
LOC653617,ILMN_1675482,"PREDICTED: Homo sapiens similar to breakpoint cluster region isoform 1 (LOC653617), mRNA.",,,,22,19975109-19975135:19975855-19975877,,-,XM_928425.1,653617,LOC653617,1.0198673292598235,7.728110916247692,13.24621416092747,6.457924734133024e-28,8.625511220329342e-27,52.546797055893755
DENND3,ILMN_1692742,"Homo sapiens DENN/MADD domain containing 3 (DENND3), mRNA.",,,,8,142274765-142274814,8q24.3c,+,NM_014957.2,22898,DENND3,-1.1632660464513682,8.028247396232466,-13.238855052553516,6.77585759350453e-28,9.032069202587518e-27,52.49887832408803
DKFZp761I2123,ILMN_1760718,"Homo sapiens hypothetical protein DKFZp761I2123 (DKFZp761I2123), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],7,44775812-44775861,7p13c,+,NM_031449.3,83637,DKFZp761I2123,1.249366646735485,8.732186936791207,13.232969076252758,7.041380870906708e-28,9.373516198609542e-27,52.46055144461582
FKBP14,ILMN_1665243,"Homo sapiens FK506 binding protein 14, 22 kDa (FKBP14), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],protein folding [goid 6457] [evidence IEA]; protein folding [goid 6457] [evidence IEA],peptidyl-prolyl cis-trans isomerase activity [goid 3755] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA]; peptidyl-prolyl cis-trans isomerase activity [goid 3755] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA],7,30019936-30019985,7p15.1b,-,NM_017946.2,55033,FKBP14,1.4463624879287664,10.004024314064843,13.231939103666859,7.088902855858043e-28,9.424237099003836e-27,52.45384467942349
PLK4,ILMN_1789123,"Homo sapiens polo-like kinase 4 (Drosophila) (PLK4), mRNA.",,protein amino acid phosphorylation [goid 6468] [pmid 10607900] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 10607900] [evidence TAS]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],4,129037441-129037490,4q28.1e,+,NM_014264.2,10733,PLK4,1.1579654478290138,6.64915621895743,13.225794268888473,7.379161711878791e-28,9.797098044543521e-27,52.41383176497954
SYNC1,ILMN_1771261,"Homo sapiens syncoilin, intermediate filament 1 (SYNC1), mRNA.",,,structural molecule activity [goid 5198] [evidence IEA],1,32918884-32918933,1p35.1b,-,NM_030786.1,81493,SYNC1,-1.4811253192513947,6.73432984481946,-13.225579636105206,7.389512266733797e-28,9.804334312520545e-27,52.41243414769105
C7orf24,ILMN_1745005,"Homo sapiens chromosome 7 open reading frame 24 (C7orf24), mRNA.",,,,7,30502993-30503042,7p15.1b,-,NM_024051.2,79017,C7orf24,1.3810578397876014,8.539214821330775,13.220931585846147,7.61725954195014e-28,1.0099809735940251e-26,52.38216747315319
MOBKL2B,ILMN_1717046,"Homo sapiens MOB1, Mps One Binder kinase activator-like 2B (yeast) (MOBKL2B), mRNA.",,,metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],9,27315805-27315854,9p21.2a,-,NM_024761.3,79817,MOBKL2B,-1.372984104106596,6.61110581054154,-13.218658008782022,7.73120534685545e-28,1.024410308476052e-26,52.367362557129475
LOC340243,ILMN_1727049,"PREDICTED: Homo sapiens similar to solute carrier family 29 (nucleoside transporters), member 4 (LOC340243), mRNA.",,,,,,,,XM_935493.1,340243,LOC340243,1.7289340057789442,6.419922681300901,13.216419341315618,7.845067448729988e-28,1.0388094607160131e-26,52.35278491146042
C9orf150,ILMN_1701361,"Homo sapiens chromosome 9 open reading frame 150 (C9orf150), mRNA.",,,,9,12812625-12812674,9p23b,+,NM_203403.1,286343,C9orf150,-1.4053824904655432,6.808913190523692,-13.215006822229563,7.917771931594648e-28,1.047743259307842e-26,52.34358691245239
CA9,ILMN_1725139,"Homo sapiens carbonic anhydrase IX (CA9), mRNA.",integral to membrane [goid 16021] [pmid 8661007] [evidence TAS]; nucleus [goid 5634] [evidence IEA]; membrane [goid 16020] [evidence IEA],one-carbon compound metabolism [goid 6730] [evidence IEA],carbonate dehydratase activity [goid 4089] [pmid 8661007] [evidence TAS]; lyase activity [goid 16829] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],9,35670757-35670806,9p13.3a,+,NM_001216.1,768,CA9,2.473033977812011,6.542226710554486,13.214004495308094,7.9697716762465515e-28,1.0525359188009307e-26,52.3370599781857
THBS2,ILMN_1678842,"Homo sapiens thrombospondin 2 (THBS2), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence NR ],cell adhesion [goid 7155] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA]; heparin binding [goid 8201] [pmid 1459996] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],6,169358052-169358101,6q27e,-,NM_003247.2,7058,THBS2,2.0262930918126596,9.907648219638196,13.212487854179077,8.049103799076291e-28,1.0623117995509132e-26,52.327183922868485
MMP25,ILMN_1717207,"Homo sapiens matrix metallopeptidase 25 (MMP25), transcript variant 2, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10628838] [evidence NAS]; membrane [goid 16020] [pmid 11034316] [evidence NAS]; cell surface [goid 9986] [pmid 12493773] [evidence IEP],peptidoglycan metabolism [goid 270] [evidence IEA]; inflammatory response [goid 6954] [pmid 10628838] [evidence NAS],metalloendopeptidase activity [goid 4222] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],16,3050524-3050573,16p13.3d,+,NM_022718.2,64386,MMP25,-1.7282274529289312,7.01275263023655,-13.210009511454764,8.180444070198664e-28,1.0775136600166877e-26,52.311045415165594
UBPH,ILMN_1700811,"Homo sapiens similar to ubiquitin binding protein (UBPH), mRNA.",,protein modification [goid 6464] [evidence IEA],,16,23489428-23489477,16p12.1c,+,NM_019116.1,56061,UBPH,1.0273547106580665,6.9998491107424705,13.206823017152184,8.352468060752169e-28,1.0994485589442725e-26,52.290295466851504
FLJ33641,ILMN_1675191,"Homo sapiens chromosome 5 open reading frame 29 (C5orf29), mRNA.",,,,5,57827608-57827657,5q11.2g,+,NM_152687.1,202309,FLJ33641,-1.3521329880383242,6.511768973252658,-13.199519527462652,8.760525205737837e-28,1.1516464409750502e-26,52.24273592225371
CCNE2,ILMN_2412384,"Homo sapiens cyclin E2 (CCNE2), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA],cell division [goid 51301] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell cycle checkpoint [goid 75] [pmid 9858585] [evidence TAS],protein binding [goid 5515] [pmid 15232106] [evidence IPI],8,95962279-95962328,8q22.1c,-,NM_057735.1,9134,CCNE2,1.4390803122732745,6.098517309208823,13.193498701550427,9.111871805907941e-28,1.1956875464523042e-26,52.20352856609527
DKFZp564K142,ILMN_1721349,"Homo sapiens implantation-associated protein (DKFZp564K142), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,X,76970258-76970307,Xq21.1a,-,NM_032121.3,84061,DKFZp564K142,2.044635225717016,12.601793021300322,13.193380554944182,9.118905475245198e-28,1.1956875464523042e-26,52.202759197155125
PITX1,ILMN_1674386,"Homo sapiens paired-like homeodomain transcription factor 1 (PITX1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; skeletal development [goid 1501] [pmid 9070926] [evidence TAS]; morphogenesis [goid 9653] [pmid 9070926] [evidence TAS]",transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA],5,134391393-134391442,5q31.1e,-,NM_002653.3,5307,PITX1,3.263175727687379,7.230369498651811,13.193371442423425,9.11944820015102e-28,1.1956875464523042e-26,52.202699856550304
N4BP2,ILMN_1782273,"Homo sapiens Nedd4 binding protein 2 (N4BP2), mRNA.",,,ATP binding [goid 5524] [pmid 12730195] [evidence IDA]; hydrolase activity [goid 16787] [evidence IEA]; endonuclease activity [goid 4519] [pmid 12730195] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 12730195] [evidence IDA]; hydrolase activity [goid 16787] [evidence IEA]; endonuclease activity [goid 4519] [pmid 12730195] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA],4,39832625-39832674,4p14b,+,NM_018177.2,55728,N4BP2,1.5716558051719929,8.913551511797301,13.185825805297181,9.580127445092783e-28,1.2544449602186937e-26,52.153562514321514
ENO2,ILMN_1765796,"Homo sapiens enolase 2 (gamma, neuronal) (ENO2), mRNA.",phosphopyruvate hydratase complex [goid 15] [evidence IEA],glycolysis [goid 6096] [evidence IEA],phosphopyruvate hydratase activity [goid 4634] [pmid 2045099] [evidence TAS]; magnesium ion binding [goid 287] [evidence IEA]; lyase activity [goid 16829] [evidence IEA],12,6902932-6902981,12p13.31d,+,NM_001975.2,2026,ENO2,1.2766648206631999,9.262813536648816,13.184999944046542,9.63194090872403e-28,1.2604046677681516e-26,52.148184457760735
KIF17,ILMN_1666625,"Homo sapiens kinesin family member 17 (KIF17), mRNA.",microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; protein transport [goid 15031] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],1,20863379-20863428,1p36.12b,-,NM_020816.1,57576,KIF17,-1.030227666645426,5.625599099378654,-13.183976666596314,9.69652900991106e-28,1.2680271400673234e-26,52.141520806948236
ZNF525,ILMN_1748432,"PREDICTED: Homo sapiens zinc finger protein 525 (ZNF525), mRNA.",,,,19,58580880-58580929,19q13.41b,+,XM_375646.3,170958,ZNF525,1.0202023417080532,6.110867515603989,13.182961552224029,9.761029922819379e-28,1.2756282605863497e-26,52.13491030542421
LOC400509,ILMN_1670371,"PREDICTED: Homo sapiens similar to FLJ12363 protein (LOC400509), mRNA.",,,,,,16p11.2d,,XM_942431.1,400509,LOC400509,1.1007931221756255,6.880422133139983,13.18265858312886,9.78036377541712e-28,1.2773206163090452e-26,52.13293734600204
LOC196752,ILMN_1803743,"Homo sapiens similar to CG32542-PA (LOC196752), mRNA.",,,,10,75217925-75217974,10q22.2a,+,NM_001010864.1,196752,LOC196752,1.537152430643065,7.387848643343107,13.174500035448478,1.0315652792795113e-27,1.3454731491410994e-26,52.07980791655777
MARCKSL1,ILMN_1714433,"Homo sapiens MARCKS-like 1 (MARCKSL1), mRNA.",plasma membrane [goid 5886] [pmid 11256614] [evidence IDA],,calmodulin binding [goid 5516] [evidence IEA],1,32572371-32572420,1p35.1b,-,NM_023009.4,65108,MARCKSL1,1.4197850472931357,11.1112468392418,13.173645691893675,1.037337507630294e-27,1.3521204464278126e-26,52.07424429677407
METTL7A,ILMN_1656285,"Homo sapiens methyltransferase like 7A (METTL7A), mRNA.",nucleus [goid 5634] [evidence IEA],,transferase activity [goid 16740] [evidence IEA]; S-adenosylmethionine-dependent methyltransferase activity [goid 8757] [evidence IEA],12,49612362-49612411,12q13.13b,+,NM_014033.2,25840,METTL7A,-1.8908365839607066,8.823750805233828,-13.171033720049586,1.0551860080352691e-27,1.3744896906751082e-26,52.05723468625089
C18orf45,ILMN_1690442,"Homo sapiens chromosome 18 open reading frame 45 (C18orf45), mRNA.",,,,18,19130737-19130786,18q11.2b,-,NM_032933.3,85019,C18orf45,1.2536047801458334,7.851202835932677,13.170191318098766,1.0610076907371725e-27,1.381173837102755e-26,52.05174880735841
KIAA0963,ILMN_1808811,"Homo sapiens strawberry notch homolog 2 (Drosophila) (SBNO2), mRNA.",,,,19,1058865-1058914,19p13.3i,-,NM_014963.1,22904,KIAA0963,1.34025062295244,8.254083677523498,13.158206738203674,1.1473969660101385e-27,1.488337906114912e-26,51.97370234903197
SLC11A1,ILMN_1735737,"Homo sapiens solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 (SLC11A1), transcript variant 1, mRNA.",membrane fraction [goid 5624] [pmid 8537108] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8537108] [evidence TAS],"ion transport [goid 6811] [evidence IEA]; transport [goid 6810] [evidence IEA]; response to pest, pathogen or parasite [goid 9613] [pmid 8490962] [evidence TAS]; iron ion transport [goid 6826] [evidence IEA]",iron ion binding [goid 5506] [evidence IEA]; transporter activity [goid 5215] [pmid 8537108] [evidence TAS],2,218968524-218968573,2q35e,+,NM_000578.2,6556,SLC11A1,-1.1203155219571146,7.198824068455819,-13.154965932995108,1.1719433364165765e-27,1.5186685411284238e-26,51.95259724944502
IPO13,ILMN_1651229,"Homo sapiens importin 13 (IPO13), mRNA.",nucleus [goid 5634] [evidence IEA]; nuclear pore [goid 5643] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],protein transport [goid 15031] [evidence IEA],protein transporter activity [goid 8565] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI],1,44205856-44205905,1p34.1f,+,NM_014652.2,9670,IPO13,1.1106599481906345,8.334985720260088,13.150400180831872,1.2074189458119477e-27,1.5636270723498672e-26,51.92286355695353
GPR37,ILMN_2218935,"Homo sapiens G protein-coupled receptor 37 (endothelin receptor type B-like) (GPR37), mRNA.",integral to plasma membrane [goid 5887] [pmid 9144577] [evidence TAS]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9144577] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],"receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity, unknown ligand [goid 16526] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]",7,124173852-124173901,7q31.33a,-,NM_005302.2,2861,GPR37,2.040022102258856,6.260718251992167,13.147615236096717,1.2295831678316243e-27,1.5913001307875252e-26,51.90472699445442
CLASP2,ILMN_1770548,"Homo sapiens cytoplasmic linker associated protein 2 (CLASP2), mRNA.",cytoplasmic microtubule [goid 5881] [pmid 11290329] [evidence IDA]; cytoskeleton [goid 5856] [evidence IEA]; Golgi apparatus [goid 5794] [pmid 11290329] [evidence IDA]; kinetochore microtubule [goid 5828] [pmid 12837247] [evidence TAS],establishment and/or maintenance of cell polarity [goid 7163] [pmid 15928712] [evidence TAS]; mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],binding [goid 5488] [evidence IEA],3,33518197-33518246,3p22.3c-p22.3b,-,NM_015097.1,23122,CLASP2,-1.1131647155694662,6.595933005655855,-13.138138195709095,1.3081009973544223e-27,1.6907289893454315e-26,51.84300866207705
SUPT5H,ILMN_1703866,"Homo sapiens suppressor of Ty 5 homolog (S. cerevisiae) (SUPT5H), mRNA.",nucleus [goid 5634] [evidence IEA],"positive regulation of transcription from RNA polymerase II promoter [goid 45944] [pmid 9450929] [evidence IDA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 9450929] [evidence IDA]; RNA elongation from RNA polymerase II promoter [goid 6368] [pmid 9450929] [evidence IDA]",protein heterodimerization activity [goid 46982] [pmid 9450929] [evidence IPI]; positive transcription elongation factor activity [goid 8159] [pmid 9450929] [evidence IDA]; protein binding [goid 5515] [pmid 16169070] [evidence IPI]; negative transcription elongation factor activity [goid 8148] [pmid 9450929] [evidence IDA],19,44658768-44658817,19q13.2a,+,NM_003169.2,6829,SUPT5H,1.1444088213268344,10.204339577497684,13.135673943234954,1.3293264733564786e-27,1.7170538462825322e-26,51.82696034280094
PACSIN3,ILMN_1682957,"Homo sapiens protein kinase C and casein kinase substrate in neurons 3 (PACSIN3), mRNA.",cytoplasm [goid 5737] [evidence ISS],endocytosis [goid 6897] [evidence IEA]; negative regulation of endocytosis [goid 45806] [evidence ISS],enzyme binding [goid 19899] [pmid 10531379] [evidence IPI]; cytoskeletal protein binding [goid 8092] [evidence ISS],11,47155817-47155866,11p11.2b,-,NM_016223.3,29763,PACSIN3,1.1422854876928792,8.37538500837609,13.130908637238155,1.3713538862911575e-27,1.770196681091192e-26,51.79592640713797
HSPB3,ILMN_1720710,"Homo sapiens heat shock 27kDa protein 3 (HSPB3), mRNA.",,protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [pmid 9858786] [evidence TAS],,5,53787838-53787887,5q11.2d,+,NM_006308.1,8988,HSPB3,-1.6136867331393532,6.108767460536734,-13.128294861978087,1.3949677352273364e-27,1.7995173724325303e-26,51.77890419426042
CTSG,ILMN_1680424,"Homo sapiens cathepsin G (CTSG), mRNA.",insoluble fraction [goid 5626] [evidence NR ],immune response [goid 6955] [pmid 2569462] [evidence TAS],cathepsin G activity [goid 4261] [pmid 2569462] [evidence TAS]; peptidase activity [goid 8233] [evidence IEA],14,24112612-24112661,14q12a,-,NM_001911.2,1511,CTSG,-2.88069942444462,8.225951965729575,-13.125090212609223,1.4244755140763172e-27,1.8352161033895012e-26,51.758033849755954
WDR51A,ILMN_1780667,"Homo sapiens WD repeat domain 51A (WDR51A), mRNA.",,,,3,52084332-52084381,3p21.1e,-,NM_015426.2,25886,WDR51A,1.3197556300924846,8.019576945782301,13.124425942281167,1.430669671621689e-27,1.8420102181342827e-26,51.753707767
LMO7,ILMN_1770479,"Homo sapiens LIM domain 7 (LMO7), mRNA.",ubiquitin ligase complex [goid 151] [pmid 10531035] [evidence NAS]; cytoplasm [goid 5737] [pmid 9826547] [evidence TAS]; nucleus [goid 5634] [pmid 9826547] [evidence TAS],protein ubiquitination [goid 16567] [pmid 10531035] [evidence NAS]; smooth muscle contraction [goid 6939] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; actin binding [goid 3779] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; ubiquitin-protein ligase activity [goid 4842] [pmid 10531035] [evidence NAS]; zinc ion binding [goid 8270] [evidence IEA],13,75331915-75331964,13q22.2a-q22.2b,+,NM_005358.3,4008,LMO7,-1.588854981676393,8.44527323768734,-13.115374875770321,1.5178028697347239e-27,1.951683792908249e-26,51.69476210373044
NTN4,ILMN_1757019,"Homo sapiens netrin 4 (NTN4), mRNA.",basement membrane [goid 5604] [evidence IEA]; basement membrane [goid 5604] [evidence IEA],,structural molecule activity [goid 5198] [evidence IEA],12,94576365-94576414,12q22d,-,NM_021229.3,59277,NTN4,-1.221484540856876,7.3869467950222,-13.114925773136113,1.5222619440528126e-27,1.9561603710089063e-26,51.69183727964412
CDKN3,ILMN_1666305,"Homo sapiens cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) (CDKN3), mRNA.",,G1/S transition of mitotic cell cycle [goid 82] [pmid 8127873] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 8242750] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; protein amino acid dephosphorylation [goid 6470] [evidence IEA]; cell cycle arrest [goid 7050] [pmid 8242750] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; protein tyrosine phosphatase activity [goid 4725] [evidence IEA]; protein tyrosine/serine/threonine phosphatase activity [goid 8138] [pmid 8242750] [evidence TAS],14,53948082-53948131,14q22.2b,+,NM_005192.2,1033,CDKN3,1.5577208388999466,6.200915591530641,13.107810613904538,1.5946812730286649e-27,2.0479064769420752e-26,51.64549895285418
QKI,ILMN_1690476,"PREDICTED: Homo sapiens quaking homolog, KH domain RNA binding (mouse), transcript variant 5 (QKI), mRNA.",,,,,,6q26c,,XM_942223.1,9444,QKI,-1.2072965355983225,6.152347715857136,-13.103872941171746,1.6362305658521054e-27,2.0985705872800593e-26,51.61985425465182
SCHIP1,ILMN_1794598,"Homo sapiens schwannomin interacting protein 1 (SCHIP1), mRNA.",cytoplasm [goid 5737] [pmid 10669747] [evidence TAS],,,3,161092629-161092673:161097206-161097210,3q25.33a-q25.33b,+,NM_014575.1,29970,SCHIP1,-1.0023333170326536,7.778573568726607,-13.102932091888722,1.6463173850209467e-27,2.110154916047348e-26,51.613726815587334
TTLL12,ILMN_1663113,"Homo sapiens tubulin tyrosine ligase-like family, member 12 (TTLL12), mRNA.",,protein modification [goid 6464] [evidence IEA],ligase activity [goid 16874] [evidence IEA]; tubulin-tyrosine ligase activity [goid 4835] [evidence IEA],22,41892701-41892750,22q13.2c,-,NM_015140.2,23170,TTLL12,1.1274884687981181,9.004917930421898,13.09232696169111,1.7644085490086438e-27,2.260069542161648e-26,51.54465877036879
LOC283932,ILMN_1710954,"Homo sapiens hypothetical protein LOC283932 (LOC283932), mRNA.",,,,16,30838591-30838640,,-,NM_175901.3,283932,LOC283932,1.4402825765630318,6.49587037810061,13.087867922663504,1.8165572793458765e-27,2.3238924581299422e-26,51.51561819442549
PACS1,ILMN_1716488,"Homo sapiens phosphofurin acidic cluster sorting protein 1 (PACS1), mRNA.",Golgi stack [goid 5795] [evidence IEA],,protein binding [goid 5515] [pmid 10707087] [evidence IPI],11,65768449-65768498,11q13.1d-q13.1e,+,NM_018026.2,55690,PACS1,1.4722661937098032,7.85842205547365,13.076568861309768,1.955707954657429e-27,2.495883933760858e-26,51.44202984462336
PODXL,ILMN_1711311,"Homo sapiens podocalyxin-like (PODXL), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 9188463] [evidence TAS],,,7,130835864-130835913,7q32.3b,-,NM_005397.2,5420,PODXL,-1.0449211773654525,9.041023630156724,-13.075132191671287,1.9741484276352555e-27,2.517448166993384e-26,51.43267307928557
P2RY6,ILMN_1660031,"Homo sapiens pyrimidinergic receptor P2Y, G-protein coupled, 6 (P2RY6), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 8670200] [evidence TAS]; membrane [goid 16020] [evidence IEA],"signal transduction [goid 7165] [evidence IEA]; G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) [goid 7200] [pmid 8670200] [evidence TAS]","receptor activity [goid 4872] [evidence IEA]; purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]",11,72686245-72686294,11q13.4b,+,NM_176797.1,5031,P2RY6,1.0001643081963065,6.243392287905836,13.061309498487946,2.160702011626162e-27,2.7502275606132567e-26,51.34264792603287
PLA2G3,ILMN_1746769,"Homo sapiens phospholipase A2, group III (PLA2G3), mRNA.",extracellular space [goid 5615] [pmid 10713052] [evidence TAS]; extracellular region [goid 5576] [evidence IEA],phospholipid metabolism [goid 6644] [pmid 10713052] [evidence TAS]; lipid catabolism [goid 16042] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; calcium-dependent phospholipase A2 activity [goid 47498] [pmid 10713052] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA],22,29860905-29860954,22q12.2c,-,NM_015715.2,50487,PLA2G3,-1.6349213831519638,6.547743961424077,-13.057501759000939,2.215121652827025e-27,2.817555882375278e-26,51.31784853404839
PTPRH,ILMN_1741465,"Homo sapiens protein tyrosine phosphatase, receptor type, H (PTPRH), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8294459] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],protein amino acid dephosphorylation [goid 6470] [pmid 8294459] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; transmembrane receptor protein tyrosine phosphatase activity [goid 5001] [pmid 8294459] [evidence TAS]; protein tyrosine phosphatase activity [goid 4725] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],19,60384744-60384793,19q13.42b,-,NM_002842.2,5794,PTPRH,1.5540668657192427,5.88414539583879,13.048950841407907,2.3423784152244906e-27,2.977529055388285e-26,51.26215712383728
S100A3,ILMN_1712545,"Homo sapiens S100 calcium binding protein A3 (S100A3), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],1,151786449-151786498,1q21.3c,-,NM_002960.1,6274,S100A3,-2.514375518777971,8.154586366550554,-13.046096829179545,2.3864597861618573e-27,3.031637295335012e-26,51.24356911764753
WASPIP,ILMN_1668417,"Homo sapiens Wiskott-Aldrich syndrome protein interacting protein (WASPIP), mRNA.",actin cytoskeleton [goid 15629] [pmid 9405671] [evidence TAS],protein complex assembly [goid 6461] [pmid 9405671] [evidence TAS]; actin polymerization and/or depolymerization [goid 8154] [pmid 9405671] [evidence TAS],actin binding [goid 3779] [pmid 9405671] [evidence TAS]; profilin binding [goid 5522] [pmid 9405671] [evidence TAS],2,175133267-175133316,2q31.1g,-,NM_003387.3,7456,WASPIP,-1.2276396344601581,7.820763340429902,-13.035092164974667,2.5643393447657506e-27,3.253475054538563e-26,51.171896140225236
PIGX,ILMN_1769508,"Homo sapiens phosphatidylinositol glycan anchor biosynthesis, class X (PIGX), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],GPI anchor biosynthesis [goid 6506] [evidence IEA],,3,197945714-197945763,3q29g,+,NM_017861.1,54965,PIGX,1.568367019289008,7.788394217438277,13.025912174641048,2.722829075161561e-27,3.450181389223085e-26,51.11210688924607
NR2C2,ILMN_1724479,"Homo sapiens nuclear receptor subfamily 2, group C, member 2 (NR2C2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [pmid 9006963] [evidence TAS]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; transcription coactivator activity [goid 3713] [pmid 9006963] [evidence TAS]; steroid hormone receptor activity [goid 3707] [evidence IEA]; transcription factor activity [goid 3700] [pmid 9006963] [evidence TAS],3,15059518-15059519:15059520-15059567,3p24.3e,+,NM_003298.2,7182,NR2C2,1.1108021163162967,6.272820055024434,13.025263317372373,2.734395218007735e-27,3.462644273537897e-26,51.107880873943294
TFRC,ILMN_1674243,"Homo sapiens transferrin receptor (p90, CD71) (TFRC), mRNA.",extracellular region [goid 5576] [pmid 1871153] [evidence IDA]; cytoplasmic membrane-bound vesicle [goid 16023] [pmid 15229288] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 6090955] [evidence TAS]; membrane [goid 16020] [pmid 1871153] [evidence NAS]; endosome [goid 5768] [pmid 14612438] [evidence IDA],endocytosis [goid 6897] [evidence IEA]; iron ion transport [goid 6826] [evidence NR ]; iron ion homeostasis [goid 6879] [pmid 1871153] [evidence NAS],transferrin receptor activity [goid 4998] [pmid 1871153] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],3,197260755-197260804,3q29f,-,NM_003234.1,7037,TFRC,-1.1671378883014079,12.014827161616543,-13.018751213472049,2.8532326274900676e-27,3.6108461992929333e-26,51.06546739538877
FAM119A,ILMN_1762888,"Homo sapiens family with sequence similarity 119, member A (FAM119A), mRNA.",,,,2,208185875-208185924,2q33.3c,-,NM_145280.3,151194,FAM119A,1.2183049886811617,9.281018523468262,13.014944655966488,2.9250753714739164e-27,3.6970883153790344e-26,51.040675147892784
FLJ39653,ILMN_1666633,"Homo sapiens hypothetical protein FLJ39653 (FLJ39653), mRNA.",,,,4,15838953-15839002,4p15.32d,+,NM_152684.1,202020,FLJ39653,1.918259635221296,7.040216973076678,13.009939061525818,3.0223091414866706e-27,3.81516475096942e-26,51.00807347380757
MOV10,ILMN_1725700,"Homo sapiens Mov10, Moloney leukemia virus 10, homolog (mouse) (MOV10), mRNA.",,development [goid 7275] [evidence IEA],helicase activity [goid 4386] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],1,113044647-113044652:113044653-113044696,1p13.2c,+,NM_020963.1,4343,MOV10,1.0806865312748322,8.719279120048647,13.005319216011587,3.114915913586652e-27,3.927110119662365e-26,50.97798414875124
C1R,ILMN_1677198,"Homo sapiens complement component 1, r subcomponent (C1R), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular region [goid 5576] [pmid 14718574] [evidence NAS],"innate immune response [goid 45087] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",complement component C1r activity [goid 3815] [pmid 2834284] [evidence TAS]; complement component C1s activity [goid 3816] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; complement component C1r activity [goid 3815] [pmid 2834284] [evidence TAS]; complement component C1s activity [goid 3816] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],12,,12p13.31d,-,NM_001733.4,715,C1R,-1.4914857038978768,7.636285016478895,-13.002978420261043,3.1629160431194672e-27,3.9801310644712993e-26,50.9627383907928
PPAP2C,ILMN_1675523,"Homo sapiens phosphatidic acid phosphatase type 2C (PPAP2C), transcript variant 3, mRNA.",membrane [goid 16020] [pmid 9607309] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [pmid 9607309] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],,hydrolase activity [goid 16787] [evidence IEA]; phosphoprotein phosphatase activity [goid 4721] [pmid 9607309] [evidence TAS]; phosphatidate phosphatase activity [goid 8195] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; phosphoprotein phosphatase activity [goid 4721] [pmid 9607309] [evidence TAS]; phosphatidate phosphatase activity [goid 8195] [evidence IEA],19,242051-242066:242067-242100,19p13.3j,-,NM_177543.1,8612,PPAP2C,1.334476134565115,6.746764454296028,12.998757178203478,3.251354058364067e-27,4.0862494974716237e-26,50.93524513304225
KIAA1542,ILMN_1766593,"Homo sapiens CTD-binding SR-like protein rA9 (KIAA1542), mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],11,601694-601743,11p15.5d,+,NM_020901.1,57661,KIAA1542,1.041611613925915,6.1334743387153425,12.995036971174846,3.33134304692391e-27,4.181525199677139e-26,50.911015124804265
GALNT3,ILMN_1671039,"Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) (GALNT3), mRNA.",membrane fraction [goid 5624] [pmid 8663203] [evidence TAS]; integral to membrane [goid 16021] [pmid 8663203] [evidence TAS]; Golgi stack [goid 5795] [evidence IEA],carbohydrate metabolism [goid 5975] [pmid 9592121] [evidence NAS],"manganese ion binding [goid 30145] [evidence IEA]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; polypeptide N-acetylgalactosaminyltransferase activity [goid 4653] [pmid 9592121] [evidence TAS]; sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]",2,166311884-166311933,2q24.3c,-,NM_004482.2,2591,GALNT3,2.259921207888909,8.760784807104043,12.986468090557523,3.523152122184969e-27,4.411215748477901e-26,50.85520522529998
C6orf32,ILMN_1726597,"Homo sapiens chromosome 6 open reading frame 32 (C6orf32), mRNA.",,,binding [goid 5488] [evidence IEA],6,24947735-24947784,6p22.2b,-,NM_015864.2,9750,C6orf32,-1.6277513187343517,7.933384929349503,-12.984582671326187,3.5668169473607276e-27,4.4575186435223887e-26,50.84292530328787
TSPO,ILMN_1681679,"Homo sapiens translocator protein (18kDa) (TSPO), transcript variant PBR, mRNA.",mitochondrial outer membrane [goid 5741] [pmid 8307574] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA]; mitochondrial outer membrane [goid 5741] [pmid 8307574] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],signal transduction [goid 7165] [evidence NAS]; signal transduction [goid 7165] [evidence NAS],benzodiazepine receptor activity [goid 8503] [pmid 8307574] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]; benzodiazepine receptor activity [goid 8503] [pmid 8307574] [evidence NAS]; receptor activity [goid 4872] [evidence IEA],22,41889087-41889136,22q13.2c,+,NM_000714.4,706,TSPO,-1.0365831923416842,11.624199202597813,-12.982574117717412,3.6139290421217745e-27,4.513576296802276e-26,50.82984338959899
CHN1,ILMN_1678493,"Homo sapiens chimerin (chimaerin) 1 (CHN1), transcript variant 1, mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; SH3/SH2 adaptor activity [goid 5070] [pmid 8336731] [evidence TAS]; diacylglycerol binding [goid 19992] [evidence IEA]; GTPase activator activity [goid 5096] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; SH3/SH2 adaptor activity [goid 5070] [pmid 8336731] [evidence TAS]; diacylglycerol binding [goid 19992] [evidence IEA]; GTPase activator activity [goid 5096] [evidence IEA],2,175372736-175372785,2q31.1g,-,NM_001822.3,1123,CHN1,-1.3899120079352603,9.004715848760823,-12.977179359016034,3.743570617659731e-27,4.669660905120692e-26,50.79470675353263
SIX4,ILMN_1743402,"Homo sapiens sine oculis homeobox homolog 4 (Drosophila) (SIX4), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; morphogenesis [goid 9653] [pmid 10640827] [evidence TAS]",transcription factor activity [goid 3700] [evidence IEA],14,60246172-60246221,14q23.1c,-,NM_017420.2,51804,SIX4,2.088702495045256,7.8733592494119415,12.976571772075808,3.75845993268919e-27,4.6853125441274337e-26,50.79074947323672
CDK6,ILMN_1802615,"Homo sapiens cyclin-dependent kinase 6 (CDK6), mRNA.",,cell proliferation [goid 8283] [pmid 8114739] [evidence TAS]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; G1 phase of mitotic cell cycle [goid 80] [pmid 8114739] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 15232106] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],7,92072593-92072642,7q21.2b,-,NM_001259.5,1021,CDK6,-1.306480184155335,8.245070860244539,-12.973128409191457,3.8439676865661984e-27,4.7889231303123595e-26,50.76832246656387
IRF7,ILMN_1798181,"Homo sapiens interferon regulatory factor 7 (IRF7), transcript variant c, mRNA.",cytoplasm [goid 5737] [pmid 9786932] [evidence TAS]; nucleus [goid 5634] [evidence ISS],"response to DNA damage stimulus [goid 6974] [evidence ISS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; response to virus [goid 9615] [evidence ISS]; transcription initiation from RNA polymerase II promoter [goid 6367] [evidence ISS]; transcription [goid 6350] [evidence IEA]; inflammatory response [goid 6954] [evidence ISS]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 9315633] [evidence TAS]",specific RNA polymerase II transcription factor activity [goid 3704] [pmid 9315633] [evidence TAS]; transcription factor activity [goid 3700] [evidence IEA],11,602640-602689,11p15.5d,-,NM_004030.1,3665,IRF7,1.168773233084364,9.272353516065193,12.964989087696795,4.053903525769656e-27,5.044185431815876e-26,50.715310117452
LOC652726,ILMN_1667932,"PREDICTED: Homo sapiens similar to ankyrin repeat domain 36 (LOC652726), mRNA.",,,,,,,,XM_942351.1,652726,LOC652726,1.8328465862438525,6.690324324088773,12.963336729457628,4.097902857092872e-27,5.0957638511320185e-26,50.70454811026036
VIPR1,ILMN_2199389,"Homo sapiens vasoactive intestinal peptide receptor 1 (VIPR1), mRNA.",integral to plasma membrane [goid 5887] [pmid 8179610] [evidence TAS]; membrane [goid 16020] [evidence IEA],"immune response [goid 6955] [pmid 8390245] [evidence TAS]; synaptic transmission [goid 7268] [pmid 8390245] [evidence TAS]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 8390245] [evidence TAS]; muscle contraction [goid 6936] [pmid 8390245] [evidence TAS]; digestion [goid 7586] [pmid 8390245] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [pmid 8389448] [evidence TAS]",receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [evidence IEA]; vasoactive intestinal polypeptide receptor activity [goid 4999] [pmid 8179610] [evidence TAS],3,42553981-42554030,3p22.1a,+,NM_004624.2,7433,VIPR1,-2.0938606494097733,10.243263145531882,-12.962604889832644,4.1175427365362925e-27,5.117005905131561e-26,50.69978155062415
PREX1,ILMN_1777342,"Homo sapiens phosphatidylinositol 3,4,5-trisphosphate-dependent RAC exchanger 1 (PREX1), mRNA.",cytosol [goid 5829] [pmid 11955434] [evidence IDA]; plasma membrane [goid 5886] [evidence TAS],actin filament polymerization [goid 30041] [evidence TAS]; superoxide metabolism [goid 6801] [evidence TAS]; neutrophil activation [goid 42119] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA],Rho GTPase activator activity [goid 5100] [evidence TAS]; phospholipid binding [goid 5543] [pmid 11955434] [evidence IDA]; enzyme binding [goid 19899] [evidence TAS]; Rho guanyl-nucleotide exchange factor activity [goid 5089] [evidence TAS],20,46674552-46674601,20q13.13b,-,NM_020820.2,57580,PREX1,-1.1198749175653049,7.049692831956881,-12.959267060437684,4.2083183756638865e-27,5.223327174955523e-26,50.6780418625231
GADD45B,ILMN_1718977,"Homo sapiens growth arrest and DNA-damage-inducible, beta (GADD45B), mRNA.",,activation of MAPKKK activity [goid 185] [pmid 9827804] [evidence TAS]; apoptosis [goid 6915] [pmid 9827804] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; response to stress [goid 6950] [pmid 9827804] [evidence TAS],,19,2429064-2429113,19p13.3g,+,NM_015675.1,4616,GADD45B,-1.6999644274208539,9.294257451765754,-12.956410067387246,4.287605257818772e-27,5.318438065619219e-26,50.65943391657828
BCYRN1,ILMN_1678757,"Homo sapiens brain cytoplasmic RNA 1, Bc1 analog (mouse) (BCYRN1) on chromosome 2.",,,,2,47416014-47416063,2p21a,+,NR_001568.1,618,BCYRN1,1.8994876918772672,10.593051202506777,12.954313388557262,4.34674092118348e-27,5.388450579370451e-26,50.64577798895268
FOLR2,ILMN_1745963,"Homo sapiens folate receptor 2 (fetal) (FOLR2), mRNA.",membrane [goid 16020] [evidence IEA]; membrane fraction [goid 5624] [pmid 2605182] [evidence TAS],folic acid transport [goid 15884] [pmid 2605182] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; folic acid binding [goid 5542] [pmid 2605182] [evidence TAS],11,71610373-71610422,11q13.4a,+,NM_000803.2,2350,FOLR2,-1.7541507147041449,8.383677026967016,-12.950776806654623,4.448342408987053e-27,5.507576418255752e-26,50.62274379357409
C17orf28,ILMN_1654013,"Homo sapiens chromosome 17 open reading frame 28 (C17orf28), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,17,70458476-70458525,17q25.1c,-,NM_030630.1,283987,C17orf28,1.033453487868261,7.868934510555814,12.941420534220542,4.728737004440178e-27,5.843889436988207e-26,50.56180523612752
LOC92017,ILMN_1670539,"Homo sapiens similar to RIKEN cDNA 4933437K13 (LOC92017), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA],,16,12528603-12528652,16p13.13a-p13.12b,+,NM_001009607.1,92017,LOC92017,1.962773865952041,6.818732343587503,12.931813787033313,5.035040262644662e-27,6.210917729654401e-26,50.49923533576331
HBLD2,ILMN_1715931,"Homo sapiens iron-sulfur cluster assembly 1 homolog (S. cerevisiae) (ISCA1), mRNA.",mitochondrion [goid 5739] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA],9,88069929-88069978,9q21.33b,-,NM_030940.3,81689,HBLD2,-1.0752229304781826,7.434474773725212,-12.926139195459992,5.2252114038471466e-27,6.441529868649027e-26,50.46227606632039
SPINK1,ILMN_1787266,"Homo sapiens serine peptidase inhibitor, Kazal type 1 (SPINK1), mRNA.",,,serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; protein binding [goid 5515] [pmid 14507909] [evidence IPI],5,147189361-147189386:147191279-147191302,5q32e,-,NM_003122.2,6690,SPINK1,4.18842863611548,8.05938716494272,12.92284675713077,5.338825847764472e-27,6.565410421762234e-26,50.440832048934475
GJA5,ILMN_1702972,"Homo sapiens gap junction protein, alpha 5, 40kDa (connexin 40) (GJA5), transcript variant A, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; connexon complex [goid 5922] [evidence IEA],cell communication [goid 7154] [evidence IEA]; transport [goid 6810] [pmid 7966354] [evidence NAS]; intercellular junction assembly [goid 7043] [pmid 7966354] [evidence TAS]; muscle contraction [goid 6936] [pmid 7966354] [evidence TAS],connexon channel activity [goid 15285] [pmid 7966354] [evidence TAS],1,145711994-145712043,1q21.1c,-,NM_005266.4,2702,GJA5,-1.0068045637988208,6.189640599814383,-12.914427556783487,5.640716401944306e-27,6.932398880227376e-26,50.38599691512408
IPP,ILMN_1789106,"Homo sapiens intracisternal A particle-promoted polypeptide (IPP), mRNA.",actin cytoskeleton [goid 15629] [pmid 10072760] [evidence TAS],,protein binding [goid 5515] [evidence IEA]; actin binding [goid 3779] [pmid 10072760] [evidence TAS],1,45937209-45937258,1p34.1b,-,NM_005897.1,3652,IPP,1.3637880368372066,7.997988719546514,12.91284293712813,5.699417230737511e-27,7.00024186326557e-26,50.375676131596116
ANKRD1,ILMN_1716264,"Homo sapiens ankyrin repeat domain 1 (cardiac muscle) (ANKRD1), mRNA.",nucleus [goid 5634] [pmid 7730328] [evidence TAS],defense response [goid 6952] [pmid 7730328] [evidence TAS]; signal transduction [goid 7165] [pmid 7730328] [evidence TAS],DNA binding [goid 3677] [pmid 7730328] [evidence TAS],10,92661948-92661997,10q23.31d,-,NM_014391.2,27063,ANKRD1,-2.789742385935427,6.660513471479124,-12.909945057956417,5.808351301311535e-27,7.129662137217251e-26,50.356801969317424
NGEF,ILMN_1809613,"Homo sapiens neuronal guanine nucleotide exchange factor (NGEF), mRNA.",,,,2,233451784-233451833,2q37.1c-q37.1d,-,NM_019850.1,25791,NGEF,1.3429378051082956,5.700474060236028,12.897015737482315,6.320312658953527e-27,7.748579392177828e-26,50.27259225058685
SFMBT2,ILMN_1660125,"Homo sapiens Scm-like with four mbt domains 2 (SFMBT2), mRNA.",nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA],,10,7244266-7244315,10p14e,-,NM_001029880.1,57713,SFMBT2,1.4432191334810378,6.157706006233018,12.895936464470196,6.365036560680657e-27,7.793858721303463e-26,50.26556287193838
C9orf125,ILMN_1809323,"Homo sapiens chromosome 9 open reading frame 125 (C9orf125), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,9,103277705-103277754,9q31.1b,-,NM_032342.1,84302,C9orf125,-1.4893140886199108,6.097262119966688,-12.888696661740081,6.673339440595675e-27,8.166371591892248e-26,50.218409609786356
DKFZp547E087,ILMN_1752832,"PREDICTED: Homo sapiens hypothetical gene LOC283846, transcript variant 2 (DKFZp547E087), mRNA.",,,,18,11629363-11629412,,-,XM_931802.1,283846,DKFZp547E087,1.9989688582279275,6.798263741055925,12.88714106165691,6.74150874399445e-27,8.244749813559961e-26,50.2082779106346
C16orf7,ILMN_1693630,"Homo sapiens chromosome 16 open reading frame 7 (C16orf7), mRNA.",,ATP synthesis coupled proton transport [goid 15986] [pmid 10231027] [evidence TAS],transporter activity [goid 5215] [pmid 10231027] [evidence TAS],16,88301132-88301181,16q24.3b,-,NM_004913.1,9605,C16orf7,1.054783972855521,8.579965061677642,12.884692170589853,6.850237538929452e-27,8.367494058540931e-26,50.192328175919066
VASH1,ILMN_1796216,"Homo sapiens vasohibin 1 (VASH1), mRNA.",,cell cycle arrest [goid 7050] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],,14,76318923-76318972,14q24.3c,+,NM_014909.2,22846,VASH1,-1.1110858461003534,9.023357334939895,-12.879827164655813,7.071469994467546e-27,8.621936115131424e-26,50.1606422254768
LMBRD1,ILMN_1652128,"Homo sapiens LMBR1 domain containing 1 (LMBRD1), mRNA.",,,,6,70442883-70442884:70443063-70443110,6q13a,-,NM_018368.2,55788,LMBRD1,-1.1372755798055039,10.65125840096198,-12.877406492974425,7.18419603353436e-27,8.754043498109347e-26,50.14487633184099
LOC648434,ILMN_1735179,"PREDICTED: Homo sapiens hypothetical protein LOC648434 (LOC648434), mRNA.",,,,,,,,XM_937486.1,648434,LOC648434,1.149420347140281,5.810870435447157,12.871998595229673,7.442565831187532e-27,9.052331741665661e-26,50.109654623286744
ANXA2,ILMN_1711899,"Homo sapiens annexin A2 (ANXA2), transcript variant 2, mRNA.",plasma membrane [goid 5886] [pmid 10809787] [evidence TAS]; soluble fraction [goid 5625] [pmid 7961821] [evidence TAS]; plasma membrane [goid 5886] [pmid 10809787] [evidence TAS]; soluble fraction [goid 5625] [pmid 7961821] [evidence TAS],skeletal development [goid 1501] [pmid 7961821] [evidence TAS]; skeletal development [goid 1501] [pmid 7961821] [evidence TAS],calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; phospholipase inhibitor activity [goid 4859] [pmid 3013422] [evidence TAS]; cytoskeletal protein binding [goid 8092] [evidence IEA]; calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; phospholipase inhibitor activity [goid 4859] [pmid 3013422] [evidence TAS]; cytoskeletal protein binding [goid 8092] [evidence IEA],15,58476750-58476799,15q22.2a,-,NM_001002857.1,302,ANXA2,-1.065680857905086,10.985594734085087,-12.868997695065955,7.58992569540236e-27,9.225955851373659e-26,50.09010975967025
CBLB,ILMN_1685580,"Homo sapiens Cas-Br-M (murine) ecotropic retroviral transforming sequence b (CBLB), mRNA.",nucleus [goid 5634] [evidence IEA],ubiquitin cycle [goid 6512] [evidence IEA]; immune response [goid 6955] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [evidence IEA],ligase activity [goid 16874] [evidence IEA]; zinc ion binding [goid 8270] [pmid 7784085] [evidence TAS]; signal transducer activity [goid 4871] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [pmid 7784085] [evidence TAS],3,106860064-106860113,3q13.11c-q13.11d,-,NM_170662.3,868,CBLB,1.0787429129159776,9.515387049311126,12.86352751580846,7.866087574756553e-27,9.550041274012689e-26,50.05448255520491
CRR9,ILMN_1752802,"Homo sapiens CLPTM1-like (CLPTM1L), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,5,1371249-1371298,5p15.33d,-,NM_030782.2,81037,CRR9,1.0420711797915043,11.560160010045715,12.847244575893244,8.749042864291212e-27,1.0589888059814798e-25,49.9484326133592
LOC402116,ILMN_1696469,"PREDICTED: Homo sapiens similar to plakophilin 4 (LOC402116), mRNA.",,,,2,209752790-209752839,2q34a,+,XM_929112.1,402116,LOC402116,1.5367360909416945,7.512911471030045,12.84571349652726,8.837000582411465e-27,1.0683426444283299e-25,49.93846082559645
KCNQ3,ILMN_1775004,"Homo sapiens potassium voltage-gated channel, KQT-like subfamily, member 3 (KCNQ3), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; voltage-gated potassium channel complex [goid 8076] [pmid 9677360] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 9677360] [evidence TAS]; synaptic transmission [goid 7268] [pmid 9425900] [evidence TAS],potassium ion binding [goid 30955] [evidence IEA]; ion channel activity [goid 5216] [evidence IEA]; voltage-gated potassium channel activity [goid 5249] [pmid 9677360] [evidence TAS],8,133210591-133210640,8q24.22b,-,NM_004519.2,3786,KCNQ3,1.0733774613514235,6.348208556703694,12.844945627863664,8.881445634036986e-27,1.0729653616068199e-25,49.933459766889435
LOC399942,ILMN_1765701,"PREDICTED: Homo sapiens similar to Tubulin alpha-2 chain (Alpha-tubulin 2), transcript variant 5 (LOC399942), mRNA.",,,,11,89655450-89655477:89655607-89655628,11q14.3b,+,XM_934471.1,399942,LOC399942,-2.5189514678170584,7.738730308567721,-12.844867786485882,8.885963635458319e-27,1.0729653616068199e-25,49.932952793218014
MGC15912,ILMN_1657701,"Homo sapiens hypothetical protein MGC15912 (MGC15912), mRNA.",,,,11,66153907-66153956,11q13.1e,+,NM_032886.1,84972,MGC15912,1.875224640476569,8.648004500369545,12.84431859802467,8.917904529133983e-27,1.0755240133750015e-25,49.92937598043915
DNAJC12,ILMN_1725773,"Homo sapiens DnaJ (Hsp40) homolog, subfamily C, member 12 (DNAJC12), transcript variant 2, mRNA.",,protein folding [goid 6457] [evidence IEA]; protein folding [goid 6457] [evidence IEA],heat shock protein binding [goid 31072] [evidence IEA]; unfolded protein binding [goid 51082] [evidence IEA]; heat shock protein binding [goid 31072] [evidence IEA]; unfolded protein binding [goid 51082] [evidence IEA],10,69241237-69241260:69241261-69241286,10q21.3d,-,NM_201262.1,56521,DNAJC12,2.1064311437455716,6.837678800249076,12.836111989879505,9.409109967102384e-27,1.1340811579625572e-25,49.87592726724769
MMP9,ILMN_1796316,"Homo sapiens matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (MMP9), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; extracellular space [goid 5615] [pmid 2251898] [evidence IDA],peptidoglycan metabolism [goid 270] [evidence IEA]; macrophage differentiation [goid 30225] [pmid 2251898] [evidence TAS]; collagen catabolism [goid 30574] [evidence IEA],zinc ion binding [goid 8270] [pmid 2251898] [evidence TAS]; gelatinase B activity [goid 4229] [pmid 16192646] [evidence IDA]; collagenase activity [goid 8133] [pmid 2551898] [evidence IDA]; collagen binding [goid 5518] [pmid 2251898] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],20,44078320-44078369,20q13.12b,+,NM_004994.2,4318,MMP9,2.7492279436381644,9.258002202519723,12.83349893511555,9.57112348498935e-27,1.1522204493842774e-25,49.858908798874744
PLA2G2D,ILMN_1788811,"Homo sapiens phospholipase A2, group IID (PLA2G2D), mRNA.",extracellular region [goid 5576] [pmid 10455175] [evidence TAS],lipid catabolism [goid 16042] [evidence IEA]; phospholipid metabolism [goid 6644] [pmid 10455175] [evidence TAS]; inflammatory response [goid 6954] [pmid 10455175] [evidence TAS],phospholipase A2 activity [goid 4623] [pmid 10455175] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],1,20311609-20311658,1p36.12b,-,NM_012400.2,26279,PLA2G2D,1.1751950065744747,7.17949855782663,12.825881909751395,1.005948470004435e-26,1.2102836432861537e-25,49.80930033626923
LXN,ILMN_1723962,"Homo sapiens latexin (LXN), mRNA.",,,metalloendopeptidase inhibitor activity [goid 8191] [evidence IEA]; enzyme inhibitor activity [goid 4857] [evidence IEA],3,159867177-159867226,3q25.32b,-,NM_020169.2,56925,LXN,-1.1960013908121017,9.33331952031964,-12.824228929889424,1.0168712199599776e-26,1.2226898659230308e-25,49.79853478097998
C1orf73,ILMN_1718354,"Homo sapiens integrator complex subunit 7 (INTS7), mRNA.",,,protein binding [goid 5515] [pmid 16239144] [evidence IPI]; binding [goid 5488] [evidence IEA],1,210181762-210181788:210181789-210181811,1q32.3b,-,NM_015434.1,25896,C1orf73,1.0119574034899763,7.030931642395446,12.819252445780101,1.0504766342357211e-26,1.260824025062286e-25,49.76612393369553
ZNF239,ILMN_1748427,"Homo sapiens zinc finger protein 239 (ZNF239), mRNA.",nucleolus [goid 5730] [evidence NR ],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; RNA binding [goid 3723] [pmid 9121460] [evidence TAS]; DNA binding [goid 3677] [pmid 9121460] [evidence TAS],10,43372116-43372156:43372157-43372165,10q11.21b,-,NM_005674.1,8187,ZNF239,1.0912025689089289,6.81185495250828,12.810851788083635,1.1097436799531037e-26,1.330362585290695e-25,49.71141242113903
RAC3,ILMN_1693340,"Homo sapiens ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) (RAC3), mRNA.",endomembrane system [goid 12505] [pmid 11956649] [evidence IDA]; intracellular [goid 5622] [evidence IEA],cell projection biogenesis [goid 30031] [pmid 11956649] [evidence IDA]; actin cytoskeleton organization and biogenesis [goid 30036] [pmid 11956649] [evidence IDA]; small GTPase mediated signal transduction [goid 7264] [evidence IEA],GTPase activity [goid 3924] [pmid 11956649] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; protein binding [goid 5515] [pmid 11956649] [evidence IPI],17,77585144-77585193,17q25.3g,+,NM_005052.2,5881,RAC3,1.3520107054196178,6.523875221397114,12.808474419161422,1.1271151669043573e-26,1.349570332700322e-25,49.695929244788516
SGCA,ILMN_1741007,"Homo sapiens sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) (SGCA), mRNA.",integral to membrane [goid 16021] [evidence IEA]; sarcoglycan complex [goid 16012] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; membrane [goid 16020] [evidence IEA]; dystrophin-associated glycoprotein complex [goid 16010] [pmid 7937874] [evidence TAS],muscle development [goid 7517] [pmid 7663524] [evidence TAS]; muscle contraction [goid 6936] [pmid 8069911] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],17,45607808-45607809:45608072-45608119,17q21.33a,+,NM_000023.1,6442,SGCA,-1.59052385701351,7.34405357507033,-12.806159720018535,1.1442899493905868e-26,1.368496910185706e-25,49.680854250646746
CYGB,ILMN_1758128,"Homo sapiens cytoglobin (CYGB), mRNA.",cytoplasm [goid 5737] [evidence NAS],transport [goid 6810] [evidence IEA]; oxygen transport [goid 15671] [pmid 11919282] [evidence NAS],heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxygen transporter activity [goid 5344] [pmid 11919282] [evidence NAS]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [evidence IEA],17,72035154-72035203,17q25.1d,-,NM_134268.3,114757,CYGB,-1.1153339843954218,9.437549607889043,-12.805630910968546,1.1482502271878372e-26,1.3724128163425475e-25,49.67741026810315
C8orf51,ILMN_1688772,"Homo sapiens chromosome 8 open reading frame 51 (C8orf51), mRNA.",,,,8,144520263-144520312,8q24.3f,-,NM_024035.1,78998,C8orf51,1.0236613965691834,6.3885997676248545,12.801891251165234,1.1766506618684797e-26,1.403841767600748e-25,49.653054976292935
ZNF651,ILMN_1699440,"Homo sapiens zinc finger protein 651 (ZNF651), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],3,42683889-42683938,3p22.1a,+,NM_145166.2,92999,ZNF651,-1.1109689371213936,6.759722657351577,-12.797929673147028,1.2075029854294767e-26,1.4380785555043435e-25,49.62725448689222
MGRN1,ILMN_1745697,"Homo sapiens mahogunin, ring finger 1 (MGRN1), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; ligase activity [goid 16874] [evidence IEA]; protein binding [goid 5515] [evidence IEA],16,4680651-4680700,16p13.3b,+,NM_015246.1,23295,MGRN1,1.486891569878141,8.899221568711537,12.791633713570809,1.2582081256846649e-26,1.496684196117644e-25,49.58625111374191
MYO3B,ILMN_1727490,"Homo sapiens myosin IIIB (MYO3B), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; myosin [goid 16459] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; myosin [goid 16459] [evidence IEA],protein amino acid phosphorylation [goid 6468] [evidence IEA]; visual perception [goid 7601] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; visual perception [goid 7601] [evidence IEA],actin binding [goid 3779] [evidence IEA]; motor activity [goid 3774] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; actin binding [goid 3779] [evidence IEA]; motor activity [goid 3774] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],2,171218732-171218781,2q31.1b,+,NM_138995.1,140469,MYO3B,1.407204279392646,6.801325066234271,12.786195685700203,1.303714274133675e-26,1.5498939510912993e-25,49.55083534887029
CXXC5,ILMN_1745256,"Homo sapiens CXXC finger 5 (CXXC5), mRNA.",,positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP],zinc ion binding [goid 8270] [evidence IEA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; DNA binding [goid 3677] [evidence IEA],5,139043454-139043503,5q31.3a,+,NM_016463.5,51523,CXXC5,1.0087820564023193,10.704460108373821,12.78594189555042,1.3058777659414342e-26,1.5515440820045258e-25,49.54918251678239
MGC40579,ILMN_1673892,"Homo sapiens hypothetical protein MGC40579 (MGC40579), mRNA.",,glycerol metabolism [goid 6071] [evidence IEA]; carbohydrate metabolism [goid 5975] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; kinase activity [goid 16301] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],3,143367285-143367302:143371857-143371888,3q23c-q23d,-,NM_152776.1,256356,MGC40579,1.231037154583868,6.760309898036431,12.785827508088094,1.3068540612185447e-26,1.5517825553033022e-25,49.54843755787251
B3GALNT1,ILMN_2325347,"Homo sapiens beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) (B3GALNT1), transcript variant 3, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein amino acid glycosylation [goid 6486] [pmid 9582303] [evidence TAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; galactosyltransferase activity [goid 8378] [evidence IEA]; galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity [goid 47273] [evidence IEA]",3,162284475-162284524,3q26.1a,-,NM_033168.2,8706,B3GALNT1,-1.499888247953498,8.445515515221555,-12.782441505132045,1.3360864771859762e-26,1.5855526830093129e-25,49.52638593994613
C20orf172,ILMN_1715905,"Homo sapiens DSN1, MIND kinetochore complex component, homolog (S. cerevisiae) (DSN1), mRNA.",nucleus [goid 5634] [evidence IEA],,protein binding [goid 5515] [pmid 15502821] [evidence IPI],20,34814159-34814208,20q11.23a,-,NM_024918.2,79980,C20orf172,1.0364293716735737,7.709549021822815,12.77323763696334,1.4188930182899888e-26,1.6808295743011308e-25,49.46644539542782
PDCL,ILMN_1694041,"Homo sapiens phosducin-like (PDCL), mRNA.",cellular component unknown [goid 8372] [evidence ND ],sensory perception [goid 7600] [evidence IEA]; signal transduction [goid 7165] [pmid 10524200] [evidence NAS]; electron transport [goid 6118] [evidence IEA]; visual perception [goid 7601] [evidence IEA],electron transporter activity [goid 5489] [evidence IEA]; regulator of G-protein signaling activity [goid 16299] [pmid 10524200] [evidence NAS],9,124621585-124621634,9q33.2b,-,NM_005388.2,5082,PDCL,-1.208490568001051,6.489762710978548,-12.77182734528153,1.43202701002551e-26,1.6943818105612303e-25,49.4572608686587
LOC652616,ILMN_1652680,"PREDICTED: Homo sapiens similar to neutrophil cytosolic factor 1 (LOC652616), mRNA.",,,,,,,,XM_942152.1,652616,LOC652616,-1.3516795739608023,5.543347088632831,-12.768852105135794,1.4601354324871535e-26,1.726618778558095e-25,49.43788465903622
ALDH3B2,ILMN_1763666,"Homo sapiens aldehyde dehydrogenase 3 family, member B2 (ALDH3B2), transcript variant 1, mRNA.",,metabolism [goid 8152] [evidence IEA]; lipid metabolism [goid 6629] [pmid 8890755] [evidence TAS]; aldehyde metabolism [goid 6081] [evidence IEA]; alcohol metabolism [goid 6066] [pmid 8890755] [evidence TAS]; metabolism [goid 8152] [evidence IEA]; lipid metabolism [goid 6629] [pmid 8890755] [evidence TAS]; aldehyde metabolism [goid 6081] [evidence IEA]; alcohol metabolism [goid 6066] [pmid 8890755] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; aldehyde dehydrogenase [NAD(P)+] activity [goid 4030] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; aldehyde dehydrogenase [NAD(P)+] activity [goid 4030] [evidence IEA],11,67186363-67186412,11q13.2a,-,NM_000695.3,222,ALDH3B2,1.6396280337617775,6.050039544143625,12.768360707634702,1.4648306804277293e-26,1.7311477999998822e-25,49.434684445839224
C1orf115,ILMN_1674817,"Homo sapiens chromosome 1 open reading frame 115 (C1orf115), mRNA.",,,,1,218938891-218938940,1q41d,+,NM_024709.2,79762,C1orf115,-1.619420754193552,9.4689233687896,-12.757138075804264,1.5762690764608716e-26,1.857436466842583e-25,49.36159783905799
BRF1,ILMN_1703686,"Homo sapiens BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae) (BRF1), transcript variant 2, mRNA.",transcription factor TFIIIB complex [goid 126] [pmid 10921893] [evidence NAS]; nucleus [goid 5634] [evidence IEA]; transcription factor complex [goid 5667] [evidence IEA]; transcription factor TFIIIB complex [goid 126] [pmid 10921893] [evidence NAS]; nucleus [goid 5634] [evidence IEA]; transcription factor complex [goid 5667] [evidence IEA],"positive regulation of transcription [goid 45941] [evidence IEA]; tRNA transcription [goid 9304] [pmid 8943358] [evidence TAS]; rRNA transcription [goid 9303] [pmid 7624363] [evidence TAS]; transcription initiation [goid 6352] [evidence IEA]; transcription initiation from RNA polymerase III promoter [goid 6384] [pmid 7624363] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; positive regulation of transcription [goid 45941] [evidence IEA]; tRNA transcription [goid 9304] [pmid 8943358] [evidence TAS]; rRNA transcription [goid 9303] [pmid 7624363] [evidence TAS]; transcription initiation [goid 6352] [evidence IEA]; transcription initiation from RNA polymerase III promoter [goid 6384] [pmid 7624363] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; RNA polymerase III transcription factor activity [goid 3709] [pmid 8943358] [evidence TAS]; protein binding [goid 5515] [pmid 7624363] [evidence TAS]; transcription regulator activity [goid 30528] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10921893] [evidence NAS]; transcriptional activator activity [goid 16563] [evidence IEA]; RNA polymerase II transcription factor activity [goid 3702] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; RNA polymerase III transcription factor activity [goid 3709] [pmid 8943358] [evidence TAS]; protein binding [goid 5515] [pmid 7624363] [evidence TAS]; transcription regulator activity [goid 30528] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10921893] [evidence NAS]; transcriptional activator activity [goid 16563] [evidence IEA]; RNA polymerase II transcription factor activity [goid 3702] [evidence IEA],14,104746939-104746988,14q32.33c,-,NM_145696.1,2972,BRF1,1.1190514192069507,7.2303190704376545,12.756777125039429,1.579990621422475e-26,1.8606505210959907e-25,49.35924718816899
KLF10,ILMN_1659122,"Homo sapiens Kruppel-like factor 10 (KLF10), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 9748269] [evidence TAS]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [pmid 9748269] [evidence TAS]; intracellular [goid 5622] [evidence IEA],"skeletal development [goid 1501] [pmid 10816551] [evidence TAS]; transcription [goid 6350] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 8532536] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9748269] [evidence TAS]; cell proliferation [goid 8283] [pmid 10816551] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 9748269] [evidence TAS]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 10816551] [evidence TAS]; skeletal development [goid 1501] [pmid 10816551] [evidence TAS]; transcription [goid 6350] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 8532536] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9748269] [evidence TAS]; cell proliferation [goid 8283] [pmid 10816551] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 9748269] [evidence TAS]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 10816551] [evidence TAS]",transcription factor activity [goid 3700] [pmid 10816551] [evidence TAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10816551] [evidence TAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],8,103736971-103737005:103737006-103737020,8q22.3b,-,NM_005655.1,7071,KLF10,-1.161628526468232,6.115533468683313,-12.752470805324926,1.6250740231832715e-26,1.9126165326971116e-25,49.331202847827555
FOSB,ILMN_1751607,"Homo sapiens FBJ murine osteosarcoma viral oncogene homolog B (FOSB), mRNA.",nucleus [goid 5634] [evidence IEA],"behavior [goid 7610] [pmid 8706134] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 1900040] [evidence TAS]; development [goid 7275] [pmid 8706134] [evidence TAS]",sequence-specific DNA binding [goid 43565] [evidence IEA]; protein dimerization activity [goid 46983] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; transcription factor binding [goid 8134] [pmid 1900040] [evidence TAS],19,50670217-50670266,19q13.32a,+,NM_006732.1,2354,FOSB,-3.301361198772348,11.567969534766103,-12.745602424758427,1.699656869860662e-26,1.9980455142286797e-25,49.28647372746651
B3GNT6,ILMN_1715384,"Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (B3GNT6), mRNA.",membrane [goid 16020] [evidence IEA]; integral to Golgi membrane [goid 30173] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA],poly-N-acetyllactosamine biosynthesis [goid 30311] [pmid 9405606] [evidence NAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [goid 8532] [pmid 9405606] [evidence NAS]",11,65869876-65869925,11q13.1e,-,NM_006876.1,11041,B3GNT6,-1.0466885619042454,8.58859177803438,-12.744514989684804,1.7117750731155288e-26,2.009929322939877e-25,49.27939203281498
LOC441066,ILMN_1714808,"PREDICTED: Homo sapiens similar to Beta-glucuronidase precursor (LOC441066), mRNA.",,,,5,98889676-98889710:98896232-98896246,5q21.1b,+,XM_496741.2,441066,LOC441066,1.4295038527495691,6.297053636055466,12.741667454107267,1.743918440254504e-26,2.045270817855341e-25,49.260848096012694
IER5L,ILMN_1755620,"Homo sapiens immediate early response 5-like (IER5L), mRNA.",,,,9,130979040-130979083:130979084-130979089,9q34.11c,-,NM_203434.1,389792,IER5L,1.4796795015309572,7.628283307501209,12.737172644306723,1.795889112229179e-26,2.1049882458981494e-25,49.231576793118705
C3,ILMN_1762260,"Homo sapiens complement component 3 (C3), mRNA.",extracellular space [goid 5615] [evidence IEA],"signal transduction [goid 7165] [pmid 10085065] [evidence TAS]; innate immune response [goid 45087] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9164946] [evidence TAS]; complement activation, classical pathway [goid 6958] [evidence IEA]; complement activation, alternative pathway [goid 6957] [evidence IEA]; inflammatory response [goid 6954] [evidence IEA]",receptor binding [goid 5102] [pmid 9164946] [evidence TAS]; endopeptidase inhibitor activity [goid 4866] [evidence IEA],19,6636154-6636157:6637135-6637180,19p13.3a,-,NM_000064.1,718,C3,-1.8039507688001333,8.45943599812351,-12.72607570066316,1.9309244104296374e-26,2.259294479758841e-25,49.15931152119125
ART4,ILMN_1805773,"Homo sapiens ADP-ribosyltransferase 4 (Dombrock blood group) (ART4), mRNA.",membrane [goid 16020] [pmid 9119374] [evidence NAS],arginine metabolism [goid 6525] [pmid 11001920] [evidence NAS]; protein amino acid ADP-ribosylation [goid 6471] [pmid 9119374] [evidence NAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; NAD(P)+-protein-arginine ADP-ribosyltransferase activity [goid 3956] [pmid 9119374] [evidence NAS]; GPI anchor binding [goid 48503] [evidence IEA]",12,14884763-14884812,12p12.3e,-,NM_021071.2,420,ART4,-1.0385741617677517,6.411645777464393,-12.722057778642437,1.9822818700637724e-26,2.3180301377110435e-25,49.133146367373506
C20orf54,ILMN_1740923,"Homo sapiens chromosome 20 open reading frame 54 (C20orf54), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,20,688957-689006,20p13f,-,NM_033409.2,113278,C20orf54,1.1370403496379051,6.192932763650756,12.721893538976348,1.98441000942868e-26,2.319163286720154e-25,49.13207682357196
CENTD3,ILMN_1812618,"Homo sapiens centaurin, delta 3 (CENTD3), mRNA.",lamellipodium [goid 30027] [evidence ISS]; ruffle [goid 1726] [evidence ISS]; cytoplasm [goid 5737] [pmid 11804589] [evidence IC ]; intracellular [goid 5622] [evidence IEA],vesicle-mediated transport [goid 16192] [pmid 15569923] [evidence TAS]; negative regulation of Rho protein signal transduction [goid 35024] [evidence ISS]; signal transduction [goid 7165] [evidence IEA]; regulation of cell shape [goid 8360] [evidence ISS]; regulation of GTPase activity [goid 43087] [evidence IEA]; negative regulation of cell migration [goid 30336] [evidence ISS]; cytoskeleton organization and biogenesis [goid 7010] [pmid 15569923] [evidence TAS],"ARF GTPase activator activity [goid 8060] [evidence ISS]; phosphatidylinositol-3,4-bisphosphate binding [goid 43325] [pmid 11804589] [evidence IDA]; phosphatidylinositol-3,4,5-triphosphate binding [goid 5547] [pmid 11804589] [evidence IDA]; Rho GTPase activator activity [goid 5100] [evidence ISS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; Rac GTPase activator activity [goid 30675] [evidence ISS]",5,141013211-141013260,5q31.3c,-,NM_022481.5,64411,CENTD3,-1.154521776045824,9.855404433854382,-12.715865886972631,2.0641142470088352e-26,2.4109047200322694e-25,49.092824371813485
GNG10,ILMN_1757074,"Homo sapiens guanine nucleotide binding protein (G protein), gamma 10 (GNG10), mRNA.",heterotrimeric G-protein complex [goid 5834] [evidence IEA],signal transduction [goid 7165] [pmid 7665596] [evidence TAS]; protein folding [goid 6457] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA]; heat shock protein binding [goid 31072] [evidence IEA]; GTPase activity [goid 3924] [pmid 7665596] [evidence TAS]; unfolded protein binding [goid 51082] [evidence IEA],9,113463766-113463815,9q31.3b,+,NM_001017998.1,2790,GNG10,-1.7796835580256927,8.67473611496782,-12.712808526734857,2.1057576330511024e-26,2.4581096103901086e-25,49.072914778088695
LOC285908,ILMN_1733103,"Homo sapiens hypothetical protein LOC285908 (LOC285908), mRNA.",,,,7,65478742-65478791,7q11.21e,-,NM_181722.2,285908,LOC285908,1.1724294974954788,6.893609589074815,12.711691399391045,2.1211823532115196e-26,2.4746715173793636e-25,49.065640043622416
MMP12,ILMN_1768035,"Homo sapiens matrix metallopeptidase 12 (macrophage elastase) (MMP12), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],peptidoglycan metabolism [goid 270] [evidence IEA]; cell motility [goid 6928] [evidence NR ],zinc ion binding [goid 8270] [pmid 8226919] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; macrophage elastase activity [goid 4234] [pmid 8226919] [evidence TAS],11,102242277-102242326,11q22.2b,-,NM_002426.2,4321,MMP12,1.8922393440647403,5.942390744006342,12.708589147649034,2.1646116915998364e-26,2.5223966642707937e-25,49.04543823970473
SMCX,ILMN_1798224,"Homo sapiens Smcy homolog, X-linked (mouse) (SMCX), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],X,53238603-53238652,Xp11.22a,-,NM_004187.1,8242,SMCX,1.1314815868514954,6.136712243919779,12.704176758803666,2.2279179806841348e-26,2.5931461871744137e-25,49.01670500903543
PTPLA,ILMN_1725791,"Homo sapiens protein tyrosine phosphatase-like (proline instead of catalytic arginine), member a (PTPLA), mRNA.",,signal transduction [goid 7165] [pmid 10644438] [evidence NAS]; protein amino acid dephosphorylation [goid 6470] [pmid 10644438] [evidence TAS]; development [goid 7275] [pmid 10644438] [evidence TAS],protein tyrosine phosphatase activity [goid 4725] [pmid 10644438] [evidence TAS],10,17681354-17681403,10p12.33c,-,NM_014241.2,9200,PTPLA,-1.762557754659415,8.143557990505604,-12.693689505059947,2.3859114841137596e-26,2.76898590337286e-25,48.948413374084275
FAM46B,ILMN_1808011,"Homo sapiens family with sequence similarity 46, member B (FAM46B), mRNA.",,,,1,27204252-27204301,1p36.11a,-,NM_052943.2,115572,FAM46B,-1.5013558313142576,7.504247400591501,-12.686701034166463,2.4973667596818914e-26,2.8933013391844403e-25,48.90290598532968
SUSD2,ILMN_1693270,"Homo sapiens sushi domain containing 2 (SUSD2), mRNA.",,,,22,22915000-22915049,22q11.23b,+,NM_019601.3,56241,SUSD2,-2.0416542646957723,12.566301299290522,-12.686261744114493,2.504544173381198e-26,2.899937489641841e-25,48.900045442060275
NOTCH1,ILMN_1729161,"Homo sapiens Notch homolog 1, translocation-associated (Drosophila) (NOTCH1), mRNA.",integral to membrane [goid 16021] [evidence NAS]; membrane [goid 16020] [evidence IEA]; nucleus [goid 5634] [pmid 10713164] [evidence TAS],"immune response [goid 6955] [pmid 1831692] [evidence NAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; negative regulation of myoblast differentiation [goid 45662] [pmid 10713164] [evidence IMP]; Notch signaling pathway [goid 7219] [pmid 10713164] [evidence TAS]; regulation of development [goid 50793] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]",protein binding [goid 5515] [pmid 10713164] [evidence IPI]; receptor activity [goid 4872] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],9,138508852-138508901,9q34.3d,-,NM_017617.2,4851,NOTCH1,-1.103016615258376,10.203550339260566,-12.682723683413199,2.5631084698306283e-26,2.964316431466544e-25,48.877006580295685
SOLH,ILMN_1763739,"Homo sapiens small optic lobes homolog (Drosophila) (SOLH), mRNA.",intracellular [goid 5622] [evidence IEA],,zinc ion binding [goid 8270] [evidence IEA]; calpain activity [goid 4198] [pmid 9722942] [evidence TAS]; transcription factor activity [goid 3700] [pmid 9722942] [evidence TAS],16,544305-544354,16p13.3f,+,NM_005632.2,6650,SOLH,1.389197226309384,6.957483244596334,12.681263561410185,2.587674684236724e-26,2.990999138198057e-25,48.86749871334508
IFIT3,ILMN_1664543,"Homo sapiens interferon-induced protein with tetratricopeptide repeats 3 (IFIT3), mRNA.",,immune response [goid 6955] [evidence IEA],binding [goid 5488] [evidence IEA],10,91082306-91082355,10q23.31b,+,NM_001031683.1,3437,IFIT3,-1.4989604125914973,7.333538756891683,-12.67996164642999,2.609777574013717e-26,3.0148054099807416e-25,48.859021061491696
C18orf34,ILMN_1673320,"Homo sapiens chromosome 18 open reading frame 34 (C18orf34), mRNA.",,,,18,28771615-28771664,18q12.1e-q12.1f,-,NM_198995.1,374864,C18orf34,-2.4143729328392656,6.155069804384768,-12.678337025346888,2.6376240499057477e-26,3.0452153485582346e-25,48.84844207709804
CD68,ILMN_1714861,"Homo sapiens CD68 antigen (CD68), mRNA.",integral to membrane [goid 16021] [pmid 7680921] [evidence TAS]; membrane [goid 16020] [evidence IEA]; lysosome [goid 5764] [evidence IEA]; membrane fraction [goid 5624] [pmid 7680921] [evidence TAS]; integral to membrane [goid 16021] [pmid 7680921] [evidence TAS]; membrane [goid 16020] [evidence IEA]; lysosome [goid 5764] [evidence IEA]; membrane fraction [goid 5624] [pmid 7680921] [evidence TAS]; membrane fraction [goid 5624] [pmid 7680921] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 7680921] [evidence TAS]; lysosome [goid 5764] [evidence IEA],,,17,7425934-7425983,17p13.1d,+,NM_001251.1,968,CD68,-1.1303129939869248,10.60443306649702,-12.67588103901732,2.6802854030157183e-26,3.0909020370915555e-25,48.83244957759922
PDLIM3,ILMN_1695299,"Homo sapiens PDZ and LIM domain 3 (PDLIM3), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],4,186660434-186660441:186660442-186660483,4q35.1f,-,NM_014476.1,27295,PDLIM3,-1.6714505101761556,9.260126332410607,-12.66705805312932,2.8393148655276817e-26,3.266763187434034e-25,48.77499802140214
LOH11CR2A,ILMN_1682996,"Homo sapiens loss of heterozygosity, 11, chromosomal region 2, gene A (LOH11CR2A), transcript variant 2, mRNA.",,cell cycle [goid 7049] [evidence IEA],,11,123499335-123499371:123499577-123499589,11q24.1c-q24.2a,+,NM_198315.2,4013,LOH11CR2A,-1.0942943190960923,7.353715577432493,-12.666045855328553,2.85815213788754e-26,3.2851843067504917e-25,48.768407073275114
SLC25A10,ILMN_1804090,"Homo sapiens solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 (SLC25A10), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],mitochondrial transport [goid 6839] [evidence IEA]; transport [goid 6810] [evidence IEA]; gluconeogenesis [goid 6094] [pmid 9733776] [evidence TAS]; dicarboxylic acid transport [goid 6835] [pmid 9733776] [evidence TAS],dicarboxylic acid transporter activity [goid 5310] [pmid 9733776] [evidence TAS]; binding [goid 5488] [evidence IEA],17,77298387-77298436,17q25.3f,+,NM_012140.3,1468,SLC25A10,1.4197802859051123,7.708008423481552,12.666021362811676,2.8586094952282116e-26,3.2851843067504917e-25,48.76824758986084
BIK,ILMN_1770505,"Homo sapiens BCL2-interacting killer (apoptosis-inducing) (BIK), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],apoptotic program [goid 8632] [pmid 7478623] [evidence TAS]; regulation of apoptosis [goid 42981] [evidence IEA]; induction of apoptosis [goid 6917] [pmid 10381623] [evidence TAS],protein binding [goid 5515] [pmid 15694340] [evidence IPI],22,41855291-41855340,22q13.2c,+,NM_001197.3,638,BIK,1.491954586959702,6.248632833267418,12.665144532749828,2.8750311402917754e-26,3.300265235511064e-25,48.762538101460585
PDGFRA,ILMN_1681949,"Homo sapiens platelet-derived growth factor receptor, alpha polypeptide (PDGFRA), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8586421] [evidence TAS],cell proliferation [goid 8283] [pmid 10806482] [evidence TAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [pmid 10806482] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; vascular endothelial growth factor receptor activity [goid 5021] [evidence IEA]; platelet-derived growth factor alpha-receptor activity [goid 5018] [pmid 10806482] [evidence TAS],4,54858477-54858526,4q12c,+,NM_006206.3,5156,PDGFRA,-1.177143357360734,8.990997587532927,-12.659142210583282,2.9900065098180446e-26,3.423943301257663e-25,48.723454154738214
EPHA1,ILMN_1664265,"Homo sapiens EPH receptor A1 (EPHA1), mRNA.",integral to plasma membrane [goid 5887] [pmid 2825356] [evidence TAS]; membrane [goid 16020] [evidence IEA],transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; signal transduction [goid 7165] [pmid 2825356] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; ephrin receptor activity [goid 5003] [evidence IEA],7,142798521-142798570,7q34f-q35a,-,NM_005232.3,2041,EPHA1,1.15880304911916,7.900858033224266,12.655515491429206,3.0616932867500974e-26,3.502479089839677e-25,48.699839082633815
C6orf26,ILMN_2134765,"Homo sapiens chromosome 6 open reading frame 26 (C6orf26), mRNA.",,,,6,31840198-31840247,6p21.33a,+,NM_001039651.1,401251,C6orf26,1.0083210540258998,5.952534760627405,12.652601283256752,3.1205396050876e-26,3.5677575096338683e-25,48.68086357823311
LOC654342,ILMN_1717060,"PREDICTED: Homo sapiens similar to lymphocyte-specific protein 1 isoform 1 (LOC654342), mRNA.",,,,2,91188289-91188338,2p11.1d,-,XM_946374.1,654342,LOC654342,1.2232024430562518,5.881790931903082,12.647462818477862,3.2270684436790914e-26,3.68323932807366e-25,48.64740535260395
AMD1,ILMN_1667994,"Homo sapiens adenosylmethionine decarboxylase 1 (AMD1), transcript variant 1, mRNA.",,spermidine biosynthesis [goid 8295] [evidence NAS]; spermine biosynthesis [goid 6597] [evidence NAS],lyase activity [goid 16829] [evidence IEA]; adenosylmethionine decarboxylase activity [goid 4014] [pmid 2460457] [evidence TAS],6,111316805-111316854,6q21h,+,NM_001634.4,262,AMD1,-1.0633799172333802,8.985191501134446,-12.643694456301317,3.3074968822879504e-26,3.766442664816011e-25,48.622868518328495
RNU101A,ILMN_1716441,"Homo sapiens small nucleolar RNA, C/D box 4A (SNORD4A) on chromosome 17.",,,,17,24073749-24073798,17q11.2a,+,NR_000010.1,26773,RNU101A,1.2336342021319,6.118908478382433,12.643501546815157,3.3116676683636667e-26,3.7690470255187853e-25,48.62161243674673
ROR1,ILMN_1655904,"Homo sapiens receptor tyrosine kinase-like orphan receptor 1 (ROR1), mRNA.",integral to plasma membrane [goid 5887] [pmid 1334494] [evidence TAS]; plasma membrane [goid 5886] [pmid 8875995] [evidence TAS]; cytoplasm [goid 5737] [pmid 8875995] [evidence TAS],transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 1334494] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; transmembrane receptor protein tyrosine kinase activity [goid 4714] [pmid 8875995] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; kinase activity [goid 16301] [evidence IEA],1,64416902-64416951,1p31.3c,+,NM_005012.1,4919,ROR1,-1.3285413980804108,6.856626206859578,-12.63935251317763,3.402655366722495e-26,3.8682004873513457e-25,48.594597160320724
IGFBP7,ILMN_2062468,"Homo sapiens insulin-like growth factor binding protein 7 (IGFBP7), mRNA.",extracellular region [goid 5576] [evidence IEA],regulation of cell growth [goid 1558] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 8939990] [evidence TAS],insulin-like growth factor binding [goid 5520] [evidence IEA],4,57594170-57594219,4q12e,-,NM_001553.1,3490,IGFBP7,-1.4975842775580883,12.42530365930633,-12.633761835110231,3.529223588633246e-26,4.009807243689608e-25,48.55819536074824
TAF13,ILMN_2061318,"Homo sapiens TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa (TAF13), mRNA.",nucleus [goid 5634] [evidence IEA]; transcription factor TFIID complex [goid 5669] [pmid 7729427] [evidence TAS]; nucleus [goid 5634] [evidence IEA]; transcription factor TFIID complex [goid 5669] [pmid 7729427] [evidence TAS],"transcription initiation [goid 6352] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription initiation [goid 6352] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [pmid 9695952] [evidence TAS]; general RNA polymerase II transcription factor activity [goid 16251] [pmid 7729427] [evidence TAS]; protein binding [goid 5515] [pmid 7729427] [evidence TAS]; transcription factor activity [goid 3700] [pmid 9695952] [evidence TAS]; general RNA polymerase II transcription factor activity [goid 16251] [pmid 7729427] [evidence TAS]; protein binding [goid 5515] [pmid 7729427] [evidence TAS],1,109419200-109419210:109420066-109420092:109420093-109420104,1p13.3b,-,NM_005645.3,6884,TAF13,1.0969387643704671,6.198692315354477,12.633131063279594,3.5437960311888063e-26,4.02407894392881e-25,48.55408832941056
HHEX,ILMN_1762712,"Homo sapiens hematopoietically expressed homeobox (HHEX), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [pmid 1360645] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 8096636] [evidence TAS]",transcription factor activity [goid 3700] [pmid 10871399] [evidence TAS],10,94445134-94445183,10q23.33a,+,NM_002729.2,3087,HHEX,-1.5016144098528308,7.712314509055947,-12.630829066287681,3.5974903114528954e-26,4.0827331906721234e-25,48.53909979322423
PBK,ILMN_1673673,"Homo sapiens PDZ binding kinase (PBK), mRNA.",cellular component unknown [goid 8372] [evidence ND ],mitosis [goid 7067] [pmid 10779557] [evidence NAS]; protein amino acid phosphorylation [goid 6468] [evidence NAS],nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 12620389] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 10779557] [evidence TAS]; ATP binding [goid 5524] [evidence NAS]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],8,27723197-27723246,8p21.1e,-,NM_018492.2,55872,PBK,1.3738995372543625,5.7176502663059985,12.625254579247462,3.7309096890496233e-26,4.231748359325672e-25,48.50280402688704
C10orf38,ILMN_1749868,"Homo sapiens chromosome 10 open reading frame 38 (C10orf38), mRNA.",,,,10,15293996-15294045,10p13c-p13b,-,NM_001010924.1,221061,C10orf38,-1.3399501658167026,9.152258930456737,-12.618969876048308,3.887269235413923e-26,4.4016119333424885e-25,48.46188449828625
GPR110,ILMN_1744299,"Homo sapiens G protein-coupled receptor 110 (GPR110), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 15203201] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 15203201] [evidence TAS],neuropeptide signaling pathway [goid 7218] [evidence IEA]; signal transduction [goid 7165] [evidence IEA]; neuropeptide signaling pathway [goid 7218] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 15203201] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 15203201] [evidence TAS],6,47084690-47084739,6p12.3e,-,NM_153840.2,266977,GPR110,1.7387686564054734,6.1272115096298405,12.603463059330936,4.301671621342613e-26,4.857101907439221e-25,48.360922334747954
KIAA0415,ILMN_2083559,"Homo sapiens KIAA0415 (KIAA0415), mRNA.",,,,7,4797531-4797542:4797543-4797580,7p22.1d,+,NM_014855.1,9907,KIAA0415,1.1435056110861481,6.972151214889214,12.588215976338516,4.7521710819138254e-26,5.359720349883417e-25,48.26165455319545
APIP,ILMN_1793598,"Homo sapiens APAF1 interacting protein (APIP), mRNA.",,apoptosis [goid 6915] [evidence IEA]; apoptosis [goid 6915] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],11,34866504-34866551:34866875-34866876,11p13b,-,NM_015957.1,51074,APIP,-1.024055293491224,8.25479739361688,-12.581426740111588,4.967664879104972e-26,5.599607825415903e-25,48.21745358996976
UNQ830,ILMN_1774265,"Homo sapiens ASCL830 (UNQ830), mRNA.",,,,2,233449250-233449299,2q37.1c,+,NM_206895.1,389084,UNQ830,1.2535446970848696,6.001172840510597,12.580810299107188,4.987708309214849e-26,5.619035351957809e-25,48.21344031750826
LOC653879,ILMN_1713182,"PREDICTED: Homo sapiens similar to Complement C3 precursor (LOC653879), mRNA.",,,,,,,,XM_936226.1,653879,LOC653879,-1.692208717546844,9.873382106409709,-12.580538572706383,4.996569082486666e-26,5.625849983252291e-25,48.21167127399086
COMP,ILMN_1677636,"Homo sapiens cartilage oligomeric matrix protein (COMP), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 7713493] [evidence TAS],skeletal development [goid 1501] [pmid 7670472] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA],extracellular matrix structural constituent [goid 5201] [pmid 7713493] [evidence TAS]; calcium ion binding [goid 5509] [pmid 7670472] [evidence TAS]; protein binding [goid 5515] [evidence IEA],19,18754711-18754724:18754725-18754760,19p13.11b,-,NM_000095.2,1311,COMP,3.4766300074641103,8.276172758165476,12.572985843899612,5.249256321010417e-26,5.903716721235324e-25,48.162500548648644
IGSF4C,ILMN_1812096,"Homo sapiens immunoglobulin superfamily, member 4C (IGSF4C), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA],19,48818486-48818535,19q13.31a,-,NM_145296.1,199731,IGSF4C,1.303902896987073,6.598599352658841,12.569442710162182,5.372160668472273e-26,6.035159497742461e-25,48.139433894755975
LENG4,ILMN_1722218,"Homo sapiens leukocyte receptor cluster (LRC) member 4 (LENG4), mRNA.",,,receptor activity [goid 4872] [evidence IEA],19,59369210-59369259,19q13.42a,-,NM_024298.2,79143,LENG4,1.0302177378930661,9.5470643065541,12.569077111682759,5.385005170264144e-26,6.046194357275252e-25,48.13705377167382
FAM105A,ILMN_1695711,"Homo sapiens family with sequence similarity 105, member A (FAM105A), mRNA.",,,,5,14663400-14663423:14663424-14663449,5p15.2a,+,NM_019018.1,54491,FAM105A,-1.412219551711635,6.749123047048836,-12.567993587174321,5.423253047871201e-26,6.08231205054972e-25,48.1299998111859
HLA-DRA,ILMN_1689655,"Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA.",plasma membrane [goid 5886] [pmid 8890155] [evidence IDA]; lysosome [goid 5764] [pmid 8890155] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 6812963] [evidence NAS]; membrane [goid 16020] [evidence IEA]; plasma membrane [goid 5886] [pmid 8890155] [evidence IDA]; lysosome [goid 5764] [pmid 8890155] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 6812963] [evidence NAS]; membrane [goid 16020] [evidence IEA],immune response [goid 6955] [pmid 6812963] [evidence NAS]; immune response [goid 6955] [pmid 6812963] [evidence NAS],MHC class II receptor activity [goid 45012] [pmid 6812963] [evidence NAS]; MHC class II receptor activity [goid 45012] [pmid 6812963] [evidence NAS],6,32519563-32519612,6p21.32b,+,NM_019111.3,3122,HLA-DRA,-1.001134789623956,14.419038363960901,-12.565371650139705,5.516933663708359e-26,6.183910853976293e-25,48.11293055439655
SLC4A2,ILMN_2078389,"Homo sapiens solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1) (SLC4A2), mRNA.",membrane fraction [goid 5624] [pmid 3015590] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],anion transport [goid 6820] [pmid 3015590] [evidence TAS],antiporter activity [goid 15297] [evidence IEA]; anion transporter activity [goid 8509] [pmid 3015590] [evidence TAS]; inorganic anion exchanger activity [goid 5452] [evidence IEA],7,150403753-150403795:150404033-150404039,7q36.1d,+,NM_003040.2,6522,SLC4A2,1.0333209566311865,8.996688356154822,12.561888322457609,5.643898453900588e-26,6.315610753112022e-25,48.09025366482922
MATN2,ILMN_1694840,"Homo sapiens matrilin 2 (MATN2), transcript variant 2, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 11124542] [evidence NAS],,calcium ion binding [goid 5509] [evidence IEA],8,99117381-99117430,8q22.1e-q22.2a,+,NM_030583.2,4147,MATN2,-1.5225845830867524,7.348748627569966,-12.56031693334634,5.702126595147047e-26,6.37363960422917e-25,48.08002379221842
GLT25D2,ILMN_1736742,"Homo sapiens glycosyltransferase 25 domain containing 2 (GLT25D2), mRNA.",,lipopolysaccharide biosynthesis [goid 9103] [evidence IEA],transferase activity [goid 16740] [evidence IEA],1,182171897-182171946,1q25.3e,-,NM_015101.1,23127,GLT25D2,-1.6459651497711105,6.266690539041046,-12.55948073995326,5.733356346717968e-26,6.401394742473946e-25,48.07458012033155
LOC613037,ILMN_2070052,Homo sapiens nuclear pore complex interacting protein pseudogene (LOC613037) on chromosome 16.,,,,16,30142001-30142050,16p11.2d,-,NR_002555.2,613037,LOC613037,1.5962309783665418,11.711497373320388,12.549965035251878,6.101020272655142e-26,6.796726815995773e-25,48.01263307257515
HBG2,ILMN_2084825,"Homo sapiens hemoglobin, gamma G (HBG2), mRNA.",hemoglobin complex [goid 5833] [evidence IEA],transport [goid 6810] [evidence IEA]; oxygen transport [goid 15671] [evidence IEA],heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxygen transporter activity [goid 5344] [evidence IEA]; binding [goid 5488] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [evidence IEA],11,5231114-5231163,11p15.4c,-,NM_000184.2,3048,HBG2,-2.9140111733326837,6.464966561154306,-12.545849502776107,6.267249761130173e-26,6.974145340416713e-25,47.985841494997416
C20orf102,ILMN_1715927,"Homo sapiens chromosome 20 open reading frame 102 (C20orf102), mRNA.",,,,20,36006935-36006984,20q11.23b,+,NM_080607.1,128434,C20orf102,2.420370209217837,7.591368568042935,12.533078915818493,6.812441395233683e-26,7.568202522811523e-25,47.90270844221785
NOXA1,ILMN_1799589,"Homo sapiens NADPH oxidase activator 1 (NOXA1), mRNA.",,,binding [goid 5488] [evidence IEA],9,139448520-139448569,9q34.3f,+,NM_006647.1,10811,NOXA1,1.1402830630254615,7.9246369226209525,12.51819050923937,7.50818525451735e-26,8.322646569107098e-25,47.805792482659676
LOC646897,ILMN_1693225,"PREDICTED: Homo sapiens hypothetical protein LOC646897 (LOC646897), mRNA.",,,,15,76230663-76230712,,+,XM_929859.1,646897,LOC646897,1.6837043596750778,6.696177183983826,12.516026647471683,7.615051606912707e-26,8.427099145525966e-25,47.791707166000734
RNF122,ILMN_1691119,"Homo sapiens ring finger protein 122 (RNF122), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],8,33524873-33524922,8p12c,-,NM_024787.2,79845,RNF122,-1.1729940229057547,6.82875469479837,-12.50993521166427,7.924124368410726e-26,8.754604106193363e-25,47.752056375421404
FAM82C,ILMN_1727309,"Homo sapiens family with sequence similarity 82, member C (FAM82C), mRNA.",,,binding [goid 5488] [evidence IEA],15,38815706-38815755,15q15.1b,-,NM_018145.1,55177,FAM82C,-1.1085107776148213,9.951825315645644,-12.505878962472908,8.136858527409575e-26,8.979716790756247e-25,47.72565353226329
NKD2,ILMN_1731206,"Homo sapiens naked cuticle homolog 2 (Drosophila) (NKD2), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],5,1091714-1091763,5p15.33d,+,NM_033120.2,85409,NKD2,-1.265705549550189,10.349523970689068,-12.505662335985988,8.148378980515762e-26,8.987473354033041e-25,47.72424348058217
C14orf82,ILMN_1690443,"PREDICTED: Homo sapiens chromosome 14 open reading frame 82 (C14orf82), mRNA.",,,,,,14q22.1c,,XM_944991.1,145438,C14orf82,2.3510225587239946,7.90708235859642,12.502834090660974,8.300293115572271e-26,9.149987033408815e-25,47.70583412048891
JAM3,ILMN_1769575,"Homo sapiens junctional adhesion molecule 3 (JAM3), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,11,133526711-133526760,11q25d,+,NM_032801.3,83700,JAM3,-1.020083878385778,9.960799470433686,-12.501819799896879,8.355460966158662e-26,9.20573034201005e-25,47.699232026054496
MAP1LC3C,ILMN_1711331,"Homo sapiens microtubule-associated protein 1 light chain 3 gamma (MAP1LC3C), mRNA.",membrane [goid 16020] [evidence IEA]; microtubule [goid 5874] [evidence IEA],ubiquitin cycle [goid 6512] [evidence IEA]; autophagy [goid 6914] [evidence IEA],,1,240225931-240225980,1q43e,-,NM_001004343.1,440738,MAP1LC3C,-1.4944348115816881,6.4520093286139595,-12.497560091277629,8.591179638098222e-26,9.455023223271135e-25,47.671505471659486
BLZF1,ILMN_2106656,"Homo sapiens basic leucine zipper nuclear factor 1 (JEM-1) (BLZF1), mRNA.",nucleus [goid 5634] [pmid 9129147] [evidence NAS]; cytoplasm [goid 5737] [pmid 11056056] [evidence NAS]; nucleus [goid 5634] [pmid 9129147] [evidence NAS]; cytoplasm [goid 5737] [pmid 11056056] [evidence NAS],protein transport [goid 15031] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 9129147] [evidence TAS]; cell proliferation [goid 8283] [pmid 9129147] [evidence TAS]; regulation of cell growth [goid 1558] [pmid 9129147] [evidence NAS]; protein transport [goid 15031] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 9129147] [evidence TAS]; cell proliferation [goid 8283] [pmid 9129147] [evidence TAS]; regulation of cell growth [goid 1558] [pmid 9129147] [evidence NAS],transcription factor activity [goid 3700] [pmid 9129147] [evidence NAS]; transcription factor activity [goid 3700] [pmid 9129147] [evidence NAS],1,167632109-167632158,1q24.2b,+,NM_003666.2,8548,BLZF1,2.15084633654671,11.054649602166714,12.49311911033437,8.844010239242766e-26,9.727925061394682e-25,47.64259937067919
SLC39A8,ILMN_1695316,"Homo sapiens solute carrier family 39 (zinc transporter), member 8 (SLC39A8), mRNA.",membrane [goid 16020] [evidence IEA],metal ion transport [goid 30001] [evidence IEA],metal ion transporter activity [goid 46873] [evidence IEA],4,103402447-103402496,4q24a,-,NM_022154.5,64116,SLC39A8,-2.1179013143713803,9.376880641331061,-12.491241907368288,8.953105775989844e-26,9.837108202416519e-25,47.63038087101784
DKK2,ILMN_1695506,"Homo sapiens dickkopf homolog 2 (Xenopus laevis) (DKK2), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 10570958] [evidence TAS]; extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 10570958] [evidence TAS],Wnt receptor signaling pathway [goid 16055] [evidence IEA]; development [goid 7275] [evidence IEA]; negative regulation of Wnt receptor signaling pathway [goid 30178] [evidence IEA]; Wnt receptor signaling pathway [goid 16055] [evidence IEA]; development [goid 7275] [evidence IEA]; negative regulation of Wnt receptor signaling pathway [goid 30178] [evidence IEA],,4,108063211-108063260,4q25a,-,NM_014421.2,27123,DKK2,-1.3574866087216275,5.551587498321419,-12.489387536848113,9.062195173320898e-26,9.951503898342729e-25,47.6183110504909
REEP6,ILMN_1697460,"Homo sapiens receptor accessory protein 6 (REEP6), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,19,1448755-1448804,19p13.3h,+,NM_138393.1,92840,REEP6,1.8778054976641139,7.740404670181972,12.486205929208667,9.252468267530282e-26,1.0149308393461945e-24,47.59760259407111
NNAT,ILMN_1691413,"Homo sapiens neuronatin (NNAT), transcript variant 1, mRNA.",,brain development [goid 7420] [pmid 8813377] [evidence TAS]; development [goid 7275] [evidence IEA]; protein-lipoylation [goid 9249] [pmid 8813377] [evidence TAS]; brain development [goid 7420] [pmid 8813377] [evidence TAS]; development [goid 7275] [evidence IEA]; protein-lipoylation [goid 9249] [pmid 8813377] [evidence TAS],auxiliary transport protein activity [goid 15457] [pmid 8813377] [evidence TAS]; auxiliary transport protein activity [goid 15457] [pmid 8813377] [evidence TAS],20,35585280-35585329,20q11.23b,+,NM_005386.2,4826,NNAT,-1.2348748796877755,6.01642659069832,-12.481886822787123,9.517175012481385e-26,1.0433952747930276e-24,47.569490692271444
ZNF322A,ILMN_1749342,"Homo sapiens zinc finger protein 322A (ZNF322A), mRNA.",intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],6,26766818-26766853:26767648-26767661,6p22.1d,-,NM_024639.2,79692,ZNF322A,1.067511883991128,6.330028821985921,12.472866635750375,1.0094666772931369e-25,1.1054958554614715e-24,47.51078188631802
PCDHB9,ILMN_2047885,"Homo sapiens protocadherin beta 9 (PCDHB9), mRNA.",integral to membrane [goid 16021] [pmid 11322959] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 11322959] [evidence NAS]; membrane [goid 16020] [evidence IEA],calcium-dependent cell-cell adhesion [goid 16339] [pmid 11322959] [evidence NAS]; synaptogenesis [goid 7416] [pmid 12231349] [evidence TAS]; synaptic transmission [goid 7268] [pmid 12231349] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; homophilic cell adhesion [goid 7156] [evidence IEA]; calcium-dependent cell-cell adhesion [goid 16339] [pmid 11322959] [evidence NAS]; synaptogenesis [goid 7416] [pmid 12231349] [evidence TAS]; synaptic transmission [goid 7268] [pmid 12231349] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; homophilic cell adhesion [goid 7156] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [pmid 11322959] [evidence NAS]; calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [pmid 11322959] [evidence NAS],5,140550934-140550983,5q31.3b,+,NM_019119.3,56127,PCDHB9,2.3919898412743272,8.728458476224361,12.47142674658753,1.0190040095442397e-25,1.1147201871493247e-24,47.501410368492685
HCST,ILMN_1699931,"Homo sapiens hematopoietic cell signal transducer (HCST), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,19,41086896-41086902:41086903-41086945,19q13.12a,+,NM_014266.3,10870,HCST,-1.181928802798657,9.906114914198966,-12.466843981815208,1.049962366565465e-25,1.1473318967909244e-24,47.47158371967325
CENPM,ILMN_2368718,"Homo sapiens centromere protein M (CENPM), transcript variant 2, mRNA.","chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromosome, pericentric region [goid 775] [evidence IEA]; chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; chromosome, pericentric region [goid 775] [evidence IEA]",,,22,40664776-40664825,22q13.2b,-,NM_001002876.1,79019,CENPM,1.173229601411328,6.684792868584561,12.452170459880055,1.1555546529626788e-25,1.2620271559212488e-24,47.37608482411822
LOC648059,ILMN_1768392,"PREDICTED: Homo sapiens hypothetical protein LOC648059 (LOC648059), mRNA.",,,,,,,,XM_937109.1,648059,LOC648059,2.08334538588797,7.431435322101297,12.44396253221336,1.2191833372726312e-25,1.3300665328326502e-24,47.32266753353767
LOC644354,ILMN_1738648,"PREDICTED: Homo sapiens similar to Apoptosis-related protein 2 (APR-2) (LOC644354), mRNA.",,,,17,41774285-41774334,17q21.31d,-,XM_930138.1,644354,LOC644354,1.6470749077791549,6.296352198492358,12.443876809366825,1.2198660224122181e-25,1.3300860695598726e-24,47.32210965564092
PGCP,ILMN_1713031,"Homo sapiens plasma glutamate carboxypeptidase (PGCP), mRNA.",extracellular space [goid 5615] [pmid 10206990] [evidence TAS]; cytoplasm [goid 5737] [pmid 10206990] [evidence TAS]; extracellular space [goid 5615] [pmid 10206990] [evidence TAS]; cytoplasm [goid 5737] [pmid 10206990] [evidence TAS],peptide metabolism [goid 6518] [pmid 10206990] [evidence TAS]; peptide metabolism [goid 6518] [pmid 10206990] [evidence TAS],peptidase activity [goid 8233] [evidence IEA]; carboxypeptidase activity [goid 4180] [evidence IEA]; glutamate carboxypeptidase II activity [goid 43275] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; carboxypeptidase activity [goid 4180] [evidence IEA]; glutamate carboxypeptidase II activity [goid 43275] [evidence IEA],8,98147487-98147536,8q22.1d-q22.1e,+,NM_016134.2,10404,PGCP,-1.1017173801294025,8.727762190958467,-12.440641221011255,1.2459151478693793e-25,1.3577489258480686e-24,47.301052800588465
ZMYND15,ILMN_1778136,"Homo sapiens zinc finger, MYND-type containing 15 (ZMYND15), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],17,4596022-4596034:4596035-4596071,17p13.2c,+,NM_032265.1,84225,ZMYND15,-1.109019700945379,8.40986440287272,-12.439912551445223,1.2518578252245596e-25,1.3634823825309192e-24,47.296310729182565
RDH13,ILMN_1660723,"Homo sapiens retinol dehydrogenase 13 (all-trans/9-cis) (RDH13), mRNA.",,metabolism [goid 8152] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA],19,60247666-60247715,19q13.42b,-,NM_138412.2,112724,RDH13,1.297123227278365,8.473689443695026,12.428289128394164,1.3505761978096372e-25,1.4686048133573489e-24,47.22066877679295
PTPRO,ILMN_1720113,"Homo sapiens protein tyrosine phosphatase, receptor type, O (PTPRO), transcript variant 6, mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7665166] [evidence TAS]; integral to membrane [goid 16021] [pmid 10498613] [evidence TAS],protein amino acid dephosphorylation [goid 6470] [pmid 10498613] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; transmembrane receptor protein tyrosine phosphatase activity [goid 5001] [pmid 7665166] [evidence TAS]; protein tyrosine phosphatase activity [goid 4725] [pmid 10498613] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA],12,15641552-15641601,12p12.3e,+,NM_030670.1,5800,PTPRO,-1.2048972339456796,7.0084245234264,-12.418677181321137,1.4380628904837028e-25,1.562887686735357e-24,47.15811914685826
ARSE,ILMN_1727462,"Homo sapiens arylsulfatase E (chondrodysplasia punctata 1) (ARSE), mRNA.",,metabolism [goid 8152] [evidence IEA]; skeletal development [goid 1501] [pmid 7720070] [evidence TAS],hydrolase activity [goid 16787] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; arylsulfatase activity [goid 4065] [pmid 9192838] [evidence TAS],X,2862991-2863040,Xp22.33c-p22.33b,-,NM_000047.1,415,ARSE,1.6781473739764143,6.214935130889369,12.416223806326657,1.4612864734896247e-25,1.5872649164810213e-24,47.14215416354615
TRK1,ILMN_1776125,Homo sapiens tRNA lysine 1 (TRK1) on chromosome 17.,,,,11,,,-,NR_001449.1,7206,TRK1,-1.5743274659268858,6.344148954483989,-12.409476588973117,1.5271069414391717e-25,1.6560626387162576e-24,47.098248311510595
UST,ILMN_1700024,"Homo sapiens uronyl-2-sulfotransferase (UST), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 10187838] [evidence TAS],protein amino acid sulfation [goid 6477] [pmid 10187838] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; sulfotransferase activity [goid 8146] [pmid 10187838] [evidence TAS],6,149439344-149439393,6q25.1a,+,NM_005715.1,10090,UST,-1.4267054954451064,7.163898732714545,-12.407878595383238,1.5431248626417922e-25,1.6725266658579077e-24,47.08784991182811
BMP5,ILMN_1660552,"Homo sapiens bone morphogenetic protein 5 (BMP5), mRNA.",extracellular space [goid 5615] [evidence IEA],ossification [goid 1503] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; growth [goid 40007] [evidence IEA]; cartilage development [goid 51216] [evidence IEA],cytokine activity [goid 5125] [evidence NAS]; growth factor activity [goid 8083] [evidence IEA],6,55731840-55731872:55733214-55733230,6p12.1b,-,NM_021073.2,653,BMP5,-1.4408719935291447,6.800356236863569,-12.40481781482198,1.5742758295892586e-25,1.705366042145202e-24,47.067933084373145
BCMO1,ILMN_1814686,"Homo sapiens beta-carotene 15,15'-monooxygenase 1 (BCMO1), mRNA.",,,"oxidoreductase activity [goid 16491] [evidence IEA]; beta-carotene 15,15'-monooxygenase activity [goid 3834] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]",16,79882169-79882218,16q23.2b,+,NM_017429.2,53630,BCMO1,1.6078008167291014,5.8188359556401235,12.4031779596942,1.591223184085838e-25,1.7227918542851434e-24,47.057262458443546
LOC653509,ILMN_1678533,"PREDICTED: Homo sapiens similar to surfactant, pulmonary-associated protein A1, transcript variant 1 (LOC653509), mRNA.",,,,10,81044828-81044877,10q22.3e,+,XM_930304.1,653509,LOC653509,-1.4972493913625406,9.485509961422945,-12.401530056974405,1.6084374198888673e-25,1.7395468052506192e-24,47.04653952801171
NOTCH4,ILMN_1711157,"Homo sapiens Notch homolog 4 (Drosophila) (NOTCH4), mRNA.",integral to plasma membrane [goid 5887] [pmid 11823422] [evidence TAS]; nucleus [goid 5634] [pmid 8681805] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; cell surface [goid 9986] [pmid 11823422] [evidence IDA],"mammary gland development [goid 30879] [pmid 9576833] [evidence IDA]; regulation of development [goid 50793] [evidence IEA]; Notch signaling pathway [goid 7219] [evidence ISS]; hemopoiesis [goid 30097] [pmid 11532344] [evidence TAS]; cell fate determination [goid 1709] [pmid 11823422] [evidence TAS]; patterning of blood vessels [goid 1569] [evidence ISS]; positive regulation of transcription, DNA-dependent [goid 45893] [pmid 11823422] [evidence TAS]; transcription [goid 6350] [evidence IEA]; embryonic development [goid 9790] [evidence ISS]; cell differentiation [goid 30154] [pmid 11823422] [evidence NAS]; negative regulation of endothelial cell differentiation [goid 45602] [evidence ISS]",protein heterodimerization activity [goid 46982] [pmid 8681805] [evidence TAS]; protein binding [goid 5515] [pmid 7671825] [evidence IPI]; receptor activity [goid 4872] [pmid 11823422] [evidence TAS]; calcium ion binding [goid 5509] [pmid 11823422] [evidence TAS],6,32270714-32270763,6p21.32b,-,NM_004557.3,4855,NOTCH4,-1.3121035851683853,8.45574545950844,-12.400726901863498,1.61689464449063e-25,1.7477486789286075e-24,47.04131340678074
ADFP,ILMN_1801077,"Homo sapiens adipose differentiation-related protein (ADFP), mRNA.",membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [pmid 9003395] [evidence TAS]; endoplasmic reticulum [goid 5783] [pmid 9003395] [evidence TAS]; lipid particle [goid 5811] [pmid 9003395] [evidence TAS],,,9,19106260-19106309,9p22.1b,-,NM_001122.2,123,ADFP,-1.2811830155152641,10.17141256118983,-12.398247596977974,1.6432831490032703e-25,1.7753136741499693e-24,47.025180690997985
A2M,ILMN_1745607,"Homo sapiens alpha-2-macroglobulin (A2M), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],intracellular protein transport [goid 6886] [evidence NR ]; protein homooligomerization [goid 51260] [evidence NAS],serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; tumor necrosis factor binding [goid 43120] [pmid 9714181] [evidence IDA]; interleukin-8 binding [goid 19959] [pmid 10880251] [evidence IPI]; interleukin-1 binding [goid 19966] [pmid 9714181] [evidence IDA]; wide-spectrum protease inhibitor activity [goid 17114] [evidence IEA]; protein carrier activity [goid 8320] [evidence NR ]; enzyme binding [goid 19899] [pmid 11435418] [evidence IPI],12,9111650-9111685:9111686-9111699,12p13.31a,-,NM_000014.4,2,A2M,-1.3517672026889098,12.213302332395665,-12.393063122118587,1.699863703647594e-25,1.8354491625785786e-24,46.99144602330901
SRPX2,ILMN_1676213,"Homo sapiens sushi-repeat-containing protein, X-linked 2 (SRPX2), mRNA.",,,,X,99812607-99812640:99812641-99812656,Xq22.1b,+,NM_014467.1,27286,SRPX2,1.8987167014222104,8.006660621805842,12.387790434075052,1.7594046236925698e-25,1.8976909817164924e-24,46.95713800392582
FLJ46109,ILMN_2246548,Homo sapiens glutathione S-transferase theta pseudogene (FLJ46109) on chromosome 22. XM_941198 XM_945014 XM_945016,,,,,,22q11.23b,,NR_003082.1,653399,FLJ46109,2.347057245876588,8.70285145609864,12.381939660878574,1.8279165198252523e-25,1.9694643903426845e-24,46.91906929631196
FBXL20,ILMN_1754489,"Homo sapiens F-box and leucine-rich repeat protein 20 (FBXL20), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],transferase activity [goid 16740] [evidence IEA],17,34670485-34670534,17q12c,-,NM_032875.1,84961,FBXL20,1.0877043712292567,8.164962809279482,12.381752600114533,1.8301504306798994e-25,1.9708100009172996e-24,46.91785217793937
CD83,ILMN_1780582,"Homo sapiens CD83 antigen (activated B lymphocytes, immunoglobulin superfamily) (CD83), mRNA.",integral to plasma membrane [goid 5887] [pmid 8422464] [evidence TAS]; plasma membrane [goid 5886] [pmid 9310491] [evidence TAS],humoral immune response [goid 6959] [pmid 8422464] [evidence TAS]; signal transduction [goid 7165] [pmid 9310491] [evidence TAS]; defense response [goid 6952] [pmid 1378080] [evidence TAS],,6,14244566-14244615,6p23b,+,NM_004233.2,9308,CD83,-1.457286558392484,9.569083743202489,-12.376819499292548,1.8900574901275484e-25,2.034226479960839e-24,46.885755059474604
KLRB1,ILMN_2079655,"Homo sapiens killer cell lectin-like receptor subfamily B, member 1 (KLRB1), mRNA.",plasma membrane [goid 5886] [pmid 8077657] [evidence TAS],cell surface receptor linked signal transduction [goid 7166] [pmid 8077657] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 8077657] [evidence TAS],sugar binding [goid 5529] [pmid 8077657] [evidence TAS]; transmembrane receptor activity [goid 4888] [pmid 8077657] [evidence TAS],12,9642375-9642424,12p13.31a,-,NM_002258.2,3820,KLRB1,-1.5762006296490876,8.673681342063848,-12.371640631597488,1.9550592244454737e-25,2.1030551055217765e-24,46.85205949017432
CCDC5,ILMN_1745946,"Homo sapiens coiled-coil domain containing 5 (spindle associated) (CCDC5), mRNA.",microtubule [goid 5874] [evidence IEA],mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],,18,41938351-41938375:41938376-41938400,18q21.1a,+,NM_138443.2,115106,CCDC5,-1.1258712822522208,6.371047482723022,-12.363993924262248,2.0551431570115339e-25,2.2095273662271237e-24,46.802308457426825
GUCY1B2,ILMN_1652166,"Homo sapiens guanylate cyclase 1, soluble, beta 2 (GUCY1B2), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA]; cGMP biosynthesis [goid 6182] [evidence IEA],metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; guanylate cyclase activity [goid 4383] [evidence IEA],13,50466844-50466893,13q14.3b,-,NM_004129.2,2974,GUCY1B2,1.6209421906607036,5.8991058208112195,12.35585303582177,2.167329501141191e-25,2.3251436278194612e-24,46.749343755810635
LOC402560,ILMN_1769288,"PREDICTED: Homo sapiens hypothetical LOC402560 (LOC402560), mRNA.",,,,,,,,XM_944321.1,402560,LOC402560,-1.1964141023250034,6.421838360697524,-12.353392417301185,2.2024280284802613e-25,2.3615316181046657e-24,46.733335270090976
XAGE1,ILMN_1691494,"Homo sapiens X antigen family, member 1D (XAGE1D), transcript variant 3, mRNA.",,,,X,52547661-52547710,Xp11.22b,-,NM_133430.1,9503,XAGE1,2.4112041702652185,6.3784249401218744,12.336812805367504,2.454199179402458e-25,2.630081263068258e-24,46.625474297795286
FLJ46309,ILMN_2194852,"Homo sapiens hypothetical protein LOC649598 (FLJ46309), mRNA.",,,,9,35175670-35175719,9p13.3b,+,NM_001039797.1,649598,FLJ46309,1.5648924723278732,13.236654964685803,12.336336082321806,2.4618490520719754e-25,2.6368670146603898e-24,46.6223730131971
ITPR1,ILMN_1789505,"Homo sapiens inositol 1,4,5-triphosphate receptor, type 1 (ITPR1), mRNA.",endoplasmic reticulum membrane [goid 5789] [evidence NAS]; endoplasmic reticulum [goid 5783] [pmid 8648241] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8132516] [evidence TAS],calcium ion transport [goid 6816] [pmid 7852357] [evidence NAS]; signal transduction [goid 7165] [pmid 8648241] [evidence NAS]; ion transport [goid 6811] [evidence IEA],"protein binding [goid 5515] [pmid 15652484] [evidence IPI]; calcium channel activity [goid 5262] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA]; inositol 1,4,5-triphosphate-sensitive calcium-release channel activity [goid 5220] [evidence IEA]; inositol-1,4,5-triphosphate receptor activity [goid 8095] [pmid 8648241] [evidence TAS]; ion channel activity [goid 5216] [evidence IEA]; calcium ion transporter activity [goid 15085] [pmid 7500840] [evidence TAS]",3,4863464-4863513,3p26.2a,+,NM_002222.1,3708,ITPR1,-1.2435369202908904,8.071594825599757,-12.330041769543257,2.56511584079396e-25,2.7460052296739193e-24,46.58142640221472
ZNF577,ILMN_1667322,"Homo sapiens zinc finger protein 577 (ZNF577), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],19,57066814-57066863,19q13.33e,-,NM_032679.1,84765,ZNF577,1.4293270236328786,8.057147937990136,12.328860576486074,2.5849720246180147e-25,2.7657818325431676e-24,46.57374246056627
PDE8B,ILMN_2301722,"Homo sapiens phosphodiesterase 8B (PDE8B), transcript variant 3, mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; two-component signal transduction system (phosphorelay) [goid 160] [evidence IEA]; cyclic nucleotide metabolism [goid 9187] [pmid 9784418] [evidence NAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; two-component signal transduction system (phosphorelay) [goid 160] [evidence IEA]; cyclic nucleotide metabolism [goid 9187] [pmid 9784418] [evidence NAS]","hydrolase activity [goid 16787] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; 3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [pmid 9784418] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; 3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [pmid 9784418] [evidence NAS]",5,76758755-76758804,5q14.1a,+,NM_001029851.1,8622,PDE8B,-1.079401374187836,6.537241866866726,-12.327036478572204,2.6159378496782343e-25,2.797417664156179e-24,46.561876341431
GLT8D2,ILMN_1802654,"Homo sapiens glycosyltransferase 8 domain containing 2 (GLT8D2), mRNA.",,carbohydrate biosynthesis [goid 16051] [evidence IEA],"transferase activity, transferring hexosyl groups [goid 16758] [evidence IEA]",12,102907345-102907394,12q23.3a,-,NM_031302.2,83468,GLT8D2,-1.4249188865995084,7.898426402167877,-12.323137377261375,2.683377786734165e-25,2.868003352402627e-24,46.536512205165444
ETNK2,ILMN_1800130,"Homo sapiens ethanolamine kinase 2 (ETNK2), mRNA.",,,kinase activity [goid 16301] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; choline kinase activity [goid 4103] [evidence NAS]; ethanolamine kinase activity [goid 4305] [evidence IEA],1,202367083-202367132,1q32.1e-q32.1f,-,NM_018208.1,55224,ETNK2,1.2940647995606485,6.223489942396773,12.317932808290468,2.776113068436083e-25,2.9639525225864007e-24,46.50265646416486
PEO1,ILMN_1701243,"Homo sapiens progressive external ophthalmoplegia 1 (PEO1), mRNA.",mitochondrion [goid 5739] [evidence IEA],DNA replication [goid 6260] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; DNA helicase activity [goid 3678] [evidence IEA],10,102743874-102743923,10q24.31a,+,NM_021830.3,56652,PEO1,1.0470721322055274,6.4507186902085305,12.317040392101651,2.7923328774870648e-25,2.9796797980139306e-24,46.49685136550318
NEK8,ILMN_1755138,"Homo sapiens NIMA (never in mitosis gene a)- related kinase 8 (NEK8), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],17,24093831-24093880,17q11.2a,+,NM_178170.2,284086,NEK8,1.5016225602293112,7.417671430873098,12.312146102868269,2.882986330353875e-25,3.074775612884879e-24,46.465014767888604
HCLS1,ILMN_1727402,"Homo sapiens hematopoietic cell-specific Lyn substrate 1 (HCLS1), mRNA.","DNA-directed RNA polymerase II, core complex [goid 5665] [pmid 2587259] [evidence TAS]; nucleus [goid 5634] [evidence ISS]; cytoplasm [goid 5737] [evidence ISS]","response to hormone stimulus [goid 9725] [evidence ISS]; positive regulation of tyrosine phosphorylation of STAT protein [goid 42531] [evidence ISS]; intracellular signaling cascade [goid 7242] [pmid 8978766] [evidence TAS]; erythrocyte differentiation [goid 30218] [evidence ISS]; regulation of transcription, DNA-dependent [goid 6355] [pmid 2587259] [evidence TAS]; positive regulation of cell proliferation [goid 8284] [evidence ISS]",transcription factor activity [goid 3700] [pmid 2587259] [evidence TAS]; protein binding [goid 5515] [evidence ISS],3,122833112-122833161,3q13.33c,-,NM_005335.3,3059,HCLS1,-1.1345448051225198,11.012502901120975,-12.309200002876517,2.9389670569502785e-25,3.128331505934783e-24,46.44585115050734
WDR34,ILMN_1685928,"Homo sapiens WD repeat domain 34 (WDR34), mRNA.",,,,9,130436048-130436082:130436326-130436340,9q34.11b,-,NM_052844.3,89891,WDR34,1.1479309783871692,8.929765024151262,12.309174527784782,2.9394558332453976e-25,3.128331505934783e-24,46.44568544265196
C7orf23,ILMN_1751143,"Homo sapiens chromosome 7 open reading frame 23 (C7orf23), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,7,86663871-86663887:86663888-86663920,7q21.12a,-,NM_024315.2,79161,C7orf23,-1.074599471035068,10.328765253757194,-12.306846134705033,2.984474196373618e-25,3.1711821413193496e-24,46.43054001572518
LOC349114,ILMN_1809173,"Homo sapiens hypothetical protein LOC349114 (LOC349114), mRNA.",,,,7,39798297-39798346,7p14.1d,+,NM_198284.1,349114,LOC349114,1.2234144753357628,7.841623083042448,12.302886383022509,3.062622203802212e-25,3.2507663158448093e-24,46.4047834776684
TRIM2,ILMN_1745079,"Homo sapiens tripartite motif-containing 2 (TRIM2), mRNA.",cytoplasm [goid 5737] [pmid 11331580] [evidence IEP]; intracellular [goid 5622] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 11331580] [evidence NAS]; protein binding [goid 5515] [evidence IEA]; myosin binding [goid 17022] [pmid 11432975] [evidence ISS],4,154479738-154479787,4q31.3d,+,NM_015271.2,23321,TRIM2,1.4551704578338907,9.46858169318298,12.298956415711537,3.142204453706e-25,3.329937855389282e-24,46.37922109666393
LMOD3,ILMN_1785703,"Homo sapiens leiomodin 3 (fetal) (LMOD3), mRNA.",actin cytoskeleton [goid 15629] [pmid 11256614] [evidence IDA]; cytoskeleton [goid 5856] [evidence IEA],,tropomyosin binding [goid 5523] [evidence IEA],3,69239594-69239643,3p14.1b,-,NM_198271.2,56203,LMOD3,2.452301324784429,10.841994004283395,12.29307382823248,3.2652063357094304e-25,3.4584567689187026e-24,46.340958734972375
PARC,ILMN_1806010,"Homo sapiens p53-associated parkin-like cytoplasmic protein (PARC), mRNA.",anaphase-promoting complex [goid 5680] [evidence IEA],ubiquitin cycle [goid 6512] [evidence IEA]; regulation of mitotic metaphase/anaphase transition [goid 30071] [evidence IEA]; cell cycle [goid 7049] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [evidence IEA],6,43300002-43300051,6p21.1d,+,NM_015089.2,23113,PARC,1.047760926142737,7.043827432038165,12.288012287307748,3.3748852815297486e-25,3.5689590228777594e-24,46.30803750705739
SEMA5A,ILMN_1656927,"Homo sapiens sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A (SEMA5A), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell-cell signaling [goid 7267] [pmid 9464278] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; cell adhesion [goid 7155] [pmid 9049630] [evidence TAS],receptor activity [goid 4872] [evidence IEA],5,9092140-9092189,5p15.2d,-,NM_003966.1,9037,SEMA5A,-1.651834829442965,7.243292333370404,-12.279517859078807,3.5672892818174063e-25,3.7644685627954994e-24,46.252789734483294
SLC30A7,ILMN_1789999,"Homo sapiens solute carrier family 30 (zinc transporter), member 7 (SLC30A7), mRNA.",Golgi apparatus [goid 5794] [pmid 11256614] [evidence IDA]; membrane [goid 16020] [evidence IEA],cation transport [goid 6812] [evidence IEA],cation transporter activity [goid 8324] [evidence IEA],1,101217499-101217548,1p21.2a,+,NM_133496.3,148867,SLC30A7,1.04346271423762,10.25385223226541,12.278629337781128,3.588037679815392e-25,3.784367838573872e-24,46.24701090820299
LEFTY2,ILMN_1781256,"Homo sapiens left-right determination factor 2 (LEFTY2), mRNA.",extracellular space [goid 5615] [evidence IEA],oocyte axis determination [goid 7309] [pmid 10053005] [evidence TAS]; cell growth [goid 16049] [evidence IEA]; cell-cell signaling [goid 7267] [evidence NR ]; development [goid 7275] [pmid 10053005] [evidence TAS]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 9153275] [evidence TAS],cytokine activity [goid 5125] [evidence IEA]; growth factor activity [goid 8083] [evidence IEA]; transforming growth factor beta receptor binding [goid 5160] [evidence IEA],1,224191049-224191098,1q42.12c,-,NM_003240.2,7044,LEFTY2,-1.7312354016792355,6.320086325762249,-12.275966326024413,3.6509485393471702e-25,3.845560594693105e-24,46.22969116220173
SSTR2,ILMN_2152257,"Homo sapiens somatostatin receptor 2 (SSTR2), mRNA.",integral to plasma membrane [goid 5887] [pmid 7914078] [evidence TAS]; plasma membrane [goid 5886] [pmid 7914078] [evidence TAS],"response to nutrient [goid 7584] [pmid 1346068] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; digestion [goid 7586] [pmid 1346068] [evidence TAS]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 7914078] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 9892014] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 1346068] [evidence TAS]",protein binding [goid 5515] [pmid 10551867] [evidence IPI]; somatostatin receptor activity [goid 4994] [pmid 7914078] [evidence TAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; PDZ domain binding [goid 30165] [pmid 10551867] [evidence IPI],17,68679500-68679549,17q25.1a,+,NM_001050.2,6752,SSTR2,2.4111058329324617,9.317121665683688,12.275081648893947,3.672091117850042e-25,3.864871072379992e-24,46.22393742702382
MX2,ILMN_2231928,"Homo sapiens myxovirus (influenza virus) resistance 2 (mouse) (MX2), mRNA.",nucleus [goid 5634] [pmid 8798556] [evidence TAS]; cytoplasm [goid 5737] [pmid 8798556] [evidence TAS],immune response [goid 6955] [evidence IEA]; response to virus [goid 9615] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; GTPase activity [goid 3924] [pmid 8798556] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA],21,41702511-41702560,21q22.3a,+,NM_002463.1,4600,MX2,1.5597477429017257,9.164192822390048,12.272606144823587,3.7319048262124696e-25,3.923696887170735e-24,46.207837440423745
C10orf26,ILMN_1658830,"Homo sapiens chromosome 10 open reading frame 26 (C10orf26), mRNA.",,,,10,104564963-104565012,10q24.32b,+,NM_017787.3,54838,C10orf26,-1.0531705242875091,8.41830293386773,-12.270867284482142,3.7745008584263034e-25,3.966397750808481e-24,46.19652848350612
HEY1,ILMN_1788203,"Homo sapiens hairy/enhancer-of-split related with YRPW motif 1 (HEY1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription regulator activity [goid 30528] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10415358] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],8,80838956-80839005,8q21.13a,-,NM_012258.2,23462,HEY1,-1.49519716915749,7.808145164203042,-12.262452121120116,3.987610125716933e-25,4.17936633815319e-24,46.14180034950059
SHE,ILMN_1712865,"Homo sapiens Src homology 2 domain containing E (SHE), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],,1,152719176-152719225,1q21.3e,-,NM_001010846.1,126669,SHE,-1.5463361122389987,7.477494365727805,-12.259991718841476,4.052160823689225e-25,4.244797579077173e-24,46.12579947608645
EMR1,ILMN_1780601,"Homo sapiens egf-like module containing, mucin-like, hormone receptor-like 1 (EMR1), mRNA.",integral to plasma membrane [goid 5887] [pmid 7601460] [evidence TAS]; membrane [goid 16020] [evidence IEA],neuropeptide signaling pathway [goid 7218] [evidence IEA]; cell adhesion [goid 7155] [pmid 7601460] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 7601460] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],19,6891122-6891171,19p13.3a,+,NM_001974.3,2015,EMR1,-1.4503795014288983,5.699038180457002,-12.258762945512684,4.084788684713363e-25,4.276737415161955e-24,46.11780839102488
C5orf28,ILMN_1694798,"Homo sapiens chromosome 5 open reading frame 28 (C5orf28), mRNA.",,,,5,43480818-43480867,5p12c,-,NM_022483.3,64417,C5orf28,1.0590611844588356,9.436407116960241,12.256294728142054,4.151123310413748e-25,4.3439160666714584e-24,46.10175695947461
LOC142937,ILMN_1701230,"PREDICTED: Homo sapiens hypothetical protein BC008131 (LOC142937), mRNA.",,,,,,,,XM_938400.1,142937,LOC142937,1.0083442567048593,5.638825972093722,12.25410022754729,4.211005261724375e-25,4.4042756548134495e-24,46.087485726311826
KIAA0460,ILMN_1705733,"Homo sapiens KIAA0460 (KIAA0460), mRNA.",,,,1,148712270-148712319,1q21.2b,+,NM_015203.2,23248,KIAA0460,1.1149682774393002,7.339792996201392,12.253134239805554,4.237637360388084e-25,4.429814436083844e-24,46.08120377872111
LOC400987,ILMN_1654313,"PREDICTED: Homo sapiens similar to ankyrin repeat domain 36 (LOC400987), mRNA.",,,,,,2q11.2a,,XM_376101.3,400987,LOC400987,1.4351171568263839,5.775874512327681,12.239766840947459,4.623932131782946e-25,4.823547137263461e-24,45.99427663763567
FTH1,ILMN_1683146,"Homo sapiens ferritin, heavy polypeptide 1 (FTH1), mRNA.",plasma membrane [goid 5886] [pmid 11821435] [evidence NAS]; ferritin complex [goid 8043] [pmid 6589621] [evidence TAS],immune response [goid 6955] [pmid 11821435] [evidence IDA]; intracellular sequestering of iron ion [goid 6880] [pmid 9924025] [evidence TAS]; iron ion transport [goid 6826] [evidence IEA]; iron ion homeostasis [goid 6879] [evidence IEA]; negative regulation of cell proliferation [goid 8285] [pmid 11821435] [evidence IDA]; cell proliferation [goid 8283] [pmid 9924025] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; ferroxidase activity [goid 4322] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; binding [goid 5488] [evidence IEA]; kinase binding [goid 19900] [pmid 11821435] [evidence NAS]; ferric iron binding [goid 8199] [evidence IEA]; protein binding [goid 5515] [pmid 16169070] [evidence IPI],11,61488556-61488605,11q12.3a,-,NM_002032.2,2495,FTH1,-1.0052005582725698,11.39338140930091,-12.237274085664142,4.699769275083765e-25,4.8950017519977074e-24,45.97806703823598
C1QC,ILMN_1785902,"Homo sapiens complement component 1, q subcomponent, C chain (C1QC), mRNA.",extracellular region [goid 5576] [pmid 9777412] [evidence NAS]; cytoplasm [goid 5737] [evidence IEA],"innate immune response [goid 45087] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",,1,22846804-22846853,1p36.12a,+,NM_172369.2,714,C1QC,-1.3619607682428025,11.910773475716645,-12.234916433896178,4.772639655217724e-25,4.965729288694551e-24,45.96273614702003
CXCL2,ILMN_1682636,"Homo sapiens chemokine (C-X-C motif) ligand 2 (CXCL2), mRNA.",soluble fraction [goid 5625] [pmid 2643119] [evidence TAS]; extracellular space [goid 5615] [pmid 9873037] [evidence TAS]; extracellular region [goid 5576] [evidence IEA],chemotaxis [goid 6935] [pmid 2643119] [evidence TAS]; inflammatory response [goid 6954] [pmid 2643119] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence NR ],chemokine activity [goid 8009] [pmid 9873037] [evidence TAS],4,75181931-75181980,4q13.3d,-,NM_002089.1,2920,CXCL2,-2.5817648317639215,9.414625167528484,-12.232416767228717,4.851133079023084e-25,5.042154319225656e-24,45.94648197231432
LAMC3,ILMN_1688642,"Homo sapiens laminin, gamma 3 (LAMC3), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; basement membrane [goid 5604] [evidence IEA]; membrane [goid 16020] [pmid 10225960] [evidence TAS],cell adhesion [goid 7155] [evidence IEA],structural molecule activity [goid 5198] [pmid 10225960] [evidence TAS]; protein binding [goid 5515] [evidence IEA],9,132957211-132957260,9q34.13a,+,NM_006059.2,10319,LAMC3,-1.8714399061302291,8.93169772169818,-12.230618659576864,4.908393070400675e-25,5.09637408160751e-24,45.93478982854731
ARL16,ILMN_1679917,"PREDICTED: Homo sapiens ADP-ribosylation factor-like 16 (ARL16), mRNA.",,,,17,77258972-77259021,17q25.3f,-,XM_290777.4,339231,ARL16,1.147214811067668,10.47592711184912,12.229673219467394,4.938770661778386e-25,5.124442910667476e-24,45.92864217074085
EIF2AK4,ILMN_1755114,"Homo sapiens eukaryotic translation initiation factor 2 alpha kinase 4 (EIF2AK4), mRNA.",cytosolic ribosome (sensu Eukaryota) [goid 5830] [evidence ISS],regulation of translational initiation [goid 6446] [evidence ISS]; protein amino acid phosphorylation [goid 6468] [evidence ISS]; tRNA aminoacylation for protein translation [goid 6418] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; eukaryotic translation initiation factor 2alpha kinase activity [goid 4694] [evidence ISS]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],15,38114867-38114916,15q15.1a,+,NM_001013703.2,440275,EIF2AK4,1.6557460759135676,9.823403493325317,12.229618053559845,4.94054896775168e-25,5.124442910667476e-24,45.9282834591507
LCOR,ILMN_2062381,"Homo sapiens ligand dependent nuclear receptor corepressor (LCOR), mRNA.",nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],10,98708585-98708634,10q24.1a-q24.1b,+,NM_032440.1,84458,LCOR,1.5452505103633687,8.606675105633617,12.226151761491076,5.0535798955625755e-25,5.2362520222897985e-24,45.90574437864356
MAMDC4,ILMN_1740759,"Homo sapiens MAM domain containing 4 (MAMDC4), mRNA.",membrane [goid 16020] [evidence IEA],,,9,138874840-138874876:138874877-138874889,9q34.3e,+,NM_206920.1,158056,MAMDC4,1.0689780647162719,6.067080040740671,12.222394134069857,5.179032025803273e-25,5.363461323616558e-24,45.88131134771882
HSH2D,ILMN_1788017,"Homo sapiens hematopoietic SH2 domain containing (HSH2D), mRNA.",nucleus [goid 5634] [evidence IEA],intracellular signaling cascade [goid 7242] [evidence IEA],,19,16129952-16130001,19p13.11f,+,NM_032855.2,84941,HSH2D,1.36410002651417,7.78850290881894,12.218298168864179,5.319327845668541e-25,5.500212482487657e-24,45.85467885714165
FLJ37078,ILMN_1717265,"Homo sapiens hypothetical protein FLJ37078 (FLJ37078), mRNA.",,,,7,75754207-75754256,7q11.23e,+,NM_153043.3,222183,FLJ37078,1.0688704477733317,5.607266130832857,12.217983600445242,5.330258263970769e-25,5.508667734789625e-24,45.8526335145004
SCN2B,ILMN_1676998,"Homo sapiens sodium channel, voltage-gated, type II, beta (SCN2B), mRNA.",membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; voltage-gated sodium channel complex [goid 1518] [pmid 9295116] [evidence TAS],ion transport [goid 6811] [evidence IEA]; synaptic transmission [goid 7268] [pmid 9295116] [evidence TAS]; sodium ion transport [goid 6814] [pmid 9295116] [evidence TAS],voltage-gated sodium channel activity [goid 5248] [pmid 9295116] [evidence TAS]; sodium ion binding [goid 31402] [evidence IEA],11,117539114-117539163,11q23.3d,-,NM_004588.3,6327,SCN2B,-1.2821929332651791,5.712007453643408,-12.215042067691869,5.433561289681203e-25,5.609633347984598e-24,45.83350764204224
SLC41A2,ILMN_1747197,"Homo sapiens solute carrier family 41, member 2 (SLC41A2), mRNA.",,cation transport [goid 6812] [evidence IEA],cation transporter activity [goid 8324] [evidence IEA],12,103723196-103723245,12q23.3b,-,NM_032148.2,84102,SLC41A2,1.2113440882924706,6.1996373358299905,12.208495972646274,5.670689706868501e-25,5.845397200155846e-24,45.790945844773134
FLJ44124,ILMN_2230162,"Homo sapiens hypothetical protein LOC641737 (FLJ44124), mRNA.",,,,7,852625-852674,7p22.3c,+,NM_001039755.1,641737,FLJ44124,1.7220772104578348,12.366931468464687,12.203475376127162,5.859542087733823e-25,6.033850648038e-24,45.7583035412464
DKFZp762I137,ILMN_1713706,"Homo sapiens zinc finger protein 786 (ZNF786), mRNA.",intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [pmid 11256614] [evidence IDA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],7,148397711-148397760,7q36.1a,-,NM_152411.1,136051,DKFZp762I137,1.9314653907952515,10.848135909395051,12.202501268068612,5.896905320769016e-25,6.069201731375846e-24,45.75197029657838
ZNF69,ILMN_2176882,"Homo sapiens zinc finger protein 69 (ZNF69), mRNA.",nucleus [goid 5634] [evidence NAS]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]",transcription factor activity [goid 3700] [evidence NAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],19,11885842-11885891,19p13.2a,+,NM_021915.1,7620,ZNF69,2.025480986477179,12.077613587436119,12.195098715719745,6.18872984155201e-25,6.356473648345617e-24,45.703842975417054
BARD1,ILMN_2074258,"Homo sapiens BRCA1 associated RING domain 1 (BARD1), mRNA.",BRCA1-BARD1 complex [goid 31436] [pmid 15265711] [evidence IDA]; ubiquitin ligase complex [goid 151] [pmid 14976165] [evidence NAS]; nucleus [goid 5634] [pmid 15632137] [evidence IMP]; cytoplasm [goid 5737] [pmid 15265711] [evidence IDA]; intracellular [goid 5622] [evidence IEA],positive regulation of apoptosis [goid 43065] [pmid 15782130] [evidence IMP]; positive regulation of protein catabolism [goid 45732] [pmid 15905410] [evidence NAS]; regulation of phosphorylation [goid 42325] [pmid 15782130] [evidence IMP]; negative regulation of protein export from nucleus [goid 46826] [pmid 15265711] [evidence IDA]; negative regulation of mRNA 3'-end processing [goid 31441] [pmid 15905410] [evidence NAS]; protein ubiquitination [goid 16567] [pmid 15905410] [evidence NAS]; negative regulation of apoptosis [goid 43066] [pmid 15265711] [evidence IMP]; tissue homeostasis [goid 1894] [pmid 15782130] [evidence TAS]; response to DNA damage stimulus [goid 6974] [pmid 15905410] [evidence NAS]; cell cycle arrest [goid 7050] [pmid 15632137] [evidence NAS],RNA binding [goid 3723] [pmid 12419249] [evidence IDA]; protein homodimerization activity [goid 42803] [pmid 15265711] [evidence IPI]; protein heterodimerization activity [goid 46982] [pmid 15265711] [evidence IPI]; protein binding [goid 5515] [pmid 15782130] [evidence IPI]; ubiquitin-protein ligase activity [goid 4842] [pmid 15905410] [evidence NAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; kinase binding [goid 19900] [pmid 15782130] [evidence NAS],2,215301702-215301751,2q35a,-,NM_000465.1,580,BARD1,1.2008942602974102,8.117731602712299,12.18985029881077,6.404336067157861e-25,6.571177232394589e-24,45.6697217237287
DUSP19,ILMN_1722492,"Homo sapiens dual specificity phosphatase 19 (DUSP19), mRNA.",,protein amino acid dephosphorylation [goid 6470] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; protein tyrosine phosphatase activity [goid 4725] [evidence IEA]; protein tyrosine/serine/threonine phosphatase activity [goid 8138] [evidence IEA],2,183672674-183672723,2q32.1a,+,NM_080876.2,142679,DUSP19,1.8626799086120638,12.905947036912883,12.185354104361773,6.595000760661582e-25,6.759875779678121e-24,45.6404915651239
LOC644297,ILMN_1722284,"PREDICTED: Homo sapiens similar to Apoptosis-related protein 2 (APR-2) (LOC644297), mRNA.",,,,17,41991780-41991829,17q21.32a,-,XM_927470.1,644297,LOC644297,1.3615381336550243,6.104338087047838,12.181910785618106,6.744844178329555e-25,6.90285638465564e-24,45.618106690284165
LOC642852,ILMN_1688246,"PREDICTED: Homo sapiens hypothetical protein LOC642852 (LOC642852), mRNA.",,,,21,45532437-45532486,21q22.3e,+,XM_926249.1,642852,LOC642852,1.1100067511463285,6.009599304836243,12.173071111557435,7.145285470909226e-25,7.30147455066148e-24,45.56064211283447
SCAMP5,ILMN_1753345,"Homo sapiens secretory carrier membrane protein 5 (SCAMP5), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein transport [goid 15031] [evidence IEA],,15,73100541-73100590,15q24.1b-q24.2a,+,NM_138967.2,192683,SCAMP5,1.099935773929233,7.1550394708783696,12.172806430344265,7.157635159160424e-25,7.310360605639702e-24,45.55892152426739
OASL,ILMN_1674811,"Homo sapiens 2'-5'-oligoadenylate synthetase-like (OASL), transcript variant 1, mRNA.",nucleolus [goid 5730] [pmid 9826176] [evidence TAS]; cytoplasm [goid 5737] [pmid 9826176] [evidence TAS]; nucleolus [goid 5730] [pmid 9826176] [evidence TAS]; cytoplasm [goid 5737] [pmid 9826176] [evidence TAS],immune response [goid 6955] [evidence IEA]; protein modification [goid 6464] [evidence IEA]; immune response [goid 6955] [evidence IEA]; protein modification [goid 6464] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; thyroid hormone receptor binding [goid 46966] [pmid 7776974] [evidence TAS]; DNA binding [goid 3677] [pmid 9826176] [evidence TAS]; double-stranded RNA binding [goid 3725] [pmid 9826176] [evidence TAS]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; thyroid hormone receptor binding [goid 46966] [pmid 7776974] [evidence TAS]; DNA binding [goid 3677] [pmid 9826176] [evidence TAS]; double-stranded RNA binding [goid 3725] [pmid 9826176] [evidence TAS],12,119942793-119942842,12q24.31a,-,NM_003733.2,8638,OASL,-1.3688454091083644,6.7037196075576775,-12.17004730687548,7.287649409700054e-25,7.439351499452994e-24,45.54098568533703
HHAT,ILMN_1693853,"Homo sapiens hedgehog acyltransferase (HHAT), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],development [goid 7275] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; acyltransferase activity [goid 8415] [evidence IEA],1,208915892-208915941,1q32.2c,+,NM_018194.1,55733,HHAT,1.0399370518737534,6.123189320331073,12.168488668199009,7.362135362182613e-25,7.5077270298955e-24,45.530853778081216
BNC2,ILMN_1656373,"Homo sapiens basonuclin 2 (BNC2), mRNA.",nucleus [goid 5634] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],9,16406696-16406745,9p22.3a-p22.2b,-,NM_017637.4,54796,BNC2,-1.1940036955611975,6.781411609868415,-12.163231045057655,7.619049545403861e-25,7.765763795437619e-24,45.49667727733011
STK36,ILMN_1693538,"Homo sapiens serine/threonine kinase 36, fused homolog (Drosophila) (STK36), mRNA.",nucleus [goid 5634] [pmid 10806483] [evidence IDA]; cytoplasm [goid 5737] [pmid 10806483] [evidence IDA],regulation of transcription factor activity [goid 51090] [pmid 10806483] [evidence IDA]; post-embryonic development [goid 9791] [evidence ISS]; protein amino acid phosphorylation [goid 6468] [pmid 10806483] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 10806483] [evidence TAS]; magnesium ion binding [goid 287] [pmid 10806483] [evidence IC ]; protein serine/threonine kinase activity [goid 4674] [pmid 10806483] [evidence TAS]; transcription factor binding [goid 8134] [pmid 10806483] [evidence IDA],2,219275622-219275671,2q35e,+,NM_015690.2,27148,STK36,1.1021449158292072,9.893216614656756,12.159426528880038,7.8105270045796695e-25,7.956874964746946e-24,45.47194709031214
IL3RA,ILMN_1747344,"Homo sapiens interleukin 3 receptor, alpha (low affinity) (IL3RA), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],development [goid 7275] [evidence NR ]; protein amino acid phosphorylation [goid 6468] [evidence NR ],interleukin-3 receptor activity [goid 4912] [pmid 1833064] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; receptor signaling protein activity [goid 5057] [evidence NR ]; hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA],X,1461338-1461358:1461359-1461387,"Xp22.33e-p22.33d,Yp11.32a",+,NM_002183.2,3563,IL3RA,-1.210959298035104,6.694280101735268,-12.154719451386654,8.05409794095101e-25,8.192495760170198e-24,45.44135073502262
ATP1A2,ILMN_1777411,"Homo sapiens ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide (ATP1A2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; sodium:potassium-exchanging ATPase complex [goid 5890] [evidence ISS]; membrane [goid 16020] [evidence IEA],ATP hydrolysis coupled proton transport [goid 15991] [evidence ISS]; metabolism [goid 8152] [evidence IEA]; potassium ion transport [goid 6813] [evidence ISS]; sperm motility [goid 30317] [evidence ISS]; sodium ion transport [goid 6814] [evidence ISS]; hydrogen ion homeostasis [goid 30641] [evidence ISS]; monovalent inorganic cation transport [goid 15672] [evidence IEA],"ATP binding [goid 5524] [evidence IEA]; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism [goid 15662] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA]; hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances [goid 16820] [evidence IEA]; potassium ion binding [goid 30955] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; monovalent inorganic cation transporter activity [goid 15077] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; sodium:potassium-exchanging ATPase activity [goid 5391] [evidence ISS]",1,158379422-158379471,1q23.2c,+,NM_000702.2,477,ATP1A2,-1.0841085473946652,5.3291914787296015,-12.154050443646518,8.089326869844332e-25,8.224148984341737e-24,45.43700219582978
RBP1,ILMN_1656837,"Homo sapiens retinol binding protein 1, cellular (RBP1), mRNA.",,transport [goid 6810] [evidence IEA]; vitamin A metabolism [goid 6776] [pmid 3472205] [evidence TAS],retinal binding [goid 16918] [evidence IEA]; retinol binding [goid 19841] [evidence IEA]; lipid binding [goid 8289] [evidence IEA],3,140719991-140720040,3q23a,-,NM_002899.2,5947,RBP1,-1.219571752160192,9.54972301465122,-12.153486389617036,8.1191487155522525e-25,8.2502756475759e-24,45.43333586585722
UPK3B,ILMN_1701565,"Homo sapiens uroplakin 3B (UPK3B), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],,,7,75978012-75978061,7q11.23f,+,NM_030570.2,80761,UPK3B,-2.0957532256577336,6.108346710859082,-12.149909521872699,8.310833853468298e-25,8.436487252166093e-24,45.410086612884264
NUCKS1,ILMN_1680692,"Homo sapiens nuclear casein kinase and cyclin-dependent kinase substrate 1 (NUCKS1), mRNA.",nucleus [goid 5634] [evidence IEA],,kinase activity [goid 16301] [evidence IEA],1,203954016-203954030:203954031-203954065,1q32.1g,-,NM_022731.2,64710,NUCKS1,1.446034399923671,7.843320026977251,12.145504645735294,8.553117236082951e-25,8.673632522024718e-24,45.38145599746383
KIAA1641,ILMN_1699521,"PREDICTED: Homo sapiens KIAA1641, transcript variant 7 (KIAA1641), mRNA.",,,,,,2q11.2b,,XM_944061.1,57730,KIAA1641,1.2345500813450219,6.752003263572181,12.1443110171246,8.6199778965167991e-25,8.737006978394535e-24,45.37369781899035
LOC51252,ILMN_1804993,"Homo sapiens hypothetical protein LOC51252 (LOC51252), mRNA.",,,,2,96905440-96905489,2q11.2a,-,NM_016490.3,51252,LOC51252,1.6077212812726938,5.980260564726064,12.14178881422452,8.762980971512639e-25,8.877454343191133e-24,45.357304523053294
PDE4D,ILMN_1791483,"Homo sapiens phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) (PDE4D), mRNA.",soluble fraction [goid 5625] [pmid 9371713] [evidence TAS]; insoluble fraction [goid 5626] [pmid 9371713] [evidence TAS],signal transduction [goid 7165] [evidence IEA],"metal ion binding [goid 46872] [evidence IEA]; 3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [pmid 10913353] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA]",5,58302551-58302600,5q11.2h-q12.1a,-,NM_006203.3,5144,PDE4D,-1.6975787789076797,7.738812703645404,-12.13850628628797,8.95264904313012e-25,9.05584439104891e-24,45.33596975283717
MTP18,ILMN_1657898,"Homo sapiens mitochondrial protein 18 kDa (MTP18), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA.",mitochondrion [goid 5739] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; apoptosis [goid 6915] [evidence IEA],,22,29153339-29153388,22q12.2b,+,NM_016498.3,51537,MTP18,1.0543015785508745,7.678027683076598,12.13443980676534,9.193313369056679e-25,9.289889590307375e-24,45.309540214116964
LOC197336,ILMN_1698185,"Homo sapiens similar to RIKEN cDNA 3230401M21 [Mus musculus] (LOC197336), mRNA.",,,,16,657663-657712,,+,NM_145294.3,197336,LOC197336,1.1078151225047872,7.492094363807642,12.132409841155825,9.315860160828986e-25,9.404224525623933e-24,45.296346940923804
LILRB5,ILMN_1732919,"Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 (LILRB5), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [evidence IEA]; cell surface receptor linked signal transduction [goid 7166] [pmid 9548455] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 9548455] [evidence TAS]; immune response [goid 6955] [evidence IEA],transmembrane receptor activity [goid 4888] [pmid 9548455] [evidence TAS]; transmembrane receptor activity [goid 4888] [pmid 9548455] [evidence TAS],19,59446415-59446461:59446462-59446464,19q13.42a,-,NM_006840.2,10990,LILRB5,-1.2005717115642422,6.530840106613909,-12.131825916555696,9.35141241298839e-25,9.435353482555305e-24,45.29255189019303
ST6GALNAC5,ILMN_1773959,"Homo sapiens ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (ST6GALNAC5), mRNA.",integral to Golgi membrane [goid 30173] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein amino acid glycosylation [goid 6486] [evidence IEA],sialyltransferase activity [goid 8373] [evidence IEA],1,77301926-77301975,1p31.1f,+,NM_030965.1,81849,ST6GALNAC5,-1.3632332520654629,6.542478052215328,-12.130037771029473,9.461129195290189e-25,9.53785378724861e-24,45.28093042487072
HLA-DPA1,ILMN_1772218,"Homo sapiens major histocompatibility complex, class II, DP alpha 1 (HLA-DPA1), mRNA.",integral to plasma membrane [goid 5887] [pmid 2461352] [evidence NAS]; membrane [goid 16020] [evidence IEA],immune response [goid 6955] [pmid 2461352] [evidence NAS],MHC class II receptor activity [goid 45012] [pmid 2461352] [evidence NAS],6,33144417-33144466,6p21.32a,-,NM_033554.2,3113,HLA-DPA1,-1.2642009233558227,13.41576848004657,-12.124182060828542,9.829506932807042e-25,9.892795508631957e-24,45.24287394605255
SYT12,ILMN_1815610,"Homo sapiens synaptotagmin XII (SYT12), mRNA.",synapse [goid 45202] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; synaptic vesicle [goid 8021] [evidence IEA],transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA],11,66574654-66574703,11q13.1f,+,NM_177963.2,91683,SYT12,1.8067423689360789,5.911046667821466,12.123728320140309,9.858642673234496e-25,9.917130347213465e-24,45.239925119050625
CNTFR,ILMN_1809456,"Homo sapiens ciliary neurotrophic factor receptor (CNTFR), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; extrinsic to membrane [goid 19898] [pmid 1648265] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extrinsic to membrane [goid 19898] [pmid 1648265] [evidence TAS],signal transduction [goid 7165] [pmid 1648265] [evidence NAS]; signal transduction [goid 7165] [pmid 1648265] [evidence NAS],ciliary neurotrophic factor receptor activity [goid 4897] [pmid 7585948] [evidence TAS]; cytokine binding [goid 19955] [pmid 15272019] [evidence IPI]; GPI anchor binding [goid 48503] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA]; ciliary neurotrophic factor receptor activity [goid 4897] [pmid 7585948] [evidence TAS]; cytokine binding [goid 19955] [pmid 15272019] [evidence IPI]; GPI anchor binding [goid 48503] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA],9,34541533-34541582,9p13.3c,-,NM_147164.1,1271,CNTFR,-1.1984458871698562,5.663964639069025,-12.122296793457963,9.9511311589623e-25,1.0005137297915463e-23,45.230621781463185
CXCR4,ILMN_1801584,"Homo sapiens chemokine (C-X-C motif) receptor 4 (CXCR4), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],C-C chemokine receptor activity [goid 16493] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; C-X-C chemokine receptor activity [goid 16494] [pmid 9468539] [evidence NAS],2,136592116-136592165,2q21.3b,-,NM_003467.2,7852,CXCR4,-1.8612545510370948,8.886250145945448,-12.121218646572975,1.0021360360100997e-24,1.0065631429964898e-23,45.22361506917268
CCL2,ILMN_1720048,"Homo sapiens chemokine (C-C motif) ligand 2 (CCL2), mRNA.",extracellular region [goid 5576] [evidence IEA]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [pmid 10942204] [evidence TAS],"cell-cell signaling [goid 7267] [evidence NR ]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 10770925] [evidence TAS]; chemotaxis [goid 6935] [pmid 10623817] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 9670957] [evidence TAS]; JAK-STAT cascade [goid 7259] [pmid 9670957] [evidence TAS]; humoral immune response [goid 6959] [pmid 9548499] [evidence TAS]; cell adhesion [goid 7155] [pmid 10198043] [evidence TAS]; anti-apoptosis [goid 6916] [pmid 12753088] [evidence IDA]; viral genome replication [goid 19079] [pmid 10985244] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 9670957] [evidence TAS]; inflammatory response [goid 6954] [evidence IEA]",signal transducer activity [goid 4871] [pmid 10770925] [evidence TAS]; protein kinase activity [goid 4672] [pmid 9973507] [evidence TAS]; chemokine activity [goid 8009] [pmid 10623817] [evidence TAS],17,29607909-29607958,17q12a,+,NM_002982.3,6347,CCL2,-1.9582655559778797,10.77715381217048,-12.110638505213844,1.0737367665717824e-24,1.0768584072966528e-23,45.154858547778026
SULT1C2,ILMN_1772148,"Homo sapiens sulfotransferase family, cytosolic, 1C, member 4 (SULT1C4), mRNA.",,,transferase activity [goid 16740] [evidence IEA]; sulfotransferase activity [goid 8146] [pmid 9852044] [evidence NAS],2,108370208-108370257,2q12.3c,+,NM_006588.2,27233,SULT1C2,-1.0166006536325272,5.515475593946461,-12.105083141917818,1.1133566687998906e-24,1.1160340796266638e-23,45.1187578604902
SLC36A4,ILMN_2082324,"Homo sapiens solute carrier family 36 (proton/amino acid symporter), member 4 (SLC36A4), mRNA.",,,,11,92520896-92520945,11q21a,-,NM_152313.2,120103,SLC36A4,1.4029915585921886,7.500654737713803,12.104043363280999,1.1209328964116553e-24,1.1230658683727791e-23,45.11200114087254
CDCA7,ILMN_1737184,"Homo sapiens cell division cycle associated 7 (CDCA7), transcript variant 2, mRNA.",,,metal ion binding [goid 46872] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; copper ion binding [goid 5507] [evidence IEA],2,173941629-173941678,2q31.1e,+,NM_145810.1,83879,CDCA7,2.228286834559561,8.18202672196124,12.100530547524881,1.146911708857058e-24,1.1473704735406007e-23,45.0891743513579
PRO0628,ILMN_2213834,Homo sapiens PRO0628 protein (PRO0628) on chromosome 20.,,,,20,39100622-39100671,20q12b-q12c,+,NR_002764.1,29053,PRO0628,2.4167403418320195,8.322076378576847,12.100051135170085,1.1505035230024893e-24,1.150388530146617e-23,45.08605909485737
ABCD1,ILMN_1772189,"Homo sapiens ATP-binding cassette, sub-family D (ALD), member 1 (ABCD1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to peroxisomal membrane [goid 5779] [pmid 8441467] [evidence NAS]; membrane [goid 16020] [evidence IEA]; peroxisome [goid 5777] [evidence IEA],transport [goid 6810] [evidence IEA]; peroxisomal membrane transport [goid 15919] [pmid 8441467] [evidence NAS]; peroxisome organization and biogenesis [goid 7031] [pmid 8441467] [evidence NAS],"ATPase activity, coupled to transmembrane movement of substances [goid 42626] [pmid 8441467] [evidence NAS]; ATPase activity [goid 16887] [evidence IEA]; transporter activity [goid 5215] [pmid 8441467] [evidence NAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]",X,152663031-152663080,Xq28f,+,NM_000033.2,215,ABCD1,1.194114695538488,6.999027001731316,12.099105820464969,1.1576188996008582e-24,1.1567852272218899e-23,45.079916395503034
FLJ41603,ILMN_1795300,"Homo sapiens FLJ41603 protein (FLJ41603), mRNA.",,,,5,148994542-148994591,5q33.1b,+,NM_001001669.1,389337,FLJ41603,-1.3824041304756172,7.005318245497073,-12.098576554287973,1.1616218667562575e-24,1.1597669815398803e-23,45.076477213322256
XRCC2,ILMN_1651569,"Homo sapiens X-ray repair complementing defective repair in Chinese hamster cells 2 (XRCC2), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],meiosis [goid 7126] [pmid 9628903] [evidence TAS]; DNA repair [goid 6281] [pmid 9628903] [evidence TAS]; DNA recombination [goid 6310] [evidence IEA]; meiosis [goid 7126] [pmid 9628903] [evidence TAS]; DNA repair [goid 6281] [pmid 9628903] [evidence TAS]; DNA recombination [goid 6310] [evidence IEA],DNA-dependent ATPase activity [goid 8094] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; DNA-dependent ATPase activity [goid 8094] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],7,151974964-151975013,7q36.1e,-,NM_005431.1,7516,XRCC2,1.2611454394762758,8.569632836305267,12.090763030294049,1.222352574791318e-24,1.219183963929446e-23,45.025705977352395
PPFIA4,ILMN_1667791,"Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 (PPFIA4), mRNA.",intracellular [goid 5622] [pmid 9624153] [evidence TAS],cell communication [goid 7154] [evidence NAS],protein binding [goid 5515] [pmid 12923177] [evidence IPI]; receptor activity [goid 4872] [evidence IEA],1,201314324-201314373,1q32.1d,+,NM_015053.1,8497,PPFIA4,1.175034710618319,5.687672963791168,12.079799727433358,1.3129509467212671e-24,1.3075919632652621e-23,44.95447171606777
P2RY5,ILMN_1786429,"Homo sapiens purinergic receptor P2Y, G-protein coupled, 5 (P2RY5), mRNA.",integral to membrane [goid 16021] [evidence NAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence NAS],"rhodopsin-like receptor activity [goid 1584] [evidence IEA]; purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]",13,47884066-47884115,13q14.2b,-,NM_005767.3,10161,P2RY5,-1.228806936994947,8.112064730563826,-12.077916501050067,1.3291754336015734e-24,1.3227470398263871e-23,44.942235870695804
TNFSF15,ILMN_1759501,"Homo sapiens tumor necrosis factor (ligand) superfamily, member 15 (TNFSF15), mRNA.",plasma membrane [goid 5886] [pmid 11911831] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 9872942] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; soluble fraction [goid 5625] [evidence NR ]; plasma membrane [goid 5886] [pmid 11911831] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 9872942] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; soluble fraction [goid 5625] [evidence NR ],immune response [goid 6955] [evidence IEA]; negative regulation of endothelial cell proliferation [goid 1937] [pmid 12345] [evidence IDA]; cytokine metabolism [goid 42107] [pmid 11911831] [evidence IDA]; activation of NF-kappaB-inducing kinase [goid 7250] [pmid 11911831] [evidence IDA]; caspase activation [goid 6919] [pmid 11911831] [evidence IDA]; signal transduction [goid 7165] [pmid 9872942] [evidence NAS]; immune response [goid 6955] [evidence IEA]; negative regulation of endothelial cell proliferation [goid 1937] [pmid 12345] [evidence IDA]; cytokine metabolism [goid 42107] [pmid 11911831] [evidence IDA]; activation of NF-kappaB-inducing kinase [goid 7250] [pmid 11911831] [evidence IDA]; caspase activation [goid 6919] [pmid 11911831] [evidence IDA]; signal transduction [goid 7165] [pmid 9872942] [evidence NAS],tumor necrosis factor receptor binding [goid 5164] [evidence IEA]; tumor necrosis factor receptor binding [goid 5164] [evidence IEA],9,116592418-116592467,9q32e,-,NM_005118.2,9966,TNFSF15,1.1617013092904385,7.4091604886258216,12.072983695342268,1.3726288006668434e-24,1.3649879246392745e-23,44.91018669431902
PRR7,ILMN_1677509,"Homo sapiens proline rich 7 (synaptic) (PRR7), mRNA.",,,,5,176815672-176815721,5q35.3a,+,NM_030567.2,80758,PRR7,1.152484642804036,6.050334302377698,12.069203955234626,1.406882860273413e-24,1.3983562974838773e-23,44.88562978100961
LDLR,ILMN_2053415,"Homo sapiens low density lipoprotein receptor (familial hypercholesterolemia) (LDLR), mRNA.",plasma membrane [goid 5886] [pmid 2777800] [evidence TAS]; coated pit [goid 5905] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 6327078] [evidence TAS],endocytosis [goid 6897] [pmid 12671190] [evidence TAS]; cholesterol metabolism [goid 8203] [evidence IEA]; lipid transport [goid 6869] [evidence IEA]; lipid metabolism [goid 6629] [pmid 10827173] [evidence TAS]; steroid metabolism [goid 8202] [evidence IEA],transmembrane receptor activity [goid 4888] [pmid 6091915] [evidence TAS]; lipid transporter activity [goid 5319] [evidence IEA]; low-density lipoprotein receptor activity [goid 5041] [pmid 2777800] [evidence TAS]; lipoprotein binding [goid 8034] [pmid 6091915] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],19,11105336-11105385,19p13.2b,+,NM_000527.2,3949,LDLR,-1.2617660886813002,11.996965933409996,-12.059457146154912,1.4992067660544967e-24,1.4849568799613054e-23,44.82230742759321
PTTG3,ILMN_2049021,Homo sapiens pituitary tumor-transforming 3 (PTTG3) on chromosome 8.,,,,8,67842374-67842423,8q13.1b,-,NR_002734.1,26255,PTTG3,1.3801905077249854,8.197359642549948,12.05436856584206,1.5497876019667966e-24,1.5320232381497858e-23,44.78924976404165
C4orf32,ILMN_1700257,"Homo sapiens chromosome 4 open reading frame 32 (C4orf32), mRNA.",,,,4,113328846-113328895,4q25f,+,NM_152400.1,132720,C4orf32,-1.0543095645255756,6.030010572722199,-12.054123366897755,1.5522675050440328e-24,1.5337169501689387e-23,44.78765686878091
VDR,ILMN_2319952,"Homo sapiens vitamin D (1,25- dihydroxyvitamin D3) receptor (VDR), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],"signal transduction [goid 7165] [pmid 2849209] [evidence TAS]; negative regulation of transcription [goid 16481] [pmid 11891224] [evidence IDA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",protein binding [goid 5515] [pmid 10866662] [evidence IPI]; steroid hormone receptor activity [goid 3707] [evidence IEA]; vitamin D3 receptor activity [goid 8434] [pmid 9070272] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA],12,46522051-46522100,12q13.11c,-,NM_000376.2,7421,VDR,1.1878092668620148,6.7172104394025425,12.046636991427068,1.6299225335357483e-24,1.6096490647079592e-23,44.73902396766848
TBX15,ILMN_1721580,"Homo sapiens T-box 15 (TBX15), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],1,119227617-119227666,1p12b,-,NM_152380.2,6913,TBX15,1.3839672492136508,5.702357141607092,12.045792595273994,1.6389214067352977e-24,1.6177375187942692e-23,44.73353874894449
ZNF444,ILMN_1727300,"Homo sapiens zinc finger protein 444 (ZNF444), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],19,61363824-61363873,19q13.42c,+,NM_018337.2,55311,ZNF444,1.0810187267448548,8.2480985975596,12.043793204872037,1.660427688307767e-24,1.6375670130513356e-23,44.72055076985209
LOC286208,ILMN_1657011,"PREDICTED: Homo sapiens hypothetical protein LOC286208, transcript variant 1 (LOC286208), mRNA.",,,,9,129913314-129913363,,-,XM_379668.3,286208,LOC286208,1.4391692817911972,7.141125011533614,12.043772905582706,1.66064747575028e-24,1.6375670130513356e-23,44.7204189070919
BC002942,ILMN_1716056,"Homo sapiens transmembrane protein 112B (TMEM112B), mRNA.",,,,22,49288446-49288495,22q13.33b,-,NM_033200.1,91289,BC002942,1.0096791478086917,9.90180640738897,12.04335100346139,1.665222142844281e-24,1.6412691937945012e-23,44.71767826415742
SPINT1,ILMN_1724946,"Homo sapiens serine peptidase inhibitor, Kunitz type 1 (SPINT1), transcript variant 1, mRNA.",membrane fraction [goid 5624] [pmid 9045658] [evidence TAS]; extracellular region [goid 5576] [pmid 9045658] [evidence TAS],,serine-type endopeptidase inhibitor activity [goid 4867] [pmid 9045658] [evidence TAS],15,38936918-38936967,15q15.1b,+,NM_181642.2,6692,SPINT1,1.132884736774904,7.824963524449643,12.036673141391248,1.7393298959790134e-24,1.7109625988768872e-23,44.6743003321767
DSP,ILMN_1655614,"Homo sapiens desmoplakin (DSP), transcript variant 2, mRNA.",cell-cell adherens junction [goid 5913] [evidence NR ]; intermediate filament [goid 5882] [evidence NR ]; cornified envelope [goid 1533] [pmid 10908733] [evidence IDA]; cell-cell adherens junction [goid 5913] [evidence NR ]; intermediate filament [goid 5882] [evidence NR ]; cornified envelope [goid 1533] [pmid 10908733] [evidence IDA],keratinocyte differentiation [goid 30216] [pmid 10908733] [evidence IDA]; peptide cross-linking [goid 18149] [pmid 10908733] [evidence IDA]; epidermis development [goid 8544] [pmid 9887343] [evidence TAS]; keratinocyte differentiation [goid 30216] [pmid 10908733] [evidence IDA]; peptide cross-linking [goid 18149] [pmid 10908733] [evidence IDA]; epidermis development [goid 8544] [pmid 9887343] [evidence TAS],"structural constituent of cytoskeleton [goid 5200] [pmid 9887343] [evidence TAS]; protein binding, bridging [goid 30674] [pmid 10908733] [evidence IDA]; structural constituent of cytoskeleton [goid 5200] [pmid 9887343] [evidence TAS]; protein binding, bridging [goid 30674] [pmid 10908733] [evidence IDA]",6,7531020-7531069,6p24.3c,+,NM_001008844.1,1832,DSP,1.1909022642118074,6.529463127122064,12.036671084581016,1.739353221769087e-24,1.7109625988768872e-23,44.67428697185851
TMEM16H,ILMN_1709124,"Homo sapiens transmembrane protein 16H (TMEM16H), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,19,17295236-17295285,19p13.11e,-,NM_020959.1,57719,TMEM16H,1.177734544365305,6.962758749501319,12.036023834884995,1.7467090721401886e-24,1.7173540597238768e-23,44.670082673074035
KCNK12,ILMN_1711988,"Homo sapiens potassium channel, subfamily K, member 12 (KCNK12), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [evidence IEA],potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [evidence IEA]; voltage-gated ion channel activity [goid 5244] [evidence IEA],2,47601456-47601505,2p16.3d,-,NM_022055.1,56660,KCNK12,1.8601994833047337,6.349721799713777,12.034863325182547,1.759975925744552e-24,1.7291973771056835e-23,44.662544465423025
NUBPL,ILMN_2048811,"Homo sapiens nucleotide binding protein-like (NUBPL), mRNA.",,,ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],14,31399175-31399224,14q12e,+,NM_025152.1,80224,NUBPL,1.8558484134092499,11.45850470547195,12.032951441684917,1.782052353742847e-24,1.7495242146068147e-23,44.650125750243106
LOC146439,ILMN_1803889,"PREDICTED: Homo sapiens hypothetical LOC146439 (LOC146439), mRNA.",,,,,,16p13.3d,,XM_940000.1,146439,LOC146439,1.2323994874683155,7.265527337846214,12.032747990462006,1.784417823533341e-24,1.7509873375799453e-23,44.648804233301945
TSPAN12,ILMN_1768115,"Homo sapiens tetraspanin 12 (TSPAN12), mRNA.",membrane fraction [goid 5624] [pmid 10719184] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 10719184] [evidence TAS],,,7,120215952-120216001,7q31.31d,-,NM_012338.3,23554,TSPAN12,-1.5465040040635403,7.175147781743462,-12.013750768164865,2.0196981613883638e-24,1.9760450275334174e-23,44.52541513391401
FLJ32130,ILMN_1676459,"Homo sapiens hypothetical protein FLJ32130 (FLJ32130), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],16,30499600-30499649,16p11.2c,-,NM_152458.4,146540,FLJ32130,1.3504162824316994,6.049746331702158,12.012716088037738,2.0333679357878065e-24,1.9874756062160446e-23,44.518695188830094
SFRP1,ILMN_2149164,"Homo sapiens secreted frizzled-related protein 1 (SFRP1), mRNA.",,cell differentiation [goid 30154] [evidence IEA]; Wnt receptor signaling pathway [goid 16055] [evidence IEA],,8,41239120-41239169,8p11.21b,-,NM_003012.3,6422,SFRP1,-2.1780860372325295,6.675209820102368,-12.007823464002026,2.0992699392323075e-24,2.0498874057667156e-23,44.486919617324155
KISS1R,ILMN_1673521,"Homo sapiens KISS1 receptor (KISS1R), mRNA.",integral to membrane [goid 16021] [pmid 11387329] [evidence IEP]; membrane [goid 16020] [evidence IEA],behavior [goid 7610] [pmid 11387329] [evidence NAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 11387329] [evidence NAS]; signal transduction [goid 7165] [evidence IEA],neuropeptide receptor activity [goid 8188] [pmid 11387329] [evidence IDA]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; protein binding [goid 5515] [pmid 11387329] [evidence IPI],19,871774-871823,19p13.3i,+,NM_032551.3,84634,KISS1R,2.1759021399266416,6.005253451957675,11.999444703759048,2.217123688684411e-24,2.1618036434306868e-23,44.432505314113946
LOC440731,ILMN_1683250,"PREDICTED: Homo sapiens hypothetical LOC440731, transcript variant 2 (LOC440731), mRNA.",,,,1,229725573-229725573:229729707-229729755,1q42.2a,-,XM_933693.1,440731,LOC440731,1.4696049973901548,6.651225781839158,11.997891211141395,2.2396904243748784e-24,2.182743595269974e-23,44.4224167632096
FLI1,ILMN_1665738,"Homo sapiens Friend leukemia virus integration 1 (FLI1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; hemostasis [goid 7599] [pmid 10891501] [evidence TAS]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10891501] [evidence TAS],11,128187303-128187352,11q24.3a,+,NM_002017.2,2313,FLI1,-1.188823909720976,5.658325436776812,-11.986065077272148,2.419176501863675e-24,2.3530813538788724e-23,44.34561985134067
LAMA3,ILMN_1688892,"Homo sapiens laminin, alpha 3 (LAMA3), transcript variant 1, mRNA.",basement membrane [goid 5604] [pmid 8586427] [evidence TAS]; laminin-1 [goid 5606] [evidence IEA],regulation of cell migration [goid 30334] [evidence IEA]; regulation of cell adhesion [goid 30155] [evidence IEA]; epidermis development [goid 8544] [pmid 8586427] [evidence TAS]; regulation of embryonic development [goid 45995] [evidence IEA],structural molecule activity [goid 5198] [pmid 8586427] [evidence NAS]; receptor binding [goid 5102] [evidence IEA],18,19787015-19787064,18q11.2b-q11.2c,+,NM_198129.1,3909,LAMA3,-1.1499155498245832,7.25027991538683,-11.981432346366452,2.4933435794048894e-24,2.4181686057553577e-23,44.3155372795237
DKFZp761B107,ILMN_1792276,"Homo sapiens hypothetical protein DKFZp761B107 (DKFZp761B107), mRNA.",,,,4,24437765-24437814,4p15.2c,-,NM_173463.2,91050,DKFZp761B107,1.4565488927534247,6.1391571481406375,11.980609183979798,2.506757612420866e-24,2.430000305683948e-23,44.31019218113494
HBG1,ILMN_1796678,"Homo sapiens hemoglobin, gamma A (HBG1), mRNA.",hemoglobin complex [goid 5833] [evidence IEA],transport [goid 6810] [evidence IEA]; oxygen transport [goid 15671] [evidence IEA],heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxygen transporter activity [goid 5344] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [evidence IEA],11,5226196-5226245,11p15.4c,-,NM_000559.2,3047,HBG1,-2.6892182586068465,6.510896126201171,-11.979904652143516,2.518295724925309e-24,2.4400029474239991e-23,44.30561741763597
BCORL1,ILMN_1767015,"Homo sapiens BCL6 co-repressor-like 1 (BCORL1), mRNA.",,,,X,129019070-129019119,Xq25h,+,NM_021946.2,63035,BCORL1,1.0900109571587997,6.349278253803095,11.977343176616595,2.5606939510809806e-24,2.4798821187428977e-23,44.28898506795408
ZNF579,ILMN_1761722,"Homo sapiens zinc finger protein 579 (ZNF579), mRNA.",nucleus [goid 5634] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],19,60780843-60780892,19q13.42c,-,NM_152600.1,163033,ZNF579,1.073608775478295,6.905962476838007,11.974206948042802,2.613578046134202e-24,2.5286493978265533e-23,44.268621071656824
CENPA,ILMN_1801257,"Homo sapiens centromere protein A, 17kDa (CENPA), mRNA.","nucleosome [goid 786] [evidence IEA]; chromosome, pericentric region [goid 775] [pmid 11084331] [evidence IDA]; chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [pmid 7962047] [evidence TAS]",nucleosome assembly [goid 6334] [evidence IEA]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [pmid 7962047] [evidence TAS],chromatin binding [goid 3682] [pmid 7962047] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],2,26870611-26870660,2p23.3a,+,NM_001809.2,1058,CENPA,1.07444624006646,6.23500857288597,11.970455967288862,2.6782632215337597e-24,2.588729011422583e-23,44.24426594914266
HSD17B7,ILMN_1671661,"Homo sapiens hydroxysteroid (17-beta) dehydrogenase 7 (HSD17B7), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],metabolism [goid 8152] [evidence IEA]; steroid biosynthesis [goid 6694] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; 3-keto-steroid reductase activity [goid 50576] [evidence IEA]; estradiol 17-beta-dehydrogenase activity [goid 4303] [pmid 10544267] [evidence TAS],1,161048944-161048993,1q23.3c,+,NM_016371.2,51478,HSD17B7,2.0012091809242385,12.827533279614588,11.96601799489196,2.7568643282227196e-24,2.662130380264487e-23,44.215450967073444
VGF,ILMN_1757497,"Homo sapiens VGF nerve growth factor inducible (VGF), mRNA.",,,growth factor activity [goid 8083] [evidence NAS],7,100592625-100592674,7q22.1d,-,NM_003378.2,7425,VGF,1.2962972118677438,5.6412221870307055,11.95885912655537,2.888541630153395e-24,2.783908522933965e-23,44.1689714689907
SLC1A1,ILMN_1658917,"Homo sapiens solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 (SLC1A1), mRNA.",membrane fraction [goid 5624] [pmid 7521911] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 7521911] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA]; synaptic transmission [goid 7268] [pmid 7521911] [evidence TAS]; dicarboxylic acid transport [goid 6835] [evidence IEA],symporter activity [goid 15293] [evidence IEA]; sodium:dicarboxylate symporter activity [goid 17153] [evidence IEA]; L-glutamate transporter activity [goid 5313] [pmid 7521911] [evidence TAS],9,4577281-4577330,9p24.2a,+,NM_004170.4,6505,SLC1A1,-1.708899723189119,6.960598074104323,-11.944450383356738,3.1729274876087034e-24,3.056520614928981e-23,44.075428362858105
NUP188,ILMN_1715416,"Homo sapiens nucleoporin 188kDa (NUP188), mRNA.",integral to membrane [goid 16021] [evidence IEA]; outer membrane [goid 19867] [evidence IEA],,porin activity [goid 15288] [evidence IEA],9,130808945-130808994,9q34.11c,+,NM_015354.1,23511,NUP188,1.0226078481840357,8.431008757429472,11.935881730716506,3.355139907712771e-24,3.228938877995052e-23,44.01980407999928
EVI2A,ILMN_1733579,"Homo sapiens ecotropic viral integration site 2A (EVI2A), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,transmembrane receptor activity [goid 4888] [pmid 2117566] [evidence NAS]; transmembrane receptor activity [goid 4888] [pmid 2117566] [evidence NAS],17,26669289-26669338,17q11.2d,-,NM_014210.2,2123,EVI2A,-1.1077650100509926,6.604514940033678,-11.934947848427152,3.375620206853677e-24,3.2470869759004024e-23,44.01374188468597
AGMAT,ILMN_1707169,"Homo sapiens agmatine ureohydrolase (agmatinase) (AGMAT), mRNA.",mitochondrion [goid 5739] [evidence IEA],arginine catabolism [goid 6527] [evidence IEA]; putrescine biosynthesis [goid 9446] [evidence IEA]; spermidine biosynthesis [goid 8295] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; arginase activity [goid 4053] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; agmatinase activity [goid 8783] [evidence IEA],1,15771847-15771896,1p36.21a,-,NM_024758.3,79814,AGMAT,1.1529808298115203,5.617883609406128,11.931778121800034,3.446069132358022e-24,3.3116691258510714e-23,43.99316623889642
ZADH1,ILMN_2105253,"Homo sapiens zinc binding alcohol dehydrogenase, domain containing 1 (ZADH1), mRNA.",cytoplasm [goid 5737] [evidence NAS]; cytoplasm [goid 5737] [evidence NAS],,zinc ion binding [goid 8270] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence NAS]; zinc ion binding [goid 8270] [evidence NAS]; oxidoreductase activity [goid 16491] [evidence NAS],14,73421462-73421511,14q24.3a,+,NM_152444.1,145482,ZADH1,1.5552844952710254,7.627609587551957,11.930805073034634,3.467988946309979e-24,3.3311340776653895e-23,43.986849977652156
CLCF1,ILMN_1661197,"Homo sapiens cardiotrophin-like cytokine factor 1 (CLCF1), mRNA.",extracellular space [goid 5615] [evidence IEA],cytokine and chemokine mediated signaling pathway [goid 19221] [pmid 10500198] [evidence NAS]; positive regulation of tyrosine phosphorylation of Stat3 protein [goid 42517] [pmid 14632778] [evidence TAS]; negative regulation of apoptosis [goid 43066] [pmid 14632778] [evidence TAS]; JAK-STAT cascade [goid 7259] [evidence ISS],cytokine activity [goid 5125] [pmid 10500198] [evidence NAS]; growth factor activity [goid 8083] [pmid 14632778] [evidence TAS],11,66888452-66888501,11q13.1f,-,NM_013246.2,23529,CLCF1,1.3452804983173259,7.830233550028195,11.929867106792809,3.489250304192832e-24,3.3483414909491694e-23,43.98076148443533
ATAD2,ILMN_2048700,"Homo sapiens ATPase family, AAA domain containing 2 (ATAD2), mRNA.",,,nucleoside-triphosphatase activity [goid 17111] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],8,124407324-124407373,8q24.13b-q24.13c,-,NM_014109.2,29028,ATAD2,1.228120122404925,6.5362247908376165,11.924230995611472,3.619777368793914e-24,3.471533208009387e-23,43.944177390421586
ANGPTL7,ILMN_1813361,"Homo sapiens angiopoietin-like 7 (ANGPTL7), mRNA.",soluble fraction [goid 5625] [evidence NR ]; cytoplasm [goid 5737] [evidence NR ],response to oxidative stress [goid 6979] [pmid 8026862] [evidence TAS],,1,11178290-11178339,1p36.22b,+,NM_021146.2,10218,ANGPTL7,-1.0457297817827023,5.456831636494698,-11.924175080012652,3.621096463972207e-24,3.471533208009387e-23,43.94381444846999
IL17RD,ILMN_1728663,"Homo sapiens interleukin 17 receptor D (IL17RD), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,transmembrane receptor activity [goid 4888] [evidence IEA],3,57103755-57103804,3p14.3b,-,NM_017563.1,54756,IL17RD,1.122068370652216,8.09054372697843,11.922973673014033,3.6495549498741575e-24,3.49546651206712e-23,43.93601628291134
DTWD2,ILMN_1794882,"Homo sapiens DTW domain containing 2 (DTWD2), mRNA.",,,,5,118204603-118204652,5q23.1c,-,NM_173666.1,285605,DTWD2,1.0166803978065628,8.359544183340159,11.922708319419659,3.655870613456964e-24,3.4998401547390874e-23,43.9342939184527
DEPDC6,ILMN_1756685,"Homo sapiens DEP domain containing 6 (DEPDC6), mRNA.",intracellular [goid 5622] [pmid 11256614] [evidence IDA]; intracellular [goid 5622] [pmid 11256614] [evidence IDA],intracellular signaling cascade [goid 7242] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],protein binding [goid 5515] [evidence IEA]; protein binding [goid 5515] [evidence IEA],8,121131437-121131486,8q24.12c,+,NM_022783.1,64798,DEPDC6,1.383634414385539,7.528814297714149,11.915147291447362,3.8404919487982386e-24,3.673067060781796e-23,43.88521792764973
WDR24,ILMN_1761442,"Homo sapiens WD repeat domain 24 (WDR24), mRNA.",,,,16,674837-674886,16p13.3f,-,NM_032259.1,84219,WDR24,1.0756808248461587,7.266844188239445,11.913503464554976,3.8818468411463435e-24,3.7108452746132847e-23,43.87454876517216
FLJ10986,ILMN_1737604,"Homo sapiens hypothetical protein FLJ10986 (FLJ10986), mRNA.",,carbohydrate metabolism [goid 5975] [evidence IEA],,1,59912323-59912372,1p32.1d-p32.1c,+,NM_018291.2,55277,FLJ10986,-1.4325507442527314,9.894104172531648,-11.904571639226454,4.114451657418119e-24,3.9294486282397e-23,43.816579432980156
FLJ23754,ILMN_1716546,"Homo sapiens hypothetical protein FLJ23754 (FLJ23754), mRNA.",,,,17,77663496-77663545,,-,NM_152675.1,201252,FLJ23754,1.3771724944258228,6.23225200446766,11.903735743736059,4.1369202579898734e-24,3.947138794557052e-23,43.811154491471235
FOXF2,ILMN_1674934,"Homo sapiens forkhead box F2 (FOXF2), mRNA.",transcription factor complex [goid 5667] [pmid 9722567] [evidence TAS]; nucleus [goid 5634] [pmid 9722567] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [evidence NR ]",transcription coactivator activity [goid 3713] [evidence NR ]; RNA polymerase II transcription factor activity [goid 3702] [evidence NR ]; transcription factor activity [goid 3700] [pmid 9722567] [evidence NAS],6,1340322-1340371,6p25.3a,+,NM_001452.1,2295,FOXF2,-1.3507342990768212,7.570376268240774,-11.89976784985109,4.2452593811000556e-24,4.0427962730628234e-23,43.78540339568101
DRD4,ILMN_2112915,"Homo sapiens dopamine receptor D4 (DRD4), mRNA.",plasma membrane [goid 5886] [pmid 1319557] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 1319557] [evidence TAS]; membrane [goid 16020] [pmid 8746407] [evidence NAS],synaptic transmission [goid 7268] [pmid 8413587] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA]; dopamine receptor signaling pathway [goid 7212] [pmid 8746407] [evidence NAS],receptor activity [goid 4872] [evidence IEA]; dopamine receptor activity [goid 4952] [pmid 8746407] [evidence NAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],11,630535-630584,11p15.5d,+,NM_000797.2,1815,DRD4,1.2552068352427517,6.341329692896866,11.8926381759704,4.447099134582906e-24,4.230982381585106e-23,43.739134606665125
F2RL1,ILMN_1673113,"Homo sapiens coagulation factor II (thrombin) receptor-like 1 (F2RL1), mRNA.",integral to plasma membrane [goid 5887] [pmid 8615752] [evidence TAS]; plasma membrane [goid 5886] [pmid 8615752] [evidence TAS]; Golgi apparatus [goid 5794] [pmid 8615752] [evidence TAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 7556175] [evidence TAS]; blood coagulation [goid 7596] [evidence IEA],receptor binding [goid 5102] [pmid 8615752] [evidence TAS]; receptor activity [goid 4872] [pmid 8615752] [evidence TAS]; thrombin receptor activity [goid 15057] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],5,76166279-76166328,5q13.3d,+,NM_005242.3,2150,F2RL1,1.2835325438639007,7.70082054542061,11.892491172706487,4.4513601132858116e-24,4.2330234385276864e-23,43.738180637969805
LOC729603,ILMN_2180519,Homo sapiens calcium binding protein P22 pseudogene (LOC729603) on chromosome 6.,,,,,,6q25.3f,,NR_003288.1,729603,LOC729603,1.1325664034470577,14.320533499399282,11.89079613700433,4.50078739876992e-24,4.277993077177603e-23,43.72718088021485
LAPTM4B,ILMN_1680196,"Homo sapiens lysosomal associated protein transmembrane 4 beta (LAPTM4B), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],transport [goid 6810] [evidence IEA]; transport [goid 6810] [evidence IEA],,8,98933500-98933549,8q22.1e,+,NM_018407.4,55353,LAPTM4B,1.0517369075617875,11.927593038939712,11.88357850233362,4.7174662131164634e-24,4.475441630727084e-23,43.68034429642687
ADC,ILMN_1659599,"Homo sapiens arginine decarboxylase (ADC), mRNA.",,polyamine biosynthesis [goid 6596] [evidence IEA]; spermatogenesis [goid 7283] [pmid 11587527] [evidence NAS],arginine decarboxylase activity [goid 8792] [evidence IEA]; lyase activity [goid 16829] [evidence IEA],1,33358486-33358535,1p35.1a,+,NM_052998.2,113451,ADC,1.120348486120636,6.635366363312841,11.882779633674756,4.742080464277428e-24,4.496660944514824e-23,43.675160438364685
FOXA3,ILMN_1792733,"Homo sapiens forkhead box A3 (FOXA3), mRNA.",nucleus [goid 5634] [pmid 7739897] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; specific RNA polymerase II transcription factor activity [goid 3704] [evidence NR ]; transcription factor activity [goid 3700] [pmid 7739897] [evidence TAS],19,51068733-51068782,19q13.32a,+,NM_004497.2,3171,FOXA3,1.9148119454846269,6.531769281827613,11.880727494847031,4.805899426342369e-24,4.555018272016017e-23,43.661844249065325
LOC123688,ILMN_1708351,"Homo sapiens similar to RIKEN cDNA C630028N24 gene (LOC123688), mRNA.",,,,15,76607527-76607576,15q25.1a,+,NM_001013619.1,123688,LOC123688,1.3687093116265956,6.929660658933477,11.87148363874302,5.1041775049566545e-24,4.833146404125544e-23,43.60186396600553
USP49,ILMN_1680279,"Homo sapiens ubiquitin specific peptidase 49 (USP49), mRNA.",,ubiquitin-dependent protein catabolism [goid 6511] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; ubiquitin thiolesterase activity [goid 4221] [evidence IEA]; cysteine-type endopeptidase activity [goid 4197] [evidence IEA],6,41873670-41873719,6p21.1f,-,NM_018561.3,25862,USP49,2.030808409654581,12.024532993859198,11.86643785956359,5.2747240642385866e-24,4.992274317752395e-23,43.56912531230954
CLDN3,ILMN_1723042,"Homo sapiens claudin 3 (CLDN3), mRNA.",integral to plasma membrane [goid 5887] [pmid 9334247] [evidence TAS]; membrane [goid 16020] [evidence IEA]; tight junction [goid 5923] [evidence ISS],calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA]; transmembrane receptor activity [goid 4888] [pmid 9334247] [evidence TAS],7,72821281-72821330,7q11.23b,-,NM_001306.2,1365,CLDN3,1.9736805091221115,9.241635230676987,11.862334762119174,5.4175961958642305e-24,5.120229791537625e-23,43.54250398275261
SCGB1A1,ILMN_1655347,"Homo sapiens secretoglobin, family 1A, member 1 (uteroglobin) (SCGB1A1), mRNA.",,signal transduction [goid 7165] [pmid 10587371] [evidence NAS]; embryo implantation [goid 7566] [pmid 10587371] [evidence TAS],phospholipase A2 inhibitor activity [goid 19834] [evidence IEA]; steroid binding [goid 5496] [evidence IEA]; cytokine activity [goid 5125] [evidence NR ],11,61947151-61947200,11q12.3a,+,NM_003357.3,7356,SCGB1A1,-4.528658567315782,11.633314775645596,-11.858305628299888,5.5616542603619164e-24,5.2489423793076056e-23,43.516363325232994
RNUXA,ILMN_1728074,"Homo sapiens RNA U, small nuclear RNA export adaptor (phosphorylation regulated) (RNUXA), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],protein transport [goid 15031] [evidence IEA]; protein transport [goid 15031] [evidence IEA],RNA binding [goid 3723] [evidence IEA]; RNA binding [goid 3723] [evidence IEA],5,125988351-125988400,5q23.2e,+,NM_032177.2,51808,RNUXA,1.15360653372647,8.634907832823098,11.854122013122916,5.7152865990636714e-24,5.386314379371924e-23,43.48922123662667
LOC643011,ILMN_1719072,"PREDICTED: Homo sapiens hypothetical protein LOC643011 (LOC643011), mRNA.",,,,13,95124628-95124677,,-,XM_931238.1,643011,LOC643011,1.2320408750221823,6.818536936610508,11.841466737719113,6.206310591885483e-24,5.832590996826903e-23,43.407122644952
EMR3,ILMN_1755873,"Homo sapiens egf-like module containing, mucin-like, hormone receptor-like 3 (EMR3), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 15203201] [evidence TAS],signal transduction [goid 7165] [evidence IEA]; neuropeptide signaling pathway [goid 7218] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity [goid 4930] [pmid 15203201] [evidence TAS],19,14591257-14591283:14597304-14597326,19p13.12b,-,NM_032571.2,84658,EMR3,-1.0218295148012269,5.5214588089908245,-11.839735093737348,6.276698007462859e-24,5.895970597808305e-23,43.39588955773698
PCDHB19P,ILMN_1690237,Homo sapiens protocadherin beta 19 pseudogene (PCDHB19P) on chromosome 5.,,,,5,140604365-140604414,5q31.3b,+,NR_001282.1,84054,PCDHB19P,2.0010114701403205,8.48649333539967,11.833982871378433,6.51628745747946e-24,6.109553863601173e-23,43.35857624255682
ABCA6,ILMN_1701551,"Homo sapiens ATP-binding cassette, sub-family A (ABC1), member 6 (ABCA6), transcript variant 2, mRNA.",,,ATPase activity [goid 16887] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; kinase activity [goid 16301] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],17,64588814-64588863,17q24.2c-q24.3a,-,NM_172346.1,23460,ABCA6,-1.03898516873174,6.714196143498996,-11.825848825573596,6.870758284045787e-24,6.438882049048623e-23,43.30581539748399
C18orf56,ILMN_1796074,"Homo sapiens chromosome 18 open reading frame 56 (C18orf56), mRNA.",,,,18,639651-639700,18p11.32c,-,NM_001012716.1,494514,C18orf56,1.4369676557199593,6.422204668079924,11.824699774567442,6.92236150981134e-24,6.484204545332645e-23,43.29836243466237
NLRP8,ILMN_2075794,"Homo sapiens NLR family, pyrin domain containing 8 (NLRP8), mRNA.",,,transferase activity [goid 16740] [evidence IEA],19,61191460-61191509,19q13.42c,+,NM_176811.2,126205,NLRP8,2.123025802418047,13.123046714239367,11.821305222475008,7.077081317867189e-24,6.626029153387305e-23,43.276345111587936
AXUD1,ILMN_1703123,"Homo sapiens AXIN1 up-regulated 1 (AXUD1), mRNA.",nucleus [goid 5634] [evidence IEA],apoptosis [goid 6915] [evidence IEA],,3,39158376-39158425,3p22.2a,-,NM_033027.2,64651,AXUD1,-1.6226334981597255,11.95357237092461,-11.820962155303643,7.092908856765285e-24,6.637741833777354e-23,43.27411998394618
TUB,ILMN_1755352,"Homo sapiens tubby homolog (mouse) (TUB), transcript variant 2, mRNA.",nucleus [goid 5634] [pmid 11000483] [evidence TAS]; cytoplasm [goid 5737] [pmid 11000483] [evidence TAS]; nucleus [goid 5634] [pmid 11000483] [evidence TAS]; cytoplasm [goid 5737] [pmid 11000483] [evidence TAS],,,11,8083980-8084029,11p15.4b,+,NM_177972.1,7275,TUB,-1.0304064210667887,6.03316914152665,-11.819955200980107,7.139569595967072e-24,6.675163947481737e-23,43.267588930021425
SERINC1,ILMN_1741613,"Homo sapiens serine incorporator 1 (SERINC1), mRNA.",plasma membrane [goid 5886] [evidence ISS]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum membrane [goid 5789] [evidence ISS],positive regulation of transferase activity [goid 51347] [evidence ISS]; sphingolipid metabolism [goid 6665] [evidence ISS]; phosphatidylserine metabolism [goid 6658] [evidence ISS]; L-serine transport [goid 15825] [evidence ISS],L-serine transporter activity [goid 15194] [evidence ISS]; protein binding [goid 5515] [evidence ISS],6,122806526-122806575,6q22.31c,-,NM_020755.2,57515,SERINC1,-1.0560208306726562,9.796561922849179,-11.810796644374529,7.578293082577356e-24,7.078734266863107e-23,43.208189347683536
APOBEC3G,ILMN_1802106,"Homo sapiens apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],response to virus [goid 9615] [evidence IEA]; RNA metabolism [goid 16070] [pmid 11863358] [evidence NAS]; negative regulation of retroviral genome replication [goid 45869] [pmid 15031497] [evidence NAS]; innate immune response [goid 45087] [pmid 15031497] [evidence NAS]; response to virus [goid 9615] [evidence IEA]; RNA metabolism [goid 16070] [pmid 11863358] [evidence NAS]; negative regulation of retroviral genome replication [goid 45869] [pmid 15031497] [evidence NAS]; innate immune response [goid 45087] [pmid 15031497] [evidence NAS],hydrolase activity [goid 16787] [evidence IEA]; RNA binding [goid 3723] [pmid 11863358] [evidence IDA]; protein homodimerization activity [goid 42803] [pmid 11863358] [evidence NAS]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 11863358] [evidence IDA]; cytidine deaminase activity [goid 4126] [pmid 15031497] [evidence NAS]; protein binding [goid 5515] [pmid 12859895] [evidence IPI]; hydrolase activity [goid 16787] [evidence IEA]; RNA binding [goid 3723] [pmid 11863358] [evidence IDA]; protein homodimerization activity [goid 42803] [pmid 11863358] [evidence NAS]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 11863358] [evidence IDA]; cytidine deaminase activity [goid 4126] [pmid 15031497] [evidence NAS]; protein binding [goid 5515] [pmid 12859895] [evidence IPI],22,37812266-37812315,22q13.1c,+,NM_021822.1,60489,APOBEC3G,-1.2992119915215081,7.642121378162958,-11.804421677447113,7.899473070677925e-24,7.37529898264694e-23,43.166845779575134
CTGF,ILMN_1699829,"Homo sapiens connective tissue growth factor (CTGF), mRNA.",extracellular space [goid 5615] [evidence NR ]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10809757] [evidence TAS]; soluble fraction [goid 5625] [evidence NR ]; plasma membrane [goid 5886] [pmid 10809757] [evidence TAS]; plasma membrane [goid 5886] [pmid 10809757] [evidence TAS]; extracellular region [goid 5576] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10809757] [evidence TAS]; extracellular space [goid 5615] [evidence NR ]; soluble fraction [goid 5625] [evidence NR ],epidermis development [goid 8544] [pmid 10809757] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; response to wounding [goid 9611] [pmid 10809757] [evidence TAS]; regulation of cell growth [goid 1558] [evidence IEA]; DNA replication [goid 6260] [evidence IEA]; cell motility [goid 6928] [evidence NR ]; cell motility [goid 6928] [evidence NR ]; response to wounding [goid 9611] [pmid 10809757] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; DNA replication [goid 6260] [evidence IEA]; regulation of cell growth [goid 1558] [evidence IEA]; epidermis development [goid 8544] [pmid 10809757] [evidence TAS],insulin-like growth factor binding [goid 5520] [pmid 9371786] [evidence TAS]; protein binding [goid 5515] [evidence IEA]; heparin binding [goid 8201] [evidence IEA]; insulin-like growth factor binding [goid 5520] [pmid 9371786] [evidence TAS]; heparin binding [goid 8201] [evidence IEA]; protein binding [goid 5515] [evidence IEA],6,132311203-132311252,6q23.2b,-,NM_001901.2,1490,CTGF,-1.311211613113306,12.79181932049203,-11.804110791993132,7.915479066943589e-24,7.386795950158924e-23,43.16482964728514
LOC401115,ILMN_1668629,"PREDICTED: Homo sapiens hypothetical gene supported by BC038466; BC062790 (LOC401115), mRNA.",,,,,,4p16.3b,,XM_937968.1,401115,LOC401115,1.1358753341607652,11.98749864776552,11.801388358397135,8.057035373202053e-24,7.511890202564151e-23,43.14717452491938
FCMD,ILMN_2357386,"Homo sapiens Fukuyama type congenital muscular dystrophy (fukutin) (FCMD), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; extracellular space [goid 5615] [pmid 9690476] [evidence TAS]; extracellular space [goid 5615] [pmid 9690476] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA],muscle development [goid 7517] [pmid 9690476] [evidence TAS]; muscle development [goid 7517] [pmid 9690476] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],9,,9q31.2a,+,NM_006731.1,2218,FCMD,1.1229945295209216,13.91669811744032,11.800309830442323,8.113811618013777e-24,7.56130148361526e-23,43.14018032028186
MAFB,ILMN_1764709,"Homo sapiens v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) (MAFB), mRNA.",nucleus [goid 5634] [pmid 8001130] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; sensory organ development [goid 7423] [pmid 8001130] [evidence TAS]",DNA binding [goid 3677] [evidence IEA],20,38748223-38748272,20q12b,-,NM_005461.3,9935,MAFB,-1.1227100698674946,10.069686261250123,-11.799897607799739,8.135617402286028e-24,7.578092783283932e-23,43.13750709096295
SLCO2A1,ILMN_1705231,"Homo sapiens solute carrier organic anion transporter family, member 2A1 (SLCO2A1), mRNA.",membrane fraction [goid 5624] [pmid 8787677] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8787677] [evidence TAS]; membrane [goid 16020] [evidence IEA],lipid transport [goid 6869] [pmid 8787677] [evidence TAS],lipid transporter activity [goid 5319] [pmid 8787677] [evidence TAS],3,135134380-135134429,3q22.1e,-,NM_005630.1,6578,SLCO2A1,-1.580221553348041,10.959415539391223,-11.795811376653505,8.354962769692495e-24,7.778785253420543e-23,43.11100869561484
SLC25A37,ILMN_1715969,"Homo sapiens solute carrier family 25, member 37 (SLC25A37), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; mitochondrial inner membrane [goid 5743] [evidence IEA],transport [goid 6810] [evidence IEA],binding [goid 5488] [evidence IEA],8,23485399-23485448,8p21.2d,+,NM_016612.1,51312,SLC25A37,1.5453933585999255,9.377511324814135,11.79109176591617,8.615669279010192e-24,8.006609890127075e-23,43.08040402891309
ALPP,ILMN_1693789,"Homo sapiens alkaline phosphatase, placental (Regan isozyme) (ALPP), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],metabolism [goid 8152] [evidence IEA],alkaline phosphatase activity [goid 4035] [pmid 3042787] [evidence NAS]; magnesium ion binding [goid 287] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],2,232955647-232955696,2q37.1c,+,NM_001632.2,250,ALPP,1.8832375304401285,12.68310294833815,11.790700504974259,8.637643465927114e-24,8.02330410706916e-23,43.07786691984573
NUPR1,ILMN_2404688,"Homo sapiens nuclear protein 1 (NUPR1), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 10092851] [evidence IDA],cell growth [goid 16049] [pmid 10092851] [evidence IDA]; induction of apoptosis [goid 6917] [evidence NAS],,,,16p11.2e,,NM_001042483.1,26471,NUPR1,-1.3387940627805879,10.135700006788046,-11.785984357852556,8.90696001256056e-24,8.26962672535089e-23,43.04728595869008
GIMAP2,ILMN_1689371,"Homo sapiens GTPase, IMAP family member 2 (GIMAP2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],7,150021053-150021102,7q36.1c,+,NM_015660.2,26157,GIMAP2,-1.2220779668159016,6.114652338073961,-11.785345816369539,8.944063065822564e-24,8.296375235094013e-23,43.04314554627605
TDRD1,ILMN_1809750,"Homo sapiens tudor domain containing 1 (TDRD1), mRNA.",,,nucleic acid binding [goid 3676] [evidence IEA],10,115981532-115981581,10q25.3a,+,NM_198795.1,56165,TDRD1,2.120696647175473,9.666943538576692,11.782489201494604,9.111948757771227e-24,8.444273772370851e-23,43.02462302546307
CRTC1,ILMN_1699843,"Homo sapiens CREB regulated transcription coactivator 1 (CRTC1), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 14506290] [evidence IDA],"transcription [goid 6350] [evidence IEA]; positive regulation of transcription from RNA polymerase II promoter [goid 45944] [pmid 14536081] [evidence IDA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",protein binding [goid 5515] [pmid 14506290] [evidence IPI]; cAMP response element binding protein binding [goid 8140] [pmid 14536081] [evidence IDA],19,18749276-18749325,19p13.11b,+,NM_015321.1,23373,CRTC1,1.1501234894405128,6.108354387307657,11.779280135544193,9.304305532639503e-24,8.606590157052759e-23,43.00381569075992
FAT,ILMN_1754795,"Homo sapiens FAT tumor suppressor homolog 1 (Drosophila) (FAT), mRNA.",integral to plasma membrane [goid 5887] [pmid 8586420] [evidence TAS]; membrane [goid 16020] [evidence IEA],morphogenesis [goid 9653] [pmid 8586420] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 8586420] [evidence TAS]; cell adhesion [goid 7155] [pmid 8586420] [evidence TAS]; homophilic cell adhesion [goid 7156] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],4,187746056-187746105,4q35.2a,-,NM_005245.3,2195,FAT,1.1823936122390215,9.833172199855674,11.777474437560384,9.414319964119175e-24,8.704330584200391e-23,42.99210792167102
LOC401622,ILMN_1660568,"Homo sapiens similar to LINE-1 reverse transcriptase homolog (LOC401622), mRNA.",,RNA-dependent DNA replication [goid 6278] [evidence IEA],RNA-directed DNA polymerase activity [goid 3964] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; RNA binding [goid 3723] [evidence IEA],X,154237948-154237997,,+,NM_001013689.1,401622,LOC401622,1.0470181548932231,5.840112796167061,11.776630874545015,9.46615948136596e-24,8.748217963194925e-23,42.9866384935295
LOC647606,ILMN_1804010,"PREDICTED: Homo sapiens hypothetical protein LOC647606 (LOC647606), mRNA.",,,,,,,,XM_937260.1,647606,LOC647606,1.0415374400308943,5.8669713948807,11.77383148126772,9.640242597628261e-24,8.904984944291147e-23,42.96848827295656
LOC441268,ILMN_1675258,"Homo sapiens hypothetical gene supported by BC044942 (LOC441268), mRNA.",,,,7,97394601-97394650,7q21.3d,-,NM_001013725.1,441268,LOC441268,1.6844969745343787,7.244127057363998,11.766442152846539,1.0115270975871472e-23,9.330859459900248e-23,42.92058060817426
AXIN2,ILMN_1724480,"Homo sapiens axin 2 (conductin, axil) (AXIN2), mRNA.",nucleus [goid 5634] [pmid 12072559] [evidence IDA]; intracellular [goid 5622] [evidence IEA],development [goid 7275] [evidence IEA]; frizzled signaling pathway [goid 7222] [evidence IEA]; signal transduction [goid 7165] [pmid 10049590] [evidence TAS],signal transducer activity [goid 4871] [evidence IEA],17,60955365-60955414,17q24.1a,-,NM_004655.2,8313,AXIN2,-1.3089697895845802,9.49100590216868,-11.754776656550023,1.0913234684889682e-23,1.0048412313634273e-22,42.8449549045779
MYO6,ILMN_1727080,"Homo sapiens myosin VI (MYO6), mRNA.",unconventional myosin [goid 16461] [pmid 9259267] [evidence TAS],actin filament-based movement [goid 30048] [pmid 10519557] [evidence NAS]; striated muscle contraction [goid 6941] [evidence NAS],"actin binding [goid 3779] [pmid 10519557] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; calmodulin binding [goid 5516] [evidence IEA]; structural constituent of muscle [goid 8307] [evidence NAS]; microfilament motor activity [goid 146] [pmid 10519557] [evidence NAS]; ATP binding [goid 5524] [evidence NAS]; ATPase activity, coupled [goid 42623] [evidence NR ]; motor activity [goid 3774] [evidence IEA]",6,76681376-76681425,6q14.1a,+,NM_004999.2,4646,MYO6,1.0476078994873825,7.856803845400277,11.754337838587084,1.0944448669337174e-23,1.0072517432203228e-22,42.84211025363355
ZNF14,ILMN_1692145,"Homo sapiens zinc finger protein 14 (ZNF14), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],19,19682836-19682885,19p13.11a,-,NM_021030.2,7561,ZNF14,1.0181776762225176,9.170061292186412,11.747710472101254,1.1426856928921212e-23,1.0506826904129394e-22,42.79914940259824
HLF,ILMN_1722829,"Homo sapiens hepatic leukemia factor (HLF), mRNA.",nucleus [goid 5634] [pmid 1386162] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 8639829] [evidence TAS]; rhythmic process [goid 48511] [evidence IEA]; development [goid 7275] [pmid 1386162] [evidence TAS]",double-stranded DNA binding [goid 3690] [pmid 1386162] [evidence TAS],17,50755617-50755666,17q22b,+,NM_002126.3,3131,HLF,-1.4560601816964818,6.916762828371095,-11.743484872888143,1.1745469566646853e-23,1.078491762686876e-22,42.77175886105018
TRIM38,ILMN_1697971,"Homo sapiens tripartite motif-containing 38 (TRIM38), mRNA.",intracellular [goid 5622] [evidence IEA],positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; protein binding [goid 5515] [evidence IEA],6,26093123-26093172,6p22.2a,+,NM_006355.2,10475,TRIM38,1.0876769759696705,8.089372388144188,11.74082345961277,1.1950680568029846e-23,1.096831269748354e-22,42.75450794502645
SNAI2,ILMN_1655740,"Homo sapiens snail homolog 2 (Drosophila) (SNAI2), mRNA.",nucleus [goid 5634] [pmid 10866665] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; ectoderm and mesoderm interaction [goid 7499] [pmid 9182671] [evidence TAS]; transcription [goid 6350] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 10866665] [evidence TAS]; development [goid 7275] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],8,49993911-49993918:49993919-49993960,8q11.21c,-,NM_003068.3,6591,SNAI2,-1.3259361394601843,6.8042085637789,-11.737904045584772,1.2179906060564702e-23,1.1163333049004973e-22,42.73558514528197
SLC6A8,ILMN_1806349,"Homo sapiens solute carrier family 6 (neurotransmitter transporter, creatine), member 8 (SLC6A8), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence IEA],ion transport [goid 6811] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA]; neurotransmitter transport [goid 6836] [evidence IEA]; neurotransmitter uptake [goid 1504] [evidence NR ]; muscle contraction [goid 6936] [pmid 8661155] [evidence TAS],symporter activity [goid 15293] [evidence IEA]; neurotransmitter:sodium symporter activity [goid 5328] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA]; creatine:sodium symporter activity [goid 5309] [pmid 7953292] [evidence TAS],X,152614922-152614971,Xq28f,+,NM_005629.1,6535,SLC6A8,1.3903508072100168,6.8840743694544795,11.732401532526975,1.2623957019694309e-23,1.15491601303175e-22,42.69992070357324
CLC,ILMN_1654875,"Homo sapiens Charcot-Leyden crystal protein (CLC), mRNA.",,development [goid 7275] [pmid 8400237] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 8400237] [evidence TAS]; lipid catabolism [goid 16042] [evidence IEA]; phospholipid metabolism [goid 6644] [evidence NR ],hydrolase activity [goid 16787] [evidence IEA]; serine esterase activity [goid 4759] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; lysophospholipase activity [goid 4622] [evidence IEA],19,44916827-44916876,19q13.2b,-,NM_001828.4,1178,CLC,-2.0680001048908148,6.041850389502185,-11.732287580490327,1.2633321816178625e-23,1.1552445287847437e-22,42.699182142910786
MMP23A,ILMN_1790052,"Homo sapiens matrix metallopeptidase 23A (MMP23A), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9740677] [evidence NAS]; intracellular [goid 5622] [evidence ISS],,metalloendopeptidase activity [goid 4222] [pmid 9740677] [evidence NAS]; zinc ion binding [goid 8270] [evidence ISS],1,1559525-1559570:1559690-1559693,1p36.33a,+,NM_004659.1,8511,MMP23A,-1.0931400420410613,7.367146955985401,-11.731495862309064,1.2698578601085648e-23,1.1601514184955327e-22,42.69405077634659
CYCSL1,ILMN_1663751,"Homo sapiens cytochrome c, somatic-like 1 (CYCSL1) on chromosome 6.",,,,6,34295306-34295355,6p21.31e,+,NR_001561.1,157317,CYCSL1,1.1058314409124836,8.728078304689985,11.724101754246869,1.33245233487631e-23,1.2162274779290697e-22,42.64612896982766
RASL11A,ILMN_1651902,"Homo sapiens RAS-like, family 11, member A (RASL11A), mRNA.",membrane [goid 16020] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],13,26745521-26745570,13q12.2a,+,NM_206827.1,387496,RASL11A,-1.4128686353831421,6.789159618366904,-11.720884633971544,1.360640076157829e-23,1.2403162299141934e-22,42.625279494622994
CP,ILMN_1813206,"Homo sapiens ceruloplasmin (ferroxidase) (CP), mRNA.",extracellular space [goid 5615] [pmid 7708681] [evidence TAS],ion transport [goid 6811] [evidence IEA]; iron ion homeostasis [goid 6879] [pmid 9445478] [evidence TAS]; copper ion transport [goid 6825] [evidence IEA]; copper ion homeostasis [goid 6878] [evidence NR ],metal ion binding [goid 46872] [evidence IEA]; ferroxidase activity [goid 4322] [pmid 7708681] [evidence TAS]; copper ion binding [goid 5507] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; copper ion transporter activity [goid 5375] [evidence IEA],3,150387020-150387069,3q24f-q25.1a,-,NM_000096.1,1356,CP,1.9591503848046523,6.426252853065944,11.720877551790343,1.36070278121834e-23,1.2403162299141934e-22,42.62523359713658
ABHD5,ILMN_1655702,"Homo sapiens abhydrolase domain containing 5 (ABHD5), mRNA.",,aromatic compound metabolism [goid 6725] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; aminopeptidase activity [goid 4177] [evidence IEA],3,43735013-43735028:43735029-43735062,3p21.33e,+,NM_016006.3,51099,ABHD5,-1.0057090958712225,7.828545279530479,-11.71849582312119,1.381954965803987e-23,1.259114524399188e-22,42.609798487202156
HLA-DQA1,ILMN_1808405,"PREDICTED: Homo sapiens major histocompatibility complex, class II, DQ alpha 1, transcript variant 2 (HLA-DQA1), mRNA.",,,,,,6p21.32b,,XM_936120.1,3117,HLA-DQA1,-1.892284422639209,12.35269056042396,-11.717751021571042,1.3886686434046572e-23,1.2640801736688071e-22,42.60497176596705
TUFT1,ILMN_1781374,"Homo sapiens tuftelin 1 (TUFT1), mRNA.",extracellular region [goid 5576] [pmid 12489194] [evidence NAS],bone mineralization [goid 30282] [pmid 12489194] [evidence NAS]; odontogenesis [goid 42476] [pmid 12489194] [evidence NAS],structural constituent of tooth enamel [goid 30345] [pmid 12489194] [evidence NAS],1,149822458-149822507,1q21.3a,+,NM_020127.1,7286,TUFT1,1.0673856547886196,9.334743855907867,11.714212541983995,1.4210124181311165e-23,1.2929339000439918e-22,42.582040903956255
SSTR1,ILMN_1673998,"Homo sapiens somatostatin receptor 1 (SSTR1), mRNA.",plasma membrane [goid 5886] [pmid 1346068] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 1346068] [evidence TAS],"negative regulation of cell proliferation [goid 8285] [pmid 9886848] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 1346068] [evidence TAS]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 8405411] [evidence TAS]; digestion [goid 7586] [pmid 1346068] [evidence TAS]; response to nutrient [goid 7584] [pmid 1346068] [evidence TAS]",receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; somatostatin receptor activity [goid 4994] [pmid 1346068] [evidence IDA],14,37751342-37751391,14q21.1a,+,NM_001049.2,6751,SSTR1,-1.1866511845156156,5.554837637287775,-11.714126871470139,1.4218047561187294e-23,1.2930667982010698e-22,42.581485730984134
CYBB,ILMN_1682312,"Homo sapiens cytochrome b-245, beta polypeptide (chronic granulomatous disease) (CYBB), mRNA.",integral to plasma membrane [goid 5887] [pmid 15233623] [evidence IDA]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 7719350] [evidence TAS]; inflammatory response [goid 6954] [pmid 7719350] [evidence TAS]; electron transport [goid 6118] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; voltage-gated ion channel activity [goid 5244] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; FAD binding [goid 50660] [evidence IEA],X,37557345-37557394,Xp11.4e,+,NM_000397.2,1536,CYBB,-1.449821108041144,9.49155720787041,-11.709588370660393,1.46441686896371e-23,1.3288005766088847e-22,42.552075344300164
ZNF486,ILMN_1805668,"PREDICTED: Homo sapiens zinc finger protein 486 (ZNF486), mRNA.",,,,19,20171476-20171525,19p12d,+,XM_371152.2,90649,ZNF486,1.4980996098520176,13.647354792639355,11.700757653959096,1.5510186566749573e-23,1.4061069906095398e-22,42.49485384573384
COL7A1,ILMN_1751161,"Homo sapiens collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive) (COL7A1), mRNA.",basement membrane [goid 5604] [pmid 9375848] [evidence TAS]; collagen type VII [goid 5590] [pmid 9375848] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA],cell adhesion [goid 7155] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA]; epidermis development [goid 8544] [pmid 8170945] [evidence TAS],serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [evidence IEA],3,48576675-48576724,3p21.31e,-,NM_000094.2,1294,COL7A1,1.8785135518194043,7.1398191847779175,11.70057057425409,1.552907618851762e-23,1.407181867662412e-22,42.493641649336674
LOC388654,ILMN_1659550,"PREDICTED: Homo sapiens similar to laminin receptor 1 (ribosomal protein SA) (LOC388654), mRNA.",,,,4,81301307-81301356,,+,XM_371273.3,388654,LOC388654,-1.2533273867839299,12.288922942090169,-11.696492453652086,1.594660632991741e-23,1.4437090472804866e-22,42.46721766383909
COL5A2,ILMN_1729117,"Homo sapiens collagen, type V, alpha 2 (COL5A2), mRNA.",collagen type V [goid 5588] [pmid 9425231] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA]; collagen [goid 5581] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],extracellular matrix structural constituent [goid 5201] [evidence IEA],2,189605701-189605750,2q32.2a,-,NM_000393.2,1290,COL5A2,1.7192978455245225,10.171748232650812,11.695960563063714,1.6001883085189796e-23,1.448058239567967e-22,42.4637713736489
DNTTIP1,ILMN_1691117,"Homo sapiens deoxynucleotidyltransferase, terminal, interacting protein 1 (DNTTIP1), mRNA.",nucleus [goid 5634] [evidence IEA],,,20,43873184-43873233,20q13.12b,+,NM_052951.2,116092,DNTTIP1,1.0904161747751306,9.88815473659837,11.693767689690777,1.6231805838477342e-23,1.4682005932018745e-22,42.4495632107393
VWA2,ILMN_1716674,"Homo sapiens von Willebrand factor A domain containing 2 (VWA2), mRNA.",,,,10,116039309-116039358,10q25.3a,+,NM_198496.1,340706,VWA2,1.3736505031690847,5.801670865455109,11.674861850996118,1.8356040584878566e-23,1.6565974741644127e-22,42.32707901099074
LOC647389,ILMN_1784554,"PREDICTED: Homo sapiens hypothetical protein LOC647389 (LOC647389), mRNA.",,,,,,,,XM_936461.1,647389,LOC647389,2.1033384777231205,9.977013353428102,11.660172309752273,2.0196398072465266e-23,1.8185847553280155e-22,42.23192489948269
LOC399900,ILMN_1701314,"Homo sapiens hypothetical gene supported by AK093779 (LOC399900), mRNA.",,,,11,61493398-61493447,11q12.3a,+,NM_001013667.1,399900,LOC399900,1.381745654388613,14.369227815101794,11.658139901026823,2.0465137750477368e-23,1.841954458441526e-22,42.21876059929952
LOC647834,ILMN_1693740,"PREDICTED: Homo sapiens hypothetical protein LOC647834 (LOC647834), mRNA.",,,,,,,,XM_943048.1,647834,LOC647834,1.3147126377661111,7.013365178849375,11.65437204205462,2.0972834701626049e-23,1.885952704315209e-22,42.19435609513663
LSDP5,ILMN_1791467,"Homo sapiens lipid storage droplet protein 5 (LSDP5), mRNA.",,,,19,4479825-4479874,19p13.3d,-,NM_001013706.2,440503,LSDP5,1.0643620597879107,6.619538397146336,11.653406651407286,2.1104927504939076e-23,1.8969783895724215e-22,42.18810337294475
TNFRSF1B,ILMN_1764788,"Homo sapiens tumor necrosis factor receptor superfamily, member 1B (TNFRSF1B), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; cytokine and chemokine mediated signaling pathway [goid 19221] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; tumor necrosis factor receptor activity [goid 5031] [pmid 8702885] [evidence TAS]; protein binding [goid 5515] [pmid 11244088] [evidence IPI],1,12191715-12191764,1p36.22a,+,NM_001066.2,7133,TNFRSF1B,-1.0955950760545825,8.529154126602982,-11.650315033381869,2.1533565620441402e-23,1.9346366454144212e-22,42.168079693468094
GLULD1,ILMN_1742620,"Homo sapiens glutamate-ammonia ligase (glutamine synthetase) domain containing 1 (GLULD1), mRNA.",,nitrogen compound metabolism [goid 6807] [evidence IEA]; glutamine biosynthesis [goid 6542] [evidence IEA]; nitrogen compound metabolism [goid 6807] [evidence IEA]; glutamine biosynthesis [goid 6542] [evidence IEA],glutamate-ammonia ligase activity [goid 4356] [evidence IEA]; glutamate-ammonia ligase activity [goid 4356] [evidence IEA],6,64047981-64048030,6q12a,-,NM_016571.1,51557,GLULD1,1.9903080467511787,5.920781183854333,11.648981714642783,2.1721097086110922e-23,1.9496045081149374e-22,42.15944427663506
LOC158301,ILMN_1767263,"PREDICTED: Homo sapiens hypothetical protein LOC158301 (LOC158301), mRNA.",,,,9,132447529-132447578,9q34.11e,+,XM_925839.1,158301,LOC158301,2.20536485156849,7.748830257644158,11.648922958922881,2.172939850607912e-23,1.9496045081149374e-22,42.15906373978029
CREB3L4,ILMN_1711171,"Homo sapiens cAMP responsive element binding protein 3-like 4 (CREB3L4), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",protein dimerization activity [goid 46983] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],1,152213079-152213128,1q21.3d,+,NM_130898.2,148327,CREB3L4,1.0721502827502958,6.372030853661953,11.635971904190814,2.363874169941248e-23,2.1161697714623932e-22,42.075190021336994
KPNA2,ILMN_1708160,"Homo sapiens karyopherin alpha 2 (RAG cohort 1, importin alpha 1) (KPNA2), mRNA. XM_001133262 XM_001133265 XM_001133267 XM_001133271",nucleus [goid 5634] [pmid 9020106] [evidence TAS]; nucleoplasm [goid 5654] [pmid 7565597] [evidence TAS]; cytoplasm [goid 5737] [pmid 7754385] [evidence TAS],intracellular protein transport [goid 6886] [evidence IEA]; M phase specific microtubule process [goid 72] [pmid 7565597] [evidence TAS]; regulation of DNA recombination [goid 18] [pmid 8016130] [evidence TAS]; DNA metabolism [goid 6259] [pmid 9168958] [evidence TAS]; G2 phase of mitotic cell cycle [goid 85] [pmid 7565597] [evidence TAS],protein transporter activity [goid 8565] [evidence IEA]; nuclear localization sequence binding [goid 8139] [pmid 9020106] [evidence TAS]; protein binding [goid 5515] [pmid 9497340] [evidence IPI],17,63473387-63473432,17q24.2b,+,NM_002266.2,3838,KPNA2,1.2246281025152355,6.084400516007981,11.632617676996844,2.415999299151275e-23,2.1618655624963646e-22,42.05346897588953
LMOD1,ILMN_1680948,"Homo sapiens leiomodin 1 (smooth muscle) (LMOD1), mRNA.",membrane fraction [goid 5624] [pmid 2026759] [evidence TAS]; cytoskeleton [goid 5856] [evidence IEA],,tropomyosin binding [goid 5523] [evidence IEA],1,200132489-200132538,1q32.1c,-,NM_012134.1,25802,LMOD1,-1.3541449147487548,6.747381671591026,-11.631134570939553,2.4394114682848436e-23,2.1808643725399084e-22,42.04386500661521
FAT3,ILMN_1780591,"PREDICTED: Homo sapiens FAT tumor suppressor homolog 3 (Drosophila) (FAT3), mRNA.",,,,11,92268980-92269029,11q14.3d,+,XM_926199.1,120114,FAT3,-1.1865153663899157,5.871807529577463,-11.63005930755695,2.4565270352440948e-23,2.1932259224080255e-22,42.03690213683328
GREM1,ILMN_1752965,"Homo sapiens gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis) (GREM1), mRNA.",extracellular space [goid 5615] [pmid 9660951] [evidence TAS],development [goid 7275] [pmid 9660951] [evidence TAS],cytokine activity [goid 5125] [evidence IEA]; protein binding [goid 5515] [pmid 16545136] [evidence IPI],15,30813620-30813669,15q13.3c-q13.3d,+,NM_013372.5,26585,GREM1,1.3978093384144072,5.8534339440862295,11.628757510190843,2.477409045174342e-23,2.210883147896888e-22,42.028472438614116
LILRB2,ILMN_2312340,"Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 (LILRB2), transcript variant 2, mRNA.",membrane fraction [goid 5624] [pmid 9079806] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9079806] [evidence TAS]; membrane [goid 16020] [evidence IEA],cellular defense response [goid 6968] [pmid 9382880] [evidence TAS]; cell surface receptor linked signal transduction [goid 7166] [pmid 9079806] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9382880] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 9382880] [evidence TAS],receptor activity [goid 4872] [pmid 9382880] [evidence TAS],,,19q13.42a,,NM_001080978.1,10288,LILRB2,-1.3006426086829421,7.196190069200931,-11.625453065788486,2.531214942131563e-23,2.256887190827465e-22,42.007075195856174
UNQ3045,ILMN_2054121,"Homo sapiens chromosome 6 open reading frame 126 (C6orf126), mRNA.",,,,6,35855184-35855233,6p21.31b,+,NM_207409.1,389383,UNQ3045,1.5187434084834281,5.55138865071884,11.623823881461025,2.558170749656323e-23,2.279905583925332e-22,41.996525993165584
LAMA2,ILMN_1788019,"Homo sapiens laminin, alpha 2 (merosin, congenital muscular dystrophy) (LAMA2), mRNA.",basement membrane [goid 5604] [pmid 2185464] [evidence TAS]; laminin-1 [goid 5606] [evidence IEA]; extracellular matrix [goid 31012] [evidence IEA],regulation of cell migration [goid 30334] [evidence IEA]; regulation of cell adhesion [goid 30155] [evidence IEA]; regulation of embryonic development [goid 45995] [evidence IEA]; muscle development [goid 7517] [pmid 7550355] [evidence TAS],structural molecule activity [goid 5198] [pmid 2185464] [evidence TAS]; receptor binding [goid 5102] [evidence IEA],6,129870374-129870423,6q22.33d-q22.33e,+,NM_000426.2,3908,LAMA2,-1.2250208858334402,7.325609564989129,-11.621629114835427,2.594938260151049e-23,2.311644020886117e-22,41.982314816720574
DNASE2B,ILMN_1789130,"Homo sapiens deoxyribonuclease II beta (DNASE2B), transcript variant 1, mRNA.",lysosome [goid 5764] [evidence IEA]; lysosome [goid 5764] [evidence IEA],DNA metabolism [goid 6259] [evidence IEA]; DNA metabolism [goid 6259] [evidence IEA],deoxyribonuclease II activity [goid 4531] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; deoxyribonuclease II activity [goid 4531] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],1,84652854-84652903,1p31.1a,+,NM_021233.2,58511,DNASE2B,-1.2466676837631052,5.825480589775134,-11.614282273690423,2.721898593353548e-23,2.419357932288662e-22,41.93474593029768
TM4SF11,ILMN_1787673,"Homo sapiens transmembrane 4 superfamily member 11 (plasmolipin) (TM4SF11), mRNA.",,,,16,55847999-55848048,16q13c,-,NM_015993.1,51090,TM4SF11,-1.5994893686136056,9.512602723914934,-11.60954531004306,2.807028317913199e-23,2.493917521527854e-22,41.904077059844695
MAP3K9,ILMN_1735553,"Homo sapiens mitogen-activated protein kinase kinase kinase 9 (MAP3K9), mRNA.",cellular component unknown [goid 8372] [evidence ND ],,nucleotide binding [goid 166] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 15610029] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; MAP kinase kinase activity [goid 4708] [pmid 8477742] [evidence NAS]; ATP binding [goid 5524] [evidence NAS]; JUN kinase kinase kinase activity [goid 4706] [evidence ISS]; protein homodimerization activity [goid 42803] [pmid 8195146] [evidence ISS]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],14,70265162-70265211,14q24.2a,-,NM_033141.2,4293,MAP3K9,1.040974009556292,6.3660543307375095,11.599858621819996,2.989479417965217e-23,2.654838179966625e-22,41.841366093278374
PRRG1,ILMN_1781791,"Homo sapiens proline rich Gla (G-carboxyglutamic acid) 1 (PRRG1), mRNA.",integral to plasma membrane [goid 5887] [pmid 9256434] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],,calcium ion binding [goid 5509] [evidence IEA],X,37201128-37201177,Xp21.1a,+,NM_000950.1,5638,PRRG1,-1.220910508365792,7.235226220237206,-11.599696176742693,2.9926379955988156e-23,2.6564641089592326e-22,41.84031448387626
EMP1,ILMN_1801616,"Homo sapiens epithelial membrane protein 1 (EMP1), mRNA.",integral to membrane [goid 16021] [pmid 8884260] [evidence TAS]; membrane fraction [goid 5624] [pmid 8996089] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell growth [goid 16049] [evidence IEA]; cell death [goid 8219] [evidence NR ]; development [goid 7275] [pmid 8996089] [evidence TAS]; cell proliferation [goid 8283] [pmid 8996089] [evidence TAS]; epidermis development [goid 8544] [pmid 7499420] [evidence TAS],,12,13260606-13260655,12p13.1b,+,NM_001423.1,2012,EMP1,-1.2291359044755605,11.376586196246489,-11.596656407253468,3.0523617359490414e-23,2.7082773220784225e-22,41.82063643917309
DARS2,ILMN_1676191,"Homo sapiens aspartyl-tRNA synthetase 2 (mitochondrial) (DARS2), mRNA.",cytoplasm [goid 5737] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA]; aspartyl-tRNA aminoacylation [goid 6422] [evidence IEA],nucleic acid binding [goid 3676] [evidence IEA]; aspartate-tRNA ligase activity [goid 4815] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],1,172094085-172094134,1q25.1a,+,NM_018122.3,55157,DARS2,1.0566287737969233,7.504837326591687,11.594203451764496,3.101422779148701e-23,2.7505880746989015e-22,41.80475756908649
FLJ40113,ILMN_1740620,"Homo sapiens golgi autoantigen, golgin subfamily a-like (FLJ40113), mRNA.",,,,15,82856078-82856121:82856122-82856127,15q25.2b,-,NM_198079.1,374650,FLJ40113,1.3792080060560012,6.870515218442849,11.593242527934947,3.1208559967585463e-23,2.7665966673967654e-22,41.79853726214371
LAPTM5,ILMN_1772359,"Homo sapiens lysosomal associated multispanning membrane protein 5 (LAPTM5), mRNA.",lysosome [goid 5764] [pmid 8661146] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8661146] [evidence TAS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA],,1,30978154-30978203,1p35.2b,-,NM_006762.1,7805,LAPTM5,-1.1030555152368215,11.48335080918907,-11.58893904879667,3.209389954742165e-23,2.8413041687823556e-22,41.77068043694899
SERPINH1,ILMN_1751028,"Homo sapiens serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) (SERPINH1), mRNA.",endoplasmic reticulum [goid 5783] [pmid 7656593] [evidence TAS]; ER-Golgi intermediate compartment [goid 5793] [pmid 15308636] [evidence IDA],protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [pmid 10023073] [evidence TAS],serine-type endopeptidase inhibitor activity [goid 4867] [pmid 1309665] [evidence TAS]; collagen binding [goid 5518] [pmid 7656593] [evidence NAS],11,74961166-74961215,11q13.5a,+,NM_001235.2,871,SERPINH1,1.0166401700557053,10.872482932922585,11.582357590468398,3.349663142485591e-23,2.96155811554802e-22,41.72808026365128
LOC652334,ILMN_1724017,"PREDICTED: Homo sapiens similar to protein immuno-reactive with anti-PTH polyclonal antibodies (LOC652334), mRNA.",,,,,,,,XM_941763.1,652334,LOC652334,1.3702998632257124,6.190341946635498,11.580359475701048,3.393449242426299e-23,2.9976217413892004e-22,41.715147488956774
ITLN1,ILMN_2165993,"Homo sapiens intelectin 1 (galactofuranose binding) (ITLN1), mRNA.",membrane [goid 16020] [evidence IEA],,sugar binding [goid 5529] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA],1,159113227-159113230:159115725-159115770,1q23.3a,-,NM_017625.2,55600,ITLN1,-4.3927138498882785,7.950752926811746,-11.575264896311825,3.507694433345742e-23,3.0958072440397715e-22,41.68217401376975
CCDC47,ILMN_1804522,"Homo sapiens coiled-coil domain containing 47 (CCDC47), mRNA.",,,,17,59176735-59176784,17q23.3b,-,NM_020198.1,57003,CCDC47,1.2284467037081912,6.942700191237996,11.572031857600708,3.5821789315783694e-23,3.160151501896826e-22,41.66124977091672
LOC653388,ILMN_1770498,"PREDICTED: Homo sapiens similar to SMA4 (LOC653388), mRNA.",,,,5,69847861-69847910,,-,XM_931940.1,653388,LOC653388,1.7072065790794513,6.94102949739254,11.569782771783515,3.634924177497105e-23,3.203857398385995e-22,41.64669406431528
C9orf28,ILMN_1652525,"Homo sapiens family with sequence similarity 125, member B (FAM125B), transcript variant 1, mRNA.",,,,9,128308937-128308986,9q33.3b,+,NM_033446.1,89853,C9orf28,-1.0805021350385466,9.31401799320021,-11.565418753550757,3.7394911671442515e-23,3.291673527154517e-22,41.618451780491824
COL4A5,ILMN_1742534,"Homo sapiens collagen, type IV, alpha 5 (Alport syndrome) (COL4A5), transcript variant 3, mRNA.",collagen type IV [goid 5587] [pmid 2349482] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA]; collagen [goid 5581] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],extracellular matrix structural constituent [goid 5201] [evidence IEA],X,107827209-107827258,Xq22.3c,+,NM_033381.1,1287,COL4A5,-1.068825190740779,7.11338635828755,-11.557009159867425,3.9495417394225303e-23,3.468939030832572e-22,41.56403145995976
NGFRAP1L1,ILMN_1806473,"Homo sapiens NGFRAP1-like 1 (NGFRAP1L1), mRNA.",,,,X,101295722-101295771,Xq22.1d,-,NM_001012978.1,340542,NGFRAP1L1,-1.5746781062771413,7.124767667616455,-11.55658452337357,3.960455179016688e-23,3.476998122938389e-22,41.56128366366245
KIF12,ILMN_2105960,"Homo sapiens kinesin family member 12 (KIF12), mRNA.",microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],9,115893872-115893921,9q32d,-,NM_138424.1,113220,KIF12,1.426296276777414,5.86469878058471,11.554472247991821,4.015191175649349e-23,3.5235063615084283e-22,41.54761543227053
TMEM8,ILMN_1741371,"Homo sapiens transmembrane protein 8 (five membrane-spanning domains) (TMEM8), mRNA.",integral to plasma membrane [goid 5887] [pmid 11006113] [evidence NAS]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],16,362151-362200,16p13.3f,-,NM_021259.1,58986,TMEM8,1.0148508832066732,9.530619494356507,11.547404066691577,4.203903858077974e-23,3.6858767919554824e-22,41.501880319967086
LRRC49,ILMN_1763941,"Homo sapiens leucine rich repeat containing 49 (LRRC49), mRNA.",microtubule [goid 5874] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],,transferase activity [goid 16740] [evidence IEA],15,69129254-69129303,15q23b,+,NM_017691.2,54839,LRRC49,-1.1110428668225092,6.840678281943972,-11.5468758407524,4.218357559497788e-23,3.696929393361005e-22,41.49846252949538
CTHRC1,ILMN_1725090,"Homo sapiens collagen triple helix repeat containing 1 (CTHRC1), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; phosphate transport [goid 6817] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA],8,104463866-104463915,8q22.3c,+,NM_138455.2,115908,CTHRC1,2.1254617971931387,8.739476628442063,11.54598158172477,4.2429401357776354e-23,3.715218653682229e-22,41.49267642898689
SLC2A6,ILMN_1778321,"Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 6 (SLC2A6), mRNA.",membrane [goid 16020] [pmid 10970791] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],carbohydrate transport [goid 8643] [evidence IEA],glucose transporter activity [goid 5355] [pmid 10970791] [evidence NAS]; transporter activity [goid 5215] [evidence IEA]; sugar porter activity [goid 5351] [evidence IEA],9,135326072-135326121,9q34.2a,-,NM_017585.2,11182,SLC2A6,-1.284285780642878,8.124116930292955,-11.545883390932644,4.245648035633246e-23,3.7159635125524925e-22,41.49204111083962
SLC7A5,ILMN_1720373,"Homo sapiens solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 (SLC7A5), mRNA.",plasma membrane [goid 5886] [pmid 9751058] [evidence NAS]; integral to membrane [goid 16021] [evidence ISS]; membrane [goid 16020] [evidence IEA],transport [goid 6810] [pmid 9751058] [evidence TAS]; neutral amino acid transport [goid 15804] [evidence ISS]; amino acid transport [goid 6865] [evidence IEA]; amino acid metabolism [goid 6520] [pmid 9751058] [evidence TAS],peptide antigen binding [goid 42605] [evidence ISS]; neutral amino acid transporter activity [goid 15175] [pmid 9751058] [evidence TAS]; amino acid permease activity [goid 15359] [evidence IEA],16,86421232-86421281,16q24.2b,-,NM_003486.5,8140,SLC7A5,1.792540228371669,9.153592867216236,11.54098797378252,4.3828643375975264e-23,3.8327075903256692e-22,41.46036736692092
RACGAP1,ILMN_2077550,"Homo sapiens Rac GTPase activating protein 1 (RACGAP1), mRNA.",microtubule [goid 5874] [evidence IEA]; nucleus [goid 5634] [pmid 11085985] [evidence IDA]; intracellular [goid 5622] [evidence IEA],spermatogenesis [goid 7283] [pmid 12590651] [evidence IEP]; cell cycle [goid 7049] [evidence IEA]; signal transduction [goid 7165] [evidence IEA]; electron transport [goid 6118] [evidence IEA]; embryonic development [goid 9790] [evidence ISS]; intracellular signaling cascade [goid 7242] [evidence IEA]; neuroblast proliferation [goid 7405] [evidence ISS]; cytokinesis [goid 910] [pmid 11085985] [evidence IDA],electron carrier activity [goid 9055] [evidence IEA]; protein binding [goid 5515] [pmid 16129829] [evidence IPI]; gamma-tubulin binding [goid 43015] [pmid 11085985] [evidence IDA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; beta-tubulin binding [goid 48487] [pmid 11085985] [evidence IDA]; diacylglycerol binding [goid 19992] [evidence IEA]; GTPase activator activity [goid 5096] [pmid 10979956] [evidence IDA],12,48669516-48669565,12q13.13a,-,NM_013277.2,29127,RACGAP1,1.0392877086719539,7.744304660485722,11.54011255166118,4.4078647235898096e-23,3.8528858623671874e-22,41.45470347822314
ANK2,ILMN_1776363,"Homo sapiens ankyrin 2, neuronal (ANK2), transcript variant 2, mRNA.",membrane [goid 16020] [evidence NR ]; actin cytoskeleton [goid 15629] [evidence NR ],metabolism [goid 8152] [evidence IEA]; signal transduction [goid 7165] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; structural constituent of cytoskeleton [goid 5200] [evidence NR ],4,114523964-114524013,4q26a,+,NM_020977.2,287,ANK2,-1.1559803087006655,5.889798124896945,-11.536277597665743,4.5190728378015357e-23,3.948367220032014e-22,41.429892315338826
LEPREL1,ILMN_1657373,"Homo sapiens leprecan-like 1 (LEPREL1), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA],protein metabolism [goid 19538] [evidence IEA],"oxidoreductase activity [goid 16491] [evidence IEA]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [goid 16702] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [goid 16706] [evidence IEA]; binding [goid 5488] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; L-ascorbic acid binding [goid 31418] [evidence IEA]",3,191157361-191157410,3q28b-q28c,-,NM_018192.2,55214,LEPREL1,-1.9007764398987756,10.65037703851842,-11.530480026529604,4.692536171054097e-23,4.090991882808295e-22,41.392385338337064
HLA-E,ILMN_1765258,"Homo sapiens major histocompatibility complex, class I, E (HLA-E), mRNA.",MHC class I protein complex [goid 42612] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,MHC class I receptor activity [goid 30106] [pmid 3260916] [evidence TAS],6,30568677-30568726,6p21.33b,+,NM_005516.4,3133,HLA-E,-1.0687725803905703,12.064460504000445,-11.527653112506123,4.7795132595047955e-23,4.1631911752795794e-22,41.37409761166128
KIF23,ILMN_1811472,"Homo sapiens kinesin family member 23 (KIF23), transcript variant 2, mRNA.",microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; spindle [goid 5819] [pmid 1406973] [evidence TAS]; kinesin complex [goid 5871] [pmid 1406973] [evidence TAS],microtubule-based movement [goid 7018] [evidence IEA]; mitotic spindle elongation [goid 22] [pmid 1406973] [evidence TAS]; mitosis [goid 7067] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; cell division [goid 51301] [evidence IEA],microtubule motor activity [goid 3777] [pmid 1406973] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],15,67526297-67526334:67527185-67527196,15q23a,+,NM_004856.4,9493,KIF23,1.0054871953955384,5.786373515887179,11.526754810188764,4.807487430723513e-23,4.1839151158728166e-22,41.36828646980834
GNPNAT1,ILMN_1686235,"Homo sapiens glucosamine-phosphate N-acetyltransferase 1 (GNPNAT1), mRNA.",membrane [goid 16020] [evidence IEA],,acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; glucosamine 6-phosphate N-acetyltransferase activity [goid 4343] [evidence IEA],14,52311815-52311864,14q22.2a,-,NM_198066.2,64841,GNPNAT1,1.0250901920385092,5.969111475219962,11.524542494364152,4.877080654536623e-23,4.2407922527583115e-22,41.353975164275106
EGFL7,ILMN_1669898,"Homo sapiens EGF-like-domain, multiple 7 (EGFL7), transcript variant 1, mRNA.",extracellular region [goid 5576] [evidence ISS]; extracellular region [goid 5576] [evidence ISS],angiogenesis [goid 1525] [evidence IEA]; vasculogenesis [goid 1570] [evidence ISS]; blood vessel development [goid 1568] [evidence ISS]; regulation of cell migration [goid 30334] [evidence ISS]; angiogenesis [goid 1525] [evidence IEA]; vasculogenesis [goid 1570] [evidence ISS]; blood vessel development [goid 1568] [evidence ISS]; regulation of cell migration [goid 30334] [evidence ISS],calcium ion binding [goid 5509] [evidence ISS]; calcium ion binding [goid 5509] [evidence ISS],9,138686361-138686361:138686537-138686559:138686560-138686585,9q34.3d,+,NM_016215.3,51162,EGFL7,-1.2144155395068514,7.128825014538083,-11.5200562124037,5.021310199631625e-23,4.364308187412231e-22,41.324954726727476
C8orf44,ILMN_1792242,"Homo sapiens chromosome 8 open reading frame 44 (C8orf44), mRNA.",,,,8,67755449-67755498,8q13.1b,+,NM_019607.1,56260,C8orf44,1.2875579146508995,6.284975488390803,11.504103965723388,5.569533128303848e-23,4.836598039544419e-22,41.22177508789469
IL18,ILMN_1778457,"Homo sapiens interleukin 18 (interferon-gamma-inducing factor) (IL18), mRNA.",extracellular space [goid 5615] [evidence IEA],granulocyte macrophage colony-stimulating factor biosynthesis [goid 42253] [pmid 10653850] [evidence TAS]; interferon-gamma biosynthesis [goid 42095] [pmid 10227975] [evidence TAS]; interleukin-2 biosynthesis [goid 42094] [pmid 10653850] [evidence TAS]; immune response [goid 6955] [pmid 8999896] [evidence TAS]; interleukin-13 biosynthesis [goid 42231] [pmid 10227975] [evidence TAS]; induction of apoptosis via death domain receptors [goid 8625] [pmid 11714750] [evidence ISS]; cell-cell signaling [goid 7267] [pmid 9792649] [evidence TAS]; T-helper 2 type immune response [goid 42092] [pmid 11905033] [evidence TAS]; angiogenesis [goid 1525] [pmid 11466388] [evidence IDA]; positive regulation of activated T cell proliferation [goid 42104] [pmid 10000000] [evidence IDA]; regulation of cell adhesion [goid 30155] [pmid 11477102] [evidence IDA]; sleep [goid 30431] [pmid 11506998] [evidence ISS]; chemokine biosynthesis [goid 42033] [pmid 11598150] [evidence TAS],signal transducer activity [goid 4871] [pmid 8999896] [evidence TAS]; interleukin-1 receptor binding [goid 5149] [evidence IEA],11,111519243-111519292,11q23.1c,-,NM_001562.2,3606,IL18,1.022552798871743,14.059114533606227,11.50394055726257,5.575447582940088e-23,4.839633632948602e-22,41.22071824408182
CXCR7,ILMN_2371458,"Homo sapiens chemokine (C-X-C motif) receptor 7 (CXCR7), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence NAS]; membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],"rhodopsin-like receptor activity [goid 1584] [evidence IEA]; G-protein coupled receptor activity, unknown ligand [goid 16526] [pmid 1315461] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]",,,2q37.3a,,NM_001047841.1,57007,CXCR7,-1.693413713577371,8.254004314889611,-11.495677983302501,5.882826631520386e-23,5.102019733136536e-22,41.1672823909028
ALS2CR14,ILMN_1787314,"Homo sapiens amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 14 (ALS2CR14), mRNA.",,,,2,203398622-203398648:203398422-203398444,,-,NM_178231.1,65068,ALS2CR14,1.8146766771007323,8.44297455727275,11.495030106872763,5.90763214006721e-23,5.119095013359235e-22,41.163092626995976
LOC653743,ILMN_1660794,"PREDICTED: Homo sapiens similar to hypothetical protein DKFZp566J091 (LOC653743), mRNA.",,,,2,30334076-30334125,,+,XM_929369.1,653743,LOC653743,-1.6258840876310767,6.822308729959891,-11.494125656129459,5.942435988108563e-23,5.144797025100655e-22,41.15724366506824
MTFR1,ILMN_1774028,"Homo sapiens mitochondrial fission regulator 1 (MTFR1), mRNA.",mitochondrion [goid 5739] [evidence IEA]; plasma membrane [goid 5886] [pmid 10942595] [evidence IDA],,,8,66784995-66785044,8q13.1a,+,NM_014637.2,9650,MTFR1,1.0232638443605913,8.2051747235157,11.4939548922147,5.949030034864674e-23,5.148278241244481e-22,41.1561393638433
FLJ37357,ILMN_2052495,"Homo sapiens hypothetical protein FLJ37357 (FLJ37357), mRNA.",,,,2,84665425-84665474,2p11.2h-p11.2g,+,NM_173645.1,284944,FLJ37357,1.0556032250023337,5.538876958625301,11.486682922935062,6.236722927304148e-23,5.39258220957223e-22,41.10911459412794
ALPL,ILMN_1701603,"Homo sapiens alkaline phosphatase, liver/bone/kidney (ALPL), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],metabolism [goid 8152] [evidence IEA]; ossification [goid 1503] [evidence IEA],alkaline phosphatase activity [goid 4035] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],1,21777336-21777385,1p36.12b,+,NM_000478.2,249,ALPL,-2.0819539189671303,11.55698054156584,-11.477460413063756,6.621648771263747e-23,5.695870533768058e-22,41.04948163645164
CNGB1,ILMN_1702383,"Homo sapiens cyclic nucleotide gated channel beta 1 (CNGB1), mRNA.",membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ]; intracellular cyclic nucleotide activated cation channel complex [goid 17071] [evidence NAS],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [evidence IEA]; visual perception [goid 7601] [pmid 7682292] [evidence TAS],ligand-gated ion channel activity [goid 15276] [pmid 7682292] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; intracellular cAMP activated cation channel activity [goid 5222] [evidence NAS]; potassium channel activity [goid 5267] [evidence IEA]; ion channel activity [goid 5216] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],16,,16q13d,-,NM_001297.1,1258,CNGB1,1.4289437179551845,6.116576250860622,11.475394089630031,6.711094554769455e-23,5.770330032308864e-22,41.036121534149956
ARPC1B,ILMN_2085760,"Homo sapiens actin related protein 2/3 complex, subunit 1B, 41kDa (ARPC1B), mRNA.",Arp2/3 protein complex [goid 5885] [pmid 9230079] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell motility [goid 6928] [pmid 9230079] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA],structural constituent of cytoskeleton [goid 5200] [pmid 9230079] [evidence TAS],7,98821298-98821337:98822244-98822253,7q22.1b,+,NM_005720.2,10095,ARPC1B,-1.4827136472190414,9.350448737407433,-11.472545217021212,6.836396541015155e-23,5.8755421818140555e-22,41.01770222813154
SNAP23,ILMN_1687519,"Homo sapiens synaptosomal-associated protein, 23kDa (SNAP23), transcript variant 1, mRNA.",plasma membrane [goid 5886] [pmid 9727496] [evidence TAS]; synapse [goid 45202] [evidence IEA]; synaptosome [goid 19717] [evidence IEA],protein transport [goid 15031] [evidence IEA]; membrane fusion [goid 6944] [pmid 10839363] [evidence TAS]; vesicle targeting [goid 6903] [pmid 8663154] [evidence TAS],t-SNARE activity [goid 5486] [evidence NR ]; protein binding [goid 5515] [pmid 16189514] [evidence IPI],15,40607825-40607874,15q15.1d,+,NM_003825.2,8773,SNAP23,-1.052770041408217,7.683921341758666,-11.468200478111894,7.03200373202968e-23,6.041061857898233e-22,40.98961250795274
ChGn,ILMN_2055523,"Homo sapiens chondroitin beta1,4 N-acetylgalactosaminyltransferase (ChGn), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to Golgi membrane [goid 30173] [pmid 11788602] [evidence ISS]; soluble fraction [goid 5625] [pmid 11514575] [evidence IDA]; intracellular [goid 5622] [evidence ISS],"morphogenesis [goid 9653] [pmid 11514575] [evidence NAS]; chondroitin sulfate biosynthesis [goid 30206] [pmid 11514575] [evidence IDA]; UDP-glucuronate metabolism [goid 46398] [pmid 11514575] [evidence IDA]; heparan sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis [goid 15014] [pmid 11514575] [evidence NAS]; cell proliferation [goid 8283] [pmid 11514575] [evidence NAS]; UDP-N-acetylgalactosamine metabolism [goid 19276] [pmid 11514575] [evidence IDA]; dermatan sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis [goid 50652] [pmid 11788602] [evidence ISS]; extracellular matrix organization and biogenesis [goid 30198] [pmid 11514575] [evidence NAS]; heparin biosynthesis [goid 30210] [pmid 11514575] [evidence NAS]; cell recognition [goid 8037] [pmid 11514575] [evidence NAS]; chondroitin sulfate proteoglycan biosynthesis, polysaccharide chain biosynthesis [goid 50653] [pmid 11788602] [evidence ISS]",transferase activity [goid 16740] [evidence IEA]; glucuronosyltransferase activity [goid 15020] [pmid 11514575] [evidence IDA]; protein binding [goid 5515] [pmid 11788602] [evidence ISS]; metal ion binding [goid 46872] [evidence ISS]; peptidoglycan glycosyltransferase activity [goid 8955] [pmid 11514575] [evidence IDA]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [goid 47237] [evidence ISS],8,19306323-19306372,8p21.3c,-,NM_018371.3,55790,ChGn,-1.2161378536138558,6.307035198600877,-11.46798463333332,7.041865825588225e-23,6.046937829972927e-22,40.98821705630447
BAIAP2L2,ILMN_1771652,"Homo sapiens BAI1-associated protein 2-like 2 (BAIAP2L2), mRNA.",,,,22,36810882-36810931,22q13.1b,-,NM_025045.3,80115,BAIAP2L2,2.0620779650833505,6.801967133023018,11.466205739849084,7.123672394458203e-23,6.11226202246451e-22,40.9767165066642
TSGA14,ILMN_1797209,"Homo sapiens testis specific, 14 (TSGA14), mRNA.",centrosome [goid 5813] [pmid 14654843] [evidence IDA]; centrosome [goid 5813] [pmid 14654843] [evidence IDA],,,7,129824133-129824182,7q32.2b,-,NM_018718.1,95681,TSGA14,1.020085016311075,6.979266916419028,11.46595370048694,7.13533950925282e-23,6.119325885174901e-22,40.97508708928188
EFNB2,ILMN_1703852,"Homo sapiens ephrin-B2 (EFNB2), mRNA.",plasma membrane [goid 5886] [pmid 8660976] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8660976] [evidence TAS]; membrane [goid 16020] [evidence IEA],morphogenesis [goid 9653] [pmid 9630219] [evidence TAS]; cell differentiation [goid 30154] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 8559144] [evidence TAS],ephrin receptor binding [goid 46875] [pmid 8559144] [evidence TAS],13,105940388-105940437,13q33.3a,-,NM_004093.2,1948,EFNB2,-1.2276328807421475,10.178688402780256,-11.456689997694076,7.577664018044271e-23,6.481996651262496e-22,40.91520091140667
FAM40B,ILMN_2161286,"Homo sapiens family with sequence similarity 40, member B (FAM40B), mRNA.",,,,7,128915140-128915189,7q32.1a,+,NM_020704.1,57464,FAM40B,2.0406317479094263,9.282190971180965,11.456622041024156,7.581007967393132e-23,6.482085786820589e-22,40.914761620259014
P8,ILMN_1810560,"Homo sapiens p8 protein (candidate of metastasis 1) (P8), mRNA.",nucleus [goid 5634] [pmid 10092851] [evidence IDA],induction of apoptosis [goid 6917] [evidence NAS]; cell growth [goid 16049] [pmid 10092851] [evidence IDA],molecular function unknown [goid 5554] [evidence ND ],16,28456834-28456840:28456841-28456883,16p11.2e,-,NM_012385.1,26471,P8,-1.3862041772781009,9.816088193221804,-11.454434802879334,7.689426090149288e-23,6.571979376834982e-22,40.900622864471984
LOC643367,ILMN_1682288,"PREDICTED: Homo sapiens region containing SMA4; hypothetical protein LOC153561, transcript variant 1 (LOC643367), mRNA.",,,,5,69848056-69848065:69849904-69849943,5q13.2a,-,XM_928286.1,643367,LOC643367,1.228754144097696,7.416243009660198,11.454234137013891,7.699449997970653e-23,6.577736787335475e-22,40.8993257357631
CMKOR1,ILMN_1798360,"Homo sapiens chemokine orphan receptor 1 (CMKOR1), mRNA.",integral to membrane [goid 16021] [evidence NAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],"rhodopsin-like receptor activity [goid 1584] [evidence IEA]; G-protein coupled receptor activity, unknown ligand [goid 16526] [pmid 1315461] [evidence NAS]; receptor activity [goid 4872] [evidence IEA]",2,237155523-237155572,2q37.3a,+,NM_020311.1,57007,CMKOR1,-1.581507624206143,10.136786502013532,-11.443824427625449,8.237744108570136e-23,7.028604866706664e-22,40.832039936142024
ANKRD30B,ILMN_1730678,"Homo sapiens ankyrin repeat domain 30B (ANKRD30B), mRNA.",cellular component unknown [goid 8372] [evidence ND ]; cellular component unknown [goid 8372] [evidence ND ],biological process unknown [goid 4] [evidence ND ]; biological process unknown [goid 4] [evidence ND ],molecular function unknown [goid 5554] [evidence ND ]; molecular function unknown [goid 5554] [evidence ND ],18,14806601-14806650,18p11.21a,+,NM_001029862.1,374860,ANKRD30B,1.427691014969076,12.43999689310799,11.439271243266088,8.48485400883832e-23,7.224040808886685e-22,40.80261164824366
FA2H,ILMN_1791531,"Homo sapiens fatty acid 2-hydroxylase (FA2H), mRNA.",,,,16,73304694-73304743,16q23.1a,-,NM_024306.2,79152,FA2H,1.3599299795680535,5.677833681831055,11.4338240223458,8.790227524733425e-23,7.474495211001545e-22,40.767406903667016
SLC2A14,ILMN_1668865,"Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 14 (SLC2A14), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],spermatogenesis [goid 7283] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; carbohydrate transport [goid 8643] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; sugar porter activity [goid 5351] [evidence IEA]; glucose transporter activity [goid 5355] [evidence IEA],12,7858049-7858098,12p13.31c,-,NM_153449.2,144195,SLC2A14,-1.2577537936220633,5.7271493802969085,-11.43277897230688,8.850056099878649e-23,7.51897759857206e-22,40.760653107332644
FLJ35880,ILMN_1768919,"Homo sapiens hypothetical protein FLJ35880 (FLJ35880), mRNA.",,,,3,131686024-131686073,3q22.1a,+,NM_153264.2,256076,FLJ35880,-1.3278340673883235,6.525949704628374,-11.429502646290565,9.040272297205689e-23,7.670812897476312e-22,40.739479846289235
TGFA,ILMN_1805175,"Homo sapiens transforming growth factor, alpha (TGFA), mRNA.",extracellular space [goid 5615] [evidence NR ]; soluble fraction [goid 5625] [evidence NR ]; integral to plasma membrane [goid 5887] [evidence NR ]; plasma membrane [goid 5886] [pmid 10918572] [evidence NAS],cell proliferation [goid 8283] [pmid 10861448] [evidence TAS]; cell-cell signaling [goid 7267] [evidence NR ],signal transducer activity [goid 4871] [pmid 10918572] [evidence TAS]; growth factor activity [goid 8083] [evidence IEA]; protein binding [goid 5515] [pmid 10918572] [evidence TAS]; epidermal growth factor receptor activating ligand activity [goid 5155] [evidence NR ]; protein-tyrosine kinase activity [goid 4713] [pmid 10918572] [evidence TAS],2,70528444-70528493,2p13.3c,-,NM_003236.1,7039,TGFA,1.4688847350955756,7.349523214828997,11.428897565079831,9.075845943731138e-23,7.697733176861917e-22,40.73556959105602
LIFR,ILMN_1709094,"Homo sapiens leukemia inhibitory factor receptor (LIFR), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 1915266] [evidence TAS],cell surface receptor linked signal transduction [goid 7166] [pmid 1915266] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; leukemia inhibitory factor receptor activity [goid 4923] [pmid 1915266] [evidence TAS],5,38511336-38511385,5p13.1c,-,NM_002310.3,3977,LIFR,-1.6319674199555276,7.0849643000023175,-11.425051844801384,9.305231833960228e-23,7.882264120824566e-22,40.71071775059159
APLN,ILMN_1689353,"Homo sapiens apelin, AGTRL1 ligand (APLN), mRNA.",,immune response [goid 6955] [pmid 10525157] [evidence TAS]; signal transduction [goid 7165] [pmid 9792798] [evidence TAS]; lactation [goid 7595] [pmid 10525157] [evidence TAS],hormone activity [goid 5179] [evidence IEA],X,128607421-128607470,Xq25g,-,NM_017413.3,8862,APLN,-1.722135708697472,6.590079396362531,-11.424890253521479,9.314995993040387e-23,7.887195930120696e-22,40.70967353721161
INSIG1,ILMN_1686989,"Homo sapiens insulin induced gene 1 (INSIG1), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],metabolism [goid 8152] [pmid 9268630] [evidence TAS]; cell proliferation [goid 8283] [pmid 9268630] [evidence TAS],,7,154726472-154726521,7q36.3a,+,NM_198336.1,3638,INSIG1,-1.179072455560549,8.095404920295856,-11.421174890097088,9.542340380373603e-23,8.072860309958354e-22,40.68566512748759
WBSCR19,ILMN_1718311,"PREDICTED: Homo sapiens Williams Beuren syndrome chromosome region 19, transcript variant 4 (WBSCR19), mRNA.",,,,,,7p13d,,XM_943679.1,285955,WBSCR19,1.3090237281718338,5.9573682898509785,11.408057903346236,1.0390195670918158e-22,8.773600315828386e-22,40.60091197168296
MGC16121,ILMN_1673409,"PREDICTED: Homo sapiens hypothetical protein MGC16121 (MGC16121), mRNA.",,,,X,133506231-133506244:133506245-133506280,Xq26.3a,-,XM_927600.1,84848,MGC16121,1.2371839617885207,5.911639875745603,11.406416013920852,1.0501488813703682e-22,8.86182151769647e-22,40.590304052461136
CSF3R,ILMN_2323172,"Homo sapiens colony stimulating factor 3 receptor (granulocyte) (CSF3R), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 7542747] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [evidence IEA]; defense response [goid 6952] [pmid 7542747] [evidence TAS]; signal transduction [goid 7165] [pmid 1371413] [evidence NAS],receptor activity [goid 4872] [pmid 7542747] [evidence TAS]; hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA]; protein binding [goid 5515] [evidence IEA],1,36704923-36704972,1p34.3d,-,NM_000760.2,1441,CSF3R,-1.478707674441253,8.067428082067867,-11.405275618718882,1.0579488565168592e-22,8.91636087665936e-22,40.58293630112461
CATSPER2,ILMN_2286014,"Homo sapiens cation channel, sperm associated 2 (CATSPER2), transcript variant 4, mRNA.",membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA],ion channel activity [goid 5216] [evidence IEA],15,41718990-41719039,15q15.3a,-,NM_172097.1,117155,CATSPER2,1.0966881936412793,9.632952556888553,11.401113475150055,1.086910753925251e-22,9.156593837699547e-22,40.556046734316716
KRT4,ILMN_1744765,"Homo sapiens keratin 4 (KRT4), mRNA.",intermediate filament [goid 5882] [pmid 2452170] [evidence NAS],cytoskeleton organization and biogenesis [goid 7010] [pmid 2452170] [evidence NAS],structural molecule activity [goid 5198] [evidence NAS],12,51486884-51486933,12q13.13d,-,NM_002272.1,3851,KRT4,-1.8964997145684883,6.207013103130334,-11.399759661110211,1.0965007229365675e-22,9.2334959867486709e-22,40.547300675488735
SGK,ILMN_1702487,"Homo sapiens serum/glucocorticoid regulated kinase (SGK), mRNA.",nucleus [goid 5634] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; sodium ion transport [goid 6814] [pmid 10884438] [evidence TAS]; response to stress [goid 6950] [pmid 9114008] [evidence TAS]; protein amino acid phosphorylation [goid 6468] [pmid 9114008] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 9114008] [evidence TAS],6,134532365-134532414,6q23.2d,-,NM_005627.2,6446,SGK,-1.1461794865178252,11.822330298336045,-11.397289930984506,1.1142136296193398e-22,9.370822320901115e-22,40.53134579358149
MGLL,ILMN_1657708,"Homo sapiens monoglyceride lipase (MGLL), transcript variant 1, mRNA.",,inflammatory response [goid 6954] [pmid 9495531] [evidence TAS]; lipid metabolism [goid 6629] [pmid 9495531] [evidence TAS]; aromatic compound metabolism [goid 6725] [evidence IEA]; inflammatory response [goid 6954] [pmid 9495531] [evidence TAS]; lipid metabolism [goid 6629] [pmid 9495531] [evidence TAS]; aromatic compound metabolism [goid 6725] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; lysophospholipase activity [goid 4622] [pmid 9495531] [evidence TAS]; serine esterase activity [goid 4759] [evidence IEA]; acylglycerol lipase activity [goid 47372] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; lysophospholipase activity [goid 4622] [pmid 9495531] [evidence TAS]; serine esterase activity [goid 4759] [evidence IEA]; acylglycerol lipase activity [goid 47372] [evidence IEA],3,128890930-128890979,3q21.3b,-,NM_007283.5,11343,MGLL,-1.0121195626122415,7.9071287698883745,-11.392931881500475,1.1461692462709733e-22,9.619360016522498e-22,40.50319312061062
HTR3A,ILMN_1662070,"Homo sapiens 5-hydroxytryptamine (serotonin) receptor 3A (HTR3A), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; postsynaptic membrane [goid 45211] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7565620] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; postsynaptic membrane [goid 45211] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7565620] [evidence TAS],ion transport [goid 6811] [evidence IEA]; synaptic transmission [goid 7268] [pmid 7565620] [evidence TAS]; digestion [goid 7586] [pmid 7565620] [evidence TAS]; ion transport [goid 6811] [evidence IEA]; synaptic transmission [goid 7268] [pmid 7565620] [evidence TAS]; digestion [goid 7586] [pmid 7565620] [evidence TAS],serotonin-activated cation-selective channel activity [goid 5232] [pmid 7565620] [evidence TAS]; ion channel activity [goid 5216] [evidence IEA]; extracellular ligand-gated ion channel activity [goid 5230] [evidence NAS]; serotonin receptor activity [goid 4993] [evidence NAS]; neurotransmitter receptor activity [goid 30594] [evidence IEA]; serotonin-activated cation-selective channel activity [goid 5232] [pmid 7565620] [evidence TAS]; ion channel activity [goid 5216] [evidence IEA]; extracellular ligand-gated ion channel activity [goid 5230] [evidence NAS]; serotonin receptor activity [goid 4993] [evidence NAS]; neurotransmitter receptor activity [goid 30594] [evidence IEA],11,113365898-113365947,11q23.2a,+,NM_000869.2,3359,HTR3A,1.1483179474977758,5.459479206088159,11.391624326004735,1.1559342372014896e-22,9.693181985719784e-22,40.49474667885118
CD58,ILMN_1785268,"Homo sapiens CD58 molecule (CD58), mRNA.",integral to plasma membrane [goid 5887] [pmid 7544493] [evidence NAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7544493] [evidence NAS]; membrane [goid 16020] [evidence IEA],cell-cell adhesion [goid 16337] [pmid 7544493] [evidence NAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ]; cell-cell adhesion [goid 16337] [pmid 7544493] [evidence NAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [evidence NR ],GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [pmid 7544493] [evidence IPI]; GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [pmid 7544493] [evidence IPI],1,116880330-116880373:116888456-116888461,1p13.1b,-,NM_001779.1,965,CD58,-1.0350931220965816,8.445568634404584,-11.389938063488527,1.1686501938758763e-22,9.791605141988498e-22,40.48385407942381
ZNF641,ILMN_1731666,"Homo sapiens zinc finger protein 641 (ZNF641), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],12,47022350-47022399,12q13.11c,-,NM_152320.1,121274,ZNF641,1.1345427099135454,7.5481201394619,11.387655635324338,1.1860845232251136e-22,9.933519941686093e-22,40.46911081161109
TMEM86B,ILMN_2049417,"Homo sapiens transmembrane protein 86B (TMEM86B), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,19,60429973-60430022,19q13.42b,-,NM_173804.3,255043,TMEM86B,1.2191625947125342,7.055849373147752,11.38344484757872,1.2189329254220374e-22,1.0200087817584326e-21,40.44191236705251
TBC1D24,ILMN_2060212,"Homo sapiens TBC1 domain family, member 24 (TBC1D24), mRNA. XM_945422",,,,16,2493115-2493164,16p13.3d,+,NM_020705.1,57465,TBC1D24,1.1161435551333891,6.599428311915388,11.381338739086772,1.2357019000129309e-22,1.033352636620366e-21,40.428309015051404
LOC643466,ILMN_1702519,"PREDICTED: Homo sapiens hypothetical protein LOC643466 (LOC643466), mRNA.",,,,9,45327237-45327286,,-,XM_926789.1,643466,LOC643466,1.0171657278729027,5.924476841838621,11.365798758606104,1.3667630512438345e-22,1.140375109644981e-21,40.32794637696287
OTC,ILMN_1749114,"Homo sapiens ornithine carbamoyltransferase (OTC), mRNA.",mitochondrial matrix [goid 5759] [pmid 6372096] [evidence NAS]; ornithine carbamoyltransferase complex [goid 9348] [evidence NAS],amino acid biosynthesis [goid 8652] [evidence IEA]; arginine biosynthesis [goid 6526] [evidence NAS]; urea cycle [goid 50] [evidence NAS],ornithine carbamoyltransferase activity [goid 4585] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; amino acid binding [goid 16597] [evidence IEA],X,38156192-38156196:38165220-38165264,Xp11.4e,+,NM_000531.3,5009,OTC,-1.0600263280704283,5.30172228213765,-11.362445796554603,1.3968132022332666e-22,1.1635070170808992e-21,40.30629411311261
ZKSCAN1,ILMN_2139052,"Homo sapiens zinc finger with KRAB and SCAN domains 1 (ZKSCAN1), mRNA.",nucleus [goid 5634] [pmid 7557990] [evidence NAS]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [pmid 7557990] [evidence NAS]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; transcription factor activity [goid 3700] [pmid 7557990] [evidence NAS],7,99473261-99473310,7q22.1b,+,NM_003439.1,7586,ZKSCAN1,1.1884955696022672,6.077959322147576,11.360275401735366,1.416615642065185e-22,1.1795108517037128e-21,40.29227890261819
FLJ23191,ILMN_1689176,"Homo sapiens hypothetical protein FLJ23191 (FLJ23191), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,4,122176576-122176625,4q27b,-,NM_024574.2,79625,FLJ23191,-1.5282799358984178,10.05853569316371,-11.359731713071307,1.4216199418169685e-22,1.182693213965651e-21,40.288768116508805
COL9A2,ILMN_1685122,"Homo sapiens collagen, type IX, alpha 2 (COL9A2), mRNA.",collagen type IX [goid 5594] [pmid 10364514] [evidence TAS]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],skeletal development [goid 1501] [pmid 10364514] [evidence TAS]; phosphate transport [goid 6817] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA],1,40538963-40539012,1p34.2d,-,NM_001852.3,1298,COL9A2,1.732790669762517,7.625431450766506,11.356543345129552,1.4513240623981349e-22,1.204900076367713e-21,40.26818016293674
VNN2,ILMN_1678939,"Homo sapiens vanin 2 (VNN2), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; membrane [goid 16020] [evidence IEA],nitrogen compound metabolism [goid 6807] [evidence IEA]; cell motility [goid 6928] [pmid 9790769] [evidence TAS]; nitrogen compound metabolism [goid 6807] [evidence IEA]; cell motility [goid 6928] [pmid 9790769] [evidence TAS],"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [goid 16811] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [goid 16811] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]",6,133106828-133106877,6q23.2b,-,NM_004665.2,8875,VNN2,-1.1357866518916486,6.2108236224158295,-11.354866122742333,1.4671976400689135e-22,1.217068423818359e-21,40.257350294152566
SLC2A3,ILMN_1775708,"Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 3 (SLC2A3), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; membrane [goid 16020] [evidence IEA],carbohydrate metabolism [goid 5975] [pmid 1695905] [evidence NAS]; glucose transport [goid 15758] [pmid 1695905] [evidence TAS]; carbohydrate transport [goid 8643] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; sugar porter activity [goid 5351] [evidence IEA]; glucose transporter activity [goid 5355] [pmid 1695905] [evidence TAS],12,7963180-7963229,12p13.31c,-,NM_006931.1,6515,SLC2A3,-1.2538458987203818,11.511013579792904,-11.33262414192832,1.694843501847499e-22,1.4018366591552194e-21,40.11375321279598
LOC647673,ILMN_1757702,"PREDICTED: Homo sapiens similar to Translationally-controlled tumor protein (TCTP) (p23) (Histamine-releasing factor) (HRF) (Fortilin) (LOC647673), mRNA.",,,,,,,,XM_936731.1,647673,LOC647673,-1.425831642127127,9.353090845829488,-11.32778218096699,1.7488970727858613e-22,1.4453503772118758e-21,40.082497849003886
KIAA0690,ILMN_1767253,"Homo sapiens ribosomal RNA processing 12 homolog (S. cerevisiae) (RRP12), mRNA.",nucleus [goid 5634] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,binding [goid 5488] [evidence IEA],10,99106694-99106743,10q24.1b,-,NM_015179.2,23223,KIAA0690,1.092125637782515,8.360255935136387,11.321750741460747,1.8186427880206367e-22,1.5011305652936015e-21,40.043566776122034
C1S,ILMN_1677603,"Homo sapiens complement component 1, s subcomponent (C1S), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],"complement activation, classical pathway [goid 6958] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]",rhodopsin-like receptor activity [goid 1584] [evidence IEA]; complement component C1s activity [goid 3816] [pmid 9856483] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],12,7039320-7039369,12p13.31d,+,NM_201442.1,716,C1S,-1.2497578178963415,8.90197569241827,-11.321101239595627,1.8263171095702813e-22,1.506843411475554e-21,40.03937460868304
UBE2L6,ILMN_1703108,"Homo sapiens ubiquitin-conjugating enzyme E2L 6 (UBE2L6), transcript variant 1, mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA]; ubiquitin cycle [goid 6512] [evidence IEA],ligase activity [goid 16874] [evidence IEA]; ubiquitin conjugating enzyme activity [goid 4840] [pmid 9153201] [evidence TAS]; ubiquitin-protein ligase activity [goid 4842] [pmid 9153201] [evidence TAS]; protein binding [goid 5515] [pmid 10085091] [evidence IPI]; ligase activity [goid 16874] [evidence IEA]; ubiquitin conjugating enzyme activity [goid 4840] [pmid 9153201] [evidence TAS]; ubiquitin-protein ligase activity [goid 4842] [pmid 9153201] [evidence TAS]; protein binding [goid 5515] [pmid 10085091] [evidence IPI],11,57091654-57091660:57091661-57091703,11q12.1a,-,NM_004223.3,9246,UBE2L6,-1.056885222754719,10.461872081756201,-11.315172821067032,1.8978770206787963e-22,1.5633068517802124e-21,40.00111151260526
ABLIM3,ILMN_1656940,"Homo sapiens actin binding LIM protein family, member 3 (ABLIM3), mRNA.",cytoplasm [goid 5737] [evidence NAS],cytoskeleton organization and biogenesis [goid 7010] [evidence IEA],actin binding [goid 3779] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence NAS],5,148619956-148620005,5q33.1b,+,NM_014945.1,22885,ABLIM3,-1.358103648777619,6.638934003481532,-11.31508115028955,1.8990052464148177e-22,1.5635924679122498e-21,40.0005198738501
MGC4728,ILMN_1685365,"Homo sapiens zinc finger protein 773 (ZNF773), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],19,62710919-62710968,19q13.43b,+,NM_198542.1,374928,MGC4728,1.2450205380518629,8.968261452686983,11.3136574662126,1.9166132411363037e-22,1.577441288714733e-21,39.99133156879027
NQO1,ILMN_1720282,"Homo sapiens NAD(P)H dehydrogenase, quinone 1 (NQO1), transcript variant 1, mRNA.",cytoplasm [goid 5737] [pmid 2843525] [evidence TAS],"nitric oxide biosynthesis [goid 6809] [pmid 9579781] [evidence TAS]; response to toxin [goid 9636] [pmid 10393963] [evidence TAS]; xenobiotic metabolism [goid 6805] [pmid 10393963] [evidence TAS]; synaptic transmission, cholinergic [goid 7271] [pmid 9579781] [evidence TAS]; electron transport [goid 6118] [evidence IEA]",oxidoreductase activity [goid 16491] [evidence IEA]; cytochrome-b5 reductase activity [goid 4128] [pmid 9579781] [evidence TAS]; NAD(P)H dehydrogenase (quinone) activity [goid 3955] [pmid 10393963] [evidence TAS],16,68300911-68300960,16q22.1e,-,NM_000903.2,1728,NQO1,1.1572513076461561,7.988528478381717,11.30660086461975,2.0063242435553742e-22,1.6499192546262199e-21,39.94579132172842
FAM55C,ILMN_1814924,"Homo sapiens family with sequence similarity 55, member C (FAM55C), mRNA.",,,,3,103024820-103024869,3q12.3a,+,NM_145037.1,91775,FAM55C,-1.0618846934638553,6.2927663379124565,-11.296581942746103,2.1409426470438877e-22,1.758455684813387e-21,39.881140166825865
MTMR12,ILMN_1802831,"Homo sapiens myotubularin related protein 12 (MTMR12), mRNA.",,phospholipid dephosphorylation [goid 46839] [evidence IEA],inositol or phosphatidylinositol phosphatase activity [goid 4437] [evidence IEA],5,32263512-32263561,5p13.3c,-,NM_019061.2,54545,MTMR12,-1.4058023419464662,6.855483626169934,-11.295450819676816,2.156696450304933e-22,1.7706681402421463e-21,39.87384162705693
CHI3L2,ILMN_2326273,"Homo sapiens chitinase 3-like 2 (CHI3L2), transcript variant 1, mRNA.",extracellular space [goid 5615] [pmid 8702629] [evidence TAS],chitin catabolism [goid 6032] [evidence IEA]; carbohydrate metabolism [goid 5975] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; chitinase activity [goid 4568] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA],1,111586462-111586509:111586510-111586511,1p13.3a,+,NM_004000.2,1117,CHI3L2,-2.1271022691273247,8.39816123865758,-11.293877751915597,2.178798035323927e-22,1.78661438896562e-21,39.86369161750162
SPI1,ILMN_1696463,"Homo sapiens spleen focus forming virus (SFFV) proviral integration oncogene spi1 (SPI1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 10867017] [evidence TAS]",RNA binding [goid 3723] [evidence IEA]; protein binding [goid 5515] [pmid 10207087] [evidence IPI]; transcription factor activity [goid 3700] [pmid 10867017] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA],11,47333039-47333088,11p11.2b,-,NM_003120.1,6688,SPI1,-1.265802815573978,8.51508961911476,-11.293041852751394,2.190634260210554e-22,1.7955841982094535e-21,39.85829816842528
PLEKHH2,ILMN_1806752,"Homo sapiens pleckstrin homology domain containing, family H (with MyTH4 domain) member 2 (PLEKHH2), mRNA.",cytoskeleton [goid 5856] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],2,43848299-43848348,2p21d,+,NM_172069.1,130271,PLEKHH2,-1.336950692346746,7.364690596422316,-11.290364072457155,2.22898518896923e-22,1.823841560289474e-21,39.841020768333344
FOXD2,ILMN_1789400,"Homo sapiens forkhead box D2 (FOXD2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",transcription factor activity [goid 3700] [pmid 9403061] [evidence TAS],1,47678781-47678830,1p33d,+,NM_004474.2,2306,FOXD2,1.3648538226803968,6.844096724523968,11.29032816717286,2.229503949062987e-22,1.823841560289474e-21,39.84078910640105
PTPN21,ILMN_1719664,"Homo sapiens protein tyrosine phosphatase, non-receptor type 21 (PTPN21), mRNA.",cytoskeleton [goid 5856] [pmid 7519780] [evidence TAS],protein amino acid dephosphorylation [goid 6470] [pmid 7519780] [evidence TAS],structural molecule activity [goid 5198] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; binding [goid 5488] [evidence IEA]; protein tyrosine phosphatase activity [goid 4725] [pmid 7519780] [evidence TAS],14,88004056-88004105,14q31.3d,-,NM_007039.2,11099,PTPN21,-1.0525509786139278,6.112933988895228,-11.290316927715,2.229666361689351e-22,1.823841560289474e-21,39.84071658911475
LOC653219,ILMN_1672582,"PREDICTED: Homo sapiens similar to G antigen, family D, 2 isoform 1a, transcript variant 1 (LOC653219), mRNA.",,,,X,52256017-52256066,,+,XM_927237.1,653219,LOC653219,1.963405945484947,6.3091486742730725,11.269214029115647,2.556416503625964e-22,2.084302420723239e-21,39.704577642887266
SLC35E1,ILMN_1752333,"Homo sapiens solute carrier family 35, member E1 (SLC35E1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],transport [goid 6810] [evidence IEA]; transport [goid 6810] [evidence IEA],,19,16524097-16524146,19p13.11f,-,NM_024881.3,79939,SLC35E1,1.1242716796372818,11.043954202742393,11.264046096352006,2.6434679305754137e-22,2.1517699900306295e-21,39.67124366668093
LOC646163,ILMN_1660439,"PREDICTED: Homo sapiens similar to 60S ribosomal protein L3 (L4) (LOC646163), mRNA.",,,,10,121819491-121819540,10q26.12a,-,XM_929125.1,646163,LOC646163,-1.4597734705678995,10.355401225833495,-11.251960550269889,2.858769671518837e-22,2.3213581001521467e-21,39.59329832854712
ABCB1,ILMN_1812070,"Homo sapiens ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1), mRNA.",integral to membrane [goid 16021] [pmid 3768958] [evidence TAS]; membrane fraction [goid 5624] [pmid 3022150] [evidence TAS]; membrane [goid 16020] [evidence IEA]; cell surface [goid 9986] [pmid 12493773] [evidence IEP]; integral to membrane [goid 16021] [pmid 3768958] [evidence TAS]; membrane fraction [goid 5624] [pmid 3022150] [evidence TAS]; membrane [goid 16020] [evidence IEA]; cell surface [goid 9986] [pmid 12493773] [evidence IEP],response to drug [goid 42493] [pmid 3022150] [evidence TAS]; transport [goid 6810] [pmid 3022150] [evidence TAS]; response to drug [goid 42493] [pmid 3022150] [evidence TAS]; transport [goid 6810] [pmid 3022150] [evidence TAS],xenobiotic-transporting ATPase activity [goid 8559] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; transporter activity [goid 5215] [pmid 3022150] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 3768958] [evidence TAS]; xenobiotic-transporting ATPase activity [goid 8559] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; transporter activity [goid 5215] [pmid 3022150] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [pmid 3768958] [evidence TAS],7,86971478-86971494:86971495-86971527,7q21.12a-q21.12b,-,NM_000927.3,5243,ABCB1,-1.5760927265822948,6.0594418620302655,-11.246307553841831,2.965400885269815e-22,2.4069671769768137e-21,39.55684353759962
LOC388969,ILMN_1679771,"Homo sapiens hypothetical LOC388969 (LOC388969), mRNA.",,,,2,85690987-85691036,2p11.2f,-,NM_001013649.1,388969,LOC388969,1.3074582933436112,7.636642471000739,11.239115734889207,3.106815983213512e-22,2.519707101424238e-21,39.51046898760459
PALLD,ILMN_1698732,"Homo sapiens palladin, cytoskeletal associated protein (PALLD), mRNA.",actin filament [goid 5884] [pmid 11598191] [evidence IDA]; nucleus [goid 5634] [pmid 11598191] [evidence IDA],cytoskeleton organization and biogenesis [goid 7010] [pmid 11598191] [evidence NAS]; protein amino acid phosphorylation [goid 6468] [evidence IEA],muscle alpha-actinin binding [goid 51371] [pmid 16125169] [evidence TAS]; vascular endothelial growth factor receptor activity [goid 5021] [evidence IEA]; protein binding [goid 5515] [pmid 11598191] [evidence IPI]; ATP binding [goid 5524] [evidence IEA],4,170085818-170085867,4q32.3e,+,NM_016081.2,23022,PALLD,-1.0233673063580397,10.869904602611507,-11.237099240248362,3.147661779388607e-22,2.550766175860966e-21,39.49746690564926
PDE3B,ILMN_2131381,"Homo sapiens phosphodiesterase 3B, cGMP-inhibited (PDE3B), mRNA.",membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [evidence IEA],"hydrolase activity [goid 16787] [evidence IEA]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [goid 4119] [pmid 8884271] [evidence TAS]; 3',5'-cyclic-nucleotide phosphodiesterase activity [goid 4114] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA]",11,14848310-14848359,11p15.2b,+,NM_000922.2,5140,PDE3B,-1.116696415461492,6.299997547039962,-11.224916996747472,3.406078881301893e-22,2.7557147697973426e-21,39.418924508832355
TEX14,ILMN_1685490,"Homo sapiens testis expressed 14 (TEX14), transcript variant 2, mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],17,53989237-53989286,17q22d,-,NM_031272.3,56155,TEX14,-1.1130388733667678,5.370730109665915,-11.224680705693535,3.4112951882568396e-22,2.7588194877381914e-21,39.417401192957975
PHLDB2,ILMN_1719792,"Homo sapiens pleckstrin homology-like domain, family B, member 2 (PHLDB2), mRNA.",,,,3,113176934-113176983,3q13.2a,+,NM_145753.1,90102,PHLDB2,-1.1621700010501215,6.468437927065895,-11.213629008302451,3.66438956555156e-22,2.9563349365949844e-21,39.34615848329538
OLFM1,ILMN_1714709,"Homo sapiens olfactomedin 1 (OLFM1), transcript variant 2, mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; membrane [goid 16020] [evidence IEA],development [goid 7275] [evidence IEA],latrotoxin receptor activity [goid 16524] [evidence IEA],9,137129482-137129531,9q34.3a-q34.3b,+,NM_006334.2,10439,OLFM1,-1.4237004794800487,8.218955969625952,-11.209691447942742,3.7590219229664243e-22,3.0302381399964635e-21,39.32077816695637
NAP1L5,ILMN_1773307,"Homo sapiens nucleosome assembly protein 1-like 5 (NAP1L5), mRNA.",nucleus [goid 5634] [evidence IEA],nucleosome assembly [goid 6334] [evidence IEA],,4,89836359-89836408,4q22.1b,-,NM_153757.1,266812,NAP1L5,-1.1698549610419953,6.851685449529174,-11.19218139017205,4.2102753576821855e-22,3.3858195078981172e-21,39.20792926015809
IHPK2,ILMN_1683328,"Homo sapiens inositol hexaphosphate kinase 2 (IHPK2), transcript variant 4, mRNA.",nucleus [goid 5634] [evidence ISS],positive regulation of apoptosis [goid 43065] [pmid 11337497] [evidence IMP]; negative regulation of cell growth [goid 30308] [pmid 11337497] [evidence IMP],transferase activity [goid 16740] [evidence IEA]; polyphosphate kinase activity [goid 8976] [pmid 10574768] [evidence TAS]; inositol hexakisphosphate kinase activity [goid 50517] [pmid 11337497] [evidence NAS],3,48706676-48706677:48707527-48707574,3p21.31e,-,NM_001005911.1,51447,IHPK2,-1.2746244084915368,6.967464053639747,-11.188091671607873,4.323233613098917e-22,3.469685444479869e-21,39.18157551242488
FLJ20130,ILMN_1756550,"Homo sapiens nucleoporin 62kDa C-terminal like (NUP62CL), mRNA.",integral to membrane [goid 16021] [evidence IEA]; nuclear pore [goid 5643] [evidence IEA]; outer membrane [goid 19867] [evidence IEA],,structural constituent of nuclear pore [goid 17056] [evidence IEA]; porin activity [goid 15288] [evidence IEA],X,106253395-106253444,Xq22.3b,-,NM_017681.1,54830,FLJ20130,1.512321905298041,6.817059028231918,11.183504564652782,4.453532693046689e-22,3.569963226060823e-21,39.152018315165705
LYPD1,ILMN_1668863,"Homo sapiens LY6/PLAUR domain containing 1 (LYPD1), mRNA.",,,,2,133118934-133118983,2q21.2b,-,NM_144586.3,116372,LYPD1,1.016290094814864,6.1634559824899835,11.177405010446964,4.632884817231139e-22,3.712245071011639e-21,39.11271835550945
KCNK3,ILMN_1768483,"Homo sapiens potassium channel, subfamily K, member 3 (KCNK3), mRNA.",integral to plasma membrane [goid 5887] [pmid 9312005] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 9312005] [evidence TAS]; synaptic transmission [goid 7268] [pmid 9312005] [evidence TAS],voltage-gated ion channel activity [goid 5244] [evidence IEA]; potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [pmid 9312005] [evidence TAS],2,26805870-26805919,2p23.3a,+,NM_002246.1,3777,KCNK3,-1.7015339001267025,7.813496125014949,-11.177063674864824,4.643131854525055e-22,3.718966458980677e-21,39.110519193525825
HIST1H2BD,ILMN_1651496,"Homo sapiens histone cluster 1, H2bd (HIST1H2BD), transcript variant 2, mRNA.",chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; nucleosome [goid 786] [evidence ISS]; chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; nucleosome [goid 786] [evidence ISS],nucleosome assembly [goid 6334] [evidence ISS]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [evidence IEA]; nucleosome assembly [goid 6334] [evidence ISS]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [evidence IEA],DNA binding [goid 3677] [evidence ISS]; DNA binding [goid 3677] [evidence ISS],6,26279283-26279332,6p22.1d,+,NM_138720.1,3017,HIST1H2BD,1.0740856842227515,7.340388865064874,11.176625567158629,4.656317190508683e-22,3.726543773907909e-21,39.10769656111474
C8B,ILMN_1731293,"Homo sapiens complement component 8, beta polypeptide (C8B), mRNA.",extracellular space [goid 5615] [evidence IEA]; membrane attack complex [goid 5579] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [pmid 2820472] [evidence TAS],"immune response [goid 6955] [pmid 8098723] [evidence TAS]; cytolysis [goid 19835] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]; response to pathogenic bacteria [goid 9618] [pmid 8098723] [evidence TAS]; complement activation, alternative pathway [goid 6957] [evidence IEA]",,1,57170103-57170139:57171596-57171608,1p32.2b,-,NM_000066.2,732,C8B,-2.1165780082809498,6.123200051651294,-11.16510614469594,5.01674279367046e-22,4.008585855261923e-21,39.03348528232314
LOC441087,ILMN_1742163,"Homo sapiens hypothetical gene supported by AK125735 (LOC441087), mRNA.",,,,5,75064202-75064251,5q13.3c,+,NM_001013716.1,441087,LOC441087,1.2673725325153455,14.302024077718398,11.164822715523522,5.025953352713743e-22,4.014342302638586e-21,39.03165949627903
FCGBP,ILMN_1718984,"PREDICTED: Homo sapiens Fc fragment of IgG binding protein (FCGBP), mRNA.",,,,,,19q13.2b,,XM_940656.1,8857,FCGBP,1.871207626618724,8.389027676084073,11.157071831370075,5.28448116552777e-22,4.212426261349786e-21,38.98173273222929
GGCX,ILMN_1758232,"Homo sapiens gamma-glutamyl carboxylase (GGCX), mRNA.",membrane fraction [goid 5624] [pmid 1749935] [evidence TAS]; integral to membrane [goid 16021] [pmid 1749935] [evidence TAS],protein modification [goid 6464] [pmid 1749935] [evidence TAS]; blood coagulation [goid 7596] [pmid 9845520] [evidence TAS]; peptidyl-glutamic acid carboxylation [goid 17187] [evidence IEA],gamma-glutamyl carboxylase activity [goid 8488] [pmid 1749935] [evidence TAS]; ligase activity [goid 16874] [evidence IEA],2,85629904-85629953,2p11.2f,-,NM_000821.3,2677,GGCX,1.024684885422766,8.279142006535116,11.156743558142683,5.2957188796125105e-22,4.219703040353927e-21,38.97961829740954
MGC42105,ILMN_1652072,"Homo sapiens hypothetical protein MGC42105 (MGC42105), mRNA.",,protein amino acid phosphorylation [goid 6468] [pmid 15733851] [evidence IDA],ATP binding [goid 5524] [pmid 15733851] [evidence IDA]; transferase activity [goid 16740] [evidence IEA]; magnesium ion binding [goid 287] [pmid 15733851] [evidence IDA]; protein serine/threonine kinase activity [goid 4674] [pmid 15733851] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA],5,43316459-43316508,5p12c,+,NM_153361.2,167359,MGC42105,-1.5610790509120056,5.903381813372167,-11.138966524163886,5.941271446476484e-22,4.7153097620428996e-21,38.8651288292105
RGS5,ILMN_1651554,"Homo sapiens regulator of G-protein signalling 5 (RGS5), mRNA.",,regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [pmid 10471929] [evidence TAS]; negative regulation of signal transduction [goid 9968] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA]; GTPase activator activity [goid 5096] [pmid 10471929] [evidence TAS],1,161379402-161379451,1q23.3c,-,NM_003617.2,8490,RGS5,-1.7324040228565938,8.149871067958912,-11.136214209159942,6.048011124801798e-22,4.796219048158318e-21,38.8474055350863
KDELR3,ILMN_1713901,"Homo sapiens KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 (KDELR3), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],protein retention in ER [goid 6621] [evidence IEA]; protein transport [goid 15031] [evidence IEA]; protein retention in ER [goid 6621] [evidence IEA]; protein transport [goid 15031] [evidence IEA],ER retention sequence binding [goid 46923] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; ER retention sequence binding [goid 46923] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],22,37207271-37207320,22q13.1b,+,NM_016657.1,11015,KDELR3,1.2057970228349557,7.720635653726174,11.13441402763387,6.118858550913233e-22,4.8466398213250974e-21,38.83581377853937
VSIG2,ILMN_1666536,"Homo sapiens V-set and immunoglobulin domain containing 2 (VSIG2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,11,124123562-124123611,11q24.2a,-,NM_014312.3,23584,VSIG2,-2.3082877844538157,9.744232830939398,-11.126260650677596,6.450255568797907e-22,5.097026596386593e-21,38.783315968520036
LOC390466,ILMN_1665781,"PREDICTED: Homo sapiens similar to SMT3 suppressor of mif two 3 homolog 2 (LOC390466), mRNA.",,,,14,34459695-34459744,,+,XM_372521.1,390466,LOC390466,-1.239838562364561,8.914087598075522,-11.12571878372784,6.47290433630037e-22,5.110886738780498e-21,38.77982721181617
ATF3,ILMN_1791346,"Homo sapiens activating transcription factor 3 (ATF3), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",transcription corepressor activity [goid 3714] [pmid 7515060] [evidence TAS]; DNA binding [goid 3677] [evidence IEA]; protein dimerization activity [goid 46983] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 7515060] [evidence TAS],1,210859111-210859160,1q32.3c,+,NM_004024.3,467,ATF3,-1.1227425926245553,7.372297470083524,-11.123808184764975,6.553398089579897e-22,5.166548633865796e-21,38.767526214919314
SCG5,ILMN_2065773,"Homo sapiens secretogranin V (7B2 protein) (SCG5), mRNA.",secretory granule [goid 30141] [evidence ISS],neuropeptide signaling pathway [goid 7218] [evidence IEA]; regulation of hormone secretion [goid 46883] [evidence ISS]; peptide hormone processing [goid 16486] [evidence ISS]; protein folding [goid 6457] [evidence IEA]; transport [goid 6810] [evidence IEA]; intracellular protein transport [goid 6886] [evidence ISS],GTP binding [goid 5525] [pmid 3134253] [evidence TAS]; unfolded protein binding [goid 51082] [pmid 7913882] [evidence IDA]; enzyme inhibitor activity [goid 4857] [evidence ISS]; enzyme activator activity [goid 8047] [evidence NR ],15,30776515-30776564,15q13.3c,+,NM_003020.1,6447,SCG5,2.338946580805377,7.4844872734770975,11.117242191880877,6.837717130021199e-22,5.388304227548805e-21,38.725254869584354
GNL3L,ILMN_1708414,"Homo sapiens guanine nucleotide binding protein-like 3 (nucleolar)-like (GNL3L), mRNA.",,,GTP binding [goid 5525] [evidence IEA],X,54605704-54605753,Xp11.22a,+,NM_019067.3,54552,GNL3L,1.192146688485698,10.549739908088892,11.116451263418815,6.872786160127353e-22,5.413807302827877e-21,38.72016319043869
TMPRSS6,ILMN_1725014,"Homo sapiens transmembrane protease, serine 6 (TMPRSS6), mRNA.",integral to membrane [goid 16021] [pmid 12149247] [evidence IDA]; membrane [goid 16020] [evidence IEA],angiogenesis [goid 1525] [pmid 12149247] [evidence NAS]; extracellular matrix organization and biogenesis [goid 30198] [pmid 12149247] [evidence NAS]; fibrinolysis [goid 42730] [pmid 12149247] [evidence IDA]; intracellular signaling cascade [goid 7242] [pmid 12149247] [evidence NAS],serine-type endopeptidase activity [goid 4252] [pmid 12149247] [evidence IDA]; peptidase activity [goid 8233] [evidence IEA],22,35791704-35791753,22q12.3d,-,NM_153609.2,164656,TMPRSS6,1.7764391884903867,5.990915758674085,11.109547203405187,7.186629434946969e-22,5.652125854340368e-21,38.67571997540405
MATN3,ILMN_1663171,"Homo sapiens matrilin 3 (MATN3), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9350998] [evidence TAS],skeletal development [goid 1501] [pmid 9350998] [evidence TAS]; extracellular matrix organization and biogenesis [goid 30198] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; collagen binding [goid 5518] [evidence IEA]; extracellular matrix structural constituent [goid 5201] [pmid 9350998] [evidence TAS],2,20060396-20060445,2p24.1d,-,NM_002381.3,4148,MATN3,-1.65484214684452,6.2701624107643905,-11.095401871120702,7.8750260656599525e-22,6.17411918188575e-21,38.58467602809099
FLRT3,ILMN_1805665,"Homo sapiens fibronectin leucine rich transmembrane protein 3 (FLRT3), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 10644439] [evidence NAS]; membrane [goid 16020] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 10644439] [evidence NAS],cell adhesion [goid 7155] [evidence IEA],"transferase activity [goid 16740] [evidence IEA]; receptor signaling protein activity [goid 5057] [pmid 10644439] [evidence NAS]; protein binding, bridging [goid 30674] [pmid 10644439] [evidence NAS]",20,14252872-14252921,20p12.1d-p12.1c,-,NM_013281.2,23767,FLRT3,-1.472720002799793,10.52046183406224,-11.092453800815223,8.026582460041299e-22,6.2904763752646424e-21,38.56570353781072
EIF2C2,ILMN_1695719,"Homo sapiens eukaryotic translation initiation factor 2C, 2 (EIF2C2), mRNA.",,protein biosynthesis [goid 6412] [pmid 10534406] [evidence NAS],protein binding [goid 5515] [pmid 14749716] [evidence IPI]; translation initiation factor activity [goid 3743] [pmid 10534406] [evidence NAS],8,141610650-141610699,8q24.3c,-,NM_012154.2,27161,EIF2C2,1.0496031441463956,10.339811589154763,11.079992421145157,8.700032177581043e-22,6.794310843444243e-21,38.48551616742872
RAC2,ILMN_1709795,"Homo sapiens ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) (RAC2), mRNA.",intracellular [goid 5622] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA]; signal transduction [goid 7165] [pmid 2674130] [evidence TAS],GTP binding [goid 5525] [evidence IEA]; GTPase activity [goid 3924] [pmid 2674130] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; protein binding [goid 5515] [pmid 11090627] [evidence IPI],22,35951411-35951460,22q13.1a,-,NM_002872.3,5880,RAC2,-1.103904316384785,11.244356657455043,-11.075711451696314,8.944170344290649e-22,6.974082628548998e-21,38.45797191083101
GPR1,ILMN_1655348,"Homo sapiens G protein-coupled receptor 1 (GPR1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7851889] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 7851889] [evidence TAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 7851889] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 7851889] [evidence TAS],"rhodopsin-like receptor activity [goid 1584] [evidence IEA]; G-protein coupled receptor activity, unknown ligand [goid 16526] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; G-protein coupled receptor activity, unknown ligand [goid 16526] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]",2,206748953-206749002,2q33.3b,-,NM_005279.2,2825,GPR1,1.0251085287117387,8.221169150023144,11.07104192165077,9.218270072260258e-22,7.179414075740881e-21,38.427929501916154
C2,ILMN_1710740,"Homo sapiens complement component 2 (C2), mRNA.",extracellular region [goid 5576] [evidence IEA]; complement component C2 complex [goid 5603] [pmid 6199794] [evidence TAS],"innate immune response [goid 45087] [evidence IEA]; complement activation, classical pathway [goid 6958] [pmid 8621452] [evidence TAS]",serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; classical-complement-pathway C3/C5 convertase activity [goid 3813] [evidence IEA],6,32021146-32021195,6p21.32b,+,NM_000063.3,717,C2,-1.3055482289776954,9.79249704058983,-11.07023258233007,9.266623297101294e-22,7.214264549743296e-21,38.4227226474037
NEXN,ILMN_1783276,"Homo sapiens nexilin (F actin binding protein) (NEXN), mRNA.",cellular component unknown [goid 8372] [evidence ND ],biological process unknown [goid 4] [evidence ND ],molecular function unknown [goid 5554] [evidence ND ],1,78181250-78181299,1p31.1e,+,NM_144573.1,91624,NEXN,-1.2382810901898074,7.5800061098187825,-11.068431208019799,9.375155325132032e-22,7.295920176788865e-21,38.411133786224994
LOC644151,ILMN_1695397,"PREDICTED: Homo sapiens similar to calpain 8 (LOC644151), mRNA.",,,,1,221784057-221784106,1q41e,-,XM_927359.1,644151,LOC644151,2.0776227706153723,9.436694295853306,11.05884647192325,9.974325323491845e-22,7.753158549822254e-21,38.349476849755796
NIBP,ILMN_1711368,"Homo sapiens NIK and IKK{beta} binding protein (NIBP), mRNA.",,,,8,140811933-140811982,8q24.3b,-,NM_031466.3,83696,NIBP,1.0204046374220015,8.08530479818817,11.058028249122499,1.0027211725220262e-21,7.791240862066291e-21,38.34421375384448
MCHR2,ILMN_2383150,"Homo sapiens melanin-concentrating hormone receptor 2 (MCHR2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [evidence IEA]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],6,,6q16.3a,-,NM_032503.1,84539,MCHR2,1.219851218295477,6.271577316174783,11.053441445227376,1.0328906723767872e-21,8.01943211987379e-21,38.314710958960106
RNASE6,ILMN_1780533,"Homo sapiens ribonuclease, RNase A family, k6 (RNASE6), mRNA.",extracellular region [goid 5576] [pmid 8836175] [evidence TAS],RNA catabolism [goid 6401] [pmid 8836175] [evidence TAS]; defense response [goid 6952] [pmid 8836175] [evidence TAS],ribonuclease activity [goid 4540] [pmid 8836175] [evidence TAS]; pancreatic ribonuclease activity [goid 4522] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],14,20320082-20320131,14q11.2b,+,NM_005615.2,6039,RNASE6,-1.2605017478800482,8.444127791932575,-11.051630830515727,1.0450477834902741e-21,8.11067341042413e-21,38.303065430225885
CTSS,ILMN_1743032,"Homo sapiens cathepsin S (CTSS), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; lysosome [goid 5764] [evidence NAS],immune response [goid 6955] [pmid 8157683] [evidence TAS],cathepsin S activity [goid 4218] [pmid 1373132] [evidence TAS],1,148969534-148969583,1q21.2c,-,NM_004079.3,1520,CTSS,-1.041398189928838,8.432645991553784,-11.049463557193373,1.0597875299431825e-21,8.221880146996198e-21,38.28912633758991
LOC649986,ILMN_1654560,"PREDICTED: Homo sapiens similar to toll-like receptor 1 (LOC649986), mRNA.",,,,,,,,XM_939071.1,649986,LOC649986,-1.0940140041330553,6.6430762992294765,-11.046396683901248,1.0810007075559796e-21,8.376708813625112e-21,38.26940209292375
RGS2,ILMN_2197365,"Homo sapiens regulator of G-protein signalling 2, 24kDa (RGS2), mRNA.",,negative regulation of signal transduction [goid 9968] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 15609325] [evidence NAS]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [pmid 10747990] [evidence TAS],GTPase activator activity [goid 5096] [pmid 10747990] [evidence TAS]; signal transducer activity [goid 4871] [evidence IEA]; calmodulin binding [goid 5516] [pmid 10747990] [evidence TAS],1,191047925-191047974,1q31.2b,+,NM_002923.1,5997,RGS2,-1.4555989747546008,11.480204463678046,-11.04439035789522,1.0951069624624727e-21,8.476170253365243e-21,38.2564991060936
PTTG1,ILMN_1753196,"Homo sapiens pituitary tumor-transforming 1 (PTTG1), mRNA.",cytoplasm [goid 5737] [pmid 9811450] [evidence TAS]; nucleus [goid 5634] [pmid 9811450] [evidence TAS]; cytoplasm [goid 5737] [pmid 9811450] [evidence TAS]; nucleus [goid 5634] [pmid 9811450] [evidence TAS],cell division [goid 51301] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; chromosome organization and biogenesis [goid 51276] [evidence IEA]; mitosis [goid 7067] [evidence IEA]; DNA metabolism [goid 6259] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9811450] [evidence TAS]; spermatogenesis [goid 7283] [pmid 9915854] [evidence TAS]; chromosome segregation [goid 7059] [evidence IEA]; cell division [goid 51301] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]; DNA repair [goid 6281] [evidence IEA]; chromosome organization and biogenesis [goid 51276] [evidence IEA]; mitosis [goid 7067] [evidence IEA]; DNA metabolism [goid 6259] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9811450] [evidence TAS]; spermatogenesis [goid 7283] [pmid 9915854] [evidence TAS]; chromosome segregation [goid 7059] [evidence IEA],protein binding [goid 5515] [pmid 12194817] [evidence IPI]; cysteine protease inhibitor activity [goid 4869] [pmid 12194817] [evidence NAS]; transcription factor activity [goid 3700] [pmid 9811450] [evidence TAS]; protein binding [goid 5515] [pmid 12194817] [evidence IPI]; cysteine protease inhibitor activity [goid 4869] [pmid 12194817] [evidence NAS]; transcription factor activity [goid 3700] [pmid 9811450] [evidence TAS],5,159781951-159781988:159782294-159782305,5q33.3d,+,NM_004219.2,9232,PTTG1,1.1989691052913987,8.712350154703996,11.042840971646228,1.1061261067207474e-21,8.554840024456402e-21,38.2465350225171
FLJ11783,ILMN_1679003,"Homo sapiens hypothetical protein FLJ11783 (FLJ11783), mRNA.",,,,11,117814732-117814781,11q23.3d,+,NM_024891.1,79951,FLJ11783,1.1685241444872867,6.010285489590555,11.041740807502707,1.1140175224330388e-21,8.612543504188655e-21,38.23946001540315
CCL3,ILMN_1671509,"Homo sapiens chemokine (C-C motif) ligand 3 (CCL3), mRNA.",extracellular space [goid 5615] [evidence IEA]; soluble fraction [goid 5625] [pmid 10706735] [evidence TAS],cell-cell signaling [goid 7267] [pmid 10679098] [evidence TAS]; chemotaxis [goid 6935] [pmid 10679098] [evidence TAS]; signal transduction [goid 7165] [pmid 10706735] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10734056] [evidence TAS]; cytoskeleton organization and biogenesis [goid 7010] [pmid 10072545] [evidence TAS]; exocytosis [goid 6887] [pmid 10734056] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 10734056] [evidence TAS]; sensory perception [goid 7600] [evidence IEA]; regulation of viral genome replication [goid 45069] [pmid 10841574] [evidence TAS]; inflammatory response [goid 6954] [pmid 10679098] [evidence TAS]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9973507] [evidence TAS]; cell motility [goid 6928] [pmid 10660125] [evidence TAS],signal transducer activity [goid 4871] [pmid 10857861] [evidence TAS]; chemokine activity [goid 8009] [pmid 10660125] [evidence TAS],17,31440747-31440756:31441445-31441484,17q12b,-,NM_002983.1,6348,CCL3,-2.1404615518581727,7.55133942532277,-11.041590969693614,1.1150966388697044e-21,8.617556411937059e-21,38.23849643733876
C14orf85,ILMN_2134381,Homo sapiens chromosome 14 open reading frame 85 (C14orf85) on chromosome 14.,,,,14,92608098-92608147,14q32.12b,+,NR_002808.1,319085,C14orf85,1.5658390738948977,13.172424818265586,11.038917088381668,1.1345300169896323e-21,8.760971277471464e-21,38.2213015715551
LOC642678,ILMN_1796206,"PREDICTED: Homo sapiens similar to myeloid/lymphoid or mixed-lineage leukemia 3 isoform 2 (LOC642678), mRNA.",,,,2,91249727-91249749:91250257-91250283,2p11.1d,-,XM_926130.1,642678,LOC642678,1.3840075755446808,7.278648971331436,11.036734405965316,1.1506437134249527e-21,8.881975084184588e-21,38.207265938126724
STEAP3,ILMN_2383349,"Homo sapiens STEAP family member 3 (STEAP3), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; multivesicular body [goid 5771] [pmid 15319436] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA]; multivesicular body [goid 5771] [pmid 15319436] [evidence IDA],protein secretion [goid 9306] [pmid 15319436] [evidence IDA]; electron transport [goid 6118] [evidence IEA]; protein secretion [goid 9306] [pmid 15319436] [evidence IDA]; electron transport [goid 6118] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; FAD binding [goid 50660] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; FAD binding [goid 50660] [evidence IEA],2,119739480-119739529,2q14.2b,+,NM_018234.2,55240,STEAP3,1.1176606029053282,9.354762857154283,11.032731303482684,1.180792572452071e-21,9.100654002165269e-21,38.18152533121064
SFTPB,ILMN_1727017,"Homo sapiens surfactant, pulmonary-associated protein B (SFTPB), transcript variant 2, mRNA.",extracellular space [goid 5615] [evidence NR ]; lysosome [goid 5764] [evidence IEA],regulation of liquid surface tension [goid 50828] [evidence IEA]; sphingolipid metabolism [goid 6665] [evidence IEA]; respiratory gaseous exchange [goid 7585] [pmid 10378403] [evidence TAS]; lipid metabolism [goid 6629] [evidence IEA],,2,85738216-85738265,2p11.2f,-,NM_198843.1,6439,SFTPB,-1.6972764855062454,10.39090848641883,-11.0288331634653,1.2109083042484191e-21,9.325578657198756e-21,38.15646108298098
ZNF533,ILMN_1657087,"Homo sapiens zinc finger protein 533 (ZNF533), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],2,180015130-180015179,2q31.2c-q31.3a,-,NM_152520.3,151126,ZNF533,-2.2077651536256697,8.415657832526449,-11.02612891373766,1.2322495762440367e-21,9.482634431342572e-21,38.139074139146025
CPNE4,ILMN_1814770,"Homo sapiens copine IV (CPNE4), mRNA.",,,,3,132736522-132736571,3q22.1b-q22.1c,-,NM_130808.1,131034,CPNE4,1.1489756100170911,5.433261873246523,11.022912280379884,1.2581237374308476e-21,9.674304280751882e-21,38.11839372018113
ZNF331,ILMN_1711199,"Homo sapiens zinc finger protein 331 (ZNF331), mRNA.",nucleus [goid 5634] [evidence NAS]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence NAS]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; transcription [goid 6350] [evidence IEA]",metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 10502321] [evidence NAS]; DNA binding [goid 3677] [evidence NAS]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 10502321] [evidence NAS]; DNA binding [goid 3677] [evidence NAS]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [pmid 10502321] [evidence NAS]; DNA binding [goid 3677] [evidence NAS],19,58775163-58775212,19q13.41b,+,NM_018555.4,55422,ZNF331,-1.0439331710058797,6.589272144800311,-11.019296490047319,1.2878564545346339e-21,9.89152857670977e-21,38.09514819274097
GZMH,ILMN_1731233,"Homo sapiens granzyme H (cathepsin G-like 2, protein h-CCPX) (GZMH), mRNA.",cytoplasm [goid 5737] [evidence NAS],apoptosis [goid 6915] [pmid 2402757] [evidence NAS]; cytolysis [goid 19835] [evidence IEA],peptidase activity [goid 8233] [evidence IEA]; chymotrypsin activity [goid 4263] [evidence IEA]; trypsin activity [goid 4295] [evidence IEA],14,24145611-24145648:24145649-24145660,14q12a,-,NM_033423.2,2999,GZMH,-1.4977945199337102,8.670881516844632,-11.015461916161662,1.3201546889042736e-21,1.0131820105714118e-20,38.070497469727314
CGN,ILMN_1746801,"Homo sapiens cingulin (CGN), mRNA.",myosin [goid 16459] [evidence IEA]; tight junction [goid 5923] [pmid 12529927] [evidence NAS],,motor activity [goid 3774] [evidence IEA]; actin binding [goid 3779] [evidence ISS]; protein binding [goid 5515] [pmid 11042084] [evidence IPI],1,149777638-149777687,1q21.3a,+,NM_020770.1,57530,CGN,1.172655465427562,10.76019995545619,11.009905564417943,1.3683947905961087e-21,1.0498022611291005e-20,38.034780678533124
SLC4A11,ILMN_1735156,"Homo sapiens solute carrier family 4, sodium bicarbonate transporter-like, member 11 (SLC4A11), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],anion transport [goid 6820] [evidence IEA],inorganic anion exchanger activity [goid 5452] [evidence IEA],20,3156309-3156358,20p13c,-,NM_032034.1,83959,SLC4A11,1.6371535634017,6.508500848548465,10.99946821857648,1.4638174923871895e-21,1.122147907574057e-20,37.967696249282106
MAP7D2,ILMN_2080080,"Homo sapiens MAP7 domain containing 2 (MAP7D2), mRNA.",,,,X,19935651-19935700,Xp22.12b,-,NM_152780.2,256714,MAP7D2,1.5320423425014136,5.50664055317428,10.99789598784658,1.4787559171445926e-21,1.1331653921956726e-20,37.9575918742041
LOC90586,ILMN_2219618,Homo sapiens AOC3 pseudogene (LOC90586) on chromosome 17.,,,,17,38274563-38274612,17q21.31a,+,NR_002773.1,90586,LOC90586,1.8618155099123346,12.405059162873115,10.997525725192403,1.4822960124231122e-21,1.135443285473263e-20,37.95521231316928
LOC644037,ILMN_1732074,"PREDICTED: Homo sapiens similar to Heterogeneous nuclear ribonucleoprotein A1 (Helix-destabilizing protein) (Single-strand binding protein) (hnRNP core protein A1) (HDP-1) (Topoisomerase-inhibitor suppressed), transcript variant 2 (LOC644037), mRNA.",,,,5,79691601-79691650,5q14.1e,-,XM_933604.1,644037,LOC644037,-1.3541608808831231,12.12717998355094,-10.993845361193058,1.5179472053599179e-21,1.16186257401841e-20,37.93156048661136
ZNF223,ILMN_1815578,"Homo sapiens zinc finger protein 223 (ZNF223), mRNA.",nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [pmid 10449920] [evidence NAS],19,49263889-49263938,19q13.31b,+,NM_013361.2,7766,ZNF223,1.8240836171004169,10.094953540972643,10.990090205359337,1.5552049049557226e-21,1.1899250377955678e-20,37.90742934194249
PAQR4,ILMN_1660793,"Homo sapiens progestin and adipoQ receptor family member IV (PAQR4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,receptor activity [goid 4872] [evidence IEA],16,2963395-2963444,16p13.3d,+,NM_152341.2,124222,PAQR4,1.0393857039978567,9.530312780063118,10.988748625996333,1.568735803463789e-21,1.1998190350039561e-20,37.89880849610623
IGFBP6,ILMN_1669362,"Homo sapiens insulin-like growth factor binding protein 6 (IGFBP6), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence NR ],regulation of cell growth [goid 1558] [evidence IEA]; signal transduction [goid 7165] [pmid 10087296] [evidence NAS]; negative regulation of cell proliferation [goid 8285] [pmid 7539002] [evidence TAS],insulin-like growth factor binding [goid 5520] [evidence IEA],12,51781127-51781176,12q13.13e,+,NM_002178.2,3489,IGFBP6,-2.088467280343991,9.808600187941131,-10.987428392387022,1.5821660919844037e-21,1.2087048174274131e-20,37.89032498384642
MLR2,ILMN_1689817,"Homo sapiens ligand-dependent corepressor (MLR2), mRNA.",nucleus [goid 5634] [evidence IEA],,DNA binding [goid 3677] [evidence IEA],10,98708150-98708199,10q24.1a-q24.1b,+,NM_032440.1,84458,MLR2,1.1162218003214823,7.973003326733626,10.98252255366791,1.6330845926529239e-21,1.2466522903395537e-20,37.85880267495161
UBE2S,ILMN_1808591,"Homo sapiens ubiquitin-conjugating enzyme E2S (UBE2S), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA]; ubiquitin cycle [goid 6512] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; ubiquitin-like activating enzyme activity [goid 8642] [evidence IEA]; ligase activity [goid 16874] [evidence IEA]; ligase activity [goid 16874] [evidence IEA]; ubiquitin-protein ligase activity [goid 4842] [evidence IEA],19,60604568-60604615:60604616-60604617,19q13.42b,-,NM_014501.2,27338,UBE2S,1.0801210556958178,9.544674646089303,10.973958957529323,1.72591696384146e-21,1.3160116849291133e-20,37.80378310449828
MMP28,ILMN_1752952,"Homo sapiens matrix metallopeptidase 28 (MMP28), transcript variant 3, mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 11121398] [evidence NAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 11121398] [evidence NAS],peptidoglycan metabolism [goid 270] [evidence IEA]; peptidoglycan metabolism [goid 270] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metalloendopeptidase activity [goid 4222] [pmid 11255011] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metalloendopeptidase activity [goid 4222] [pmid 11255011] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],17,31130376-31130425,17q12b,-,NM_001032278.1,79148,MMP28,-1.5178704270745813,7.552447251143866,-10.967936902629848,1.7943339037898715e-21,1.3660971364926844e-20,37.76509671746063
AIRE,ILMN_2261519,"Homo sapiens autoimmune regulator (autoimmune polyendocrinopathy candidiasis ectodermal dystrophy) (AIRE), transcript variant AIRE-1, mRNA.",cytoplasm [goid 5737] [evidence IEA]; nucleus [goid 5634] [pmid 9398840] [evidence NAS],"transcription [goid 6350] [evidence IEA]; humoral immune response [goid 6959] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [pmid 9398840] [evidence NAS]",protein binding [goid 5515] [evidence IEA]; transcription factor activity [goid 3700] [pmid 9398839] [evidence TAS]; translation regulator activity [goid 45182] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],21,44542391-44542440,21q22.3d,+,NM_000383.1,326,AIRE,1.1650009047638203,13.704120835801834,10.964558875515527,1.8338898475757413e-21,1.3946206032039313e-20,37.74339741223136
ZNF600,ILMN_1678457,"Homo sapiens zinc finger protein 600 (ZNF600), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA],19,57959336-57959385,19q13.41a,-,NM_198457.1,162966,ZNF600,1.6562817839586126,7.656319522006303,10.963508024032869,1.846371634918928e-21,1.4030460946243035e-20,37.73664732302434
TBX2,ILMN_1792256,"Homo sapiens T-box 2 (TBX2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]; transcription [goid 6350] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],17,56841035-56841084,17q23.2b,+,NM_005994.3,6909,TBX2,-1.3637744294034633,9.902896736693993,-10.959691807627443,1.8924169753616142e-21,1.4363990456386637e-20,37.71213496033239
C14orf124,ILMN_1771629,"Homo sapiens chromosome 14 open reading frame 124 (C14orf124), mRNA.",,nucleotide-sugar metabolism [goid 9225] [evidence IEA],catalytic activity [goid 3824] [evidence IEA]; NAD binding [goid 51287] [evidence IEA],14,23981413-23981462,14q12a,-,NM_020195.1,56948,C14orf124,-1.208623296440341,6.612028988179529,-10.9584599143353,1.9075239024088187e-21,1.4473165809402973e-20,37.704222552525536
IL4I1,ILMN_1659960,"Homo sapiens interleukin 4 induced 1 (IL4I1), transcript variant 1, mRNA.",,electron transport [goid 6118] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA],19,55085015-55085064,19q13.33b,-,NM_152899.1,259307,IL4I1,1.6315394864294843,6.591061098215632,10.955706175299765,1.941730063964256e-21,1.4727117179604563e-20,37.68653591725822
LOC653829,ILMN_1743476,"PREDICTED: Homo sapiens similar to Williams Beuren syndrome chromosome region 19, transcript variant 6 (LOC653829), mRNA.",,,,,,,,XM_935802.1,653829,LOC653829,2.002117214534284,8.117045321484447,10.945023387934352,2.0803213292893574e-21,1.575437893884234e-20,37.61792983624633
JOSD2,ILMN_2169025,"Homo sapiens Josephin domain containing 2 (JOSD2), mRNA.",,,,19,55701261-55701310,19q13.33c,-,NM_138334.1,126119,JOSD2,1.1999023571455183,7.60747460379671,10.94495737234313,2.0812077550091164e-21,1.5755128551730006e-20,37.61750591135626
BMP8B,ILMN_2123415,"Homo sapiens bone morphogenetic protein 8b (osteogenic protein 2) (BMP8B), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],ossification [goid 1503] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; growth [goid 40007] [evidence IEA]; cartilage development [goid 51216] [evidence IEA],cytokine activity [goid 5125] [evidence IEA]; growth factor activity [goid 8083] [evidence IEA],1,39996519-39996568,1p34.2d,-,NM_001720.3,656,BMP8B,1.2681637903337393,6.282999487755005,10.944239539015634,2.09087084076516e-21,1.582229341226525e-20,37.61289630953396
FAM73A,ILMN_2123557,"Homo sapiens family with sequence similarity 73, member A (FAM73A), mRNA.",,,,1,78116356-78116405,1p31.1e,+,NM_198549.1,374986,FAM73A,1.2446258356380415,8.324006054234465,10.943405494669724,2.1021545362534127e-21,1.5901666526033377e-20,37.60754051658126
LOC391045,ILMN_1806015,"PREDICTED: Homo sapiens similar to Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (LOC391045), mRNA.",,,,1,65223429-65223478,1p31.3b,-,XM_372780.3,391045,LOC391045,-1.1440564224263907,5.678445589375822,-10.930394277990695,2.2862587865216187e-21,1.7248667345672905e-20,37.52399822366245
LOC284757,ILMN_1657398,"Homo sapiens hypothetical protein LOC284757 (LOC284757), mRNA.",,,,20,58332875-58332924,20q13.33a,+,NM_001004305.1,284757,LOC284757,1.8112475165844115,6.468449504190722,10.927511049300996,2.329185194380039e-21,1.7552669442243247e-20,37.5054878834902
FLJ14166,ILMN_1763745,"Homo sapiens hypothetical protein FLJ14166 (FLJ14166), mRNA.",nucleus [goid 5634] [evidence IEA],cytokinesis [goid 910] [evidence IEA],,5,159612823-159612872,5q33.3d,-,NM_024565.4,79616,FLJ14166,1.0542397670981005,6.64718336976511,10.926776858513275,2.3402439240134778e-21,1.7629367632402736e-20,37.500774507370835
OSBP2,ILMN_1781966,"Homo sapiens oxysterol binding protein 2 (OSBP2), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA],lipid transport [goid 6869] [evidence IEA]; steroid metabolism [goid 8202] [evidence IEA],,22,29633500-29633549,22q12.2b-q12.2c,+,NM_030758.3,23762,OSBP2,1.0029502496956617,6.37589711677925,10.919631473240612,2.4506451356922254e-21,1.8447143670026354e-20,37.45490518673873
LOC338758,ILMN_1795835,"PREDICTED: Homo sapiens hypothetical protein LOC338758 (LOC338758), mRNA.",,,,12,88628314-88628363,12q21.33b,+,XM_931359.1,338758,LOC338758,-1.2604154147914652,8.742337337320734,-10.908655027660858,2.6304452556259483e-21,1.9778259554514834e-20,37.38445256128849
RHPN2,ILMN_1753143,"Homo sapiens rhophilin, Rho GTPase binding protein 2 (RHPN2), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],protein binding [goid 5515] [evidence IEA],19,38161365-38161414,19q13.11a-q13.11b,-,NM_033103.3,85415,RHPN2,1.2997443289607418,9.96618920830619,10.907078175027616,2.65733423099724e-21,1.9972931365061147e-20,37.37433248022379
SCEL,ILMN_1710325,"Homo sapiens sciellin (SCEL), transcript variant 1, mRNA.",cornified envelope [goid 1533] [pmid 9813070] [evidence TAS]; cytoplasm [goid 5737] [pmid 11112355] [evidence ISS]; cornified envelope [goid 1533] [pmid 9813070] [evidence TAS]; cytoplasm [goid 5737] [pmid 11112355] [evidence ISS],keratinocyte differentiation [goid 30216] [pmid 14632196] [evidence IDA]; embryonic development [goid 9790] [pmid 11112355] [evidence ISS]; epidermis development [goid 8544] [pmid 11112355] [evidence ISS]; keratinocyte differentiation [goid 30216] [pmid 14632196] [evidence IDA]; embryonic development [goid 9790] [pmid 11112355] [evidence ISS]; epidermis development [goid 8544] [pmid 11112355] [evidence ISS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 14632196] [evidence IPI]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 14632196] [evidence IPI],13,77106532-77106581,13q22.3b,+,NM_003843.2,8796,SCEL,-1.2388799451770716,6.99262349548323,-10.901649713386439,2.752016616586626e-21,2.0653544060264522e-20,37.33949507390911
CABYR,ILMN_2412139,"Homo sapiens calcium binding tyrosine-(Y)-phosphorylation regulated (fibrousheathin 2) (CABYR), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],signal transduction [goid 7165] [evidence IEA],cAMP-dependent protein kinase regulator activity [goid 8603] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],18,19993964-19994013,18q11.2c,+,NM_153768.1,26256,CABYR,1.5940847965896259,6.1901494688766325,10.898243627725185,2.8131360183700746e-21,2.1096411340160587e-20,37.31763787658763
MESP1,ILMN_1806603,"Homo sapiens mesoderm posterior 1 homolog (mouse) (MESP1), mRNA.",nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA],transcription regulator activity [goid 30528] [evidence IEA],15,88094155-88094204,15q26.1b,-,NM_018670.1,55897,MESP1,1.685384850177046,7.853248047736738,10.893281775485352,2.904603928680763e-21,2.1774190859889363e-20,37.285799265670406
GABPA,ILMN_1750029,"Homo sapiens GA binding protein transcription factor, alpha subunit 60kDa (GABPA), mRNA.",nucleus [goid 5634] [pmid 9016666] [evidence TAS]; nucleus [goid 5634] [pmid 9016666] [evidence TAS],"transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 8441384] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 8441384] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [pmid 8441384] [evidence TAS]; transcription coactivator activity [goid 3713] [pmid 8441384] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 8441384] [evidence TAS]; protein binding [goid 5515] [pmid 10675337] [evidence IPI]; RNA polymerase II transcription factor activity [goid 3702] [pmid 8441384] [evidence TAS]; transcription coactivator activity [goid 3713] [pmid 8441384] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 8441384] [evidence TAS]; protein binding [goid 5515] [pmid 10675337] [evidence IPI],21,26065252-26065301,21q21.3a,+,NM_002040.2,2551,GABPA,-1.1081040149766306,6.7926722980475,-10.889301877785059,2.9801101638504693e-21,2.2323490886679218e-20,37.26026334437046
SNORA33,ILMN_2096747,"Homo sapiens small nucleolar RNA, H/ACA box 33 (SNORA33) on chromosome 6.",,,,6,133180116-133180165,6q23.2b,+,NR_002436.1,594839,SNORA33,1.1805186262474816,6.383617839427306,10.886199438021336,3.0403250316433624e-21,2.275750962705589e-20,37.240358506965755
DPY19L1,ILMN_1791296,"PREDICTED: Homo sapiens dpy-19-like 1 (C. elegans) (DPY19L1), mRNA.",,,,,,7p14.3a,,XM_938743.1,23333,DPY19L1,1.0530352090140678,10.085683183433376,10.877517714529924,3.215356772531026e-21,2.4031699030556883e-20,37.18466294535587
ABCA2,ILMN_1747627,"Homo sapiens ATP-binding cassette, sub-family A (ABC1), member 2 (ABCA2), transcript variant 1, mRNA.",integral to membrane [goid 16021] [evidence NAS]; ATP-binding cassette (ABC) transporter complex [goid 43190] [pmid 11178988] [evidence NAS]; lysosomal membrane [goid 5765] [pmid 11309290] [evidence IDA],transport [goid 6810] [pmid 11178988] [evidence NAS]; lipid metabolism [goid 6629] [pmid 11178988] [evidence NAS]; cholesterol metabolism [goid 8203] [pmid 15238223] [evidence IDA],"nucleotide binding [goid 166] [evidence IEA]; ATPase activity, coupled to transmembrane movement of substances [goid 42626] [pmid 7766993] [evidence NAS]; ATPase activity [goid 16887] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]",9,139021747-139021796,9q34.3e,-,NM_001606.3,20,ABCA2,1.0911909014145085,6.736913071013408,10.869054091042996,3.395663549878021e-21,2.536984178713945e-20,37.13037397531965
ITGAM,ILMN_1685009,"Homo sapiens integrin, alpha M (complement component receptor 3, alpha; also known as CD11b (p170), macrophage antigen alpha polypeptide) (ITGAM), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integrin complex [goid 8305] [pmid 2563162] [evidence TAS],cell-matrix adhesion [goid 7160] [evidence IEA]; cell adhesion [goid 7155] [pmid 2563162] [evidence TAS]; integrin-mediated signaling pathway [goid 7229] [evidence IEA],magnesium ion binding [goid 287] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],16,31251381-31251430,16p11.2c,+,NM_000632.2,3684,ITGAM,-1.3874669427639201,8.60193508994791,-10.86866147715225,3.404268267082157e-21,2.5424635867032397e-20,37.12785577571378
C21orf24,ILMN_2211724,"Homo sapiens chromosome 21 open reading frame 24 (C21orf24), mRNA.",,,,21,39043113-39043162,21q22.2a,-,NM_001001789.1,400866,C21orf24,1.3279228945412314,14.230107323769973,10.864134085494456,3.505078606104649e-21,2.615800550202977e-20,37.098818530423
DNAJB4,ILMN_1813019,"Homo sapiens DnaJ (Hsp40) homolog, subfamily B, member 4 (DNAJB4), mRNA.",,response to heat [goid 9408] [pmid 9546042] [evidence TAS]; protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [pmid 9546042] [evidence TAS]; response to heat [goid 9408] [pmid 9546042] [evidence TAS]; protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [pmid 9546042] [evidence TAS],heat shock protein binding [goid 31072] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 9546042] [evidence TAS]; heat shock protein binding [goid 31072] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 9546042] [evidence TAS],1,78254973-78255022,1p31.1e,+,NM_007034.3,11080,DNAJB4,-1.1238753283069025,5.665405719886144,-10.859182388332613,3.618749961399712e-21,2.6976136075888762e-20,37.06706234513233
HNRPU,ILMN_1743677,"Homo sapiens heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) (HNRPU), transcript variant 1, mRNA.",heterogeneous nuclear ribonucleoprotein complex [goid 30530] [pmid 7509195] [evidence TAS]; ribonucleoprotein complex [goid 30529] [evidence IEA],RNA processing [goid 6396] [pmid 1628625] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [pmid 1628625] [evidence TAS]; ATP binding [goid 5524] [evidence IEA]; DNA binding [goid 3677] [pmid 1628625] [evidence TAS],1,243080265-243080314,1q44b,-,NM_031844.2,3192,HNRPU,1.2327994781084755,9.894886811657843,10.847940682607922,3.890654135391351e-21,2.8970676569002656e-20,36.99497655063902
ZNF281,ILMN_1683127,"Homo sapiens zinc finger protein 281 (ZNF281), mRNA.","DNA-directed RNA polymerase II, core complex [goid 5665] [pmid 10448078] [evidence TAS]; nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA]","transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 10448078] [evidence TAS]",DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; specific RNA polymerase II transcription factor activity [goid 3704] [pmid 10448078] [evidence TAS],1,198642187-198642236,1q32.1b,-,NM_012482.3,23528,ZNF281,1.1252471250887304,9.037081964572259,10.843697596363793,3.998499908277416e-21,2.975157536809764e-20,36.96777179546753
FLJ13265,ILMN_1807525,"Homo sapiens cyclin N-terminal domain containing 2 (CNTD2), mRNA.",,,,19,45420261-45420310,19q13.2b,-,NM_024877.1,79935,FLJ13265,1.1836191617070542,5.5542198878409765,10.83765274879862,4.157311430558445e-21,3.0887295619240014e-20,36.92901820536761
RBP7,ILMN_1716465,"Homo sapiens retinol binding protein 7, cellular (RBP7), mRNA.",,transport [goid 6810] [evidence IEA],retinal binding [goid 16918] [evidence IEA]; retinol binding [goid 19841] [evidence IEA]; lipid binding [goid 8289] [evidence IEA],1,9998450-9998477:9998478-9998499,1p36.22d,+,NM_052960.1,116362,RBP7,-1.373395002586303,6.912210442002323,-10.818761607476269,4.695331223890584e-21,3.472982888266278e-20,36.807931599718195
APXL2,ILMN_1738322,"Homo sapiens shroom family member 1 (SHROOM1), mRNA.",,,,5,132186256-132186305,5q31.1c,-,NM_133456.1,134549,APXL2,1.103390393658442,6.653504264669923,10.813090195394379,4.870020217089308e-21,3.598204006777064e-20,36.771586888394005
KIRREL,ILMN_1742781,"Homo sapiens kin of IRRE like (Drosophila) (KIRREL), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],1,156332331-156332380,1q23.1e,+,NM_018240.3,55243,KIRREL,1.0972403178068415,6.247495240413967,10.81135207174074,4.92484434128899e-21,3.636025298173805e-20,36.76044896981363
CYP26B1,ILMN_1812297,"Homo sapiens cytochrome P450, family 26, subfamily B, polypeptide 1 (CYP26B1), mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence NAS]; microsome [goid 5792] [evidence NAS],electron transport [goid 6118] [evidence NAS],heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; monooxygenase activity [goid 4497] [evidence NAS],2,72210302-72210351,2p13.3a,-,NM_019885.2,56603,CYP26B1,-1.7900455353555378,7.261191869183973,-10.796653539888663,5.4137839071842585e-21,3.986712860321776e-20,36.66627346654246
ATHL1,ILMN_1794707,"Homo sapiens ATH1, acid trehalase-like 1 (yeast) (ATHL1), mRNA.",,,,11,285278-285327,11p15.5d,+,NM_025092.1,80162,ATHL1,2.1025694964092985,9.164781917065985,10.787219695507208,5.752813554917823e-21,4.225488017870624e-20,36.60584173002655
ABCA4,ILMN_1794965,"Homo sapiens ATP-binding cassette, sub-family A (ABC1), member 4 (ABCA4), mRNA.",membrane fraction [goid 5624] [pmid 9054934] [evidence TAS]; integral to plasma membrane [goid 5887] [evidence IEA],"visual perception [goid 7601] [pmid 9425888] [evidence TAS]; transport [goid 6810] [pmid 9054934] [evidence TAS]; phototransduction, visible light [goid 7603] [pmid 9202155] [evidence TAS]; sensory perception [goid 7600] [evidence IEA]","nucleotide binding [goid 166] [evidence IEA]; ATPase activity, coupled to transmembrane movement of substances [goid 42626] [pmid 9054934] [evidence TAS]; ATPase activity [goid 16887] [evidence IEA]; transporter activity [goid 5215] [pmid 9054934] [evidence TAS]; ATP binding [goid 5524] [pmid 9054934] [evidence TAS]",1,94231064-94231113,1p22.1a,-,NM_000350.1,24,ABCA4,2.2488585902339358,6.933213478728316,10.785209528750496,5.827747520261688e-21,4.278956784785169e-20,36.59296615349553
PPP1R9A,ILMN_1741674,"PREDICTED: Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 9A, transcript variant 3 (PPP1R9A), mRNA.",,,,7,94757970-94758019,7q21.3b,+,XM_934519.1,55607,PPP1R9A,1.0765452514294243,6.773683769474739,10.779611105544413,6.041614374803805e-21,4.4278615535192134e-20,36.557109276504264
STK23,ILMN_1697338,"Homo sapiens SFRS protein kinase 3 (SRPK3), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence NAS],ATP binding [goid 5524] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence NAS]; nucleotide binding [goid 166] [evidence IEA],X,152704054-152704103,Xq28f,+,NM_014370.2,26576,STK23,1.204520858895843,5.921942686949318,10.777362641067999,6.129696266188814e-21,4.4891274851356436e-20,36.54270922730034
LOC643357,ILMN_1760338,"PREDICTED: Homo sapiens similar to SMT3 suppressor of mif two 3 homolog 2 (LOC643357), mRNA.",,,,7,55767228-55767277,,+,XM_926688.1,643357,LOC643357,-1.0169405868381087,11.04494405337018,-10.775103278373011,6.2194954483253095e-21,4.548233367327953e-20,36.52823993376214
CHMP5,ILMN_1732534,"Homo sapiens chromatin modifying protein 5 (CHMP5), mRNA.",,protein transport [goid 15031] [evidence IEA]; protein transport [goid 15031] [evidence IEA],,9,33268139-33268188,9p13.3e,+,NM_016410.2,51510,CHMP5,-1.1610616764548674,9.182224664644348,-10.7684524306198,6.491525183985628e-21,4.73505052428671e-20,36.48565013850232
FCHO1,ILMN_1654571,"Homo sapiens FCH domain only 1 (FCHO1), mRNA.",,,,19,17759616-17759655:17760093-17760102,19p13.11d,+,NM_015122.1,23149,FCHO1,1.1328160646253806,6.606644229517978,10.766320882948772,6.5811956808091745e-21,4.796980218458009e-20,36.47200144224391
PPP1R14D,ILMN_1788267,"Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 14D (PPP1R14D), mRNA.",,,protein phosphatase inhibitor activity [goid 4864] [evidence IEA],15,38895204-38895251:38895452-38895453,15q15.1b,-,NM_017726.6,54866,PPP1R14D,1.5519732857963264,6.733583282947384,10.761228092390446,6.800475141109515e-21,4.944182653463633e-20,36.439393365141065
RHBDL2,ILMN_2053536,"Homo sapiens rhomboid, veinlet-like 2 (Drosophila) (RHBDL2), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],1,39124491-39124540,1p34.3a,-,NM_017821.3,54933,RHBDL2,1.5224930676168613,8.746083052030619,10.751166479935419,7.255348962982053e-21,5.2653254280502325e-20,36.37497930637055
C12orf49,ILMN_2161556,"Homo sapiens chromosome 12 open reading frame 49 (C12orf49), mRNA.",,,,12,115638269-115638318,12q24.22a,-,NM_024738.1,79794,C12orf49,-1.0116688798460052,8.084564217717585,-10.748285488275522,7.391097775568961e-21,5.3618957321821526e-20,36.356537356632785
LOC644584,ILMN_1679044,"PREDICTED: Homo sapiens similar to RNA-binding protein EWS (LOC644584), mRNA.",,,,14,35420492-35420541,,+,XM_927700.1,644584,LOC644584,-1.0890553511871346,5.955441835438773,-10.747300791830737,7.43807406139821e-21,5.394019058370981e-20,36.35023427758328
FLJ12078,ILMN_1775444,"PREDICTED: Homo sapiens hypothetical protein FLJ12078 (FLJ12078), misc RNA.",,,,,,,,XR_001261.1,80042,FLJ12078,1.329901178576402,6.7739428352535676,10.745335145350259,7.532740431452796e-21,5.456736804942343e-20,36.337652420235315
AIM2,ILMN_1681301,"Homo sapiens absent in melanoma 2 (AIM2), mRNA.",,immune response [goid 6955] [pmid 9242382] [evidence TAS]; immune response [goid 6955] [pmid 9242382] [evidence TAS],,1,157302354-157302403,1q23.1g-q23.2a,-,NM_004833.1,9447,AIM2,1.0352346673117294,5.913166576942697,10.735125872981104,8.044100241724879e-21,5.810337820809797e-20,36.272311016488636
PAPSS1,ILMN_1781819,"Homo sapiens 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1), mRNA.",intracellular [goid 5622] [evidence ISS],"skeletal development [goid 1501] [evidence ISS]; sulfate assimilation [goid 103] [evidence IEA]; nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [evidence NR ]",sulfate adenylyltransferase (ATP) activity [goid 4781] [evidence ISS]; adenylylsulfate kinase activity [goid 4020] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence ISS]; nucleotidyltransferase activity [goid 16779] [evidence ISS],4,108754882-108754931,4q25a,-,NM_005443.4,9061,PAPSS1,-1.0179976351769913,9.185638799860746,-10.728944842301924,8.370374047872323e-21,6.039467866924971e-20,36.23275679306893
CYTL1,ILMN_2201596,"Homo sapiens cytokine-like 1 (CYTL1), mRNA.",extracellular space [goid 5615] [pmid 10857752] [evidence TAS]; soluble fraction [goid 5625] [pmid 10857752] [evidence TAS],signal transduction [goid 7165] [pmid 10857752] [evidence TAS],receptor binding [goid 5102] [pmid 10857752] [evidence TAS],4,5067685-5067734,4p16.2a,-,NM_018659.2,54360,CYTL1,-1.8061743778626456,5.809667614927956,-10.727497069182292,8.448685269833337e-21,6.091578193831547e-20,36.22349268415847
LOC653086,ILMN_1814039,"PREDICTED: Homo sapiens similar to RAN-binding protein 2-like 1 isoform 2, transcript variant 10 (LOC653086), mRNA.",,,,2,112851351-112851400,,-,XM_930995.1,653086,LOC653086,1.467810686228928,12.206043973394891,10.725713350932834,8.546173612995375e-21,6.157701796053137e-20,36.21207922815966
FBP1,ILMN_1728799,"Homo sapiens fructose-1,6-bisphosphatase 1 (FBP1), mRNA.",,fructose metabolism [goid 6000] [pmid 7558035] [evidence TAS]; gluconeogenesis [goid 6094] [evidence IEA]; carbohydrate metabolism [goid 5975] [evidence IEA],"fructose-bisphosphatase activity [goid 42132] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; phosphoric ester hydrolase activity [goid 42578] [evidence IEA]; fructose-2,6-bisphosphate 2-phosphatase activity [goid 4331] [pmid 8387495] [evidence TAS]",9,96405486-96405535,9q22.32a,-,NM_000507.2,2203,FBP1,-1.242579000262456,12.021322253577818,-10.724366120212808,8.62054901614973e-21,6.208781307239877e-20,36.20345895494839
LRRFIP1,ILMN_2214997,"Homo sapiens leucine rich repeat (in FLII) interacting protein 1 (LRRFIP1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",DNA binding [goid 3677] [evidence IEA],2,238338330-238338379,2q37.3b,+,NM_004735.2,9208,LRRFIP1,1.8602979038606087,11.956167095722014,10.710413036936394,9.429859044956822e-21,6.777033756160061e-20,36.114191923229086
WFDC10B,ILMN_1661076,"Homo sapiens WAP four-disulfide core domain 10B (WFDC10B), transcript variant 2, mRNA.",,,,20,43767021-43767044:43767045-43767070,20q13.12b,-,NM_172131.2,280664,WFDC10B,1.0336648701606226,5.729231160473036,10.70787450395325,9.585047084899885e-21,6.883618882795294e-20,36.09795361320297
ZNF195,ILMN_1688515,"Homo sapiens zinc finger protein 195 (ZNF195), mRNA.",nucleus [goid 5634] [evidence NAS],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]",DNA binding [goid 3677] [evidence NAS]; metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [pmid 9344677] [evidence NAS],11,3336846-3336895,11p15.4d,-,NM_007152.1,7748,ZNF195,1.0139740288584553,7.301243622915883,10.703555871201559,9.854933383043342e-21,7.074901583348804e-20,36.070330155502
FRY,ILMN_1678437,"Homo sapiens furry homolog (Drosophila) (FRY), mRNA.",,,ATP binding [goid 5524] [evidence IEA],13,31768074-31768123,13q13.1a,+,NM_023037.1,10129,FRY,-1.0063704046190924,6.105770091868685,-10.699951032925094,1.0086007096597079e-20,7.235598063417511e-20,36.04727398605484
ACACB,ILMN_1763852,"Homo sapiens acetyl-Coenzyme A carboxylase beta (ACACB), mRNA.",,fatty acid biosynthesis [goid 6633] [evidence IEA]; metabolism [goid 8152] [evidence IEA],acetyl-CoA carboxylase activity [goid 3989] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; biotin binding [goid 9374] [evidence IEA]; biotin carboxylase activity [goid 4075] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; ligase activity [goid 16874] [evidence IEA],12,108190342-108190391,12q24.11a-q24.11b,+,NM_001093.2,32,ACACB,-1.0833933444588109,8.868627815958929,-10.69922100401626,1.0133456643075259e-20,7.267032276510745e-20,36.042604976410956
LOC645466,ILMN_1712204,"PREDICTED: Homo sapiens hypothetical protein LOC645466 (LOC645466), mRNA.",,,,1,78085373-78085380:78085381-78085422,1p31.1e,+,XM_930477.1,645466,LOC645466,1.1860127302565742,6.60122320464358,10.694664615262957,1.0434680278222134e-20,7.480368434491884e-20,36.013465272374106
C16orf60,ILMN_1720526,"Homo sapiens centromere protein N (CENPN), mRNA.",,,,16,79611335-79611382:79613861-79613862,16q23.2b,+,NM_018455.3,55839,C16orf60,1.15913426944869,7.496227936204753,10.691744970128557,1.0632376756109264e-20,7.616634233305913e-20,35.99479435686557
AGR2,ILMN_1814151,"Homo sapiens anterior gradient homolog 2 (Xenopus laevis) (AGR2), mRNA.",,,,7,16798155-16798204,7p21.1b,-,NM_006408.2,10551,AGR2,1.6928417028976996,8.151352759917248,10.686965838915985,1.0964078322559782e-20,7.839131446792046e-20,35.96423425825389
TMSL8,ILMN_1681737,"Homo sapiens thymosin-like 8 (TMSL8), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; cytoplasm [goid 5737] [evidence NAS],cytoskeleton organization and biogenesis [goid 7010] [evidence IEA],actin binding [goid 3779] [evidence IEA],X,101655524-101655573,Xq22.1e,-,NM_021992.2,11013,TMSL8,-2.174920078184205,6.6367971467990925,-10.686261849412778,1.101380413982738e-20,7.870149758202365e-20,35.959732825570406
KIAA0492,ILMN_1745841,"PREDICTED: Homo sapiens KIAA0492 protein (KIAA0492), mRNA.",,,,,,1q25.1a,,XM_944290.1,57238,KIAA0492,1.7576285496492243,6.667690509697349,10.684603979573819,1.1131797067601258e-20,7.951624267353301e-20,35.9491323376926
PIP5KL1,ILMN_2103774,"Homo sapiens phosphatidylinositol-4-phosphate 5-kinase-like 1 (PIP5KL1), mRNA.",,,kinase activity [goid 16301] [evidence IEA]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [goid 16308] [evidence IEA],9,129723816-129723865,9q34.11a,-,NM_173492.1,138429,PIP5KL1,1.004308572772282,5.852637828050439,10.68214486496352,1.1309141750798524e-20,8.075421418628725e-20,35.933409235988535
PVR,ILMN_1677305,"Homo sapiens poliovirus receptor (PVR), mRNA.",extracellular space [goid 5615] [pmid 2170108] [evidence TAS]; integral to membrane [goid 16021] [pmid 2170108] [evidence TAS]; cytoplasm [goid 5737] [pmid 2170108] [evidence TAS],,receptor activity [goid 4872] [pmid 2538245] [evidence TAS],19,49858494-49858543,19q13.31b,+,NM_006505.2,5817,PVR,1.0074655595544382,8.168083549310571,10.670135195211062,1.2216573068265508e-20,8.717160982519839e-20,35.85663169040979
SELENBP1,ILMN_1680652,"Homo sapiens selenium binding protein 1 (SELENBP1), mRNA.",,,selenium binding [goid 8430] [pmid 9027582] [evidence TAS],1,149603638-149603642:149603643-149603687,1q21.3a,-,NM_003944.2,8991,SELENBP1,-1.368001013243756,11.071741907802336,-10.669414362812162,1.2273292175611109e-20,8.754510868079396e-20,35.8520239523434
PRAM1,ILMN_1711493,"Homo sapiens PML-RARA regulated adaptor molecule 1 (PRAM1), mRNA.",,,,19,8461072-8461072:8461073-8461110:8461222-8461232,19p13.2d,-,NM_032152.3,84106,PRAM1,-1.3969345516744154,7.037596205409146,-10.66479227458946,1.2643277668553487e-20,9.008785598020591e-20,35.82247984998921
SLC23A3,ILMN_1788118,"Homo sapiens solute carrier family 23 (nucleobase transporters), member 3 (SLC23A3), mRNA.",membrane [goid 16020] [evidence IEA],transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA],2,219734537-219734586,2q35f,-,NM_144712.2,151295,SLC23A3,1.0135912915190248,5.7122204558600735,10.663630147561118,1.2738039821234974e-20,9.071399038665617e-20,35.81505199359141
PRKD1,ILMN_1785891,"Homo sapiens protein kinase D1 (PRKD1), mRNA.",Golgi apparatus [goid 5794] [evidence NR ]; cytosol [goid 5829] [pmid 10856238] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 8119958] [evidence TAS]; plasma membrane [goid 5886] [pmid 10856238] [evidence TAS],cell proliferation [goid 8283] [pmid 8119958] [evidence TAS]; intracellular signaling cascade [goid 7242] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 8119958] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; atypical protein kinase C activity [goid 4700] [pmid 8119958] [evidence TAS]; protein binding [goid 5515] [pmid 12893243] [evidence IPI]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; diacylglycerol binding [goid 19992] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],14,29115520-29115569,14q12d,-,NM_002742.1,5587,PRKD1,-1.2217521652262198,7.841704948339032,-10.656360573180564,1.334710222152297e-20,9.493381487672647e-20,35.768591293224574
HSPB7,ILMN_2200836,"Homo sapiens heat shock 27kDa protein family, member 7 (cardiovascular) (HSPB7), mRNA.",,protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [pmid 10593960] [evidence TAS],protein C-terminus binding [goid 8022] [pmid 10593960] [evidence TAS],1,16213331-16213380,1p36.13f,-,NM_014424.3,27129,HSPB7,-1.2017277157941173,6.5003910665861175,-10.654114552686119,1.3541088790884785e-20,9.627935484293631e-20,35.754237951692474
MGC39900,ILMN_1731640,"PREDICTED: Homo sapiens hypothetical protein MGC39900 (MGC39900), mRNA.",,,,,,Xq22.2b,,XM_936687.1,286527,MGC39900,-1.0461099000298848,6.307781208680892,-10.652981594116254,1.3640005719710198e-20,9.694821827352102e-20,35.74699792773889
HRASLS,ILMN_1655867,"Homo sapiens HRAS-like suppressor (HRASLS), mRNA.",,,,3,194463691-194463718:194471087-194471108,3q29b,+,NM_020386.2,57110,HRASLS,1.1880928873630845,5.553502900494967,10.645587836046015,1.4303480772389058e-20,1.0153806606302496e-19,35.699752748019186
LOC388743,ILMN_1753766,"PREDICTED: Homo sapiens similar to calpain 8, transcript variant 5 (LOC388743), mRNA.",,,,,,1q41e,,XM_943925.1,388743,LOC388743,1.4342595226158803,7.330833592954024,10.636495018220407,1.5163709062082888e-20,1.0739663395191307e-19,35.64165953797151
FLJ10213,ILMN_2186877,"Homo sapiens hypothetical protein FLJ10213 (FLJ10213), mRNA.",,,,3,73194965-73195014,3p13b,+,NM_018029.3,55096,FLJ10213,1.7219345416230825,7.3960041282086015,10.628193044554607,1.5994097291145207e-20,1.1307770268594816e-19,35.58862742518638
CHRNE,ILMN_1703346,"Homo sapiens cholinergic receptor, nicotinic, epsilon (CHRNE), mRNA.",nicotinic acetylcholine-gated receptor-channel complex [goid 5892] [pmid 7531341] [evidence TAS]; postsynaptic membrane [goid 45211] [evidence IEA],"ion transport [goid 6811] [evidence IEA]; muscle contraction [goid 6936] [pmid 8872460] [evidence TAS]; synaptic transmission, cholinergic [goid 7271] [pmid 8872460] [evidence TAS]; signal transduction [goid 7165] [pmid 8872460] [evidence TAS]",cation transporter activity [goid 8324] [pmid 8872460] [evidence TAS]; acetylcholine receptor activity [goid 15464] [pmid 8872460] [evidence TAS]; nicotinic acetylcholine-activated cation-selective channel activity [goid 4889] [pmid 7531341] [evidence TAS]; ion channel activity [goid 5216] [evidence IEA]; extracellular ligand-gated ion channel activity [goid 5230] [evidence IEA],17,4742189-4742238,17p13.2b,-,NM_000080.2,1145,CHRNE,-1.080370801041294,6.038116955903822,-10.627140585409954,1.6102556031896355e-20,1.1380428862104637e-19,35.58190500856312
APOB48R,ILMN_1697925,"Homo sapiens apolipoprotein B48 receptor (APOB48R), mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; nucleus [goid 5634] [evidence IEA],lipid metabolism [goid 6629] [pmid 10852956] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; lipoprotein binding [goid 8034] [pmid 10852956] [evidence TAS],16,28417416-28417465,16p11.2e,+,NM_018690.1,55911,APOB48R,-1.1231143059365678,6.5670242288271545,-10.625019734398624,1.6323348880878186e-20,1.1532399873185408e-19,35.56835880414353
DEFA1,ILMN_1679357,"Homo sapiens defensin, alpha 1 (DEFA1), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],response to virus [goid 9615] [evidence IEA]; xenobiotic metabolism [goid 6805] [evidence IEA]; response to virus [goid 9615] [evidence IEA]; xenobiotic metabolism [goid 6805] [evidence IEA],,8,6823476-6823525,8p23.1f,-,NM_004084.2,1667,DEFA1,-2.282388773405769,5.8758708250556335,-10.616454449063744,1.7246191274358222e-20,1.2162911350629514e-19,35.513656402752204
MPP6,ILMN_1679995,"Homo sapiens membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) (MPP6), mRNA.",membrane [goid 16020] [pmid 11311936] [evidence NAS],protein complex assembly [goid 6461] [pmid 11311936] [evidence NAS],protein binding [goid 5515] [pmid 11311936] [evidence IPI],7,24686627-24686664:24693582-24693593,7p15.3a,+,NM_016447.2,51678,MPP6,1.03544620385669,6.07724712097186,10.616268597860456,1.7266781678136393e-20,1.217314192445923e-19,35.512469555785465
OR11L1,ILMN_1785650,"Homo sapiens olfactory receptor, family 11, subfamily L, member 1 (OR11L1), mRNA.",,,,1,246071016-246071065,1q44e,-,NM_001001959.1,391189,OR11L1,-1.1674243343742061,7.692934530367181,-10.615082826190163,1.7398731453750183e-20,1.2261846386989564e-19,35.50489730675256
RBP4,ILMN_1814719,"Homo sapiens retinol binding protein 4, plasma (RBP4), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [pmid 6316270] [evidence TAS],visual perception [goid 7601] [evidence IEA]; transport [goid 6810] [evidence IEA],retinal binding [goid 16918] [evidence IEA]; transporter activity [goid 5215] [evidence IEA]; binding [goid 5488] [evidence IEA]; retinol binding [goid 19841] [evidence IEA],10,95343601-95343650,10q23.33b,-,NM_006744.3,5950,RBP4,-1.3077163932928757,5.990559546103247,-10.614449763722668,1.7469588370739416e-20,1.2307448032456135e-19,35.500854685542535
MBD4,ILMN_2055310,"Homo sapiens methyl-CpG binding domain protein 4 (MBD4), mRNA.",nucleus [goid 5634] [pmid 9774669] [evidence TAS],base-excision repair [goid 6284] [evidence IEA],hydrolase activity [goid 16787] [evidence IEA]; satellite DNA binding [goid 3696] [pmid 9774669] [evidence TAS]; endodeoxyribonuclease activity [goid 4520] [pmid 10097147] [evidence TAS]; DNA binding [goid 3677] [evidence IEA]; protein binding [goid 5515] [pmid 14667819] [evidence IPI],3,130632633-130632682,3q21.3d,-,NM_003925.1,8930,MBD4,1.7528042667242083,12.019151035373397,10.614044876441586,1.7515057093509357e-20,1.2335137709501415e-19,35.49826917429563
HOMER3,ILMN_1811579,"Homo sapiens homer homolog 3 (Drosophila) (HOMER3), mRNA.",,protein targeting [goid 6605] [pmid 10653696] [evidence TAS]; metabotropic glutamate receptor signaling pathway [goid 7216] [pmid 9808458] [evidence TAS],protein binding [goid 5515] [pmid 10653696] [evidence NAS],19,18901217-18901251:18901252-18901266,19p13.11b,-,NM_004838.2,9454,HOMER3,1.0152135899987886,7.63507591669618,10.604017703312955,1.8679544406488818e-20,1.3132126650914556e-19,35.434244313586255
HK3,ILMN_1670302,"Homo sapiens hexokinase 3 (white cell) (HK3), nuclear gene encoding mitochondrial protein, mRNA.",membrane [goid 16020] [evidence NAS],glycolysis [goid 6096] [evidence NAS],kinase activity [goid 16301] [evidence IEA]; ATP binding [goid 5524] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; hexokinase activity [goid 4396] [evidence NAS],5,176240673-176240679:176240680-176240722,5q35.2d,-,NM_002115.1,3101,HK3,-1.449041573624065,8.122806007663872,-10.602618633241628,1.8848047065281556e-20,1.324593346266784e-19,35.425312013481935
DLX3,ILMN_1789357,"Homo sapiens distal-less homeobox 3 (DLX3), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; skeletal development [goid 1501] [evidence NR ]; development [goid 7275] [evidence IEA]",transcription factor activity [goid 3700] [pmid 9467018] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA],17,45422494-45422543,17q21.33a,-,NM_005220.2,1747,DLX3,1.0930427097466389,6.159156592366066,10.599514131032082,1.9227383900456133e-20,1.3503036050555505e-19,35.40549229325904
LOC90639,ILMN_1656656,"Homo sapiens hypothetical protein LOC90639 (LOC90639), mRNA.",,,,7,972327-972376,7p22.3c,-,NM_001031617.1,90639,LOC90639,1.2416791536596268,9.121144733549599,10.59832196764015,1.9375068418645716e-20,1.360197785685135e-19,35.39788160633737
PANX2,ILMN_1694810,"Homo sapiens pannexin 2 (PANX2), mRNA.",gap junction [goid 5921] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,22,48960774-48960823,22q13.33b,+,NM_052839.2,56666,PANX2,1.3594106270483897,7.857283985619677,10.595368570811672,1.974582455512758e-20,1.3853731118473363e-19,35.37902806227981
OSTbeta,ILMN_1750312,"Homo sapiens organic solute transporter beta (OSTbeta), mRNA.",plasma membrane [goid 5886] [pmid 12719432] [evidence IDA],,,15,63130924-63130973,15q22.31b,+,NM_178859.2,123264,OSTbeta,-1.1085359570483906,5.515014302629566,-10.592399482044327,2.0125682423219e-20,1.4109132933558716e-19,35.36007539964121
CLIC4,ILMN_2063584,"Homo sapiens chloride intracellular channel 4 (CLIC4), mRNA.",microvillus [goid 5902] [pmid 10793131] [evidence IDA]; membrane [goid 16020] [evidence IEA]; actin cytoskeleton [goid 15629] [pmid 12163372] [evidence TAS]; soluble fraction [goid 5625] [pmid 10793131] [evidence IDA]; cytoplasm [goid 5737] [pmid 10793131] [evidence IDA]; intracellular [goid 5622] [pmid 11256614] [evidence IDA]; microvillus [goid 5902] [pmid 10793131] [evidence IDA]; membrane [goid 16020] [evidence IEA]; actin cytoskeleton [goid 15629] [pmid 12163372] [evidence TAS]; soluble fraction [goid 5625] [pmid 10793131] [evidence IDA]; cytoplasm [goid 5737] [pmid 10793131] [evidence IDA]; intracellular [goid 5622] [pmid 11256614] [evidence IDA],ion transport [goid 6811] [evidence IEA]; cell differentiation [goid 30154] [pmid 12163372] [evidence TAS]; chloride transport [goid 6821] [pmid 10793131] [evidence NAS]; negative regulation of cell migration [goid 30336] [pmid 12163372] [evidence IDA]; ion transport [goid 6811] [evidence IEA]; cell differentiation [goid 30154] [pmid 12163372] [evidence TAS]; chloride transport [goid 6821] [pmid 10793131] [evidence NAS]; negative regulation of cell migration [goid 30336] [pmid 12163372] [evidence IDA],voltage-gated chloride channel activity [goid 5247] [evidence IEA]; protein binding [goid 5515] [pmid 10793131] [evidence IPI]; voltage-gated chloride channel activity [goid 5247] [evidence IEA]; protein binding [goid 5515] [pmid 10793131] [evidence IPI],1,25043065-25043114,1p36.11c,+,NM_013943.1,25932,CLIC4,-1.0860837371794556,8.824138638679043,-10.592277506798588,2.014144252638225e-20,1.411523579922438e-19,35.35929681445618
LOC648075,ILMN_1794510,"PREDICTED: Homo sapiens hypothetical protein LOC648075, transcript variant 1 (LOC648075), mRNA.",,,,,,,,XM_943636.1,648075,LOC648075,1.3252704538366649,6.485745959130055,10.591372429320378,2.0258770362527324e-20,1.4192488704952615e-19,35.35351963315314
YBX2,ILMN_1755354,"Homo sapiens Y box binding protein 2 (YBX2), mRNA.",cytoplasm [goid 5737] [pmid 10100484] [evidence TAS]; nucleus [goid 5634] [pmid 10100484] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; spermatogenesis [goid 7283] [pmid 10100484] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [pmid 10100484] [evidence TAS]; translational attenuation [goid 9386] [pmid 10100484] [evidence TAS]",DNA binding [goid 3677] [evidence IEA]; RNA binding [goid 3723] [evidence IEA],17,7132333-7132382,17p13.1d,-,NM_015982.1,51087,YBX2,1.2344569983481346,5.714712165830903,10.578302315060059,2.203108581895542e-20,1.5385618326899128e-19,35.270103050385124
CHD8,ILMN_1806122,"Homo sapiens chromodomain helicase DNA binding protein 8 (CHD8), mRNA.",chromatin [goid 785] [evidence IEA]; nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; chromatin modification [goid 16568] [evidence IEA]; chromatin assembly or disassembly [goid 6333] [evidence IEA]",nucleotide binding [goid 166] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; helicase activity [goid 4386] [evidence IEA]; transcription regulator activity [goid 30528] [evidence NAS]; ATP binding [goid 5524] [evidence IEA]; chromatin binding [goid 3682] [evidence IEA],14,20923549-20923598,14q11.2c,-,NM_020920.1,57680,CHD8,1.1251899053460939,9.8768256022301,10.576587526715038,2.2274805881798807e-20,1.5544970913255338e-19,35.25916039272631
GNG12,ILMN_1673380,"Homo sapiens guanine nucleotide binding protein (G protein), gamma 12 (GNG12), mRNA.",heterotrimeric G-protein complex [goid 5834] [evidence IEA]; membrane [goid 16020] [evidence IEA],signal transduction [goid 7165] [pmid 10819326] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA],1,67941908-67941957,1p31.3a,-,NM_018841.3,55970,GNG12,-1.450074079471893,6.851641943597289,-10.576308078913444,2.2314777344967695e-20,1.556743602224943e-19,35.25737717335149
FAM63A,ILMN_1689552,"Homo sapiens family with sequence similarity 63, member A (FAM63A), mRNA.",,,protein binding [goid 5515] [pmid 15231747] [evidence IPI],1,149235922-149235971,1q21.2d,-,NM_018379.2,55793,FAM63A,1.6703240990088482,10.519516881669206,10.57546531663783,2.2435757469978524e-20,1.5640928064785029e-19,35.25199937467399
ALDH3B1,ILMN_1727965,"Homo sapiens aldehyde dehydrogenase 3 family, member B1 (ALDH3B1), transcript variant 1, mRNA.",,metabolism [goid 8152] [evidence IEA]; lipid metabolism [goid 6629] [pmid 7828891] [evidence TAS]; aldehyde metabolism [goid 6081] [evidence IEA]; alcohol metabolism [goid 6066] [pmid 7828891] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; aldehyde dehydrogenase [NAD(P)+] activity [goid 4030] [evidence IEA],11,67542575-67542624,11q13.2a,+,NM_000694.2,221,ALDH3B1,-1.0755223457517076,8.003357349887601,-10.571752471698154,2.2976579661359475e-20,1.6001232365627582e-19,35.22830815183391
RB1,ILMN_1696591,"Homo sapiens retinoblastoma 1 (including osteosarcoma) (RB1), mRNA.",nucleus [goid 5634] [pmid 3657987] [evidence TAS]; chromatin [goid 785] [pmid 3657987] [evidence TAS],"positive regulation of transcription, DNA-dependent [goid 45893] [pmid 15572661] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 15572661] [evidence NAS]; regulation of transcription, DNA-dependent [goid 6355] [pmid 3413073] [evidence NAS]; transcription [goid 6350] [evidence IEA]; negative regulation of transcription from RNA polymerase II promoter [goid 122] [pmid 9491888] [evidence TAS]; cell cycle checkpoint [goid 75] [pmid 10825186] [evidence TAS]; M phase [goid 279] [pmid 7542657] [evidence NAS]; negative regulation of protein kinase activity [goid 6469] [pmid 9858607] [evidence IPI]; negative regulation of cell growth [goid 30308] [pmid 7542657] [evidence TAS]; G1 phase [goid 51318] [pmid 7542657] [evidence TAS]",protein binding [goid 5515] [pmid 9858607] [evidence IPI]; transcription factor activity [goid 3700] [pmid 3657987] [evidence TAS]; transcription coactivator activity [goid 3713] [pmid 15572661] [evidence NAS]; androgen receptor binding [goid 50681] [pmid 15572661] [evidence NAS],13,47952504-47952553,13q14.2b,+,NM_000321.1,5925,RB1,-1.1140441229427083,6.35622768894605,-10.571618439284089,2.2996344424162818e-20,1.6003855973518249e-19,35.2274529381775
PLCXD3,ILMN_1798841,"Homo sapiens phosphatidylinositol-specific phospholipase C, X domain containing 3 (PLCXD3), mRNA.",,intracellular signaling cascade [goid 7242] [evidence IEA],phospholipase C activity [goid 4629] [evidence IEA],5,41343016-41343065,5p13.1a,-,NM_001005473.1,345557,PLCXD3,-1.2787332599196874,5.945963021056716,-10.555693138970675,2.5469575738215256e-20,1.765137760201631e-19,35.12585476590711
AKAP8L,ILMN_1768962,"Homo sapiens A kinase (PRKA) anchor protein 8-like (AKAP8L), mRNA.",chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [pmid 10761695] [evidence TAS]; intracellular [goid 5622] [evidence IEA],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DEAD/H-box RNA helicase binding [goid 17151] [pmid 10748171] [evidence TAS]; DNA binding [goid 3677] [evidence IEA],19,15352218-15352241:15352328-15352353,19p13.12a,-,NM_014371.2,26993,AKAP8L,1.0752297943793376,8.587036050271838,10.554888313270203,2.5601379713578815e-20,1.7736579131207927e-19,35.12072106477061
TLR7,ILMN_1677827,"Homo sapiens toll-like receptor 7 (TLR7), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],positive regulation of interleukin-8 biosynthesis [goid 45416] [pmid 16188996] [evidence IMP]; defense response to virus [goid 51607] [pmid 16188996] [evidence IMP]; positive regulation of interferon-gamma biosynthesis [goid 45078] [pmid 16286015] [evidence IDA]; positive regulation of interferon-beta biosynthesis [goid 45359] [pmid 16286015] [evidence IDA]; inflammatory response [goid 6954] [evidence IEA],single-stranded RNA binding [goid 3727] [evidence ISS]; transferase activity [goid 16740] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; double-stranded RNA binding [goid 3725] [pmid 16111635] [evidence IDA],X,12818206-12818255,Xp22.2,+,NM_016562.3,51284,TLR7,-1.2250046491691995,7.072790484302759,-10.553296120907085,2.58641356188917e-20,1.7900021634824806e-19,35.11056526127296
CEP27,ILMN_1738482,"Homo sapiens centrosomal protein 27kDa (CEP27), mRNA.",centrosome [goid 5813] [pmid 14654843] [evidence IDA],,,15,40646836-40646885,15q15.1d,+,NM_018097.1,55142,CEP27,1.5769571494225474,10.157352726059221,10.547097102721358,2.6913015915063142e-20,1.85937714926997e-19,35.07102776801908
C6orf205,ILMN_1700978,"Homo sapiens chromosome 6 open reading frame 205 (C6orf205), mRNA.",,,,6,31065450-31065499,6p21.33a,+,NM_001010909.1,394263,C6orf205,1.9279707162317132,6.8919481931359226,10.543073507957331,2.7616405047739366e-20,1.905998731269987e-19,35.045367707396125
LOC644931,ILMN_1731922,"PREDICTED: Homo sapiens hypothetical LOC644931 (LOC644931), mRNA.",,,,17,17526414-17526463,17p11.2g,-,XM_932522.1,644931,LOC644931,1.3664158533391069,7.770206866366942,10.541374645054848,2.791887020640019e-20,1.9262095003091551e-19,35.03453398309881
LOC643591,ILMN_1780806,"PREDICTED: Homo sapiens hypothetical protein LOC643591 (LOC643591), mRNA.",,,,2,97568247-97568293:97572420-97572422,,-,XM_931666.1,643591,LOC643591,1.0610735020890383,7.534746190427671,10.53952966177778,2.825109352417218e-20,1.948458735717466e-19,35.022768845826185
SYMPK,ILMN_1802089,"Homo sapiens symplekin (SYMPK), mRNA.",tight junction [goid 5923] [evidence IEA]; nucleoplasm [goid 5654] [pmid 8769423] [evidence IDA]; cytoplasm [goid 5737] [pmid 8769423] [evidence IDA],cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],19,51010704-51010753,19q13.32a,-,NM_004819.1,8189,SYMPK,1.0408991338587583,7.644182375877075,10.537878616923262,2.855173560215399e-20,1.968515251302195e-19,35.012240776352165
PRF1,ILMN_1740633,"Homo sapiens perforin 1 (pore forming protein) (PRF1), mRNA.",cytosol [goid 5829] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cellular defense response [goid 6968] [pmid 10779745] [evidence TAS]; virus-infected cell apoptosis [goid 6926] [evidence NR ]; pathogenesis [goid 9405] [pmid 1505959] [evidence TAS]; hemolysis of host red blood cells [goid 19836] [evidence NR ]; cytolysis [goid 19835] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA],10,72027389-72027438,10q22.1b,-,NM_005041.3,5551,PRF1,-1.5493614335833454,7.885498313071149,-10.53693153696145,2.87256290403916e-20,1.979822204065295e-19,35.006201768576744
RAB11FIP4,ILMN_1681467,"Homo sapiens RAB11 family interacting protein 4 (class II) (RAB11FIP4), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],17,26889135-26889184,17q11.2d,+,NM_032932.3,84440,RAB11FIP4,1.0500179489559018,6.434428709712261,10.535705086343919,2.8952388035813395e-20,1.9947637046162342e-19,34.99838153261096
NAPSB,ILMN_1723043,"PREDICTED: Homo sapiens napsin B aspartic peptidase pseudogene, transcript variant 3 (NAPSB), misc RNA.",,,,,,19q13.33c,,XR_001413.1,256236,NAPSB,-1.3212302523465027,7.928849415638595,-10.532287903066496,2.959365175351443e-20,2.0354409910083077e-19,34.976593475918826
FLJ14054,ILMN_1769556,"Homo sapiens hypothetical protein FLJ14054 (FLJ14054), mRNA.",,,,5,32827158-32827207,5p13.3b,+,NM_024563.2,79614,FLJ14054,-1.6081870048970552,6.79120297387408,-10.530198328238985,2.999273657159946e-20,2.060057237640103e-19,34.96327100074461
CFB,ILMN_1774287,"Homo sapiens complement factor B (CFB), mRNA.",extracellular region [goid 5576] [evidence IEA],"innate immune response [goid 45087] [evidence IEA]; complement activation, alternative pathway [goid 6957] [pmid 8225386] [evidence NAS]; complement activation [goid 6956] [evidence IEA]",peptidase activity [goid 8233] [evidence IEA]; complement binding [goid 1848] [pmid 11367526] [evidence TAS]; alternative-complement-pathway C3/C5 convertase activity [goid 3812] [evidence IEA]; serine-type endopeptidase activity [goid 4252] [evidence IEA],6,32027200-32027229:32027311-32027330,6p21.32b,+,NM_001710.4,629,CFB,1.6610949521371836,11.035185862103127,10.525686673540774,3.087280805548824e-20,2.1190502352459991e-19,34.934507950158306
ATG4B,ILMN_2411915,"Homo sapiens ATG4 autophagy related 4 homolog B (S. cerevisiae) (ATG4B), transcript variant 2, mRNA.",microtubule associated complex [goid 5875] [pmid 12446702] [evidence ISS]; cytosol [goid 5829] [pmid 12446702] [evidence ISS]; cytoplasm [goid 5737] [pmid 12446702] [evidence ISS],ubiquitin cycle [goid 6512] [evidence IEA]; autophagic vacuole formation [goid 45] [pmid 12446702] [evidence ISS]; protein transport [goid 15031] [evidence IEA]; protein targeting to membrane [goid 6612] [pmid 12446702] [evidence ISS]; autophagy [goid 6914] [pmid 12446702] [evidence IGI],cysteine-type peptidase activity [goid 8234] [pmid 15169837] [evidence IDA]; protein binding [goid 5515] [pmid 15187094] [evidence IPI],2,242225803-242225812:242239098-242239137,2q37.3g,+,NM_178326.2,23192,ATG4B,-1.6410077543260364,7.655989228245798,-10.525328012651137,3.094386576642237e-20,2.1231991298168e-19,34.9322214959775
CPD,ILMN_1703074,"Homo sapiens carboxypeptidase D (CPD), mRNA.",membrane fraction [goid 5624] [pmid 9064476] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; metallocarboxypeptidase D activity [goid 8472] [evidence IEA]; carboxypeptidase A activity [goid 4182] [evidence IEA]; metallopeptidase activity [goid 8237] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; carboxypeptidase activity [goid 4180] [evidence IEA]; carboxypeptidase D activity [goid 4187] [pmid 9064476] [evidence TAS],17,25819570-25819619,17q11.2c,+,NM_001304.3,1362,CPD,1.0241409249886058,10.823866653483828,10.524462183839358,3.111607610677746e-20,2.1342833415989149e-19,34.92670192493171
SEMA3G,ILMN_1676067,"Homo sapiens sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G (SEMA3G), mRNA.",membrane [goid 16020] [evidence IEA],development [goid 7275] [evidence IEA],receptor activity [goid 4872] [evidence IEA],3,52442679-52442728,3p21.1d,-,NM_020163.1,56920,SEMA3G,-1.1020203845030796,5.714303764528308,-10.51545429620911,3.2965399900558344e-20,2.2557172408015433e-19,34.869283093342126
ALDOB,ILMN_1747716,"Homo sapiens aldolase B, fructose-bisphosphate (ALDOB), mRNA.",cytoplasm [goid 5737] [pmid 3383242] [evidence TAS],glycolysis [goid 6096] [pmid 3383242] [evidence TAS]; fructose metabolism [goid 6000] [pmid 3383242] [evidence TAS],lyase activity [goid 16829] [evidence IEA]; fructose-bisphosphate aldolase activity [goid 4332] [pmid 3383242] [evidence TAS],9,103223911-103223911:103223912-103223960,9q31.1b,-,NM_000035.2,229,ALDOB,1.1806498988012661,6.244538328868479,10.513591419340226,3.336131560268708e-20,2.2820280430036346e-19,34.85740985166481
C9orf130,ILMN_1738678,"PREDICTED: Homo sapiens chromosome 9 open reading frame 130 (C9orf130), mRNA.",,,,,,,,XM_939697.1,286354,C9orf130,1.703076734173612,8.865940085027715,10.51282816169739,3.3524896189856056e-20,2.291650573852545e-19,34.85254527415807
NKG7,ILMN_1682993,"Homo sapiens natural killer cell group 7 sequence (NKG7), mRNA.",integral to plasma membrane [goid 5887] [pmid 8458737] [evidence TAS]; membrane [goid 16020] [evidence IEA],,,19,56566846-56566895,19q13.33d,-,NM_005601.3,4818,NKG7,-1.5325957533827843,9.31115318762862,-10.512431924643577,3.361013243591617e-20,2.296692383120938e-19,34.850019909448626
FLJ10178,ILMN_1703279,"Homo sapiens chromosome X open reading frame 57 (CXorf57), mRNA.",,,nucleic acid binding [goid 3676] [evidence IEA],X,105808986-105809035,Xq22.3b,+,NM_018015.3,55086,FLJ10178,-1.2829840548185212,6.7566474059592965,-10.504372185450496,3.5391571977608035e-20,2.41430130285708e-19,34.798656494166245
MYOC,ILMN_2052331,"Homo sapiens myocilin, trabecular meshwork inducible glucocorticoid response (MYOC), mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; cilium [goid 5929] [evidence NR ]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; cilium [goid 5929] [evidence NR ],morphogenesis [goid 9653] [pmid 9169133] [evidence TAS]; visual perception [goid 7601] [evidence NR ]; morphogenesis [goid 9653] [pmid 9169133] [evidence TAS]; visual perception [goid 7601] [evidence NR ],latrotoxin receptor activity [goid 16524] [evidence IEA]; structural molecule activity [goid 5198] [pmid 9169133] [evidence TAS]; latrotoxin receptor activity [goid 16524] [evidence IEA]; structural molecule activity [goid 5198] [pmid 9169133] [evidence TAS],1,169871551-169871600,1q24.3b,-,NM_000261.1,4653,MYOC,-1.2280901397263015,5.483952445004164,-10.50427161041623,3.541438665939147e-20,2.4150342477201923e-19,34.79801559724417
KIAA0408,ILMN_1661519,"Homo sapiens KIAA0408 (KIAA0408), mRNA.",,,,6,127803433-127803482,6q22.33a,-,NM_014702.3,9729,KIAA0408,1.5370518824526016,7.718117208498578,10.497667639804414,3.6944990997541494e-20,2.515981551663752e-19,34.75593572885071
C1GALT1,ILMN_1662578,"Homo sapiens core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 (C1GALT1), mRNA.",,,"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [goid 16263] [evidence IEA]",7,7250130-7250179,7p21.3e,+,NM_020156.1,56913,C1GALT1,1.338571412551123,6.776239806465871,10.497088622807905,3.708229456008844e-20,2.5244727783540304e-19,34.752246550047744
LOC648024,ILMN_1665736,"PREDICTED: Homo sapiens similar to eukaryotic translation initiation factor 4A, isoform 1, transcript variant 2 (LOC648024), mRNA.",,,,,,,,XM_943353.1,648024,LOC648024,-1.3751466826032015,9.479555694546528,-10.496547409251624,3.7211093739506494e-20,2.5323794678232857e-19,34.74879827228849
NEDD4L,ILMN_1733627,"Homo sapiens neural precursor cell expressed, developmentally down-regulated 4-like (NEDD4L), mRNA.",intracellular [goid 5622] [pmid 11244092] [evidence IC ],positive regulation of endocytosis [goid 45807] [pmid 11244092] [evidence NAS]; response to metal ion [goid 10038] [pmid 11244092] [evidence IDA]; excretion [goid 7588] [pmid 11244092] [evidence NAS]; sodium ion transport [goid 6814] [pmid 11244092] [evidence NAS]; sodium ion homeostasis [goid 6883] [pmid 11244092] [evidence NAS]; protein ubiquitination [goid 16567] [pmid 11244092] [evidence NAS]; regulation of protein catabolism [goid 42176] [pmid 11244092] [evidence NAS]; water homeostasis [goid 30104] [pmid 11244092] [evidence NAS],protein binding [goid 5515] [pmid 11244092] [evidence IPI]; sodium channel regulator activity [goid 17080] [pmid 11244092] [evidence IDA]; ubiquitin-protein ligase activity [goid 4842] [pmid 11244092] [evidence NAS]; ligase activity [goid 16874] [evidence IEA],18,54216019-54216068,18q21.31b,+,NM_015277.2,23327,NEDD4L,-1.2099360193071487,9.693992644032479,-10.49025872988009,3.874079535878564e-20,2.6337948812048356e-19,34.70873341346476
PLCH1,ILMN_2043060,"Homo sapiens phospholipase C, eta 1 (PLCH1), mRNA.",,lipid metabolism [goid 6629] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],phosphoinositide phospholipase C activity [goid 4435] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],3,156680640-156680689,3q25.31a,-,NM_014996.1,23007,PLCH1,1.1652503628580018,6.670838217082267,10.473806430971957,4.304590179440572e-20,2.916567568921333e-19,34.60394037761655
CYBA,ILMN_1744604,"Homo sapiens cytochrome b-245, alpha polypeptide (CYBA), mRNA.",mitochondrion [goid 5739] [evidence NR ]; membrane [goid 16020] [evidence IEA],electron transport [goid 6118] [evidence IEA]; superoxide metabolism [goid 6801] [evidence NR ]; transport [goid 6810] [evidence IEA],heme binding [goid 20037] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; electron carrier activity [goid 9055] [pmid 2243141] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA],16,87240088-87240106:87240664-87240694,16q24.3a,-,NM_000101.2,1535,CYBA,-1.0006064664507797,12.723828382066488,-10.473301528164905,4.318530726316928e-20,2.9250224364302337e-19,34.600724940759676
TBXAS1,ILMN_2282641,"Homo sapiens thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) (TBXAS1), transcript variant TXS-I, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],fatty acid biosynthesis [goid 6633] [evidence IEA]; blood coagulation [goid 7596] [evidence NR ]; prostaglandin biosynthesis [goid 1516] [evidence IEA]; electron transport [goid 6118] [evidence IEA],"heme binding [goid 20037] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; thromboxane-A synthase activity [goid 4796] [evidence IEA]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [goid 16712] [evidence IEA]",7,139364041-139364090,7q34c,+,NM_001061.2,6916,TBXAS1,-1.0144918249853987,9.425997301214714,-10.473183903498033,4.3217848451194133e-20,2.926235911375608e-19,34.59997586128788
RNASE1,ILMN_1795183,"Homo sapiens ribonuclease, RNase A family, 1 (pancreatic) (RNASE1), transcript variant 3, mRNA.",extracellular region [goid 5576] [evidence NR ],,pancreatic ribonuclease activity [goid 4522] [pmid 8049276] [evidence TAS]; RNA binding [goid 3723] [evidence NR ]; hydrolase activity [goid 16787] [evidence IEA]; endonuclease activity [goid 4519] [evidence IEA],14,20339551-20339596:20339597-20339600,14q11.2b,-,NM_198232.1,6035,RNASE1,-1.3421692749607708,12.223950374095255,-10.470960900683668,4.383746630244203e-20,2.966182028337031e-19,34.58581925015252
RPL21,ILMN_2290808,"Homo sapiens ribosomal protein L21 (RPL21), mRNA.",ribosome [goid 5840] [evidence IEA]; cytosolic large ribosomal subunit (sensu Eukaryota) [goid 5842] [pmid 7772601] [evidence TAS]; intracellular [goid 5622] [evidence IEA],protein biosynthesis [goid 6412] [pmid 7772601] [evidence TAS],RNA binding [goid 3723] [pmid 7772601] [evidence TAS]; structural constituent of ribosome [goid 3735] [pmid 7772601] [evidence TAS],13,26723694-26723722:26725902-26725913:26725914-26725922,13q12.2a,+,NM_000982.3,6144,RPL21,-1.1554133453362745,10.975472793135308,-10.453956190044527,4.8879647198417627e-20,3.29842826693403e-19,34.47755016460164
LOC648852,ILMN_1677691,"PREDICTED: Homo sapiens hypothetical protein LOC648852 (LOC648852), mRNA.",,,,,,,,XM_940430.1,648852,LOC648852,2.2461754055884224,11.354475108681575,10.444340388796403,5.198268313888592e-20,3.5054584571716535e-19,34.41634279560195
ET,ILMN_1756152,"Homo sapiens major facilitator superfamily domain containing 11 (MFSD11), mRNA.",,,,17,72286774-72286823,17q25.2a,+,NM_024311.2,79157,ET,1.2396591213006953,10.389226384100665,10.435703089593012,5.493701739369375e-20,3.6922399866074054e-19,34.36137409350226
NBLA10383,ILMN_1691418,"Homo sapiens putative protein product of Nbla10383 (NBLA10383), mRNA.",,,,17,15280224-15280273,17p12a,-,NM_173622.2,284040,NBLA10383,1.0138702365664596,7.931062927150901,10.434978678331191,5.519227766027169e-20,3.7081500719500197e-19,34.35676430313737
UGCGL1,ILMN_1755462,"Homo sapiens UDP-glucose ceramide glucosyltransferase-like 1 (UGCGL1), transcript variant 1, mRNA.",endoplasmic reticulum [goid 5783] [pmid 10694380] [evidence IDA]; ER-Golgi intermediate compartment [goid 5793] [evidence ISS]; endoplasmic reticulum [goid 5783] [pmid 10694380] [evidence IDA]; ER-Golgi intermediate compartment [goid 5793] [evidence ISS],posttranslational protein folding [goid 51084] [pmid 10694380] [evidence TAS]; protein amino acid glycosylation [goid 6486] [evidence IEA]; posttranslational protein folding [goid 51084] [pmid 10694380] [evidence TAS]; protein amino acid glycosylation [goid 6486] [evidence IEA],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 10694380] [evidence IDA]; UDP-glucose:glycoprotein glucosyltransferase activity [goid 3980] [pmid 10694380] [evidence IDA]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 10694380] [evidence IDA]; UDP-glucose:glycoprotein glucosyltransferase activity [goid 3980] [pmid 10694380] [evidence IDA]",2,128664910-128664959,2q14.3e,+,NM_020120.2,56886,UGCGL1,1.0587764146863057,7.571551958148915,10.431197436501185,5.65439915564355e-20,3.7951431837006424e-19,34.332703484486274
LOC440704,ILMN_1673421,"PREDICTED: Homo sapiens hypothetical gene supported by BC042042 (LOC440704), mRNA.",,,,,,,,XM_944716.1,440704,LOC440704,1.4793686942761664,11.477944091631722,10.415133713030793,6.266418841907811e-20,4.191859183847927e-19,34.230507554677786
DKFZp434K191,ILMN_1652533,"Homo sapiens hypothetical protein DKFZp434K191 (DKFZp434K191), mRNA.",,,,22,17227437-17227477,22q11.21b,+,NM_001029950.1,29797,DKFZp434K191,1.6112822615639182,9.145475288104025,10.414257809614902,6.301627342879591e-20,4.2140026696635986e-19,34.22493611128219
ANKRD44,ILMN_1755049,"Homo sapiens ankyrin repeat domain 44 (ANKRD44), mRNA.",,,,2,197568143-197568192,2q33.1a,-,NM_153697.1,91526,ANKRD44,1.1365985726046315,6.485634657060981,10.41357306044737,6.329289361060846e-20,4.229673397999513e-19,34.22058063148571
WDR66,ILMN_1800341,"Homo sapiens WD repeat domain 66 (WDR66), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],12,120923859-120923887:120925941-120925961,12q24.31b-q24.31c,+,NM_144668.3,144406,WDR66,2.5660119541140496,7.212669001569521,10.412168249895581,6.386419445165312e-20,4.2664267198286334e-19,34.21164525495456
SLC16A9,ILMN_1732410,"Homo sapiens solute carrier family 16, member 9 (monocarboxylic acid transporter 9) (SLC16A9), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA],10,61080823-61080872,10q21.1f,-,NM_194298.1,220963,SLC16A9,1.9221368080592605,7.349264413002462,10.386356112827832,7.532572285875597e-20,5.005370517960775e-19,34.04751217362977
HSF4,ILMN_1704101,"Homo sapiens heat shock transcription factor 4 (HSF4), mRNA.",nucleus [goid 5634] [evidence IEA]; nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [pmid 8972228] [evidence TAS]; protein folding [goid 6457] [evidence IEA]; transcription [goid 6350] [evidence IEA]; response to unfolded protein [goid 6986] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [pmid 8972228] [evidence TAS]; protein folding [goid 6457] [evidence IEA]; response to unfolded protein [goid 6986] [evidence IEA]; transcription [goid 6350] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription corepressor activity [goid 3714] [pmid 8972228] [evidence TAS]; transcription factor activity [goid 3700] [pmid 8972228] [evidence TAS]; transcription corepressor activity [goid 3714] [pmid 8972228] [evidence TAS]; transcription factor activity [goid 3700] [pmid 8972228] [evidence TAS],16,65760723-65760752:65761035-65761054,16q22.1a,+,NM_001538.1,3299,HSF4,1.0006397298032743,6.03250053973394,10.384562031989645,7.619465763828876e-20,5.06142998016893e-19,34.036107343191304
C10orf73,ILMN_1738047,"PREDICTED: Homo sapiens chromosome 10 open reading frame 73 (C10orf73), mRNA.",,,,,,10q11.22d,,XM_937528.1,170370,C10orf73,-1.2426543180131233,6.987187398020593,-10.381863050495532,7.752072719179436e-20,5.14610056288461e-19,34.018950940685244
LOC644250,ILMN_1654320,"PREDICTED: Homo sapiens hypothetical protein LOC644250 (LOC644250), mRNA.",,,,13,47980580-47980629,,-,XM_929199.1,644250,LOC644250,1.6606778319125421,10.811536910227037,10.374572621409753,8.121881330996836e-20,5.3862314110236895e-19,33.97261332020733
SELE,ILMN_1739393,"Homo sapiens selectin E (endothelial adhesion molecule 1) (SELE), mRNA.",plasma membrane [goid 5886] [pmid 2466335] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 2466335] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell adhesion [goid 7155] [evidence IEA]; inflammatory response [goid 6954] [pmid 2466335] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA]; inflammatory response [goid 6954] [pmid 2466335] [evidence TAS],sugar binding [goid 5529] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; sugar binding [goid 5529] [evidence IEA]; protein binding [goid 5515] [evidence IEA],1,167958962-167959011,1q24.2c,-,NM_000450.1,6401,SELE,-1.0802900516303744,5.736784829258393,-10.36773583184357,8.484641018595687e-20,5.624940275018638e-19,33.929165493361346
DKFZP586H2123,ILMN_1658356,"Homo sapiens regeneration associated muscle protease (DKFZP586H2123), transcript variant 2, mRNA.",,,serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],11,35410028-35410077,11p13b-p13a,-,NM_001001991.1,25891,DKFZP586H2123,-1.644071382667823,8.427677506192053,-10.364637860181745,8.654294133112499e-20,5.731715227253058e-19,33.90947994180087
CX3CR1,ILMN_1745788,"Homo sapiens chemokine (C-X3-C motif) receptor 1 (CX3CR1), mRNA.",plasma membrane [goid 5886] [pmid 9390561] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9390561] [evidence TAS]; plasma membrane [goid 5886] [pmid 9390561] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9390561] [evidence TAS],cell adhesion [goid 7155] [pmid 10754298] [evidence TAS]; chemotaxis [goid 6935] [pmid 10754298] [evidence TAS]; cellular defense response [goid 6968] [pmid 10754298] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10754298] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; cell adhesion [goid 7155] [pmid 10754298] [evidence TAS]; chemotaxis [goid 6935] [pmid 10754298] [evidence TAS]; cellular defense response [goid 6968] [pmid 10754298] [evidence TAS]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 10754298] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],rhodopsin-like receptor activity [goid 1584] [evidence IEA]; C-X-C chemokine receptor activity [goid 16494] [evidence IEA]; coreceptor activity [goid 15026] [evidence NR ]; protein binding [goid 5515] [pmid 9931005] [evidence IPI]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; C-X-C chemokine receptor activity [goid 16494] [evidence IEA]; coreceptor activity [goid 15026] [evidence NR ]; protein binding [goid 5515] [pmid 9931005] [evidence IPI],3,39280494-39280543,3p22.2a,-,NM_001337.3,1524,CX3CR1,-1.258587948548426,6.5760894743322105,-10.362562021735013,8.769860507020324e-20,5.806332528936553e-19,33.89629009201044
WBSCR18,ILMN_1771824,"Homo sapiens Williams Beuren syndrome chromosome region 18 (WBSCR18), mRNA.",,protein folding [goid 6457] [evidence IEA],heat shock protein binding [goid 31072] [evidence IEA]; unfolded protein binding [goid 51082] [evidence IEA],7,72733445-72733494,7q11.23b,-,NM_032317.2,84277,WBSCR18,1.0132113162650986,7.515644053895614,10.347492795778251,9.656214841636805e-20,6.369981752438813e-19,33.80055791365
SLC5A8,ILMN_1811221,"Homo sapiens solute carrier family 5 (iodide transporter), member 8 (SLC5A8), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],ion transport [goid 6811] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA],transporter activity [goid 5215] [evidence IEA],12,100073632-100073681,12q23.2a,-,NM_145913.2,160728,SLC5A8,1.943133666844031,8.984923090894581,10.347026095474854,9.685046821996135e-20,6.384791328319561e-19,33.79759353962177
PAQR5,ILMN_1806434,"Homo sapiens progestin and adipoQ receptor family member V (PAQR5), mRNA.",,,,15,67485623-67485672,15q23a,+,NM_017705.2,54852,PAQR5,-1.08032502284866,6.387782498496851,-10.345991469744684,9.749270682434229e-20,6.425013432613441e-19,33.79102193833386
NFIA,ILMN_1758049,"Homo sapiens nuclear factor I/A (NFIA), mRNA.",nucleus [goid 5634] [pmid 7590749] [evidence NAS]; intracellular [goid 5622] [evidence IEA],"transcription [goid 6350] [evidence IEA]; DNA replication [goid 6260] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [pmid 7590749] [evidence NAS]; viral genome replication [goid 19079] [pmid 7590749] [evidence NAS]; electron transport [goid 6118] [evidence IEA]",heme binding [goid 20037] [evidence IEA]; transcription factor activity [goid 3700] [pmid 7590749] [evidence NAS]; electron carrier activity [goid 9055] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA],1,61694189-61694238,1p31.3d,+,NM_005595.1,4774,NFIA,-1.2295670878091567,8.466671143110332,-10.345420485678824,9.784895846035633e-20,6.446367997612148e-19,33.787395298334324
FUT8,ILMN_1741422,"Homo sapiens fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (FUT8), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; Golgi apparatus [goid 5794] [pmid 11698403] [evidence NAS]; membrane [goid 16020] [evidence IEA],oligosaccharide biosynthesis [goid 9312] [pmid 9133635] [evidence TAS]; N-glycan processing [goid 6491] [pmid 11698403] [evidence TAS]; L-fucose catabolism [goid 42355] [pmid 11698403] [evidence NAS]; embryonic development (sensu Mammalia) [goid 1701] [pmid 11698403] [evidence NAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; glycoprotein 6-alpha-L-fucosyltransferase activity [goid 8424] [pmid 11698403] [evidence TAS]",14,65279249-65279298,14q23.3a,+,NM_178154.1,2530,FUT8,1.069119879625986,8.00478154680403,10.34057033897201,1.0092789652302631e-19,6.640464826151629e-19,33.75659108837731
KRT16,ILMN_1736760,"Homo sapiens keratin 16 (focal non-epidermolytic palmoplantar keratoderma) (KRT16), mRNA.",intermediate filament [goid 5882] [pmid 2451124] [evidence NAS]; intermediate filament [goid 5882] [pmid 2451124] [evidence NAS],cell proliferation [goid 8283] [pmid 8595410] [evidence TAS]; epidermis development [goid 8544] [pmid 7539673] [evidence TAS]; cytoskeleton organization and biogenesis [goid 7010] [pmid 2451124] [evidence NAS]; cell proliferation [goid 8283] [pmid 8595410] [evidence TAS]; epidermis development [goid 8544] [pmid 7539673] [evidence TAS]; cytoskeleton organization and biogenesis [goid 7010] [pmid 2451124] [evidence NAS],structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 15731013] [evidence IPI]; structural constituent of cytoskeleton [goid 5200] [pmid 2451124] [evidence NAS]; structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 15731013] [evidence IPI]; structural constituent of cytoskeleton [goid 5200] [pmid 2451124] [evidence NAS],17,37020692-37020741,17q21.2b,-,NM_005557.2,3868,KRT16,1.1221037686585484,5.940284646997776,10.329148447487894,1.085655557947073e-19,7.135938371683652e-19,33.6840611690626
LOC349338,ILMN_1739199,"Homo sapiens CXYorf1-related protein (FLJ00038), mRNA.",,,,2,114072737-114072786,Yq12w,+,NM_182905.1,375690,LOC349338,1.0503186469118653,8.941264657127709,10.324746069041192,1.1166086137762877e-19,7.3297589056548435e-19,33.656110491969834
KIAA0514,ILMN_1723505,"PREDICTED: Homo sapiens KIAA0514 (KIAA0514), mRNA.",,,,,,10q11.22a,,XM_941898.1,9721,KIAA0514,-1.212846633148457,7.0948868920671675,-10.31789643350206,1.1665264737897139e-19,7.647398980204651e-19,33.61262749632708
GPRC5A,ILMN_1682599,"Homo sapiens G protein-coupled receptor, family C, group 5, member A (GPRC5A), mRNA.",integral to plasma membrane [goid 5887] [pmid 9857033] [evidence TAS]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [evidence IEA]; signal transduction [goid 7165] [pmid 9857033] [evidence TAS],"receptor activity [goid 4872] [evidence IEA]; metabotropic glutamate, GABA-B-like receptor activity [goid 8067] [evidence IEA]",12,12957521-12957570,12p13.1b,+,NM_003979.3,9052,GPRC5A,-1.2636203864650177,9.813683500171289,-10.314559567547722,1.1916441214881754e-19,7.80439135277755e-19,33.591446680581534
LOC389432,ILMN_1755215,"Homo sapiens sterile alpha motif domain containing 5 (SAMD5), mRNA.",,,,6,147932558-147932607,6q24.3b,+,NM_001030060.1,389432,LOC389432,-1.2950606538117855,6.310403251406147,-10.312968293905428,1.2038112743705932e-19,7.881497374871345e-19,33.581346584901425
TNF,ILMN_1728106,"Homo sapiens tumor necrosis factor (TNF superfamily, member 2) (TNF), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; soluble fraction [goid 5625] [pmid 3856324] [evidence TAS],"immune response [goid 6955] [evidence IEA]; apoptosis [goid 6915] [pmid 3856324] [evidence TAS]; response to wounding [goid 9611] [evidence NR ]; leukocyte adhesion [goid 7159] [pmid 10820279] [evidence TAS]; cell-cell signaling [goid 7267] [evidence NR ]; response to virus [goid 9615] [pmid 10490959] [evidence TAS]; anti-apoptosis [goid 6916] [pmid 10748004] [evidence TAS]; activation of NF-kappaB transcription factor [goid 51092] [pmid 15790681] [evidence IDA]; regulation of transcription, DNA-dependent [goid 6355] [pmid 2537468] [evidence TAS]; signal transduction [goid 7165] [pmid 10820279] [evidence TAS]",tumor necrosis factor receptor binding [goid 5164] [pmid 3001529] [evidence TAS]; protein binding [goid 5515] [pmid 2848815] [evidence IPI],6,31653868-31653917,6p21.33a,+,NM_000594.2,7124,TNF,-1.3593119112888896,6.365365330605972,-10.307836453528187,1.2439002226768754e-19,8.130661762600106e-19,33.5487762732493
CCR1,ILMN_1678833,"Homo sapiens chemokine (C-C motif) receptor 1 (CCR1), mRNA.",plasma membrane [goid 5886] [pmid 15474493] [evidence IDA]; integral to plasma membrane [goid 5887] [pmid 7505609] [evidence TAS],"cell-cell signaling [goid 7267] [pmid 10734056] [evidence TAS]; cell adhesion [goid 7155] [pmid 10910894] [evidence TAS]; G-protein signaling, coupled to cyclic nucleotide second messenger [goid 7187] [pmid 7505609] [evidence TAS]; chemotaxis [goid 6935] [pmid 15474493] [evidence NAS]; cytokine and chemokine mediated signaling pathway [goid 19221] [pmid 15474493] [evidence NAS]; inflammatory response [goid 6954] [pmid 7683036] [evidence TAS]",C-C chemokine receptor activity [goid 16493] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; protein binding [goid 5515] [pmid 15474493] [evidence IPI],3,46218584-46218633,3p21.31i,-,NM_001295.2,1230,CCR1,-1.0038200027846509,6.455926861613023,-10.304897441699184,1.267455671728078e-19,8.276518629221731e-19,33.530124856837176
LOC653490,ILMN_1731063,"PREDICTED: Homo sapiens similar to suppression of tumorigenicity 5 (LOC653490), mRNA.",,,,11,8728844-8728848:8789370-8789414,,-,XM_932255.1,653490,LOC653490,1.1328476379331986,6.328793218907027,10.302322590139463,1.2884575767123685e-19,8.408173253379344e-19,33.51378544291277
LOC650230,ILMN_1703102,"PREDICTED: Homo sapiens similar to heat shock 70kD protein binding protein (LOC650230), mRNA.",,,,,,,,XM_941946.1,650230,LOC650230,-1.220528635810675,7.545568668684581,-10.296648074825711,1.33597471860362e-19,8.706899729583462e-19,33.47777953482113
LOC653610,ILMN_1695435,"PREDICTED: Homo sapiens similar to Histone H2A.o (H2A/o) (H2A.2) (H2a-615) (LOC653610), mRNA.",,,,1,148089810-148089859,,+,XM_928387.1,653610,LOC653610,1.4586838990931996,6.374757293796859,10.282038658659756,1.4665028493834226e-19,9.542045206654804e-19,33.38510062909406
COL3A1,ILMN_1773079,"Homo sapiens collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) (COL3A1), mRNA.",collagen type III [goid 5586] [pmid 1672129] [evidence TAS]; cytoplasm [goid 5737] [evidence IEA]; collagen [goid 5581] [evidence IEA],phosphate transport [goid 6817] [evidence IEA]; circulation [goid 8015] [pmid 2243125] [evidence TAS],extracellular matrix structural constituent [goid 5201] [evidence IEA],2,189585339-189585388,2q32.2a,+,NM_000090.2,1281,COL3A1,1.6350531242688913,11.713989001989207,10.276220575116222,1.5219564392034265e-19,9.89321131760304e-19,33.34820032787851
SLC2A5,ILMN_1671337,"Homo sapiens solute carrier family 2 (facilitated glucose/fructose transporter), member 5 (SLC2A5), mRNA.",plasma membrane [goid 5886] [pmid 1634504] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],fructose transport [goid 15755] [pmid 1634504] [evidence TAS]; carbohydrate metabolism [goid 5975] [pmid 1634504] [evidence TAS]; glucose transport [goid 15758] [pmid 1695905] [evidence TAS]; carbohydrate transport [goid 8643] [evidence IEA],fructose transporter activity [goid 5353] [pmid 1634504] [evidence TAS]; transporter activity [goid 5215] [evidence IEA]; sugar porter activity [goid 5351] [evidence IEA]; glucose transporter activity [goid 5355] [pmid 1695905] [evidence TAS],1,9019938-9019987,1p36.23a,-,NM_003039.1,6518,SLC2A5,1.5783246539434233,6.727824877095051,10.276141898467372,1.522720473497357e-19,9.894963050904554e-19,33.34770136595881
MYOM2,ILMN_1716733,"Homo sapiens myomesin (M-protein) 2, 165kDa (MYOM2), mRNA.",striated muscle thick filament [goid 5863] [evidence IEA],striated muscle contraction [goid 6941] [evidence IEA],structural constituent of muscle [goid 8307] [pmid 7505783] [evidence TAS],8,2080589-2080638,8p23.3a,+,NM_003970.1,9172,MYOM2,-1.5844995199906151,7.357098392695944,-10.275485275517783,1.5291119117142866e-19,9.933269847266054e-19,33.34353714217866
LEMD1,ILMN_1785444,"Homo sapiens LEM domain containing 1 (LEMD1), mRNA.",,,,1,203617473-203617485:203617486-203617522,1q32.1g,-,NM_001001552.3,93273,LEMD1,1.6398069217442428,6.019404639799325,10.27060272883724,1.5774838699577095e-19,1.0234207934537566e-18,33.31257452482522
ARL17P1,ILMN_1698680,"Homo sapiens ADP-ribosylation factor-like 17 pseudogene 1 (ARL17P1), mRNA.",Golgi stack [goid 5795] [evidence IEA],protein transport [goid 15031] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; GTP binding [goid 5525] [evidence IEA],17,41949510-41949559,17q21.32a,-,NM_016632.1,51326,ARL17P1,1.1589876569616964,6.160656555747253,10.261530087562145,1.6714537678698956e-19,1.0822798377844942e-18,33.255049413688404
HSPC268,ILMN_1779751,"Homo sapiens hypothetical protein HSPC268 (HSPC268), mRNA.",,,,7,138680945-138680990:138680991-138680994,7q34b,+,NM_197964.1,154791,HSPC268,1.0434367996492178,9.790951567149683,10.257384297641766,1.7162312960247273e-19,1.1094783770876492e-18,33.228766902741725
EGR1,ILMN_1762899,"Homo sapiens early growth response 1 (EGR1), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; transcription factor activity [goid 3700] [pmid 3127059] [evidence TAS],5,137832431-137832480,5q31.2c,+,NM_001964.2,1958,EGR1,-1.2919424340824577,12.030640943226917,-10.256809655668206,1.7225314736524395e-19,1.113191528580039e-18,33.22512411437293
LMTK3,ILMN_1668194,"PREDICTED: Homo sapiens lemur tyrosine kinase 3 (LMTK3), mRNA.",,,,,,19q13.32c,,XM_936372.1,114783,LMTK3,1.1823486487402057,9.052483118337339,10.255823316840731,1.7333991415407176e-19,1.1198530844025405e-18,33.21887159387775
BMPR2,ILMN_1789095,"Homo sapiens bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2), mRNA.",integral to plasma membrane [goid 5887] [pmid 7791754] [evidence TAS]; membrane [goid 16020] [evidence IEA],transmembrane receptor protein serine/threonine kinase signaling pathway [goid 7178] [pmid 7644468] [evidence TAS]; skeletal development [goid 1501] [evidence NR ]; protein amino acid phosphorylation [goid 6468] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; manganese ion binding [goid 30145] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; transforming growth factor beta receptor activity [goid 5024] [evidence IEA]; protein binding [goid 5515] [pmid 15188402] [evidence IPI],2,203140150-203140199,2q33.1g,+,NM_001204.5,659,BMPR2,-1.0144119633548225,9.40019139500257,-10.248650140959445,1.8145174345446763e-19,1.1715025760041912e-18,33.173404135242556
LEP,ILMN_2207504,"Homo sapiens leptin (obesity homolog, mouse) (LEP), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 9054940] [evidence TAS]; extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 9054940] [evidence TAS],cell-cell signaling [goid 7267] [evidence NR ]; signal transduction [goid 7165] [evidence IEA]; energy reserve metabolism [goid 6112] [pmid 9537324] [evidence TAS]; cell-cell signaling [goid 7267] [evidence NR ]; signal transduction [goid 7165] [evidence IEA]; energy reserve metabolism [goid 6112] [pmid 9537324] [evidence TAS],hormone activity [goid 5179] [evidence IEA]; hormone activity [goid 5179] [evidence IEA],7,127684194-127684243,7q32.1a,+,NM_000230.1,3952,LEP,1.0228105664620255,7.327734265075715,10.247145839292699,1.832003030314398e-19,1.18241021388808e-18,33.16386999032837
FLJ37396,ILMN_1771618,"Homo sapiens hypothetical protein FLJ37396 (FLJ37396), mRNA.",,,,6,109698391-109698410:109698621-109698650,6q21f,+,NM_173671.1,285754,FLJ37396,1.3272257851134386,6.507851982274056,10.234041252580576,1.9916086569287298e-19,1.2833528504937206e-18,33.08082785253553
LOC642033,ILMN_1673753,"PREDICTED: Homo sapiens similar to ATP-binding cassette, sub-family F, member 1 isoform b (LOC642033), mRNA.",,,,,,,,XM_936103.1,642033,LOC642033,1.1151082598397215,7.400012006312006,10.227554608653044,2.0756659736575324e-19,1.336656736431925e-18,33.039731917643756
LOC649419,ILMN_1721659,"PREDICTED: Homo sapiens similar to peptidase (prosome, macropain) 26S subunit, ATPase 1, transcript variant 1 (LOC649419), mRNA.",,,,,,,,XM_941569.1,649419,LOC649419,-1.1363418323680765,9.734664010530564,-10.226455165326746,2.090259542823068e-19,1.3456213942343611e-18,33.032767028590676
EGFL6,ILMN_1716309,"Homo sapiens EGF-like-domain, multiple 6 (EGFL6), mRNA.",membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [pmid 10610727] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [pmid 10610727] [evidence TAS],cell cycle [goid 7049] [pmid 10610727] [evidence TAS]; cell cycle [goid 7049] [pmid 10610727] [evidence TAS],integrin binding [goid 5178] [pmid 10610727] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA]; integrin binding [goid 5178] [pmid 10610727] [evidence TAS]; calcium ion binding [goid 5509] [evidence IEA],X,13555228-13555277,Xp22.2,+,NM_015507.2,25975,EGFL6,-1.079782054827903,7.729621466488928,-10.22591336120897,2.0974888027930004e-19,1.3498409767218511e-18,33.02933480522561
CYP3A7,ILMN_1685043,"Homo sapiens cytochrome P450, family 3, subfamily A, polypeptide 7 (CYP3A7), mRNA.",membrane fraction [goid 5624] [evidence ISS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA]; microsome [goid 5792] [evidence IEA],xenobiotic metabolism [goid 6805] [evidence ISS]; electron transport [goid 6118] [evidence IEA],"heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; unspecific monooxygenase activity [goid 50381] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [pmid 2722762] [evidence TAS]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [goid 16712] [evidence IEA]",7,99141045-99141058:99141059-99141094,7q22.1b,-,NM_000765.2,1551,CYP3A7,-1.080685785352678,5.338496417961832,-10.223009459612964,2.1366622126792402e-19,1.374167070115276e-18,33.01093987726024
HDC,ILMN_1792323,"Homo sapiens histidine decarboxylase (HDC), mRNA.",,histidine metabolism [goid 6547] [pmid 1487235] [evidence TAS]; amino acid metabolism [goid 6520] [evidence IEA]; catecholamine biosynthesis [goid 42423] [evidence IEA],lyase activity [goid 16829] [evidence IEA]; histidine decarboxylase activity [goid 4398] [pmid 1487235] [evidence TAS],15,48321494-48321543,15q21.2a,-,NM_002112.1,3067,HDC,-1.4880861936415126,7.924585900789756,-10.222516990999518,2.1433775198013938e-19,1.3776003024794824e-18,33.007820427900704
GGT1,ILMN_1686531,"Homo sapiens gamma-glutamyltransferase 1 (GGT1), transcript variant 4, mRNA.",membrane [goid 16020] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],amino acid metabolism [goid 6520] [pmid 2904146] [evidence TAS]; glutathione biosynthesis [goid 6750] [evidence IEA],acyltransferase activity [goid 8415] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; gamma-glutamyltransferase activity [goid 3840] [evidence IEA],22,23353408-23353457,22q11.23b,+,NM_001032364.1,2678,GGT1,-1.304018879737784,8.035521008151616,-10.217482165774703,2.21325094848709e-19,1.4197731637489484e-18,32.97593029105835
RGS22,ILMN_1669983,"Homo sapiens regulator of G-protein signalling 22 (RGS22), mRNA.",,,signal transducer activity [goid 4871] [evidence IEA],8,101044363-101044382:101046739-101046768,8q22.2b,-,NM_015668.2,26166,RGS22,-1.2470289221272148,5.699383414447244,-10.215353610550363,2.2434695903441044e-19,1.4381150774979697e-18,32.96244931459695
MT1E,ILMN_1718968,"Homo sapiens metallothionein 1E (functional) (MT1E), mRNA.",cytoplasm [goid 5737] [evidence NAS],biological process unknown [goid 4] [evidence ND ],metal ion binding [goid 46872] [evidence IEA]; cadmium ion binding [goid 46870] [evidence NAS]; zinc ion binding [goid 8270] [evidence NAS]; copper ion binding [goid 5507] [evidence NAS],16,55218122-55218171,16q13b,+,NM_175617.2,4493,MT1E,-1.622867112302325,9.300033206503182,-10.215312339251124,2.244059555897708e-19,1.4381150774979697e-18,32.96218793373467
STRA6,ILMN_1807652,"Homo sapiens stimulated by retinoic acid gene 6 homolog (mouse) (STRA6), mRNA.",,,,15,72259138-72259187,15q24.1b,-,NM_022369.2,64220,STRA6,1.4895050571997883,5.593116262276191,10.21461308278533,2.254078833098627e-19,1.4434765513393119e-18,32.957759415322585
HABP2,ILMN_1737041,"Homo sapiens hyaluronan binding protein 2 (HABP2), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [pmid 8827452] [evidence TAS],cell adhesion [goid 7155] [pmid 8827452] [evidence TAS],serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; glycosaminoglycan binding [goid 5539] [pmid 8827452] [evidence TAS],10,115339090-115339139,10q25.3a,+,NM_004132.2,3026,HABP2,2.1144831751668303,6.430616510871748,10.214464894651814,2.2562078613685256e-19,1.444088512164474e-18,32.956820922019524
SCNN1G,ILMN_1814215,"Homo sapiens sodium channel, nonvoltage-gated 1, gamma (SCNN1G), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8640238] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8640238] [evidence TAS],excretion [goid 7588] [pmid 8640238] [evidence TAS]; sodium ion transport [goid 6814] [pmid 8521520] [evidence TAS]; ion transport [goid 6811] [evidence IEA]; excretion [goid 7588] [pmid 8640238] [evidence TAS]; sodium ion transport [goid 6814] [pmid 8521520] [evidence TAS]; ion transport [goid 6811] [evidence IEA],protein binding [goid 5515] [pmid 11244092] [evidence IPI]; ion channel activity [goid 5216] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA]; amiloride-sensitive sodium channel activity [goid 15280] [pmid 8640238] [evidence TAS]; protein binding [goid 5515] [pmid 11244092] [evidence IPI]; ion channel activity [goid 5216] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA]; amiloride-sensitive sodium channel activity [goid 15280] [pmid 8640238] [evidence TAS],16,23135217-23135266,16p12.1c,+,NM_001039.2,6340,SCNN1G,-1.387721665063573,7.393529141701363,-10.203928010808754,2.4128440905981515e-19,1.5404015496071415e-18,32.89009774564627
DOCK9,ILMN_1773413,"Homo sapiens dedicator of cytokinesis 9 (DOCK9), mRNA.",,,GTPase binding [goid 51020] [evidence IEA]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence IEA]; GTP binding [goid 5525] [evidence IEA],13,98244898-98244947,13q32.3a,-,NM_015296.1,23348,DOCK9,-1.1121390509097857,7.599020506452844,-10.198405901721443,2.499214179529904e-19,1.5935078809443697e-18,32.85513630782079
TMEM118,ILMN_1738093,"Homo sapiens transmembrane protein 118 (TMEM118), mRNA.",,,,12,115774987-115775036,12q24.22a,+,NM_032814.1,84900,TMEM118,1.1058752410160206,7.229578935756138,10.194914182131756,2.5554105099374874e-19,1.6272645920696769e-18,32.83303191993887
FLJ90586,ILMN_1683470,"Homo sapiens transmembrane protein 139 (TMEM139), mRNA.",,,,7,142695101-142695150,7q34f,+,NM_153345.1,135932,FLJ90586,-1.4498724245747736,6.872156980692511,-10.189138672131032,2.651139991694029e-19,1.687150412016989e-18,32.796473878459466
VLDLR,ILMN_2361862,"Homo sapiens very low density lipoprotein receptor (VLDLR), transcript variant 2, mRNA.",membrane fraction [goid 5624] [pmid 15082773] [evidence IDA]; membrane [goid 16020] [evidence IEA]; plasma membrane [goid 5886] [pmid 10380922] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA]; coated pit [goid 5905] [evidence IEA],memory [goid 7613] [pmid 7550352] [evidence TAS]; lipid transport [goid 6869] [evidence IEA]; signal transduction [goid 7165] [pmid 10380922] [evidence TAS]; steroid metabolism [goid 8202] [evidence IEA]; endocytosis [goid 6897] [evidence IEA]; cholesterol metabolism [goid 8203] [evidence IEA]; lipid metabolism [goid 6629] [evidence IEA],low-density lipoprotein receptor activity [goid 5041] [pmid 10380922] [evidence TAS]; lipid transporter activity [goid 5319] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],9,2643893-2643942,9p24.2b,+,NM_001018056.1,7436,VLDLR,-1.1635248531096636,7.843552960540854,-10.188586736396463,2.660473375005116e-19,1.6925517102417287e-18,32.7929804708854
C5orf4,ILMN_1716154,"Homo sapiens chromosome 5 open reading frame 4 (C5orf4), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],metabolism [goid 8152] [evidence IEA],catalytic activity [goid 3824] [evidence IEA],5,154182228-154182277,5q33.2b,-,NM_032385.1,10826,C5orf4,-1.0228028699200662,7.009432336020135,-10.182867147316639,2.759142315931763e-19,1.7536505545477356e-18,32.75678168904058
ANG,ILMN_1760727,"Homo sapiens angiogenin, ribonuclease, RNase A family, 5 (ANG), mRNA.",basal lamina [goid 5605] [pmid 15166501] [evidence IDA]; extracellular space [goid 5615] [pmid 16490744] [evidence IDA]; nucleolus [goid 5730] [evidence ISS]; nucleus [goid 5634] [pmid 15735021] [evidence IDA],actin filament polymerization [goid 30041] [evidence ISS]; cell communication [goid 7154] [pmid 10103013] [evidence NAS]; negative regulation of smooth muscle cell proliferation [goid 48662] [pmid 10103013] [evidence IDA]; positive regulation of protein secretion [goid 50714] [pmid 2646638] [evidence IDA]; cell differentiation [goid 30154] [evidence IEA]; rRNA transcription [goid 9303] [pmid 15735021] [evidence IMP]; ribosome biogenesis [goid 7046] [pmid 15735021] [evidence IMP]; diacylglycerol biosynthesis [goid 6651] [pmid 2457905] [evidence IDA]; ovarian follicle development [goid 1541] [pmid 12770725] [evidence NAS]; phospholipase C activation [goid 7202] [pmid 2457905] [evidence IMP]; angiogenesis [goid 1525] [pmid 16567967] [evidence TAS]; response to hypoxia [goid 1666] [pmid 16490744] [evidence IDA]; homeostasis [goid 42592] [pmid 15166501] [evidence NAS]; positive regulation of endothelial cell proliferation [goid 1938] [pmid 9707554] [evidence IDA]; calcium-dependent phospholipase A2 activation [goid 43006] [pmid 2646638] [evidence IMP]; negative regulation of protein biosynthesis [goid 17148] [evidence IEA],actin binding [goid 3779] [pmid 11782452] [evidence IDA]; heparin binding [goid 8201] [pmid 10103013] [evidence IDA]; rRNA binding [goid 19843] [pmid 2457905] [evidence TAS]; copper ion binding [goid 5507] [pmid 9245697] [evidence IDA]; receptor binding [goid 5102] [pmid 9122172] [evidence IDA]; endonuclease activity [goid 4519] [pmid 10103013] [evidence TAS]; DNA binding [goid 3677] [pmid 10649442] [evidence IC ]; ribonuclease activity [goid 4540] [pmid 2730651] [evidence IDA]; hydrolase activity [goid 16787] [evidence IEA]; pancreatic ribonuclease activity [goid 4522] [evidence IEA],14,20232018-20232067,14q11.2b,+,NM_001145.2,283,ANG,-1.1198105974047312,10.648006020068937,-10.163858585804336,3.114012832769721e-19,1.972306703325628e-18,32.636512826801784
IGSF9B,ILMN_1660204,"PREDICTED: Homo sapiens immunoglobulin superfamily, member 9B (IGSF9B), mRNA.",,,,,,11q25d,,XM_940668.1,22997,IGSF9B,1.4919909646849128,6.063200655129119,10.16077153832218,3.175791762325918e-19,2.0107987841967392e-18,32.616985855286316
NLRP3,ILMN_2310896,"Homo sapiens NLR family, pyrin domain containing 3 (NLRP3), transcript variant 1, mRNA.",cytoplasm [goid 5737] [pmid 15967716] [evidence TAS],detection of biotic stimulus [goid 9595] [pmid 15967716] [evidence TAS]; inflammatory response [goid 6954] [pmid 12093792] [evidence IMP]; defense response [goid 6952] [pmid 15967716] [evidence TAS]; protein oligomerization [goid 51259] [pmid 15967716] [evidence TAS]; positive regulation of interleukin-1 beta secretion [goid 50718] [pmid 15030775] [evidence IDA]; signal transduction [goid 7165] [pmid 11786556] [evidence NAS]; induction of apoptosis [goid 6917] [pmid 12032915] [evidence NAS]; apoptosis [goid 6915] [evidence IEA],peptidoglycan binding [goid 42834] [pmid 15967716] [evidence TAS]; protein binding [goid 5515] [pmid 15030775] [evidence IPI]; transferase activity [goid 16740] [evidence IEA],1,245678577-245678626,1q44e,+,NM_004895.3,114548,NLRP3,-1.255943853897274,6.8633063957041784,-10.135315434819796,3.734070733008362e-19,2.3560796980773042e-18,32.45601871096458
IL18R1,ILMN_1781700,"Homo sapiens interleukin 18 receptor 1 (IL18R1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; plasma membrane [goid 5886] [pmid 9325300] [evidence TAS],immune response [goid 6955] [pmid 9325300] [evidence TAS]; signal transduction [goid 7165] [pmid 9325300] [evidence TAS],interleukin-1 receptor activity [goid 4908] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],2,102381204-102381253,2q12.1a,+,NM_003855.2,8809,IL18R1,-1.3342428668191149,6.948105094978002,-10.123221563461337,4.0325688767416393e-19,2.538019442775927e-18,32.379579368574014
IGF2BP3,ILMN_1807423,"Homo sapiens insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3), mRNA.",cytoplasm [goid 5737] [pmid 9891060] [evidence TAS],"morphogenesis [goid 9653] [pmid 9891060] [evidence TAS]; regulation of translation [goid 6445] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; RNA processing [goid 6396] [pmid 9891060] [evidence TAS]",RNA binding [goid 3723] [pmid 9891060] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA],7,23316661-23316710,7p15.3b,-,NM_006547.2,10643,IGF2BP3,1.9528910064585334,6.780068151747092,10.118708347690792,4.1499559724690064e-19,2.6102583809229764e-18,32.35105924267154
C6orf168,ILMN_1715096,"Homo sapiens chromosome 6 open reading frame 168 (C6orf168), mRNA.",,,,6,99835701-99835750,6q16.2a-q16.3a,-,NM_032511.1,84553,C6orf168,1.088676753224461,6.233530834213178,10.115578350582629,4.2333596174849697e-19,2.6610449018736813e-18,32.331281831008454
B3Gn-T6,ILMN_1680081,"Homo sapiens beta-1,3-N-acetylglucosaminyltransferase protein (B3Gn-T6), mRNA.",membrane [goid 16020] [pmid 11821425] [evidence NAS],"protein amino acid glycosylation [goid 6486] [evidence IEA]; O-glycan processing, core 3 [goid 16269] [pmid 11821425] [evidence NAS]","beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [goid 47223] [pmid 11821425] [evidence NAS]; transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; galactosyltransferase activity [goid 8378] [pmid 11821425] [evidence IDA]",11,76430231-76430280,11q13.5c,+,NM_138706.2,192134,B3Gn-T6,1.8458333911509381,5.816761476052009,10.105767736474814,4.505754851209641e-19,2.827827574121785e-18,32.2693014707643
TSPAN5,ILMN_1799028,"Homo sapiens tetraspanin 5 (TSPAN5), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],electron transport [goid 6118] [evidence IEA],cytochrome-c oxidase activity [goid 4129] [evidence IEA],4,99616396-99616445,4q23a,-,NM_005723.2,10098,TSPAN5,1.2387330717801346,7.977124549563154,10.103431097920701,4.573166522224714e-19,2.8674370346810428e-18,32.254541489236495
OMD,ILMN_1749846,"Homo sapiens osteomodulin (OMD), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],cell adhesion [goid 7155] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; protein binding [goid 5515] [evidence IEA],9,94216694-94216743,9q22.31a,-,NM_005014.1,4958,OMD,-1.3361789379637639,6.25953406918732,-10.100498187168697,4.659204663864719e-19,2.9204688883021712e-18,32.236016180466926
ZNF514,ILMN_1687223,"Homo sapiens zinc finger protein 514 (ZNF514), mRNA.",nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; intracellular [goid 5622] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; DNA binding [goid 3677] [evidence IEA],2,95177708-95177757,2q11.1c,-,NM_032788.1,84874,ZNF514,1.0145579324451122,7.491247091350204,10.096660373262731,4.7742292021278775e-19,2.989758305983555e-18,32.211777168245234
NFIL3,ILMN_1707312,"Homo sapiens nuclear factor, interleukin 3 regulated (NFIL3), mRNA.",nucleus [goid 5634] [pmid 7565758] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; immune response [goid 6955] [pmid 7565758] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [pmid 7565758] [evidence TAS]",protein dimerization activity [goid 46983] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription corepressor activity [goid 3714] [pmid 1620116] [evidence TAS]; transcription factor activity [goid 3700] [pmid 7565758] [evidence TAS],9,93211451-93211500,9q22.31a,-,NM_005384.2,4783,NFIL3,-1.2196272851600067,8.562369761134676,-10.091453041385217,4.934837132561542e-19,3.0884022942849962e-18,32.17889211041006
SLC9A5,ILMN_1714023,"Homo sapiens solute carrier family 9 (sodium/hydrogen exchanger), member 5 (SLC9A5), mRNA.",integral to membrane [goid 16021] [pmid 9933641] [evidence TAS],ion transport [goid 6811] [evidence IEA]; sodium ion transport [goid 6814] [evidence IEA]; regulation of pH [goid 6885] [evidence IEA],sodium:hydrogen antiporter activity [goid 15385] [pmid 9933641] [evidence TAS]; antiporter activity [goid 15297] [evidence IEA]; solute:hydrogen antiporter activity [goid 15299] [evidence IEA]; sodium ion binding [goid 31402] [evidence IEA],16,65863371-65863420,16q22.1a,+,NM_004594.1,6553,SLC9A5,1.027253645260302,5.89743802439432,10.08905380596081,5.010636639779008e-19,3.1338798964894777e-18,32.16374199050647
CSAD,ILMN_1779515,"Homo sapiens cysteine sulfinic acid decarboxylase (CSAD), mRNA.",,carboxylic acid metabolism [goid 19752] [evidence IEA]; carboxylic acid metabolism [goid 19752] [evidence IEA],carboxy-lyase activity [goid 16831] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; sulfinoalanine decarboxylase activity [goid 4782] [evidence IEA]; carboxy-lyase activity [goid 16831] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; sulfinoalanine decarboxylase activity [goid 4782] [evidence IEA],12,51838507-51838556,12q13.13e,-,NM_015989.3,51380,CSAD,1.0518907481797592,7.153490661892946,10.078466637413154,5.359215541608521e-19,3.338330776977064e-18,32.096899243253645
LOC643882,ILMN_1746919,"PREDICTED: Homo sapiens hypothetical protein LOC643882 (LOC643882), mRNA.",,,,12,8382616-8382665,,+,XM_931879.1,643882,LOC643882,1.8782866762569528,8.330058943510386,10.06168759169435,5.961801061368207e-19,3.709070759821364e-18,31.990999191122633
IFIT2,ILMN_1739428,"Homo sapiens interferon-induced protein with tetratricopeptide repeats 2 (IFIT2), mRNA.",,immune response [goid 6955] [evidence IEA],binding [goid 5488] [evidence IEA],10,91058378-91058427,10q23.31b,+,NM_001547.3,3433,IFIT2,-1.1725796360559926,9.267971986368048,-10.058181747088687,6.095990409863346e-19,3.789020693399995e-18,31.968877763157536
GPR4,ILMN_2074477,"Homo sapiens G protein-coupled receptor 4 (GPR4), mRNA.",integral to plasma membrane [goid 5887] [pmid 8595909] [evidence TAS]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 7498459] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],"receptor activity [goid 4872] [evidence IEA]; G-protein coupled receptor activity, unknown ligand [goid 16526] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]",19,50785018-50785067,19q13.32a,-,NM_005282.1,2828,GPR4,-1.2244278433105675,7.465399698786728,-10.052535845085918,6.318446139995006e-19,3.921199453133377e-18,31.93325687731395
PSG1,ILMN_1798000,"Homo sapiens pregnancy specific beta-1-glycoprotein 1 (PSG1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; extracellular space [goid 5615] [evidence NR ],pregnancy [goid 7565] [pmid 1572651] [evidence TAS],,19,48063432-48063481,19q13.31a,-,NM_006905.2,5669,PSG1,1.9537872283956812,5.861191418717713,10.024793902399933,7.5347093761726555e-19,4.658667033327024e-18,31.758301207573446
GCHFR,ILMN_1694780,"Homo sapiens GTP cyclohydrolase I feedback regulator (GCHFR), mRNA.",,nitric oxide biosynthesis [goid 6809] [pmid 8702680] [evidence TAS]; neurotransmitter metabolism [goid 42133] [pmid 8702680] [evidence TAS],,15,38846896-38846945,15q15.1b,+,NM_005258.2,2644,GCHFR,-1.16189097909845,10.64506468015822,-10.018272589692408,7.852933569316384e-19,4.852424177111865e-18,31.717191911873456
NELF,ILMN_1665095,"Homo sapiens nasal embryonic LHRH factor (NELF), mRNA.",,,,9,139462516-139462565,9q34.3f,-,NM_015537.3,26012,NELF,1.0708785489904509,7.766639817365927,10.012529647344836,8.144243464368029e-19,5.0277699239455576e-18,31.68099492488667
KIAA0367,ILMN_1810628,"Homo sapiens KIAA0367 (KIAA0367), mRNA.",,induction of apoptosis [goid 6917] [pmid 16288218] [evidence IMP]; G1 phase [goid 51318] [pmid 16288218] [evidence IEP],,9,78416421-78416470,9q21.13c,-,NM_015225.1,23273,KIAA0367,-1.3095184786775809,7.064401574786276,-10.011993531099762,8.171981236520069e-19,5.041782318232918e-18,31.677616124486086
LOC388135,ILMN_2141118,"Homo sapiens similar to RIKEN cDNA 6030419C18 gene (LOC388135), mRNA.",,,,15,71819378-71819427,15q24.1b,-,NM_001039614.1,388135,LOC388135,-1.0833831568354002,5.929654276786568,-10.00627555361535,8.473739229253464e-19,5.2199068503356935e-18,31.64158218968759
HSD17B1,ILMN_1773623,"Homo sapiens hydroxysteroid (17-beta) dehydrogenase 1 (HSD17B1), mRNA.",cytoplasm [goid 5737] [pmid 8547176] [evidence TAS],estrogen biosynthesis [goid 6703] [evidence IEA]; metabolism [goid 8152] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; estradiol 17-beta-dehydrogenase activity [goid 4303] [pmid 2330005] [evidence NAS],17,37960564-37960613,17q21.31a,+,NM_000413.1,3292,HSD17B1,1.2936188302263183,6.060464645921376,9.999420224146059,8.85018555159076e-19,5.441749001727963e-18,31.59838769132414
HOXC9,ILMN_1718898,"Homo sapiens homeobox C9 (HOXC9), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]",transcriptional activator activity [goid 16563] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],12,52683077-52683126,12q13.13f,+,NM_006897.1,3225,HOXC9,1.2255371745177426,5.457070811049598,9.999252359395827,8.859609517319864e-19,5.444197396269528e-18,31.59733009261818
TYMS,ILMN_1806040,"Homo sapiens thymidylate synthetase (TYMS), mRNA.",,"dTMP biosynthesis [goid 6231] [evidence IEA]; deoxyribonucleoside monophosphate biosynthesis [goid 9157] [pmid 2987839] [evidence TAS]; phosphoinositide-mediated signaling [goid 48015] [pmid 15504738] [evidence NAS]; DNA replication [goid 6260] [pmid 15504738] [evidence NAS]; nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 2987839] [evidence TAS]; DNA repair [goid 6281] [pmid 15504738] [evidence NAS]; nucleotide biosynthesis [goid 9165] [evidence IEA]",transferase activity [goid 16740] [evidence IEA]; thymidylate synthase activity [goid 4799] [evidence IEA]; methyltransferase activity [goid 8168] [evidence IEA],18,663033-663082,18p11.32c,+,NM_001071.1,7298,TYMS,1.2554280094646177,8.18602484512375,9.991851986680693,9.285155994316965e-19,5.700441888134208e-18,31.550709992871965
KCNK1,ILMN_1718863,"Homo sapiens potassium channel, subfamily K, member 1 (KCNK1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; voltage-gated potassium channel complex [goid 8076] [pmid 8605869] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; voltage-gated potassium channel complex [goid 8076] [pmid 8605869] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 8605869] [evidence TAS]; ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 8605869] [evidence TAS],voltage-gated ion channel activity [goid 5244] [evidence IEA]; potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [evidence IEA]; ion channel activity [goid 5216] [evidence IEA]; inward rectifier potassium channel activity [goid 5242] [pmid 8605869] [evidence TAS]; voltage-gated ion channel activity [goid 5244] [evidence IEA]; potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [evidence IEA]; ion channel activity [goid 5216] [evidence IEA]; inward rectifier potassium channel activity [goid 5242] [pmid 8605869] [evidence TAS],1,231874087-231874136,1q42.2c,+,NM_002245.2,3775,KCNK1,1.493880448910197,7.897485928298485,9.989924822118526,9.399277338319422e-19,5.763430615540759e-18,31.538570883758254
LOH3CR2A,ILMN_2052135,"Homo sapiens loss of heterozygosity, 3, chromosomal region 2, gene A (LOH3CR2A), mRNA.",,,,3,8590113-8590162,3p26.1a,+,NM_013343.1,29931,LOH3CR2A,-1.3341652713968228,6.454291886300788,-9.98000093749797,1.0009442853518849e-18,6.1281803125215765e-18,31.476070314006968
C8orf1,ILMN_1757732,"Homo sapiens oxidative stress induced growth inhibitor family member 2 (OSGIN2), mRNA.",,germ cell development [goid 7281] [evidence NAS]; meiosis [goid 7126] [evidence NAS],,8,91007391-91007440,8q21.3d,+,NM_004337.1,734,C8orf1,-1.054276181928227,7.843946107810556,-9.977834956561402,1.0147776520656475e-18,6.207175561763826e-18,31.462431089377148
ANKRD36,ILMN_2280568,"Homo sapiens ankyrin repeat domain 36 (ANKRD36), mRNA.",,,catalytic activity [goid 3824] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA],2,97143180-97143203:97143204-97143229,2q11.2b,+,NM_198555.3,375248,ANKRD36,1.1140009322637807,5.899578302285315,9.961978256702517,1.1220200963934061e-18,6.833905049814085e-18,31.36260427281526
LOC644642,ILMN_1812250,"PREDICTED: Homo sapiens hypothetical protein LOC644642 (LOC644642), mRNA.",,,,1,142987262-142987311,,-,XM_932279.1,644642,LOC644642,1.5402738597941577,7.896189582190469,9.946873842443607,1.234653070403172e-18,7.494823614267799e-18,31.26755155818772
OLFML2A,ILMN_1761425,"Homo sapiens olfactomedin-like 2A (OLFML2A), mRNA.",membrane [goid 16020] [evidence IEA],,latrotoxin receptor activity [goid 16524] [evidence IEA],9,126616630-126616679,9q33.3a,+,NM_182487.1,169611,OLFML2A,-1.310841624114758,8.991079963911163,-9.944277833531933,1.2551154169385445e-18,7.60749750442484e-18,31.2512185212126
FLJ90166,ILMN_1689431,"Homo sapiens adenomatosis polyposis coli down-regulated 1-like (APCDD1L), mRNA.",,,,20,56467866-56467915,20q13.32a,-,NM_153360.1,164284,FLJ90166,1.1537262785834992,5.62101906497663,9.94372173601802,1.25954245063962e-18,7.629707948046478e-18,31.247719924489985
MMP1,ILMN_1726448,"Homo sapiens matrix metallopeptidase 1 (interstitial collagenase) (MMP1), mRNA.",extracellular space [goid 5615] [evidence NR ]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],peptidoglycan metabolism [goid 270] [evidence IEA]; collagen catabolism [goid 30574] [evidence IEA],zinc ion binding [goid 8270] [pmid 2167156] [evidence TAS]; interstitial collagenase activity [goid 4232] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],11,102165974-102166023,11q22.2b,-,NM_002421.2,4312,MMP1,1.8109822619637033,6.174530182024854,9.933018902519152,1.3478426437327452e-18,8.149784108735197e-18,31.18039469193411
LOC650611,ILMN_1656509,"PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16), transcript variant 1 (LOC650611), mRNA.",,,,,,,,XM_940706.1,650611,LOC650611,1.4374485169952287,6.590150279679619,9.926942981418645,1.4006863998228431e-18,8.464190120101314e-18,31.1421830389841
SELL,ILMN_1724422,"Homo sapiens selectin L (lymphocyte adhesion molecule 1) (SELL), mRNA.",integral to plasma membrane [goid 5887] [pmid 1692315] [evidence TAS]; plasma membrane [goid 5886] [pmid 10882119] [evidence TAS],cell adhesion [goid 7155] [pmid 10747985] [evidence TAS]; cell motility [goid 6928] [evidence NR ],protein binding [goid 5515] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],1,167926921-167926970,1q24.2c,-,NM_000655.2,6402,SELL,-1.476057330122913,6.937083192734903,-9.923807057391311,1.4287626331313652e-18,8.631244795800831e-18,31.122463502702807
NR4A1,ILMN_1661178,"Homo sapiens nuclear receptor subfamily 4, group A, member 1 (NR4A1), transcript variant 1, mRNA.",nucleus [goid 5634] [evidence IEA],"transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [pmid 2626032] [evidence TAS]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; ligand-dependent nuclear receptor activity [goid 4879] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; steroid hormone receptor activity [goid 3707] [evidence IEA],12,50732595-50732644,12q13.13c,+,NM_002135.3,3164,NR4A1,-1.0839185008075205,5.507806126852954,-9.914556464256377,1.514892150846505e-18,9.140519346844654e-18,31.06430276487312
SOCS3,ILMN_1781001,"Homo sapiens suppressor of cytokine signaling 3 (SOCS3), mRNA.",,anti-apoptosis [goid 6916] [pmid 9266833] [evidence TAS]; JAK-STAT cascade [goid 7259] [pmid 9266833] [evidence TAS]; regulation of cell growth [goid 1558] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA]; negative regulation of signal transduction [goid 9968] [evidence IEA],protein kinase inhibitor activity [goid 4860] [pmid 9266833] [evidence TAS],17,73865148-73865197,17q25.3b,-,NM_003955.3,9021,SOCS3,-1.5987233178271314,7.656825203964534,-9.911342467211087,1.5460116788815264e-18,9.322664759210844e-18,31.04409890521321
LOC644979,ILMN_1699058,"PREDICTED: Homo sapiens hypothetical LOC644979 (LOC644979), mRNA.",,,,19,253478-253527,19p13.3j,-,XM_928051.1,644979,LOC644979,-1.043140232080102,6.490586625637564,-9.906512169159631,1.5939826631040195e-18,9.600362770435045e-18,31.013737871003983
FOS,ILMN_1669523,"Homo sapiens v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS), mRNA.",nucleus [goid 5634] [pmid 9443941] [evidence TAS],DNA methylation [goid 6306] [pmid 9888853] [evidence TAS]; inflammatory response [goid 6954] [pmid 9443941] [evidence TAS]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 10918580] [evidence TAS],protein dimerization activity [goid 46983] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; specific RNA polymerase II transcription factor activity [goid 3704] [pmid 10918580] [evidence TAS]; transcription factor activity [goid 3700] [evidence IEA],14,74818114-74818163,14q24.3b,+,NM_005252.2,2353,FOS,-1.8712137465646688,12.034911850093918,-9.895026989957092,1.7140825777833106e-18,1.030509742075976e-17,30.941562945130464
LRFN4,ILMN_1809417,"Homo sapiens leucine rich repeat and fibronectin type III domain containing 4 (LRFN4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,11,66384318-66384367,11q13.1e,+,NM_024036.3,78999,LRFN4,1.1748034415300737,6.714102310213468,9.889061295282184,1.7799798853423657e-18,1.06980587401412e-17,30.9040821634271
LOC643977,ILMN_1745599,"PREDICTED: Homo sapiens hypothetical protein LOC643977, transcript variant 1 (LOC643977), mRNA.",,,,5,43028024-43028073,,-,XM_932991.1,643977,LOC643977,1.354300303451664,7.095172576666525,9.8886485061725,1.7846318149574278e-18,1.0722796802903367e-17,30.901488946495633
LOC644940,ILMN_1750748,"PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16) (LOC644940), mRNA.",,,,17,20345444-20345493,,-,XM_930405.1,644940,LOC644940,2.571902882364596,8.459257802811168,9.884243245375341,1.8350374643475424e-18,1.1009124313842768e-17,30.873816073635787
PLOD2,ILMN_1771599,"Homo sapiens procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 9054364] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 9054364] [evidence TAS],protein metabolism [goid 19538] [evidence IEA]; protein modification [goid 6464] [pmid 9054364] [evidence TAS]; protein metabolism [goid 19538] [evidence IEA]; protein modification [goid 6464] [pmid 9054364] [evidence TAS],"oxidoreductase activity [goid 16491] [evidence IEA]; procollagen-lysine 5-dioxygenase activity [goid 8475] [pmid 9054364] [evidence TAS]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [goid 16702] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; L-ascorbic acid binding [goid 31418] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]; procollagen-lysine 5-dioxygenase activity [goid 8475] [pmid 9054364] [evidence TAS]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [goid 16702] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; L-ascorbic acid binding [goid 31418] [evidence IEA]",3,147270216-147270265,3q24c,-,NM_182943.2,5352,PLOD2,1.0486025396983454,7.512431397920704,9.882971838974319,1.849847014500358e-18,1.1091321266443859e-17,30.865829987258756
C3AR1,ILMN_1787529,"Homo sapiens complement component 3a receptor 1 (C3AR1), mRNA.",integral to plasma membrane [goid 5887] [pmid 8702752] [evidence TAS]; plasma membrane [goid 5886] [pmid 8702752] [evidence TAS],circulation [goid 8015] [pmid 8765043] [evidence TAS]; chemotaxis [goid 6935] [evidence IEA]; cellular defense response [goid 6968] [evidence NR ]; signal transduction [goid 7165] [evidence IEA]; cell motility [goid 6928] [evidence NR ]; smooth muscle contraction [goid 6939] [evidence NR ]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8898085] [evidence TAS]; inflammatory response [goid 6954] [pmid 8765043] [evidence TAS],complement component C3a receptor activity [goid 4876] [pmid 8765043] [evidence TAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA]; phosphoinositide phospholipase C activity [goid 4435] [pmid 8765043] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; C3a anaphylatoxin receptor activity [goid 4943] [pmid 8702752] [evidence TAS],12,8102341-8102390,12p13.31c,-,NM_004054.2,719,C3AR1,-1.092512446857926,7.291400089217015,-9.861373966354359,2.120409155698333e-18,1.2656666583297208e-17,30.730208957730547
PDIA6,ILMN_1680626,"Homo sapiens protein disulfide isomerase family A, member 6 (PDIA6), mRNA.",endoplasmic reticulum [goid 5783] [pmid 16130169] [evidence TAS]; ER-Golgi intermediate compartment [goid 5793] [pmid 15308636] [evidence IDA],protein folding [goid 6457] [pmid 7590364] [evidence TAS],electron carrier activity [goid 9055] [evidence IEA]; protein disulfide oxidoreductase activity [goid 15035] [evidence IEA]; isomerase activity [goid 16853] [evidence IEA]; protein disulfide isomerase activity [goid 3756] [pmid 7590364] [evidence TAS],2,10844978-10845016:10846274-10846284,2p25.1c,-,NM_005742.2,10130,PDIA6,1.1299931986506024,9.228183989906837,9.859996230534291,2.138948427055502e-18,1.276351927483641e-17,30.721560327401782
TMEM156,ILMN_1810374,"Homo sapiens transmembrane protein 156 (TMEM156), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,4,38645609-38645657:38649047-38649047,4p14c,-,NM_024943.1,80008,TMEM156,1.0174011698215129,6.667737335445439,9.856908190198222,2.1810906717073102e-18,1.3011109767298707e-17,30.70217656537909
LOC441124,ILMN_1778111,"PREDICTED: Homo sapiens hypothetical LOC441124 (LOC441124), mRNA.",,,,1,222205319-222205368,1q42.11a,-,XM_499022.2,441124,LOC441124,1.4243694048488749,8.016023257709355,9.851532654516339,2.256432268135069e-18,1.344451960120502e-17,30.668437971849073
SNCAIP,ILMN_1807969,"Homo sapiens synuclein, alpha interacting protein (synphilin) (SNCAIP), mRNA.",presynaptic membrane [goid 42734] [pmid 11956199] [evidence NAS]; cell soma [goid 43025] [pmid 11956199] [evidence NAS]; cytoplasm [goid 5737] [pmid 14506261] [evidence IDA],dopamine metabolism [goid 42417] [pmid 14506261] [evidence IDA]; regulation of neurotransmitter secretion [goid 46928] [pmid 14506261] [evidence IDA],protein binding [goid 5515] [pmid 12364339] [evidence IPI],5,121827524-121827573,5q23.2a,+,NM_005460.2,9627,SNCAIP,-1.201358780418845,6.939505163860606,-9.850190986136909,2.2756373563621925e-18,1.3542817437862804e-17,30.660017997614247
GATA5,ILMN_1760153,"Homo sapiens GATA binding protein 5 (GATA5), mRNA.",nucleus [goid 5634] [evidence IEA],"metabolism [goid 8152] [evidence IEA]; transcription [goid 6350] [evidence IEA]; positive regulation of transcription [goid 45941] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcriptional activator activity [goid 16563] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],20,60472061-60472110,20q13.33c,-,NM_080473.3,140628,GATA5,-1.0717067256335575,5.957720922813926,-9.843574270594717,2.3727588982246933e-18,1.409983963043649e-17,30.618497650473927
MSX1,ILMN_1777397,"Homo sapiens msh homeo box homolog 1 (Drosophila) (MSX1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; skeletal development [goid 1501] [pmid 8696335] [evidence TAS]; development [goid 7275] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],4,4916048-4916097,4p16.2a,+,NM_002448.1,4487,MSX1,-1.3567197909545037,7.467984227336474,-9.840325927266644,2.421938665591809e-18,1.4379272647228757e-17,30.59811681451503
BPNT1,ILMN_1712718,"Homo sapiens 3'(2'), 5'-bisphosphate nucleotidase 1 (BPNT1), mRNA.",,"nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 10224133] [evidence TAS]","magnesium ion binding [goid 287] [evidence IEA]; inositol or phosphatidylinositol phosphatase activity [goid 4437] [evidence IEA]; 3'(2'),5'-bisphosphate nucleotidase activity [goid 8441] [pmid 10224133] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]",1,218298840-218298889,1q41d,-,NM_006085.3,10380,BPNT1,1.0991311727890007,9.294976931437633,9.836942731318443,2.4742396217633692e-18,1.46810754306766e-17,30.576891806877633
MT2A,ILMN_1686664,"Homo sapiens metallothionein 2A (MT2A), mRNA.",,copper ion homeostasis [goid 6878] [pmid 6719135] [evidence TAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; copper ion binding [goid 5507] [evidence NR ],16,55200021-55200068:55200069-55200070,16q13b,+,NM_005953.2,4502,MT2A,-1.4083968900470811,12.77963040026606,-9.820830892267596,2.7391662815596115e-18,1.6192137671767222e-17,30.475838693228837
CTSW,ILMN_1794364,"Homo sapiens cathepsin W (lymphopain) (CTSW), mRNA.",,immune response [goid 6955] [pmid 9823953] [evidence TAS],cysteine-type endopeptidase activity [goid 4197] [evidence IEA],11,65407706-65407755,11q13.1d,+,NM_001335.2,1521,CTSW,-1.1005478051305735,7.326792290582108,-9.81791213193172,2.7900970680437904e-18,1.6486787400301287e-17,30.457537083998965
C6orf72,ILMN_2220403,"Homo sapiens chromosome 6 open reading frame 72 (C6orf72), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,6,149942706-149942755,6q25.1a,+,NM_138785.1,116254,C6orf72,-1.2378051286072118,7.286454292797226,-9.8151548311180985,2.8390764122684122e-18,1.6768455011370768e-17,30.440249235170242
LRP5L,ILMN_1718633,"Homo sapiens low density lipoprotein receptor-related protein 5-like (LRP5L), mRNA.",,,,22,24077507-24077556,22q11.23c,-,NM_182492.1,91355,LRP5L,1.0828188774882301,8.222226879195563,9.803790642880987,3.050146229910728e-18,1.7986243963470043e-17,30.369011462094868
LOC112714,ILMN_1652464,"Homo sapiens tubulin, alpha 3e (TUBA3E), mRNA.",microtubule [goid 5874] [evidence IEA]; protein complex [goid 43234] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; protein polymerization [goid 51258] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; GTPase activity [goid 3924] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],2,130667866-130667915,2q21.1b,-,NM_207312.1,112714,LOC112714,-1.185149291914522,6.218218629778726,-9.803169536772856,3.0621223453480487e-18,1.8046227948666794e-17,30.36511863150892
SNX10,ILMN_2170949,"Homo sapiens sorting nexin 10 (SNX10), mRNA.",,protein transport [goid 15031] [evidence IEA]; intracellular signaling cascade [goid 7242] [evidence IEA],phosphoinositide binding [goid 35091] [evidence IEA]; protein binding [goid 5515] [evidence IEA],7,26379889-26379938,7p15.2b,+,NM_013322.2,29887,SNX10,-1.4550090780876186,7.7078348444104154,-9.801121928555311,3.101936808166084e-18,1.826472974037287e-17,30.35228556471202
IRF1,ILMN_1708375,"Homo sapiens interferon regulatory factor 1 (IRF1), mRNA.",nucleus [goid 5634] [evidence IEA],"immune response [goid 6955] [evidence IEA]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 2475256] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; cell cycle [goid 7049] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],5,131846773-131846822,5q31.1b,-,NM_002198.1,3659,IRF1,-1.1478661663733387,10.698031414641786,-9.797674643195739,3.1701350760274975e-18,1.864434526783015e-17,30.33068189049117
HIST2H2AC,ILMN_1768973,"Homo sapiens histone cluster 2, H2ac (HIST2H2AC), mRNA.",chromosome [goid 5694] [evidence IEA]; nucleus [goid 5634] [evidence IEA]; nucleosome [goid 786] [evidence NAS],nucleosome assembly [goid 6334] [evidence NAS]; chromosome organization and biogenesis (sensu Eukaryota) [goid 7001] [evidence NAS],DNA binding [goid 3677] [evidence NAS],1,148125457-148125506,1q21.2a,+,NM_003517.2,8338,HIST2H2AC,1.2431767260233908,10.115259775593167,9.796374297624869,3.1962461261641515e-18,1.8792386862266338e-17,30.32253333837763
HSD3B7,ILMN_1653042,"Homo sapiens hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 (HSD3B7), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],steroid biosynthesis [goid 6694] [evidence IEA]; bile acid biosynthesis [goid 6699] [pmid 11067870] [evidence TAS]; C21-steroid hormone biosynthesis [goid 6700] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA]; steroid delta-isomerase activity [goid 4769] [evidence IEA]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [goid 3854] [pmid 11067870] [evidence NAS],16,30907561-30907610,16p11.2c,+,NM_025193.2,80270,HSD3B7,1.0835843201799467,8.295374270414039,9.794641923342656,3.231365374380079e-18,1.8983993926017694e-17,30.311677958426976
ACP5,ILMN_2078599,"Homo sapiens acid phosphatase 5, tartrate resistant (ACP5), mRNA.",lysosome [goid 5764] [evidence IEA]; integral to membrane [goid 16021] [pmid 2338077] [evidence TAS],,metal ion binding [goid 46872] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; acid phosphatase activity [goid 3993] [pmid 8359686] [evidence TAS],19,11546718-11546767,19p13.2a,-,NM_001611.2,54,ACP5,-1.5914413921574866,8.889560204938844,-9.784701334518655,3.4404419435007398e-18,2.0174783823435756e-17,30.24939853351986
FLJ90805,ILMN_1789112,"Homo sapiens hypothetical protein FLJ90805 (FLJ90805), mRNA.",,,,19,47520974-47521023,19q13.2c,+,NM_173633.1,284339,FLJ90805,1.2042423166154377,5.995582475691644,9.779231398336517,3.561179444097235e-18,2.086444460248828e-17,30.215135878981258
LOC644591,ILMN_1710362,"PREDICTED: Homo sapiens similar to peptidylprolyl isomerase A (cyclophilin A)-like 4 (LOC644591), mRNA.",,,,1,142556030-142556079,1q21.1a,-,XM_927706.1,644591,LOC644591,1.0569856667746373,6.423560718129371,9.779105484085704,3.564007862182645e-18,2.0874903192784065e-17,30.21434723767962
RAXL1,ILMN_1653412,"Homo sapiens retina and anterior neural fold homeobox like 1 (RAXL1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],19,3720269-3720318,19p13.3e,-,NM_032753.2,84839,RAXL1,1.5223121995267928,9.797925179359364,9.763229116404297,3.939166396338739e-18,2.3011632484071677e-17,30.114930865478954
CEACAM5,ILMN_1670959,"Homo sapiens carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5), mRNA.",membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 3814146] [evidence TAS],,,19,46916801-46916850,19q13.2c,+,NM_004363.1,1048,CEACAM5,3.088117317573058,7.926660047890573,9.744042148017533,4.44538369282679e-18,2.5923415017801927e-17,29.9948434366636
SLC27A3,ILMN_1719627,"Homo sapiens solute carrier family 27 (fatty acid transporter), member 3 (SLC27A3), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; mitochondrion [goid 5739] [evidence IEA],metabolism [goid 8152] [evidence IEA]; lipid metabolism [goid 6629] [evidence IEA]; fatty acid metabolism [goid 6631] [evidence IEA],ligase activity [goid 16874] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],1,152019144-152019193,1q21.3d,+,NM_024330.1,11000,SLC27A3,-1.0197517381104522,9.934942608375003,-9.74263016047281,4.485099487885168e-18,2.6139781693447838e-17,29.986008677566026
FLJ35773,ILMN_1670611,"Homo sapiens hypothetical protein FLJ35773 (FLJ35773), mRNA.",,,,17,8641427-8641476,17p13.1c,-,NM_152599.2,162387,FLJ35773,1.1544106337572275,6.027521743693841,9.737739239273322,4.6254206654907876e-18,2.6918387630930683e-17,29.955409101997198
COL22A1,ILMN_1784532,"Homo sapiens collagen, type XXII, alpha 1 (COL22A1), mRNA.",cytoplasm [goid 5737] [evidence IEA],phosphate transport [goid 6817] [evidence IEA],,8,139669749-139669798,8q24.23c,-,NM_152888.1,169044,COL22A1,1.06280763370762,5.647949263465837,9.727184599242712,4.943306839336719e-18,2.8718258780908557e-17,29.889389624064094
FLJ90231,ILMN_1789048,"Homo sapiens hypothetical protein FLJ90231 (FLJ90231), mRNA.",beta-galactosidase complex [goid 9341] [evidence IEA],carbohydrate metabolism [goid 5975] [evidence IEA],beta-galactosidase activity [goid 4565] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],11,133694344-133694393,,+,NM_173581.1,283176,FLJ90231,1.22069807100711,5.377773978620714,9.706773376152256,5.6210547135289984e-18,3.2495250710282633e-17,29.761773941108196
C11orf9,ILMN_1811437,"Homo sapiens chromosome 11 open reading frame 9 (C11orf9), mRNA.",,,,11,61312296-61312345,11q12.2b,+,NM_013279.1,745,C11orf9,-1.508039348059997,6.866121089309752,-9.706175285484473,5.64225109276625e-18,3.260836506761038e-17,29.758035676442127
RAPGEFL1,ILMN_1758613,"Homo sapiens Rap guanine nucleotide exchange factor (GEF)-like 1 (RAPGEFL1), mRNA.",membrane fraction [goid 5624] [pmid 9582122] [evidence TAS],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9582122] [evidence TAS]; small GTPase mediated signal transduction [goid 7264] [evidence IEA],guanyl-nucleotide exchange factor activity [goid 5085] [pmid 9582122] [evidence TAS],17,35605294-35605343,17q21.1d-q21.2a,+,NM_016339.1,51195,RAPGEFL1,1.2903931063818357,7.5161111211715985,9.705872324800147,5.653018390409014e-18,3.266115852015696e-17,29.756142096632836
SCGB3A2,ILMN_1670306,"Homo sapiens secretoglobin, family 3A, member 2 (SCGB3A2), mRNA.",,,,5,147241328-147241377,5q33.1a,+,NM_054023.2,117156,SCGB3A2,-2.3895564856580336,11.531140232195996,-9.704091468702703,5.716725316141912e-18,3.2991127812335555e-17,29.745011638748743
MFSD2,ILMN_1789638,"Homo sapiens major facilitator superfamily domain containing 2 (MFSD2), mRNA.",,,sugar porter activity [goid 5351] [evidence IEA],1,40207775-40207824,1p34.2d,+,NM_032793.2,84879,MFSD2,-1.3242411874245814,7.643678092302039,-9.695125832125235,6.048477360243369e-18,3.4845359926216335e-17,29.688984625596675
S100A12,ILMN_1748915,"Homo sapiens S100 calcium binding protein A12 (S100A12), mRNA.",insoluble fraction [goid 5626] [pmid 7626002] [evidence TAS]; cytosol [goid 5829] [pmid 7626002] [evidence TAS],xenobiotic metabolism [goid 6805] [pmid 11522286] [evidence IDA]; inflammatory response [goid 6954] [pmid 8619876] [evidence TAS],zinc ion binding [goid 8270] [pmid 11522286] [evidence TAS]; calcium ion binding [goid 5509] [pmid 7626002] [evidence TAS],1,151612983-151613032,1q21.3c,-,NM_005621.1,6283,S100A12,-1.482863243139449,5.562117368049192,-9.686597461844826,6.3818177311714175e-18,3.6734007239723166e-17,29.635703719779393
KCNMB1,ILMN_1652065,"Homo sapiens potassium large conductance calcium-activated channel, subfamily M, beta member 1 (KCNMB1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 8799178] [evidence TAS]; synaptic transmission [goid 7268] [pmid 8799178] [evidence TAS]; smooth muscle contraction [goid 6939] [evidence NR ],ion channel activity [goid 5216] [evidence IEA]; calcium-activated potassium channel activity [goid 15269] [pmid 8612769] [evidence TAS]; potassium channel regulator activity [goid 15459] [pmid 8612769] [evidence TAS],5,169737910-169737959,5q35.1c,-,NM_004137.2,3779,KCNMB1,-1.020642365892737,8.525317758627178,-9.685506839217505,6.425744239941654e-18,3.6965581009992127e-17,29.628891024377623
MGC34647,ILMN_1713686,"Homo sapiens chromosome 16 open reading frame 77 (C16orf77), mRNA.",,,,16,69251743-69251792,16q22.1f,+,NM_152456.1,146433,MGC34647,-1.0145617028090363,6.080679194518683,-9.684421224809451,6.469767984533517e-18,3.7208139647757003e-17,29.62210982949697
ADH5,ILMN_1738604,"Homo sapiens alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5), mRNA.",,ethanol oxidation [goid 6069] [pmid 8460164] [evidence TAS],metal ion binding [goid 46872] [evidence IEA]; formaldehyde dehydrogenase (glutathione) activity [goid 4327] [pmid 8460164] [evidence TAS]; fatty acid binding [goid 5504] [pmid 8460164] [evidence TAS]; electron transporter activity [goid 5489] [pmid 8460164] [evidence TAS]; alcohol dehydrogenase activity [goid 4022] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA],4,100212201-100212250,4q23a,-,NM_000671.3,128,ADH5,-1.1411733688972827,6.10414992470318,-9.67827670914735,6.724659614139904e-18,3.862962663213069e-17,29.583732721659125
BCL6B,ILMN_1651285,"Homo sapiens B-cell CLL/lymphoma 6, member B (zinc finger protein) (BCL6B), mRNA.",nucleus [goid 5634] [evidence IEA],,metal ion binding [goid 46872] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; protein binding [goid 5515] [evidence IEA],17,6873650-6873685,17p13.1d,+,NM_181844.2,255877,BCL6B,-1.1421532659224978,6.806591958144153,-9.676885054144444,6.783764029794873e-18,3.894678642988115e-17,29.5750417542436
CYP24A1,ILMN_1685663,"Homo sapiens cytochrome P450, family 24, subfamily A, polypeptide 1 (CYP24A1), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [evidence IEA],electron transport [goid 6118] [pmid 7632726] [evidence NAS],electron transporter activity [goid 5489] [pmid 8506296] [evidence TAS]; metal ion binding [goid 46872] [evidence IEA]; heme binding [goid 20037] [evidence IEA]; oxygen binding [goid 19825] [pmid 8506296] [evidence TAS]; monooxygenase activity [goid 4497] [pmid 8506296] [evidence TAS]; iron ion binding [goid 5506] [evidence IEA],20,52203887-52203936,20q13.2c,-,NM_000782.3,1591,CYP24A1,1.906489259128839,5.7537553191825355,9.67510755971381,6.860008033577139e-18,3.9361927369031086e-17,29.563941714049193
TNNI3,ILMN_1768637,"Homo sapiens troponin I type 3 (cardiac) (TNNI3), mRNA.",troponin complex [goid 5861] [pmid 12809519] [evidence TAS],negative regulation of angiogenesis [goid 16525] [pmid 12809519] [evidence TAS]; regulation of muscle contraction [goid 6937] [pmid 12809519] [evidence TAS],protein binding [goid 5515] [pmid 12809519] [evidence IPI]; actin binding [goid 3779] [pmid 12809519] [evidence TAS]; calcium channel inhibitor activity [goid 19855] [pmid 12809519] [evidence IPI],19,60355059-60355097:60357210-60357220,19q13.42b,-,NM_000363.3,7137,TNNI3,1.1808253137255669,5.765716530437465,9.671812936799137,7.00359114605001e-18,4.015124689116579e-17,29.54336909407698
ENTPD4,ILMN_1806304,"Homo sapiens ectonucleoside triphosphate diphosphohydrolase 4 (ENTPD4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to Golgi membrane [goid 30173] [pmid 9556635] [evidence IDA]; integral to membrane [goid 16021] [evidence IEA]; lysosome [goid 5764] [evidence IEA]; vacuole [goid 5773] [evidence IEA],UDP catabolism [goid 6256] [pmid 9556635] [evidence IDA],calcium ion binding [goid 5509] [evidence IEA]; uridine-diphosphatase activity [goid 45134] [pmid 9556635] [evidence IDA]; magnesium ion binding [goid 287] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA],8,23346502-23346551,8p21.3a,-,NM_004901.1,9583,ENTPD4,1.007230776003845,7.749628833336647,9.667561501057403,7.193303285532539e-18,4.1179860411140214e-17,29.516824797636453
CITED2,ILMN_1663092,"Homo sapiens Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 (CITED2), mRNA.",nucleus [goid 5634] [pmid 10552932] [evidence NAS],"positive regulation of transcription, DNA-dependent [goid 45893] [evidence ISS]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 9434189] [evidence TAS]; heart development [goid 7507] [pmid 16287139] [evidence IMP]; positive regulation of transforming growth factor beta receptor signaling pathway [goid 30511] [evidence ISS]; determination of left/right symmetry [goid 7368] [evidence ISS]; positive regulation of progression through cell cycle [goid 45787] [evidence ISS]",transcription factor activity [goid 3700] [evidence ISS]; protein binding [goid 5515] [pmid 10552932] [evidence NAS],6,139735356-139735405,6q24.1a,-,NM_006079.3,10370,CITED2,-1.0529811192826166,10.876444143836675,-9.667220128893288,7.208756435394281e-18,4.1244979188168146e-17,29.514693548207823
MGC5457,ILMN_1733412,"PREDICTED: Homo sapiens hypothetical protein MGC5457 (MGC5457), misc RNA.",,,,,,,,XR_001379.1,84719,MGC5457,1.1996726542300822,6.354908429023588,9.667208219078326,7.209296162178123e-18,4.1244979188168146e-17,29.51461919342257
TXNL6,ILMN_1742917,"Homo sapiens thioredoxin-like 6 (TXNL6), mRNA.",,electron transport [goid 6118] [evidence IEA],electron carrier activity [goid 9055] [evidence IEA]; protein disulfide oxidoreductase activity [goid 15035] [evidence IEA],19,17427256-17427305,19p13.11d,-,NM_138454.1,115861,TXNL6,1.140267880694318,5.9729693364128025,9.667173660371317,7.210862515004607e-18,4.1244979188168146e-17,29.51440343830931
HLA-DPB1,ILMN_1749070,"Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [evidence IEA]; pathogenesis [goid 9405] [pmid 8105536] [evidence TAS],MHC class II receptor activity [goid 45012] [pmid 8105536] [evidence TAS],6,33162730-33162779,6p21.32a,+,NM_002121.4,3115,HLA-DPB1,-1.224486861215837,8.781313991593684,-9.665778971607999,7.27435951003071e-18,4.159628038773776e-17,29.505696374075114
ARRDC4,ILMN_1660544,"Homo sapiens arrestin domain containing 4 (ARRDC4), mRNA.",,,,15,96317363-96317412,15q26.3a,+,NM_183376.1,91947,ARRDC4,-1.1001168436126232,6.649774915370145,-9.660523482631385,7.518671260241554e-18,4.295387344945567e-17,29.472889497156324
FLJ38717,ILMN_1771320,"Homo sapiens FLJ38717 protein (FLJ38717), mRNA.",,,,6,42861220-42861269,6p21.1e,+,NM_001004322.1,401261,FLJ38717,1.541927637702222,8.276388326119655,9.657489203717677,7.663427685382612e-18,4.373355993415154e-17,29.45395063112648
LOC642817,ILMN_1695034,"PREDICTED: Homo sapiens similar to Heterogeneous nuclear ribonucleoprotein A1 (Helix-destabilizing protein) (Single-strand binding protein) (hnRNP core protein A1) (HDP-1) (Topoisomerase-inhibitor suppressed) (LOC642817), mRNA.",,,,6,5555355-5555404,6p25.1b,-,XM_926703.1,642817,LOC642817,-1.1890908120968362,11.328970296319744,-9.654923846830544,7.787975545854755e-18,4.4431655181483306e-17,29.4379399350602
FLJ25778,ILMN_1685855,"PREDICTED: Homo sapiens hypothetical protein FLJ25778 (FLJ25778), mRNA.",,,,,,7q34b,,XM_939098.1,254048,FLJ25778,1.1729067120746226,7.488654962165037,9.649644384034376,8.050669794322056e-18,4.5891111465753755e-17,29.40499402037333
MAOA,ILMN_1663640,"Homo sapiens monoamine oxidase A (MAOA), nuclear gene encoding mitochondrial protein, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence NR ]; mitochondrion [goid 5739] [evidence IEA],catecholamine metabolism [goid 6584] [evidence IEA]; electron transport [goid 6118] [evidence IEA]; behavior [goid 7610] [pmid 8211186] [evidence TAS]; neurotransmitter catabolism [goid 42135] [evidence IEA],amine oxidase activity [goid 8131] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA],X,43490870-43490919,Xp11.3c,+,NM_000240.2,4128,MAOA,-1.0052600149396227,12.131233666510907,-9.616714998233785,9.900268284178531e-18,5.616233848308592e-17,29.199618992500902
UGT8,ILMN_1758816,"Homo sapiens UDP glycosyltransferase 8 (UDP-galactose ceramide galactosyltransferase) (UGT8), mRNA.",microsome [goid 5792] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; endoplasmic reticulum [goid 5783] [evidence IEA],metabolism [goid 8152] [evidence IEA]; peripheral nervous system development [goid 7422] [pmid 8661025] [evidence TAS]; glycosphingolipid biosynthesis [goid 6688] [evidence NR ]; central nervous system development [goid 7417] [pmid 8661025] [evidence TAS],"2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity [goid 3851] [evidence IEA]; transferase activity, transferring hexosyl groups [goid 16758] [evidence IEA]",4,115816633-115816682,4q26b,+,NM_003360.2,7368,UGT8,1.0250054291006059,5.746438287469716,9.608857369209643,1.0400790772478177e-17,5.883489447999531e-17,29.15064233218866
C9orf9,ILMN_1813837,"Homo sapiens chromosome 9 open reading frame 9 (C9orf9), mRNA.",,,,9,134753552-134753601,9q34.13b,+,NM_018956.3,11092,C9orf9,-1.2615626035133731,7.301683055770255,-9.601448927998367,1.0895744989288225e-17,6.159990555119491e-17,29.104476135082514
LOC653383,ILMN_1806631,"PREDICTED: Homo sapiens similar to CG33932-PA, isoform A (LOC653383), mRNA.",,,,9,13192-13241,,-,XM_927177.1,653383,LOC653383,-1.0551934981205138,6.546818839740462,-9.594423830898014,1.138672483965956e-17,6.426673923608138e-17,29.060708369153772
HLA-DRB3,ILMN_1717261,"Homo sapiens major histocompatibility complex, class II, DR beta 3 (HLA-DRB3), mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [evidence NAS]; signal transduction [goid 7165] [pmid 8775462] [evidence NAS],MHC class II receptor activity [goid 45012] [evidence NAS],,,,,NM_022555.3,3125,HLA-DRB3,-1.4612094378968656,11.85533593140287,-9.580741689401664,1.2407055717998316e-17,6.98088781793336e-17,28.9754927952169
MAP3K13,ILMN_1673896,"Homo sapiens mitogen-activated protein kinase kinase kinase 13 (MAP3K13), mRNA.",membrane fraction [goid 5624] [pmid 9353328] [evidence IDA]; membrane [goid 16020] [evidence IEA]; IkappaB kinase complex [goid 8385] [pmid 12492477] [evidence IPI],JNK cascade [goid 7254] [pmid 11726277] [evidence IPI]; activation of MAPKK activity [goid 186] [pmid 11726277] [evidence IDA]; activation of NF-kappaB transcription factor [goid 51092] [pmid 12492477] [evidence IDA],transferase activity [goid 16740] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; protein homodimerization activity [goid 42803] [pmid 11163770] [evidence IDA]; protein kinase binding [goid 19901] [pmid 9353328] [evidence ISS]; ATP binding [goid 5524] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [pmid 9353328] [evidence IDA]; protein binding [goid 5515] [pmid 12492477] [evidence IPI]; MAP kinase kinase kinase activity [goid 4709] [pmid 11726277] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [evidence IEA],3,186683021-186683070,3q27.2a,+,NM_004721.3,9175,MAP3K13,1.0888556035118837,6.779920707697443,9.569070595762161,1.3349008853453483e-17,7.500336117379873e-17,28.902830729617868
FLJ10246,ILMN_1712211,"PREDICTED: Homo sapiens FLJ10246 (FLJ10246), misc RNA.",,,,,,,,XR_001525.1,55104,FLJ10246,1.217816048582697,6.191239986462063,9.56374667694725,1.3802013794677113e-17,7.749783627173842e-17,28.869693666111715
CD47,ILMN_1771333,"Homo sapiens CD47 antigen (Rh-related antigen, integrin-associated signal transducer) (CD47), transcript variant 4, mRNA.",integral to plasma membrane [goid 5887] [pmid 7998989] [evidence TAS]; plasma membrane [goid 5886] [pmid 10429193] [evidence TAS],cell-matrix adhesion [goid 7160] [evidence NR ]; cell adhesion [goid 7155] [evidence IEA]; integrin-mediated signaling pathway [goid 7229] [pmid 8294396] [evidence TAS],protein binding [goid 5515] [evidence IEA],3,109245076-109245125,3q13.12b,-,NM_001025080.1,961,CD47,-1.0414815342774748,9.14381263967641,-9.560745013969495,1.4064133350563885e-17,7.886636212950735e-17,28.851013156499434
LOC440928,ILMN_1713764,"PREDICTED: Homo sapiens hypothetical LOC440928 (LOC440928), mRNA.",,,,,,,,XM_942885.1,440928,LOC440928,1.0324646834080777,5.578708458184557,9.54602986094665,1.5422589340414266e-17,8.626647121135271e-17,28.759460187169473
CCL4L1,ILMN_1716276,"Homo sapiens chemokine (C-C motif) ligand 4-like 1 (CCL4L1), mRNA.",,,,17,31563350-31563399,17q12b,+,NM_001001435.2,9560,CCL4L1,-1.5480324758261181,8.178190104751376,-9.540437094730017,1.5972481121511507e-17,8.92175885759917e-17,28.724674763951263
LOC442609,ILMN_1699383,"PREDICTED: Homo sapiens similar to Williams Beuren syndrome chromosome region 19, transcript variant 8 (LOC442609), mRNA.",,,,,,7q22.1f,,XM_935827.1,442609,LOC442609,1.8237223227918493,8.497564153330396,9.539490711579822,1.6067442997026337e-17,8.972296943469243e-17,28.718789128354715
COL17A1,ILMN_1651282,"Homo sapiens collagen, type XVII, alpha 1 (COL17A1), transcript variant short, mRNA.",intercellular junction [goid 5911] [pmid 9012408] [evidence TAS]; microsome [goid 5792] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; membrane [goid 16020] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 9012408] [evidence TAS],electron transport [goid 6118] [evidence IEA]; cell-matrix adhesion [goid 7160] [pmid 9012408] [evidence TAS]; epidermis development [goid 8544] [pmid 9012408] [evidence TAS]; phosphate transport [goid 6817] [evidence IEA],monooxygenase activity [goid 4497] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; heme binding [goid 20037] [evidence IEA],10,105781170-105781219,10q25.1a,-,NM_130778.1,1308,COL17A1,1.6789402969922493,6.656506604334619,9.507888488544252,1.9582637789429158e-17,1.0886618974462312e-16,28.522352466634388
CCL5,ILMN_1773352,"Homo sapiens chemokine (C-C motif) ligand 5 (CCL5), mRNA.",extracellular space [goid 5615] [evidence IEA]; extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],exocytosis [goid 6887] [pmid 10734056] [evidence TAS]; inflammatory response [goid 6954] [pmid 10415069] [evidence TAS]; signal transduction [goid 7165] [pmid 10770925] [evidence TAS]; cellular defense response [goid 6968] [pmid 10640778] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 10713092] [evidence TAS]; chemotaxis [goid 6935] [pmid 10713092] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 10734056] [evidence TAS]; response to virus [goid 9615] [pmid 10640778] [evidence TAS]; cell adhesion [goid 7155] [pmid 10910894] [evidence TAS]; response to oxidative stress [goid 6979] [pmid 10713092] [evidence TAS]; cell motility [goid 6928] [pmid 9558100] [evidence TAS]; exocytosis [goid 6887] [pmid 10734056] [evidence TAS]; inflammatory response [goid 6954] [pmid 10415069] [evidence TAS]; signal transduction [goid 7165] [pmid 10770925] [evidence TAS]; cellular defense response [goid 6968] [pmid 10640778] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 10713092] [evidence TAS]; chemotaxis [goid 6935] [pmid 10713092] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 10734056] [evidence TAS]; response to virus [goid 9615] [pmid 10640778] [evidence TAS]; cell adhesion [goid 7155] [pmid 10910894] [evidence TAS]; response to oxidative stress [goid 6979] [pmid 10713092] [evidence TAS]; cell motility [goid 6928] [pmid 9558100] [evidence TAS],chemokine activity [goid 8009] [pmid 10770925] [evidence TAS]; signal transducer activity [goid 4871] [pmid 10770925] [evidence TAS]; chemoattractant activity [goid 42056] [pmid 15001559] [evidence IDA]; chemokine activity [goid 8009] [pmid 10770925] [evidence TAS]; signal transducer activity [goid 4871] [pmid 10770925] [evidence TAS]; chemoattractant activity [goid 42056] [pmid 15001559] [evidence IDA],17,31223411-31223460,17q12b,-,NM_002985.2,6352,CCL5,-1.144593140998646,11.208987146853515,-9.502991851377653,2.0191922348315844e-17,1.121599062590515e-16,28.491932891799884
OLFML3,ILMN_1727532,"Homo sapiens olfactomedin-like 3 (OLFML3), mRNA.",,,,1,114326107-114326156,1p13.2b,+,NM_020190.2,56944,OLFML3,-1.0652406010853248,9.475501811080596,-9.482074898776828,2.3014263975402742e-17,1.2753660542633035e-16,28.36204292306312
KIAA1875,ILMN_1789500,"Homo sapiens KIAA1875 (KIAA1875), mRNA.",,,,8,145243215-145243264,8q24.3g,+,NM_032529.1,340390,KIAA1875,1.097145748485171,6.533703616550699,9.479017182844059,2.3458497132271182e-17,1.2987205606598834e-16,28.34306239402259
LOC647436,ILMN_1772998,"PREDICTED: Homo sapiens similar to ribosomal protein L5, transcript variant 1 (LOC647436), mRNA.",,,,,,,,XM_937113.1,647436,LOC647436,-1.3181422386243904,6.9424884517472885,-9.45776304096277,2.679130091144023e-17,1.4791400348678149e-16,28.21118045132539
NOV,ILMN_1787186,"Homo sapiens nephroblastoma overexpressed gene (NOV), mRNA.",extracellular region [goid 5576] [evidence IEA],regulation of cell growth [goid 1558] [evidence IEA],growth factor activity [goid 8083] [evidence IEA]; insulin-like growth factor binding [goid 5520] [evidence IEA],8,120505381-120505430,8q24.12b,+,NM_002514.2,4856,NOV,-1.4693085222513949,7.264089324194216,-9.457307659346341,2.68676396442896e-17,1.4821277474578061e-16,28.20835579620379
CXCL13,ILMN_1718552,"Homo sapiens chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) (CXCL13), mRNA.",extracellular space [goid 5615] [evidence IEA]; soluble fraction [goid 5625] [pmid 9486651] [evidence TAS],sensory perception [goid 7600] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 9486651] [evidence TAS]; chemotaxis [goid 6935] [pmid 9486651] [evidence TAS]; inflammatory response [goid 6954] [evidence IEA],chemokine activity [goid 8009] [pmid 9486651] [evidence TAS],4,78751655-78751704,4q21.1c,+,NM_006419.1,10563,CXCL13,1.8217783512053058,6.630738571631019,9.456178874358493,2.705780016613283e-17,1.4917951659520132e-16,28.20135431307309
SLC44A4,ILMN_1719250,"Homo sapiens solute carrier family 44, member 4 (SLC44A4), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,6,31939298-31939347,6p21.32b,-,NM_032794.1,80736,SLC44A4,1.108959952967119,11.018223286010178,9.45563469976459,2.7149952319052935e-17,1.4956394438315284e-16,28.197979067755156
MUC16,ILMN_2125346,"Homo sapiens mucin 16, cell surface associated (MUC16), mRNA.",extrinsic to membrane [goid 19898] [pmid 12766047] [evidence IDA],cell adhesion [goid 7155] [pmid 14676194] [evidence NAS],protein binding [goid 5515] [pmid 14676194] [evidence IPI],19,8820577-8820607:8820608-8820626,19p13.2d,-,NM_024690.2,94025,MUC16,2.365241468630021,7.033226477529936,9.450369995431588,2.8057778595189843e-17,1.543949488813417e-16,28.16532778376442
FLJ21106,ILMN_1761963,"Homo sapiens hypothetical protein FLJ21106 (FLJ21106), mRNA.",,,,4,129171495-129171544,4q28.2a,+,NM_025097.1,80167,FLJ21106,1.075668504495379,6.850187242716883,9.449076252915987,2.82854518624306e-17,1.5556221024285633e-16,28.15730494594775
RICS,ILMN_1722726,"Homo sapiens Rho GTPase-activating protein (RICS), mRNA.",intracellular [goid 5622] [evidence IEA],signal transduction [goid 7165] [evidence IEA],GTPase activator activity [goid 5096] [evidence IEA],11,128343563-128343612,11q24.3a-q24.3b,-,NM_014715.2,9743,RICS,1.0057980314466217,8.474477744763398,9.443945966734614,2.920652495265677e-17,1.6053960199251559e-16,28.12549400532388
DNHD3,ILMN_1714296,"Homo sapiens dynein, axonemal, heavy chain 2 (DNAH2), mRNA.",dynein complex [goid 30286] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; transport [goid 6810] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; ATPase activity [goid 16887] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],17,7677666-7677715,17p13.1d,+,NM_020877.2,146754,DNHD3,2.075171076569829,7.864246903561599,9.431347973065334,3.159692646333136e-17,1.7329805501050818e-16,28.047401183490898
TNFSF13B,ILMN_1758418,"Homo sapiens tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B), mRNA.",integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; soluble fraction [goid 5625] [pmid 10908663] [evidence TAS],immune response [goid 6955] [evidence IEA]; cell proliferation [goid 8283] [pmid 10908663] [evidence TAS]; signal transduction [goid 7165] [pmid 10908663] [evidence TAS]; positive regulation of cell proliferation [goid 8284] [pmid 10359578] [evidence TAS],tumor necrosis factor receptor binding [goid 5164] [evidence IEA],13,107720716-107720765,13q33.3b,+,NM_006573.3,10673,TNFSF13B,-1.0286743557840197,8.777221460876092,-9.42376185094159,3.312924733548149e-17,1.8150328058278028e-16,28.00039158738916
KCNJ2,ILMN_1780334,"Homo sapiens potassium inwardly-rectifying channel, subfamily J, member 2 (KCNJ2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [evidence IEA],potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [evidence IEA]; inward rectifier potassium channel activity [goid 5242] [evidence IEA]; protein binding [goid 5515] [pmid 11287423] [evidence IPI]; voltage-gated ion channel activity [goid 5244] [evidence IEA],17,65687523-65687572,17q24.3a,+,NM_000891.2,3759,KCNJ2,-1.0900115906836856,7.465292510790822,-9.42047322570882,3.381628315887817e-17,1.8521658730983697e-16,27.98001629942347
ST6GALNAC2,ILMN_1658706,"Homo sapiens ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (ST6GALNAC2), mRNA.",integral to Golgi membrane [goid 30173] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],protein amino acid glycosylation [goid 6486] [evidence IEA],sialyltransferase activity [goid 8373] [evidence IEA],17,72073145-72073194,17q25.1d,-,NM_006456.1,10610,ST6GALNAC2,-1.143396055835658,7.1586323103817655,-9.415668495656636,3.484561854657707e-17,1.9048938138795464e-16,27.950251655284987
NES,ILMN_1738147,"Homo sapiens nestin (NES), mRNA.",intermediate filament [goid 5882] [pmid 9917366] [evidence NAS],central nervous system development [goid 7417] [pmid 9917366] [evidence NAS],structural molecule activity [goid 5198] [evidence IEA],1,154905342-154905391,1q23.1a,-,NM_006617.1,10763,NES,-1.1721832219382549,8.867164517065744,-9.398393460175386,3.8810829816561546e-17,2.1170313058063342e-16,27.8432740747916
PCP4,ILMN_1682326,"Homo sapiens Purkinje cell protein 4 (PCP4), mRNA.",,central nervous system development [goid 7417] [pmid 8914602] [evidence TAS],,21,40222892-40222906:40222907-40222941,21q22.2b,+,NM_006198.2,5121,PCP4,2.4760343953432473,6.496736692549785,9.396198338088176,3.934581725219047e-17,2.145043900767921e-16,27.82968490882221
ROPN1L,ILMN_1696466,"Homo sapiens ropporin 1-like (ROPN1L), mRNA.",,,,5,10514353-10514402,5p15.2c,+,NM_031916.2,83853,ROPN1L,-2.2797039264341157,7.15117422112452,-9.384537086967986,4.2313317990998526e-17,2.3024336860590115e-16,27.757511132862696
LOC653583,ILMN_1805853,"PREDICTED: Homo sapiens similar to pleckstrin homology-like domain, family B, member 1 (LOC653583), mRNA.",,,,19,48671276-48671325,19q13.31a,-,XM_928224.1,653583,LOC653583,1.088157558069545,6.771413344326975,9.33893519445656,5.621543562843147e-17,3.035785252506496e-16,27.475542273305777
LOC654204,ILMN_1788540,"PREDICTED: Homo sapiens similar to pleckstrin homology-like domain, family B, member 1 (LOC654204), mRNA.",,,,,,,,XM_940949.1,654204,LOC654204,1.096470473977039,6.834858822622342,9.337003823157012,5.689539135944854e-17,3.0700188519952705e-16,27.46360965258198
RND3,ILMN_1759513,"Homo sapiens Rho family GTPase 3 (RND3), mRNA.",intracellular [goid 5622] [evidence IEA],small GTPase mediated signal transduction [goid 7264] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],2,151033301-151033350,2q23.3a,-,NM_005168.3,390,RND3,-1.1405826065506623,9.003231345276703,-9.336794002864721,5.696975135258392e-17,3.073202440179291e-16,27.46231336379624
RUNDC2A,ILMN_1775357,"Homo sapiens RUN domain containing 2A (RUNDC2A), mRNA.",,"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],16,12054236-12054285,16p13.13a,+,NM_032167.1,84127,RUNDC2A,1.019658343368869,5.83729266875545,9.32512592555956,6.126073492315493e-17,3.300228283097695e-16,27.390241486493757
MGC3020,ILMN_1656420,"Homo sapiens hypothetical protein MGC3020 (MGC3020), mRNA.",,,,16,31625980-31626029,,+,NM_024048.2,79014,MGC3020,1.3351278588441273,7.8631720330878165,9.319953169740403,6.326448609712799e-17,3.4054232925244467e-16,27.358299360558775
IL18RAP,ILMN_1721762,"Homo sapiens interleukin 18 receptor accessory protein (IL18RAP), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],cell surface receptor linked signal transduction [goid 7166] [pmid 9792649] [evidence TAS]; inflammatory response [goid 6954] [pmid 9792649] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA],2,102435293-102435342,2q12.1a,+,NM_003853.2,8807,IL18RAP,-1.2803908610531236,7.009542320311857,-9.318440480112637,6.386267787316313e-17,3.4366983832335883e-16,27.348959464512838
KRT19,ILMN_1730777,"Homo sapiens keratin 19 (KRT19), mRNA.",intermediate filament [goid 5882] [pmid 2448790] [evidence TAS]; costamere [goid 43034] [pmid 16000376] [evidence IDA],,structural constituent of cytoskeleton [goid 5200] [pmid 2448790] [evidence TAS]; protein binding [goid 5515] [pmid 16000376] [evidence IPI]; structural molecule activity [goid 5198] [evidence IEA]; structural constituent of muscle [goid 8307] [pmid 16000376] [evidence IDA],17,36933718-36933767,17q21.2b,-,NM_002276.3,3880,KRT19,1.0866340261376983,12.692346842249929,9.314984456282781,6.525055683897175e-17,3.509497691489642e-16,27.32762253078166
PTPRN2,ILMN_1728844,"Homo sapiens protein tyrosine phosphatase, receptor type, N polypeptide 2 (PTPRN2), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 8798755] [evidence TAS]; membrane [goid 16020] [evidence IEA],protein amino acid dephosphorylation [goid 6470] [pmid 8798755] [evidence TAS],transmembrane receptor protein tyrosine phosphatase activity [goid 5001] [pmid 8798755] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; protein tyrosine phosphatase activity [goid 4725] [evidence IEA],7,157024937-157024986,7q36.3c-q36.3e,-,NM_002847.2,5799,PTPRN2,-1.0183180581986946,6.088109401788143,-9.304860228520743,6.949135045796197e-17,3.7345767928093014e-16,27.26513173791959
RPL39L,ILMN_1712413,"Homo sapiens ribosomal protein L39-like (RPL39L), mRNA.",ribosome [goid 5840] [evidence IEA]; cytosolic large ribosomal subunit (sensu Eukaryota) [goid 5842] [pmid 12490704] [evidence NAS]; intracellular [goid 5622] [evidence IEA]; ribosome [goid 5840] [evidence IEA]; cytosolic large ribosomal subunit (sensu Eukaryota) [goid 5842] [pmid 12490704] [evidence NAS]; intracellular [goid 5622] [evidence IEA],protein biosynthesis [goid 6412] [evidence IEA]; spermatogenesis [goid 7283] [pmid 12490704] [evidence IEP]; protein biosynthesis [goid 6412] [evidence IEA]; spermatogenesis [goid 7283] [pmid 12490704] [evidence IEP],structural constituent of ribosome [goid 3735] [evidence IEA]; structural constituent of ribosome [goid 3735] [evidence IEA],3,188339722-188339771,3q27.3b,-,NM_052969.1,116832,RPL39L,1.1449221845494781,8.21126426156273,9.296040760781157,7.340839336030788e-17,3.9397938153246783e-16,27.210712185299258
TUBB2B,ILMN_1680874,"Homo sapiens tubulin, beta 2B (TUBB2B), mRNA.",microtubule [goid 5874] [evidence IEA]; protein complex [goid 43234] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; protein polymerization [goid 51258] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; GTPase activity [goid 3924] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],6,3169836-3169885,6p25.2b,-,NM_178012.3,347733,TUBB2B,1.9100629450158362,7.472226859869257,9.292523449685762,7.503113610339347e-17,4.025805768722704e-16,27.189013625181786
CD8A,ILMN_1760374,"Homo sapiens CD8 antigen, alpha polypeptide (p32) (CD8A), transcript variant 1, mRNA.",integral to plasma membrane [goid 5887] [pmid 2496167] [evidence NAS]; integral to plasma membrane [goid 5887] [pmid 2496167] [evidence NAS],transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 9830036] [evidence NAS]; cellular defense response (sensu Vertebrata) [goid 16066] [pmid 2496167] [evidence NAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 9830036] [evidence NAS]; cellular defense response (sensu Vertebrata) [goid 16066] [pmid 2496167] [evidence NAS],MHC class I protein binding [goid 42288] [pmid 11131152] [evidence NAS]; protein binding [goid 5515] [pmid 2493728] [evidence IPI]; coreceptor activity [goid 15026] [pmid 11131152] [evidence NAS]; MHC class I protein binding [goid 42288] [pmid 11131152] [evidence NAS]; protein binding [goid 5515] [pmid 2493728] [evidence IPI]; coreceptor activity [goid 15026] [pmid 11131152] [evidence NAS],2,86869963-86870012,2p11.2e,-,NM_001768.4,925,CD8A,-1.0031976601803354,7.775318562383188,-9.276695094501337,8.278667551153902e-17,4.4229527466885786e-16,27.091400012674832
LOC387934,ILMN_1779852,"PREDICTED: Homo sapiens similar to Fatty acid-binding protein, epidermal (E-FABP) (Psoriasis-associated fatty acid-binding protein homolog) (PA-FABP) (LOC387934), mRNA.",,,,,,13q22.1a,,XM_937508.1,387934,LOC387934,-1.39269001906447,6.880053094135113,-9.273906668176632,8.423329788649176e-17,4.496637737761279e-16,27.0742093234983
LOC641849,ILMN_1745900,"PREDICTED: Homo sapiens similar to 40S ribosomal protein S3a (V-fos transformation effector protein) (LOC641849), mRNA.",,,,,,,,XM_935589.1,641849,LOC641849,-1.383016748417683,6.844782625678397,-9.266296151027566,8.831083686200325e-17,4.70802884075396e-16,27.027298880410946
LCN2,ILMN_1692223,"Homo sapiens lipocalin 2 (oncogene 24p3) (LCN2), mRNA.",soluble fraction [goid 5625] [evidence NR ]; cytoplasm [goid 5737] [evidence NR ],transport [goid 6810] [evidence IEA],transporter activity [goid 5215] [evidence IEA]; binding [goid 5488] [evidence IEA],9,129954359-129954384:129955200-129955219:129955220-129955223,9q34.11b,+,NM_005564.2,3934,LCN2,2.1528681549061783,10.926981602262778,9.26617604059115,8.837673852597805e-17,4.710287118880577e-16,27.026558631999713
LOC644852,ILMN_1727165,"PREDICTED: Homo sapiens hypothetical protein LOC644852, transcript variant 2 (LOC644852), mRNA.",,,,1,245748660-245748709,1q44e,+,XM_934218.1,644852,LOC644852,1.0315407291190581,7.082664830898651,9.264727367983241,8.917545351076167e-17,4.751591142059439e-16,27.017630613621144
CH25H,ILMN_1741021,"Homo sapiens cholesterol 25-hydroxylase (CH25H), mRNA.",membrane fraction [goid 5624] [evidence NR ],metabolism [goid 8152] [evidence IEA]; lipid metabolism [goid 6629] [pmid 9852097] [evidence TAS],steroid hydroxylase activity [goid 8395] [pmid 9852097] [evidence TAS]; catalytic activity [goid 3824] [evidence IEA],10,90956152-90956201,10q23.31b,-,NM_003956.2,9023,CH25H,-1.9682063888550942,8.688279386486986,-9.25011533193989,9.764420606838377e-17,5.172531837480069e-16,26.927603495210576
DDIT4L,ILMN_1696537,"Homo sapiens DNA-damage-inducible transcript 4-like (DDIT4L), mRNA.",,,,4,101326239-101326288,4q23b,-,NM_145244.2,115265,DDIT4L,1.625228511537303,7.225450927136485,9.249541424810765,9.799267748612775e-17,5.189617499053584e-16,26.924068503429766
C15orf28,ILMN_1686662,"PREDICTED: Homo sapiens chromosome 15 open reading frame 28 (C15orf28), misc RNA.",,,,,,15q23a,,XR_001373.1,80035,C15orf28,1.2314036517064961,6.6945477937546025,9.242892223413532,1.02121334531295e-16,5.396840098526546e-16,26.883117832217614
PGAM1,ILMN_1661366,"Homo sapiens phosphoglycerate mutase 1 (brain) (PGAM1), mRNA.",cytosol [goid 5829] [evidence NAS]; cytosol [goid 5829] [evidence NAS],metabolism [goid 8152] [evidence IEA]; glycolysis [goid 6096] [evidence NAS]; metabolism [goid 8152] [evidence IEA]; glycolysis [goid 6096] [evidence NAS],"phosphoglycerate mutase activity [goid 4619] [pmid 2846554] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA]; intramolecular transferase activity, phosphotransferases [goid 16868] [evidence IEA]; bisphosphoglycerate mutase activity [goid 4082] [evidence NAS]; isomerase activity [goid 16853] [evidence IEA]; bisphosphoglycerate phosphatase activity [goid 4083] [evidence NAS]; catalytic activity [goid 3824] [evidence IEA]; phosphoglycerate mutase activity [goid 4619] [pmid 2846554] [evidence NAS]; hydrolase activity [goid 16787] [evidence IEA]; intramolecular transferase activity, phosphotransferases [goid 16868] [evidence IEA]; bisphosphoglycerate mutase activity [goid 4082] [evidence NAS]; isomerase activity [goid 16853] [evidence IEA]; bisphosphoglycerate phosphatase activity [goid 4083] [evidence NAS]; catalytic activity [goid 3824] [evidence IEA]",10,99176017-99176054:99176055-99176066,10q24.1b,+,NM_002629.2,5223,PGAM1,-1.1586925173840736,8.996260203594414,-9.235169170577942,1.0713440051225604e-16,5.654299882482772e-16,26.835565657696954
LOC645968,ILMN_1695370,"PREDICTED: Homo sapiens similar to 40S ribosomal protein S3a (V-fos transformation effector protein) (LOC645968), mRNA.",,,,7,94163044-94163065:94163066-94163093,7q21.3b,-,XM_928934.1,645968,LOC645968,-1.413706424452168,7.414079489554798,-9.225788758963475,1.1355350920892047e-16,5.979677010592095e-16,26.777826325743945
LOC653157,ILMN_1665332,"PREDICTED: Homo sapiens similar to Iduronate 2-sulfatase precursor (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) (LOC653157), mRNA.",,,,X,148415560-148415609,,+,XM_926258.1,653157,LOC653157,1.0937409537681013,6.176923029796658,9.223144910525178,1.1543084737697143e-16,6.0761388958654145e-16,26.761556095263877
EBF,ILMN_1778681,"Homo sapiens early B-cell factor 1 (EBF1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; development [goid 7275] [evidence IEA]",zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; transcription regulator activity [goid 30528] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; protein binding [goid 5515] [pmid 14594818] [evidence IDA],5,158058476-158058525,5q33.3c,-,NM_024007.2,1879,EBF,-1.065166688137741,7.040479652818806,-9.212673954478138,1.2317418436092228e-16,6.468422783972003e-16,26.69713292882907
PPBP,ILMN_1767281,"Homo sapiens pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) (PPBP), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],immune response [goid 6955] [evidence IEA]; chemotaxis [goid 6935] [evidence IEA]; cell proliferation [goid 8283] [evidence IEA]; glucose transport [goid 15758] [pmid 4005226] [evidence TAS],glucose transporter activity [goid 5355] [pmid 4005226] [evidence TAS]; growth factor activity [goid 8083] [evidence IEA]; chemokine activity [goid 8009] [evidence IEA],4,75071933-75071955:75072098-75072124,4q13.3d,-,NM_002704.2,5473,PPBP,-1.5006539959505538,5.599621045807764,-9.211596124704569,1.2399999885524742e-16,6.508373497103333e-16,26.690502884658557
B4GALNT4,ILMN_1796663,"Homo sapiens beta-1,4-N-acetyl-galactosaminyl transferase 4 (B4GALNT4), mRNA.",,,acetylgalactosaminyltransferase activity [goid 8376] [pmid 15044014] [evidence IDA],11,370870-370919,11p15.5d,+,NM_178537.3,338707,B4GALNT4,1.2003662814588028,5.442344777409022,9.207908344214182,1.2686738699720795e-16,6.65712740372446e-16,26.667820207700757
PTPLAD2,ILMN_1690114,"Homo sapiens protein tyrosine phosphatase-like A domain containing 2 (PTPLAD2), mRNA.",,,,9,20993986-20994035,9p21.3d,-,NM_001010915.1,401494,PTPLAD2,1.4336837382587895,10.591078256344279,9.195881607524269,1.3668474876509978e-16,7.157258448814751e-16,26.593867383034663
LOC644063,ILMN_1701753,"PREDICTED: Homo sapiens similar to heterogeneous nuclear ribonucleoprotein K isoform a, transcript variant 2 (LOC644063), mRNA.",,,,3,97550966-97551015,3q11.2b,+,XM_931572.1,644063,LOC644063,-1.7446240787877478,8.3173060325933,-9.19227944067176,1.3976961493436514e-16,7.316877173225478e-16,26.571723751176393
PPARGC1B,ILMN_2195703,"Homo sapiens peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PPARGC1B), mRNA.",nucleus [goid 5634] [evidence ISS],"estrogen receptor signaling pathway [goid 30520] [evidence ISS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]; positive regulation of transcription from RNA polymerase II promoter [goid 45944] [evidence ISS]",ligand-dependent nuclear receptor transcription coactivator activity [goid 30374] [evidence ISS]; AF-2 domain binding [goid 50682] [evidence ISS]; nucleotide binding [goid 166] [evidence IEA]; RNA binding [goid 3723] [evidence ISS],5,149202104-149202133:149205516-149205535,5q33.1b-q33.1c,+,NM_133263.2,133522,PPARGC1B,-1.2463486967086022,6.611185044152652,-9.191628096349497,1.4033476766751825e-16,7.340700735926026e-16,26.567720043128688
FLJ23878,ILMN_1777637,"Homo sapiens schlafen-like 1 (SLFNL1), mRNA.",,,,1,41253923-41253972,1p34.2c,-,NM_144990.2,200172,FLJ23878,-1.1323698015504418,6.064860872853994,-9.185295127856264,1.4594956135175452e-16,7.622445375948589e-16,26.52879721301506
CKMT1B,ILMN_1763491,"Homo sapiens creatine kinase, mitochondrial 1B (CKMT1B), nuclear gene encoding mitochondrial protein, mRNA.",mitochondrion [goid 5739] [pmid 2914937] [evidence TAS],,kinase activity [goid 16301] [evidence IEA]; creatine kinase activity [goid 4111] [pmid 2914937] [evidence TAS],15,41678337-41678386,15q15.3a,+,NM_020990.3,1159,CKMT1B,1.2418667192660937,5.707606678153718,9.169760345661937,1.6068685319842454e-16,8.376817505977275e-16,26.433357194265746
SEMA3B,ILMN_1653501,"Homo sapiens sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B (SEMA3B), transcript variant 2, mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 8633026] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 8633026] [evidence TAS],development [goid 7275] [evidence IEA]; axon guidance [goid 7411] [pmid 8633026] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 8633026] [evidence TAS]; development [goid 7275] [evidence IEA]; axon guidance [goid 7411] [pmid 8633026] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 8633026] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA],3,50289448-50289497,3p21.31b,+,NM_001005914.1,7869,SEMA3B,-1.0273152749201424,7.585517399138878,-9.158699227021375,1.7207328035057973e-16,8.95407592523901e-16,26.36543454765323
PSMC4,ILMN_1687887,"Homo sapiens proteasome (prosome, macropain) 26S subunit, ATPase, 4 (PSMC4), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA]; proteasome complex (sensu Eukaryota) [goid 502] [pmid 8603043] [evidence TAS]; cytosol [goid 5829] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],protein catabolism [goid 30163] [evidence IEA],ATPase activity [goid 16887] [pmid 9473509] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],19,45168927-45168949:45168950-45168976,19q13.2b,+,NM_153001.1,5704,PSMC4,-1.1232394740393374,8.104088184088575,-9.155016651761414,1.7603943741637677e-16,9.155698112365133e-16,26.34282715876097
CFH,ILMN_1657803,"Homo sapiens complement factor H (CFH), transcript variant 2, mRNA.",extracellular space [goid 5615] [pmid 9312129] [evidence TAS]; extracellular space [goid 5615] [pmid 9312129] [evidence TAS]; extracellular space [goid 5615] [pmid 9312129] [evidence TAS],"innate immune response [goid 45087] [evidence IEA]; complement activation, alternative pathway [goid 6957] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]; complement activation, alternative pathway [goid 6957] [evidence IEA]; innate immune response [goid 45087] [evidence IEA]; complement activation, alternative pathway [goid 6957] [evidence IEA]",,1,194937229-194937278,1q31.3c,+,NM_001014975.1,3075,CFH,-1.0483914575169146,8.220422221195896,-9.152992029872257,1.7825856173037732e-16,9.261483518829887e-16,26.330399268824628
C6,ILMN_1688242,"Homo sapiens complement component 6 (C6), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane attack complex [goid 5579] [evidence IEA]; extracellular space [goid 5615] [evidence NR ],"innate immune response [goid 45087] [evidence IEA]; cytolysis [goid 19835] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",,5,41178489-41178538,5p13.1a,-,NM_000065.1,729,C6,-2.059592530275344,6.9098280274920825,-9.152098042913568,1.7924726536987457e-16,9.310434282244161e-16,26.324911933934544
TMC5,ILMN_1730117,"Homo sapiens transmembrane channel-like 5 (TMC5), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,16,19417350-19417399,16p12.3a,+,NM_024780.3,79838,TMC5,1.2890063591995071,7.677350213130402,9.133705793583195,2.0084270615321082e-16,1.040243558041274e-15,26.212059358685586
DSG2,ILMN_1704196,"Homo sapiens desmoglein 2 (DSG2), mRNA.",intercellular junction [goid 5911] [pmid 8143788] [evidence TAS]; membrane [goid 16020] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],homophilic cell adhesion [goid 7156] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [evidence IEA],18,27380565-27380614,18q12.1d,+,NM_001943.1,1829,DSG2,1.067144932328583,7.621652076966932,9.128021986378016,2.080257159081815e-16,1.0766111029205628e-15,26.177199670676877
FKSG30,ILMN_1814998,"Homo sapiens actin-like protein (FKSG30), mRNA.",actin filament [goid 5884] [evidence IEA]; actin filament [goid 5884] [evidence IEA],,structural constituent of cytoskeleton [goid 5200] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; structural constituent of cytoskeleton [goid 5200] [evidence IEA]; protein binding [goid 5515] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],2,132100979-132101028,2q21.1d,+,NM_001017421.1,440915,FKSG30,-1.1189215685820173,12.400897348137766,-9.12210891003792,2.1576966115700128e-16,1.115823049994645e-15,26.140941610212586
RASEF,ILMN_1779517,"Homo sapiens RAS and EF-hand domain containing (RASEF), mRNA.",,small GTPase mediated signal transduction [goid 7264] [evidence IEA]; protein transport [goid 15031] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],9,84787248-84787297,9q21.32b,-,NM_152573.2,158158,RASEF,1.6182608855198701,8.19844226445484,9.119150841380108,2.1975053528435206e-16,1.1355291089796787e-15,26.122806174416525
TNFRSF12A,ILMN_1689004,"Homo sapiens tumor necrosis factor receptor superfamily, member 12A (TNFRSF12A), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],angiogenesis [goid 1525] [evidence IEA]; cell motility [goid 6928] [pmid 10551889] [evidence TAS]; apoptosis [goid 6915] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],16,3012033-3012082,16p13.3d,+,NM_016639.1,51330,TNFRSF12A,1.1972323952812225,10.037137941412189,9.109220747819622,2.336558650203656e-16,1.2045829805017974e-15,26.06194095497677
LCN6,ILMN_1792800,"Homo sapiens lipocalin 6 (LCN6), mRNA.",,fertilization (sensu Metazoa) [goid 7338] [evidence IEA]; transport [goid 6810] [evidence IEA]; lipid metabolism [goid 6629] [evidence IEA],binding [goid 5488] [evidence IEA]; transporter activity [goid 5215] [evidence IEA],9,138758381-138758415:138758612-138758626,9q34.3e,-,NM_198946.2,158062,LCN6,-1.2630156197247242,5.500223677768214,-9.106434187438328,2.377128050610909e-16,1.2248668049606764e-15,26.044865134493662
C4BPA,ILMN_1810752,"Homo sapiens complement component 4 binding protein, alpha (C4BPA), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular space [goid 5615] [evidence NR ],"innate immune response [goid 45087] [evidence IEA]; complement activation, classical pathway [goid 6958] [evidence IEA]",,1,205384554-205384603,1q32.2a,+,NM_000715.3,722,C4BPA,-1.9877934593388673,11.328804544995739,-9.090748021143993,2.6189210405144177e-16,1.3449530846666445e-15,25.94877470025954
SULT1C1,ILMN_1766079,"Homo sapiens sulfotransferase family, cytosolic, 1C, member 2 (SULT1C2), transcript variant 1, mRNA.",cytoplasm [goid 5737] [pmid 9169148] [evidence TAS]; cytoplasm [goid 5737] [pmid 9169148] [evidence TAS],amine metabolism [goid 9308] [pmid 9169148] [evidence TAS]; amine metabolism [goid 9308] [pmid 9169148] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; sulfotransferase activity [goid 8146] [pmid 9169148] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; sulfotransferase activity [goid 8146] [pmid 9169148] [evidence TAS],2,108283737-108283786,2q12.3c,+,NM_001056.3,6819,SULT1C1,1.0798764465587807,5.796274312837348,9.089641631289426,2.636870698141434e-16,1.3531292364302083e-15,25.941999299262676
MANSC1,ILMN_1652490,"Homo sapiens MANSC domain containing 1 (MANSC1), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,12,12374286-12374335,12p13.2a,-,NM_018050.2,54682,MANSC1,-1.0004695789999118,7.482032005456426,-9.076885119961473,2.8528764731346637e-16,1.4617247752747338e-15,25.863900275930135
FNDC6,ILMN_1765668,"Homo sapiens interleukin 20 receptor beta (IL20RB), mRNA.",,,,3,138212311-138212360,,+,NM_144717.2,53833,FNDC6,1.3200493080035764,5.9352097001333215,9.066901166850704,3.034131713591783e-16,1.5514159807192536e-15,25.802801847563266
EDN2,ILMN_1680814,"Homo sapiens endothelin 2 (EDN2), mRNA.",extracellular region [goid 5576] [evidence IEA]; soluble fraction [goid 5625] [pmid 1701397] [evidence TAS],regulation of vasoconstriction [goid 19229] [evidence IEA]; pathogenesis [goid 9405] [evidence IEA]; cell-cell signaling [goid 7267] [evidence NR ]; protein kinase C activation [goid 7205] [pmid 9492062] [evidence TAS]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [pmid 9492062] [evidence TAS],growth factor activity [goid 8083] [evidence NR ],1,41717284-41717333,1p34.2c,-,NM_001956.2,1907,EDN2,1.004817768912135,5.45623866062115,9.0654233318173425,3.0619169265649067e-16,1.5648233427001443e-15,25.79375995537115
RAD51AP1,ILMN_1670353,"Homo sapiens RAD51 associated protein 1 (RAD51AP1), mRNA.",nucleus [goid 5634] [pmid 9396801] [evidence IC ],DNA repair [goid 6281] [pmid 9396801] [evidence NAS]; double-strand break repair via homologous recombination [goid 724] [pmid 9396801] [evidence NAS],protein binding [goid 5515] [pmid 9396801] [evidence IPI]; double-stranded DNA binding [goid 3690] [pmid 9396801] [evidence IDA]; DNA binding [goid 3677] [evidence IEA]; RNA binding [goid 3723] [pmid 9396801] [evidence IDA]; single-stranded DNA binding [goid 3697] [pmid 9396801] [evidence IDA],12,4539054-4539103,12p13.32a,+,NM_006479.2,10635,RAD51AP1,1.0853889369931604,6.548206581221365,9.062171762913357,3.123944447951373e-16,1.5948936084361078e-15,25.773867544979822
SLC7A10,ILMN_1681087,"Homo sapiens solute carrier family 7, (neutral amino acid transporter, y+ system) member 10 (SLC7A10), mRNA.",integral to plasma membrane [goid 5887] [pmid 10863037] [evidence NAS]; membrane [goid 16020] [pmid 10734121] [evidence TAS],neutral amino acid transport [goid 15804] [pmid 10863037] [evidence IDA]; transport [goid 6810] [evidence IEA]; amino acid transport [goid 6865] [evidence IEA],L-serine transporter activity [goid 15194] [pmid 10863037] [evidence TAS]; amino acid-polyamine transporter activity [goid 5279] [evidence IEA],19,38391632-38391636:38391637-38391681,19q13.11b,-,NM_019849.1,56301,SLC7A10,1.3273684095963523,5.6420286435086,9.057098811702067,3.2232209716704705e-16,1.6439002090538561e-15,25.742837204283298
SPATA18,ILMN_1667948,"Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA.",,,,4,52657892-52657941,4q12a,+,NM_145263.1,132671,SPATA18,-1.642964177240219,7.472070557189349,-9.045824640975264,3.4552274710597555e-16,1.7599845020611912e-15,25.67389654580701
SULF1,ILMN_1702363,"Homo sapiens sulfatase 1 (SULF1), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; extracellular space [goid 5615] [pmid 12368295] [evidence NAS]; cell surface [goid 9986] [pmid 12368295] [evidence IDA],metabolism [goid 8152] [evidence IEA]; apoptosis [goid 6915] [evidence IEA]; heparan sulfate proteoglycan metabolism [goid 30201] [pmid 12368295] [evidence NAS],hydrolase activity [goid 16787] [evidence IEA]; arylsulfatase activity [goid 4065] [pmid 12368295] [evidence IDA],8,70735259-70735308,8q13.2c-q13.3a,+,NM_015170.1,23213,SULF1,1.5418673733884756,9.120405052869275,9.033410945730918,3.729925682671398e-16,1.8970094829407556e-15,25.598022109269046
PZP,ILMN_1708183,"Homo sapiens pregnancy-zone protein (PZP), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],pregnancy [goid 7565] [pmid 2692707] [evidence TAS],wide-spectrum protease inhibitor activity [goid 17114] [evidence IEA]; serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA]; endopeptidase inhibitor activity [goid 4866] [evidence IEA],12,9192843-9192857:9193424-9193458,12p13.31a,-,NM_002864.1,5858,PZP,-1.3326392224729426,5.892089438587671,-9.032134069568492,3.7593842698102013e-16,1.911020337153519e-15,25.59021969006195
IGF2BP2,ILMN_1702447,"Homo sapiens insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2), transcript variant 1, mRNA.",cytoplasm [goid 5737] [pmid 10190901] [evidence TAS],morphogenesis [goid 9653] [pmid 9891060] [evidence TAS]; translational attenuation [goid 9386] [pmid 9891060] [evidence TAS],nucleotide binding [goid 166] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA]; nucleic acid binding [goid 3676] [evidence IEA]; RNA binding [goid 3723] [pmid 9891060] [evidence TAS],3,186844539-186844588,3q27.2b,-,NM_006548.4,10644,IGF2BP2,1.2465926019433375,8.566032745288618,9.028541550293252,3.843513320973155e-16,1.952793664957615e-15,25.568269463507747
GP9,ILMN_1743290,"Homo sapiens glycoprotein IX (platelet) (GP9), mRNA.",plasma membrane [goid 5886] [pmid 10429193] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 2771955] [evidence TAS],blood coagulation [goid 7596] [pmid 9432024] [evidence TAS]; cell adhesion [goid 7155] [pmid 2771955] [evidence NAS],transferase activity [goid 16740] [evidence IEA]; protein binding [goid 5515] [evidence IEA],3,130263874-130263923,3q21.3c,+,NM_000174.2,2815,GP9,-1.1708173791434717,5.524996216498575,-9.021797991069816,4.006518971672662e-16,2.0309711574671046e-15,25.527074628910455
TRIP13,ILMN_1796589,"Homo sapiens thyroid hormone receptor interactor 13 (TRIP13), mRNA.",nucleus [goid 5634] [pmid 7776974] [evidence TAS],transcription from RNA polymerase II promoter [goid 6366] [pmid 7776974] [evidence TAS],ATP binding [goid 5524] [evidence IEA]; transcription cofactor activity [goid 3712] [pmid 7776974] [evidence TAS]; nucleotide binding [goid 166] [evidence IEA]; nucleoside-triphosphatase activity [goid 17111] [evidence IEA],5,970891-970940,5p15.33d,+,NM_004237.2,9319,TRIP13,1.7026753621067137,7.4260382202170465,9.018363241114015,4.092167137587321e-16,2.073862210963706e-15,25.50609665387647
FLJ40919,ILMN_1797475,"Homo sapiens hypothetical protein FLJ40919 (FLJ40919), mRNA.",,,,13,42263444-42263493,13q14.11c,+,NM_182508.1,144809,FLJ40919,-2.4853180648909845,6.718155377536806,-9.007268324758314,4.381457951574957e-16,2.214861311144814e-15,25.438352693275995
PLCE1,ILMN_1784447,"Homo sapiens phospholipase C, epsilon 1 (PLCE1), mRNA.",membrane fraction [goid 5624] [pmid 11022048] [evidence IDA]; cytosol [goid 5829] [pmid 11022048] [evidence IDA]; plasma membrane [goid 5886] [pmid 11022048] [evidence IDA],cell proliferation [goid 8283] [pmid 11022048] [evidence NAS]; cytoskeleton organization and biogenesis [goid 7010] [evidence ISS]; heart development [goid 7507] [evidence ISS]; regulation of protein kinase activity [goid 45859] [evidence ISS]; regulation of cell growth [goid 1558] [evidence ISS]; Ras protein signal transduction [goid 7265] [pmid 11022048] [evidence TAS]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [evidence ISS]; regulation of smooth muscle contraction [goid 6940] [evidence ISS]; epidermal growth factor receptor signaling pathway [goid 7173] [pmid 11022048] [evidence NAS]; small GTPase mediated signal transduction [goid 7264] [evidence IEA]; calcium-mediated signaling [goid 19722] [pmid 11022048] [evidence NAS]; lipid metabolism [goid 6629] [evidence IEA]; diacylglycerol biosynthesis [goid 6651] [evidence ISS]; inositol phosphate-mediated signaling [goid 48016] [evidence ISS]; phospholipid metabolism [goid 6644] [pmid 11022048] [evidence IC ]; protein kinase C activation [goid 7205] [pmid 11022048] [evidence NAS],calcium ion binding [goid 5509] [evidence IEA]; enzyme binding [goid 19899] [pmid 11022048] [evidence IPI]; phosphoinositide phospholipase C activity [goid 4435] [pmid 11022048] [evidence IDA]; receptor signaling protein activity [goid 5057] [pmid 11022048] [evidence TAS]; Ras GTPase binding [goid 17016] [pmid 11022048] [evidence TAS]; guanyl-nucleotide exchange factor activity [goid 5085] [evidence ISS],10,96077863-96077912,10q23.33b,+,NM_016341.2,51196,PLCE1,-1.0195353405676082,7.154457305979784,-9.006232726968069,4.409476081876424e-16,2.227781860275105e-15,25.432030966911697
RAMP1,ILMN_1764754,"Homo sapiens receptor (G protein-coupled) activity modifying protein 1 (RAMP1), mRNA.",plasma membrane [goid 5886] [pmid 9620797] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 9620797] [evidence TAS],intracellular protein transport [goid 6886] [evidence IEA]; regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [pmid 9620797] [evidence TAS]; transport [goid 6810] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; protein transporter activity [goid 8565] [pmid 9620797] [evidence TAS],2,238485302-238485351,2q37.3b,+,NM_005855.2,10267,RAMP1,1.2781132782755282,8.016831224929218,8.998916016255022,4.612569551538201e-16,2.3269866764290552e-15,25.387373912224852
LOC651559,ILMN_1700025,"PREDICTED: Homo sapiens similar to Phosphoglycerate mutase 1 (Phosphoglycerate mutase isozyme B) (PGAM-B) (BPG-dependent PGAM 1) (LOC651559), mRNA.",,,,,,,,XM_940732.1,651559,LOC651559,-1.082569680340292,9.484492977008241,-8.985947193592708,4.995659866204577e-16,2.5132804275338492e-15,25.30825080792784
GLRX,ILMN_1737308,"Homo sapiens glutaredoxin (thioltransferase) (GLRX), mRNA.",,transport [goid 6810] [evidence IEA]; electron transport [goid 6118] [evidence IEA]; cell redox homeostasis [goid 45454] [evidence IEA],electron carrier activity [goid 9055] [evidence IEA]; glutathione disulfide oxidoreductase activity [goid 15038] [pmid 7851394] [evidence TAS]; protein disulfide oxidoreductase activity [goid 15035] [evidence IEA],5,95175728-95175777,5q15d,-,NM_002064.1,2745,GLRX,-1.0144030181794381,9.74586975982251,-8.983000920266532,5.087007547996941e-16,2.5566653358533738e-15,25.29028110515332
LOC388886,ILMN_1737255,"Homo sapiens similar to hypothetical protein LOC192734 (LOC388886), mRNA.",,,,22,23311759-23311808,22q11.23b,-,NM_207644.1,388886,LOC388886,1.0793618047217404,7.902720410140677,8.975311942328089,5.333296068865941e-16,2.6764130360137887e-15,25.243394795536176
EFCAB1,ILMN_1699562,"Homo sapiens EF-hand calcium binding domain 1 (EFCAB1), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA],8,49798702-49798751,8q11.21c,-,NM_024593.2,79645,EFCAB1,-2.3716099435729863,6.91477331428862,-8.965655503535237,5.659458029108648e-16,2.8329856453941913e-15,25.18453123024561
LOC440160,ILMN_1715693,"PREDICTED: Homo sapiens hypothetical LOC440160 (LOC440160), mRNA.",,,,,,,,XM_498571.2,440160,LOC440160,1.3456316845239131,6.5047096772811175,8.964992521601715,5.682565167143999e-16,2.8431298790751968e-15,25.18049065605034
SCNN1D,ILMN_1754757,"Homo sapiens sodium channel, nonvoltage-gated 1, delta (SCNN1D), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [evidence NR ]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; sodium ion transport [goid 6814] [pmid 7499195] [evidence TAS],amiloride-sensitive sodium channel activity [goid 15280] [pmid 7499195] [evidence TAS]; sodium ion binding [goid 31402] [evidence IEA]; sodium channel activity [goid 5272] [evidence IEA]; ion channel activity [goid 5216] [evidence IEA],1,1217213-1217262,1p36.33a,+,NM_002978.2,6339,SCNN1D,1.0690397760141126,7.187795396403167,8.964177041338377,5.711116032077568e-16,2.8567002392451994e-15,25.175520818475604
TMPRSS13,ILMN_1671154,"Homo sapiens transmembrane protease, serine 13 (TMPRSS13), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 11267681] [evidence NAS],,scavenger receptor activity [goid 5044] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA]; chymotrypsin activity [goid 4263] [evidence IEA]; trypsin activity [goid 4295] [evidence IEA],11,117276857-117276906,11q23.3c,-,NM_032046.1,84000,TMPRSS13,1.0192944955844183,6.360673583301438,8.960005719201373,5.859403825857454e-16,2.928677285729601e-15,25.150101741988692
CD48,ILMN_2061043,"Homo sapiens CD48 molecule (CD48), mRNA.",plasma membrane [goid 5886] [pmid 2828034] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 1693656] [evidence TAS],defense response [goid 6952] [pmid 2828034] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [pmid 12356317] [evidence IPI],1,158915342-158915391,1q23.3a,-,NM_001778.2,962,CD48,-1.2718695897544174,8.507746853059187,-8.954851932645292,6.047912600548622e-16,3.0206349303988227e-15,25.118701535242003
NR4A2,ILMN_1782305,"Homo sapiens nuclear receptor subfamily 4, group A, member 2 (NR4A2), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 7877627] [evidence TAS]; nucleus [goid 5634] [pmid 7877627] [evidence TAS],"transcription [goid 6350] [evidence IEA]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 7877627] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [pmid 7877627] [evidence NAS]; transcription [goid 6350] [evidence IEA]; antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 7877627] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; signal transduction [goid 7165] [pmid 7877627] [evidence NAS]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; steroid hormone receptor activity [goid 3707] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; steroid hormone receptor activity [goid 3707] [evidence IEA],2,156889936-156889985,2q24.1c,-,NM_006186.2,4929,NR4A2,-1.9176827258591258,8.694819928793159,-8.954309476174346,6.06810118565837e-16,3.029961779951402e-15,25.115396911127675
JUN,ILMN_1806023,"Homo sapiens jun oncogene (JUN), mRNA.",nucleus [goid 5634] [evidence IEA]; nuclear chromosome [goid 228] [pmid 10918580] [evidence TAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [pmid 9443941] [evidence TAS]; protein dimerization activity [goid 46983] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 10973489] [evidence TAS],1,59019838-59019887,1p32.1f,-,NM_002228.3,3725,JUN,-1.1205453568828645,11.620892963449755,-8.950477240942151,6.212646240812964e-16,3.100589323676373e-15,25.09205310176761
IGSF21,ILMN_1730039,"Homo sapiens immunoglobin superfamily, member 21 (IGSF21), mRNA.",,,,1,18577366-18577407:18577408-18577415,1p36.13c,+,NM_032880.2,84966,IGSF21,-1.022997707849286,5.949396558193445,-8.947030293658804,6.345579685435672e-16,3.1653542345100204e-15,25.071059276699863
ITGA2,ILMN_1665792,"Homo sapiens integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) (ITGA2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integrin complex [goid 8305] [pmid 2545729] [evidence TAS]; plasma membrane [goid 5886] [pmid 2545729] [evidence TAS],cell-matrix adhesion [goid 7160] [pmid 2545729] [evidence TAS]; blood coagulation [goid 7596] [pmid 2933589] [evidence TAS]; cell adhesion [goid 7155] [pmid 10942362] [evidence TAS]; integrin-mediated signaling pathway [goid 7229] [evidence IEA],magnesium ion binding [goid 287] [evidence IEA]; collagen binding [goid 5518] [pmid 9391074] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],5,52423650-52423699,5q11.2b,+,NM_002203.2,3673,ITGA2,1.3086307927451255,8.746495620778854,8.935087906599412,6.828389607847641e-16,3.3918177575425918e-15,24.998345730093583
CRIPAK,ILMN_2140700,"Homo sapiens cysteine-rich PAK1 inhibitor (CRIPAK), mRNA.",nucleus [goid 5634] [evidence IEA],,,4,1379469-1379518,4p16.3c,+,NM_175918.2,285464,CRIPAK,1.0598887979233353,8.014562568502186,8.933248863609919,6.905915194836279e-16,3.4294750860830046e-15,24.98715143073332
BATF,ILMN_1668822,"Homo sapiens basic leucine zipper transcription factor, ATF-like (BATF), mRNA.",nucleus [goid 5634] [evidence IEA],"antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 8630063] [evidence TAS]; transcription [goid 6350] [evidence IEA]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",RNA polymerase II transcription factor activity [goid 3702] [pmid 8570175] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; protein dimerization activity [goid 46983] [evidence IEA]; transcription factor activity [goid 3700] [pmid 8630063] [evidence TAS],14,75082963-75083012,14q24.3b,+,NM_006399.2,10538,BATF,1.1820647813865355,8.10779828477351,8.929822539313443,7.052693846077761e-16,3.4988916060581165e-15,24.966297502281932
LOC648526,ILMN_1711087,"PREDICTED: Homo sapiens similar to epiplakin 1 (LOC648526), mRNA.",,,,,,,,XM_937579.1,648526,LOC648526,1.1336108939639669,7.927742486266349,8.914759365100377,7.735636345024114e-16,3.825373504479547e-15,24.874651126699554
FLJ46266,ILMN_1766038,"Homo sapiens FLJ46266 protein (FLJ46266), mRNA.",,,,11,110912756-110912805,11q23.1b,+,NM_207430.1,399949,FLJ46266,-2.4873238807713856,6.764490884102027,-8.911799050486735,7.877386346196102e-16,3.890662700930427e-15,24.856646685400023
CCDC34,ILMN_1657547,"Homo sapiens coiled-coil domain containing 34 (CCDC34), transcript variant 1, mRNA.",,,,11,27335569-27335618,11p14.1d,-,NM_030771.1,91057,CCDC34,1.0057965053549003,7.330179126465327,8.904972803861654,8.214166405513971e-16,4.052997322848915e-15,24.815138071691678
EGLN3,ILMN_1667626,"Homo sapiens egl nine homolog 3 (C. elegans) (EGLN3), mRNA.",nucleus [goid 5634] [evidence IEA],protein metabolism [goid 19538] [evidence IEA]; apoptosis [goid 6915] [evidence IEA],"L-ascorbic acid binding [goid 31418] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors [goid 16706] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [goid 16702] [evidence IEA]; oxidoreductase activity [goid 16491] [evidence IEA]",14,33463218-33463267,14q13.1c,-,NM_022073.2,112399,EGLN3,1.2506699358069602,6.035634581054576,8.901206847893917,8.40604892251145e-16,4.14256716358643e-15,24.792243171089275
LOC653158,ILMN_1659490,"PREDICTED: Homo sapiens similar to hypothetical protein MGC40405, transcript variant 1 (LOC653158), mRNA.",,,,5,60710651-60710700,,+,XM_926814.1,653158,LOC653158,1.4860262484463576,8.220085181261087,8.893687389222618,8.802606718929551e-16,4.3294630096446026e-15,24.746539501125845
C20orf127,ILMN_1662640,"Homo sapiens chromosome 20 open reading frame 127 (C20orf127), mRNA.",,,metal ion binding [goid 46872] [evidence IEA],20,33269618-33269649:33269650-33269667,20q11.22b,+,NM_080757.1,140851,C20orf127,-1.5814152515034934,9.126884866448949,-8.8893748770764809,9.038369844449147e-16,4.441053630838373e-15,24.72033410089827
C14orf152,ILMN_1762696,"Homo sapiens chromosome 14 open reading frame 152 (C14orf152), mRNA.",,,,14,93465587-93465636,14q32.13a,+,NM_138344.2,90050,C14orf152,-1.7377446844289048,6.136830078724307,-8.8887137736843,9.075062626393599e-16,4.457988043920528e-15,24.716317246862936
LOC163233,ILMN_1773236,"PREDICTED: Homo sapiens similar to Zinc finger protein 93 (Zinc finger protein HTF34) (LOC163233), mRNA.",,,,,,,,XM_938234.1,163233,LOC163233,1.077642738834804,5.931218118232086,8.88660514515332,9.193088385781324e-16,4.51374999810338e-15,24.70350597256381
IGFBP3,ILMN_1746085,"Homo sapiens insulin-like growth factor binding protein 3 (IGFBP3), transcript variant 1, mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],positive regulation of apoptosis [goid 43065] [pmid 11971816] [evidence IMP]; negative regulation of signal transduction [goid 9968] [pmid 11940579] [evidence NAS]; positive regulation of myoblast differentiation [goid 45663] [pmid 12599210] [evidence IDA]; regulation of cell growth [goid 1558] [evidence IEA],protein tyrosine phosphatase activator activity [goid 8160] [pmid 11940579] [evidence IDA]; insulin-like growth factor binding [goid 5520] [pmid 12599210] [evidence NAS]; metal ion binding [goid 46872] [pmid 14576163] [evidence NAS],7,45918727-45918776,7p13b,-,NM_001013398.1,3486,IGFBP3,1.398544957723466,10.595576102608975,8.88254814683759,9.424477259443314e-16,4.622822775360181e-15,24.678860185905947
LOC653774,ILMN_1793367,"PREDICTED: Homo sapiens similar to phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila) (LOC653774), mRNA.",,,,19,18223890-18223939,,-,XM_933803.1,653774,LOC653774,1.1807893867322905,5.670501962609986,8.875856550636293,9.818840863803515e-16,4.8073004863614774e-15,24.63821841703671
C6orf141,ILMN_1761762,"Homo sapiens chromosome 6 open reading frame 141 (C6orf141), mRNA.",,,,6,49630741-49630790,6p12.3b,+,NM_153344.1,135398,C6orf141,1.1693455460980422,5.971923518172251,8.862804846146233,1.0635822204316306e-15,5.1978879009272264e-15,24.558980123649953
NOX4,ILMN_1735996,"Homo sapiens NADPH oxidase 4 (NOX4), mRNA.",nucleus [goid 5634] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 10869423] [evidence TAS]; endoplasmic reticulum [goid 5783] [evidence IEA],oxygen and reactive oxygen species metabolism [goid 6800] [pmid 10869423] [evidence IDA]; cell aging [goid 7569] [pmid 10869423] [evidence ISS]; electron transport [goid 6118] [pmid 10869423] [evidence IDA]; negative regulation of cell proliferation [goid 8285] [pmid 10869423] [evidence ISS]; inflammatory response [goid 6954] [pmid 10869423] [evidence TAS]; superoxide release [goid 42554] [pmid 10869423] [evidence ISS],heme binding [goid 20037] [pmid 10869423] [evidence TAS]; electron carrier activity [goid 9055] [pmid 10869423] [evidence TAS]; NAD(P)H oxidase activity [goid 16174] [pmid 10869423] [evidence TAS]; oxygen sensor activity [goid 19826] [pmid 10869423] [evidence TAS]; nucleotide binding [goid 166] [pmid 10869423] [evidence TAS]; iron ion binding [goid 5506] [evidence IEA]; FAD binding [goid 50660] [pmid 10869423] [evidence TAS],11,88699220-88699269,11q14.3a,-,NM_016931.2,50507,NOX4,1.17716781177369,7.359998018008404,8.858863676438531,1.0895549514644235e-15,5.320948862730894e-15,24.53506118326208
FLJ13841,ILMN_1700583,"Homo sapiens hypothetical protein LOC79755 (FLJ13841), mRNA.",nucleus [goid 5634] [evidence IEA],,nucleic acid binding [goid 3676] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],17,78381220-78381269,17q25.3h,-,NM_024702.1,79755,FLJ13841,1.5735000331385143,7.297917092637289,8.853881931027116,1.1232887929288926e-15,5.474972513744527e-15,24.504832531491857
TMEM46,ILMN_1760412,"Homo sapiens transmembrane protein 46 (TMEM46), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,13,25517063-25517112,13q12.13b,-,NM_001007538.1,387914,TMEM46,-1.9397636065612591,8.14470610575363,-8.853377769755799,1.1267600139913386e-15,5.4905539113343165e-15,24.5017736844554
FLNC,ILMN_1715748,"Homo sapiens filamin C, gamma (actin binding protein 280) (FLNC), mRNA.",actin cytoskeleton [goid 15629] [evidence NR ],,actin binding [goid 3779] [evidence IEA]; protein binding [goid 5515] [pmid 11038172] [evidence IPI],7,128286512-128286561,7q32.1a,+,NM_001458.2,2318,FLNC,-1.3674482502401553,8.84264216472362,-8.848412021754628,1.1615245624989092e-15,5.658578876668657e-15,24.47164889188862
IL1F7,ILMN_1697710,"Homo sapiens interleukin 1 family, member 7 (zeta) (IL1F7), transcript variant 1, mRNA.",extracellular region [goid 5576] [pmid 10744718] [evidence TAS]; extracellular space [goid 5615] [evidence IEA],immune response [goid 6955] [pmid 10744718] [evidence NAS],interleukin-1 receptor antagonist activity [goid 5152] [evidence IEA],2,113391688-113391737,2q13d,+,NM_014439.3,27178,IL1F7,1.8509513682380074,6.523756337756903,8.843438569662862,1.1974111637005797e-15,5.830567671774446e-15,24.441483541724068
FXYD3,ILMN_1665372,"Homo sapiens FXYD domain containing ion transport regulator 3 (FXYD3), transcript variant 2, mRNA.",integral to plasma membrane [goid 5887] [pmid 7836447] [evidence TAS]; membrane [goid 16020] [evidence IEA],ion transport [goid 6811] [evidence IEA]; chloride transport [goid 6821] [pmid 7836447] [evidence TAS],ion channel activity [goid 5216] [evidence IEA]; chloride channel activity [goid 5254] [pmid 7836447] [evidence TAS],19,40301943-40301992,19q13.11c-q13.12a,+,NM_021910.1,5349,FXYD3,-1.0881756899318358,6.424751591976538,-8.832977140449026,1.2765326583249799e-15,6.194728456892117e-15,24.378052337994575
GGTL4,ILMN_2403896,"Homo sapiens gamma-glutamyltransferase-like 4 (GGTL4), transcript variant 1, mRNA.",,glutathione biosynthesis [goid 6750] [evidence NAS],gamma-glutamyltransferase activity [goid 3840] [evidence NAS],22,21319236-21319285,22q11.22b,+,NM_199127.1,91227,GGTL4,-1.2094625009735793,7.061816231547624,-8.828978538622962,1.3081284896903527e-15,6.3434403348823504e-15,24.353814715711756
MYRIP,ILMN_1668125,"Homo sapiens myosin VIIA and Rab interacting protein (MYRIP), mRNA.",,intracellular protein transport [goid 6886] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; Rab GTPase binding [goid 17137] [evidence IEA]; actin binding [goid 3779] [evidence IEA]; protein binding [goid 5515] [evidence IEA],3,40276483-40276532,3p22.1c,+,NM_015460.2,25924,MYRIP,-1.1725057181549587,5.424905317174403,-8.824759460267977,1.3423092087874463e-15,6.501312672335808e-15,24.32824503259856
DEFA3,ILMN_1725661,"Homo sapiens defensin, alpha 3, neutrophil-specific (DEFA3), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular region [goid 5576] [evidence IEA],xenobiotic metabolism [goid 6805] [evidence IEA]; response to virus [goid 9615] [evidence IEA]; xenobiotic metabolism [goid 6805] [evidence IEA]; response to virus [goid 9615] [evidence IEA],,8,6863176-6863225,8p23.1f,-,NM_005217.2,1668,DEFA3,-1.800103575466645,5.6930394616306295,-8.824152320150636,1.3473004305329435e-15,6.523907796249549e-15,24.3245658349593
CT45-4,ILMN_1672783,"Homo sapiens cancer/testis antigen CT45-4 (CT45-4), mRNA.",,,,X,134756415-134756464,Xq26.3b,-,NM_001017436.1,441520,CT45-4,-1.7454208750886142,6.264980114205618,-8.820805251477404,1.3751491321329328e-15,6.6523171749796234e-15,24.304284661517762
CCL3L3,ILMN_1747355,"Homo sapiens chemokine (C-C motif) ligand 3-like 3 (CCL3L3), mRNA.",extracellular region [goid 5576] [evidence IEA],immune response [goid 6955] [evidence IEA],chemokine activity [goid 8009] [evidence IEA],17,31547400-31547424:31548110-31548134,17q12b,-,NM_001001437.3,414062,CCL3L3,-1.5817732878947792,8.304129632309037,-8.814348134329194,1.4305004661033576e-15,6.9117250243409755e-15,24.265166502257635
LOC402221,ILMN_1811909,"PREDICTED: Homo sapiens similar to actin alpha 1 skeletal muscle protein (LOC402221), mRNA.",,,,,,5q21.1a,,XM_938988.1,402221,LOC402221,-1.1534499177721909,9.552189180787268,-8.797177646203584,1.5886932520549949e-15,7.661261650305216e-15,24.161196544048963
LOC646962,ILMN_2189675,"Homo sapiens hypothetical protein LOC646962 (LGLL338), mRNA.",,,,9,35896885-35896934,9p13.3a,+,NM_001039792.1,646962,LOC646962,-1.2439927508289923,6.396234306115765,-8.787294093857204,1.6875102213367998e-15,8.126041999640598e-15,24.101384091820172
CAMK2N1,ILMN_1794863,"Homo sapiens calcium/calmodulin-dependent protein kinase II inhibitor 1 (CAMK2N1), mRNA.",ruffle [goid 1726] [pmid 11919189] [evidence IDA]; cytosol [goid 5829] [pmid 11919189] [evidence IDA]; lamellipodium [goid 30027] [pmid 11919189] [evidence IDA],cell migration [goid 16477] [pmid 11919189] [evidence TAS]; cell adhesion [goid 7155] [pmid 11919189] [evidence TAS],kinase activity [goid 16301] [evidence IEA]; protein binding [goid 5515] [pmid 11919189] [evidence TAS],1,20682709-20682728:20682729-20682758,1p36.12b,-,NM_018584.4,55450,CAMK2N1,-1.4567021819165724,10.975018212338057,-8.783934877480107,1.7224676814433522e-15,8.284407060172739e-15,24.081060741464213
ZBTB16,ILMN_1750496,"Homo sapiens zinc finger and BTB domain containing 16 (ZBTB16), transcript variant 1, mRNA.",nuclear speck [goid 16607] [pmid 8541544] [evidence IDA]; transcriptional repressor complex [goid 17053] [pmid 12802276] [evidence IDA]; nucleus [goid 5634] [pmid 9294197] [evidence IDA]; intracellular [goid 5622] [evidence IEA]; nuclear speck [goid 16607] [pmid 8541544] [evidence IDA]; transcriptional repressor complex [goid 17053] [pmid 12802276] [evidence IDA]; nucleus [goid 5634] [pmid 9294197] [evidence IDA]; intracellular [goid 5622] [evidence IEA],"mesonephros development [goid 1823] [pmid 8541544] [evidence ISS]; apoptosis [goid 6915] [pmid 9294197] [evidence NAS]; transcription [goid 6350] [evidence IEA]; negative regulation of transcription, DNA-dependent [goid 45892] [pmid 12802276] [evidence IDA]; central nervous system development [goid 7417] [pmid 8541544] [evidence ISS]; negative regulation of myeloid cell differentiation [goid 45638] [pmid 8541544] [evidence ISS]; mesonephros development [goid 1823] [pmid 8541544] [evidence ISS]; apoptosis [goid 6915] [pmid 9294197] [evidence NAS]; transcription [goid 6350] [evidence IEA]; negative regulation of transcription, DNA-dependent [goid 45892] [pmid 12802276] [evidence IDA]; central nervous system development [goid 7417] [pmid 8541544] [evidence ISS]; negative regulation of myeloid cell differentiation [goid 45638] [pmid 8541544] [evidence ISS]",protein homodimerization activity [goid 42803] [pmid 8622986] [evidence IDA]; DNA binding [goid 3677] [pmid 9294197] [evidence NAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; specific transcriptional repressor activity [goid 16566] [pmid 12802276] [evidence IDA]; protein homodimerization activity [goid 42803] [pmid 8622986] [evidence IDA]; DNA binding [goid 3677] [pmid 9294197] [evidence NAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; specific transcriptional repressor activity [goid 16566] [pmid 12802276] [evidence IDA],11,113435646-113435695,11q23.2a,+,NM_006006.4,7704,ZBTB16,-1.714839758832503,7.2511023435375614,-8.779397522247821,1.7708301178058006e-15,8.504745318544997e-15,24.053614197537257
HS3ST1,ILMN_2228035,"Homo sapiens heparan sulfate (glucosamine) 3-O-sulfotransferase 1 (HS3ST1), mRNA.",Golgi lumen [goid 5796] [pmid 9346953] [evidence TAS]; integral to membrane [goid 16021] [pmid 9988767] [evidence TAS],,transferase activity [goid 16740] [evidence IEA]; heparin-glucosamine 3-O-sulfotransferase activity [goid 8467] [evidence IEA],4,11009243-11009292,4p15.33e,-,NM_005114.2,9957,HS3ST1,1.3743858517693592,7.141963395596896,8.768544786310276,1.892048303168507e-15,9.069502263966337e-15,23.987987189757895
LOC91461,ILMN_1734445,"Homo sapiens hypothetical protein BC007901 (LOC91461), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],ATP binding [goid 5524] [evidence IEA]; protein-tyrosine kinase activity [goid 4713] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],2,42138814-42138863,2p21f,+,NM_138370.1,91461,LOC91461,-1.0831115571375705,7.232707712499541,-8.752961605500458,2.080652291920211e-15,9.940231866461218e-15,23.893807894318343
MYEOV,ILMN_2198413,"Homo sapiens myeloma overexpressed gene (in a subset of t(11;14) positive multiple myelomas) (MYEOV), mRNA.",,,,11,68820979-68821028,11q13.2c,+,NM_138768.2,26579,MYEOV,1.630275744350107,5.827709425884591,8.743793867444023,2.200216495300723e-15,1.0483908463438168e-14,23.83843056560933
FASN,ILMN_1784871,"Homo sapiens fatty acid synthase (FASN), mRNA.",,fatty acid biosynthesis [goid 6633] [evidence IEA],"transferase activity [goid 16740] [evidence IEA]; protein kinase binding [goid 19901] [pmid 11034606] [evidence IPI]; [acyl-carrier protein] S-acetyltransferase activity [goid 4313] [evidence IEA]; phosphopantetheine binding [goid 31177] [evidence IEA]; [acyl-carrier protein] S-malonyltransferase activity [goid 4314] [evidence IEA]; 3-oxoacyl-[acyl-carrier protein] reductase activity [goid 4316] [evidence IEA]; cofactor binding [goid 48037] [evidence IEA]; 3-oxoacyl-[acyl-carrier protein] synthase activity [goid 4315] [evidence IEA]; protein binding [goid 5515] [pmid 11034606] [evidence IPI]; oxidoreductase activity [goid 16491] [evidence IEA]; hydrolase activity, acting on ester bonds [goid 16788] [evidence IEA]; lyase activity [goid 16829] [evidence IEA]; oleoyl-[acyl-carrier protein] hydrolase activity [goid 4320] [evidence IEA]; enoyl-[acyl-carrier protein] reductase (NADPH, B-specific) activity [goid 4319] [evidence IEA]; catalytic activity [goid 3824] [evidence IEA]",17,77629503-77629552,17q25.3g,-,NM_004104.4,2194,FASN,-1.060914633519717,11.73388349083912,-8.739114931547189,2.263844279830179e-15,1.0769138457166481e-14,23.810176039796247
HDGFRP3,ILMN_1784256,"Homo sapiens hepatoma-derived growth factor, related protein 3 (HDGFRP3), mRNA.",nucleus [goid 5634] [pmid 10581169] [evidence IDA],cell proliferation [goid 8283] [pmid 10581169] [evidence NAS],chromatin binding [goid 3682] [evidence ISS]; growth factor activity [goid 8083] [evidence IEA],15,81598242-81598291,15q25.2b,-,NM_016073.2,50810,HDGFRP3,-1.0563559475846205,6.7747050980429915,-8.720749941873,2.5317471034909244e-15,1.2003600958920953e-14,23.69933099629145
GNLY,ILMN_1708779,"Homo sapiens granulysin (GNLY), transcript variant NKG5, mRNA.",extracellular space [goid 5615] [pmid 2212946] [evidence TAS],cellular defense response [goid 6968] [pmid 9756476] [evidence TAS]; xenobiotic metabolism [goid 6805] [evidence IEA],,2,85775009-85775052:85775053-85775058,2p11.2f,+,NM_006433.2,10578,GNLY,-1.1383512182662194,7.136556063785354,-8.712443979205288,2.663035620441277e-15,1.2611128211547709e-14,23.649227811852754
MXRA5,ILMN_1803213,"Homo sapiens matrix-remodelling associated 5 (MXRA5), mRNA.",,protein amino acid phosphorylation [goid 6468] [evidence IEA],vascular endothelial growth factor receptor activity [goid 5021] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],X,3236720-3236769,Xp22.33b,-,NM_015419.1,25878,MXRA5,1.068321674976323,10.822045523215367,8.701690266724379,2.843106770250083e-15,1.3432085067098858e-14,23.584386152591527
ATOH8,ILMN_1654065,"Homo sapiens atonal homolog 8 (Drosophila) (ATOH8), mRNA.",nucleus [goid 5634] [evidence IEA],regulation of transcription [goid 45449] [evidence IEA],transcription regulator activity [goid 30528] [evidence IEA],2,85868440-85868489,2p11.2f,+,NM_032827.3,84913,ATOH8,-1.5725663526755689,8.593646419319663,-8.699143728358552,2.8874897558425665e-15,1.3635330430705233e-14,23.569035734422307
WNT10A,ILMN_1658426,"Homo sapiens wingless-type MMTV integration site family, member 10A (WNT10A), mRNA.",extracellular region [goid 5576] [evidence IEA],development [goid 7275] [evidence IEA]; frizzled-2 signaling pathway [goid 7223] [evidence IEA],signal transducer activity [goid 4871] [evidence IEA],2,219466511-219466560,2q35e,+,NM_025216.2,80326,WNT10A,1.0740774811774996,6.17535828444668,8.690795782092202,3.0378659192215447e-15,1.4321776934916272e-14,23.51872665324585
MT1X,ILMN_1775170,"Homo sapiens metallothionein 1X (MT1X), mRNA.",,response to metal ion [goid 10038] [pmid 9074634] [evidence TAS],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [pmid 9074634] [evidence TAS]; copper ion binding [goid 5507] [evidence IEA]; cadmium ion binding [goid 46870] [evidence IEA],16,55273897-55273946,16q13b,+,NM_005952.2,4501,MT1X,-1.515279972273028,11.578036063183962,-8.686439547973213,3.119399901320375e-15,1.469577424667249e-14,23.492481003906583
LOC646100,ILMN_1676407,"PREDICTED: Homo sapiens hypothetical protein LOC646100 (LOC646100), mRNA.",,,,7,97357845-97357894,,+,XM_929061.1,646100,LOC646100,1.117406712778691,6.097778796960707,8.679763884545167,3.2485821999681537e-15,1.5268412651388964e-14,23.452270868169357
ABP1,ILMN_1731433,"Homo sapiens amiloride binding protein 1 (amine oxidase (copper-containing)) (ABP1), mRNA.",peroxisome [goid 5777] [pmid 1356107] [evidence NAS],metabolism [goid 8152] [evidence NR ],oxidoreductase activity [goid 16491] [evidence IEA]; amine oxidase activity [goid 8131] [pmid 8144586] [evidence IDA]; heparin binding [goid 8201] [evidence IEA]; drug binding [goid 8144] [evidence NR ]; calcium ion binding [goid 5509] [evidence IEA]; copper ion binding [goid 5507] [evidence IEA],7,150189216-150189230:150189231-150189265,7q36.1c,+,NM_001091.2,26,ABP1,1.7899486392151456,6.406949843840658,8.674270096182628,3.3588688333651176e-15,1.577564498074396e-14,23.419188471791443
HMOX1,ILMN_1800512,"Homo sapiens heme oxygenase (decycling) 1 (HMOX1), mRNA.",microsome [goid 5792] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 3345742] [evidence TAS]; membrane fraction [goid 5624] [pmid 3345742] [evidence TAS],heme oxidation [goid 6788] [evidence IEA]; positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP],oxidoreductase activity [goid 16491] [evidence IEA]; heme oxygenase (decyclizing) activity [goid 4392] [pmid 9884342] [evidence TAS]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; iron ion binding [goid 5506] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],22,34119915-34119964,22q12.3c,+,NM_002133.1,3162,HMOX1,-1.0752394838178123,8.580493077372456,-8.672822640599282,3.3885399941026017e-15,1.5911266886178094e-14,23.410473540576966
TM4SF18,ILMN_1739170,"Homo sapiens transmembrane 4 L six family member 18 (TM4SF18), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],,,3,150522768-150522817,3q25.1a,-,NM_138786.1,116441,TM4SF18,-1.4429152119170903,7.32244937370454,-8.658931007597449,3.686875380263249e-15,1.7275644638947797e-14,23.3268622177268
USP22,ILMN_1666609,"PREDICTED: Homo sapiens ubiquitin specific peptidase 22, transcript variant 2 (USP22), mRNA.",,,,,,17p11.2b,,XM_942262.1,23326,USP22,-1.0506274047664403,7.2063757459736335,-8.654906192490232,3.778086432515388e-15,1.7694745632436306e-14,23.3026471499983
LOC441763,ILMN_1703337,"PREDICTED: Homo sapiens hypothetical LOC441763 (LOC441763), mRNA.",,,,16,33871429-33871478,,+,XM_930284.1,441763,LOC441763,1.3050358469734995,10.404085027965689,8.621509403678386,4.626689365199227e-15,2.149809587062381e-14,23.101884517062558
SBDS,ILMN_1679045,"Homo sapiens Shwachman-Bodian-Diamond syndrome (SBDS), mRNA.",,,,7,66090474-66090523,7q11.21e,-,NM_016038.2,51119,SBDS,-1.2192512342612165,9.140381021008752,-8.613173465856333,4.866489186825431e-15,2.256517164542369e-14,23.051820346506496
TM4SF4,ILMN_1792404,"Homo sapiens transmembrane 4 L six family member 4 (TM4SF4), mRNA.",membrane fraction [goid 5624] [pmid 7665614] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 7665614] [evidence TAS]; membrane [goid 16020] [evidence IEA],negative regulation of cell proliferation [goid 8285] [pmid 7665614] [evidence TAS],,3,150703657-150703706,3q25.1a,+,NM_004617.2,7104,TM4SF4,2.275341087271573,6.555160795424091,8.611279401781605,4.922673713161127e-15,2.281511597241784e-14,23.040447550068627
C10orf107,ILMN_1770399,"Homo sapiens chromosome 10 open reading frame 107 (C10orf107), mRNA.",,,,10,63195865-63195914,10q21.2b,+,NM_173554.1,219621,C10orf107,-1.5422463232630372,6.413381416345519,-8.600755880066368,5.246773226933132e-15,2.4244212176553837e-14,22.977277377898112
MRC1L1,ILMN_1683806,"Homo sapiens mannose receptor, C type 1-like 1 (MRC1L1), mRNA.",,,receptor activity [goid 4872] [evidence IEA]; sugar binding [goid 5529] [evidence IEA],10,17931703-17931752,10p12.33c,+,NM_001009567.1,414308,MRC1L1,-1.1399041456882282,5.362033468173434,-8.598054645404106,5.3333273137392756e-15,2.462709736748106e-14,22.96106736068956
CABP4,ILMN_1688864,"Homo sapiens calcium binding protein 4 (CABP4), mRNA.",flagellum (sensu Bacteria) [goid 9288] [evidence IEA],ciliary or flagellar motility [goid 1539] [evidence IEA]; signal transduction [goid 7165] [pmid 10625670] [evidence NAS],calcium ion binding [goid 5509] [pmid 10625670] [evidence NAS],11,66983024-66983073,11q13.1f,+,NM_145200.2,57010,CABP4,1.0766194468751893,5.735549972751917,8.592787704343495,5.5061907596421296e-15,2.5384300626479202e-14,22.929466330596888
C9orf24,ILMN_1763695,"Homo sapiens chromosome 9 open reading frame 24 (C9orf24), transcript variant 2, mRNA.",,,,9,34369170-34369179:34369644-34369683,9p13.3c,-,NM_147168.1,84688,C9orf24,-2.8930249377052233,8.41292380486592,-8.590929723224246,5.5684886785026064e-15,2.56537696245637e-14,22.91832046235693
LUM,ILMN_1790529,"Homo sapiens lumican (LUM), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 7665616] [evidence TAS]; fibrillar collagen [goid 5583] [pmid 10734230] [evidence IDA]; extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 7665616] [evidence TAS]; fibrillar collagen [goid 5583] [pmid 10734230] [evidence IDA],collagen fibril organization [goid 30199] [pmid 10892350] [evidence NAS]; visual perception [goid 7601] [pmid 10802664] [evidence TAS]; collagen fibril organization [goid 30199] [pmid 10892350] [evidence NAS]; visual perception [goid 7601] [pmid 10802664] [evidence TAS],extracellular matrix structural constituent [goid 5201] [pmid 10892350] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; collagen binding [goid 5518] [pmid 10892350] [evidence IDA]; extracellular matrix structural constituent [goid 5201] [pmid 10892350] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; collagen binding [goid 5518] [pmid 10892350] [evidence IDA],12,90022113-90022162,12q21.33c,-,NM_002345.3,4060,LUM,-1.1524002752997902,10.248282729980588,-8.56732891036993,6.4234537245596216e-15,2.9450151723416343e-14,22.77682324456506
HPN,ILMN_1687235,"Homo sapiens hepsin (transmembrane protease, serine 1) (HPN), transcript variant 2, mRNA.",integral to plasma membrane [goid 5887] [pmid 1885621] [evidence TAS]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 1885621] [evidence TAS]; membrane [goid 16020] [evidence IEA],,serine-type endopeptidase activity [goid 4252] [evidence IEA]; scavenger receptor activity [goid 5044] [evidence IEA]; serine-type endopeptidase activity [goid 4252] [evidence IEA]; scavenger receptor activity [goid 5044] [evidence IEA],19,40248762-40248776:40248993-40249027,19q13.11c,+,NM_002151.1,3249,HPN,1.07599761570241,8.297159464997048,8.566315987815939,6.462930895890495e-15,2.9624357701025663e-14,22.770753742967116
TOP1P2,ILMN_2043109,Homo sapiens topoisomerase (DNA) I pseudogene 2 (TOP1P2) on chromosome 22.,,,,22,23491609-23491658,22q11.23c,+,NR_001283.1,7152,TOP1P2,1.102162411491208,7.498841551285747,8.561605949836713,6.649685342458255e-15,3.045248439732313e-14,22.742534573298144
C1orf87,ILMN_1669805,"Homo sapiens chromosome 1 open reading frame 87 (C1orf87), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],1,60229061-60229093:60235869-60235885,1p32.1b,-,NM_152377.1,127795,C1orf87,-1.5083386789525903,5.814168126671199,-8.547208654318313,7.254409169172627e-15,3.3123281300047e-14,22.65631416451955
INPP4B,ILMN_2198878,"Homo sapiens inositol polyphosphate-4-phosphatase, type II, 105kDa (INPP4B), mRNA.",,signal transduction [goid 7165] [pmid 9295334] [evidence TAS],"phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [goid 16316] [pmid 9295334] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]",4,143222645-143222694,4q31.21b,-,NM_003866.1,8821,INPP4B,1.1784615692351883,7.148578124075439,8.52797649719092,8.148176260661836e-15,3.7077259636871055e-14,22.541228827213814
PLSCR1,ILMN_1745242,"Homo sapiens phospholipid scramblase 1 (PLSCR1), mRNA.",plasma membrane [goid 5886] [pmid 9218461] [evidence TAS]; integral to membrane [goid 16021] [evidence IEA],phospholipid scrambling [goid 17121] [pmid 9218461] [evidence TAS]; response to virus [goid 9615] [evidence IEA]; platelet activation [goid 30168] [pmid 9218461] [evidence NAS],calcium ion binding [goid 5509] [pmid 9218461] [evidence NAS]; phospholipid scramblase activity [goid 17128] [pmid 9218461] [evidence TAS]; protein binding [goid 5515] [pmid 16189514] [evidence IPI],3,147729187-147729236,3q24d,-,NM_021105.1,5359,PLSCR1,-1.2013237966842238,6.969435043284806,-8.512476014956949,8.947411143778618e-15,4.056646321430378e-14,22.448548647006177
KIT,ILMN_1790160,"Homo sapiens v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [pmid 9990072] [evidence TAS]; protein amino acid dephosphorylation [goid 6470] [evidence NR ]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; signal transduction [goid 7165] [pmid 9990072] [evidence TAS]; protein amino acid dephosphorylation [goid 6470] [evidence NR ]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA],receptor activity [goid 4872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; vascular endothelial growth factor receptor activity [goid 5021] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; receptor signaling protein tyrosine kinase activity [goid 4716] [pmid 9438854] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; vascular endothelial growth factor receptor activity [goid 5021] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; receptor signaling protein tyrosine kinase activity [goid 4716] [pmid 9438854] [evidence TAS],4,55301107-55301156,4q12c,+,NM_000222.1,3815,KIT,-1.1991532878911038,9.29309003410042,-8.508782953102898,9.14903463405164e-15,4.146180859753232e-14,22.426477051692622
HAMP,ILMN_1729188,"Homo sapiens hepcidin antimicrobial peptide (HAMP), mRNA.",extracellular region [goid 5576] [pmid 11034317] [evidence NAS],immune response [goid 6955] [pmid 11113131] [evidence TAS]; xenobiotic metabolism [goid 6805] [evidence IEA]; iron ion homeostasis [goid 6879] [evidence IEA],hormone activity [goid 5179] [evidence IEA],19,40467698-40467747,19q13.12a,+,NM_021175.2,57817,HAMP,1.4858817631103163,6.478442555770264,8.508187599720019,9.181957577298754e-15,4.1592168260492066e-14,22.422919277306114
IL1RL1,ILMN_2242900,"Homo sapiens interleukin 1 receptor-like 1 (IL1RL1), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],immune response [goid 6955] [pmid 10527832] [evidence NAS]; signal transduction [goid 7165] [pmid 1482686] [evidence TAS]; immune response [goid 6955] [pmid 10527832] [evidence NAS]; signal transduction [goid 7165] [pmid 1482686] [evidence TAS],interleukin-1 receptor activity [goid 4908] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; receptor signaling protein activity [goid 5057] [pmid 1482686] [evidence TAS]; protein binding [goid 5515] [pmid 8621446] [evidence IPI]; interleukin-1 receptor activity [goid 4908] [evidence IEA]; transmembrane receptor activity [goid 4888] [evidence IEA]; receptor signaling protein activity [goid 5057] [pmid 1482686] [evidence TAS]; protein binding [goid 5515] [pmid 8621446] [evidence IPI],2,102327480-102327529,2q12.1a,+,NM_003856.2,9173,IL1RL1,-2.00507023788482,6.341482924857828,-8.503403425269962,9.450827098067385e-15,4.278102909007517e-14,22.394333113501787
MT1A,ILMN_1691156,"Homo sapiens metallothionein 1A (MT1A), mRNA.",cytoplasm [goid 5737] [evidence NAS],,zinc ion binding [goid 8270] [evidence NAS]; metal ion binding [goid 46872] [evidence IEA]; copper ion binding [goid 5507] [evidence NAS]; cadmium ion binding [goid 46870] [evidence NAS],16,55231274-55231323,16q13b,+,NM_005946.2,4489,MT1A,-1.1157961790784903,13.105923377288894,-8.472746200796202,1.1369173475781507e-14,5.116383781003968e-14,22.211304192343775
KRT15,ILMN_1770612,"Homo sapiens keratin 15 (KRT15), mRNA.",intermediate filament [goid 5882] [pmid 2580298] [evidence TAS],epidermis development [goid 8544] [pmid 2452170] [evidence TAS],protein binding [goid 5515] [pmid 16189514] [evidence IPI]; structural constituent of cytoskeleton [goid 5200] [pmid 2580298] [evidence TAS],17,36923743-36923792,17q21.2b,-,NM_002275.2,3866,KRT15,1.943412717194347,7.187419626310565,8.46285974812971,1.2066681035509446e-14,5.4217416159549295e-14,22.15233693740106
TM7SF4,ILMN_1793730,"Homo sapiens transmembrane 7 superfamily member 4 (TM7SF4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 11169400] [evidence NAS]; cell surface [goid 9986] [pmid 11169400] [evidence IDA],osteoclast differentiation [goid 30316] [evidence ISS],,8,105437739-105437788,8q22.3d,+,NM_030788.2,81501,TM7SF4,-1.3871279494209814,6.405423487702986,-8.460463855466564,1.2242011852620846e-14,5.4980510246293576e-14,22.138050927110513
LOC441294,ILMN_2231608,"Homo sapiens similar to CTAGE6 (LOC441294), mRNA.",,,,7,142981292-142981341,7q35a,+,NM_001008747.1,441294,LOC441294,1.0216641097490156,6.290346459345013,8.454801777992818,1.2666474645461824e-14,5.686130237971734e-14,22.104296088966315
LOC196549,ILMN_1677910,"Homo sapiens similar to hypothetical protein FLJ20897 (LOC196549), mRNA.",,,,13,31425162-31425211,13q13.1a,+,NM_145293.2,196549,LOC196549,1.3743814830582295,6.341668241426525,8.449100165868739,1.3108659547600966e-14,5.881992828625255e-14,22.070314779565514
TUBB1,ILMN_1710280,"Homo sapiens tubulin, beta 1 (TUBB1), mRNA.",microtubule [goid 5874] [evidence IEA]; protein complex [goid 43234] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; protein polymerization [goid 51258] [evidence IEA],GTP binding [goid 5525] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; GTPase activity [goid 3924] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],20,57034856-57034905,20q13.32b,+,NM_030773.2,81027,TUBB1,-1.166617946318981,5.509836354227474,-8.432394416119292,1.4494417218968113e-14,6.484890423012388e-14,21.970802796209654
SCIN,ILMN_1813561,"Homo sapiens scinderin (SCIN), mRNA.",cytoskeleton [goid 5856] [evidence IEA]; cell cortex [goid 5938] [evidence ISS]; cytoplasm [goid 5737] [evidence ISS],calcium ion-dependent exocytosis [goid 17156] [evidence ISS]; positive regulation of apoptosis [goid 43065] [pmid 11568009] [evidence IMP]; barbed-end actin filament capping [goid 51016] [evidence IEA]; positive regulation of secretion [goid 51047] [evidence ISS]; negative regulation of cell proliferation [goid 8285] [pmid 11568009] [evidence IMP]; actin nucleation [goid 45010] [evidence ISS]; actin filament severing [goid 51014] [pmid 11568009] [evidence IMP]; positive regulation of megakaryocyte differentiation [goid 45654] [pmid 11568009] [evidence IMP],"actin filament binding [goid 51015] [evidence ISS]; phosphatidylserine binding [goid 1786] [evidence ISS]; phosphatidylinositol binding [goid 5545] [pmid 11568009] [evidence TAS]; phosphatidylinositol-4,5-bisphosphate binding [goid 5546] [evidence ISS]; calcium ion binding [goid 5509] [pmid 11568009] [evidence TAS]",7,12658795-12658844,7p21.3a,+,NM_033128.1,85477,SCIN,1.4925872927183548,8.292344776325644,8.417700715956755,1.583287164243523e-14,7.063190542293067e-14,21.883342176256505
IGSF4,ILMN_1680132,"Homo sapiens cell adhesion molecule 1 (CADM1), mRNA.",basolateral plasma membrane [goid 16323] [pmid 12826663] [evidence ISS]; plasma membrane [goid 5886] [pmid 15811952] [evidence IDA]; intercellular junction [goid 5911] [pmid 12826663] [evidence ISS],cell recognition [goid 8037] [pmid 15811952] [evidence IDA]; heterophilic cell adhesion [goid 7157] [pmid 12826663] [evidence ISS]; homophilic cell adhesion [goid 7156] [pmid 12826663] [evidence ISS]; cell adhesion [goid 7155] [evidence IEA]; calcium-independent cell-cell adhesion [goid 16338] [pmid 12202822] [evidence ISS]; positive regulation of cytokine secretion [goid 50715] [pmid 15811952] [evidence IDA],protein C-terminus binding [goid 8022] [pmid 12826663] [evidence ISS]; receptor binding [goid 5102] [pmid 15811952] [evidence IPI]; protein binding [goid 5515] [evidence IEA]; PDZ domain binding [goid 30165] [pmid 12826663] [evidence ISS]; protein homodimerization activity [goid 42803] [pmid 12826663] [evidence ISS],11,114550295-114550344,11q23.2c,-,NM_014333.2,23705,IGSF4,-1.1775044061605833,10.630198962611006,-8.392999504940327,1.8364799156650595e-14,8.167212747860971e-14,21.736454527364053
CXCL5,ILMN_1752562,"Homo sapiens chemokine (C-X-C motif) ligand 5 (CXCL5), mRNA.",extracellular space [goid 5615] [evidence IEA],cell-cell signaling [goid 7267] [pmid 7929219] [evidence TAS]; chemotaxis [goid 6935] [pmid 10820279] [evidence TAS]; positive regulation of cell proliferation [goid 8284] [pmid 10463948] [evidence TAS]; signal transduction [goid 7165] [pmid 10820279] [evidence TAS]; inflammatory response [goid 6954] [evidence NR ],chemokine activity [goid 8009] [pmid 10820279] [evidence TAS],4,75080983-75081032,4q13.3d,-,NM_002994.3,6374,CXCL5,-1.6725976366661701,6.14962724883615,-8.389943191854213,1.8704784112895085e-14,8.312868070431027e-14,21.718292204499257
LOC653098,ILMN_1676725,"PREDICTED: Homo sapiens similar to chromosome 1 open reading frame 116 (LOC653098), mRNA.",,,,1,205260176-205260225,,-,XM_925981.1,653098,LOC653098,-1.0734838323933635,7.903904180797796,-8.359370623161295,2.2468847977211462e-14,9.937150979841885e-14,21.53676259130551
NINJ2,ILMN_1731745,"Homo sapiens ninjurin 2 (NINJ2), mRNA.",integral to plasma membrane [goid 5887] [pmid 10627596] [evidence TAS]; membrane [goid 16020] [evidence IEA],tissue regeneration [goid 42246] [evidence IEA]; neuron adhesion [goid 7158] [pmid 10627596] [evidence TAS]; cell adhesion [goid 7155] [evidence IEA],protein binding [goid 5515] [evidence IEA],12,543798-543847,12p13.33d,-,NM_016533.4,4815,NINJ2,-1.0849216792178886,10.937730860672753,-8.353803333961679,2.3231060214573648e-14,1.0271979066810819e-13,21.50373531920627
LOC653261,ILMN_1694280,"PREDICTED: Homo sapiens similar to Acidic mammalian chitinase precursor (AMCase) (TSA1902) (LOC653261), mRNA.",,,,1,111625779-111625828,,+,XM_926640.1,653261,LOC653261,-1.8559035337029162,5.8843776741991665,-8.351276910643831,2.35853604475387e-14,1.0424031186974914e-13,21.48875061892752
LOC642921,ILMN_1669057,"PREDICTED: Homo sapiens hypothetical protein LOC642921 (LOC642921), mRNA.",,,,9,98735416-98735465,9q22.33a,-,XM_927226.1,642921,LOC642921,1.0271198752524517,6.232561955679138,8.348761876424401,2.3943388059392248e-14,1.0575260668704638e-13,21.47383533279246
SRD5A2L,ILMN_1678435,"Homo sapiens steroid 5 alpha-reductase 2-like (SRD5A2L), mRNA.",integral to membrane [goid 16021] [evidence IEA],,3-oxo-5-alpha-steroid 4-dehydrogenase activity [goid 3865] [evidence IEA],4,55931935-55931984,4q12d,+,NM_024592.1,79644,SRD5A2L,1.044513117296086,6.351065909695533,8.343016221011553,2.4781669720686914e-14,1.0931032799195409e-13,21.43976798974238
LOC649143,ILMN_1707951,"PREDICTED: Homo sapiens similar to HLA class II histocompatibility antigen, DRB1-9 beta chain precursor (MHC class I antigen DRB1*9) (DR-9) (DR9), transcript variant 2 (LOC649143), mRNA.",,,,,,,,XM_944822.1,649143,LOC649143,-1.2093462101544326,8.545373766829044,-8.338811259879508,2.541355980302359e-14,1.1199878954601233e-13,21.414841949053
WDRPUH,ILMN_1802539,"Homo sapiens WD40-repeat protein upregulated in HCC (WDRPUH), mRNA.",cytoskeleton [goid 5856] [evidence IEA],,,17,9487118-9487167,17p13.1b,+,NM_145054.2,146845,WDRPUH,-1.7890940371339958,6.080105204862869,-8.333987033805474,2.6158219728579693e-14,1.1512838986568906e-13,21.38625147457976
TFCP2L1,ILMN_1736527,"Homo sapiens transcription factor CP2-like 1 (TFCP2L1), mRNA.",nucleus [goid 5634] [evidence IEA],transcription [goid 6350] [evidence IEA]; steroid biosynthesis [goid 6694] [pmid 10644752] [evidence TAS]; pregnancy [goid 7565] [pmid 10644752] [evidence TAS]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 10644752] [evidence TAS],transcription corepressor activity [goid 3714] [pmid 10644752] [evidence TAS]; transcription factor activity [goid 3700] [pmid 10644752] [evidence TAS],2,121695121-121695170,2q14.2e,-,NM_014553.1,29842,TFCP2L1,1.326347934279016,7.516669088212337,8.329125425615599,2.6930547896645954e-14,1.1847546225067991e-13,21.357446414153223
ZIC2,ILMN_1696339,"Homo sapiens Zic family member 2 (odd-paired homolog, Drosophila) (ZIC2), mRNA.",nucleus [goid 5634] [evidence IEA]; voltage-gated potassium channel complex [goid 8076] [evidence IEA]; intracellular [goid 5622] [evidence IEA],potassium ion transport [goid 6813] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; brain development [goid 7420] [pmid 9771712] [evidence TAS],DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; voltage-gated potassium channel activity [goid 5249] [evidence IEA],13,99436571-99436620,13q32.3b,+,NM_007129.2,7546,ZIC2,1.268988549224594,5.54201558676833,8.32801087631118,2.7110771926229932e-14,1.192158955384634e-13,21.35084368735292
FBXL16,ILMN_1697561,"Homo sapiens F-box and leucine-rich repeat protein 16 (FBXL16), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],transferase activity [goid 16740] [evidence IEA],16,682825-682874,16p13.3f,-,NM_153350.2,146330,FBXL16,1.2856460082376238,6.380952207787275,8.309033890417437,3.0369626358665044e-14,1.3342896007557538e-13,21.238478232224395
VMO1,ILMN_1735910,"Homo sapiens vitelline membrane outer layer 1 homolog (chicken) (VMO1), mRNA.",,,,17,4635486-4635535,17p13.2c,-,NM_182566.1,284013,VMO1,-1.1750704904434137,7.578824713101223,-8.300663745987492,3.1927801237986575e-14,1.4002881349619365e-13,21.188951448216173
PLA1A,ILMN_1792506,"Homo sapiens phospholipase A1 member A (PLA1A), mRNA.",,phosphatidylserine metabolism [goid 6658] [pmid 10196188] [evidence TAS]; lipid metabolism [goid 6629] [pmid 10196188] [evidence TAS],phospholipase A1 activity [goid 8970] [pmid 10196188] [evidence TAS]; catalytic activity [goid 3824] [evidence IEA],3,120830993-120831005:120831006-120831042,3q13.33a,+,NM_015900.1,51365,PLA1A,-1.3348434197840602,7.016303218908373,-8.299844773840212,3.2084454935508576e-14,1.406542012159631e-13,21.18410664989875
CD1C,ILMN_1654210,"Homo sapiens CD1C antigen, c polypeptide (CD1C), mRNA.",integral to plasma membrane [goid 5887] [pmid 1702817] [evidence TAS]; plasma membrane [goid 5886] [pmid 2701945] [evidence TAS],antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9601940] [evidence TAS],,1,156529893-156529942,1q23.1e,+,NM_001765.1,911,CD1C,-1.0585107446655622,7.299800545032405,-8.294188452603995,3.3187419021782866e-14,1.4539388653116523e-13,21.150650988416643
C14orf78,ILMN_1657111,"PREDICTED: Homo sapiens chromosome 14 open reading frame 78, transcript variant 1 (C14orf78), mRNA.",,,,14,104474690-104474739,14q32.33c,-,XM_290629.6,113146,C14orf78,1.4778109641012502,9.62286956608174,8.286796552244262,3.468569313691736e-14,1.5152649525839357e-13,21.10694425812293
WNT7A,ILMN_1778575,"Homo sapiens wingless-type MMTV integration site family, member 7A (WNT7A), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence NR ],morphogenesis [goid 9653] [pmid 9161407] [evidence TAS]; cell-cell signaling [goid 7267] [evidence NR ]; sex differentiation [goid 7548] [pmid 9790192] [evidence TAS]; development [goid 7275] [evidence IEA]; signal transduction [goid 7165] [pmid 8893824] [evidence NAS]; frizzled-2 signaling pathway [goid 7223] [evidence IEA],receptor binding [goid 5102] [pmid 8893824] [evidence NAS]; signal transducer activity [goid 4871] [evidence IEA],3,13835227-13835276,3p25.1b,-,NM_004625.3,7476,WNT7A,-1.0839037751225238,6.029685733321898,-8.279336486835474,3.6265801069367605e-14,1.5818751859513998e-13,21.062851091178807
PKIB,ILMN_2337263,"Homo sapiens protein kinase (cAMP-dependent, catalytic) inhibitor beta (PKIB), transcript variant 3, mRNA.",,negative regulation of protein kinase activity [goid 6469] [evidence IEA],kinase activity [goid 16301] [evidence IEA]; cAMP-dependent protein kinase inhibitor activity [goid 4862] [evidence IEA],6,123080714-123080763,6q22.31c,+,NM_032471.4,5570,PKIB,1.3333189473669531,6.677326684546148,8.274254477411489,3.738289998660195e-14,1.6295360848190236e-13,21.032823141834804
C20orf85,ILMN_1661618,"Homo sapiens chromosome 20 open reading frame 85 (C20orf85), mRNA.",,,,20,56169276-56169284:56169285-56169325,20q13.32a,+,NM_178456.2,128602,C20orf85,-2.5100969235716706,7.207205386887195,-8.27159853683993,3.798022705987094e-14,1.6548527504658052e-13,21.017133140171033
CHST6,ILMN_1670881,"Homo sapiens carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 (CHST6), mRNA.",integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA]; intrinsic to Golgi membrane [goid 31228] [evidence ISS],N-acetylglucosamine metabolism [goid 6044] [pmid 11352640] [evidence IDA]; keratan sulfate biosynthesis [goid 18146] [pmid 11278593] [evidence IDA]; sulfur metabolism [goid 6790] [pmid 11352640] [evidence IDA]; carbohydrate metabolism [goid 5975] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; N-acetylglucosamine 6-O-sulfotransferase activity [goid 1517] [pmid 11352640] [evidence IDA],16,74064683-74064732,16q23.1a,-,NM_021615.3,4166,CHST6,1.1613342238550244,5.981048126574957,8.266623379440878,3.912474332771035e-14,1.702434079184253e-13,20.987748055591773
CST7,ILMN_1679826,"Homo sapiens cystatin F (leukocystatin) (CST7), mRNA.",,immune response [goid 6955] [pmid 9632704] [evidence TAS],cysteine protease inhibitor activity [goid 4869] [pmid 9733783] [evidence TAS],20,24888342-24888348:24888349-24888391,20p11.21a,+,NM_003650.2,8530,CST7,-1.0970201557278623,8.251652820858743,-8.266593073367504,3.9131818923272587e-14,1.702434079184253e-13,20.98756907979633
SUSD4,ILMN_2360307,"Homo sapiens sushi domain containing 4 (SUSD4), transcript variant 2, mRNA.",,,,1,221504747-221504783:221508467-221508479,1q41e,-,NM_001037175.1,55061,SUSD4,1.198653046449106,6.152775443550442,8.265252268039365,3.944613195906786e-14,1.7153623304434462e-13,20.979651086181605
RNF39,ILMN_1730223,"Homo sapiens ring finger protein 39 (RNF39), transcript variant 1, mRNA.",ubiquitin ligase complex [goid 151] [evidence IEA],protein ubiquitination [goid 16567] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA],6,30146148-30146197,6p21.33b,-,NM_025236.2,80352,RNF39,1.152454830593583,6.742930214769316,8.263450225129011,3.987251682745212e-14,1.7331508074813424e-13,20.969010154155683
CPAMD8,ILMN_1726250,"Homo sapiens C3 and PZP-like, alpha-2-macroglobulin domain containing 8 (CPAMD8), mRNA.",,,endopeptidase inhibitor activity [goid 4866] [evidence IEA],19,16864931-16864980,19p13.11e,-,NM_015692.1,27151,CPAMD8,-1.0193195481405555,6.4559262700183355,-8.258453849064683,4.107877811709567e-14,1.7840334112586287e-13,20.939512047688766
MMP13,ILMN_1663873,"Homo sapiens matrix metallopeptidase 13 (collagenase 3) (MMP13), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA]; extracellular space [goid 5615] [pmid 8207000] [evidence TAS],peptidoglycan metabolism [goid 270] [evidence IEA]; collagen catabolism [goid 30574] [evidence IEA],zinc ion binding [goid 8270] [pmid 8207000] [evidence TAS]; collagenase activity [goid 8133] [pmid 8609233] [evidence TAS]; metalloendopeptidase activity [goid 4222] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],11,102319653-102319702,11q22.2b,-,NM_002427.2,4322,MMP13,1.0168078020010682,5.286856359854375,8.23681624736529,4.673443832839876e-14,2.0200100282449826e-13,20.81185309116364
LOC642829,ILMN_1793950,"PREDICTED: Homo sapiens prostate-specific P704P (P704P), mRNA.",,,,14,19058193-19058242,14q11.1d,-,XM_926231.1,641455,LOC642829,-1.2521340926088493,7.255755464097485,-8.22737692781816,4.943755067982165e-14,2.1340809363578673e-13,20.756206962389903
JUNB,ILMN_2086077,"Homo sapiens jun B proto-oncogene (JUNB), mRNA.",chromatin [goid 785] [pmid 2513129] [evidence TAS]; nucleus [goid 5634] [evidence IEA],transcription [goid 6350] [evidence IEA]; regulation of transcription from RNA polymerase II promoter [goid 6357] [pmid 2513129] [evidence TAS],RNA polymerase II transcription factor activity [goid 3702] [pmid 2513129] [evidence TAS]; transcription coactivator activity [goid 3713] [pmid 2513129] [evidence TAS]; sequence-specific DNA binding [goid 43565] [evidence IEA]; protein dimerization activity [goid 46983] [evidence IEA]; transcription corepressor activity [goid 3714] [pmid 2513129] [evidence TAS]; transcription factor activity [goid 3700] [evidence IEA],19,12764585-12764629:12764630-12764634,19p13.13c,+,NM_002229.2,3726,JUNB,-1.214260451015301,10.327070014902565,-8.214106632728798,5.350184974580706e-14,2.304553304013149e-13,20.678022708404264
LOC653994,ILMN_1737586,"PREDICTED: Homo sapiens similar to Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosome region 1 protein homolog), transcript variant 2 (LOC653994), mRNA.",,,,,,,,XM_944429.1,653994,LOC653994,-1.7467671965532983,7.075621867445245,-8.213432771094022,5.3716851599386483e-14,2.3133163297471476e-13,20.674053973529475
TESC,ILMN_1750181,"Homo sapiens tescalcin (TESC), mRNA.",,,calcium ion binding [goid 5509] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI],12,115961343-115961392,12q24.22a-q24.22b,-,NM_017899.1,54997,TESC,1.4340065672880726,9.596867867503876,8.209185531772226,5.5091831753670515e-14,2.370488967155784e-13,20.649042893895363
PLA2G4C,ILMN_1810191,"Homo sapiens phospholipase A2, group IVC (cytosolic, calcium-independent) (PLA2G4C), mRNA.",membrane [goid 16020] [pmid 10085124] [evidence TAS]; cytosol [goid 5829] [pmid 10085124] [evidence TAS],glycerophospholipid catabolism [goid 46475] [pmid 10085124] [evidence IDA]; intracellular signaling cascade [goid 7242] [pmid 10085124] [evidence NAS]; arachidonic acid metabolism [goid 19369] [pmid 10085124] [evidence NAS]; lipid catabolism [goid 16042] [evidence IEA]; inflammatory response [goid 6954] [pmid 10085124] [evidence NAS]; parturition [goid 7567] [pmid 10085124] [evidence NAS],hydrolase activity [goid 16787] [evidence IEA]; phospholipid binding [goid 5543] [pmid 10085124] [evidence NAS]; calcium-independent phospholipase A2 activity [goid 47499] [pmid 10085124] [evidence IDA],19,53243026-53243075,19q13.32c,-,NM_003706.1,8605,PLA2G4C,-1.0332426405383828,8.710829320476025,-8.205334775680168,5.6368596573912134e-14,2.4243828036346387e-13,20.626371404914387
C17orf60,ILMN_1747347,"PREDICTED: Homo sapiens chromosome 17 open reading frame 60, transcript variant 4 (C17orf60), mRNA.",,,,,,17q23.3b,,XM_945975.1,284021,C17orf60,-1.0310010823305031,6.42568359910941,-8.191967301916941,6.103275737827697e-14,2.6165489814111115e-13,20.547705241855404
ACE2,ILMN_1667018,"Homo sapiens angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 (ACE2), mRNA.",integral to membrane [goid 16021] [evidence IEA]; extracellular region [goid 5576] [pmid 10969042] [evidence IDA]; membrane [goid 16020] [evidence IEA],,peptidyl-dipeptidase A activity [goid 4246] [evidence IEA]; viral receptor activity [goid 1618] [pmid 14647384] [evidence NAS]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; carboxypeptidase activity [goid 4180] [pmid 10969042] [evidence IDA]; protein binding [goid 5515] [pmid 14647384] [evidence NAS],X,15489259-15489308,Xp22.2,-,NM_021804.1,59272,ACE2,1.2009526413180458,6.104936662046295,8.19073658990701,6.148094822822263e-14,2.635198826371633e-13,20.54046540102501
ISG15,ILMN_2054019,"Homo sapiens ISG15 ubiquitin-like modifier (ISG15), mRNA.",cytoplasm [goid 5737] [evidence NAS]; extracellular space [goid 5615] [evidence NAS],response to virus [goid 9615] [evidence IEA]; cell-cell signaling [goid 7267] [evidence NAS]; immune response [goid 6955] [evidence IEA]; ubiquitin cycle [goid 6512] [pmid 16112642] [evidence IDA],protein binding [goid 5515] [evidence NAS],1,939540-939589,1p36.33b,+,NM_005101.1,9636,ISG15,1.2132612393264992,10.353197013311437,8.190471733945845,6.157782732052988e-14,2.6387859692207365e-13,20.538907408781512
HSPA2,ILMN_1766499,"Homo sapiens heat shock 70kDa protein 2 (HSPA2), mRNA.",cell surface [goid 9986] [pmid 12493773] [evidence IEP]; cell surface [goid 9986] [pmid 12493773] [evidence IEP],male meiosis [goid 7140] [pmid 8622925] [evidence TAS]; response to unfolded protein [goid 6986] [pmid 7829106] [evidence TAS]; protein folding [goid 6457] [evidence IEA]; male meiosis [goid 7140] [pmid 8622925] [evidence TAS]; response to unfolded protein [goid 6986] [pmid 7829106] [evidence TAS]; protein folding [goid 6457] [evidence IEA],unfolded protein binding [goid 51082] [pmid 3037489] [evidence TAS]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; unfolded protein binding [goid 51082] [pmid 3037489] [evidence TAS]; ATP binding [goid 5524] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],14,64079042-64079091,14q23.3a,+,NM_021979.2,3306,HSPA2,-1.073730696954696,7.154080350291064,-8.186100568926333,6.319875650469828e-14,2.7059292106698124e-13,20.513197538636838
CKM,ILMN_1757521,"Homo sapiens creatine kinase, muscle (CKM), mRNA.",cytoplasm [goid 5737] [evidence NAS],,creatine kinase activity [goid 4111] [pmid 3778496] [evidence TAS],19,50501675-50501724,19q13.32a,-,NM_001824.2,1158,CKM,1.0723777922019693,5.3694640550967065,8.18306988313893,6.434737373668333e-14,2.752752306443361e-13,20.495375428560195
CST5,ILMN_1688022,"Homo sapiens cystatin D (CST5), mRNA.",,,cysteine protease inhibitor activity [goid 4869] [pmid 1939105] [evidence TAS],20,23804797-23804824:23804825-23804846,20p11.21b,-,NM_001900.4,1473,CST5,-1.2297423371370373,6.165910568144949,-8.162162152189383,7.285550230103529e-14,3.107424621699241e-13,20.37250396503098
RBP2,ILMN_2219681,"Homo sapiens retinol binding protein 2, cellular (RBP2), mRNA.",,transport [goid 6810] [evidence IEA]; vitamin A metabolism [goid 6776] [pmid 2992469] [evidence TAS]; epidermis development [goid 8544] [pmid 1654334] [evidence TAS],retinal binding [goid 16918] [evidence IEA]; retinol binding [goid 19841] [evidence IEA]; lipid binding [goid 8289] [evidence IEA],3,140656263-140656312,3q23a,-,NM_004164.2,5948,RBP2,-1.1542464489857966,5.904446729909644,-8.114732950179887,9.651561229750215e-14,4.08263080517637e-13,20.094275889052653
NR5A2,ILMN_1811303,"Homo sapiens nuclear receptor subfamily 5, group A, member 2 (NR5A2), transcript variant 1, mRNA.",nucleus [goid 5634] [pmid 9786908] [evidence TAS]; nucleus [goid 5634] [pmid 9786908] [evidence TAS],"morphogenesis [goid 9653] [pmid 9786908] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9786908] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; homeostasis [goid 42592] [pmid 16289203] [evidence NAS]; transcription [goid 6350] [evidence IEA]; embryonic development [goid 9790] [pmid 16289203] [evidence TAS]; morphogenesis [goid 9653] [pmid 9786908] [evidence TAS]; transcription from RNA polymerase II promoter [goid 6366] [pmid 9786908] [evidence TAS]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; homeostasis [goid 42592] [pmid 16289203] [evidence NAS]; transcription [goid 6350] [evidence IEA]; embryonic development [goid 9790] [pmid 16289203] [evidence TAS]","transcription factor activity [goid 3700] [evidence IEA]; ligand-dependent nuclear receptor activity [goid 4879] [evidence IEA]; RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [pmid 9786908] [evidence TAS]; protein binding [goid 5515] [pmid 12040021] [evidence IPI]; sequence-specific DNA binding [goid 43565] [pmid 16289203] [evidence IDA]; lipid binding [goid 8289] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; steroid hormone receptor activity [goid 3707] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA]; ligand-dependent nuclear receptor activity [goid 4879] [evidence IEA]; RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [pmid 9786908] [evidence TAS]; protein binding [goid 5515] [pmid 12040021] [evidence IPI]; sequence-specific DNA binding [goid 43565] [pmid 16289203] [evidence IDA]; lipid binding [goid 8289] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]; steroid hormone receptor activity [goid 3707] [evidence IEA]",1,198412730-198412779,1q32.1a,+,NM_205860.1,2494,NR5A2,-1.1175399515589088,6.520747685483519,-8.112853102754922,9.759607930219677e-14,4.1274621743359817e-13,20.083262942424426
CACHD1,ILMN_1738854,"Homo sapiens cache domain containing 1 (CACHD1), mRNA.",membrane [goid 16020] [evidence IEA],,,1,64930924-64930973,1p31.3c-p31.3b,+,NM_020925.1,57685,CACHD1,-1.0615852728853596,7.427309232862864,-8.111385847093398,9.844772917945932e-14,4.1608410760934136e-13,20.07466790988608
LOC644945,ILMN_1738546,"PREDICTED: Homo sapiens similar to Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16) (LOC644945), mRNA.",,,,17,20346821-20346868:20346983-20346984,17p11.2c,-,XM_930406.1,644945,LOC644945,1.3873567744740312,5.976710330226588,8.1098742983405,9.933279364519669e-14,4.196474947747245e-13,20.06581412465936
CCDC3,ILMN_1671295,"Homo sapiens coiled-coil domain containing 3 (CCDC3), mRNA.",endoplasmic reticulum [goid 5783] [pmid 11256614] [evidence IDA],,,10,12978864-12978913,10p13e,-,NM_031455.2,83643,CCDC3,-1.0069430216685484,8.439377899049315,-8.108354068140612,1.0023089779764058e-13,4.230843466529942e-13,20.056910217317963
CEBPA,ILMN_1715715,"Homo sapiens CCAAT/enhancer binding protein (C/EBP), alpha (CEBPA), mRNA.",nucleus [goid 5634] [pmid 8758458] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; generation of precursor metabolites and energy [goid 6091] [pmid 8643605] [evidence TAS]; transcription [goid 6350] [pmid 15664994] [evidence IDA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 8643605] [evidence TAS]; cytokine and chemokine mediated signaling pathway [goid 19221] [pmid 15664994] [evidence NAS]","RNA polymerase II transcription factor activity, enhancer binding [goid 3705] [pmid 8758458] [evidence NAS]; transcription factor binding [goid 8134] [pmid 15664994] [evidence IPI]; protein dimerization activity [goid 46983] [evidence IEA]; sequence-specific DNA binding [goid 43565] [evidence IEA]",19,38483061-38483110,19q13.11b,-,NM_004364.2,1050,CEBPA,-1.0611245370111693,10.256053896635471,-8.106810378608666,1.0115109855533138e-13,4.2678852380748e-13,20.04786965816944
CLDN10,ILMN_1685194,"Homo sapiens claudin 10 (CLDN10), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; tight junction [goid 5923] [evidence ISS]; integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; tight junction [goid 5923] [evidence ISS],cell adhesion [goid 7155] [pmid 10508613] [evidence TAS]; calcium-independent cell-cell adhesion [goid 16338] [evidence ISS]; cell adhesion [goid 7155] [pmid 10508613] [evidence TAS]; calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA],13,95003169-95003218,13q32.1b,+,NM_006984.3,9071,CLDN10,1.8671526333595674,6.4461551576020275,8.099259192584855,1.0577450241884614e-13,4.458260468498575e-13,20.003657300092378
HOXC8,ILMN_1718285,"Homo sapiens homeobox C8 (HOXC8), mRNA.",nucleus [goid 5634] [evidence NAS],"regulation of transcription, DNA-dependent [goid 6355] [evidence NAS]; development [goid 7275] [evidence NAS]",transcription factor activity [goid 3700] [evidence NAS],12,52692510-52692559,12q13.13f,+,NM_022658.3,3224,HOXC8,1.0732681887099567,5.717880433308302,8.09419452649407,1.0899224078312459e-13,4.589050407383747e-13,19.974013703312572
EBI2,ILMN_1798706,"Homo sapiens Epstein-Barr virus induced gene 2 (lymphocyte-specific G protein-coupled receptor) (EBI2), mRNA.",integral to plasma membrane [goid 5887] [pmid 8383238] [evidence TAS],immune response [goid 6955] [pmid 8383238] [evidence TAS]; signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8383238] [evidence TAS],"rhodopsin-like receptor activity [goid 1584] [evidence IEA]; purinergic nucleotide receptor activity, G-protein coupled [goid 45028] [evidence IEA]; receptor activity [goid 4872] [evidence IEA]",13,98745378-98745427,13q32.3a,-,NM_004951.3,1880,EBI2,-1.157611566465408,8.388550305967986,-8.092418866662603,1.1014319510358308e-13,4.63555962901239e-13,19.96362265809399
TEKT1,ILMN_1654570,"Homo sapiens tektin 1 (TEKT1), mRNA.",microtubule [goid 5874] [evidence IEA],microtubule cytoskeleton organization and biogenesis [goid 226] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA],17,6644051-6644069:6644070-6644100,17p13.2a,-,NM_053285.1,83659,TEKT1,-2.315517996414936,7.170863322255589,-8.088956876784282,1.124219597415738e-13,4.729475547748967e-13,19.9433662024053
TNNT1,ILMN_2115991,"Homo sapiens troponin T type 1 (skeletal, slow) (TNNT1), mRNA.",,regulation of muscle contraction [goid 6937] [pmid 8135831] [evidence TAS],tropomyosin binding [goid 5523] [pmid 8135831] [evidence TAS]; protein binding [goid 5515] [pmid 15967462] [evidence IPI],19,60337379-60337384:60340283-60340326,19q13.42b,-,NM_003283.3,7138,TNNT1,1.1999036248912462,5.989035262712885,8.084744451307502,1.1525779347173942e-13,4.840633777881113e-13,19.91872401574087
CCRN4L,ILMN_1689378,"Homo sapiens CCR4 carbon catabolite repression 4-like (S. cerevisiae) (CCRN4L), mRNA.",nucleus [goid 5634] [pmid 10521507] [evidence TAS],transcription from RNA polymerase II promoter [goid 6366] [pmid 10521507] [evidence TAS]; rhythmic process [goid 48511] [evidence IEA],transcription factor activity [goid 3700] [pmid 10521507] [evidence TAS],4,140186450-140186499,4q31.1b,+,NM_012118.2,25819,CCRN4L,1.0307821699478152,6.930105317077419,8.077747877863363,1.2012546335495848e-13,5.042950631149831e-13,19.877807392976393
IL1A,ILMN_1658483,"Homo sapiens interleukin 1, alpha (IL1A), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 1924307] [evidence TAS]; cytoplasm [goid 5737] [evidence NR ],apoptosis [goid 6915] [pmid 1924307] [evidence TAS]; cell-cell signaling [goid 7267] [evidence NR ]; negative regulation of cell proliferation [goid 8285] [pmid 3493774] [evidence TAS]; chemotaxis [goid 6935] [evidence NR ]; fever [goid 1660] [evidence IEA]; anti-apoptosis [goid 6916] [pmid 10748004] [evidence TAS]; cell proliferation [goid 8283] [pmid 6209582] [evidence TAS],interleukin-1 receptor binding [goid 5149] [evidence IEA]; signal transducer activity [goid 4871] [pmid 10861041] [evidence TAS],2,113248305-113248354,2q13d,-,NM_000575.3,3552,IL1A,-1.1749667453049,5.914443162464844,-8.046256687460492,1.4468169534333993e-13,6.04466769770212e-13,19.69383789386974
C7orf10,ILMN_1763011,"Homo sapiens chromosome 7 open reading frame 10 (C7orf10), mRNA.",,metabolism [goid 8152] [evidence IEA],transferase activity [goid 16740] [evidence IEA],7,40866633-40866682,7p14.1c,+,NM_024728.1,79783,C7orf10,1.0475753183469294,6.902692174872092,8.042737583710778,1.4771763068768417e-13,6.16764264357092e-13,19.673299315054173
LTB4R,ILMN_1747251,"Homo sapiens leukotriene B4 receptor (LTB4R), mRNA.",integral to plasma membrane [goid 5887] [pmid 9177352] [evidence TAS],"signal transduction [goid 7165] [evidence IEA]; G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) [goid 7200] [pmid 8702478] [evidence TAS]; inflammatory response [goid 6954] [pmid 9177352] [evidence TAS]; cell motility [goid 6928] [pmid 9177352] [evidence TAS]; muscle contraction [goid 6936] [pmid 8702478] [evidence TAS]",nucleotide binding [goid 166] [pmid 8702478] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; leukotriene receptor activity [goid 4974] [pmid 9177352] [evidence TAS],14,23855752-23855756:23855757-23855801,14q12a,+,NM_181657.1,1241,LTB4R,1.0085518725927143,6.7229266230040565,8.041728058874002,1.4860014570293208e-13,6.200914115463186e-13,19.66740815284774
G0S2,ILMN_1691846,"Homo sapiens G0/G1switch 2 (G0S2), mRNA.",,cell cycle [goid 7049] [evidence IEA],,1,207915967-207916016,1q32.2b,+,NM_015714.2,50486,G0S2,-1.2968526352540124,7.391863159101356,-8.028814505321723,1.603607861054405e-13,6.678806428804441e-13,19.592079130817233
C20orf133,ILMN_1725633,"Homo sapiens MACRO domain containing 2 (MACROD2), transcript variant 2, mRNA.",,,,20,15125509-15125558,20p12.1d-p12.1b,+,NM_001033087.1,140733,C20orf133,-1.798496576377647,6.710249279976309,-8.025879741227188,1.63159614800834e-13,6.792545927871591e-13,19.57496720831454
PCSK1N,ILMN_1755582,"Homo sapiens proprotein convertase subtilisin/kexin type 1 inhibitor (PCSK1N), mRNA.",extracellular space [goid 5615] [pmid 10632593] [evidence TAS]; soluble fraction [goid 5625] [pmid 10632593] [evidence TAS],,endopeptidase inhibitor activity [goid 4866] [pmid 10632593] [evidence TAS]; receptor binding [goid 5102] [pmid 10632593] [evidence TAS],X,48574769-48574809:48575223-48575231,Xp11.23c,-,NM_013271.2,27344,PCSK1N,1.6094784796303845,7.471167835144674,8.004855359701688,1.84676700667822e-13,7.665998811124031e-13,19.452460758245678
SPINK5L3,ILMN_1697543,"PREDICTED: Homo sapiens serine PI Kazal type 5-like 3 (SPINK5L3), mRNA.",,,,5,147641902-147641951,5q33.1a,+,XM_376433.2,153218,SPINK5L3,1.1448952458986215,5.484474300949216,7.987840747270045,2.0413027483976911e-13,8.44374310315092e-13,19.353424251743995
D4S234E,ILMN_1772627,"Homo sapiens DNA segment on chromosome 4 (unique) 234 expressed sequence (D4S234E), mRNA.",integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA]; cytoplasm [goid 5737] [pmid 9013775] [evidence TAS]; nucleus [goid 5634] [pmid 9013775] [evidence TAS],dopamine receptor signaling pathway [goid 7212] [evidence IEA],dopamine receptor binding [goid 50780] [evidence IEA],4,4471438-4471487,4p16.2b,+,NM_014392.2,27065,D4S234E,-1.044694299582904,6.205315480064401,-7.980017610041172,2.1374353315585962e-13,8.828613978906771e-13,19.30792014347262
CCL3L1,ILMN_1773245,"Homo sapiens chemokine (C-C motif) ligand 3-like 1 (CCL3L1), mRNA.",extracellular region [goid 5576] [evidence NAS]; extracellular space [goid 5615] [evidence IEA]; extracellular region [goid 5576] [evidence NAS]; extracellular space [goid 5615] [evidence IEA],inflammatory response [goid 6954] [pmid 1694014] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 2271120] [evidence TAS]; chemotaxis [goid 6935] [evidence NAS]; inflammatory response [goid 6954] [pmid 1694014] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 2271120] [evidence TAS]; chemotaxis [goid 6935] [evidence NAS],chemokine activity [goid 8009] [evidence NAS]; chemokine activity [goid 8009] [evidence NAS],17,31649793-31649842,17q12b,-,NM_021006.4,6349,CCL3L1,-1.2317234853153805,6.365899553505931,-7.973002434099735,2.227447215463231e-13,9.187129228404109e-13,19.267132727144002
PNMA3,ILMN_1783805,"Homo sapiens paraneoplastic antigen MA3 (PNMA3), mRNA.",,,nucleic acid binding [goid 3676] [evidence IEA],X,151979356-151979405,Xq28f,+,NM_013364.2,29944,PNMA3,1.1252709362256148,6.359014662321918,7.972419574900411,2.2350927526171977e-13,9.214864165333792e-13,19.26374461400239
MGC24103,ILMN_1811779,"PREDICTED: Homo sapiens hypothetical protein MGC24103 (MGC24103), misc RNA.",,,,9,16516491-16516540,,-,XR_001080.1,158295,MGC24103,1.5143056065512637,7.202428275004176,7.96094508901309,2.3910148657638985e-13,9.829345681981525e-13,19.197067163305647
LOC649598,ILMN_1661303,"PREDICTED: Homo sapiens hypothetical protein LOC649598 (LOC649598), mRNA.",,,,,,9p13.3b,,XM_941608.1,649598,LOC649598,1.371235652110662,6.685548505185715,7.958584835086931,2.4243996466076803e-13,9.9543172849018e-13,19.18335727898505
RPIB9,ILMN_1808157,"Homo sapiens Rap2-binding protein 9 (RPIB9), mRNA.",,,,7,87297603-87297652,7q21.12a-q21.12b,+,NM_138290.1,154661,RPIB9,-1.3566337326646076,6.0395844932416365,-7.953537984991997,2.4973428143466543e-13,1.0237007791323062e-12,19.154048084300946
CYR61,ILMN_2188264,"Homo sapiens cysteine-rich, angiogenic inducer, 61 (CYR61), mRNA.",extracellular region [goid 5576] [evidence IEA],chemotaxis [goid 6935] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA]; regulation of cell growth [goid 1558] [evidence IEA]; cell proliferation [goid 8283] [pmid 9135077] [evidence TAS]; morphogenesis [goid 9653] [pmid 9135077] [evidence TAS],insulin-like growth factor binding [goid 5520] [evidence IEA]; heparin binding [goid 8201] [evidence IEA],1,85821467-85821516,1p22.3e,+,NM_001554.3,3491,CYR61,-1.216495804607236,11.452421743916554,-7.917438492161949,3.0864714220376353e-13,1.2561863346649512e-12,18.94464968566829
LOC643674,ILMN_1813801,"PREDICTED: Homo sapiens similar to peptidase (prosome, macropain) 26S subunit, ATPase 1 (LOC643674), mRNA.",,,,12,18737391-18737440,,+,XM_928643.1,643674,LOC643674,-1.0080834712960955,7.588621584677811,-7.915065324732883,3.1297019819266554e-13,1.2727454726501732e-12,18.9308991354363
CKMT1A,ILMN_1732066,"Homo sapiens creatine kinase, mitochondrial 1A (CKMT1A), nuclear gene encoding mitochondrial protein, mRNA.",,,,15,41777634-41777638:41778131-41778175,15q15.3a,+,NM_001015001.1,548596,CKMT1A,1.471828253499785,6.654983484428959,7.888903205113172,3.647918413098822e-13,1.4756884676360945e-12,18.77943645708944
HPGD,ILMN_2166457,"Homo sapiens hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD), mRNA.",cytosol [goid 5829] [pmid 15581601] [evidence TAS],prostaglandin metabolism [goid 6693] [pmid 15581601] [evidence TAS]; metabolism [goid 8152] [evidence IEA]; pregnancy [goid 7565] [pmid 15531523] [evidence IDA]; lipid metabolism [goid 6629] [evidence IEA]; fatty acid metabolism [goid 6631] [evidence IEA]; parturition [goid 7567] [pmid 15531523] [evidence IDA]; transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 15574495] [evidence IDA],oxidoreductase activity [goid 16491] [evidence IEA]; protein homodimerization activity [goid 42803] [pmid 2025296] [evidence TAS]; NAD binding [goid 51287] [pmid 15581601] [evidence IDA]; prostaglandin E receptor activity [goid 4957] [pmid 10198228] [evidence IDA]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [goid 16404] [pmid 15581601] [evidence IDA],4,175648475-175648524,4q34.1d,-,NM_000860.3,3248,HPGD,-1.8209366179815536,9.499772874647403,-7.8863644953275385,3.702517771483923e-13,1.4968675605546641e-12,18.76475114054314
SLC6A3,ILMN_2105797,"Homo sapiens solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 (SLC6A3), mRNA.",cytoplasm [goid 5737] [pmid 10823899] [evidence TAS]; integral to plasma membrane [goid 5887] [evidence IEA]; plasma membrane [goid 5886] [pmid 11343649] [evidence IDA],monoamine transport [goid 15844] [pmid 16024787] [evidence IDA],protein binding [goid 5515] [pmid 11343649] [evidence IPI]; dopamine:sodium symporter activity [goid 5330] [evidence IEA]; monoamine transporter activity [goid 8504] [pmid 16024787] [evidence IDA]; symporter activity [goid 15293] [evidence IEA],5,1446076-1446125,5p15.33d,-,NM_001044.2,6531,SLC6A3,1.3516052365558435,5.895279017521466,7.878342570499719,3.880419452617405e-13,1.5662584710100674e-12,18.7183621488021
LOC285498,ILMN_1787259,"Homo sapiens ring finger protein 212 (RNF212), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [evidence IEA],4,1055595-1055644,4p16.3c,-,NM_194439.1,285498,LOC285498,1.0191747955653065,6.206221178457304,7.852026884268401,4.5256036627004957e-13,1.8164148060844838e-12,18.566337565490173
GFRA3,ILMN_1810716,"Homo sapiens GDNF family receptor alpha 3 (GFRA3), mRNA.",membrane [goid 16020] [evidence IEA]; extrinsic to membrane [goid 19898] [pmid 9490034] [evidence TAS],peripheral nervous system development [goid 7422] [pmid 9576965] [evidence TAS]; signal transduction [goid 7165] [pmid 9576965] [evidence TAS],receptor activity [goid 4872] [evidence IEA]; GPI anchor binding [goid 48503] [evidence IEA]; receptor binding [goid 5102] [pmid 9407096] [evidence TAS],5,137616255-137616304,5q31.2c,-,NM_001496.3,2676,GFRA3,1.727648455667933,6.494276599423861,7.839311133801393,4.874369327770157e-13,1.952480110310817e-12,18.49296370585433
C19orf4,ILMN_1730945,"Homo sapiens chromosome 19 open reading frame 4 (C19orf4), mRNA.",integral to membrane [goid 16021] [pmid 10527841] [evidence TAS]; membrane [goid 16020] [evidence IEA]; membrane fraction [goid 5624] [pmid 10527841] [evidence TAS],,,19,18592697-18592746,19p13.11b,+,NM_012109.1,25789,C19orf4,1.6363971724331234,6.4696034246008205,7.838833190427139,4.887984904288296e-13,1.9575420729583714e-12,18.490206900405155
THY1,ILMN_1779875,"Homo sapiens Thy-1 cell surface antigen (THY1), mRNA.",lipid raft [goid 45121] [pmid 15093746] [evidence NAS]; external side of plasma membrane [goid 9897] [evidence ISS]; integral to plasma membrane [goid 5887] [pmid 2864289] [evidence TAS]; plasma membrane [goid 5886] [evidence ISS]; growth cone [goid 30426] [evidence ISS]; endoplasmic reticulum [goid 5783] [pmid 11256614] [evidence IDA]; cytosol [goid 5829] [evidence ISS],positive regulation of release of sequestered calcium ion into cytosol [goid 51281] [evidence ISS]; negative regulation of axonogenesis [goid 50771] [evidence ISS]; T cell receptor signaling pathway [goid 50852] [evidence ISS]; cell-cell adhesion [goid 16337] [evidence ISS]; positive regulation of GTPase activity [goid 43547] [evidence ISS]; positive regulation of T cell activation [goid 50870] [evidence ISS]; negative regulation of protein kinase activity [goid 6469] [evidence ISS]; positive regulation of peptidyl-tyrosine phosphorylation [goid 50731] [evidence ISS]; focal adhesion formation [goid 48041] [evidence ISS]; angiogenesis [goid 1525] [evidence ISS]; negative regulation of T cell receptor signaling pathway [goid 50860] [evidence ISS]; retinal cone cell development [goid 46549] [evidence ISS]; negative regulation of apoptosis [goid 43066] [evidence ISS]; negative regulation of fibroblast proliferation [goid 48147] [evidence ISS]; mast cell activation [goid 45576] [evidence ISS]; negative regulation of cell migration [goid 30336] [evidence ISS]; cytoskeleton organization and biogenesis [goid 7010] [evidence ISS],Rho GTPase activator activity [goid 5100] [evidence ISS]; protein binding [goid 5515] [pmid 7513706] [evidence IPI]; integrin binding [goid 5178] [pmid 15004192] [evidence IPI]; GPI anchor binding [goid 48503] [evidence ISS],11,118794230-118794279,11q23.3f,-,NM_006288.2,7070,THY1,1.3457545835428206,9.8999826952641925,7.825301508037369,5.289500646467669e-13,2.115377352279135e-12,18.412187833639635
CEL,ILMN_1723418,"Homo sapiens carboxyl ester lipase (bile salt-stimulated lipase) (CEL), mRNA.",cytoplasm [goid 5737] [evidence ISS]; endoplasmic reticulum [goid 5783] [evidence IEA],lipid catabolism [goid 16042] [evidence IEA]; lipid metabolism [goid 6629] [evidence ISS]; fatty acid catabolism [goid 9062] [pmid 7578248] [evidence NAS]; triacylglycerol metabolism [goid 6641] [pmid 2265692] [evidence IC ]; cholesterol catabolism [goid 6707] [pmid 12031288] [evidence IDA]; cholesterol absorption [goid 30299] [pmid 12031288] [evidence NAS]; protein amino acid esterification [goid 18350] [pmid 7578248] [evidence NAS]; pancreatic juice secretion [goid 30157] [pmid 1854805] [evidence IDA],heparin binding [goid 8201] [pmid 7578248] [evidence NAS]; sterol esterase activity [goid 4771] [pmid 12031288] [evidence NAS]; triacylglycerol lipase activity [goid 4806] [pmid 2265692] [evidence NAS]; serine esterase activity [goid 4759] [pmid 2265692] [evidence TAS]; hydrolase activity [goid 16787] [pmid 2265692] [evidence TAS],9,134936935-134936972:134936973-134936984,9q34.2a,+,NM_001807.2,1056,CEL,1.0432137534267785,6.063382478761336,7.817457064891862,5.537044815967966e-13,2.2121643905328887e-12,18.366988230877062
GPNMB,ILMN_1801205,"Homo sapiens glycoprotein (transmembrane) nmb (GPNMB), transcript variant 1, mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [pmid 7814155] [evidence TAS],negative regulation of cell proliferation [goid 8285] [pmid 7814155] [evidence TAS],,7,23280846-23280895,7p15.3b,+,NM_001005340.1,10457,GPNMB,-1.0282628921220685,10.767584403116341,-7.80372150081666,5.998430085686111e-13,2.3912450518909683e-12,18.287895094251965
LOC652815,ILMN_1709650,"PREDICTED: Homo sapiens similar to FK506-binding protein 9 precursor (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase) (LOC652815), mRNA.",,,,,,,,XM_942488.1,652815,LOC652815,-1.0057380951816839,6.15663850428341,-7.800302722618815,6.119065093351813e-13,2.4378784226958e-12,18.268218957316897
CTSL2,ILMN_1748352,"Homo sapiens cathepsin L2 (CTSL2), mRNA.",lysosome [goid 5764] [evidence IEA],,cathepsin L activity [goid 4217] [pmid 9563472] [evidence TAS],9,98835003-98835051:98835052-98835052,9q22.33a,-,NM_001333.2,1515,CTSL2,1.0111694614207165,6.635649934732133,7.797630660994585,6.215021516128738e-13,2.474137494920489e-12,18.252843222221074
SNF1LK,ILMN_1717639,"Homo sapiens SNF1-like kinase (SNF1LK), mRNA.",cytoplasm [goid 5737] [evidence ISS],regulation of cell differentiation [goid 45595] [evidence ISS]; cell cycle [goid 7049] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence ISS]; protein kinase cascade [goid 7243] [evidence ISS],nucleotide binding [goid 166] [evidence IEA]; magnesium ion binding [goid 287] [evidence ISS]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence ISS]; ATP binding [goid 5524] [evidence ISS]; protein-tyrosine kinase activity [goid 4713] [evidence IEA],21,43659254-43659303,21q22.3c,-,NM_173354.2,150094,SNF1LK,-1.165539564200877,9.522276226001742,-7.7881216935425925,6.56874280120656e-13,2.6107947152670015e-12,18.198146219814177
FOXA1,ILMN_1766650,"Homo sapiens forkhead box A1 (FOXA1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [pmid 8652662] [evidence TAS],14,37129209-37129258,14q21.1a,-,NM_004496.2,3169,FOXA1,1.0462555727642577,9.998928258026982,7.787297341572598,6.600330652219111e-13,2.622828514192651e-12,18.19340590114495
TNFAIP3,ILMN_1702691,"Homo sapiens tumor necrosis factor, alpha-induced protein 3 (TNFAIP3), mRNA.",nucleus [goid 5634] [pmid 11463333] [evidence IDA],ubiquitin cycle [goid 6512] [evidence IEA]; apoptosis [goid 6915] [evidence IEA]; anti-apoptosis [goid 6916] [evidence NAS]; negative regulation of I-kappaB kinase/NF-kappaB cascade [goid 43124] [pmid 11463333] [evidence IDA],cysteine-type peptidase activity [goid 8234] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 11463333] [evidence IPI],6,138245727-138245776,6q23.3d,+,NM_006290.2,7128,TNFAIP3,-1.0052809307974666,9.312830661047036,-7.786682837444629,6.623975283578721e-13,2.6317016972566134e-12,18.189872436100835
C15orf48,ILMN_1654696,"Homo sapiens chromosome 15 open reading frame 48 (C15orf48), transcript variant 2, mRNA.",nucleus [goid 5634] [pmid 12209954] [evidence IDA]; nucleus [goid 5634] [pmid 12209954] [evidence IDA],,,15,43510201-43510250,15q21.1a,+,NM_032413.2,84419,C15orf48,1.023620827800955,6.806479821843372,7.782746470921938,6.777439279550034e-13,2.691069757992401e-12,18.167241014936224
FLJ46082,ILMN_1663665,"Homo sapiens FLJ46082 protein (FLJ46082), mRNA.",,,,9,134438353-134438402,9q34.13b,+,NM_207417.1,389799,FLJ46082,-1.6879589036725875,5.938493554340448,-7.774504400808221,7.110261822541424e-13,2.8193047670513043e-12,18.11987218957428
CCL22,ILMN_2160476,"Homo sapiens chemokine (C-C motif) ligand 22 (CCL22), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 9743322] [evidence TAS],antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9151897] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 9151897] [evidence TAS]; response to virus [goid 9615] [pmid 9381181] [evidence TAS]; chemotaxis [goid 6935] [pmid 10861057] [evidence TAS]; signal transduction [goid 7165] [pmid 9743322] [evidence TAS]; inflammatory response [goid 6954] [pmid 9151897] [evidence TAS],chemokine activity [goid 8009] [pmid 10861057] [evidence TAS],16,55957285-55957334,16q13c,+,NM_002990.3,6367,CCL22,1.2040205061944693,7.115477632230929,7.765992753240955,7.470957679392315e-13,2.9570508654655082e-12,18.0709788919686
GPX2,ILMN_2133205,"Homo sapiens glutathione peroxidase 2 (gastrointestinal) (GPX2), mRNA.",cytoplasm [goid 5737] [pmid 8428933] [evidence TAS],response to oxidative stress [goid 6979] [evidence IEA],electron carrier activity [goid 9055] [pmid 8428933] [evidence TAS]; glutathione peroxidase activity [goid 4602] [pmid 8428933] [evidence TAS]; selenium binding [goid 8430] [evidence IEA],14,64475906-64475955,14q23.3a,-,NM_002083.2,2877,GPX2,2.2785517218878297,7.011089326691112,7.761733298744469,7.658202919902981e-13,3.0263741659375632e-12,18.046520882866695
TYRP1,ILMN_2054652,"Homo sapiens tyrosinase-related protein 1 (TYRP1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; melanosome [goid 42470] [evidence ISS]; membrane [goid 16020] [evidence IEA],metabolism [goid 8152] [evidence IEA]; melanin biosynthesis from tyrosine [goid 6583] [evidence ISS],oxidoreductase activity [goid 16491] [evidence IEA]; protein homodimerization activity [goid 42803] [evidence ISS]; protein heterodimerization activity [goid 46982] [evidence ISS]; copper ion binding [goid 5507] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; monooxygenase activity [goid 4497] [evidence IEA]; protein binding [goid 5515] [evidence ISS],9,12699921-12699970,9p23b,+,NM_000550.1,7306,TYRP1,-1.0424535210748775,5.7545374630193,-7.756580243717494,7.890951198225852e-13,3.116505163326152e-12,18.016940253818305
LOC349136,ILMN_1700248,"Homo sapiens WD repeat domain 86 (WDR86), mRNA.",,electron transport [goid 6118] [evidence IEA],,7,150709154-150709203,7q36.1d,-,NM_198285.1,349136,LOC349136,1.3162073049671887,7.46543317841879,7.74374351528247,8.501646698627312e-13,3.3504224373869464e-12,17.943292680049083
GZMB,ILMN_2109489,"Homo sapiens granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) (GZMB), mRNA.",cytoplasm [goid 5737] [evidence NR ]; immunological synapse [goid 1772] [pmid 12524539] [evidence TAS]; nucleus [goid 5634] [pmid 11909973] [evidence TAS],apoptosis [goid 6915] [pmid 12524539] [evidence TAS]; cleavage of lamin [goid 6922] [pmid 11331782] [evidence IDA]; cytolysis [goid 19835] [evidence IEA],peptidase activity [goid 8233] [evidence IEA]; granzyme B activity [goid 4278] [pmid 12524539] [evidence TAS]; serine-type endopeptidase activity [goid 4252] [evidence IEA],14,24170064-24170113,14q12a,-,NM_004131.3,3002,GZMB,-1.1424321431244966,8.992360062079445,-7.743620635426597,8.507713094267103e-13,3.352152886768338e-12,17.9425879665756
VTCN1,ILMN_1753101,"Homo sapiens V-set domain containing T cell activation inhibitor 1 (VTCN1), mRNA.",,,receptor activity [goid 4872] [evidence IEA],1,117487817-117487866,1p13.1a,-,NM_024626.1,79679,VTCN1,1.6095033368130105,6.267556780475914,7.743034586767229,8.536704459158617e-13,3.3629136211625435e-12,17.93922706244686
TMEM71,ILMN_1674402,"Homo sapiens transmembrane protein 71 (TMEM71), mRNA.",integral to membrane [goid 16021] [evidence IEA],,,8,133791561-133791610,8q24.22b,-,NM_144649.1,137835,TMEM71,-1.0203221829290605,7.050159188096607,-7.719752653540713,9.771088112145563e-13,3.832580492997616e-12,17.80580641913877
C15orf26,ILMN_1686373,"Homo sapiens chromosome 15 open reading frame 26 (C15orf26), mRNA.",,,,15,79228403-79228452,15q25.1b,+,NM_173528.1,161502,C15orf26,-1.2557421244941525,5.719642700574407,-7.717559954475934,9.896070707721276e-13,3.879321761757196e-12,17.7932506868408
PPARGC1A,ILMN_1750062,"Homo sapiens peroxisome proliferative activated receptor, gamma, coactivator 1, alpha (PPARGC1A), mRNA.","nucleus [goid 5634] [pmid 12588810] [evidence TAS]; DNA-directed RNA polymerase II, core complex [goid 5665] [pmid 12588810] [evidence TAS]","cellular respiration [goid 45333] [pmid 11551810] [evidence TAS]; thermoregulation [goid 1659] [pmid 1258810] [evidence TAS]; response to starvation [goid 42594] [pmid 11854298] [evidence NAS]; protein stabilization [goid 50821] [pmid 14636573] [evidence TAS]; gluconeogenesis [goid 6094] [pmid 11854298] [evidence NAS]; brown fat cell differentiation [goid 50873] [pmid 12588810] [evidence TAS]; cell glucose homeostasis [goid 1678] [pmid 11854298] [evidence NAS]; positive regulation of transcription, DNA-dependent [goid 45893] [pmid 15572661] [evidence NAS]; androgen receptor signaling pathway [goid 30521] [pmid 15572661] [evidence NAS]; transcription initiation from RNA polymerase II promoter [goid 6367] [pmid 14636573] [evidence TAS]; positive regulation of histone acetylation [goid 35066] [pmid 14636573] [evidence TAS]; transcription [goid 6350] [evidence IEA]; positive regulation of fatty acid oxidation [goid 46321] [pmid 12588810] [evidence TAS]; positive regulation of gluconeogenesis [goid 45722] [pmid 12588810] [evidence TAS]; mRNA processing [goid 6397] [pmid 12588810] [evidence TAS]; digestion [goid 7586] [pmid 10585775] [evidence TAS]; mitochondrion organization and biogenesis [goid 7005] [pmid 11854298] [evidence NAS]; protein complex assembly [goid 6461] [pmid 14636573] [evidence TAS]; RNA splicing [goid 8380] [pmid 12588810] [evidence TAS]; fatty acid oxidation [goid 19395] [pmid 11854298] [evidence NAS]",nucleotide binding [goid 166] [evidence IEA]; DNA binding [goid 3677] [pmid 10713165] [evidence TAS]; RNA binding [goid 3723] [pmid 12588810] [evidence TAS]; androgen receptor binding [goid 50681] [pmid 15572661] [evidence NAS]; transcription factor binding [goid 8134] [pmid 12588810] [evidence TAS]; ligand-dependent nuclear receptor transcription coactivator activity [goid 30374] [pmid 12588810] [evidence TAS]; RNA polymerase II transcription mediator activity [goid 16455] [pmid 14636573] [evidence TAS],4,23402860-23402909,4p15.2d,-,NM_013261.2,10891,PPARGC1A,-1.2844832370611439,7.113119304369537,-7.711817861434382,1.023091560341005e-12,4.004306717391007e-12,17.760378645635633
DMBT1,ILMN_1681612,"Homo sapiens deleted in malignant brain tumors 1 (DMBT1), transcript variant 3, mRNA.",cytoplasm [goid 5737] [evidence ISS]; phagocytic vesicle membrane [goid 30670] [evidence ISS]; membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [evidence ISS]; cytoplasm [goid 5737] [evidence ISS]; phagocytic vesicle membrane [goid 30670] [evidence ISS]; membrane [goid 16020] [evidence IEA]; extracellular region [goid 5576] [evidence ISS],induction of bacterial agglutination [goid 43152] [evidence ISS]; cell cycle [goid 7049] [evidence IEA]; epithelial cell differentiation [goid 30855] [evidence ISS]; innate immune response [goid 45087] [evidence ISS]; induction of bacterial agglutination [goid 43152] [evidence ISS]; cell cycle [goid 7049] [evidence IEA]; epithelial cell differentiation [goid 30855] [evidence ISS]; innate immune response [goid 45087] [evidence ISS],calcium-dependent protein binding [goid 48306] [evidence ISS]; scavenger receptor activity [goid 5044] [evidence ISS]; pattern recognition receptor activity [goid 8329] [evidence ISS]; calcium-dependent protein binding [goid 48306] [evidence ISS]; scavenger receptor activity [goid 5044] [evidence ISS]; pattern recognition receptor activity [goid 8329] [evidence ISS],10,124364789-124364812:124366734-124366759,10q26.13b,+,NM_017579.1,1755,DMBT1,-1.1056225276707004,8.134982642603902,-7.707462030843425,1.0492380974465015e-12,4.102629637230722e-12,17.73545040576954
MYBPH,ILMN_1705297,"Homo sapiens myosin binding protein H (MYBPH), mRNA.",cytoskeleton [goid 5856] [evidence NR ]; striated muscle thick filament [goid 5863] [evidence IEA],cell adhesion [goid 7155] [evidence IEA]; regulation of striated muscle contraction [goid 6942] [pmid 8486381] [evidence TAS],structural constituent of muscle [goid 8307] [pmid 8486381] [evidence TAS]; protein binding [goid 5515] [evidence IEA],1,201403623-201403672,1q32.1e,-,NM_004997.2,4608,MYBPH,1.4654980699143483,5.961124360223761,7.685883892688129,1.1888443794356311e-12,4.628604464632829e-12,17.612059093387508
SIGLECP16,ILMN_2229261,"Homo sapiens sialic acid binding Ig-like lectin, pseudogene 16 (SIGLECP16) on chromosome 19.",,,,19,55170774-55170823,19q13.33b,+,NR_002825.1,400709,SIGLECP16,-1.0932952431685354,5.690052076103323,-7.681197428659326,1.2215141297577669e-12,4.7474853745519425e-12,17.58528220383174
C22orf15,ILMN_1802771,"Homo sapiens chromosome 22 open reading frame 15 (C22orf15), mRNA.",,,,22,22437931-22437980,22q11.23a,+,NM_182520.1,150248,C22orf15,-1.613826584331826,6.19753429623543,-7.677701399455657,1.2464625183969526e-12,4.842567391861403e-12,17.56531217513725
CTAGE6,ILMN_1806463,"PREDICTED: Homo sapiens CTAGE family, member 6 (CTAGE6), mRNA.",,,,7,143083292-143083341,7q35a,-,XM_498461.2,340307,CTAGE6,1.051294771283101,6.568105846327902,7.6447920770353,1.507462731146086e-12,5.8237718333212756e-12,17.37754243797759
GZMA,ILMN_1779324,"Homo sapiens granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) (GZMA), mRNA.",nucleus [goid 5634] [pmid 11909973] [evidence TAS]; immunological synapse [goid 1772] [pmid 12524539] [evidence TAS],cytolysis [goid 19835] [evidence IEA]; immune response [goid 6955] [pmid 12524539] [evidence TAS]; cleavage of lamin [goid 6922] [pmid 11331782] [evidence IDA]; apoptosis [goid 6915] [pmid 12524539] [evidence TAS],protein homodimerization activity [goid 42803] [pmid 12819770] [evidence IDA]; granzyme A activity [goid 4277] [pmid 12819770] [evidence IDA]; peptidase activity [goid 8233] [evidence IEA],5,54441606-54441655,5q11.2d,+,NM_006144.2,3001,GZMA,-1.1262111998845477,8.837469387371362,-7.621649177699318,1.722717668341716e-12,6.615764896004041e-12,17.24573074821739
CEACAM6,ILMN_1712522,"Homo sapiens carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) (CEACAM6), mRNA.",integral to plasma membrane [goid 5887] [pmid 3220478] [evidence TAS]; membrane [goid 16020] [evidence IEA],cell-cell signaling [goid 7267] [pmid 3220478] [evidence TAS]; signal transduction [goid 7165] [pmid 3220478] [evidence TAS],GPI anchor binding [goid 48503] [evidence IEA],19,46967587-46967636,19q13.2c,+,NM_002483.3,4680,CEACAM6,1.1239434121477014,13.583451952281923,7.6187142181311165,1.7521035382978076e-12,6.7260336903803785e-12,17.22902840475613
SLN,ILMN_1778595,"Homo sapiens sarcolipin (SLN), mRNA.",sarcoplasmic reticulum [goid 16529] [evidence IEA]; membrane [goid 16020] [evidence IEA]; smooth endoplasmic reticulum [goid 5790] [evidence NR ]; integral to membrane [goid 16021] [pmid 9367679] [evidence TAS],transport [goid 6810] [pmid 9367679] [evidence TAS],enzyme regulator activity [goid 30234] [evidence IEA],11,107083412-107083461,11q22.3c,-,NM_003063.1,6588,SLN,-1.588168281481094,6.478524855072403,-7.6168880013972515,1.7706380631359837e-12,6.794577362336931e-12,17.218637304899296
KIF1A,ILMN_1759330,"Homo sapiens kinesin family member 1A (KIF1A), mRNA.",microtubule associated complex [goid 5875] [evidence IEA]; microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA]; anterograde axon cargo transport [goid 8089] [pmid 7539720] [evidence TAS],ATP binding [goid 5524] [evidence IEA]; microtubule motor activity [goid 3777] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],2,241301894-241301943,2q37.3f,-,NM_004321.4,547,KIF1A,1.6110879206767557,5.859458030953349,7.600103364329704,1.950334756435909e-12,7.472672885248884e-12,17.123190317408017
MST1,ILMN_1707464,"Homo sapiens macrophage stimulating 1 (hepatocyte growth factor-like) (MST1), mRNA.",,blood coagulation [goid 7596] [evidence IEA],serine-type endopeptidase activity [goid 4252] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],3,49696456-49696464:49696465-49696505,3p21.31c,-,NM_020998.2,4485,MST1,1.1385714260946287,9.600546265653156,7.583565126797886,2.1450169193298085e-12,8.199751341603136e-12,17.029245244228456
KIAA1199,ILMN_1813704,"Homo sapiens KIAA1199 (KIAA1199), mRNA.",,,,15,79030856-79030905,15q25.1b,+,NM_018689.1,57214,KIAA1199,1.5710369879697144,8.705418142973544,7.5729776540549985,2.2796190826315063e-12,8.694361152362024e-12,16.96915606277478
C9orf18,ILMN_1748642,"Homo sapiens chromosome 9 open reading frame 18 (C9orf18), mRNA.",,,,9,123971800-123971849,9q33.2b,+,NM_198469.1,254956,C9orf18,-1.6414039016329642,5.8572337604888105,-7.56016078119028,2.4537863413803694e-12,9.326625592389519e-12,16.896469180562562
FLJ23514,ILMN_1794534,"Homo sapiens coiled-coil domain containing 81 (CCDC81), mRNA.",,,DNA binding [goid 3677] [evidence IEA],11,85811608-85811657,11q14.2a,+,NM_021827.2,60494,FLJ23514,-1.0216761569807957,5.720362529712306,-7.543516054627156,2.6997480241253294e-12,1.0238164986106822e-11,16.802164480883526
APOLD1,ILMN_1723522,"Homo sapiens apolipoprotein L domain containing 1 (APOLD1), mRNA.",,,,12,12835338-12835387,12p13.1b,+,NM_030817.1,81575,APOLD1,-1.5433525952472262,8.400454706073761,-7.541913867328435,2.724673083447323e-12,1.0328772082912853e-11,16.79309232338727
RPS23,ILMN_1772459,"Homo sapiens ribosomal protein S23 (RPS23), mRNA.",intracellular [goid 5622] [evidence IEA]; cytosolic small ribosomal subunit (sensu Eukaryota) [goid 5843] [pmid 15883184] [evidence IDA],translation [goid 43037] [evidence ISS],translation regulator activity [goid 45182] [evidence ISS]; structural constituent of ribosome [goid 3735] [pmid 15883184] [evidence IDA],5,81605044-81605093,5q14.2a,-,NM_001025.4,6228,RPS23,-1.056040141024635,11.09636684457539,-7.529040239673773,2.933386529712071e-12,1.1098940560983193e-11,16.7202318844082
TRPM8,ILMN_1661637,"Homo sapiens transient receptor potential cation channel, subfamily M, member 8 (TRPM8), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],sensory perception [goid 7600] [evidence IEA]; cation transport [goid 6812] [evidence IEA],cation channel activity [goid 5261] [evidence IEA],2,234592827-234592876,2q37.1e,+,NM_024080.3,79054,TRPM8,1.0422578416472357,5.2961475692107385,7.5283215998132125,2.9454925739965577e-12,1.1142638574498606e-11,16.716166440884876
TEP1,ILMN_1770682,"Homo sapiens telomerase-associated protein 1 (TEP1), mRNA.","chromosome [goid 5694] [evidence IEA]; chromosome, telomeric region [goid 781] [evidence IEA]; nuclear matrix [goid 16363] [pmid 7876352] [evidence IDA]; telomerase holoenzyme complex [goid 5697] [pmid 12135483] [evidence IDA]; nucleus [goid 5634] [evidence IEA]; soluble fraction [goid 5625] [evidence ISS]; cytoplasm [goid 5737] [pmid 7876352] [evidence IDA]",,telomerase activity [goid 3720] [pmid 12135483] [evidence IDA]; RNA binding [goid 3723] [evidence ISS]; nucleotide binding [goid 166] [evidence IEA]; ATP binding [goid 5524] [evidence IEA],14,19906082-19906131,14q11.2b,-,NM_007110.3,7011,TEP1,1.0485878280039023,7.326840374244941,7.527723190757532,2.955610938969217e-12,1.1169261267726882e-11,16.712781306299128
GJA1,ILMN_1727087,"Homo sapiens gap junction protein, alpha 1, 43kDa (connexin 43) (GJA1), mRNA.",membrane [goid 16020] [evidence IEA]; connexon complex [goid 5922] [pmid 1850831] [evidence TAS]; integral to plasma membrane [goid 5887] [pmid 15709751] [evidence TAS],cell-cell signaling [goid 7267] [pmid 7715640] [evidence TAS]; transport [goid 6810] [pmid 1696265] [evidence TAS]; gap junction assembly [goid 16264] [pmid 15709751] [evidence TAS]; heart development [goid 7507] [pmid 7715640] [evidence TAS]; positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP]; muscle contraction [goid 6936] [pmid 7715640] [evidence TAS],connexon channel activity [goid 15285] [pmid 1850831] [evidence TAS]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP]; protein binding [goid 5515] [evidence ISS]; ion transporter activity [goid 15075] [pmid 1696265] [evidence TAS],6,121812181-121812230,6q22.31c,+,NM_000165.2,2697,GJA1,-1.0775924847698803,9.698817870322364,-7.52319254795996,3.0333424137557622e-12,1.1448993588837067e-11,16.68715628923971
RGS16,ILMN_1808226,"Homo sapiens regulator of G-protein signalling 16 (RGS16), mRNA.",,regulation of G-protein coupled receptor protein signaling pathway [goid 8277] [pmid 10747990] [evidence TAS]; visual perception [goid 7601] [pmid 9469939] [evidence TAS]; negative regulation of signal transduction [goid 9968] [evidence IEA],calmodulin binding [goid 5516] [pmid 10747990] [evidence TAS]; signal transducer activity [goid 4871] [evidence IEA]; GTPase activator activity [goid 5096] [pmid 10747990] [evidence TAS],1,180834738-180834787,1q25.3c,-,NM_002928.2,6004,RGS16,-1.0693446774983286,8.127378080671972,-7.515215955125161,3.1751403199190155e-12,1.1950377637498055e-11,16.642059833540692
LOC653600,ILMN_1693262,"PREDICTED: Homo sapiens similar to Neutrophil defensin 1 precursor (HNP-1) (HP-1) (HP1) (Defensin, alpha 1) (LOC653600), mRNA.",,,,8,6842670-6842695:6843166-6843174:6843175-6843189,,-,XM_928349.1,653600,LOC653600,-1.1411611133995407,5.396242716610938,-7.513320052863696,3.209796270434423e-12,1.2071730033618784e-11,16.63134466209639
FLJ32771,ILMN_1732739,"Homo sapiens chromosome 11 open reading frame 66 (C11orf66), mRNA.",,,,11,61011263-61011288:61013830-61013853,11q12.2b,+,NM_145017.1,220004,FLJ32771,-1.0222137515340188,5.780746945871726,-7.4753521840951445,3.9881830656643534e-12,1.490948557134013e-11,16.41704382197917
TUBA4,ILMN_1677635,"Homo sapiens tubulin, alpha 4 (TUBA4), mRNA.",microtubule [goid 5874] [evidence IEA],microtubule-based movement [goid 7018] [evidence IEA],nucleotide binding [goid 166] [evidence IEA]; structural molecule activity [goid 5198] [evidence IEA]; GTP binding [goid 5525] [evidence IEA],2,219844848-219844897,2q35f,+,NM_025019.1,80086,TUBA4,-1.4483374019378426,5.706610348683367,-7.4595390816734355,4.364983363027903e-12,1.6281615795574626e-11,16.327950900310192
KLK11,ILMN_1695924,"Homo sapiens kallikrein-related peptidase 11 (KLK11), transcript variant 1, mRNA.",,,serine-type endopeptidase activity [goid 4252] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],19,56217339-56217388,19q13.33d,-,NM_006853.2,11012,KLK11,-1.0180081047535419,7.670229369349522,-7.445419998282447,4.7310421189310744e-12,1.760109533573316e-11,16.248482512074688
DYNLRB2,ILMN_1697317,"Homo sapiens dynein, light chain, roadblock-type 2 (DYNLRB2), mRNA.",microtubule [goid 5874] [evidence IEA]; cytoplasmic dynein complex [goid 5868] [pmid 11750132] [evidence NAS],microtubule-based movement [goid 7018] [pmid 11750132] [evidence NAS],microtubule motor activity [goid 3777] [pmid 11750132] [evidence NAS]; protein binding [goid 5515] [pmid 12077152] [evidence NAS],16,79141961-79142010,16q23.2a,+,NM_130897.1,83657,DYNLRB2,-1.4115046667908127,8.099588554839269,-7.4392421406762885,4.900609175155833e-12,1.822177817813007e-11,16.21373470211163
LOC649970,ILMN_1715476,"PREDICTED: Homo sapiens similar to creatine kinase, mitochondrial 1B precursor (LOC649970), mRNA.",,,,,,,,XM_939056.1,649970,LOC649970,1.573932164757756,7.443159840824036,7.40987745100379,5.792417875622448e-12,2.1398577705955308e-11,16.048770503916394
KRTHB1,ILMN_1801442,"Homo sapiens keratin 81 (KRT81), mRNA.",intermediate filament [goid 5882] [evidence IEA],,structural molecule activity [goid 5198] [evidence IEA],12,50966078-50966127,12q13.13d,-,NM_002281.2,3887,KRTHB1,1.5658602059787485,5.894207662450721,7.40532514892007,5.944346300595078e-12,2.194768052819825e-11,16.023226336500528
LOC647725,ILMN_1806703,"PREDICTED: Homo sapiens hypothetical protein LOC647725 (LOC647725), mRNA.",,,,,,,,XM_936787.1,647725,LOC647725,-1.2075499058835488,5.6885690062996535,-7.39951442052181,6.1440092087524055e-12,2.2643090117649316e-11,15.990632406622291
IL2RB,ILMN_1684349,"Homo sapiens interleukin 2 receptor, beta (IL2RB), mRNA.",plasma membrane [goid 5886] [pmid 2467293] [evidence TAS]; external side of plasma membrane [goid 9897] [evidence ISS]; integral to plasma membrane [goid 5887] [pmid 8514792] [evidence TAS],positive regulation of survival gene product activity [goid 45885] [pmid 7736574] [evidence IDA]; cytokine and chemokine mediated signaling pathway [goid 19221] [pmid 7736574] [evidence IDA]; signal transduction [goid 7165] [pmid 2785715] [evidence TAS]; protein complex assembly [goid 6461] [pmid 2467293] [evidence TAS],interleukin-2 receptor activity [goid 4911] [pmid 2467293] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; hematopoietin/interferon-class (D200-domain) cytokine receptor activity [goid 4896] [evidence IEA],22,35852138-35852187,22q12.3d,-,NM_000878.2,3560,IL2RB,-1.0668552817880474,8.14676932162305,-7.398570771675615,6.1770539366186666e-12,2.27523002878988e-11,15.985340456814638
C20orf103,ILMN_1713561,"Homo sapiens chromosome 20 open reading frame 103 (C20orf103), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,20,9458993-9459042,20p12.2b,+,NM_012261.2,24141,C20orf103,1.3034801986503126,7.2573163095018085,7.378637634859663,6.917610432838657e-12,2.5377255141224025e-11,15.8736365488804
PAEP,ILMN_1748004,"Homo sapiens progestagen-associated endometrial protein (placental protein 14, pregnancy-associated endometrial alpha-2-globulin, alpha uterine protein) (PAEP), transcript variant 2, mRNA.",,development [goid 7275] [pmid 3194393] [evidence TAS]; transport [goid 6810] [evidence IEA],binding [goid 5488] [evidence IEA]; transporter activity [goid 5215] [evidence IEA],9,137597462-137597468:137598220-137598262,9q34.3b,+,NM_002571.2,5047,PAEP,1.7975482407074796,5.84185068774567,7.3764235079391245,7.005100951059007e-12,2.5684086463036212e-11,15.861238232713587
CPXM2,ILMN_1741688,"Homo sapiens carboxypeptidase X (M14 family), member 2 (CPXM2), mRNA.",,cell adhesion [goid 7155] [evidence IEA],carboxypeptidase A activity [goid 4182] [evidence IEA],10,125495392-125495441,10q26.13c,-,NM_198148.1,119587,CPXM2,-1.1859524973818605,8.531748497533561,-7.356369485484711,7.849031446591178e-12,2.8657558610108813e-11,15.749029706738272
SYT13,ILMN_1658499,"Homo sapiens synaptotagmin XIII (SYT13), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; transport vesicle [goid 30133] [pmid 11256614] [evidence IDA],,,11,45218650-45218699,11p11.2d,-,NM_020826.1,57586,SYT13,1.3791702904258276,5.654675174496669,7.351613039744058,8.063503096519281e-12,2.939769860698939e-11,15.72243889834982
AKR1B10,ILMN_1672148,"Homo sapiens aldo-keto reductase family 1, member B10 (aldose reductase) (AKR1B10), mRNA.",,digestion [goid 7586] [pmid 9565553] [evidence TAS]; steroid metabolism [goid 8202] [pmid 9565553] [evidence TAS]; aldehyde metabolism [goid 6081] [pmid 9565553] [evidence TAS],oxidoreductase activity [goid 16491] [evidence IEA]; aldo-keto reductase activity [goid 4033] [pmid 9565553] [evidence TAS],7,133874286-133874309:133876339-133876364,7q33b,+,NM_020299.3,57016,AKR1B10,1.819633979408347,5.983171717794092,7.346688730140462,8.29164674952904e-12,3.020194213809886e-11,15.694918962834622
CACNA1I,ILMN_2300664,"Homo sapiens calcium channel, voltage-dependent, T type, alpha 1I subunit (CACNA1I), transcript variant 2, mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; voltage-gated calcium channel complex [goid 5891] [evidence NAS],ion transport [goid 6811] [evidence IEA]; calcium ion transport [goid 6816] [evidence NAS]; signal transduction [goid 7165] [pmid 10454147] [evidence TAS],low voltage-gated calcium channel activity [goid 8332] [evidence NAS]; calcium ion binding [goid 5509] [evidence IEA],22,38415607-38415656,22q13.1d,+,NM_001003406.1,8911,CACNA1I,1.0654824188874032,5.6346902091335345,7.323681167418051,9.445013648435935e-12,3.4209962541257454e-11,15.566465077222519
IGJ,ILMN_2105441,"Homo sapiens immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides (IGJ), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],immune response [goid 6955] [pmid 2984306] [evidence NAS],antigen binding [goid 3823] [pmid 2984306] [evidence NAS],4,71740977-71741026,4q13.3b,-,NM_144646.2,3512,IGJ,-1.7269803395480778,10.537706179178336,-7.310811597093011,1.0157894936236174e-11,3.669901803615265e-11,15.494703548956652
TCN1,ILMN_1768469,"Homo sapiens transcobalamin I (vitamin B12 binding protein, R binder family) (TCN1), mRNA.",,ion transport [goid 6811] [evidence IEA]; cobalt ion transport [goid 6824] [evidence IEA]; cobalamin transport [goid 15889] [pmid 2777761] [evidence TAS],cobalt ion binding [goid 50897] [evidence IEA]; binding [goid 5488] [evidence IEA]; cobalt ion transporter activity [goid 15087] [evidence IEA],11,59377062-59377085:59377252-59377277,11q12.1d,-,NM_001062.2,6947,TCN1,2.0574546769821573,6.1487284139727105,7.306932942625102,1.0382990043204546e-11,3.749194455593513e-11,15.473088744253479
FBXO2,ILMN_1803211,"Homo sapiens F-box protein 2 (FBXO2), mRNA.",,protein catabolism [goid 30163] [evidence IEA]; ubiquitin cycle [goid 6512] [evidence IEA],ubiquitin-protein ligase activity [goid 4842] [pmid 10531035] [evidence TAS]; protein binding [goid 5515] [evidence IEA]; ubiquitin conjugating enzyme activity [goid 4840] [pmid 10531035] [evidence TAS],1,11631219-11631268,1p36.22b,-,NM_012168.4,26232,FBXO2,1.1609668804573605,7.55497859209042,7.28962639938611,1.1448933364211368e-11,4.116267003614395e-11,15.376716099976191
CYP1A2,ILMN_1683607,"Homo sapiens cytochrome P450, family 1, subfamily A, polypeptide 2 (CYP1A2), mRNA.",membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 2813353] [evidence NAS]; microsome [goid 5792] [evidence IEA],electron transport [goid 6118] [evidence IEA],heme binding [goid 20037] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; electron carrier activity [goid 9055] [pmid 2813353] [evidence TAS]; unspecific monooxygenase activity [goid 50381] [evidence IEA]; iron ion binding [goid 5506] [evidence IEA]; oxygen binding [goid 19825] [pmid 2813353] [evidence TAS],15,72835909-72835958,15q24.1b,+,NM_000761.3,1544,CYP1A2,-1.1985866273986439,5.397716676051157,-7.286889583931139,1.1627124245145356e-11,4.176579926335158e-11,15.36148683568675
RSHL3,ILMN_1689212,"Homo sapiens radial spokehead-like 3 (RSHL3), mRNA.",,,,6,117060572-117060621,6q22.1d,+,NM_001010892.1,345895,RSHL3,-1.3828243302664323,6.44526068601721,-7.28647935557709,1.1654068862485717e-11,4.1855072662109894e-11,15.359204338245467
CD19,ILMN_1782704,"Homo sapiens CD19 antigen (CD19), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 2472450] [evidence TAS]; plasma membrane [goid 5886] [pmid 2472450] [evidence TAS],cell surface receptor linked signal transduction [goid 7166] [pmid 1714482] [evidence TAS]; cellular defense response [goid 6968] [pmid 1373518] [evidence TAS],receptor signaling protein activity [goid 5057] [pmid 1373518] [evidence TAS]; protein binding [goid 5515] [pmid 8647200] [evidence IPI],16,28857792-28857800:28857963-28858003,16p11.2e,+,NM_001770.3,930,CD19,1.2702329669141186,6.556449814398271,7.277417100431577,1.2265285035803878e-11,4.400283718780061e-11,15.30879930776774
MTE,ILMN_2136089,"Homo sapiens metallothionein E (MTE), mRNA.",,,metal ion binding [goid 46872] [evidence IEA],,,,,NM_175621.2,644314,MTE,-1.21670247815182,9.562102779660995,-7.262096468104369,1.337144513900237e-11,4.78169569868024e-11,15.223659084347906
APOC1,ILMN_1789007,"Homo sapiens apolipoprotein C-I (APOC1), mRNA.",extracellular region [goid 5576] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 11256614] [evidence IDA],lipoprotein metabolism [goid 42157] [evidence IEA]; lipid transport [goid 6869] [evidence IEA]; lipid metabolism [goid 6629] [pmid 2897845] [evidence TAS],lipid transporter activity [goid 5319] [evidence IEA],19,50114323-50114327:50114328-50114372,19q13.32a,+,NM_001645.3,341,APOC1,-1.0059308790080301,12.192539874218058,-7.254959839579499,1.3919821039128902e-11,4.9689166699534535e-11,15.1840312431256
ST6GALNAC1,ILMN_1772951,"Homo sapiens ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (ST6GALNAC1), mRNA.",Golgi apparatus [goid 5794] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; Golgi stack [goid 5795] [evidence IEA],protein amino acid glycosylation [goid 6486] [pmid 10536037] [evidence NAS],"sialyltransferase activity [goid 8373] [evidence IEA]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [goid 1665] [evidence IEA]",17,72132881-72132930,17q25.1d,-,NM_018414.2,55808,ST6GALNAC1,1.4984435545475785,7.537004661715231,7.247129634878809,1.4547075030547393e-11,5.1845008409546176e-11,15.140575628462601
CRLF1,ILMN_1681515,"Homo sapiens cytokine receptor-like factor 1 (CRLF1), mRNA.",extracellular space [goid 5615] [pmid 9686600] [evidence TAS],antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9686600] [evidence TAS],cytokine binding [goid 19955] [pmid 15034937] [evidence IPI]; receptor activity [goid 4872] [pmid 9686600] [evidence TAS],19,18565266-18565315,19p13.11c-p13.11b,-,NM_004750.2,9244,CRLF1,1.8712856413123742,7.0440369311877875,7.217866384997809,1.7148407122537688e-11,6.078039498808398e-11,14.978390398500755
KCNK17,ILMN_1717702,"Homo sapiens potassium channel, subfamily K, member 17 (KCNK17), mRNA.",membrane [goid 16020] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],ion transport [goid 6811] [evidence IEA]; potassium ion transport [goid 6813] [pmid 11248242] [evidence IDA],potassium ion binding [goid 30955] [evidence IEA]; potassium channel activity [goid 5267] [pmid 11248242] [evidence IDA]; voltage-gated ion channel activity [goid 5244] [evidence IEA],6,39374978-39375027,6p21.2a,-,NM_031460.2,89822,KCNK17,-1.0603523642388808,6.941095475890535,-7.210794345128144,1.7843056179482955e-11,6.313065747817771e-11,14.939247009959876
CCL18,ILMN_1654411,"Homo sapiens chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) (CCL18), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],antimicrobial humoral response (sensu Vertebrata) [goid 19735] [pmid 9233607] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 9233607] [evidence TAS]; chemotaxis [goid 6935] [pmid 9192897] [evidence TAS]; inflammatory response [goid 6954] [evidence IEA]; signal transduction [goid 7165] [pmid 9233607] [evidence TAS]; response to biotic stimulus [goid 9607] [pmid 9233607] [evidence TAS],chemokine activity [goid 8009] [pmid 9192897] [evidence TAS],17,31422539-31422588,17q12b,+,NM_002988.2,6362,CCL18,-1.5765666422127618,7.523189698547572,-7.187468378732207,2.0337204655185183e-11,7.173956113204252e-11,14.810282783101082
CSPG2,ILMN_1687301,"Homo sapiens versican (VCAN), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [pmid 2583089] [evidence TAS],cell recognition [goid 8037] [pmid 2583089] [evidence TAS]; development [goid 7275] [pmid 2583089] [evidence TAS]; cell adhesion [goid 7155] [pmid 2583089] [evidence TAS],hyaluronic acid binding [goid 5540] [pmid 2583089] [evidence TAS]; sugar binding [goid 5529] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],5,82912585-82912634,5q14.3a,+,NM_004385.2,1462,CSPG2,1.034698997278939,9.970497051809764,7.1703661753112735,2.2381755088859628e-11,7.875732603199146e-11,14.715869218090935
OSM,ILMN_1780546,"Homo sapiens oncostatin M (OSM), mRNA.",extracellular space [goid 5615] [pmid 2779549] [evidence TAS],development [goid 7275] [pmid 1717982] [evidence TAS]; negative regulation of cell proliferation [goid 8285] [pmid 1717982] [evidence TAS]; regulation of cell growth [goid 1558] [evidence IEA]; cell proliferation [goid 8283] [pmid 1542793] [evidence TAS]; immune response [goid 6955] [evidence IEA]; cell-cell signaling [goid 7267] [evidence NR ],oncostatin-M receptor binding [goid 5147] [pmid 9920829] [evidence TAS]; cytokine activity [goid 5125] [pmid 2779549] [evidence TAS],22,28988989-28989038,22q12.2b,-,NM_020530.3,5008,OSM,-1.4973032150535772,7.01279368637406,-7.1662141146869285,2.2907991751550816e-11,8.05240862552756e-11,14.692965602658992
LRRC31,ILMN_1803528,"Homo sapiens leucine rich repeat containing 31 (LRRC31), mRNA.",,,,3,171040055-171040104,3q26.2b,-,NM_024727.1,79782,LRRC31,1.1732873246985367,6.98298924760109,7.151708162787852,2.4844220703248692e-11,8.719227641301523e-11,14.613003305988252
EDN1,ILMN_1682775,"Homo sapiens endothelin 1 (EDN1), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [pmid 2670930] [evidence TAS]; soluble fraction [goid 5625] [pmid 2670930] [evidence TAS],regulation of vasoconstriction [goid 19229] [evidence IEA]; pathogenesis [goid 9405] [evidence IEA]; cell-cell signaling [goid 7267] [evidence NR ]; signal transduction [goid 7165] [pmid 2670930] [evidence TAS]; positive regulation of cell proliferation [goid 8284] [pmid 8144511] [evidence TAS],hormone activity [goid 5179] [pmid 2670930] [evidence TAS],6,12404601-12404650,6p24.1b,+,NM_001955.2,1906,EDN1,-1.1247270025560017,9.871498162009178,-7.139787194181535,2.6555684845330076e-11,9.300300059257206e-11,14.5473551835964
TFAP2D,ILMN_1659378,"Homo sapiens transcription factor AP-2 delta (activating enhancer binding protein 2 delta) (TFAP2D), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],6,50848453-50848502,6p12.3a,+,NM_172238.1,83741,TFAP2D,1.199540510550455,5.410634264164257,7.137915649416769,2.6834749279287418e-11,9.393101182295008e-11,14.537054008518405
ENDOGL1,ILMN_1709747,"Homo sapiens endonuclease G-like 1 (ENDOGL1), mRNA.",,,endonuclease activity [goid 4519] [pmid 10231028] [evidence NAS]; nucleic acid binding [goid 3676] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA],3,38540810-38540857:38540858-38540859,3p22.2a,+,NM_005107.1,9941,ENDOGL1,-1.0874256869206782,9.327761903227223,-7.130615997064064,2.7951138839213152e-11,9.763379642021241e-11,14.496889791274446
MEG3,ILMN_1671149,"PREDICTED: Homo sapiens maternally expressed 3, transcript variant 74 (MEG3), misc RNA.",,,,14,100381551-100381600,14q32.2b,+,XR_000943.1,55384,MEG3,1.2321876381249375,7.290351283530103,7.099452289593142,3.3256033640614944e-11,1.155787252182428e-10,14.32566883923097
C6orf97,ILMN_1772588,"Homo sapiens chromosome 6 open reading frame 97 (C6orf97), mRNA.",,,,6,151983417-151983466,6q25.1c,+,NM_025059.2,80129,C6orf97,-1.107274900232512,5.879979611000029,-7.079851708425011,3.7089665884239536e-11,1.284781916571788e-10,14.218185618708985
ELF5,ILMN_1684699,"Homo sapiens E74-like factor 5 (ets domain transcription factor) (ELF5), transcript variant 2, mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; transcription [goid 6350] [evidence IEA]",sequence-specific DNA binding [goid 43565] [evidence IEA]; transcription factor activity [goid 3700] [evidence IEA],11,34483876-34483876:34491800-34491848,11p13c,-,NM_001422.2,2001,ELF5,-1.0186354910898539,6.346996272811155,-7.07723689605618,3.763301078549057e-11,1.3031520937973266e-10,14.203858982536358
ERN2,ILMN_1678899,"Homo sapiens endoplasmic reticulum to nucleus signalling 2 (ERN2), mRNA.",endoplasmic reticulum [goid 5783] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA],"rRNA catabolism [goid 16075] [pmid 11175748] [evidence IDA]; mRNA processing [goid 6397] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [pmid 11175748] [evidence IDA]; transcription [goid 6350] [evidence IEA]; electron transport [goid 6118] [evidence IEA]; negative regulation of transcription [goid 16481] [pmid 11175748] [evidence IMP]; regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; induction of apoptosis [goid 6917] [pmid 11175748] [evidence IMP]; apoptosis [goid 6915] [evidence IEA]","magnesium ion binding [goid 287] [pmid 11175748] [evidence IDA]; nucleotide binding [goid 166] [evidence IEA]; endonuclease activity [goid 4519] [pmid 11175748] [evidence IDA]; protein serine/threonine kinase activity [goid 4674] [pmid 11175748] [evidence IDA]; ATP binding [goid 5524] [pmid 11175748] [evidence IDA]; endoribonuclease activity, producing 5'-phosphomonoesters [goid 16891] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]",16,23609234-23609283,16p12.1c,-,NM_033266.2,10595,ERN2,1.1066658065213586,5.88499260491401,7.052856116819986,4.309267528594679e-11,1.486036275631202e-10,14.070414102974526
CPXM,ILMN_1712046,"Homo sapiens carboxypeptidase X (M14 family), member 1 (CPXM1), mRNA.",,cell adhesion [goid 7155] [evidence IEA],zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; metallopeptidase activity [goid 8237] [evidence IEA]; carboxypeptidase activity [goid 4180] [evidence IEA]; carboxypeptidase A activity [goid 4182] [evidence IEA],20,2722820-2722835:2722836-2722869,20p13c,-,NM_019609.3,56265,CPXM,1.0837365430003638,6.750916335817934,7.0178518278963224,5.232307837340039e-11,1.7932171156132153e-10,13.879261456807699
C1orf158,ILMN_1733298,"Homo sapiens chromosome 1 open reading frame 158 (C1orf158), mRNA.",,,,1,12743506-12743555,1p36.21d,+,NM_152290.1,93190,C1orf158,-1.3633049516969162,5.812798740553713,-7.017734143938301,5.23571872730576e-11,1.7940787856813433e-10,13.878619680468416
LOC641805,ILMN_1780772,"PREDICTED: Homo sapiens similar to PMS1 protein homolog 2 (DNA mismatch repair protein PMS2) (LOC641805), mRNA.",,,,,,,,XM_935564.1,641805,LOC641805,-1.0773160655304777,5.29241365442744,-6.989618112504664,6.116785744074599e-11,2.084562240971633e-10,13.725461223268264
PLAU,ILMN_1656057,"Homo sapiens plasminogen activator, urokinase (PLAU), mRNA.",extracellular space [goid 5615] [evidence NR ],blood coagulation [goid 7596] [evidence IEA]; fibrinolysis [goid 42730] [evidence IEA]; chemotaxis [goid 6935] [pmid 10749881] [evidence TAS]; signal transduction [goid 7165] [pmid 10749881] [evidence TAS],serine-type endopeptidase activity [goid 4252] [evidence IEA]; kinase activity [goid 16301] [evidence IEA]; plasminogen activator activity [goid 8243] [evidence IEA]; peptidase activity [goid 8233] [evidence IEA],10,75346964-75347013,10q22.2a,+,NM_002658.2,5328,PLAU,1.0390890291281654,9.952955434233107,6.956477305107579,7.344507645967073e-11,2.4851836458736544e-10,13.54536580200144
ECM1,ILMN_1658333,"Homo sapiens extracellular matrix protein 1 (ECM1), transcript variant 1, mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular space [goid 5615] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 9367673] [evidence TAS],positive regulation of I-kappaB kinase/NF-kappaB cascade [goid 43123] [pmid 12761501] [evidence IMP]; transport [goid 6810] [evidence IEA],carrier activity [goid 5386] [evidence IEA]; signal transducer activity [goid 4871] [pmid 12761501] [evidence IMP],1,148750879-148750928,1q21.2b,+,NM_004425.2,1893,ECM1,1.046348024816158,7.53311117077962,6.941735477782674,7.965930973938503e-11,2.6881826096569667e-10,13.465407176320367
ITGA10,ILMN_1700144,"Homo sapiens integrin, alpha 10 (ITGA10), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integrin complex [goid 8305] [pmid 9685391] [evidence TAS],cell-matrix adhesion [goid 7160] [pmid 9685391] [evidence TAS]; integrin-mediated signaling pathway [goid 7229] [evidence IEA],magnesium ion binding [goid 287] [evidence IEA]; collagen binding [goid 5518] [pmid 9685391] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],1,144255050-144255099,1q21.1b,+,NM_003637.3,8515,ITGA10,-1.0081986112731007,7.246287204746989,-6.889094391886733,1.0638417436477701e-10,3.558232298044899e-10,13.180656484846365
MUC13,ILMN_1651568,"Homo sapiens mucin 13, cell surface associated (MUC13), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],,,3,126107260-126107309,3q21.2a,-,NM_033049.2,56667,MUC13,1.3712743296870062,5.696180742483567,6.854954884288644,1.2826009795120875e-10,4.2621292805311157e-10,12.996635250235956
FLJ23834,ILMN_1809817,"Homo sapiens hypothetical protein FLJ23834 (FLJ23834), mRNA.",membrane [goid 16020] [evidence IEA],homophilic cell adhesion [goid 7156] [evidence IEA],calcium ion binding [goid 5509] [evidence IEA],7,105460957-105461006,7q22.2b-q22.2c,+,NM_152750.2,222256,FLJ23834,-1.7720441556602164,6.843143273996326,-6.77521684753525,1.981297169413549e-10,6.489080662240348e-10,12.56884188453049
KYNU,ILMN_1737514,"Homo sapiens kynureninase (L-kynurenine hydrolase) (KYNU), transcript variant 1, mRNA.",cytoplasm [goid 5737] [evidence IEA]; cytoplasm [goid 5737] [evidence IEA],NAD biosynthesis [goid 9435] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; tryptophan catabolism [goid 6569] [evidence IEA]; NAD biosynthesis [goid 9435] [evidence IEA]; metabolism [goid 8152] [evidence IEA]; tryptophan catabolism [goid 6569] [evidence IEA],pyridoxal phosphate binding [goid 30170] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; kynureninase activity [goid 30429] [evidence IEA]; peptidase activity [goid 8233] [pmid 9180257] [evidence TAS]; transaminase activity [goid 8483] [evidence IEA]; pyridoxal phosphate binding [goid 30170] [evidence IEA]; hydrolase activity [goid 16787] [evidence IEA]; kynureninase activity [goid 30429] [evidence IEA]; peptidase activity [goid 8233] [pmid 9180257] [evidence TAS]; transaminase activity [goid 8483] [evidence IEA],2,143459996-143460045,2q22.2a,+,NM_003937.2,8942,KYNU,-1.192791422049277,8.06407001426958,-6.76831588142094,2.0570232117453427e-10,6.728285175837962e-10,12.531952354918035
SLC22A4,ILMN_1685057,"Homo sapiens solute carrier family 22 (organic cation transporter), member 4 (SLC22A4), mRNA.",integral to plasma membrane [goid 5887] [pmid 9426230] [evidence TAS]; nucleus [goid 5634] [evidence IEA]; nucleosome [goid 786] [evidence IEA]; plasma membrane [goid 5886] [pmid 9426230] [evidence TAS],ion transport [goid 6811] [evidence IEA]; organic cation transport [goid 15695] [pmid 9426230] [evidence TAS]; sodium ion transport [goid 6814] [evidence IEA]; fluid secretion [goid 7589] [pmid 9426230] [evidence TAS]; nucleosome assembly [goid 6334] [evidence IEA],sodium ion binding [goid 31402] [evidence IEA]; DNA binding [goid 3677] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; symporter activity [goid 15293] [evidence IEA]; nucleotide binding [goid 166] [pmid 9426230] [evidence TAS]; organic cation porter activity [goid 8513] [pmid 9426230] [evidence TAS]; ion transporter activity [goid 15075] [evidence IEA],5,131699588-131699592:131704157-131704201,5q31.1b,+,NM_003059.2,6583,SLC22A4,-1.0268337728657393,6.120441157955181,-6.759602881499223,2.156718021328582e-10,7.039415036010157e-10,12.48540722241657
MDAC1,ILMN_1815773,"Homo sapiens transmembrane protein 190 (TMEM190), mRNA.",,,,19,60580873-60580898:60580982-60581005,19q13.42b,+,NM_139172.1,147744,MDAC1,-1.6679508672993322,5.8806309504388725,-6.754761354896793,2.2141575800989307e-10,7.222182077375189e-10,12.459558476642266
LOC389394,ILMN_1671615,"PREDICTED: Homo sapiens similar to TRP (transient receptor potential) channel family member (trp-4) (LOC389394), mRNA.",,,,,,,,XM_941689.1,389394,LOC389394,-1.0838206112529045,5.477072563157546,-6.712582341152378,2.7827284123735166e-10,9.010653839580728e-10,12.234816887005733
SERPINA3,ILMN_1788874,"Homo sapiens serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 (SERPINA3), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS]; intracellular [goid 5622] [pmid 9880565] [evidence NAS],regulation of lipid metabolism [goid 19216] [pmid 11835318] [evidence NAS]; acute-phase response [goid 6953] [evidence IEA]; inflammatory response [goid 6954] [pmid 12475184] [evidence NAS],DNA binding [goid 3677] [pmid 9880565] [evidence IC ]; chymotrypsin inhibitor activity [goid 30569] [pmid 9880565] [evidence NAS]; protein binding [goid 5515] [pmid 14687906] [evidence IPI],14,94160006-94160055,14q32.13b,+,NM_001085.4,12,SERPINA3,-1.3715281295262045,10.658840041592278,-6.704641067475877,2.9048388852444997e-10,9.395411641767207e-10,12.192594405497092
WDR72,ILMN_1763196,"Homo sapiens WD repeat domain 72 (WDR72), mRNA.",,,,15,51594718-51594767,15q21.3a,-,NM_182758.1,256764,WDR72,1.3087797695138548,6.1561695191865775,6.688121752156374,3.176009926785413e-10,1.0227845906184218e-9,12.104856560345757
PTGER1,ILMN_1744929,"Homo sapiens prostaglandin E receptor 1 (subtype EP1), 42kDa (PTGER1), mRNA.",integral to plasma membrane [goid 5887] [pmid 8253813] [evidence TAS]; membrane [goid 16020] [evidence IEA],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8253813] [evidence TAS]; signal transduction [goid 7165] [evidence IEA],prostaglandin E receptor activity [goid 4957] [pmid 8253813] [evidence TAS]; receptor activity [goid 4872] [evidence IEA]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],19,14444337-14444371:14444372-14444386,19p13.12c,-,NM_000955.2,5731,PTGER1,-1.1256360877258302,7.676337069587606,-6.683138422531965,3.262603112876038e-10,1.0491508049248436e-9,12.078413604435058
PRSS3,ILMN_1685699,"Homo sapiens protease, serine, 3 (mesotrypsin) (PRSS3), mRNA.",extracellular space [goid 5615] [pmid 6698368] [evidence IDA],digestion [goid 7586] [pmid 14507909] [evidence TAS],serine-type endopeptidase activity [goid 4252] [evidence IEA]; trypsin activity [goid 4295] [pmid 14507909] [evidence IDA]; peptidase activity [goid 8233] [evidence IEA]; calcium ion binding [goid 5509] [pmid 6698368] [evidence IDA]; protein binding [goid 5515] [pmid 14507909] [evidence IPI],9,33788069-33788080:33788484-33788521,9p13.3d,+,NM_002771.2,5646,PRSS3,1.2478332085946802,5.6553612415021455,6.665151490433536,3.5949401131783623e-10,1.152315952971366e-9,11.983065165943755
HSD17B13,ILMN_1683844,"Homo sapiens hydroxysteroid (17-beta) dehydrogenase 13 (HSD17B13), mRNA.",,metabolism [goid 8152] [evidence IEA],oxidoreductase activity [goid 16491] [evidence IEA],4,88444840-88444889,4q22.1a,-,NM_178135.2,345275,HSD17B13,-1.1966567745066232,5.606021753413784,-6.637653444930474,4.1684620287315514e-10,1.328913133697592e-9,11.837588124522524
CILP,ILMN_1723847,"Homo sapiens cartilage intermediate layer protein, nucleotide pyrophosphohydrolase (CILP), mRNA.",extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],"nucleobase, nucleoside, nucleotide and nucleic acid metabolism [goid 6139] [pmid 9722584] [evidence TAS]",phosphoprotein phosphatase activity [goid 4721] [pmid 9722584] [evidence TAS],15,63275926-63275975,15q22.31b,-,NM_003613.2,8483,CILP,1.189675993827005,6.676089560330454,6.6180721685623665,4.6308855199185237e-10,1.4718785938447946e-9,11.734208929306126
LDLRAD1,ILMN_1731343,"Homo sapiens low density lipoprotein receptor class A domain containing 1 (LDLRAD1), mRNA.",,,,1,54247327-54247376,1p32.3b,-,NM_001010978.2,388633,LDLRAD1,-1.4224424726366394,6.121083276228281,-6.616547084723875,4.668951508181137e-10,1.4835061422215052e-9,11.726164781539845
MYOZ1,ILMN_1731157,"Homo sapiens myozenin 1 (MYOZ1), mRNA.",nucleus [goid 5634] [evidence IEA],,structural molecule activity [goid 5198] [evidence IEA],10,75061506-75061555,10q22.2a,-,NM_021245.2,58529,MYOZ1,-1.0641599551867769,7.164939450233758,-6.595533498467023,5.225900106970496e-10,1.6549510816756202e-9,11.615438351360874
POU2AF1,ILMN_1811049,"Homo sapiens POU domain, class 2, associating factor 1 (POU2AF1), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]; humoral immune response [goid 6959] [pmid 7859290] [evidence TAS]; transcription [goid 6350] [evidence IEA]; transcription from RNA polymerase II promoter [goid 6366] [pmid 7859290] [evidence TAS]",transcription coactivator activity [goid 3713] [pmid 7859290] [evidence TAS],11,110728486-110728535,11q23.1b,-,NM_006235.1,5450,POU2AF1,1.078391922018306,6.619043770153758,6.56128643551778,6.276836355988938e-10,1.9768131876377565e-9,11.43542658477716
JSRP1,ILMN_1739726,"Homo sapiens junctional sarcoplasmic reticulum protein 1 (JSRP1), mRNA.",,,,19,,19p13.3g,-,NM_144616.2,126306,JSRP1,1.6249716027671646,8.213054353178693,6.560734604974647,6.295369445786972e-10,1.9823379268383024e-9,11.432530555271937
SCGB3A1,ILMN_1679666,"Homo sapiens secretoglobin, family 3A, member 1 (SCGB3A1), mRNA.",extracellular region [goid 5576] [pmid 11481438] [evidence NAS]; extracellular space [goid 5615] [evidence IEA],regulation of cell proliferation [goid 42127] [pmid 11481438] [evidence NAS]; negative regulation of cell growth [goid 30308] [pmid 11481438] [evidence NAS],cytokine activity [goid 5125] [pmid 11481438] [evidence NAS],5,179950251-179950300,5q35.3f,-,NM_052863.2,92304,SCGB3A1,-1.8699854750569092,12.472454694174184,-6.558544996636861,6.369439206655144e-10,2.0047151116368746e-9,11.42104082340027
LOC284422,ILMN_1774375,"PREDICTED: Homo sapiens similar to HSPC323 (LOC284422), mRNA.",,,,,,19p13.3f,,XM_939969.1,284422,LOC284422,1.0553551145701165,5.650920900352355,6.558046627222555,6.386417437432846e-10,2.009742687765907e-9,11.418426001736
NYD-SP14,ILMN_1694979,"Homo sapiens tetratricopeptide repeat domain 29 (TTC29), mRNA.",,,binding [goid 5488] [evidence IEA],4,147944089-147944138,4q31.23a,-,NM_031956.1,83894,NYD-SP14,-1.1557021441748168,5.693317029702959,-6.549625969569243,6.680115896701399e-10,2.09985481321605e-9,11.374262709819076
ARMC4,ILMN_1776395,"Homo sapiens armadillo repeat containing 4 (ARMC4), mRNA.",,,binding [goid 5488] [evidence IEA],10,28141508-28141557,10p12.1a-p11.23c,-,NM_018076.2,55130,ARMC4,-1.0271125789076327,5.711211505536522,-6.538804718417611,7.077128065187431e-10,2.2190750404054244e-9,11.317558673702214
MS4A8B,ILMN_1808249,"Homo sapiens membrane-spanning 4-domains, subfamily A, member 8B (MS4A8B), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],signal transduction [goid 7165] [evidence IEA],receptor activity [goid 4872] [evidence IEA],11,60239514-60239563,11q12.2a,+,NM_031457.1,83661,MS4A8B,-1.95412268136009,7.02765023455673,-6.5359609908007945,7.185255542162765e-10,2.2522731143285697e-9,11.30266661524002
AGTRL1,ILMN_1700183,"Homo sapiens angiotensin II receptor-like 1 (AGTRL1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence IEA]; integral to plasma membrane [goid 5887] [pmid 8294032] [evidence TAS]; plasma membrane [goid 5886] [pmid 9792798] [evidence TAS],signal transduction [goid 7165] [evidence IEA]; G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 9792798] [evidence TAS],receptor activity [goid 4872] [pmid 9792798] [evidence TAS]; rhodopsin-like receptor activity [goid 1584] [evidence IEA],11,56757745-56757794,11q12.1a,-,NM_005161.2,187,AGTRL1,-1.2096723705120906,8.426176770977358,-6.461563676873417,1.0669778168057734e-9,3.3021024220649518e-9,10.914439596974725
CCL13,ILMN_1783593,"Homo sapiens chemokine (C-C motif) ligand 13 (CCL13), mRNA.",extracellular region [goid 5576] [evidence IEA]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [pmid 9195948] [evidence TAS],cell-cell signaling [goid 7267] [pmid 9195948] [evidence TAS]; chemotaxis [goid 6935] [pmid 9195948] [evidence TAS]; calcium ion homeostasis [goid 6874] [pmid 9195948] [evidence TAS]; signal transduction [goid 7165] [pmid 9558100] [evidence TAS]; inflammatory response [goid 6954] [pmid 9195948] [evidence TAS],chemokine receptor activity [goid 4950] [evidence NR ]; signal transducer activity [goid 4871] [pmid 9558100] [evidence NAS]; chemokine activity [goid 8009] [pmid 9558100] [evidence TAS],17,29709538-29709587,17q12a,+,NM_005408.2,6357,CCL13,-1.183943253277688,8.74023102300184,-6.45949771630032,1.0787183286291433e-9,3.336888732098315e-9,10.903696903201569
PLA2G2A,ILMN_1740586,"Homo sapiens phospholipase A2, group IIA (platelets, synovial fluid) (PLA2G2A), mRNA.",extracellular region [goid 5576] [pmid 9272153] [evidence TAS]; membrane [goid 16020] [evidence IEA]; endoplasmic reticulum [goid 5783] [pmid 11256614] [evidence IDA],lipid catabolism [goid 16042] [evidence IEA]; phospholipid metabolism [goid 6644] [evidence IEA],calcium-dependent phospholipase A2 activity [goid 47498] [pmid 9272153] [evidence TAS]; hydrolase activity [goid 16787] [evidence IEA]; calcium ion binding [goid 5509] [evidence IEA],1,20174643-20174692,1p36.13a,-,NM_000300.2,5320,PLA2G2A,-1.5236992944508483,6.154937219216186,-6.444067073207562,1.170519638885952e-9,3.607479503208584e-9,10.82352536733976
C6orf117,ILMN_1794829,"Homo sapiens chromosome 6 open reading frame 117 (C6orf117), mRNA.",,,,6,84856946-84856995,6q14.3a,+,NM_138409.1,112609,C6orf117,-1.0398811174080347,6.060162338967388,-6.425202480433376,1.2932371451318677e-9,3.973447297266341e-9,10.725669910553213
LOC145837,ILMN_1688228,"PREDICTED: Homo sapiens hypothetical protein LOC145837, transcript variant 2 (LOC145837), mRNA.",,,,15,67650682-67650731,15q23a,+,XM_934770.1,145837,LOC145837,1.2792418807791712,6.140768620858427,6.406891049347254,1.424424625647465e-9,4.353786726238081e-9,10.630850250054246
ROS1,ILMN_1811234,"Homo sapiens v-ros UR2 sarcoma virus oncogene homolog 1 (avian) (ROS1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane fraction [goid 5624] [pmid 3785223] [evidence TAS]; sodium:potassium-exchanging ATPase complex [goid 5890] [pmid 3785223] [evidence TAS]; membrane [goid 16020] [evidence IEA],transmembrane receptor protein tyrosine kinase signaling pathway [goid 7169] [evidence IEA]; protein amino acid phosphorylation [goid 6468] [evidence IEA]; signal transduction [goid 7165] [pmid 2827175] [evidence TAS],transferase activity [goid 16740] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA]; transmembrane receptor protein tyrosine kinase activity [goid 4714] [evidence IEA]; ATP binding [goid 5524] [evidence IEA]; receptor activity [goid 4872] [pmid 2827175] [evidence TAS],6,117716351-117716400,6q22.2a-q22.2b,-,NM_002944.2,6098,ROS1,-1.021031701528078,7.965574002276409,-6.401467319769484,1.465733957964525e-9,4.474581176526429e-9,10.602796837214468
WBSCR27,ILMN_1719170,"Homo sapiens Williams Beuren syndrome chromosome region 27 (WBSCR27), mRNA.",,,,7,72886999-72887008:72887009-72887048,7q11.23b,-,NM_152559.2,155368,WBSCR27,1.208191897848085,7.786296004223662,6.377748966280433,1.660656330078669e-9,5.0450063547242644e-9,10.480287374342014
MFAP5,ILMN_1733415,"Homo sapiens microfibrillar associated protein 5 (MFAP5), mRNA.",microfibril [goid 1527] [evidence IEA]; extracellular space [goid 5615] [evidence NR ]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence IEA],,extracellular matrix structural constituent [goid 5201] [pmid 8557636] [evidence TAS],12,8689900-8689949,12p13.31b,-,NM_003480.2,8076,MFAP5,-1.6891449896387467,7.2637252358798134,-6.376549692374402,1.671161789572778e-9,5.076150764501615e-9,10.474100284408335
PERP,ILMN_1775829,"Homo sapiens PERP, TP53 apoptosis effector (PERP), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA],apoptosis [goid 6915] [evidence IEA]; cell adhesion [goid 7155] [evidence IEA],structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [evidence IEA],6,138453788-138453837,6q23.3d,-,NM_022121.2,64065,PERP,1.004397106372143,8.229581748050748,6.353041745520455,1.890790631479967e-9,5.714643346624045e-9,10.352965853379148
FLJ10916,ILMN_2173294,"Homo sapiens hypothetical protein FLJ10916 (FLJ10916), mRNA.",,metabolism [goid 8152] [evidence IEA],catalytic activity [goid 3824] [evidence IEA],2,88267171-88267220,2p11.2d-p11.2c,+,NM_018271.2,55258,FLJ10916,1.0546893612662203,9.861306824949079,6.33861538306534,2.039370331227714e-9,6.13682081323569e-9,10.278763900765702
LOC401551,ILMN_2077008,"Homo sapiens WD repeat domain 38 (WDR38), mRNA.",,,,,,,,NM_001045476.1,401551,LOC401551,-1.343102862261544,6.695171717640831,-6.3312883149299495,2.1191682401412525e-9,6.368326546822797e-9,10.241116847397782
AGR3,ILMN_1728787,"Homo sapiens anterior gradient homolog 3 (Xenopus laevis) (AGR3), mRNA.",,,,7,16884704-16884753,7p21.1b,-,NM_176813.3,155465,AGR3,-1.2132810171658708,8.514644955328775,-6.30204693657476,2.469338292190274e-9,7.380717142238272e-9,10.091139681063966
DKFZp666G057,ILMN_2184884,"Homo sapiens hypothetical protein DKFZp666G057 (DKFZp666G057), mRNA.",,,,15,80363867-80363916,15q25.2a,+,NM_001008226.1,283726,DKFZp666G057,-1.1197951247012004,5.4949113850086215,-6.301577349796844,2.475401852332208e-9,7.3977356626531465e-9,10.088734698003469
CXCL14,ILMN_1748323,"Homo sapiens chemokine (C-X-C motif) ligand 14 (CXCL14), mRNA.",extracellular region [goid 5576] [evidence IEA]; Golgi apparatus [goid 5794] [pmid 11256614] [evidence IDA]; extracellular space [goid 5615] [evidence IEA],cell-cell signaling [goid 7267] [pmid 10049774] [evidence TAS]; chemotaxis [goid 6935] [pmid 10049774] [evidence TAS]; inflammatory response [goid 6954] [evidence NR ]; signal transduction [goid 7165] [pmid 10049774] [evidence TAS],chemokine activity [goid 8009] [pmid 10049774] [evidence TAS],5,134934392-134934441,5q31.1f,-,NM_004887.3,9547,CXCL14,1.61916539109109,7.8168958518432214,6.269527517581819,2.9257243069451464e-9,8.692885644989381e-9,9.924854328167703
C6orf165,ILMN_1757837,"Homo sapiens chromosome 6 open reading frame 165 (C6orf165), transcript variant 1, mRNA.",,,,6,88230585-88230634,6q15a,+,NM_001031743.1,154313,C6orf165,-1.0493697067939012,5.96333385176878,-6.2673240057500195,2.959485096874516e-9,8.787975336637773e-9,9.913606168968174
BMP2,ILMN_1722718,"Homo sapiens bone morphogenetic protein 2 (BMP2), mRNA.",extracellular space [goid 5615] [evidence IEA],growth [goid 40007] [evidence IEA]; cell-cell signaling [goid 7267] [pmid 2315314] [evidence TAS]; cartilage development [goid 51216] [evidence IEA]; cell differentiation [goid 30154] [evidence IEA]; ossification [goid 1503] [evidence IEA],cytokine activity [goid 5125] [evidence IEA]; growth factor activity [goid 8083] [evidence IEA],20,6707486-6707535,20p12.3b,+,NM_001200.1,650,BMP2,-1.079817199103406,8.750075800187142,-6.239455957794751,3.4209456789971453e-9,1.0092344610052327e-8,9.771562036237208
CCDC60,ILMN_1722446,"Homo sapiens coiled-coil domain containing 60 (CCDC60), mRNA.",,,,12,118462957-118463006,12q24.23b-q24.23c,+,NM_178499.2,160777,CCDC60,-1.0162425767817478,5.760625233976487,-6.230703303700837,3.5799534568238e-9,1.0542789043881453e-8,9.727031057616236
C1orf173,ILMN_1751569,"Homo sapiens chromosome 1 open reading frame 173 (C1orf173), mRNA.",,,,1,74806841-74806890,1p31.1h,-,NM_001002912.2,127254,C1orf173,-1.0180892724956898,5.7621896997206115,-6.22772052856426,3.6357817859888026e-9,1.0697753231479994e-8,9.711864486124623
GZMK,ILMN_1710734,"Homo sapiens granzyme K (granzyme 3; tryptase II) (GZMK), mRNA.",cytoplasm [goid 5737] [evidence NR ],,serine-type endopeptidase activity [goid 4252] [evidence IEA],5,54365361-54365410,5q11.2d,+,NM_002104.2,3003,GZMK,-1.0426292462600228,8.231880957953408,-6.217688632211667,3.8298939487939445e-9,1.124574671668172e-8,9.66088847065364
LOC387882,ILMN_1716382,"Homo sapiens hypothetical protein (LOC387882), mRNA.",,,,12,104288777-104288826,12q23.3b,+,NM_207376.1,387882,LOC387882,-1.2037697600747954,8.238844197838269,-6.214438869668544,3.894930707158948e-9,1.143000492649402e-8,9.644386186312682
S100A9,ILMN_1750974,"Homo sapiens S100 calcium binding protein A9 (calgranulin B) (S100A9), mRNA.",extracellular space [goid 5615] [evidence NR ],cell-cell signaling [goid 7267] [pmid 3313057] [evidence TAS]; inflammatory response [goid 6954] [pmid 3313057] [evidence TAS],calcium ion binding [goid 5509] [pmid 2149559] [evidence TAS]; signal transducer activity [goid 4871] [pmid 3313057] [evidence TAS],1,151599776-151599825,1q21.3c,+,NM_002965.2,6280,S100A9,-1.1655527193659783,11.959680617733728,-6.083055853861426,7.660775981874193e-9,2.199408894322555e-8,8.98179470146212
NELL2,ILMN_1725417,"Homo sapiens NEL-like 2 (chicken) (NELL2), mRNA.",extracellular region [goid 5576] [evidence NAS],cell adhesion [goid 7155] [evidence NAS],structural molecule activity [goid 5198] [evidence NAS]; calcium ion binding [goid 5509] [evidence NAS]; protein binding [goid 5515] [pmid 16713569] [evidence IPI],12,43188674-43188723,12q12g,-,NM_006159.1,4753,NELL2,-1.0537821183318457,6.842238647941676,-6.049042428255413,9.114270549736018e-9,2.6002898211766467e-8,8.811729372201585
LRRC50,ILMN_1776967,"Homo sapiens leucine rich repeat containing 50 (LRRC50), mRNA.",,,transferase activity [goid 16740] [evidence IEA],16,82767369-82767406:82768836-82768847,16q24.1a,+,NM_178452.3,123872,LRRC50,-1.048578202202707,6.217653236792686,-6.04787790568556,9.168549267876973e-9,2.6150297042292585e-8,8.805917661523774
SPAG6,ILMN_1772458,"Homo sapiens sperm associated antigen 6 (SPAG6), transcript variant 1, mRNA.",flagellum [goid 19861] [evidence IEA]; cytoskeleton [goid 5856] [evidence IEA]; axoneme [goid 5930] [pmid 10493827] [evidence TAS]; microtubule [goid 5874] [evidence IEA],,binding [goid 5488] [evidence IEA],10,22739969-22740018,10p12.31a,+,NM_012443.2,9576,SPAG6,-1.3195718665198601,6.1699057661781,-6.03581510831172,9.74978287134665e-9,2.771720029694569e-8,8.745758969065148
HLA-DRB4,ILMN_1752592,"Homo sapiens major histocompatibility complex, class II, DR beta 4 (HLA-DRB4), mRNA.",integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA]; integral to plasma membrane [goid 5887] [evidence NR ]; membrane [goid 16020] [evidence IEA],immune response [goid 6955] [evidence IEA]; pathogenesis [goid 9405] [pmid 10425186] [evidence TAS]; signal transduction [goid 7165] [pmid 8775462] [evidence NAS]; immune response [goid 6955] [evidence IEA]; pathogenesis [goid 9405] [pmid 10425186] [evidence TAS]; signal transduction [goid 7165] [pmid 8775462] [evidence NAS],MHC class II receptor activity [goid 45012] [pmid 10425186] [evidence TAS]; MHC class II receptor activity [goid 45012] [pmid 10425186] [evidence TAS],,,,,NM_021983.4,3126,HLA-DRB4,-1.6035642926902227,10.923427613375567,-5.981545475449515,1.284387306290624e-8,3.617401636298255e-8,8.47606974850599
IRX2,ILMN_1782412,"Homo sapiens iroquois homeobox protein 2 (IRX2), mRNA.",nucleus [goid 5634] [evidence IEA],"regulation of transcription, DNA-dependent [goid 6355] [evidence IEA]",transcription factor activity [goid 3700] [evidence IEA],5,2800055-2800104,5p15.33b,-,NM_033267.2,153572,IRX2,-1.1314211731245294,9.205084535397887,-5.981263567472049,1.2862225154003099e-8,3.621550814541148e-8,8.474672947524615
ZMYND10,ILMN_2125763,"Homo sapiens zinc finger, MYND-type containing 10 (ZMYND10), mRNA.",cytoplasm [goid 5737] [pmid 11256614] [evidence IDA],,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI],3,50353767-50353816,3p21.31b,-,NM_015896.2,51364,ZMYND10,-1.3544709639188337,6.444015477087576,-5.9510459380278675,1.498589382853932e-8,4.1958825037981354e-8,8.325198725361341
LRRC46,ILMN_1768818,"Homo sapiens leucine rich repeat containing 46 (LRRC46), mRNA.",,,transferase activity [goid 16740] [evidence IEA],17,43269334-43269383,17q21.32b,+,NM_033413.2,90506,LRRC46,-1.0430167541025055,6.213502475692204,-5.944140612029016,1.5517446245014586e-8,4.3374275561644565e-8,8.29111019191865
TFF1,ILMN_1722489,"Homo sapiens trefoil factor 1 (TFF1), mRNA.",,carbohydrate metabolism [goid 5975] [pmid 2303034] [evidence TAS]; defense response [goid 6952] [evidence NR ]; digestion [goid 7586] [pmid 9043862] [evidence NAS],growth factor activity [goid 8083] [evidence IEA],21,42656492-42656541,21q22.3b,-,NM_003225.2,7031,TFF1,1.514218895166124,5.688604235938813,5.932774230315457,1.643289450652585e-8,4.581791433759325e-8,8.235055722132065
C6orf206,ILMN_1659985,"Homo sapiens chromosome 6 open reading frame 206 (C6orf206), mRNA.",,,,6,43732353-43732402,6p21.1c,+,NM_152732.2,221421,C6orf206,-1.1721280603317474,5.995301408430636,-5.926130187721532,1.6992293776836635e-8,4.732486273482007e-8,8.202322453726152
HLA-DRB6,ILMN_2066060,"Homo sapiens major histocompatibility complex, class II, DR beta 6 (pseudogene) (HLA-DRB6) on chromosome 6.",,,,6,32628571-32628620,6p21.32b,-,NR_001298.1,3128,HLA-DRB6,-1.2502155681873468,11.34146035400959,-5.899134885883966,1.9463422986237428e-8,5.395181035032397e-8,8.069571878695447
MT1G,ILMN_1715401,"Homo sapiens metallothionein 1G (MT1G), mRNA.",,,zinc ion binding [goid 8270] [evidence IEA]; metal ion binding [goid 46872] [evidence IEA]; copper ion binding [goid 5507] [evidence IEA]; cadmium ion binding [goid 46870] [evidence IEA],16,55258248-55258291:55258292-55258297,16q13b,-,NM_005950.1,4495,MT1G,-1.4260932896579543,9.407498438527615,-5.892034044210509,2.0169854909482497e-8,5.583265869243578e-8,8.034719333595481
CRKRS,ILMN_1707448,"Homo sapiens Cdc2-related kinase, arginine/serine-rich (CRKRS), mRNA.",nucleus [goid 5634] [pmid 11683387] [evidence IDA],,RNA polymerase II transcription factor activity [goid 3702] [pmid 11683387] [evidence NAS]; ATP binding [goid 5524] [evidence IEA]; transferase activity [goid 16740] [evidence IEA]; protein serine/threonine kinase activity [goid 4674] [evidence IEA]; nucleotide binding [goid 166] [evidence IEA],17,34941769-34941818,17q12c,+,NM_016507.1,51755,CRKRS,1.028924368783409,9.103911542656718,5.87910786188687,2.1520852488718827e-8,5.9481864427999216e-8,7.9713456531526194
DNAI1,ILMN_1745880,"Homo sapiens dynein, axonemal, intermediate polypeptide 1 (DNAI1), mRNA.",cytoskeleton [goid 5856] [pmid 10577904] [evidence TAS]; microtubule [goid 5874] [evidence IEA]; dynein complex [goid 30286] [evidence IEA]; cilium [goid 5929] [pmid 10577904] [evidence TAS],,motor activity [goid 3774] [pmid 10577904] [evidence TAS],9,34510899-34510948,9p13.3c,+,NM_012144.2,27019,DNAI1,-1.1467769885910197,6.113527970965177,-5.863121379773952,2.331471717517683e-8,6.4315574416233e-8,7.893095135394292
FGB,ILMN_1678049,"Homo sapiens fibrinogen beta chain (FGB), mRNA.",soluble fraction [goid 5625] [pmid 6688356] [evidence TAS]; fibrinogen complex [goid 5577] [pmid 6688356] [evidence TAS],blood coagulation [goid 7596] [evidence IEA]; positive regulation of cell proliferation [goid 8284] [evidence NR ],,4,155711083-155711132,4q32.1a,+,NM_005141.2,2244,FGB,1.2431574424463383,5.644436779468162,5.8485735207588885,2.5073879629644732e-8,6.898764901401702e-8,7.822008802913686
CHST9,ILMN_1700547,"Homo sapiens carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 (CHST9), mRNA.",intrinsic to Golgi membrane [goid 31228] [evidence ISS]; integral to membrane [goid 16021] [pmid 11139592] [evidence NAS]; Golgi stack [goid 5795] [evidence IEA],sulfur metabolism [goid 6790] [pmid 11445554] [evidence IDA]; carbohydrate metabolism [goid 5975] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; N-acetylgalactosamine 4-O-sulfotransferase activity [goid 1537] [pmid 11445554] [evidence IDA],18,22749905-22749954,18q11.2e,-,NM_031422.1,83539,CHST9,-1.2936460450453406,5.944201825496563,-5.7918886271215335,3.325491513841962e-8,9.041504852418804e-8,7.546144405338277
CLDN2,ILMN_1795190,"Homo sapiens claudin 2 (CLDN2), mRNA.",tight junction [goid 5923] [evidence ISS]; membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence ISS],calcium-independent cell-cell adhesion [goid 16338] [evidence ISS],structural molecule activity [goid 5198] [evidence IEA],X,106060454-106060503,Xq22.3b,+,NM_020384.2,9075,CLDN2,1.405210573402072,6.365983912013568,5.786141978567974,3.4217424267649855e-08,9.285531327100751e-8,7.518277571828202
VSIG1,ILMN_1806198,"Homo sapiens V-set and immunoglobulin domain containing 1 (VSIG1), mRNA.",membrane [goid 16020] [evidence IEA],,,X,107208870-107208919,Xq22.3c,+,NM_182607.3,340547,VSIG1,1.2143189196031763,5.7922872426993175,5.750930795640908,4.073867932141632e-8,1.0971860221603147e-7,7.347934889542596
LOC389816,ILMN_1680757,"PREDICTED: Homo sapiens similar to CDNA sequence BC004853 (LOC389816), mRNA.",,,,,,9q34.3e,,XM_939320.1,389816,LOC389816,1.4347240462103645,7.803356488782263,5.729126136901406,4.5370925555493255e-8,1.2168652527001462e-7,7.2427997113204885
DPP4,ILMN_1692535,"Homo sapiens dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2) (DPP4), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [pmid 9710254] [evidence TAS],prolyl oligopeptidase activity [goid 4287] [evidence IEA]; aminopeptidase activity [goid 4177] [evidence IEA]; dipeptidyl-peptidase IV activity [goid 4274] [pmid 9710254] [evidence TAS],2,162557231-162557280,2q24.2d,-,NM_001935.3,1803,DPP4,1.0755346077616847,7.691443675073046,5.7133916127369915,4.902971403868038e-8,1.312707772629355e-7,7.167099981156383
SLC1A7,ILMN_1704629,"Homo sapiens solute carrier family 1 (glutamate transporter), member 7 (SLC1A7), mRNA.",membrane [goid 16020] [evidence IEA]; integral to membrane [goid 16021] [evidence NAS],transport [goid 6810] [evidence IEA]; dicarboxylic acid transport [goid 6835] [pmid 9108121] [evidence TAS],symporter activity [goid 15293] [evidence IEA]; sodium:dicarboxylate symporter activity [goid 17153] [evidence IEA]; L-glutamate transporter activity [goid 5313] [pmid 9108121] [evidence TAS],1,53325531-53325580,1p32.3c,-,NM_006671.3,6512,SLC1A7,1.4901713497539273,6.676180238992894,5.691346363225791,5.46453052692929e-8,1.4574023831351805e-7,7.06127563414087
S100P,ILMN_1801216,"Homo sapiens S100 calcium binding protein P (S100P), mRNA.",nucleus [goid 5634] [pmid 15632002] [evidence IDA]; cytoplasm [goid 5737] [pmid 15632002] [evidence TAS],,magnesium ion binding [goid 287] [pmid 15632002] [evidence TAS]; calcium ion binding [goid 5509] [pmid 1633809] [evidence TAS]; calcium-dependent protein binding [goid 48306] [pmid 15632002] [evidence IPI],4,6749666-6749670:6749671-6749715,4p16.1f,+,NM_005980.2,6286,S100P,1.859718341621404,9.487077278684714,5.638420493508079,7.081882823699563e-8,1.8673472790798742e-7,6.808348521849368
HAS1,ILMN_1754716,"Homo sapiens hyaluronan synthase 1 (HAS1), mRNA.",integral to plasma membrane [goid 5887] [pmid 9169154] [evidence TAS]; membrane [goid 16020] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [evidence NR ],substrate-bound cell migration [goid 6929] [evidence NR ]; cell adhesion [goid 7155] [pmid 8798544] [evidence TAS]; glycosaminoglycan biosynthesis [goid 6024] [pmid 8798544] [evidence TAS],"transferase activity, transferring glycosyl groups [goid 16757] [evidence IEA]; hyaluronan synthase activity [goid 50501] [evidence IEA]",19,56908379-56908428,19q13.33e,-,NM_001523.1,3036,HAS1,-1.1682448102089928,5.545498795110823,-5.615460755469072,7.921150227778931e-8,2.077964779826942e-7,6.699127612173184
LOC440585,ILMN_1777170,"PREDICTED: Homo sapiens hypothetical LOC440585, transcript variant 3 (LOC440585), mRNA.",,,,,,1p34.2a,,XM_942137.1,440585,LOC440585,-1.784220123483907,8.80503059783963,-5.541672002900044,1.1330705673584947e-7,2.934689438408901e-7,6.350183742499885
HLA-DQB1,ILMN_1661266,"Homo sapiens major histocompatibility complex, class II, DQ beta 1 (HLA-DQB1), mRNA.",integral to membrane [goid 16021] [evidence IEA]; membrane [goid 16020] [evidence NAS],immune response [goid 6955] [evidence NAS],MHC class II receptor activity [goid 45012] [evidence NAS],6,32736001-32736004:32737102-32737147,6p21.32b,-,NM_002123.2,3119,HLA-DQB1,-1.3023716809621142,10.665198362088658,-5.481911063899229,1.5108094013821624e-7,3.8620511693949536e-7,6.069918739199947
HP,ILMN_1812433,"Homo sapiens haptoglobin (HP), mRNA.",extracellular region [goid 5576] [pmid 14718574] [evidence NAS],defense response [goid 6952] [pmid 7036344] [evidence TAS]; iron ion homeostasis [goid 6879] [evidence NAS],serine-type endopeptidase activity [goid 4252] [evidence IEA]; hemoglobin binding [goid 30492] [evidence IEA],16,70652001-70652050,16q22.3a,+,NM_005143.2,3240,HP,-1.6062637781547426,8.622069192555045,-5.481298304109917,1.515257337706849e-7,3.8721422770286743e-7,6.067055986122842
FLJ23152,ILMN_1696243,"PREDICTED: Homo sapiens hypothetical gene supported by AK026805 (FLJ23152), mRNA.",,,,6,17239415-17239464,6p22.3e,+,XM_376469.2,401236,FLJ23152,-1.4245534953438224,7.4635209317158955,-5.435994336765207,1.8820259406245816e-7,4.7641162727753833e-7,5.856020122116922
MUC5AC,ILMN_1748303,"PREDICTED: Homo sapiens mucin 5, subtypes A and C, tracheobronchial/gastric (MUC5AC), mRNA.",,,,11,1178751-1178800,11p15.5c,+,XM_495860.2,4586,MUC5AC,1.7074432529261756,6.540803378404871,5.423567169706234,1.9969200872546804e-7,5.044744584064602e-7,5.7983461817482045
GSTA2,ILMN_1655613,"Homo sapiens glutathione S-transferase A2 (GSTA2), mRNA.",,metabolism [goid 8152] [evidence IEA]; metabolism [goid 8152] [evidence IEA],transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 3138230] [evidence TAS]; transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 3138230] [evidence TAS],6,52729056-52729066:52730618-52730656,6p12.1d,-,NM_000846.3,2939,GSTA2,-1.3907236390244346,6.630045929297205,-5.419366379169111,2.0372831685942035e-7,5.142167482935893e-7,5.778871465604414
C10orf81,ILMN_1757099,"Homo sapiens chromosome 10 open reading frame 81 (C10orf81), mRNA.",,,protein binding [goid 5515] [evidence IEA],10,115532029-115532078,10q25.3a,+,NM_024889.3,79949,C10orf81,1.2698712711519002,6.787600789703792,5.387995616253221,2.3649091383443847e-7,5.932435060179845e-7,5.633773728642531
GRP,ILMN_1777199,"Homo sapiens gastrin-releasing peptide (GRP), transcript variant 1, mRNA.",extracellular space [goid 5615] [pmid 8756537] [evidence IDA]; soluble fraction [goid 5625] [evidence NR ],neuropeptide signaling pathway [goid 7218] [pmid 8756537] [evidence IDA]; signal transduction [goid 7165] [pmid 3027901] [evidence NAS],neuropeptide hormone activity [goid 5184] [pmid 8756537] [evidence IDA]; growth factor activity [goid 8083] [evidence NR ],18,55043872-55043921,18q21.32a,+,NM_002091.3,2922,GRP,-1.0608824404163748,6.648435072167595,-5.306734150293813,3.4708596328272444e-7,8.599994988682044e-7,5.2606948836353595
CCL8,ILMN_1772964,"Homo sapiens chemokine (C-C motif) ligand 8 (CCL8), mRNA.",extracellular region [goid 5576] [evidence IEA]; membrane [goid 16020] [evidence IEA]; extracellular space [goid 5615] [evidence IEA],response to virus [goid 9615] [pmid 9468473] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 10734056] [evidence TAS]; chemotaxis [goid 6935] [pmid 9468473] [evidence TAS]; inflammatory response [goid 6954] [evidence IEA]; signal transduction [goid 7165] [pmid 9119400] [evidence TAS]; calcium ion transport [goid 6816] [pmid 10734056] [evidence TAS]; exocytosis [goid 6887] [pmid 10734056] [evidence TAS],signal transducer activity [goid 4871] [pmid 10734056] [evidence TAS]; heparin binding [goid 8201] [evidence IEA]; chemokine activity [goid 8009] [pmid 9468473] [evidence TAS],17,29672323-29672372,17q12a,+,NM_005623.2,6355,CCL8,-1.148476502235141,8.836913134950487,-5.250367240275665,4.518989376052683e-7,1.1102153663563614e-6,5.0042868281710895
FBXO15,ILMN_1755281,"Homo sapiens F-box protein 15 (FBXO15), mRNA.",,ubiquitin cycle [goid 6512] [evidence IEA],,18,69891752-69891801,18q22.3c,-,NM_152676.1,201456,FBXO15,-1.0298994131589332,7.202085630372948,-5.241766817828761,4.703886714392664e-7,1.1540817336795635e-6,4.965337054550496
TNNC2,ILMN_1693428,"Homo sapiens troponin C type 2 (fast) (TNNC2), mRNA.",troponin complex [goid 5861] [evidence NR ],regulation of muscle contraction [goid 6937] [pmid 2373703] [evidence TAS],calcium ion binding [goid 5509] [evidence IEA],20,43886352-43886401,20q13.12b,-,NM_003279.2,7125,TNNC2,1.0353967309465615,6.322601161417454,5.20059386138936,5.695995387525428e-7,1.3882991316068797e-6,4.779509908595045
GDF15,ILMN_2188862,"Homo sapiens growth differentiation factor 15 (GDF15), mRNA.",extracellular space [goid 5615] [evidence IEA]; extracellular region [goid 5576] [pmid 9326641] [evidence TAS],transforming growth factor beta receptor signaling pathway [goid 7179] [pmid 9348093] [evidence TAS]; signal transduction [goid 7165] [pmid 9326641] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 9326641] [evidence TAS],growth factor activity [goid 8083] [evidence IEA]; cytokine activity [goid 5125] [pmid 9326641] [evidence TAS],19,18360697-18360745:18360746-18360746,19p13.11c,+,NM_004864.1,9518,GDF15,1.039323269964969,10.36770700188566,5.132169027842887,7.81146362358262e-7,1.8859872593295651e-6,4.473036653819507
LOC652358,ILMN_1782937,"PREDICTED: Homo sapiens similar to Glutathione S-transferase A1 (GTH1) (HA subunit 1) (GST-epsilon) (GSTA1-1) (GST class-alpha) (LOC652358), mRNA.",,,,,,,,XM_941789.1,652358,LOC652358,-1.4123896189508267,7.2741915171388065,-5.007016035656625,1.3818593456035428e-6,3.261559724765328e-6,3.920179888131969
MSLN,ILMN_2353161,"Homo sapiens mesothelin (MSLN), transcript variant 2, mRNA.",membrane [goid 16020] [pmid 8552591] [evidence NAS],cell adhesion [goid 7155] [pmid 8552591] [evidence NAS],peptide antigen binding [goid 42605] [pmid 14676194] [evidence IPI]; GPI anchor binding [goid 48503] [evidence IEA]; protein binding [goid 5515] [evidence IEA],16,758810-758859,16p13.3f,+,NM_013404.3,10232,MSLN,-1.36327586896744,11.81750153361414,-4.9892795229658615,1.4970588133491381e-6,3.522657031340651e-6,3.8426453754612684
FNDC1,ILMN_1734653,"Homo sapiens fibronectin type III domain containing 1 (FNDC1), mRNA.",,,,6,159612580-159612629,6q25.3e,+,NM_032532.1,84624,FNDC1,1.0296099634133453,7.363503089747876,4.977986413382686,1.5752053982952825e-6,3.698710199400541e-6,3.793384411870308
GSTA1,ILMN_1701831,"Homo sapiens glutathione S-transferase A1 (GSTA1), mRNA.",cytoplasm [goid 5737] [evidence NAS]; cytoplasm [goid 5737] [evidence NAS],glutathione metabolism [goid 6749] [pmid 11851347] [evidence IDA]; metabolism [goid 8152] [pmid 3800996] [evidence IC ]; glutathione metabolism [goid 6749] [pmid 11851347] [evidence IDA]; metabolism [goid 8152] [pmid 3800996] [evidence IC ],transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 1731620] [evidence NAS]; transferase activity [goid 16740] [evidence IEA]; glutathione transferase activity [goid 4364] [pmid 1731620] [evidence NAS],6,52770382-52770394:52771938-52771974,6p12.1d,-,NM_145740.2,2938,GSTA1,-1.3154488599889884,7.191561366893878,-4.966109697352625,1.6616553807272697e-6,3.894845461292316e-6,3.741667298609279
ANXA10,ILMN_1699421,"Homo sapiens annexin A10 (ANXA10), mRNA.",,,calcium-dependent phospholipid binding [goid 5544] [evidence IEA]; calcium ion binding [goid 5509] [pmid 10458909] [evidence TAS],4,169345121-169345160:169345161-169345170,4q32.3e,+,NM_007193.3,11199,ANXA10,1.0028416330100747,5.403799802916325,4.858431722661553,2.68652499135585e-6,6.179100129560621e-6,3.2770053785746676
HMGCS2,ILMN_1815203,"Homo sapiens 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial) (HMGCS2), mRNA.",mitochondrion [goid 5739] [pmid 7851882] [evidence TAS],cholesterol biosynthesis [goid 6695] [evidence IEA]; acetyl-CoA metabolism [goid 6084] [evidence IEA],hydroxymethylglutaryl-CoA synthase activity [goid 4421] [evidence IEA]; transferase activity [goid 16740] [evidence IEA],1,120092776-120092825,1p12a,-,NM_005518.2,3158,HMGCS2,-1.2706670143515382,6.517609437347952,-4.831740260014012,3.0229281313915706e-6,6.926562763729105e-6,3.163009789219755
IL8,ILMN_1666733,"Homo sapiens interleukin 8 (IL8), mRNA.",extracellular space [goid 5615] [pmid 10823949] [evidence TAS],G-protein coupled receptor protein signaling pathway [goid 7186] [pmid 8381837] [evidence TAS]; neutrophil chemotaxis [goid 30593] [pmid 11564821] [evidence IGI]; sensory perception [goid 7600] [evidence IEA]; induction of positive chemotaxis [goid 50930] [pmid 11564821] [evidence IGI]; negative regulation of cell proliferation [goid 8285] [pmid 9551928] [evidence TAS]; intracellular signaling cascade [goid 7242] [pmid 10734056] [evidence TAS]; regulation of retroviral genome replication [goid 45091] [pmid 11483765] [evidence IDA]; chemotaxis [goid 6935] [pmid 10620615] [evidence TAS]; cell-cell signaling [goid 7267] [pmid 10881932] [evidence IC ]; cell cycle arrest [goid 7050] [pmid 11564821] [evidence IDA]; neutrophil activation [goid 42119] [pmid 11483765] [evidence TAS]; calcium-mediated signaling [goid 19722] [pmid 11877327] [evidence TAS]; angiogenesis [goid 1525] [pmid 11483765] [evidence TAS]; regulation of cell adhesion [goid 30155] [pmid 2007144] [evidence IDA]; cell motility [goid 6928] [pmid 10820279] [evidence TAS],chemokine activity [goid 8009] [pmid 10881932] [evidence TAS]; protein binding [goid 5515] [pmid 10880251] [evidence IPI]; interleukin-8 receptor binding [goid 5153] [pmid 1840701] [evidence IPI],4,74827512-74827561,4q13.3d,+,NM_000584.2,3576,IL8,-1.1665854466743202,9.737250216180026,-4.801754212872835,3.449513437444776e-6,7.858562647039624e-6,3.03551063341793
CAPS,ILMN_1757660,"Homo sapiens calcyphosine (CAPS), transcript variant 2, mRNA.",,intracellular signaling cascade [goid 7242] [pmid 2540953] [evidence TAS],calcium ion binding [goid 5509] [pmid 2540953] [evidence TAS],19,5866751-5866800,19p13.3b,+,NM_080590.1,828,CAPS,-1.2490040480031652,8.70455986823333,-4.776061459786981,3.860860450276407e-6,8.75729462522734e-6,2.9267459279619654
DEFB1,ILMN_1686573,"Homo sapiens defensin, beta 1 (DEFB1), mRNA.",extracellular region [goid 5576] [evidence IEA],innate immune response [goid 45087] [pmid 12517831] [evidence NAS],,8,6722756-6722789:6722790-6722805,8p23.1f,-,NM_005218.3,1672,DEFB1,-1.1784355318372128,7.222887314924316,-4.650506172030526,6.655150842731535e-6,1.4782000228837982e-5,2.401665032434863
TFPI2,ILMN_2068104,"Homo sapiens tissue factor pathway inhibitor 2 (TFPI2), mRNA.",extracellular region [goid 5576] [evidence IEA]; extracellular matrix (sensu Metazoa) [goid 5578] [pmid 8914837] [evidence TAS],blood coagulation [goid 7596] [evidence IEA],extracellular matrix structural constituent [goid 5201] [pmid 8914837] [evidence TAS]; serine-type endopeptidase inhibitor activity [goid 4867] [evidence IEA],7,93354075-93354124,7q21.3a,-,NM_006528.2,7980,TFPI2,1.1461375813815415,6.220753415521224,4.630003923650797,7.267009284582103e-6,1.608566453876742e-5,2.31694671874995
CT45-3,ILMN_1757689,"Homo sapiens cancer/testis antigen CT45-3 (CT45-3), mRNA.",,,,X,134718990-134718992:134718993-134719039,Xq26.3b,+,NM_001017435.1,441519,CT45-3,-1.1370564350700372,5.573337572417994,-4.577272926436455,9.100314310180499e-6,1.99342115960249e-5,2.1003885497925197
TSGA2,ILMN_1684571,"Homo sapiens testis specific A2 homolog (mouse) (TSGA2), mRNA.",,meiosis [goid 7126] [evidence IEA],,21,42766047-42766049:42769077-42769123,21q22.3b,-,NM_080860.2,89765,TSGA2,-1.1539293015579695,7.369495744828456,-4.506299233808335,1.2283294426818708e-5,2.656909782613932e-5,1.8119668862461324
KRT17,ILMN_1666845,"Homo sapiens keratin 17 (KRT17), mRNA.",intermediate filament [goid 5882] [pmid 1281771] [evidence TAS],epidermis development [goid 8544] [pmid 7539673] [evidence TAS],structural molecule activity [goid 5198] [evidence IEA]; protein binding [goid 5515] [pmid 16189514] [evidence IPI]; structural constituent of cytoskeleton [goid 5200] [pmid 1281771] [evidence TAS],17,37029235-37029284,17q21.2b,-,NM_000422.1,3872,KRT17,1.234735701653836,8.410739081848199,4.3983854518114995,1.9257811972666304e-5,4.097737976700068e-5,1.3802311971105077
LOC138255,ILMN_1699537,"Homo sapiens chromosome 9 open reading frame 135 (C9orf135), mRNA.",,,,9,71662659-71662708,9q21.11b,+,NM_001010940.1,138255,LOC138255,-1.136089221702684,6.666637470721505,-4.284075469103612,3.0745961832755794e-5,6.420008394382988e-5,0.9319931908673347
PLUNC,ILMN_1774250,"Homo sapiens palate, lung and nasal epithelium carcinoma associated (PLUNC), transcript variant 1, mRNA.",extracellular region [goid 5576] [pmid 11425234] [evidence IDA],innate immune response [goid 45087] [pmid 11971875] [evidence NAS],lipid binding [goid 8289] [evidence IEA],20,31291794-31291843,20q11.21c,+,NM_016583.2,51297,PLUNC,1.388624295713262,6.544484810467277,3.5948473159323213,4.2580364178709557e-4,7.910380004527585e-4,-1.5634838193807123
PROM1,ILMN_1786720,"Homo sapiens prominin 1 (PROM1), mRNA.",integral to plasma membrane [goid 5887] [pmid 9389720] [evidence TAS]; membrane [goid 16020] [evidence IEA],visual perception [goid 7601] [evidence IEA],,4,15578982-15579031,4p15.32d,-,NM_006017.1,8842,PROM1,1.1440638872631954,7.914846901728101,3.4390718434704204,7.354119585467781e-4,0.0013299098397147448,-2.0760587256184166
HLA-DRB1,ILMN_1715169,"Homo sapiens major histocompatibility complex, class II, DR beta 1 (HLA-DRB1), mRNA.",membrane [goid 16020] [pmid 3129499] [evidence NAS]; integral to membrane [goid 16021] [evidence IEA],immune response [goid 6955] [pmid 3129499] [evidence NAS],MHC class II receptor activity [goid 45012] [pmid 3129499] [evidence NAS],6,32654825-32654845:32654846-32654859:32656002-32656016,6p21.32b,-,NM_002124.1,3123,HLA-DRB1,-1.233631354771374,9.058834971523956,-2.254072412904643,0.025478196909609018,0.037796972178205476,-5.302345287231274
